Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:white substance'
(id=13104460 ; fe=en:white substance ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=97174 creation date=2019-08-22 touchdate=2025-10-12 16:16:28.000)
≈ 5206 relations sortantes

  1. en:white substance -- r_associated #0: 121 / 1 -> anatomie
    n1=en:white substance | n2=anatomie | rel=r_associated | relid=0 | w=121
  2. en:white substance -- r_associated #0: 121 / 1 -> blanche
    n1=en:white substance | n2=blanche | rel=r_associated | relid=0 | w=121
  3. en:white substance -- r_associated #0: 121 / 1 -> matière
    n1=en:white substance | n2=matière | rel=r_associated | relid=0 | w=121
  4. en:white substance -- r_associated #0: 106 / 0.876 -> en:'ballooned' neurons with autofluorescent fine granular material
    n1=en:white substance | n2=en:'ballooned' neurons with autofluorescent fine granular material | rel=r_associated | relid=0 | w=106
  5. en:white substance -- r_associated #0: 106 / 0.876 -> en:'double contour' convolutional calcification on ct scan
    n1=en:white substance | n2=en:'double contour' convolutional calcification on ct scan | rel=r_associated | relid=0 | w=106
  6. en:white substance -- r_associated #0: 106 / 0.876 -> en:'dragonfly-like' pattern
    n1=en:white substance | n2=en:'dragonfly-like' pattern | rel=r_associated | relid=0 | w=106
  7. en:white substance -- r_associated #0: 106 / 0.876 -> en:'dragonfly' pattern on imaging
    n1=en:white substance | n2=en:'dragonfly' pattern on imaging | rel=r_associated | relid=0 | w=106
  8. en:white substance -- r_associated #0: 106 / 0.876 -> en:'spheroid' inclusions in axons
    n1=en:white substance | n2=en:'spheroid' inclusions in axons | rel=r_associated | relid=0 | w=106
  9. en:white substance -- r_associated #0: 106 / 0.876 -> en:3-4 hz slow sharp waves seen on eeg
    n1=en:white substance | n2=en:3-4 hz slow sharp waves seen on eeg | rel=r_associated | relid=0 | w=106
  10. en:white substance -- r_associated #0: 106 / 0.876 -> en:a subset of patients develop frontotemporal dementia
    n1=en:white substance | n2=en:a subset of patients develop frontotemporal dementia | rel=r_associated | relid=0 | w=106
  11. en:white substance -- r_associated #0: 106 / 0.876 -> en:a subset of patients have neurologic abnormalities
    n1=en:white substance | n2=en:a subset of patients have neurologic abnormalities | rel=r_associated | relid=0 | w=106
  12. en:white substance -- r_associated #0: 106 / 0.876 -> en:abducens nerve palsy (cn vi)
    n1=en:white substance | n2=en:abducens nerve palsy (cn vi) | rel=r_associated | relid=0 | w=106
  13. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal 'cap' on the dorsal pons extending into the fourth ventricle
    n1=en:white substance | n2=en:abnormal 'cap' on the dorsal pons extending into the fourth ventricle | rel=r_associated | relid=0 | w=106
  14. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal 'hobby horse' ataxic gait
    n1=en:white substance | n2=en:abnormal 'hobby horse' ataxic gait | rel=r_associated | relid=0 | w=106
  15. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal behavior
    n1=en:white substance | n2=en:abnormal behavior | rel=r_associated | relid=0 | w=106
  16. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal cell orientation
    n1=en:white substance | n2=en:abnormal cell orientation | rel=r_associated | relid=0 | w=106
  17. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal coordination
    n1=en:white substance | n2=en:abnormal coordination | rel=r_associated | relid=0 | w=106
  18. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal cortical eeg discharges triggered by intermittent light
    n1=en:white substance | n2=en:abnormal cortical eeg discharges triggered by intermittent light | rel=r_associated | relid=0 | w=106
  19. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal cortical lamination
    n1=en:white substance | n2=en:abnormal cortical lamination | rel=r_associated | relid=0 | w=106
  20. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal cortical layering
    n1=en:white substance | n2=en:abnormal cortical layering | rel=r_associated | relid=0 | w=106
  21. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal corticospinal tract decussation
    n1=en:white substance | n2=en:abnormal corticospinal tract decussation | rel=r_associated | relid=0 | w=106
  22. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal eeg (abnormal slowing of background activity)
    n1=en:white substance | n2=en:abnormal eeg (abnormal slowing of background activity) | rel=r_associated | relid=0 | w=106
  23. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal eeg (poor alpha rhythms)
    n1=en:white substance | n2=en:abnormal eeg (poor alpha rhythms) | rel=r_associated | relid=0 | w=106
  24. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal eeg activity during sleep
    n1=en:white substance | n2=en:abnormal eeg activity during sleep | rel=r_associated | relid=0 | w=106
  25. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal eeg with epileptiform changes
    n1=en:white substance | n2=en:abnormal eeg with epileptiform changes | rel=r_associated | relid=0 | w=106
  26. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on ct scan
    n1=en:white substance | n2=en:abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on ct scan | rel=r_associated | relid=0 | w=106
  27. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal gyri
    n1=en:white substance | n2=en:abnormal gyri | rel=r_associated | relid=0 | w=106
  28. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal gyri (in 1 of 2 patients)
    n1=en:white substance | n2=en:abnormal gyri (in 1 of 2 patients) | rel=r_associated | relid=0 | w=106
  29. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal interictal eeg (in some patients)
    n1=en:white substance | n2=en:abnormal interictal eeg (in some patients) | rel=r_associated | relid=0 | w=106
  30. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal involuntary movement
    n1=en:white substance | n2=en:abnormal involuntary movement | rel=r_associated | relid=0 | w=106
  31. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal lipid peak on brain mrs
    n1=en:white substance | n2=en:abnormal lipid peak on brain mrs | rel=r_associated | relid=0 | w=106
  32. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal lower motor neuron morphology
    n1=en:white substance | n2=en:abnormal lower motor neuron morphology | rel=r_associated | relid=0 | w=106
  33. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal ocular motility
    n1=en:white substance | n2=en:abnormal ocular motility | rel=r_associated | relid=0 | w=106
  34. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal posture
    n1=en:white substance | n2=en:abnormal posture | rel=r_associated | relid=0 | w=106
  35. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal primitive reflexes
    n1=en:white substance | n2=en:abnormal primitive reflexes | rel=r_associated | relid=0 | w=106
  36. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal purkinje cells
    n1=en:white substance | n2=en:abnormal purkinje cells | rel=r_associated | relid=0 | w=106
  37. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal rapid eye movement sleep
    n1=en:white substance | n2=en:abnormal rapid eye movement sleep | rel=r_associated | relid=0 | w=106
  38. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal septum pellucidum
    n1=en:white substance | n2=en:abnormal septum pellucidum | rel=r_associated | relid=0 | w=106
  39. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal sleep-wake cycles
    n1=en:white substance | n2=en:abnormal sleep-wake cycles | rel=r_associated | relid=0 | w=106
  40. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal visual evoked potential
    n1=en:white substance | n2=en:abnormal visual evoked potential | rel=r_associated | relid=0 | w=106
  41. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal visual sensitivity of the brain in reaction to intermittent photic stimulation
    n1=en:white substance | n2=en:abnormal visual sensitivity of the brain in reaction to intermittent photic stimulation | rel=r_associated | relid=0 | w=106
  42. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormal white matter signals, in the basal ganglia or cerebellum seen on brain mri
    n1=en:white substance | n2=en:abnormal white matter signals, in the basal ganglia or cerebellum seen on brain mri | rel=r_associated | relid=0 | w=106
  43. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormality of the corpus callosum
    n1=en:white substance | n2=en:abnormality of the corpus callosum | rel=r_associated | relid=0 | w=106
  44. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormality of the posterior cranial fossa
    n1=en:white substance | n2=en:abnormality of the posterior cranial fossa | rel=r_associated | relid=0 | w=106
  45. en:white substance -- r_associated #0: 106 / 0.876 -> en:abnormally marked pontobulbar sulcus
    n1=en:white substance | n2=en:abnormally marked pontobulbar sulcus | rel=r_associated | relid=0 | w=106
  46. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of anterior pituitary
    n1=en:white substance | n2=en:absence of anterior pituitary | rel=r_associated | relid=0 | w=106
  47. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of balloon cells (in type iia)
    n1=en:white substance | n2=en:absence of balloon cells (in type iia) | rel=r_associated | relid=0 | w=106
  48. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of language development
    n1=en:white substance | n2=en:absence of language development | rel=r_associated | relid=0 | w=106
  49. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of lower motor neuron involvement
    n1=en:white substance | n2=en:absence of lower motor neuron involvement | rel=r_associated | relid=0 | w=106
  50. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of myelin in the posterior column of the spinal cord (1 patient)
    n1=en:white substance | n2=en:absence of myelin in the posterior column of the spinal cord (1 patient) | rel=r_associated | relid=0 | w=106
  51. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of neuropathologic findings in the brainstem and anterior horn cells
    n1=en:white substance | n2=en:absence of neuropathologic findings in the brainstem and anterior horn cells | rel=r_associated | relid=0 | w=106
  52. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of olfactory bulbs
    n1=en:white substance | n2=en:absence of olfactory bulbs | rel=r_associated | relid=0 | w=106
  53. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of primitive reflexes
    n1=en:white substance | n2=en:absence of primitive reflexes | rel=r_associated | relid=0 | w=106
  54. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of spontaneous movements
    n1=en:white substance | n2=en:absence of spontaneous movements | rel=r_associated | relid=0 | w=106
  55. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of the cerebellar vermis
    n1=en:white substance | n2=en:absence of the cerebellar vermis | rel=r_associated | relid=0 | w=106
  56. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of the inferior olives
    n1=en:white substance | n2=en:absence of the inferior olives | rel=r_associated | relid=0 | w=106
  57. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of the olfactory bulbs and tracts
    n1=en:white substance | n2=en:absence of the olfactory bulbs and tracts | rel=r_associated | relid=0 | w=106
  58. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence of transverse pontine fibers
    n1=en:white substance | n2=en:absence of transverse pontine fibers | rel=r_associated | relid=0 | w=106
  59. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence or atrophy of the putamen
    n1=en:white substance | n2=en:absence or atrophy of the putamen | rel=r_associated | relid=0 | w=106
  60. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence or hypoplasia of the anterior limb of the internal capsule
    n1=en:white substance | n2=en:absence or hypoplasia of the anterior limb of the internal capsule | rel=r_associated | relid=0 | w=106
  61. en:white substance -- r_associated #0: 106 / 0.876 -> en:absence seizures (stage 2 and 3)
    n1=en:white substance | n2=en:absence seizures (stage 2 and 3) | rel=r_associated | relid=0 | w=106
  62. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent corpus callosum (variable)
    n1=en:white substance | n2=en:absent corpus callosum (variable) | rel=r_associated | relid=0 | w=106
  63. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent cortical responses of somatosensory evoked potentials
    n1=en:white substance | n2=en:absent cortical responses of somatosensory evoked potentials | rel=r_associated | relid=0 | w=106
  64. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent olfactory bulbs
    n1=en:white substance | n2=en:absent olfactory bulbs | rel=r_associated | relid=0 | w=106
  65. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent olfactory tract or bulbs
    n1=en:white substance | n2=en:absent olfactory tract or bulbs | rel=r_associated | relid=0 | w=106
  66. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent olfactory tracts and bulbs
    n1=en:white substance | n2=en:absent olfactory tracts and bulbs | rel=r_associated | relid=0 | w=106
  67. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent optic nerves, chiasm, and tracts
    n1=en:white substance | n2=en:absent optic nerves, chiasm, and tracts | rel=r_associated | relid=0 | w=106
  68. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent or delayed psychomotor development, severe
    n1=en:white substance | n2=en:absent or delayed psychomotor development, severe | rel=r_associated | relid=0 | w=106
  69. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent or delayed speech development
    n1=en:white substance | n2=en:absent or delayed speech development | rel=r_associated | relid=0 | w=106
  70. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent or immature dentate nuclei
    n1=en:white substance | n2=en:absent or immature dentate nuclei | rel=r_associated | relid=0 | w=106
  71. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent or limited speech development
    n1=en:white substance | n2=en:absent or limited speech development | rel=r_associated | relid=0 | w=106
  72. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent or poor expressive speech
    n1=en:white substance | n2=en:absent or poor expressive speech | rel=r_associated | relid=0 | w=106
  73. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent pituitary
    n1=en:white substance | n2=en:absent pituitary | rel=r_associated | relid=0 | w=106
  74. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent primitive reflexes
    n1=en:white substance | n2=en:absent primitive reflexes | rel=r_associated | relid=0 | w=106
  75. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent rem sleep
    n1=en:white substance | n2=en:absent rem sleep | rel=r_associated | relid=0 | w=106
  76. en:white substance -- r_associated #0: 106 / 0.876 -> en:absent speech
    n1=en:white substance | n2=en:absent speech | rel=r_associated | relid=0 | w=106
  77. en:white substance -- r_associated #0: 106 / 0.876 -> en:accumulation of autofluorescent material in neurons
    n1=en:white substance | n2=en:accumulation of autofluorescent material in neurons | rel=r_associated | relid=0 | w=106
  78. en:white substance -- r_associated #0: 106 / 0.876 -> en:action and postural tremor
    n1=en:white substance | n2=en:action and postural tremor | rel=r_associated | relid=0 | w=106
  79. en:white substance -- r_associated #0: 106 / 0.876 -> en:action dystonia
    n1=en:white substance | n2=en:action dystonia | rel=r_associated | relid=0 | w=106
  80. en:white substance -- r_associated #0: 106 / 0.876 -> en:action myoclonus
    n1=en:white substance | n2=en:action myoclonus | rel=r_associated | relid=0 | w=106
  81. en:white substance -- r_associated #0: 106 / 0.876 -> en:action myoclonus (triggered by voluntary movements)
    n1=en:white substance | n2=en:action myoclonus (triggered by voluntary movements) | rel=r_associated | relid=0 | w=106
  82. en:white substance -- r_associated #0: 106 / 0.876 -> en:actual effective cognition
    n1=en:white substance | n2=en:actual effective cognition | rel=r_associated | relid=0 | w=106
  83. en:white substance -- r_associated #0: 106 / 0.876 -> en:acute cerebrovascular accidents
    n1=en:white substance | n2=en:acute cerebrovascular accidents | rel=r_associated | relid=0 | w=106
  84. en:white substance -- r_associated #0: 106 / 0.876 -> en:acute episodes of neuropathic symptoms
    n1=en:white substance | n2=en:acute episodes of neuropathic symptoms | rel=r_associated | relid=0 | w=106
  85. en:white substance -- r_associated #0: 106 / 0.876 -> en:acute necrotizing encephalopathy
    n1=en:white substance | n2=en:acute necrotizing encephalopathy | rel=r_associated | relid=0 | w=106
  86. en:white substance -- r_associated #0: 106 / 0.876 -> en:acute neurologic deficits due to cerebrovascular disease
    n1=en:white substance | n2=en:acute neurologic deficits due to cerebrovascular disease | rel=r_associated | relid=0 | w=106
  87. en:white substance -- r_associated #0: 106 / 0.876 -> en:acute poliomyelitis
    n1=en:white substance | n2=en:acute poliomyelitis | rel=r_associated | relid=0 | w=106
  88. en:white substance -- r_associated #0: 106 / 0.876 -> en:addiction
    n1=en:white substance | n2=en:addiction | rel=r_associated | relid=0 | w=106
  89. en:white substance -- r_associated #0: 106 / 0.876 -> en:adipose tissue in subarachnoid space
    n1=en:white substance | n2=en:adipose tissue in subarachnoid space | rel=r_associated | relid=0 | w=106
  90. en:white substance -- r_associated #0: 106 / 0.876 -> en:afebrile seizure
    n1=en:white substance | n2=en:afebrile seizure | rel=r_associated | relid=0 | w=106
  91. en:white substance -- r_associated #0: 106 / 0.876 -> en:affected children are unable to sit without support
    n1=en:white substance | n2=en:affected children are unable to sit without support | rel=r_associated | relid=0 | w=106
  92. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of corpus callosum, partial or complete (rare)
    n1=en:white substance | n2=en:agenesis of corpus callosum, partial or complete (rare) | rel=r_associated | relid=0 | w=106
  93. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of pineal gland
    n1=en:white substance | n2=en:agenesis of pineal gland | rel=r_associated | relid=0 | w=106
  94. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the anterior commissure
    n1=en:white substance | n2=en:agenesis of the anterior commissure | rel=r_associated | relid=0 | w=106
  95. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the corpus callosum (1 patient)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (1 patient) | rel=r_associated | relid=0 | w=106
  96. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the corpus callosum (in 2 patients)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (in 2 patients) | rel=r_associated | relid=0 | w=106
  97. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the corpus callosum (less common)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (less common) | rel=r_associated | relid=0 | w=106
  98. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the corpus callosum (rare)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (rare) | rel=r_associated | relid=0 | w=106
  99. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the corpus callosum (variable)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (variable) | rel=r_associated | relid=0 | w=106
  100. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis of the rostrum of corpus callosum
    n1=en:white substance | n2=en:agenesis of the rostrum of corpus callosum | rel=r_associated | relid=0 | w=106
  101. en:white substance -- r_associated #0: 106 / 0.876 -> en:agenesis or hypoplasia of the corpus callosum
    n1=en:white substance | n2=en:agenesis or hypoplasia of the corpus callosum | rel=r_associated | relid=0 | w=106
  102. en:white substance -- r_associated #0: 106 / 0.876 -> en:agitation
    n1=en:white substance | n2=en:agitation | rel=r_associated | relid=0 | w=106
  103. en:white substance -- r_associated #0: 106 / 0.876 -> en:agyria (1 patient)
    n1=en:white substance | n2=en:agyria (1 patient) | rel=r_associated | relid=0 | w=106
  104. en:white substance -- r_associated #0: 106 / 0.876 -> en:agyria (posterior-to-anterior gradient)
    n1=en:white substance | n2=en:agyria (posterior-to-anterior gradient) | rel=r_associated | relid=0 | w=106
  105. en:white substance -- r_associated #0: 106 / 0.876 -> en:agyria (wws)
    n1=en:white substance | n2=en:agyria (wws) | rel=r_associated | relid=0 | w=106
  106. en:white substance -- r_associated #0: 106 / 0.876 -> en:akathisia
    n1=en:white substance | n2=en:akathisia | rel=r_associated | relid=0 | w=106
  107. en:white substance -- r_associated #0: 106 / 0.876 -> en:alobar holoprosencephaly (rare)
    n1=en:white substance | n2=en:alobar holoprosencephaly (rare) | rel=r_associated | relid=0 | w=106
  108. en:white substance -- r_associated #0: 106 / 0.876 -> en:alpha-synuclein immunoreactive neuronal and glial inclusions
    n1=en:white substance | n2=en:alpha-synuclein immunoreactive neuronal and glial inclusions | rel=r_associated | relid=0 | w=106
  109. en:white substance -- r_associated #0: 106 / 0.876 -> en:alpha-synuclein-containing inclusions
    n1=en:white substance | n2=en:alpha-synuclein-containing inclusions | rel=r_associated | relid=0 | w=106
  110. en:white substance -- r_associated #0: 106 / 0.876 -> en:alpha-synuclein-immunoreactive lewy neurites
    n1=en:white substance | n2=en:alpha-synuclein-immunoreactive lewy neurites | rel=r_associated | relid=0 | w=106
  111. en:white substance -- r_associated #0: 106 / 0.876 -> en:altered breathing patterns
    n1=en:white substance | n2=en:altered breathing patterns | rel=r_associated | relid=0 | w=106
  112. en:white substance -- r_associated #0: 106 / 0.876 -> en:altered mental status
    n1=en:white substance | n2=en:altered mental status | rel=r_associated | relid=0 | w=106
  113. en:white substance -- r_associated #0: 106 / 0.876 -> en:alzheimer's disease
    n1=en:white substance | n2=en:alzheimer's disease | rel=r_associated | relid=0 | w=106
  114. en:white substance -- r_associated #0: 106 / 0.876 -> en:amnesia
    n1=en:white substance | n2=en:amnesia | rel=r_associated | relid=0 | w=106
  115. en:white substance -- r_associated #0: 106 / 0.876 -> en:amyloid deposition in the leptomeningeal vessels, brainstem, spinal cord
    n1=en:white substance | n2=en:amyloid deposition in the leptomeningeal vessels, brainstem, spinal cord | rel=r_associated | relid=0 | w=106
  116. en:white substance -- r_associated #0: 106 / 0.876 -> en:amyloid-like plaques are not immunoreactive to app (104760)
    n1=en:white substance | n2=en:amyloid-like plaques are not immunoreactive to app (104760) | rel=r_associated | relid=0 | w=106
  117. en:white substance -- r_associated #0: 106 / 0.876 -> en:amyloid-like plaques, immunoreactive to prp, predominantly in the cerebellum
    n1=en:white substance | n2=en:amyloid-like plaques, immunoreactive to prp, predominantly in the cerebellum | rel=r_associated | relid=0 | w=106
  118. en:white substance -- r_associated #0: 106 / 0.876 -> en:amyotrophic lateral sclerosis
    n1=en:white substance | n2=en:amyotrophic lateral sclerosis | rel=r_associated | relid=0 | w=106
  119. en:white substance -- r_associated #0: 106 / 0.876 -> en:anarthria speech disorder
    n1=en:white substance | n2=en:anarthria speech disorder | rel=r_associated | relid=0 | w=106
  120. en:white substance -- r_associated #0: 106 / 0.876 -> en:anencephaly (1 patient)
    n1=en:white substance | n2=en:anencephaly (1 patient) | rel=r_associated | relid=0 | w=106
  121. en:white substance -- r_associated #0: 106 / 0.876 -> en:angiitis, cerebral
    n1=en:white substance | n2=en:angiitis, cerebral | rel=r_associated | relid=0 | w=106
  122. en:white substance -- r_associated #0: 106 / 0.876 -> en:ankle clonus
    n1=en:white substance | n2=en:ankle clonus | rel=r_associated | relid=0 | w=106
  123. en:white substance -- r_associated #0: 106 / 0.876 -> en:ankle clonus (in some patients)
    n1=en:white substance | n2=en:ankle clonus (in some patients) | rel=r_associated | relid=0 | w=106
  124. en:white substance -- r_associated #0: 106 / 0.876 -> en:ankle clonus (in some)
    n1=en:white substance | n2=en:ankle clonus (in some) | rel=r_associated | relid=0 | w=106
  125. en:white substance -- r_associated #0: 106 / 0.876 -> en:anomalies of the folding of the right sylvian area
    n1=en:white substance | n2=en:anomalies of the folding of the right sylvian area | rel=r_associated | relid=0 | w=106
  126. en:white substance -- r_associated #0: 106 / 0.876 -> en:anomalies of the temporal area
    n1=en:white substance | n2=en:anomalies of the temporal area | rel=r_associated | relid=0 | w=106
  127. en:white substance -- r_associated #0: 106 / 0.876 -> en:anomia
    n1=en:white substance | n2=en:anomia | rel=r_associated | relid=0 | w=106
  128. en:white substance -- r_associated #0: 106 / 0.876 -> en:anosmia (1 patient)
    n1=en:white substance | n2=en:anosmia (1 patient) | rel=r_associated | relid=0 | w=106
  129. en:white substance -- r_associated #0: 106 / 0.876 -> en:anosmia (in contiguous gene syndrome patients)
    n1=en:white substance | n2=en:anosmia (in contiguous gene syndrome patients) | rel=r_associated | relid=0 | w=106
  130. en:white substance -- r_associated #0: 106 / 0.876 -> en:anosmia (in some patients)
    n1=en:white substance | n2=en:anosmia (in some patients) | rel=r_associated | relid=0 | w=106
  131. en:white substance -- r_associated #0: 106 / 0.876 -> en:antenatal intracerebral hemorrhage
    n1=en:white substance | n2=en:antenatal intracerebral hemorrhage | rel=r_associated | relid=0 | w=106
  132. en:white substance -- r_associated #0: 106 / 0.876 -> en:anterior basal encephalocele
    n1=en:white substance | n2=en:anterior basal encephalocele | rel=r_associated | relid=0 | w=106
  133. en:white substance -- r_associated #0: 106 / 0.876 -> en:anterior horn atrophy
    n1=en:white substance | n2=en:anterior horn atrophy | rel=r_associated | relid=0 | w=106
  134. en:white substance -- r_associated #0: 106 / 0.876 -> en:anterior pituitary adenoma
    n1=en:white substance | n2=en:anterior pituitary adenoma | rel=r_associated | relid=0 | w=106
  135. en:white substance -- r_associated #0: 106 / 0.876 -> en:anterior sacral meningocele
    n1=en:white substance | n2=en:anterior sacral meningocele | rel=r_associated | relid=0 | w=106
  136. en:white substance -- r_associated #0: 106 / 0.876 -> en:anxiety
    n1=en:white substance | n2=en:anxiety | rel=r_associated | relid=0 | w=106
  137. en:white substance -- r_associated #0: 106 / 0.876 -> en:anxiety adverse event
    n1=en:white substance | n2=en:anxiety adverse event | rel=r_associated | relid=0 | w=106
  138. en:white substance -- r_associated #0: 106 / 0.876 -> en:apathy
    n1=en:white substance | n2=en:apathy | rel=r_associated | relid=0 | w=106
  139. en:white substance -- r_associated #0: 106 / 0.876 -> en:aplasia of corpus callosum
    n1=en:white substance | n2=en:aplasia of corpus callosum | rel=r_associated | relid=0 | w=106
  140. en:white substance -- r_associated #0: 106 / 0.876 -> en:aplasia of olfactory bulbs, bilateral
    n1=en:white substance | n2=en:aplasia of olfactory bulbs, bilateral | rel=r_associated | relid=0 | w=106
  141. en:white substance -- r_associated #0: 106 / 0.876 -> en:aplasia of the corpus callosum (wws) encephalocele (1 patient, meb)
    n1=en:white substance | n2=en:aplasia of the corpus callosum (wws) encephalocele (1 patient, meb) | rel=r_associated | relid=0 | w=106
  142. en:white substance -- r_associated #0: 106 / 0.876 -> en:aplasia of the inferior half of the cerebellar vermis
    n1=en:white substance | n2=en:aplasia of the inferior half of the cerebellar vermis | rel=r_associated | relid=0 | w=106
  143. en:white substance -- r_associated #0: 106 / 0.876 -> en:aplasia/hypoplasia of the cerebellar vermis
    n1=en:white substance | n2=en:aplasia/hypoplasia of the cerebellar vermis | rel=r_associated | relid=0 | w=106
  144. en:white substance -- r_associated #0: 106 / 0.876 -> en:aplasia/hypoplasia of the cerebellum
    n1=en:white substance | n2=en:aplasia/hypoplasia of the cerebellum | rel=r_associated | relid=0 | w=106
  145. en:white substance -- r_associated #0: 106 / 0.876 -> en:appendicular hypertonia
    n1=en:white substance | n2=en:appendicular hypertonia | rel=r_associated | relid=0 | w=106
  146. en:white substance -- r_associated #0: 106 / 0.876 -> en:approximately 30% of patients show normal early development
    n1=en:white substance | n2=en:approximately 30% of patients show normal early development | rel=r_associated | relid=0 | w=106
  147. en:white substance -- r_associated #0: 106 / 0.876 -> en:apraxia (in some patients)
    n1=en:white substance | n2=en:apraxia (in some patients) | rel=r_associated | relid=0 | w=106
  148. en:white substance -- r_associated #0: 106 / 0.876 -> en:apraxias
    n1=en:white substance | n2=en:apraxias | rel=r_associated | relid=0 | w=106
  149. en:white substance -- r_associated #0: 106 / 0.876 -> en:aqueductal stenosis
    n1=en:white substance | n2=en:aqueductal stenosis | rel=r_associated | relid=0 | w=106
  150. en:white substance -- r_associated #0: 106 / 0.876 -> en:arachnoid cyst
    n1=en:white substance | n2=en:arachnoid cyst | rel=r_associated | relid=0 | w=106
  151. en:white substance -- r_associated #0: 106 / 0.876 -> en:arachnoid cyst (in some patients)
    n1=en:white substance | n2=en:arachnoid cyst (in some patients) | rel=r_associated | relid=0 | w=106
  152. en:white substance -- r_associated #0: 106 / 0.876 -> en:arachnoid cysts (1 patient)
    n1=en:white substance | n2=en:arachnoid cysts (1 patient) | rel=r_associated | relid=0 | w=106
  153. en:white substance -- r_associated #0: 106 / 0.876 -> en:arachnoid cysts of the cerebellopontine angle (reported in 1 family)
    n1=en:white substance | n2=en:arachnoid cysts of the cerebellopontine angle (reported in 1 family) | rel=r_associated | relid=0 | w=106
  154. en:white substance -- r_associated #0: 106 / 0.876 -> en:arachnoid hemangiomata
    n1=en:white substance | n2=en:arachnoid hemangiomata | rel=r_associated | relid=0 | w=106
  155. en:white substance -- r_associated #0: 106 / 0.876 -> en:arachnoidal cysts
    n1=en:white substance | n2=en:arachnoidal cysts | rel=r_associated | relid=0 | w=106
  156. en:white substance -- r_associated #0: 106 / 0.876 -> en:areflexia
    n1=en:white substance | n2=en:areflexia | rel=r_associated | relid=0 | w=106
  157. en:white substance -- r_associated #0: 106 / 0.876 -> en:areflexia (30%)
    n1=en:white substance | n2=en:areflexia (30%) | rel=r_associated | relid=0 | w=106
  158. en:white substance -- r_associated #0: 106 / 0.876 -> en:areflexia of upper limbs
    n1=en:white substance | n2=en:areflexia of upper limbs | rel=r_associated | relid=0 | w=106
  159. en:white substance -- r_associated #0: 106 / 0.876 -> en:argyrophilic hyperphosphorylated tau-positive inclusions (pick bodies)
    n1=en:white substance | n2=en:argyrophilic hyperphosphorylated tau-positive inclusions (pick bodies) | rel=r_associated | relid=0 | w=106
  160. en:white substance -- r_associated #0: 106 / 0.876 -> en:arhinencephaly
    n1=en:white substance | n2=en:arhinencephaly | rel=r_associated | relid=0 | w=106
  161. en:white substance -- r_associated #0: 106 / 0.876 -> en:arm pain
    n1=en:white substance | n2=en:arm pain | rel=r_associated | relid=0 | w=106
  162. en:white substance -- r_associated #0: 106 / 0.876 -> en:arnold-chiari i malformation
    n1=en:white substance | n2=en:arnold-chiari i malformation | rel=r_associated | relid=0 | w=106
  163. en:white substance -- r_associated #0: 106 / 0.876 -> en:arrest of psychomotor development after seizure onset
    n1=en:white substance | n2=en:arrest of psychomotor development after seizure onset | rel=r_associated | relid=0 | w=106
  164. en:white substance -- r_associated #0: 106 / 0.876 -> en:arrested hydrocephalus (rare)
    n1=en:white substance | n2=en:arrested hydrocephalus (rare) | rel=r_associated | relid=0 | w=106
  165. en:white substance -- r_associated #0: 106 / 0.876 -> en:articulation difficulties
    n1=en:white substance | n2=en:articulation difficulties | rel=r_associated | relid=0 | w=106
  166. en:white substance -- r_associated #0: 106 / 0.876 -> en:articulation, unintelligible
    n1=en:white substance | n2=en:articulation, unintelligible | rel=r_associated | relid=0 | w=106
  167. en:white substance -- r_associated #0: 106 / 0.876 -> en:aspects of radionuclide imaging
    n1=en:white substance | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=106
  168. en:white substance -- r_associated #0: 106 / 0.876 -> en:asperger syndrome (rare)
    n1=en:white substance | n2=en:asperger syndrome (rare) | rel=r_associated | relid=0 | w=106
  169. en:white substance -- r_associated #0: 106 / 0.876 -> en:associated with paresthesias and dysesthesias
    n1=en:white substance | n2=en:associated with paresthesias and dysesthesias | rel=r_associated | relid=0 | w=106
  170. en:white substance -- r_associated #0: 106 / 0.876 -> en:association between poor metabolizers (pm) and parkinson disease
    n1=en:white substance | n2=en:association between poor metabolizers (pm) and parkinson disease | rel=r_associated | relid=0 | w=106
  171. en:white substance -- r_associated #0: 106 / 0.876 -> en:astrocyte
    n1=en:white substance | n2=en:astrocyte | rel=r_associated | relid=0 | w=106
  172. en:white substance -- r_associated #0: 106 / 0.876 -> en:astrocytic gliosis
    n1=en:white substance | n2=en:astrocytic gliosis | rel=r_associated | relid=0 | w=106
  173. en:white substance -- r_associated #0: 106 / 0.876 -> en:astrocytosis
    n1=en:white substance | n2=en:astrocytosis | rel=r_associated | relid=0 | w=106
  174. en:white substance -- r_associated #0: 106 / 0.876 -> en:astrogliosis (in some patients)
    n1=en:white substance | n2=en:astrogliosis (in some patients) | rel=r_associated | relid=0 | w=106
  175. en:white substance -- r_associated #0: 106 / 0.876 -> en:asymmetry of symptoms
    n1=en:white substance | n2=en:asymmetry of symptoms | rel=r_associated | relid=0 | w=106
  176. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia (1 patient)
    n1=en:white substance | n2=en:ataxia (1 patient) | rel=r_associated | relid=0 | w=106
  177. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia (cvs+)
    n1=en:white substance | n2=en:ataxia (cvs+) | rel=r_associated | relid=0 | w=106
  178. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia (deletion patients)
    n1=en:white substance | n2=en:ataxia (deletion patients) | rel=r_associated | relid=0 | w=106
  179. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia (in some patients)
    n1=en:white substance | n2=en:ataxia (in some patients) | rel=r_associated | relid=0 | w=106
  180. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia (uncommon)
    n1=en:white substance | n2=en:ataxia (uncommon) | rel=r_associated | relid=0 | w=106
  181. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia in those who survive
    n1=en:white substance | n2=en:ataxia in those who survive | rel=r_associated | relid=0 | w=106
  182. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia with febrile episodes (rare)
    n1=en:white substance | n2=en:ataxia with febrile episodes (rare) | rel=r_associated | relid=0 | w=106
  183. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia with jerky arm movements
    n1=en:white substance | n2=en:ataxia with jerky arm movements | rel=r_associated | relid=0 | w=106
  184. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia worsens in the dark
    n1=en:white substance | n2=en:ataxia worsens in the dark | rel=r_associated | relid=0 | w=106
  185. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, (1 family)
    n1=en:white substance | n2=en:ataxia, (1 family) | rel=r_associated | relid=0 | w=106
  186. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, cerebellar (in some patients)
    n1=en:white substance | n2=en:ataxia, cerebellar (in some patients) | rel=r_associated | relid=0 | w=106
  187. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, cerebellar (upper and lower limbs affected)
    n1=en:white substance | n2=en:ataxia, cerebellar (upper and lower limbs affected) | rel=r_associated | relid=0 | w=106
  188. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, cerebellar, limb and gait
    n1=en:white substance | n2=en:ataxia, cerebellar, limb and gait | rel=r_associated | relid=0 | w=106
  189. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, episodic (episodes last from hours to days)
    n1=en:white substance | n2=en:ataxia, episodic (episodes last from hours to days) | rel=r_associated | relid=0 | w=106
  190. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, episodic, occurring after febrile illness or stress
    n1=en:white substance | n2=en:ataxia, episodic, occurring after febrile illness or stress | rel=r_associated | relid=0 | w=106
  191. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, gait and appendicular
    n1=en:white substance | n2=en:ataxia, gait and appendicular | rel=r_associated | relid=0 | w=106
  192. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxia, mild
    n1=en:white substance | n2=en:ataxia, mild | rel=r_associated | relid=0 | w=106
  193. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxias, appendicular
    n1=en:white substance | n2=en:ataxias, appendicular | rel=r_associated | relid=0 | w=106
  194. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxias, sensory
    n1=en:white substance | n2=en:ataxias, sensory | rel=r_associated | relid=0 | w=106
  195. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxic gait
    n1=en:white substance | n2=en:ataxic gait | rel=r_associated | relid=0 | w=106
  196. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxic gait (in some patients)
    n1=en:white substance | n2=en:ataxic gait (in some patients) | rel=r_associated | relid=0 | w=106
  197. en:white substance -- r_associated #0: 106 / 0.876 -> en:ataxic gait (juvenile form)
    n1=en:white substance | n2=en:ataxic gait (juvenile form) | rel=r_associated | relid=0 | w=106
  198. en:white substance -- r_associated #0: 106 / 0.876 -> en:atelencephaly
    n1=en:white substance | n2=en:atelencephaly | rel=r_associated | relid=0 | w=106
  199. en:white substance -- r_associated #0: 106 / 0.876 -> en:athetoid and dystonic hand movements (in some patients)
    n1=en:white substance | n2=en:athetoid and dystonic hand movements (in some patients) | rel=r_associated | relid=0 | w=106
  200. en:white substance -- r_associated #0: 106 / 0.876 -> en:athetosis
    n1=en:white substance | n2=en:athetosis | rel=r_associated | relid=0 | w=106
  201. en:white substance -- r_associated #0: 106 / 0.876 -> en:athetosis (in some patients)
    n1=en:white substance | n2=en:athetosis (in some patients) | rel=r_associated | relid=0 | w=106
  202. en:white substance -- r_associated #0: 106 / 0.876 -> en:athetosis (later)
    n1=en:white substance | n2=en:athetosis (later) | rel=r_associated | relid=0 | w=106
  203. en:white substance -- r_associated #0: 106 / 0.876 -> en:athetosis, mild (in one patient)
    n1=en:white substance | n2=en:athetosis, mild (in one patient) | rel=r_associated | relid=0 | w=106
  204. en:white substance -- r_associated #0: 106 / 0.876 -> en:atretic occipital cephalocele
    n1=en:white substance | n2=en:atretic occipital cephalocele | rel=r_associated | relid=0 | w=106
  205. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophic pons (in some)
    n1=en:white substance | n2=en:atrophic pons (in some) | rel=r_associated | relid=0 | w=106
  206. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy and weakness of limb musculature
    n1=en:white substance | n2=en:atrophy and weakness of limb musculature | rel=r_associated | relid=0 | w=106
  207. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy and weakness of the tongue, jaw, and throat muscles
    n1=en:white substance | n2=en:atrophy and weakness of the tongue, jaw, and throat muscles | rel=r_associated | relid=0 | w=106
  208. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of cerebellum, brainstem, cervical spinal cord
    n1=en:white substance | n2=en:atrophy of cerebellum, brainstem, cervical spinal cord | rel=r_associated | relid=0 | w=106
  209. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of hippocampal dentate gyrus
    n1=en:white substance | n2=en:atrophy of hippocampal dentate gyrus | rel=r_associated | relid=0 | w=106
  210. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of pyramids
    n1=en:white substance | n2=en:atrophy of pyramids | rel=r_associated | relid=0 | w=106
  211. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of the frontal and parietal cortex
    n1=en:white substance | n2=en:atrophy of the frontal and parietal cortex | rel=r_associated | relid=0 | w=106
  212. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of the granular cell layer of the cerebellum
    n1=en:white substance | n2=en:atrophy of the granular cell layer of the cerebellum | rel=r_associated | relid=0 | w=106
  213. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of the motor cortex in older patients seen on mri
    n1=en:white substance | n2=en:atrophy of the motor cortex in older patients seen on mri | rel=r_associated | relid=0 | w=106
  214. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of the pituitary (1 patient)
    n1=en:white substance | n2=en:atrophy of the pituitary (1 patient) | rel=r_associated | relid=0 | w=106
  215. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of the posterior columns and spinocerebellar tracts
    n1=en:white substance | n2=en:atrophy of the posterior columns and spinocerebellar tracts | rel=r_associated | relid=0 | w=106
  216. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy of the spinal cord
    n1=en:white substance | n2=en:atrophy of the spinal cord | rel=r_associated | relid=0 | w=106
  217. en:white substance -- r_associated #0: 106 / 0.876 -> en:atrophy/degeneration involving the spinal cord
    n1=en:white substance | n2=en:atrophy/degeneration involving the spinal cord | rel=r_associated | relid=0 | w=106
  218. en:white substance -- r_associated #0: 106 / 0.876 -> en:attacks characterized by lethargy, incoordination, loss of motor skills
    n1=en:white substance | n2=en:attacks characterized by lethargy, incoordination, loss of motor skills | rel=r_associated | relid=0 | w=106
  219. en:white substance -- r_associated #0: 106 / 0.876 -> en:attention deficit disorder
    n1=en:white substance | n2=en:attention deficit disorder | rel=r_associated | relid=0 | w=106
  220. en:white substance -- r_associated #0: 106 / 0.876 -> en:attention deficit hyperactivity disorder
    n1=en:white substance | n2=en:attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=106
  221. en:white substance -- r_associated #0: 106 / 0.876 -> en:atypical absence seizure
    n1=en:white substance | n2=en:atypical absence seizure | rel=r_associated | relid=0 | w=106
  222. en:white substance -- r_associated #0: 106 / 0.876 -> en:atypical absence, atonic/tonic, or tonic-clonic seizures
    n1=en:white substance | n2=en:atypical absence, atonic/tonic, or tonic-clonic seizures | rel=r_associated | relid=0 | w=106
  223. en:white substance -- r_associated #0: 106 / 0.876 -> en:auditory auras
    n1=en:white substance | n2=en:auditory auras | rel=r_associated | relid=0 | w=106
  224. en:white substance -- r_associated #0: 106 / 0.876 -> en:auditory, olfactory, and visual auras
    n1=en:white substance | n2=en:auditory, olfactory, and visual auras | rel=r_associated | relid=0 | w=106
  225. en:white substance -- r_associated #0: 106 / 0.876 -> en:aura
    n1=en:white substance | n2=en:aura | rel=r_associated | relid=0 | w=106
  226. en:white substance -- r_associated #0: 106 / 0.876 -> en:autism (rare)
    n1=en:white substance | n2=en:autism (rare) | rel=r_associated | relid=0 | w=106
  227. en:white substance -- r_associated #0: 106 / 0.876 -> en:autofluorescent lipopigment in neurons
    n1=en:white substance | n2=en:autofluorescent lipopigment in neurons | rel=r_associated | relid=0 | w=106
  228. en:white substance -- r_associated #0: 106 / 0.876 -> en:autofluorescent pigment in microglia and macrophages
    n1=en:white substance | n2=en:autofluorescent pigment in microglia and macrophages | rel=r_associated | relid=0 | w=106
  229. en:white substance -- r_associated #0: 106 / 0.876 -> en:automatism
    n1=en:white substance | n2=en:automatism | rel=r_associated | relid=0 | w=106
  230. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic abnormalities
    n1=en:white substance | n2=en:autonomic abnormalities | rel=r_associated | relid=0 | w=106
  231. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic dysfunction (in patients with hsan2d)
    n1=en:white substance | n2=en:autonomic dysfunction (in patients with hsan2d) | rel=r_associated | relid=0 | w=106
  232. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic dysregulation
    n1=en:white substance | n2=en:autonomic dysregulation | rel=r_associated | relid=0 | w=106
  233. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic features may occur
    n1=en:white substance | n2=en:autonomic features may occur | rel=r_associated | relid=0 | w=106
  234. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic instability (22%)
    n1=en:white substance | n2=en:autonomic instability (22%) | rel=r_associated | relid=0 | w=106
  235. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic involvement affecting limbs during episodes
    n1=en:white substance | n2=en:autonomic involvement affecting limbs during episodes | rel=r_associated | relid=0 | w=106
  236. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic involvement may occur
    n1=en:white substance | n2=en:autonomic involvement may occur | rel=r_associated | relid=0 | w=106
  237. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic manifestations
    n1=en:white substance | n2=en:autonomic manifestations | rel=r_associated | relid=0 | w=106
  238. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic signs
    n1=en:white substance | n2=en:autonomic signs | rel=r_associated | relid=0 | w=106
  239. en:white substance -- r_associated #0: 106 / 0.876 -> en:autonomic symptoms
    n1=en:white substance | n2=en:autonomic symptoms | rel=r_associated | relid=0 | w=106
  240. en:white substance -- r_associated #0: 106 / 0.876 -> en:average intellect
    n1=en:white substance | n2=en:average intellect | rel=r_associated | relid=0 | w=106
  241. en:white substance -- r_associated #0: 106 / 0.876 -> en:axial dystonia
    n1=en:white substance | n2=en:axial dystonia | rel=r_associated | relid=0 | w=106
  242. en:white substance -- r_associated #0: 106 / 0.876 -> en:axial hypotonia (1 patient)
    n1=en:white substance | n2=en:axial hypotonia (1 patient) | rel=r_associated | relid=0 | w=106
  243. en:white substance -- r_associated #0: 106 / 0.876 -> en:axial hypotonia (rare)
    n1=en:white substance | n2=en:axial hypotonia (rare) | rel=r_associated | relid=0 | w=106
  244. en:white substance -- r_associated #0: 106 / 0.876 -> en:axial imbalance (34%)
    n1=en:white substance | n2=en:axial imbalance (34%) | rel=r_associated | relid=0 | w=106
  245. en:white substance -- r_associated #0: 106 / 0.876 -> en:axial muscle stiffness, symmetric
    n1=en:white substance | n2=en:axial muscle stiffness, symmetric | rel=r_associated | relid=0 | w=106
  246. en:white substance -- r_associated #0: 106 / 0.876 -> en:axial rigidity
    n1=en:white substance | n2=en:axial rigidity | rel=r_associated | relid=0 | w=106
  247. en:white substance -- r_associated #0: 106 / 0.876 -> en:axonal 'spheroid' inclusions in the cns
    n1=en:white substance | n2=en:axonal 'spheroid' inclusions in the cns | rel=r_associated | relid=0 | w=106
  248. en:white substance -- r_associated #0: 106 / 0.876 -> en:axonal loss
    n1=en:white substance | n2=en:axonal loss | rel=r_associated | relid=0 | w=106
  249. en:white substance -- r_associated #0: 106 / 0.876 -> en:axonal loss and gliosis in the corticospinal tracts
    n1=en:white substance | n2=en:axonal loss and gliosis in the corticospinal tracts | rel=r_associated | relid=0 | w=106
  250. en:white substance -- r_associated #0: 106 / 0.876 -> en:axonal swelling or thickening
    n1=en:white substance | n2=en:axonal swelling or thickening | rel=r_associated | relid=0 | w=106
  251. en:white substance -- r_associated #0: 106 / 0.876 -> en:axonal swelling or thickening in the cns
    n1=en:white substance | n2=en:axonal swelling or thickening in the cns | rel=r_associated | relid=0 | w=106
  252. en:white substance -- r_associated #0: 106 / 0.876 -> en:axonal swellings or spheroids
    n1=en:white substance | n2=en:axonal swellings or spheroids | rel=r_associated | relid=0 | w=106
  253. en:white substance -- r_associated #0: 106 / 0.876 -> en:babinski sign
    n1=en:white substance | n2=en:babinski sign | rel=r_associated | relid=0 | w=106
  254. en:white substance -- r_associated #0: 106 / 0.876 -> en:back pain
    n1=en:white substance | n2=en:back pain | rel=r_associated | relid=0 | w=106
  255. en:white substance -- r_associated #0: 106 / 0.876 -> en:background slowing
    n1=en:white substance | n2=en:background slowing | rel=r_associated | relid=0 | w=106
  256. en:white substance -- r_associated #0: 106 / 0.876 -> en:ballooned neurons
    n1=en:white substance | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=106
  257. en:white substance -- r_associated #0: 106 / 0.876 -> en:band heterotopia (1 patient)
    n1=en:white substance | n2=en:band heterotopia (1 patient) | rel=r_associated | relid=0 | w=106
  258. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia atrophy
    n1=en:white substance | n2=en:basal ganglia atrophy | rel=r_associated | relid=0 | w=106
  259. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia atrophy, progressive
    n1=en:white substance | n2=en:basal ganglia atrophy, progressive | rel=r_associated | relid=0 | w=106
  260. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia calcification
    n1=en:white substance | n2=en:basal ganglia calcification | rel=r_associated | relid=0 | w=106
  261. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia calcifications (in some patients)
    n1=en:white substance | n2=en:basal ganglia calcifications (in some patients) | rel=r_associated | relid=0 | w=106
  262. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia calcifications (rare)
    n1=en:white substance | n2=en:basal ganglia calcifications (rare) | rel=r_associated | relid=0 | w=106
  263. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia cysts
    n1=en:white substance | n2=en:basal ganglia cysts | rel=r_associated | relid=0 | w=106
  264. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia dysfunction
    n1=en:white substance | n2=en:basal ganglia dysfunction | rel=r_associated | relid=0 | w=106
  265. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia gliosis
    n1=en:white substance | n2=en:basal ganglia gliosis | rel=r_associated | relid=0 | w=106
  266. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia lesions may be present before onset of clinical symptoms
    n1=en:white substance | n2=en:basal ganglia lesions may be present before onset of clinical symptoms | rel=r_associated | relid=0 | w=106
  267. en:white substance -- r_associated #0: 106 / 0.876 -> en:basal ganglia lucencies
    n1=en:white substance | n2=en:basal ganglia lucencies | rel=r_associated | relid=0 | w=106
  268. en:white substance -- r_associated #0: 106 / 0.876 -> en:behavioral variant of frontotemporal dementia
    n1=en:white substance | n2=en:behavioral variant of frontotemporal dementia | rel=r_associated | relid=0 | w=106
  269. en:white substance -- r_associated #0: 106 / 0.876 -> en:beta-amyloid-positive senile plaques
    n1=en:white substance | n2=en:beta-amyloid-positive senile plaques | rel=r_associated | relid=0 | w=106
  270. en:white substance -- r_associated #0: 106 / 0.876 -> en:between 2 and 7% of children will develop afebrile seizure disorders later in life
    n1=en:white substance | n2=en:between 2 and 7% of children will develop afebrile seizure disorders later in life | rel=r_associated | relid=0 | w=106
  271. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral calcification of basal ganglia and cerebellum
    n1=en:white substance | n2=en:bilateral calcification of basal ganglia and cerebellum | rel=r_associated | relid=0 | w=106
  272. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral convulsive seizures
    n1=en:white substance | n2=en:bilateral convulsive seizures | rel=r_associated | relid=0 | w=106
  273. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral perisylvian cortical malformations on mri
    n1=en:white substance | n2=en:bilateral perisylvian cortical malformations on mri | rel=r_associated | relid=0 | w=106
  274. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral schizencephaly
    n1=en:white substance | n2=en:bilateral schizencephaly | rel=r_associated | relid=0 | w=106
  275. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral signals in the basal ganglia
    n1=en:white substance | n2=en:bilateral signals in the basal ganglia | rel=r_associated | relid=0 | w=106
  276. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral striatal necrosis
    n1=en:white substance | n2=en:bilateral striatal necrosis | rel=r_associated | relid=0 | w=106
  277. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral thalamic lesions on mri
    n1=en:white substance | n2=en:bilateral thalamic lesions on mri | rel=r_associated | relid=0 | w=106
  278. en:white substance -- r_associated #0: 106 / 0.876 -> en:bilateral, symmetric intracerebral calcifications, especially in the basal ganglia and periventricular areas
    n1=en:white substance | n2=en:bilateral, symmetric intracerebral calcifications, especially in the basal ganglia and periventricular areas | rel=r_associated | relid=0 | w=106
  279. en:white substance -- r_associated #0: 106 / 0.876 -> en:biopsy shows foamy lipid-laden macrophages
    n1=en:white substance | n2=en:biopsy shows foamy lipid-laden macrophages | rel=r_associated | relid=0 | w=106
  280. en:white substance -- r_associated #0: 106 / 0.876 -> en:biopsy shows white matter hypomyelination, demyelination, gliosis
    n1=en:white substance | n2=en:biopsy shows white matter hypomyelination, demyelination, gliosis | rel=r_associated | relid=0 | w=106
  281. en:white substance -- r_associated #0: 106 / 0.876 -> en:blindness
    n1=en:white substance | n2=en:blindness | rel=r_associated | relid=0 | w=106
  282. en:white substance -- r_associated #0: 106 / 0.876 -> en:blood supply aspects
    n1=en:white substance | n2=en:blood supply aspects | rel=r_associated | relid=0 | w=106
  283. en:white substance -- r_associated #0: 106 / 0.876 -> en:blurring of the gray-white junction (in type iib)
    n1=en:white substance | n2=en:blurring of the gray-white junction (in type iib) | rel=r_associated | relid=0 | w=106
  284. en:white substance -- r_associated #0: 106 / 0.876 -> en:borderline intelligence
    n1=en:white substance | n2=en:borderline intelligence | rel=r_associated | relid=0 | w=106
  285. en:white substance -- r_associated #0: 106 / 0.876 -> en:bradykinesia (in severe cases)
    n1=en:white substance | n2=en:bradykinesia (in severe cases) | rel=r_associated | relid=0 | w=106
  286. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain and spinal cord structure
    n1=en:white substance | n2=en:brain and spinal cord structure | rel=r_associated | relid=0 | w=106
  287. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain atrophy (1 patient)
    n1=en:white substance | n2=en:brain atrophy (1 patient) | rel=r_associated | relid=0 | w=106
  288. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain atrophy (in some patients)
    n1=en:white substance | n2=en:brain atrophy (in some patients) | rel=r_associated | relid=0 | w=106
  289. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain atrophy seen on mri
    n1=en:white substance | n2=en:brain atrophy seen on mri | rel=r_associated | relid=0 | w=106
  290. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain calcification (if left untreated)
    n1=en:white substance | n2=en:brain calcification (if left untreated) | rel=r_associated | relid=0 | w=106
  291. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain cell
    n1=en:white substance | n2=en:brain cell | rel=r_associated | relid=0 | w=106
  292. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain cerebrospinal fluid pathway
    n1=en:white substance | n2=en:brain cerebrospinal fluid pathway | rel=r_associated | relid=0 | w=106
  293. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain circuit
    n1=en:white substance | n2=en:brain circuit | rel=r_associated | relid=0 | w=106
  294. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain commissure
    n1=en:white substance | n2=en:brain commissure | rel=r_associated | relid=0 | w=106
  295. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain edema
    n1=en:white substance | n2=en:brain edema | rel=r_associated | relid=0 | w=106
  296. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain edema following head injury (less common)
    n1=en:white substance | n2=en:brain edema following head injury (less common) | rel=r_associated | relid=0 | w=106
  297. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows calcification of the dentate nucleus
    n1=en:white substance | n2=en:brain imaging shows calcification of the dentate nucleus | rel=r_associated | relid=0 | w=106
  298. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows decreased white matter density
    n1=en:white substance | n2=en:brain imaging shows decreased white matter density | rel=r_associated | relid=0 | w=106
  299. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows diffuse white matter abnormalities
    n1=en:white substance | n2=en:brain imaging shows diffuse white matter abnormalities | rel=r_associated | relid=0 | w=106
  300. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows functional defects in the cortical and subcortical motor-related areas of the frontal lobe
    n1=en:white substance | n2=en:brain imaging shows functional defects in the cortical and subcortical motor-related areas of the frontal lobe | rel=r_associated | relid=0 | w=106
  301. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows generalized atrophy
    n1=en:white substance | n2=en:brain imaging shows generalized atrophy | rel=r_associated | relid=0 | w=106
  302. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows hypomyelination
    n1=en:white substance | n2=en:brain imaging shows hypomyelination | rel=r_associated | relid=0 | w=106
  303. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain imaging shows white-matter hypodensities and demyelination
    n1=en:white substance | n2=en:brain imaging shows white-matter hypodensities and demyelination | rel=r_associated | relid=0 | w=106
  304. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain injury
    n1=en:white substance | n2=en:brain injury | rel=r_associated | relid=0 | w=106
  305. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain iron accumulation in the basal ganglia (in some patients)
    n1=en:white substance | n2=en:brain iron accumulation in the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=106
  306. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain morphology
    n1=en:white substance | n2=en:brain morphology | rel=r_associated | relid=0 | w=106
  307. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows abnormal cortical thickening in the anteromesial frontal areas (1 family)
    n1=en:white substance | n2=en:brain mri shows abnormal cortical thickening in the anteromesial frontal areas (1 family) | rel=r_associated | relid=0 | w=106
  308. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows arrest in myelination
    n1=en:white substance | n2=en:brain mri shows arrest in myelination | rel=r_associated | relid=0 | w=106
  309. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows cerebellar atrophy
    n1=en:white substance | n2=en:brain mri shows cerebellar atrophy | rel=r_associated | relid=0 | w=106
  310. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows cerebellar atrophy (1 patient)
    n1=en:white substance | n2=en:brain mri shows cerebellar atrophy (1 patient) | rel=r_associated | relid=0 | w=106
  311. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows cerebellar hypoplasia
    n1=en:white substance | n2=en:brain mri shows cerebellar hypoplasia | rel=r_associated | relid=0 | w=106
  312. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows flattening of the ventral pons
    n1=en:white substance | n2=en:brain mri shows flattening of the ventral pons | rel=r_associated | relid=0 | w=106
  313. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows hypoplasia of the corpus callosum
    n1=en:white substance | n2=en:brain mri shows hypoplasia of the corpus callosum | rel=r_associated | relid=0 | w=106
  314. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows lesions consistent with epileptic episodes
    n1=en:white substance | n2=en:brain mri shows lesions consistent with epileptic episodes | rel=r_associated | relid=0 | w=106
  315. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows lesions in the basal ganglia
    n1=en:white substance | n2=en:brain mri shows lesions in the basal ganglia | rel=r_associated | relid=0 | w=106
  316. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows molar tooth sign
    n1=en:white substance | n2=en:brain mri shows molar tooth sign | rel=r_associated | relid=0 | w=106
  317. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mri shows proportionate pontocerebellar hypoplasia
    n1=en:white substance | n2=en:brain mri shows proportionate pontocerebellar hypoplasia | rel=r_associated | relid=0 | w=106
  318. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mrs shows decreased creatine content
    n1=en:white substance | n2=en:brain mrs shows decreased creatine content | rel=r_associated | relid=0 | w=106
  319. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain mrs shows reduced choline and inositol peaks in the parieto-occipital white matter
    n1=en:white substance | n2=en:brain mrs shows reduced choline and inositol peaks in the parieto-occipital white matter | rel=r_associated | relid=0 | w=106
  320. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain region
    n1=en:white substance | n2=en:brain region | rel=r_associated | relid=0 | w=106
  321. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain regulatory center
    n1=en:white substance | n2=en:brain regulatory center | rel=r_associated | relid=0 | w=106
  322. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain stem atrophy
    n1=en:white substance | n2=en:brain stem atrophy | rel=r_associated | relid=0 | w=106
  323. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain stem atrophy, progressive
    n1=en:white substance | n2=en:brain stem atrophy, progressive | rel=r_associated | relid=0 | w=106
  324. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain tissue shows abnormal spherical aggregates of iron and ferritin in the basal ganglia, forebrain, and cerebellum
    n1=en:white substance | n2=en:brain tissue shows abnormal spherical aggregates of iron and ferritin in the basal ganglia, forebrain, and cerebellum | rel=r_associated | relid=0 | w=106
  325. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain tissue shows cavitation of the basal ganglia
    n1=en:white substance | n2=en:brain tissue shows cavitation of the basal ganglia | rel=r_associated | relid=0 | w=106
  326. en:white substance -- r_associated #0: 106 / 0.876 -> en:brain vascular anomalies (rare)
    n1=en:white substance | n2=en:brain vascular anomalies (rare) | rel=r_associated | relid=0 | w=106
  327. en:white substance -- r_associated #0: 106 / 0.876 -> en:brainstem concavity
    n1=en:white substance | n2=en:brainstem concavity | rel=r_associated | relid=0 | w=106
  328. en:white substance -- r_associated #0: 106 / 0.876 -> en:brainstem damage
    n1=en:white substance | n2=en:brainstem damage | rel=r_associated | relid=0 | w=106
  329. en:white substance -- r_associated #0: 106 / 0.876 -> en:brainstem dysplasia
    n1=en:white substance | n2=en:brainstem dysplasia | rel=r_associated | relid=0 | w=106
  330. en:white substance -- r_associated #0: 106 / 0.876 -> en:brainstem lesions, hyperintense on t2-weighted imaging
    n1=en:white substance | n2=en:brainstem lesions, hyperintense on t2-weighted imaging | rel=r_associated | relid=0 | w=106
  331. en:white substance -- r_associated #0: 106 / 0.876 -> en:brainstem may show neuronal loss
    n1=en:white substance | n2=en:brainstem may show neuronal loss | rel=r_associated | relid=0 | w=106
  332. en:white substance -- r_associated #0: 106 / 0.876 -> en:brainstem white matter lesions
    n1=en:white substance | n2=en:brainstem white matter lesions | rel=r_associated | relid=0 | w=106
  333. en:white substance -- r_associated #0: 106 / 0.876 -> en:breathing difficulty due to vocal cord paralysis
    n1=en:white substance | n2=en:breathing difficulty due to vocal cord paralysis | rel=r_associated | relid=0 | w=106
  334. en:white substance -- r_associated #0: 106 / 0.876 -> en:brisk knee reflexes (early-on)
    n1=en:white substance | n2=en:brisk knee reflexes (early-on) | rel=r_associated | relid=0 | w=106
  335. en:white substance -- r_associated #0: 106 / 0.876 -> en:brisk lower limb reflexes (in some patients)
    n1=en:white substance | n2=en:brisk lower limb reflexes (in some patients) | rel=r_associated | relid=0 | w=106
  336. en:white substance -- r_associated #0: 106 / 0.876 -> en:brisk reflexes (1 patient)
    n1=en:white substance | n2=en:brisk reflexes (1 patient) | rel=r_associated | relid=0 | w=106
  337. en:white substance -- r_associated #0: 106 / 0.876 -> en:brisk tendon reflex
    n1=en:white substance | n2=en:brisk tendon reflex | rel=r_associated | relid=0 | w=106
  338. en:white substance -- r_associated #0: 106 / 0.876 -> en:broad gait
    n1=en:white substance | n2=en:broad gait | rel=r_associated | relid=0 | w=106
  339. en:white substance -- r_associated #0: 106 / 0.876 -> en:broad-based gait
    n1=en:white substance | n2=en:broad-based gait | rel=r_associated | relid=0 | w=106
  340. en:white substance -- r_associated #0: 106 / 0.876 -> en:broad-based gait (1 patient)
    n1=en:white substance | n2=en:broad-based gait (1 patient) | rel=r_associated | relid=0 | w=106
  341. en:white substance -- r_associated #0: 106 / 0.876 -> en:buccolingofacial dyspraxia
    n1=en:white substance | n2=en:buccolingofacial dyspraxia | rel=r_associated | relid=0 | w=106
  342. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulbar and upper limb symptoms more severe than lower limb symptoms
    n1=en:white substance | n2=en:bulbar and upper limb symptoms more severe than lower limb symptoms | rel=r_associated | relid=0 | w=106
  343. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulbar dysfunction (in some patients)
    n1=en:white substance | n2=en:bulbar dysfunction (in some patients) | rel=r_associated | relid=0 | w=106
  344. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulbar dysfunction (juvenile-onset, less common)
    n1=en:white substance | n2=en:bulbar dysfunction (juvenile-onset, less common) | rel=r_associated | relid=0 | w=106
  345. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulbar involvement
    n1=en:white substance | n2=en:bulbar involvement | rel=r_associated | relid=0 | w=106
  346. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulbar paresis
    n1=en:white substance | n2=en:bulbar paresis | rel=r_associated | relid=0 | w=106
  347. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulbar signs
    n1=en:white substance | n2=en:bulbar signs | rel=r_associated | relid=0 | w=106
  348. en:white substance -- r_associated #0: 106 / 0.876 -> en:bulging of the caudate nuclei
    n1=en:white substance | n2=en:bulging of the caudate nuclei | rel=r_associated | relid=0 | w=106
  349. en:white substance -- r_associated #0: 106 / 0.876 -> en:burst suppression pattern seen on eeg
    n1=en:white substance | n2=en:burst suppression pattern seen on eeg | rel=r_associated | relid=0 | w=106
  350. en:white substance -- r_associated #0: 106 / 0.876 -> en:by 10-15 years after onset, postural dystonia spreads to all limbs
    n1=en:white substance | n2=en:by 10-15 years after onset, postural dystonia spreads to all limbs | rel=r_associated | relid=0 | w=106
  351. en:white substance -- r_associated #0: 106 / 0.876 -> en:c3hex, decreased ability to smell
    n1=en:white substance | n2=en:c3hex, decreased ability to smell | rel=r_associated | relid=0 | w=106
  352. en:white substance -- r_associated #0: 106 / 0.876 -> en:calcification in the pons and cerebellum
    n1=en:white substance | n2=en:calcification in the pons and cerebellum | rel=r_associated | relid=0 | w=106
  353. en:white substance -- r_associated #0: 106 / 0.876 -> en:calcifications in white matter, basal ganglia, brainstem, cerebellum, and spinal cord
    n1=en:white substance | n2=en:calcifications in white matter, basal ganglia, brainstem, cerebellum, and spinal cord | rel=r_associated | relid=0 | w=106
  354. en:white substance -- r_associated #0: 106 / 0.876 -> en:calcifications may be seen in the thalamus, hippocampus, subcortical white matter, and cortex
    n1=en:white substance | n2=en:calcifications may be seen in the thalamus, hippocampus, subcortical white matter, and cortex | rel=r_associated | relid=0 | w=106
  355. en:white substance -- r_associated #0: 106 / 0.876 -> en:calicification of the falx cerebri
    n1=en:white substance | n2=en:calicification of the falx cerebri | rel=r_associated | relid=0 | w=106
  356. en:white substance -- r_associated #0: 106 / 0.876 -> en:candidal meningitis (in some patients)
    n1=en:white substance | n2=en:candidal meningitis (in some patients) | rel=r_associated | relid=0 | w=106
  357. en:white substance -- r_associated #0: 106 / 0.876 -> en:cataplexy
    n1=en:white substance | n2=en:cataplexy | rel=r_associated | relid=0 | w=106
  358. en:white substance -- r_associated #0: 106 / 0.876 -> en:cataplexy often triggered by strong emotions
    n1=en:white substance | n2=en:cataplexy often triggered by strong emotions | rel=r_associated | relid=0 | w=106
  359. en:white substance -- r_associated #0: 106 / 0.876 -> en:catatonia
    n1=en:white substance | n2=en:catatonia | rel=r_associated | relid=0 | w=106
  360. en:white substance -- r_associated #0: 106 / 0.876 -> en:catatonic behavior
    n1=en:white substance | n2=en:catatonic behavior | rel=r_associated | relid=0 | w=106
  361. en:white substance -- r_associated #0: 106 / 0.876 -> en:caudate nuclei atrophy
    n1=en:white substance | n2=en:caudate nuclei atrophy | rel=r_associated | relid=0 | w=106
  362. en:white substance -- r_associated #0: 106 / 0.876 -> en:cavitating leukoencephalopathy
    n1=en:white substance | n2=en:cavitating leukoencephalopathy | rel=r_associated | relid=0 | w=106
  363. en:white substance -- r_associated #0: 106 / 0.876 -> en:cavitating white matter degeneration
    n1=en:white substance | n2=en:cavitating white matter degeneration | rel=r_associated | relid=0 | w=106
  364. en:white substance -- r_associated #0: 106 / 0.876 -> en:cavum septum pellucidum atrophy
    n1=en:white substance | n2=en:cavum septum pellucidum atrophy | rel=r_associated | relid=0 | w=106
  365. en:white substance -- r_associated #0: 106 / 0.876 -> en:cavum vergae
    n1=en:white substance | n2=en:cavum vergae | rel=r_associated | relid=0 | w=106
  366. en:white substance -- r_associated #0: 106 / 0.876 -> en:ccerebellar ataxia
    n1=en:white substance | n2=en:ccerebellar ataxia | rel=r_associated | relid=0 | w=106
  367. en:white substance -- r_associated #0: 106 / 0.876 -> en:cell loss and gliosis in the basal ganglia
    n1=en:white substance | n2=en:cell loss and gliosis in the basal ganglia | rel=r_associated | relid=0 | w=106
  368. en:white substance -- r_associated #0: 106 / 0.876 -> en:cellular aspects of
    n1=en:white substance | n2=en:cellular aspects of | rel=r_associated | relid=0 | w=106
  369. en:white substance -- r_associated #0: 106 / 0.876 -> en:cellular secretion
    n1=en:white substance | n2=en:cellular secretion | rel=r_associated | relid=0 | w=106
  370. en:white substance -- r_associated #0: 106 / 0.876 -> en:central facial palsy (in some patients)
    n1=en:white substance | n2=en:central facial palsy (in some patients) | rel=r_associated | relid=0 | w=106
  371. en:white substance -- r_associated #0: 106 / 0.876 -> en:central hypotonia
    n1=en:white substance | n2=en:central hypotonia | rel=r_associated | relid=0 | w=106
  372. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system
    n1=en:white substance | n2=en:central nervous system | rel=r_associated | relid=0 | w=106
  373. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system degeneration
    n1=en:white substance | n2=en:central nervous system degeneration | rel=r_associated | relid=0 | w=106
  374. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system demyelination
    n1=en:white substance | n2=en:central nervous system demyelination | rel=r_associated | relid=0 | w=106
  375. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system involvement (in some patients)
    n1=en:white substance | n2=en:central nervous system involvement (in some patients) | rel=r_associated | relid=0 | w=106
  376. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system malformations (40%)
    n1=en:white substance | n2=en:central nervous system malformations (40%) | rel=r_associated | relid=0 | w=106
  377. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system neoplasm
    n1=en:white substance | n2=en:central nervous system neoplasm | rel=r_associated | relid=0 | w=106
  378. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous system space
    n1=en:white substance | n2=en:central nervous system space | rel=r_associated | relid=0 | w=106
  379. en:white substance -- r_associated #0: 106 / 0.876 -> en:central nervous tissue
    n1=en:white substance | n2=en:central nervous tissue | rel=r_associated | relid=0 | w=106
  380. en:white substance -- r_associated #0: 106 / 0.876 -> en:central neural pathway/tract
    n1=en:white substance | n2=en:central neural pathway/tract | rel=r_associated | relid=0 | w=106
  381. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar and brainstem atrophy, mild (1 patient)
    n1=en:white substance | n2=en:cerebellar and brainstem atrophy, mild (1 patient) | rel=r_associated | relid=0 | w=106
  382. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia
    n1=en:white substance | n2=en:cerebellar ataxia | rel=r_associated | relid=0 | w=106
  383. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia (1 patient)
    n1=en:white substance | n2=en:cerebellar ataxia (1 patient) | rel=r_associated | relid=0 | w=106
  384. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia (rare)
    n1=en:white substance | n2=en:cerebellar ataxia (rare) | rel=r_associated | relid=0 | w=106
  385. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia (seen in hhs variant)
    n1=en:white substance | n2=en:cerebellar ataxia (seen in hhs variant) | rel=r_associated | relid=0 | w=106
  386. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia, adult-onset (in 1 family)
    n1=en:white substance | n2=en:cerebellar ataxia, adult-onset (in 1 family) | rel=r_associated | relid=0 | w=106
  387. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia, gait and stance
    n1=en:white substance | n2=en:cerebellar ataxia, gait and stance | rel=r_associated | relid=0 | w=106
  388. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia, mild, late-onset
    n1=en:white substance | n2=en:cerebellar ataxia, mild, late-onset | rel=r_associated | relid=0 | w=106
  389. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar ataxia, slowly progressive
    n1=en:white substance | n2=en:cerebellar ataxia, slowly progressive | rel=r_associated | relid=0 | w=106
  390. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy
    n1=en:white substance | n2=en:cerebellar atrophy | rel=r_associated | relid=0 | w=106
  391. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy (1 patient)
    n1=en:white substance | n2=en:cerebellar atrophy (1 patient) | rel=r_associated | relid=0 | w=106
  392. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy (96% of patients)
    n1=en:white substance | n2=en:cerebellar atrophy (96% of patients) | rel=r_associated | relid=0 | w=106
  393. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy (in 1 family)
    n1=en:white substance | n2=en:cerebellar atrophy (in 1 family) | rel=r_associated | relid=0 | w=106
  394. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy (in some patients)
    n1=en:white substance | n2=en:cerebellar atrophy (in some patients) | rel=r_associated | relid=0 | w=106
  395. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy (juvenile form)
    n1=en:white substance | n2=en:cerebellar atrophy (juvenile form) | rel=r_associated | relid=0 | w=106
  396. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy (reported in 1 patient)
    n1=en:white substance | n2=en:cerebellar atrophy (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  397. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy in older patients
    n1=en:white substance | n2=en:cerebellar atrophy in older patients | rel=r_associated | relid=0 | w=106
  398. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy with signal hyperintensity in the cerebellar cortex seen on t2-weighted mri
    n1=en:white substance | n2=en:cerebellar atrophy with signal hyperintensity in the cerebellar cortex seen on t2-weighted mri | rel=r_associated | relid=0 | w=106
  399. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, diffuse, severe
    n1=en:white substance | n2=en:cerebellar atrophy, diffuse, severe | rel=r_associated | relid=0 | w=106
  400. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, mild
    n1=en:white substance | n2=en:cerebellar atrophy, mild | rel=r_associated | relid=0 | w=106
  401. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, mild (in 1 of 3 families)
    n1=en:white substance | n2=en:cerebellar atrophy, mild (in 1 of 3 families) | rel=r_associated | relid=0 | w=106
  402. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, particularly of the hemispheres
    n1=en:white substance | n2=en:cerebellar atrophy, particularly of the hemispheres | rel=r_associated | relid=0 | w=106
  403. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, progressive (1 patient)
    n1=en:white substance | n2=en:cerebellar atrophy, progressive (1 patient) | rel=r_associated | relid=0 | w=106
  404. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, progressive (cerebellar vermal atrophy before cerebral atrophy)
    n1=en:white substance | n2=en:cerebellar atrophy, progressive (cerebellar vermal atrophy before cerebral atrophy) | rel=r_associated | relid=0 | w=106
  405. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar atrophy, progressive (in some patients)
    n1=en:white substance | n2=en:cerebellar atrophy, progressive (in some patients) | rel=r_associated | relid=0 | w=106
  406. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar cell paucity, more marked in vermis than hemispheres
    n1=en:white substance | n2=en:cerebellar cell paucity, more marked in vermis than hemispheres | rel=r_associated | relid=0 | w=106
  407. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar cortex shows normal layers
    n1=en:white substance | n2=en:cerebellar cortex shows normal layers | rel=r_associated | relid=0 | w=106
  408. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar cyst (rare)
    n1=en:white substance | n2=en:cerebellar cyst (rare) | rel=r_associated | relid=0 | w=106
  409. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar degeneration
    n1=en:white substance | n2=en:cerebellar degeneration | rel=r_associated | relid=0 | w=106
  410. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar dysfunction, progressive
    n1=en:white substance | n2=en:cerebellar dysfunction, progressive | rel=r_associated | relid=0 | w=106
  411. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar enlargement
    n1=en:white substance | n2=en:cerebellar enlargement | rel=r_associated | relid=0 | w=106
  412. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar gangliocytoma manifesting as seizure and tremor
    n1=en:white substance | n2=en:cerebellar gangliocytoma manifesting as seizure and tremor | rel=r_associated | relid=0 | w=106
  413. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hemangioblastoma
    n1=en:white substance | n2=en:cerebellar hemangioblastoma | rel=r_associated | relid=0 | w=106
  414. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar herniation (rare)
    n1=en:white substance | n2=en:cerebellar herniation (rare) | rel=r_associated | relid=0 | w=106
  415. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar heterotopias
    n1=en:white substance | n2=en:cerebellar heterotopias | rel=r_associated | relid=0 | w=106
  416. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia (in 1 of 2 patients)
    n1=en:white substance | n2=en:cerebellar hypoplasia (in 1 of 2 patients) | rel=r_associated | relid=0 | w=106
  417. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia (in 1 of 2 sibs)
    n1=en:white substance | n2=en:cerebellar hypoplasia (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=106
  418. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia (in most patients)
    n1=en:white substance | n2=en:cerebellar hypoplasia (in most patients) | rel=r_associated | relid=0 | w=106
  419. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia (in some)
    n1=en:white substance | n2=en:cerebellar hypoplasia (in some) | rel=r_associated | relid=0 | w=106
  420. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia (male)
    n1=en:white substance | n2=en:cerebellar hypoplasia (male) | rel=r_associated | relid=0 | w=106
  421. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia (seen in hhs variant)
    n1=en:white substance | n2=en:cerebellar hypoplasia (seen in hhs variant) | rel=r_associated | relid=0 | w=106
  422. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia due to enlarged foramen magnum
    n1=en:white substance | n2=en:cerebellar hypoplasia due to enlarged foramen magnum | rel=r_associated | relid=0 | w=106
  423. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia or agenesis
    n1=en:white substance | n2=en:cerebellar hypoplasia or agenesis | rel=r_associated | relid=0 | w=106
  424. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia predominantly affecting the vermis
    n1=en:white substance | n2=en:cerebellar hypoplasia predominantly affecting the vermis | rel=r_associated | relid=0 | w=106
  425. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar hypoplasia/atrophy (27%)
    n1=en:white substance | n2=en:cerebellar hypoplasia/atrophy (27%) | rel=r_associated | relid=0 | w=106
  426. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar lesion nos
    n1=en:white substance | n2=en:cerebellar lesion nos | rel=r_associated | relid=0 | w=106
  427. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar medulla
    n1=en:white substance | n2=en:cerebellar medulla | rel=r_associated | relid=0 | w=106
  428. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar neuronal loss
    n1=en:white substance | n2=en:cerebellar neuronal loss | rel=r_associated | relid=0 | w=106
  429. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar origin most likely
    n1=en:white substance | n2=en:cerebellar origin most likely | rel=r_associated | relid=0 | w=106
  430. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar signs
    n1=en:white substance | n2=en:cerebellar signs | rel=r_associated | relid=0 | w=106
  431. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar signs (in some patients)
    n1=en:white substance | n2=en:cerebellar signs (in some patients) | rel=r_associated | relid=0 | w=106
  432. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar signs (less common)
    n1=en:white substance | n2=en:cerebellar signs (less common) | rel=r_associated | relid=0 | w=106
  433. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar signs (may be permanent in 50% of patients)
    n1=en:white substance | n2=en:cerebellar signs (may be permanent in 50% of patients) | rel=r_associated | relid=0 | w=106
  434. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar signs during episodes
    n1=en:white substance | n2=en:cerebellar signs during episodes | rel=r_associated | relid=0 | w=106
  435. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar signs may develop
    n1=en:white substance | n2=en:cerebellar signs may develop | rel=r_associated | relid=0 | w=106
  436. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar stroke
    n1=en:white substance | n2=en:cerebellar stroke | rel=r_associated | relid=0 | w=106
  437. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar vermis aplasia or hypoplasia
    n1=en:white substance | n2=en:cerebellar vermis aplasia or hypoplasia | rel=r_associated | relid=0 | w=106
  438. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar vermis atrophy
    n1=en:white substance | n2=en:cerebellar vermis atrophy | rel=r_associated | relid=0 | w=106
  439. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar vermis hypoplasia
    n1=en:white substance | n2=en:cerebellar vermis hypoplasia | rel=r_associated | relid=0 | w=106
  440. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebellar vermis hypoplasia (in 1 patient)
    n1=en:white substance | n2=en:cerebellar vermis hypoplasia (in 1 patient) | rel=r_associated | relid=0 | w=106
  441. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral arterial hemorrhage
    n1=en:white substance | n2=en:cerebral arterial hemorrhage | rel=r_associated | relid=0 | w=106
  442. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy
    n1=en:white substance | n2=en:cerebral atrophy | rel=r_associated | relid=0 | w=106
  443. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy (1 patient)
    n1=en:white substance | n2=en:cerebral atrophy (1 patient) | rel=r_associated | relid=0 | w=106
  444. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy (in severe cases)
    n1=en:white substance | n2=en:cerebral atrophy (in severe cases) | rel=r_associated | relid=0 | w=106
  445. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy (in some patients)
    n1=en:white substance | n2=en:cerebral atrophy (in some patients) | rel=r_associated | relid=0 | w=106
  446. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy (rare)
    n1=en:white substance | n2=en:cerebral atrophy (rare) | rel=r_associated | relid=0 | w=106
  447. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy diffuse
    n1=en:white substance | n2=en:cerebral atrophy diffuse | rel=r_associated | relid=0 | w=106
  448. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy, frontotemporal, progressive
    n1=en:white substance | n2=en:cerebral atrophy, frontotemporal, progressive | rel=r_associated | relid=0 | w=106
  449. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy, generalized mild
    n1=en:white substance | n2=en:cerebral atrophy, generalized mild | rel=r_associated | relid=0 | w=106
  450. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy, mild
    n1=en:white substance | n2=en:cerebral atrophy, mild | rel=r_associated | relid=0 | w=106
  451. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral atrophy, progressive, from anterior to posterior
    n1=en:white substance | n2=en:cerebral atrophy, progressive, from anterior to posterior | rel=r_associated | relid=0 | w=106
  452. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral calcification
    n1=en:white substance | n2=en:cerebral calcification | rel=r_associated | relid=0 | w=106
  453. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral cortex myoclonus
    n1=en:white substance | n2=en:cerebral cortex myoclonus | rel=r_associated | relid=0 | w=106
  454. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral cortical and cerebellar atrophy (patient a)
    n1=en:white substance | n2=en:cerebral cortical and cerebellar atrophy (patient a) | rel=r_associated | relid=0 | w=106
  455. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral cortical atrophy, diffuse
    n1=en:white substance | n2=en:cerebral cortical atrophy, diffuse | rel=r_associated | relid=0 | w=106
  456. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral cortical neurodegeneration
    n1=en:white substance | n2=en:cerebral cortical neurodegeneration | rel=r_associated | relid=0 | w=106
  457. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral dysmyelination
    n1=en:white substance | n2=en:cerebral dysmyelination | rel=r_associated | relid=0 | w=106
  458. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral edema
    n1=en:white substance | n2=en:cerebral edema | rel=r_associated | relid=0 | w=106
  459. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral hemorrhage
    n1=en:white substance | n2=en:cerebral hemorrhage | rel=r_associated | relid=0 | w=106
  460. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral infarction
    n1=en:white substance | n2=en:cerebral infarction | rel=r_associated | relid=0 | w=106
  461. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral infarction dandy-walker malformation
    n1=en:white substance | n2=en:cerebral infarction dandy-walker malformation | rel=r_associated | relid=0 | w=106
  462. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral oligogyria
    n1=en:white substance | n2=en:cerebral oligogyria | rel=r_associated | relid=0 | w=106
  463. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral palsy
    n1=en:white substance | n2=en:cerebral palsy | rel=r_associated | relid=0 | w=106
  464. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral spongiosis
    n1=en:white substance | n2=en:cerebral spongiosis | rel=r_associated | relid=0 | w=106
  465. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral thrombosis
    n1=en:white substance | n2=en:cerebral thrombosis | rel=r_associated | relid=0 | w=106
  466. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral vasculitis or vasculopathy (rare)
    n1=en:white substance | n2=en:cerebral vasculitis or vasculopathy (rare) | rel=r_associated | relid=0 | w=106
  467. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral white matter atrophy, progressive
    n1=en:white substance | n2=en:cerebral white matter atrophy, progressive | rel=r_associated | relid=0 | w=106
  468. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebral white matter lesion
    n1=en:white substance | n2=en:cerebral white matter lesion | rel=r_associated | relid=0 | w=106
  469. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebrovascular accident
    n1=en:white substance | n2=en:cerebrovascular accident | rel=r_associated | relid=0 | w=106
  470. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebrovascular ischemia
    n1=en:white substance | n2=en:cerebrovascular ischemia | rel=r_associated | relid=0 | w=106
  471. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings)
    n1=en:white substance | n2=en:cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings) | rel=r_associated | relid=0 | w=106
  472. en:white substance -- r_associated #0: 106 / 0.876 -> en:cerebrum
    n1=en:white substance | n2=en:cerebrum | rel=r_associated | relid=0 | w=106
  473. en:white substance -- r_associated #0: 106 / 0.876 -> en:cervical cord compression
    n1=en:white substance | n2=en:cervical cord compression | rel=r_associated | relid=0 | w=106
  474. en:white substance -- r_associated #0: 106 / 0.876 -> en:cervical myelopathy
    n1=en:white substance | n2=en:cervical myelopathy | rel=r_associated | relid=0 | w=106
  475. en:white substance -- r_associated #0: 106 / 0.876 -> en:cervical segment of spinal cord
    n1=en:white substance | n2=en:cervical segment of spinal cord | rel=r_associated | relid=0 | w=106
  476. en:white substance -- r_associated #0: 106 / 0.876 -> en:characteristic arm position with wrist and elbow flexion
    n1=en:white substance | n2=en:characteristic arm position with wrist and elbow flexion | rel=r_associated | relid=0 | w=106
  477. en:white substance -- r_associated #0: 106 / 0.876 -> en:characteristic findings on mri
    n1=en:white substance | n2=en:characteristic findings on mri | rel=r_associated | relid=0 | w=106
  478. en:white substance -- r_associated #0: 106 / 0.876 -> en:chemical aspects
    n1=en:white substance | n2=en:chemical aspects | rel=r_associated | relid=0 | w=106
  479. en:white substance -- r_associated #0: 106 / 0.876 -> en:chiari i malformation on mri
    n1=en:white substance | n2=en:chiari i malformation on mri | rel=r_associated | relid=0 | w=106
  480. en:white substance -- r_associated #0: 106 / 0.876 -> en:chiari malformation type ii
    n1=en:white substance | n2=en:chiari malformation type ii | rel=r_associated | relid=0 | w=106
  481. en:white substance -- r_associated #0: 106 / 0.876 -> en:chiari type i malformation (in some patients)
    n1=en:white substance | n2=en:chiari type i malformation (in some patients) | rel=r_associated | relid=0 | w=106
  482. en:white substance -- r_associated #0: 106 / 0.876 -> en:childhood polyphagia
    n1=en:white substance | n2=en:childhood polyphagia | rel=r_associated | relid=0 | w=106
  483. en:white substance -- r_associated #0: 106 / 0.876 -> en:chorea
    n1=en:white substance | n2=en:chorea | rel=r_associated | relid=0 | w=106
  484. en:white substance -- r_associated #0: 106 / 0.876 -> en:chorea (in some patients)
    n1=en:white substance | n2=en:chorea (in some patients) | rel=r_associated | relid=0 | w=106
  485. en:white substance -- r_associated #0: 106 / 0.876 -> en:chorea of all limbs
    n1=en:white substance | n2=en:chorea of all limbs | rel=r_associated | relid=0 | w=106
  486. en:white substance -- r_associated #0: 106 / 0.876 -> en:chorea of hands
    n1=en:white substance | n2=en:chorea of hands | rel=r_associated | relid=0 | w=106
  487. en:white substance -- r_associated #0: 106 / 0.876 -> en:chorea, mild (in some)
    n1=en:white substance | n2=en:chorea, mild (in some) | rel=r_associated | relid=0 | w=106
  488. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreic movements (10 to 22% of patients)
    n1=en:white substance | n2=en:choreic movements (10 to 22% of patients) | rel=r_associated | relid=0 | w=106
  489. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreoathetoid movements
    n1=en:white substance | n2=en:choreoathetoid movements | rel=r_associated | relid=0 | w=106
  490. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreoathetosis
    n1=en:white substance | n2=en:choreoathetosis | rel=r_associated | relid=0 | w=106
  491. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreoathetosis (2 patients)
    n1=en:white substance | n2=en:choreoathetosis (2 patients) | rel=r_associated | relid=0 | w=106
  492. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreoathetosis (described in 1 patient)
    n1=en:white substance | n2=en:choreoathetosis (described in 1 patient) | rel=r_associated | relid=0 | w=106
  493. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreoathetosis of the face, trunk, extremities
    n1=en:white substance | n2=en:choreoathetosis of the face, trunk, extremities | rel=r_associated | relid=0 | w=106
  494. en:white substance -- r_associated #0: 106 / 0.876 -> en:choreodystonia of the upper limbs
    n1=en:white substance | n2=en:choreodystonia of the upper limbs | rel=r_associated | relid=0 | w=106
  495. en:white substance -- r_associated #0: 106 / 0.876 -> en:choroid plexus cyst
    n1=en:white substance | n2=en:choroid plexus cyst | rel=r_associated | relid=0 | w=106
  496. en:white substance -- r_associated #0: 106 / 0.876 -> en:chronic encephalopathy
    n1=en:white substance | n2=en:chronic encephalopathy | rel=r_associated | relid=0 | w=106
  497. en:white substance -- r_associated #0: 106 / 0.876 -> en:chronic headaches
    n1=en:white substance | n2=en:chronic headaches | rel=r_associated | relid=0 | w=106
  498. en:white substance -- r_associated #0: 106 / 0.876 -> en:chronic pain
    n1=en:white substance | n2=en:chronic pain | rel=r_associated | relid=0 | w=106
  499. en:white substance -- r_associated #0: 106 / 0.876 -> en:chronic subtype, headaches occur without remission for 1 year
    n1=en:white substance | n2=en:chronic subtype, headaches occur without remission for 1 year | rel=r_associated | relid=0 | w=106
  500. en:white substance -- r_associated #0: 106 / 0.876 -> en:chronic-progressive course with episodes of rapid deterioration following fever or head trauma
    n1=en:white substance | n2=en:chronic-progressive course with episodes of rapid deterioration following fever or head trauma | rel=r_associated | relid=0 | w=106
  501. en:white substance -- r_associated #0: 106 / 0.876 -> en:clonic convulsion
    n1=en:white substance | n2=en:clonic convulsion | rel=r_associated | relid=0 | w=106
  502. en:white substance -- r_associated #0: 106 / 0.876 -> en:clonus
    n1=en:white substance | n2=en:clonus | rel=r_associated | relid=0 | w=106
  503. en:white substance -- r_associated #0: 106 / 0.876 -> en:clonus may occur
    n1=en:white substance | n2=en:clonus may occur | rel=r_associated | relid=0 | w=106
  504. en:white substance -- r_associated #0: 106 / 0.876 -> en:closed-lip schizencephaly
    n1=en:white substance | n2=en:closed-lip schizencephaly | rel=r_associated | relid=0 | w=106
  505. en:white substance -- r_associated #0: 106 / 0.876 -> en:clumsiness
    n1=en:white substance | n2=en:clumsiness | rel=r_associated | relid=0 | w=106
  506. en:white substance -- r_associated #0: 106 / 0.876 -> en:clumsiness in childhood
    n1=en:white substance | n2=en:clumsiness in childhood | rel=r_associated | relid=0 | w=106
  507. en:white substance -- r_associated #0: 106 / 0.876 -> en:clumsiness, unsteadiness
    n1=en:white substance | n2=en:clumsiness, unsteadiness | rel=r_associated | relid=0 | w=106
  508. en:white substance -- r_associated #0: 106 / 0.876 -> en:clumsy gait
    n1=en:white substance | n2=en:clumsy gait | rel=r_associated | relid=0 | w=106
  509. en:white substance -- r_associated #0: 106 / 0.876 -> en:cns venous malformations
    n1=en:white substance | n2=en:cns venous malformations | rel=r_associated | relid=0 | w=106
  510. en:white substance -- r_associated #0: 106 / 0.876 -> en:coarse tremors
    n1=en:white substance | n2=en:coarse tremors | rel=r_associated | relid=0 | w=106
  511. en:white substance -- r_associated #0: 106 / 0.876 -> en:cobblestone lissencephaly
    n1=en:white substance | n2=en:cobblestone lissencephaly | rel=r_associated | relid=0 | w=106
  512. en:white substance -- r_associated #0: 106 / 0.876 -> en:cobblestone lissencephaly (1 patient)
    n1=en:white substance | n2=en:cobblestone lissencephaly (1 patient) | rel=r_associated | relid=0 | w=106
  513. en:white substance -- r_associated #0: 106 / 0.876 -> en:cobblestone lissencephaly (posterior brain regions more affected than anterior regions)
    n1=en:white substance | n2=en:cobblestone lissencephaly (posterior brain regions more affected than anterior regions) | rel=r_associated | relid=0 | w=106
  514. en:white substance -- r_associated #0: 106 / 0.876 -> en:cobblestone lissencephaly, type ii
    n1=en:white substance | n2=en:cobblestone lissencephaly, type ii | rel=r_associated | relid=0 | w=106
  515. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognition is preserved
    n1=en:white substance | n2=en:cognition is preserved | rel=r_associated | relid=0 | w=106
  516. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognition is spared
    n1=en:white substance | n2=en:cognition is spared | rel=r_associated | relid=0 | w=106
  517. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive decline (rare)
    n1=en:white substance | n2=en:cognitive decline (rare) | rel=r_associated | relid=0 | w=106
  518. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive decline in adulthood
    n1=en:white substance | n2=en:cognitive decline in adulthood | rel=r_associated | relid=0 | w=106
  519. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive decline in older patients
    n1=en:white substance | n2=en:cognitive decline in older patients | rel=r_associated | relid=0 | w=106
  520. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive defects (rare)
    n1=en:white substance | n2=en:cognitive defects (rare) | rel=r_associated | relid=0 | w=106
  521. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive defects (variable from mild to severe)
    n1=en:white substance | n2=en:cognitive defects (variable from mild to severe) | rel=r_associated | relid=0 | w=106
  522. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive defects in executive function and attention
    n1=en:white substance | n2=en:cognitive defects in executive function and attention | rel=r_associated | relid=0 | w=106
  523. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive deficits (less common)
    n1=en:white substance | n2=en:cognitive deficits (less common) | rel=r_associated | relid=0 | w=106
  524. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive delay
    n1=en:white substance | n2=en:cognitive delay | rel=r_associated | relid=0 | w=106
  525. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive delay, mild to severe
    n1=en:white substance | n2=en:cognitive delay, mild to severe | rel=r_associated | relid=0 | w=106
  526. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive dysfunction
    n1=en:white substance | n2=en:cognitive dysfunction | rel=r_associated | relid=0 | w=106
  527. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive dysfunction (in some patients)
    n1=en:white substance | n2=en:cognitive dysfunction (in some patients) | rel=r_associated | relid=0 | w=106
  528. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive dysfunction (rare)
    n1=en:white substance | n2=en:cognitive dysfunction (rare) | rel=r_associated | relid=0 | w=106
  529. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive function, variable
    n1=en:white substance | n2=en:cognitive function, variable | rel=r_associated | relid=0 | w=106
  530. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment (3 patients)
    n1=en:white substance | n2=en:cognitive impairment (3 patients) | rel=r_associated | relid=0 | w=106
  531. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment (cvs+)
    n1=en:white substance | n2=en:cognitive impairment (cvs+) | rel=r_associated | relid=0 | w=106
  532. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment (in 1 of 3 patients)
    n1=en:white substance | n2=en:cognitive impairment (in 1 of 3 patients) | rel=r_associated | relid=0 | w=106
  533. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment (in some patients)
    n1=en:white substance | n2=en:cognitive impairment (in some patients) | rel=r_associated | relid=0 | w=106
  534. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment, gradual onset
    n1=en:white substance | n2=en:cognitive impairment, gradual onset | rel=r_associated | relid=0 | w=106
  535. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment, mild (1 patient)
    n1=en:white substance | n2=en:cognitive impairment, mild (1 patient) | rel=r_associated | relid=0 | w=106
  536. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment, mild (44%)
    n1=en:white substance | n2=en:cognitive impairment, mild (44%) | rel=r_associated | relid=0 | w=106
  537. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment, mild (in 2 of 3 patients)
    n1=en:white substance | n2=en:cognitive impairment, mild (in 2 of 3 patients) | rel=r_associated | relid=0 | w=106
  538. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment, mild to moderate
    n1=en:white substance | n2=en:cognitive impairment, mild to moderate | rel=r_associated | relid=0 | w=106
  539. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive impairment, mild to severe
    n1=en:white substance | n2=en:cognitive impairment, mild to severe | rel=r_associated | relid=0 | w=106
  540. en:white substance -- r_associated #0: 106 / 0.876 -> en:cognitive regression
    n1=en:white substance | n2=en:cognitive regression | rel=r_associated | relid=0 | w=106
  541. en:white substance -- r_associated #0: 106 / 0.876 -> en:cogwheel rigidities
    n1=en:white substance | n2=en:cogwheel rigidities | rel=r_associated | relid=0 | w=106
  542. en:white substance -- r_associated #0: 106 / 0.876 -> en:colpocephaly
    n1=en:white substance | n2=en:colpocephaly | rel=r_associated | relid=0 | w=106
  543. en:white substance -- r_associated #0: 106 / 0.876 -> en:coma
    n1=en:white substance | n2=en:coma | rel=r_associated | relid=0 | w=106
  544. en:white substance -- r_associated #0: 106 / 0.876 -> en:coma (if untreated)
    n1=en:white substance | n2=en:coma (if untreated) | rel=r_associated | relid=0 | w=106
  545. en:white substance -- r_associated #0: 106 / 0.876 -> en:coma (in up to 33% of patients)
    n1=en:white substance | n2=en:coma (in up to 33% of patients) | rel=r_associated | relid=0 | w=106
  546. en:white substance -- r_associated #0: 106 / 0.876 -> en:coma (less common)
    n1=en:white substance | n2=en:coma (less common) | rel=r_associated | relid=0 | w=106
  547. en:white substance -- r_associated #0: 106 / 0.876 -> en:coma may occur after force feeding of high protein diet
    n1=en:white substance | n2=en:coma may occur after force feeding of high protein diet | rel=r_associated | relid=0 | w=106
  548. en:white substance -- r_associated #0: 106 / 0.876 -> en:commissure of neuraxis
    n1=en:white substance | n2=en:commissure of neuraxis | rel=r_associated | relid=0 | w=106
  549. en:white substance -- r_associated #0: 106 / 0.876 -> en:communication defects
    n1=en:white substance | n2=en:communication defects | rel=r_associated | relid=0 | w=106
  550. en:white substance -- r_associated #0: 106 / 0.876 -> en:complete or partial absence of the corpus callosum
    n1=en:white substance | n2=en:complete or partial absence of the corpus callosum | rel=r_associated | relid=0 | w=106
  551. en:white substance -- r_associated #0: 106 / 0.876 -> en:complex partial seizures
    n1=en:white substance | n2=en:complex partial seizures | rel=r_associated | relid=0 | w=106
  552. en:white substance -- r_associated #0: 106 / 0.876 -> en:complex partial seizures (in some patients)
    n1=en:white substance | n2=en:complex partial seizures (in some patients) | rel=r_associated | relid=0 | w=106
  553. en:white substance -- r_associated #0: 106 / 0.876 -> en:complex partial seizures, often with secondary generalization, are the most common type
    n1=en:white substance | n2=en:complex partial seizures, often with secondary generalization, are the most common type | rel=r_associated | relid=0 | w=106
  554. en:white substance -- r_associated #0: 106 / 0.876 -> en:concentration impairment
    n1=en:white substance | n2=en:concentration impairment | rel=r_associated | relid=0 | w=106
  555. en:white substance -- r_associated #0: 106 / 0.876 -> en:confusion (later-onset)
    n1=en:white substance | n2=en:confusion (later-onset) | rel=r_associated | relid=0 | w=106
  556. en:white substance -- r_associated #0: 106 / 0.876 -> en:congenital absence of the vermis
    n1=en:white substance | n2=en:congenital absence of the vermis | rel=r_associated | relid=0 | w=106
  557. en:white substance -- r_associated #0: 106 / 0.876 -> en:congenital cerebellar hypoplasia
    n1=en:white substance | n2=en:congenital cerebellar hypoplasia | rel=r_associated | relid=0 | w=106
  558. en:white substance -- r_associated #0: 106 / 0.876 -> en:congenital hypotonia, mild
    n1=en:white substance | n2=en:congenital hypotonia, mild | rel=r_associated | relid=0 | w=106
  559. en:white substance -- r_associated #0: 106 / 0.876 -> en:consciousness fluctuating
    n1=en:white substance | n2=en:consciousness fluctuating | rel=r_associated | relid=0 | w=106
  560. en:white substance -- r_associated #0: 106 / 0.876 -> en:constructional apraxia (in a subset of patients)
    n1=en:white substance | n2=en:constructional apraxia (in a subset of patients) | rel=r_associated | relid=0 | w=106
  561. en:white substance -- r_associated #0: 106 / 0.876 -> en:continuous spike-wave discharges during sleep
    n1=en:white substance | n2=en:continuous spike-wave discharges during sleep | rel=r_associated | relid=0 | w=106
  562. en:white substance -- r_associated #0: 106 / 0.876 -> en:continuous spike-waves during slow-wave sleep
    n1=en:white substance | n2=en:continuous spike-waves during slow-wave sleep | rel=r_associated | relid=0 | w=106
  563. en:white substance -- r_associated #0: 106 / 0.876 -> en:contractures (older children and adolescents)
    n1=en:white substance | n2=en:contractures (older children and adolescents) | rel=r_associated | relid=0 | w=106
  564. en:white substance -- r_associated #0: 106 / 0.876 -> en:convulsions, febrile (in some patients)
    n1=en:white substance | n2=en:convulsions, febrile (in some patients) | rel=r_associated | relid=0 | w=106
  565. en:white substance -- r_associated #0: 106 / 0.876 -> en:convulsive seizures
    n1=en:white substance | n2=en:convulsive seizures | rel=r_associated | relid=0 | w=106
  566. en:white substance -- r_associated #0: 106 / 0.876 -> en:corpus callosum abnormalities (in some patients)
    n1=en:white substance | n2=en:corpus callosum abnormalities (in some patients) | rel=r_associated | relid=0 | w=106
  567. en:white substance -- r_associated #0: 106 / 0.876 -> en:corpus callosum lipoma
    n1=en:white substance | n2=en:corpus callosum lipoma | rel=r_associated | relid=0 | w=106
  568. en:white substance -- r_associated #0: 106 / 0.876 -> en:corpus callosum, agenesis of (in some patients)
    n1=en:white substance | n2=en:corpus callosum, agenesis of (in some patients) | rel=r_associated | relid=0 | w=106
  569. en:white substance -- r_associated #0: 106 / 0.876 -> en:corpus callosum, thin (rare)
    n1=en:white substance | n2=en:corpus callosum, thin (rare) | rel=r_associated | relid=0 | w=106
  570. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical and brainstem neuronal loss
    n1=en:white substance | n2=en:cortical and brainstem neuronal loss | rel=r_associated | relid=0 | w=106
  571. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical and subcortical atrophy (1 patient)
    n1=en:white substance | n2=en:cortical and subcortical atrophy (1 patient) | rel=r_associated | relid=0 | w=106
  572. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical and subcortical hyperintensities
    n1=en:white substance | n2=en:cortical and subcortical hyperintensities | rel=r_associated | relid=0 | w=106
  573. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical and subcortical neuronal loss in the frontal and temporal regions
    n1=en:white substance | n2=en:cortical and subcortical neuronal loss in the frontal and temporal regions | rel=r_associated | relid=0 | w=106
  574. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical and subcortical regions involved
    n1=en:white substance | n2=en:cortical and subcortical regions involved | rel=r_associated | relid=0 | w=106
  575. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical atrophy (43%)
    n1=en:white substance | n2=en:cortical atrophy (43%) | rel=r_associated | relid=0 | w=106
  576. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical atrophy (frontal area)
    n1=en:white substance | n2=en:cortical atrophy (frontal area) | rel=r_associated | relid=0 | w=106
  577. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical atrophy (in 2 siblings)
    n1=en:white substance | n2=en:cortical atrophy (in 2 siblings) | rel=r_associated | relid=0 | w=106
  578. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical atrophy, progressive
    n1=en:white substance | n2=en:cortical atrophy, progressive | rel=r_associated | relid=0 | w=106
  579. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical blindness (in 1 moroccan patient)
    n1=en:white substance | n2=en:cortical blindness (in 1 moroccan patient) | rel=r_associated | relid=0 | w=106
  580. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical cell layer
    n1=en:white substance | n2=en:cortical cell layer | rel=r_associated | relid=0 | w=106
  581. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical cytotoxic edema
    n1=en:white substance | n2=en:cortical cytotoxic edema | rel=r_associated | relid=0 | w=106
  582. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical degeneration
    n1=en:white substance | n2=en:cortical degeneration | rel=r_associated | relid=0 | w=106
  583. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical dysplasia
    n1=en:white substance | n2=en:cortical dysplasia | rel=r_associated | relid=0 | w=106
  584. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical dysplasia (1 patient)
    n1=en:white substance | n2=en:cortical dysplasia (1 patient) | rel=r_associated | relid=0 | w=106
  585. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical dysplasia (2 patients)
    n1=en:white substance | n2=en:cortical dysplasia (2 patients) | rel=r_associated | relid=0 | w=106
  586. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical dysplasia, focal (1 patient)
    n1=en:white substance | n2=en:cortical dysplasia, focal (1 patient) | rel=r_associated | relid=0 | w=106
  587. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical gyral simplification
    n1=en:white substance | n2=en:cortical gyral simplification | rel=r_associated | relid=0 | w=106
  588. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical hypergyria (in some patients)
    n1=en:white substance | n2=en:cortical hypergyria (in some patients) | rel=r_associated | relid=0 | w=106
  589. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical malformations
    n1=en:white substance | n2=en:cortical malformations | rel=r_associated | relid=0 | w=106
  590. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical myoclonic tremors characterized by 8 to 10-hz discharges
    n1=en:white substance | n2=en:cortical myoclonic tremors characterized by 8 to 10-hz discharges | rel=r_associated | relid=0 | w=106
  591. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical neuronal loss
    n1=en:white substance | n2=en:cortical neuronal loss | rel=r_associated | relid=0 | w=106
  592. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical origin of the tremor
    n1=en:white substance | n2=en:cortical origin of the tremor | rel=r_associated | relid=0 | w=106
  593. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical reflex myoclonus
    n1=en:white substance | n2=en:cortical reflex myoclonus | rel=r_associated | relid=0 | w=106
  594. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical simplification
    n1=en:white substance | n2=en:cortical simplification | rel=r_associated | relid=0 | w=106
  595. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical thinning
    n1=en:white substance | n2=en:cortical thinning | rel=r_associated | relid=0 | w=106
  596. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical tubers
    n1=en:white substance | n2=en:cortical tubers | rel=r_associated | relid=0 | w=106
  597. en:white substance -- r_associated #0: 106 / 0.876 -> en:cortical venous thromboses
    n1=en:white substance | n2=en:cortical venous thromboses | rel=r_associated | relid=0 | w=106
  598. en:white substance -- r_associated #0: 106 / 0.876 -> en:corticobasal degeneration (in some patients)
    n1=en:white substance | n2=en:corticobasal degeneration (in some patients) | rel=r_associated | relid=0 | w=106
  599. en:white substance -- r_associated #0: 106 / 0.876 -> en:corticospinal signs (87% of patients in 1 report)
    n1=en:white substance | n2=en:corticospinal signs (87% of patients in 1 report) | rel=r_associated | relid=0 | w=106
  600. en:white substance -- r_associated #0: 106 / 0.876 -> en:corticospinal tract atrophy
    n1=en:white substance | n2=en:corticospinal tract atrophy | rel=r_associated | relid=0 | w=106
  601. en:white substance -- r_associated #0: 106 / 0.876 -> en:corticospinal tract hypoplasia
    n1=en:white substance | n2=en:corticospinal tract hypoplasia | rel=r_associated | relid=0 | w=106
  602. en:white substance -- r_associated #0: 106 / 0.876 -> en:cranial nerve anomalies
    n1=en:white substance | n2=en:cranial nerve anomalies | rel=r_associated | relid=0 | w=106
  603. en:white substance -- r_associated #0: 106 / 0.876 -> en:cranial nerve dysfunction
    n1=en:white substance | n2=en:cranial nerve dysfunction | rel=r_associated | relid=0 | w=106
  604. en:white substance -- r_associated #0: 106 / 0.876 -> en:cranial nerve palsies can arise with head and neck paragangliomas
    n1=en:white substance | n2=en:cranial nerve palsies can arise with head and neck paragangliomas | rel=r_associated | relid=0 | w=106
  605. en:white substance -- r_associated #0: 106 / 0.876 -> en:crawling and standing not achieved
    n1=en:white substance | n2=en:crawling and standing not achieved | rel=r_associated | relid=0 | w=106
  606. en:white substance -- r_associated #0: 106 / 0.876 -> en:ct scan shows dense calcifications in the basal ganglia
    n1=en:white substance | n2=en:ct scan shows dense calcifications in the basal ganglia | rel=r_associated | relid=0 | w=106
  607. en:white substance -- r_associated #0: 106 / 0.876 -> en:cystic cavitation of the white matter
    n1=en:white substance | n2=en:cystic cavitation of the white matter | rel=r_associated | relid=0 | w=106
  608. en:white substance -- r_associated #0: 106 / 0.876 -> en:cystic degeneration of cerebral white matter with preserved cortex
    n1=en:white substance | n2=en:cystic degeneration of cerebral white matter with preserved cortex | rel=r_associated | relid=0 | w=106
  609. en:white substance -- r_associated #0: 106 / 0.876 -> en:cystic degeneration of the white matter
    n1=en:white substance | n2=en:cystic degeneration of the white matter | rel=r_associated | relid=0 | w=106
  610. en:white substance -- r_associated #0: 106 / 0.876 -> en:cystic destruction of brain tissue, including basal ganglia
    n1=en:white substance | n2=en:cystic destruction of brain tissue, including basal ganglia | rel=r_associated | relid=0 | w=106
  611. en:white substance -- r_associated #0: 106 / 0.876 -> en:cystic lesions in the basal ganglia, brainstem, and cerebral hemispheres similar to leigh syndrome (256000)
    n1=en:white substance | n2=en:cystic lesions in the basal ganglia, brainstem, and cerebral hemispheres similar to leigh syndrome (256000) | rel=r_associated | relid=0 | w=106
  612. en:white substance -- r_associated #0: 106 / 0.876 -> en:cytopathic effect
    n1=en:white substance | n2=en:cytopathic effect | rel=r_associated | relid=0 | w=106
  613. en:white substance -- r_associated #0: 106 / 0.876 -> en:dandy-walker malformation
    n1=en:white substance | n2=en:dandy-walker malformation | rel=r_associated | relid=0 | w=106
  614. en:white substance -- r_associated #0: 106 / 0.876 -> en:dandy-walker malformation (in 1 of 4 patients)
    n1=en:white substance | n2=en:dandy-walker malformation (in 1 of 4 patients) | rel=r_associated | relid=0 | w=106
  615. en:white substance -- r_associated #0: 106 / 0.876 -> en:dandy-walker malformation (variable)
    n1=en:white substance | n2=en:dandy-walker malformation (variable) | rel=r_associated | relid=0 | w=106
  616. en:white substance -- r_associated #0: 106 / 0.876 -> en:dandy-walker malformation (wws)
    n1=en:white substance | n2=en:dandy-walker malformation (wws) | rel=r_associated | relid=0 | w=106
  617. en:white substance -- r_associated #0: 106 / 0.876 -> en:deafness
    n1=en:white substance | n2=en:deafness | rel=r_associated | relid=0 | w=106
  618. en:white substance -- r_associated #0: 106 / 0.876 -> en:decerebrate or decorticate posturing late
    n1=en:white substance | n2=en:decerebrate or decorticate posturing late | rel=r_associated | relid=0 | w=106
  619. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased amount of myelin-specific lipids
    n1=en:white substance | n2=en:decreased amount of myelin-specific lipids | rel=r_associated | relid=0 | w=106
  620. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased amount of myelin-specific proteins
    n1=en:white substance | n2=en:decreased amount of myelin-specific proteins | rel=r_associated | relid=0 | w=106
  621. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased brain volume (female)
    n1=en:white substance | n2=en:decreased brain volume (female) | rel=r_associated | relid=0 | w=106
  622. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased brain weight
    n1=en:white substance | n2=en:decreased brain weight | rel=r_associated | relid=0 | w=106
  623. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased cerebellar folia
    n1=en:white substance | n2=en:decreased cerebellar folia | rel=r_associated | relid=0 | w=106
  624. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased cerebral volume, especially of the frontal lobes
    n1=en:white substance | n2=en:decreased cerebral volume, especially of the frontal lobes | rel=r_associated | relid=0 | w=106
  625. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased cognition (later-onset)
    n1=en:white substance | n2=en:decreased cognition (later-onset) | rel=r_associated | relid=0 | w=106
  626. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased core body temperature
    n1=en:white substance | n2=en:decreased core body temperature | rel=r_associated | relid=0 | w=106
  627. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased csf volume in posterior fossa
    n1=en:white substance | n2=en:decreased csf volume in posterior fossa | rel=r_associated | relid=0 | w=106
  628. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased delineation of the basal ganglia (in some patients)
    n1=en:white substance | n2=en:decreased delineation of the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=106
  629. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased fine motor coordination
    n1=en:white substance | n2=en:decreased fine motor coordination | rel=r_associated | relid=0 | w=106
  630. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased iq
    n1=en:white substance | n2=en:decreased iq | rel=r_associated | relid=0 | w=106
  631. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased iq (1 patient)
    n1=en:white substance | n2=en:decreased iq (1 patient) | rel=r_associated | relid=0 | w=106
  632. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased iq (some patients)
    n1=en:white substance | n2=en:decreased iq (some patients) | rel=r_associated | relid=0 | w=106
  633. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased iron content in the substantia nigra
    n1=en:white substance | n2=en:decreased iron content in the substantia nigra | rel=r_associated | relid=0 | w=106
  634. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased mental processing speed
    n1=en:white substance | n2=en:decreased mental processing speed | rel=r_associated | relid=0 | w=106
  635. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased myelin
    n1=en:white substance | n2=en:decreased myelin | rel=r_associated | relid=0 | w=106
  636. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased myelination seen on mri
    n1=en:white substance | n2=en:decreased myelination seen on mri | rel=r_associated | relid=0 | w=106
  637. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased n-acetylaspartate
    n1=en:white substance | n2=en:decreased n-acetylaspartate | rel=r_associated | relid=0 | w=106
  638. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased nonverbal iq
    n1=en:white substance | n2=en:decreased nonverbal iq | rel=r_associated | relid=0 | w=106
  639. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased numbers of astrocytes
    n1=en:white substance | n2=en:decreased numbers of astrocytes | rel=r_associated | relid=0 | w=106
  640. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased pyramidal cells
    n1=en:white substance | n2=en:decreased pyramidal cells | rel=r_associated | relid=0 | w=106
  641. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased rapid automatized naming (ran) speed
    n1=en:white substance | n2=en:decreased rapid automatized naming (ran) speed | rel=r_associated | relid=0 | w=106
  642. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased reflexes (in some patients)
    n1=en:white substance | n2=en:decreased reflexes (in some patients) | rel=r_associated | relid=0 | w=106
  643. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased sleep latency
    n1=en:white substance | n2=en:decreased sleep latency | rel=r_associated | relid=0 | w=106
  644. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased speech
    n1=en:white substance | n2=en:decreased speech | rel=r_associated | relid=0 | w=106
  645. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased spontaneous movements at birth
    n1=en:white substance | n2=en:decreased spontaneous movements at birth | rel=r_associated | relid=0 | w=106
  646. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased supratentorial volume
    n1=en:white substance | n2=en:decreased supratentorial volume | rel=r_associated | relid=0 | w=106
  647. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased tendon reflex
    n1=en:white substance | n2=en:decreased tendon reflex | rel=r_associated | relid=0 | w=106
  648. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased vibration sense, suggesting posterior column involvement
    n1=en:white substance | n2=en:decreased vibration sense, suggesting posterior column involvement | rel=r_associated | relid=0 | w=106
  649. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased vibratory sense
    n1=en:white substance | n2=en:decreased vibratory sense | rel=r_associated | relid=0 | w=106
  650. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased volume of the posterior cranial fossa with normal hindbrain volume
    n1=en:white substance | n2=en:decreased volume of the posterior cranial fossa with normal hindbrain volume | rel=r_associated | relid=0 | w=106
  651. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased white matter
    n1=en:white substance | n2=en:decreased white matter | rel=r_associated | relid=0 | w=106
  652. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreased white matter volume
    n1=en:white substance | n2=en:decreased white matter volume | rel=r_associated | relid=0 | w=106
  653. en:white substance -- r_associated #0: 106 / 0.876 -> en:decreasing responsiveness
    n1=en:white substance | n2=en:decreasing responsiveness | rel=r_associated | relid=0 | w=106
  654. en:white substance -- r_associated #0: 106 / 0.876 -> en:deep posterior interpeduncular fossa
    n1=en:white substance | n2=en:deep posterior interpeduncular fossa | rel=r_associated | relid=0 | w=106
  655. en:white substance -- r_associated #0: 106 / 0.876 -> en:defect in axonal guidance
    n1=en:white substance | n2=en:defect in axonal guidance | rel=r_associated | relid=0 | w=106
  656. en:white substance -- r_associated #0: 106 / 0.876 -> en:defect in morphosyntactic rules
    n1=en:white substance | n2=en:defect in morphosyntactic rules | rel=r_associated | relid=0 | w=106
  657. en:white substance -- r_associated #0: 106 / 0.876 -> en:defective myelination of the deep white matter
    n1=en:white substance | n2=en:defective myelination of the deep white matter | rel=r_associated | relid=0 | w=106
  658. en:white substance -- r_associated #0: 106 / 0.876 -> en:defective opercularization
    n1=en:white substance | n2=en:defective opercularization | rel=r_associated | relid=0 | w=106
  659. en:white substance -- r_associated #0: 106 / 0.876 -> en:defects in auditory cue processing
    n1=en:white substance | n2=en:defects in auditory cue processing | rel=r_associated | relid=0 | w=106
  660. en:white substance -- r_associated #0: 106 / 0.876 -> en:deficit in basic reading
    n1=en:white substance | n2=en:deficit in basic reading | rel=r_associated | relid=0 | w=106
  661. en:white substance -- r_associated #0: 106 / 0.876 -> en:deficit in expressive language
    n1=en:white substance | n2=en:deficit in expressive language | rel=r_associated | relid=0 | w=106
  662. en:white substance -- r_associated #0: 106 / 0.876 -> en:deficit in nonword repetition (nwr)
    n1=en:white substance | n2=en:deficit in nonword repetition (nwr) | rel=r_associated | relid=0 | w=106
  663. en:white substance -- r_associated #0: 106 / 0.876 -> en:deficit in reading comprehension
    n1=en:white substance | n2=en:deficit in reading comprehension | rel=r_associated | relid=0 | w=106
  664. en:white substance -- r_associated #0: 106 / 0.876 -> en:deficit in spelling
    n1=en:white substance | n2=en:deficit in spelling | rel=r_associated | relid=0 | w=106
  665. en:white substance -- r_associated #0: 106 / 0.876 -> en:deficits in language expression
    n1=en:white substance | n2=en:deficits in language expression | rel=r_associated | relid=0 | w=106
  666. en:white substance -- r_associated #0: 106 / 0.876 -> en:degeneration of purkinje cells in the cerebellum
    n1=en:white substance | n2=en:degeneration of purkinje cells in the cerebellum | rel=r_associated | relid=0 | w=106
  667. en:white substance -- r_associated #0: 106 / 0.876 -> en:degeneration of the dentatorubral and pallidoluysian systems
    n1=en:white substance | n2=en:degeneration of the dentatorubral and pallidoluysian systems | rel=r_associated | relid=0 | w=106
  668. en:white substance -- r_associated #0: 106 / 0.876 -> en:deja vu feeling
    n1=en:white substance | n2=en:deja vu feeling | rel=r_associated | relid=0 | w=106
  669. en:white substance -- r_associated #0: 106 / 0.876 -> en:delay in gross motor development due to weakness
    n1=en:white substance | n2=en:delay in gross motor development due to weakness | rel=r_associated | relid=0 | w=106
  670. en:white substance -- r_associated #0: 106 / 0.876 -> en:delay of gross motor function
    n1=en:white substance | n2=en:delay of gross motor function | rel=r_associated | relid=0 | w=106
  671. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed ambulation
    n1=en:white substance | n2=en:delayed ambulation | rel=r_associated | relid=0 | w=106
  672. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed cerebellar development (in some patients)
    n1=en:white substance | n2=en:delayed cerebellar development (in some patients) | rel=r_associated | relid=0 | w=106
  673. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed cerebral myelination
    n1=en:white substance | n2=en:delayed cerebral myelination | rel=r_associated | relid=0 | w=106
  674. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed cognitive development (in some patients)
    n1=en:white substance | n2=en:delayed cognitive development (in some patients) | rel=r_associated | relid=0 | w=106
  675. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed cognitive development/learning disabilities (93%)
    n1=en:white substance | n2=en:delayed cognitive development/learning disabilities (93%) | rel=r_associated | relid=0 | w=106
  676. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development (about 25%)
    n1=en:white substance | n2=en:delayed development (about 25%) | rel=r_associated | relid=0 | w=106
  677. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development (in some)
    n1=en:white substance | n2=en:delayed development (in some) | rel=r_associated | relid=0 | w=106
  678. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development in early childhood (in some patients)
    n1=en:white substance | n2=en:delayed development in early childhood (in some patients) | rel=r_associated | relid=0 | w=106
  679. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development may occur
    n1=en:white substance | n2=en:delayed development may occur | rel=r_associated | relid=0 | w=106
  680. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development, after 8-15 months
    n1=en:white substance | n2=en:delayed development, after 8-15 months | rel=r_associated | relid=0 | w=106
  681. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development, severe
    n1=en:white substance | n2=en:delayed development, severe | rel=r_associated | relid=0 | w=106
  682. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed development, variable (in some patients)
    n1=en:white substance | n2=en:delayed development, variable (in some patients) | rel=r_associated | relid=0 | w=106
  683. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed intellectual development
    n1=en:white substance | n2=en:delayed intellectual development | rel=r_associated | relid=0 | w=106
  684. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed motor and speech development, mild (1 family)
    n1=en:white substance | n2=en:delayed motor and speech development, mild (1 family) | rel=r_associated | relid=0 | w=106
  685. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed motor development (1 patient)
    n1=en:white substance | n2=en:delayed motor development (1 patient) | rel=r_associated | relid=0 | w=106
  686. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed motor development due to muscle weakness
    n1=en:white substance | n2=en:delayed motor development due to muscle weakness | rel=r_associated | relid=0 | w=106
  687. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed motor development, mild, transient
    n1=en:white substance | n2=en:delayed motor development, mild, transient | rel=r_associated | relid=0 | w=106
  688. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed myelination (1 patient)
    n1=en:white substance | n2=en:delayed myelination (1 patient) | rel=r_associated | relid=0 | w=106
  689. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed myelination (reported in 1 patient)
    n1=en:white substance | n2=en:delayed myelination (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  690. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed myelination on brain mri (reported in 1 patient)
    n1=en:white substance | n2=en:delayed myelination on brain mri (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  691. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed myelination, mild
    n1=en:white substance | n2=en:delayed myelination, mild | rel=r_associated | relid=0 | w=106
  692. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed myelinization (in some patients)
    n1=en:white substance | n2=en:delayed myelinization (in some patients) | rel=r_associated | relid=0 | w=106
  693. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed onset of phrase speech (> 36 months)
    n1=en:white substance | n2=en:delayed onset of phrase speech (> 36 months) | rel=r_associated | relid=0 | w=106
  694. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed opercularization
    n1=en:white substance | n2=en:delayed opercularization | rel=r_associated | relid=0 | w=106
  695. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed or absent independent walking
    n1=en:white substance | n2=en:delayed or absent independent walking | rel=r_associated | relid=0 | w=106
  696. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development (1 patient)
    n1=en:white substance | n2=en:delayed psychomotor development (1 patient) | rel=r_associated | relid=0 | w=106
  697. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development (in most patients)
    n1=en:white substance | n2=en:delayed psychomotor development (in most patients) | rel=r_associated | relid=0 | w=106
  698. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development (in some)
    n1=en:white substance | n2=en:delayed psychomotor development (in some) | rel=r_associated | relid=0 | w=106
  699. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development after onset of seizures
    n1=en:white substance | n2=en:delayed psychomotor development after onset of seizures | rel=r_associated | relid=0 | w=106
  700. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development, mild (in 3 of 5 patients)
    n1=en:white substance | n2=en:delayed psychomotor development, mild (in 3 of 5 patients) | rel=r_associated | relid=0 | w=106
  701. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development, mild (in some patients)
    n1=en:white substance | n2=en:delayed psychomotor development, mild (in some patients) | rel=r_associated | relid=0 | w=106
  702. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development, severe
    n1=en:white substance | n2=en:delayed psychomotor development, severe | rel=r_associated | relid=0 | w=106
  703. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development, severe (> 90%)
    n1=en:white substance | n2=en:delayed psychomotor development, severe (> 90%) | rel=r_associated | relid=0 | w=106
  704. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development, severe (in 2 of 6 patients)
    n1=en:white substance | n2=en:delayed psychomotor development, severe (in 2 of 6 patients) | rel=r_associated | relid=0 | w=106
  705. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed psychomotor development, variable
    n1=en:white substance | n2=en:delayed psychomotor development, variable | rel=r_associated | relid=0 | w=106
  706. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed speech and language development
    n1=en:white substance | n2=en:delayed speech and language development | rel=r_associated | relid=0 | w=106
  707. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed speech development, severe
    n1=en:white substance | n2=en:delayed speech development, severe | rel=r_associated | relid=0 | w=106
  708. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed walking (less common)
    n1=en:white substance | n2=en:delayed walking (less common) | rel=r_associated | relid=0 | w=106
  709. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed walking and running in early childhood
    n1=en:white substance | n2=en:delayed walking and running in early childhood | rel=r_associated | relid=0 | w=106
  710. en:white substance -- r_associated #0: 106 / 0.876 -> en:delayed walking, mild (in some patients)
    n1=en:white substance | n2=en:delayed walking, mild (in some patients) | rel=r_associated | relid=0 | w=106
  711. en:white substance -- r_associated #0: 106 / 0.876 -> en:delirium
    n1=en:white substance | n2=en:delirium | rel=r_associated | relid=0 | w=106
  712. en:white substance -- r_associated #0: 106 / 0.876 -> en:delirium (later-onset)
    n1=en:white substance | n2=en:delirium (later-onset) | rel=r_associated | relid=0 | w=106
  713. en:white substance -- r_associated #0: 106 / 0.876 -> en:delusion
    n1=en:white substance | n2=en:delusion | rel=r_associated | relid=0 | w=106
  714. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (<20%)
    n1=en:white substance | n2=en:dementia (<20%) | rel=r_associated | relid=0 | w=106
  715. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (1 family)
    n1=en:white substance | n2=en:dementia (1 family) | rel=r_associated | relid=0 | w=106
  716. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (5%)
    n1=en:white substance | n2=en:dementia (5%) | rel=r_associated | relid=0 | w=106
  717. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (in some patients)
    n1=en:white substance | n2=en:dementia (in some patients) | rel=r_associated | relid=0 | w=106
  718. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (later-onset)
    n1=en:white substance | n2=en:dementia (later-onset) | rel=r_associated | relid=0 | w=106
  719. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (onset in fifth decade)
    n1=en:white substance | n2=en:dementia (onset in fifth decade) | rel=r_associated | relid=0 | w=106
  720. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia (subtype 3a)
    n1=en:white substance | n2=en:dementia (subtype 3a) | rel=r_associated | relid=0 | w=106
  721. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia in a subset of patients
    n1=en:white substance | n2=en:dementia in a subset of patients | rel=r_associated | relid=0 | w=106
  722. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia may occur
    n1=en:white substance | n2=en:dementia may occur | rel=r_associated | relid=0 | w=106
  723. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia of frontal lobe type
    n1=en:white substance | n2=en:dementia of frontal lobe type | rel=r_associated | relid=0 | w=106
  724. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia, presenile, progressive, beginning around age 30 years
    n1=en:white substance | n2=en:dementia, presenile, progressive, beginning around age 30 years | rel=r_associated | relid=0 | w=106
  725. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia, progressive, with onset of disease
    n1=en:white substance | n2=en:dementia, progressive, with onset of disease | rel=r_associated | relid=0 | w=106
  726. en:white substance -- r_associated #0: 106 / 0.876 -> en:dementia, rapidly progressive
    n1=en:white substance | n2=en:dementia, rapidly progressive | rel=r_associated | relid=0 | w=106
  727. en:white substance -- r_associated #0: 106 / 0.876 -> en:demyelination, symmetric
    n1=en:white substance | n2=en:demyelination, symmetric | rel=r_associated | relid=0 | w=106
  728. en:white substance -- r_associated #0: 106 / 0.876 -> en:dense calcifications in the cerebellar dentate nucleus
    n1=en:white substance | n2=en:dense calcifications in the cerebellar dentate nucleus | rel=r_associated | relid=0 | w=106
  729. en:white substance -- r_associated #0: 106 / 0.876 -> en:dental arcade
    n1=en:white substance | n2=en:dental arcade | rel=r_associated | relid=0 | w=106
  730. en:white substance -- r_associated #0: 106 / 0.876 -> en:depersonalization
    n1=en:white substance | n2=en:depersonalization | rel=r_associated | relid=0 | w=106
  731. en:white substance -- r_associated #0: 106 / 0.876 -> en:depression, psychotic
    n1=en:white substance | n2=en:depression, psychotic | rel=r_associated | relid=0 | w=106
  732. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay
    n1=en:white substance | n2=en:developmental delay | rel=r_associated | relid=0 | w=106
  733. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (1 patient)
    n1=en:white substance | n2=en:developmental delay (1 patient) | rel=r_associated | relid=0 | w=106
  734. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (100%)
    n1=en:white substance | n2=en:developmental delay (100%) | rel=r_associated | relid=0 | w=106
  735. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (apparent after the first year of life)
    n1=en:white substance | n2=en:developmental delay (apparent after the first year of life) | rel=r_associated | relid=0 | w=106
  736. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (in most patients)
    n1=en:white substance | n2=en:developmental delay (in most patients) | rel=r_associated | relid=0 | w=106
  737. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (in some patients who survive infancy)
    n1=en:white substance | n2=en:developmental delay (in some patients who survive infancy) | rel=r_associated | relid=0 | w=106
  738. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (in some)
    n1=en:white substance | n2=en:developmental delay (in some) | rel=r_associated | relid=0 | w=106
  739. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (microdeletion patients only)
    n1=en:white substance | n2=en:developmental delay (microdeletion patients only) | rel=r_associated | relid=0 | w=106
  740. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (seen in recessive form)
    n1=en:white substance | n2=en:developmental delay (seen in recessive form) | rel=r_associated | relid=0 | w=106
  741. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (type ii)
    n1=en:white substance | n2=en:developmental delay (type ii) | rel=r_associated | relid=0 | w=106
  742. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay (uncommon)
    n1=en:white substance | n2=en:developmental delay (uncommon) | rel=r_associated | relid=0 | w=106
  743. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay evident by 12-24 months of age
    n1=en:white substance | n2=en:developmental delay evident by 12-24 months of age | rel=r_associated | relid=0 | w=106
  744. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay if undiagnosed or untreated
    n1=en:white substance | n2=en:developmental delay if undiagnosed or untreated | rel=r_associated | relid=0 | w=106
  745. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay or regression
    n1=en:white substance | n2=en:developmental delay or regression | rel=r_associated | relid=0 | w=106
  746. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, mild
    n1=en:white substance | n2=en:developmental delay, mild | rel=r_associated | relid=0 | w=106
  747. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, mild (in some patients)
    n1=en:white substance | n2=en:developmental delay, mild (in some patients) | rel=r_associated | relid=0 | w=106
  748. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, moderate (in some patients)
    n1=en:white substance | n2=en:developmental delay, moderate (in some patients) | rel=r_associated | relid=0 | w=106
  749. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, severe
    n1=en:white substance | n2=en:developmental delay, severe | rel=r_associated | relid=0 | w=106
  750. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, severe (2p21del)
    n1=en:white substance | n2=en:developmental delay, severe (2p21del) | rel=r_associated | relid=0 | w=106
  751. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, significant
    n1=en:white substance | n2=en:developmental delay, significant | rel=r_associated | relid=0 | w=106
  752. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental delay, variable severity
    n1=en:white substance | n2=en:developmental delay, variable severity | rel=r_associated | relid=0 | w=106
  753. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression
    n1=en:white substance | n2=en:developmental regression | rel=r_associated | relid=0 | w=106
  754. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression after age 2 years
    n1=en:white substance | n2=en:developmental regression after age 2 years | rel=r_associated | relid=0 | w=106
  755. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression after onset of seizures
    n1=en:white substance | n2=en:developmental regression after onset of seizures | rel=r_associated | relid=0 | w=106
  756. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression after the first year
    n1=en:white substance | n2=en:developmental regression after the first year | rel=r_associated | relid=0 | w=106
  757. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression in affected children
    n1=en:white substance | n2=en:developmental regression in affected children | rel=r_associated | relid=0 | w=106
  758. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression, after age 2 years (some)
    n1=en:white substance | n2=en:developmental regression, after age 2 years (some) | rel=r_associated | relid=0 | w=106
  759. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental regression, severe
    n1=en:white substance | n2=en:developmental regression, severe | rel=r_associated | relid=0 | w=106
  760. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental retardation, severe
    n1=en:white substance | n2=en:developmental retardation, severe | rel=r_associated | relid=0 | w=106
  761. en:white substance -- r_associated #0: 106 / 0.876 -> en:developmental stagnation
    n1=en:white substance | n2=en:developmental stagnation | rel=r_associated | relid=0 | w=106
  762. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulties in fine bimanual activities
    n1=en:white substance | n2=en:difficulties in fine bimanual activities | rel=r_associated | relid=0 | w=106
  763. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulties in fine movement of the hands
    n1=en:white substance | n2=en:difficulties in fine movement of the hands | rel=r_associated | relid=0 | w=106
  764. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulties with fine motor skills and coordination
    n1=en:white substance | n2=en:difficulties with fine motor skills and coordination | rel=r_associated | relid=0 | w=106
  765. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty in phonologic coding
    n1=en:white substance | n2=en:difficulty in phonologic coding | rel=r_associated | relid=0 | w=106
  766. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty in spelling
    n1=en:white substance | n2=en:difficulty in spelling | rel=r_associated | relid=0 | w=106
  767. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty reading
    n1=en:white substance | n2=en:difficulty reading | rel=r_associated | relid=0 | w=106
  768. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty running and climbing stairs
    n1=en:white substance | n2=en:difficulty running and climbing stairs | rel=r_associated | relid=0 | w=106
  769. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty sleeping
    n1=en:white substance | n2=en:difficulty sleeping | rel=r_associated | relid=0 | w=106
  770. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty standing
    n1=en:white substance | n2=en:difficulty standing | rel=r_associated | relid=0 | w=106
  771. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty standing alone
    n1=en:white substance | n2=en:difficulty standing alone | rel=r_associated | relid=0 | w=106
  772. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty walking and climbing stairs
    n1=en:white substance | n2=en:difficulty walking and climbing stairs | rel=r_associated | relid=0 | w=106
  773. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty walking, running
    n1=en:white substance | n2=en:difficulty walking, running | rel=r_associated | relid=0 | w=106
  774. en:white substance -- r_associated #0: 106 / 0.876 -> en:difficulty writing
    n1=en:white substance | n2=en:difficulty writing | rel=r_associated | relid=0 | w=106
  775. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse atrophy of cerebral hemispheres, corpus callosum, and brainstem
    n1=en:white substance | n2=en:diffuse atrophy of cerebral hemispheres, corpus callosum, and brainstem | rel=r_associated | relid=0 | w=106
  776. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse axonal swelling
    n1=en:white substance | n2=en:diffuse axonal swelling | rel=r_associated | relid=0 | w=106
  777. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse brain and spinal cord atrophy on brain ct/mri
    n1=en:white substance | n2=en:diffuse brain and spinal cord atrophy on brain ct/mri | rel=r_associated | relid=0 | w=106
  778. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse cerebral atrophy on ct and mri
    n1=en:white substance | n2=en:diffuse cerebral atrophy on ct and mri | rel=r_associated | relid=0 | w=106
  779. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse cerebral atrophy seen on mri
    n1=en:white substance | n2=en:diffuse cerebral atrophy seen on mri | rel=r_associated | relid=0 | w=106
  780. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse demyelination (increased signal intensity in t2-weighted images, especially frontal lobes)
    n1=en:white substance | n2=en:diffuse demyelination (increased signal intensity in t2-weighted images, especially frontal lobes) | rel=r_associated | relid=0 | w=106
  781. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse enlargement of subarachnoid spaces and lateral ventricles (rare)
    n1=en:white substance | n2=en:diffuse enlargement of subarachnoid spaces and lateral ventricles (rare) | rel=r_associated | relid=0 | w=106
  782. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse leukoencephalopathy
    n1=en:white substance | n2=en:diffuse leukoencephalopathy | rel=r_associated | relid=0 | w=106
  783. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse periventricular leukoencephalopathy
    n1=en:white substance | n2=en:diffuse periventricular leukoencephalopathy | rel=r_associated | relid=0 | w=106
  784. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse slowing
    n1=en:white substance | n2=en:diffuse slowing | rel=r_associated | relid=0 | w=106
  785. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse slowing of background
    n1=en:white substance | n2=en:diffuse slowing of background | rel=r_associated | relid=0 | w=106
  786. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse swelling of cerebral white matter
    n1=en:white substance | n2=en:diffuse swelling of cerebral white matter | rel=r_associated | relid=0 | w=106
  787. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse white matter abnormalities on brain mri
    n1=en:white substance | n2=en:diffuse white matter abnormalities on brain mri | rel=r_associated | relid=0 | w=106
  788. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse white matter abnormalities seen on brain mri
    n1=en:white substance | n2=en:diffuse white matter abnormalities seen on brain mri | rel=r_associated | relid=0 | w=106
  789. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse white matter changes (meb)
    n1=en:white substance | n2=en:diffuse white matter changes (meb) | rel=r_associated | relid=0 | w=106
  790. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse white matter dysmyelination
    n1=en:white substance | n2=en:diffuse white matter dysmyelination | rel=r_associated | relid=0 | w=106
  791. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse white matter hyperintensities on t2-weighed imaging
    n1=en:white substance | n2=en:diffuse white matter hyperintensities on t2-weighed imaging | rel=r_associated | relid=0 | w=106
  792. en:white substance -- r_associated #0: 106 / 0.876 -> en:diffuse white matter loss
    n1=en:white substance | n2=en:diffuse white matter loss | rel=r_associated | relid=0 | w=106
  793. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilatation of the 3rd ventricle (in one family)
    n1=en:white substance | n2=en:dilatation of the 3rd ventricle (in one family) | rel=r_associated | relid=0 | w=106
  794. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilatation of the lateral and third ventricles
    n1=en:white substance | n2=en:dilatation of the lateral and third ventricles | rel=r_associated | relid=0 | w=106
  795. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilatation of the lateral ventricles (in one family)
    n1=en:white substance | n2=en:dilatation of the lateral ventricles (in one family) | rel=r_associated | relid=0 | w=106
  796. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilated lateral ventricles (1 patient)
    n1=en:white substance | n2=en:dilated lateral ventricles (1 patient) | rel=r_associated | relid=0 | w=106
  797. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilated venous sinuses
    n1=en:white substance | n2=en:dilated venous sinuses | rel=r_associated | relid=0 | w=106
  798. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilated ventricles (finding)
    n1=en:white substance | n2=en:dilated ventricles (finding) | rel=r_associated | relid=0 | w=106
  799. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilation of cerebral ventricles
    n1=en:white substance | n2=en:dilation of cerebral ventricles | rel=r_associated | relid=0 | w=106
  800. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilation of lateral ventricles
    n1=en:white substance | n2=en:dilation of lateral ventricles | rel=r_associated | relid=0 | w=106
  801. en:white substance -- r_associated #0: 106 / 0.876 -> en:dilation of lateral ventricles (in some patients)
    n1=en:white substance | n2=en:dilation of lateral ventricles (in some patients) | rel=r_associated | relid=0 | w=106
  802. en:white substance -- r_associated #0: 106 / 0.876 -> en:diplegia
    n1=en:white substance | n2=en:diplegia | rel=r_associated | relid=0 | w=106
  803. en:white substance -- r_associated #0: 106 / 0.876 -> en:discrepancy between verbal and nonverbal abilities
    n1=en:white substance | n2=en:discrepancy between verbal and nonverbal abilities | rel=r_associated | relid=0 | w=106
  804. en:white substance -- r_associated #0: 106 / 0.876 -> en:disordered sleep pattern (in some patients)
    n1=en:white substance | n2=en:disordered sleep pattern (in some patients) | rel=r_associated | relid=0 | w=106
  805. en:white substance -- r_associated #0: 106 / 0.876 -> en:disorganised speech
    n1=en:white substance | n2=en:disorganised speech | rel=r_associated | relid=0 | w=106
  806. en:white substance -- r_associated #0: 106 / 0.876 -> en:disorganized brain cytoarchitecture
    n1=en:white substance | n2=en:disorganized brain cytoarchitecture | rel=r_associated | relid=0 | w=106
  807. en:white substance -- r_associated #0: 106 / 0.876 -> en:disorganized cortical architecture
    n1=en:white substance | n2=en:disorganized cortical architecture | rel=r_associated | relid=0 | w=106
  808. en:white substance -- r_associated #0: 106 / 0.876 -> en:disorganized slow background activity seen on eeg
    n1=en:white substance | n2=en:disorganized slow background activity seen on eeg | rel=r_associated | relid=0 | w=106
  809. en:white substance -- r_associated #0: 106 / 0.876 -> en:disorientation
    n1=en:white substance | n2=en:disorientation | rel=r_associated | relid=0 | w=106
  810. en:white substance -- r_associated #0: 106 / 0.876 -> en:disproportionately small cerebral cortex
    n1=en:white substance | n2=en:disproportionately small cerebral cortex | rel=r_associated | relid=0 | w=106
  811. en:white substance -- r_associated #0: 106 / 0.876 -> en:distal amyotrophy
    n1=en:white substance | n2=en:distal amyotrophy | rel=r_associated | relid=0 | w=106
  812. en:white substance -- r_associated #0: 106 / 0.876 -> en:distal muscle weakness
    n1=en:white substance | n2=en:distal muscle weakness | rel=r_associated | relid=0 | w=106
  813. en:white substance -- r_associated #0: 106 / 0.876 -> en:distal sensory impairment
    n1=en:white substance | n2=en:distal sensory impairment | rel=r_associated | relid=0 | w=106
  814. en:white substance -- r_associated #0: 106 / 0.876 -> en:distal sensory loss to all modalities, lower limbs more affected than upper limbs
    n1=en:white substance | n2=en:distal sensory loss to all modalities, lower limbs more affected than upper limbs | rel=r_associated | relid=0 | w=106
  815. en:white substance -- r_associated #0: 106 / 0.876 -> en:distal weakness occurs later
    n1=en:white substance | n2=en:distal weakness occurs later | rel=r_associated | relid=0 | w=106
  816. en:white substance -- r_associated #0: 106 / 0.876 -> en:disturbance of consciousness
    n1=en:white substance | n2=en:disturbance of consciousness | rel=r_associated | relid=0 | w=106
  817. en:white substance -- r_associated #0: 106 / 0.876 -> en:disturbed gait
    n1=en:white substance | n2=en:disturbed gait | rel=r_associated | relid=0 | w=106
  818. en:white substance -- r_associated #0: 106 / 0.876 -> en:disturbed sleep-wake cycle
    n1=en:white substance | n2=en:disturbed sleep-wake cycle | rel=r_associated | relid=0 | w=106
  819. en:white substance -- r_associated #0: 106 / 0.876 -> en:dizziness
    n1=en:white substance | n2=en:dizziness | rel=r_associated | relid=0 | w=106
  820. en:white substance -- r_associated #0: 106 / 0.876 -> en:dizziness adverse event
    n1=en:white substance | n2=en:dizziness adverse event | rel=r_associated | relid=0 | w=106
  821. en:white substance -- r_associated #0: 106 / 0.876 -> en:dizziness may occur
    n1=en:white substance | n2=en:dizziness may occur | rel=r_associated | relid=0 | w=106
  822. en:white substance -- r_associated #0: 106 / 0.876 -> en:dopaminergic fiber systems in the brain
    n1=en:white substance | n2=en:dopaminergic fiber systems in the brain | rel=r_associated | relid=0 | w=106
  823. en:white substance -- r_associated #0: 106 / 0.876 -> en:dorsal horn of the spinal cord
    n1=en:white substance | n2=en:dorsal horn of the spinal cord | rel=r_associated | relid=0 | w=106
  824. en:white substance -- r_associated #0: 106 / 0.876 -> en:dorsal intermediate sulcus
    n1=en:white substance | n2=en:dorsal intermediate sulcus | rel=r_associated | relid=0 | w=106
  825. en:white substance -- r_associated #0: 106 / 0.876 -> en:dorsal root of the spinal nerve
    n1=en:white substance | n2=en:dorsal root of the spinal nerve | rel=r_associated | relid=0 | w=106
  826. en:white substance -- r_associated #0: 106 / 0.876 -> en:double cortex syndrome
    n1=en:white substance | n2=en:double cortex syndrome | rel=r_associated | relid=0 | w=106
  827. en:white substance -- r_associated #0: 106 / 0.876 -> en:dream disorder
    n1=en:white substance | n2=en:dream disorder | rel=r_associated | relid=0 | w=106
  828. en:white substance -- r_associated #0: 106 / 0.876 -> en:dream enactment
    n1=en:white substance | n2=en:dream enactment | rel=r_associated | relid=0 | w=106
  829. en:white substance -- r_associated #0: 106 / 0.876 -> en:drop attack
    n1=en:white substance | n2=en:drop attack | rel=r_associated | relid=0 | w=106
  830. en:white substance -- r_associated #0: 106 / 0.876 -> en:drug dependence
    n1=en:white substance | n2=en:drug dependence | rel=r_associated | relid=0 | w=106
  831. en:white substance -- r_associated #0: 106 / 0.876 -> en:drug effect
    n1=en:white substance | n2=en:drug effect | rel=r_associated | relid=0 | w=106
  832. en:white substance -- r_associated #0: 106 / 0.876 -> en:dural and choroid plexus calcifications
    n1=en:white substance | n2=en:dural and choroid plexus calcifications | rel=r_associated | relid=0 | w=106
  833. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria
    n1=en:white substance | n2=en:dysarthria | rel=r_associated | relid=0 | w=106
  834. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria (1 family)
    n1=en:white substance | n2=en:dysarthria (1 family) | rel=r_associated | relid=0 | w=106
  835. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria (74%)
    n1=en:white substance | n2=en:dysarthria (74%) | rel=r_associated | relid=0 | w=106
  836. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria (less common)
    n1=en:white substance | n2=en:dysarthria (less common) | rel=r_associated | relid=0 | w=106
  837. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria (onset in third decade)
    n1=en:white substance | n2=en:dysarthria (onset in third decade) | rel=r_associated | relid=0 | w=106
  838. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria may occur
    n1=en:white substance | n2=en:dysarthria may occur | rel=r_associated | relid=0 | w=106
  839. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthria, mild (in some patients)
    n1=en:white substance | n2=en:dysarthria, mild (in some patients) | rel=r_associated | relid=0 | w=106
  840. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysarthrias, spastic
    n1=en:white substance | n2=en:dysarthrias, spastic | rel=r_associated | relid=0 | w=106
  841. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysautonomia may occur
    n1=en:white substance | n2=en:dysautonomia may occur | rel=r_associated | relid=0 | w=106
  842. en:white substance -- r_associated #0: 106 / 0.876 -> en:dyscalculia
    n1=en:white substance | n2=en:dyscalculia | rel=r_associated | relid=0 | w=106
  843. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysdiadochokinesis
    n1=en:white substance | n2=en:dysdiadochokinesis | rel=r_associated | relid=0 | w=106
  844. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysdiadochokinesis (1 family)
    n1=en:white substance | n2=en:dysdiadochokinesis (1 family) | rel=r_associated | relid=0 | w=106
  845. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysfunction of the autonomic nervous system
    n1=en:white substance | n2=en:dysfunction of the autonomic nervous system | rel=r_associated | relid=0 | w=106
  846. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysgenesis of corpus callosum
    n1=en:white substance | n2=en:dysgenesis of corpus callosum | rel=r_associated | relid=0 | w=106
  847. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysgenesis of the anterior commissure (in some)
    n1=en:white substance | n2=en:dysgenesis of the anterior commissure (in some) | rel=r_associated | relid=0 | w=106
  848. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysgenesis of the corpus callosum (1 patient)
    n1=en:white substance | n2=en:dysgenesis of the corpus callosum (1 patient) | rel=r_associated | relid=0 | w=106
  849. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysgraphias
    n1=en:white substance | n2=en:dysgraphias | rel=r_associated | relid=0 | w=106
  850. en:white substance -- r_associated #0: 106 / 0.876 -> en:dyskinesia
    n1=en:white substance | n2=en:dyskinesia | rel=r_associated | relid=0 | w=106
  851. en:white substance -- r_associated #0: 106 / 0.876 -> en:dyskinesia buccoglossal
    n1=en:white substance | n2=en:dyskinesia buccoglossal | rel=r_associated | relid=0 | w=106
  852. en:white substance -- r_associated #0: 106 / 0.876 -> en:dyskinetic movements
    n1=en:white substance | n2=en:dyskinetic movements | rel=r_associated | relid=0 | w=106
  853. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmetria (1 family)
    n1=en:white substance | n2=en:dysmetria (1 family) | rel=r_associated | relid=0 | w=106
  854. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmetria (1 patient)
    n1=en:white substance | n2=en:dysmetria (1 patient) | rel=r_associated | relid=0 | w=106
  855. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmetria (in 1 of 3 families)
    n1=en:white substance | n2=en:dysmetria (in 1 of 3 families) | rel=r_associated | relid=0 | w=106
  856. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmetria, mild
    n1=en:white substance | n2=en:dysmetria, mild | rel=r_associated | relid=0 | w=106
  857. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmetrias, cerebellar
    n1=en:white substance | n2=en:dysmetrias, cerebellar | rel=r_associated | relid=0 | w=106
  858. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmorphic basal ganglia
    n1=en:white substance | n2=en:dysmorphic basal ganglia | rel=r_associated | relid=0 | w=106
  859. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmorphic basal ganglia (in some patients)
    n1=en:white substance | n2=en:dysmorphic basal ganglia (in some patients) | rel=r_associated | relid=0 | w=106
  860. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmorphic basal ganglia (in some)
    n1=en:white substance | n2=en:dysmorphic basal ganglia (in some) | rel=r_associated | relid=0 | w=106
  861. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmorphic corpus callosum
    n1=en:white substance | n2=en:dysmorphic corpus callosum | rel=r_associated | relid=0 | w=106
  862. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmyelinating leukodystrophy
    n1=en:white substance | n2=en:dysmyelinating leukodystrophy | rel=r_associated | relid=0 | w=106
  863. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmyelination of the brain and spinal cord
    n1=en:white substance | n2=en:dysmyelination of the brain and spinal cord | rel=r_associated | relid=0 | w=106
  864. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysmyelination of the brain, myelin is not formed properly
    n1=en:white substance | n2=en:dysmyelination of the brain, myelin is not formed properly | rel=r_associated | relid=0 | w=106
  865. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysphagia
    n1=en:white substance | n2=en:dysphagia | rel=r_associated | relid=0 | w=106
  866. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysplasia of the cerebellar hemispheres
    n1=en:white substance | n2=en:dysplasia of the cerebellar hemispheres | rel=r_associated | relid=0 | w=106
  867. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysplastic basal ganglia
    n1=en:white substance | n2=en:dysplastic basal ganglia | rel=r_associated | relid=0 | w=106
  868. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysplastic c-shaped inferior olivary nuclei
    n1=en:white substance | n2=en:dysplastic c-shaped inferior olivary nuclei | rel=r_associated | relid=0 | w=106
  869. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysplastic cerebellar gangliocytoma
    n1=en:white substance | n2=en:dysplastic cerebellar gangliocytoma | rel=r_associated | relid=0 | w=106
  870. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysplastic cerebellum
    n1=en:white substance | n2=en:dysplastic cerebellum | rel=r_associated | relid=0 | w=106
  871. en:white substance -- r_associated #0: 106 / 0.876 -> en:dysplastic pons
    n1=en:white substance | n2=en:dysplastic pons | rel=r_associated | relid=0 | w=106
  872. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia (1 patient)
    n1=en:white substance | n2=en:dystonia (1 patient) | rel=r_associated | relid=0 | w=106
  873. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia (57%)
    n1=en:white substance | n2=en:dystonia (57%) | rel=r_associated | relid=0 | w=106
  874. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia (in some patients)
    n1=en:white substance | n2=en:dystonia (in some patients) | rel=r_associated | relid=0 | w=106
  875. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia (less common)
    n1=en:white substance | n2=en:dystonia (less common) | rel=r_associated | relid=0 | w=106
  876. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia (may spontaneously remit in childhood or adolescence)
    n1=en:white substance | n2=en:dystonia (may spontaneously remit in childhood or adolescence) | rel=r_associated | relid=0 | w=106
  877. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia 18 (disorder)
    n1=en:white substance | n2=en:dystonia 18 (disorder) | rel=r_associated | relid=0 | w=106
  878. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia at onset (16%)
    n1=en:white substance | n2=en:dystonia at onset (16%) | rel=r_associated | relid=0 | w=106
  879. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia with diurnal variation
    n1=en:white substance | n2=en:dystonia with diurnal variation | rel=r_associated | relid=0 | w=106
  880. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia, episodic, primary affects hands and feet
    n1=en:white substance | n2=en:dystonia, episodic, primary affects hands and feet | rel=r_associated | relid=0 | w=106
  881. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia, generalized, dopa-unresponsive
    n1=en:white substance | n2=en:dystonia, generalized, dopa-unresponsive | rel=r_associated | relid=0 | w=106
  882. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia, limb, exercise-induced
    n1=en:white substance | n2=en:dystonia, limb, exercise-induced | rel=r_associated | relid=0 | w=106
  883. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia, progressive
    n1=en:white substance | n2=en:dystonia, progressive | rel=r_associated | relid=0 | w=106
  884. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonia, trunk and limbs (upper and lower)
    n1=en:white substance | n2=en:dystonia, trunk and limbs (upper and lower) | rel=r_associated | relid=0 | w=106
  885. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic hand posturing (44% of patients)
    n1=en:white substance | n2=en:dystonic hand posturing (44% of patients) | rel=r_associated | relid=0 | w=106
  886. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic posturing (rare)
    n1=en:white substance | n2=en:dystonic posturing (rare) | rel=r_associated | relid=0 | w=106
  887. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic posturing of the hands
    n1=en:white substance | n2=en:dystonic posturing of the hands | rel=r_associated | relid=0 | w=106
  888. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic tongue protrusion
    n1=en:white substance | n2=en:dystonic tongue protrusion | rel=r_associated | relid=0 | w=106
  889. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic tremor
    n1=en:white substance | n2=en:dystonic tremor | rel=r_associated | relid=0 | w=106
  890. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic vocal tremor
    n1=en:white substance | n2=en:dystonic vocal tremor | rel=r_associated | relid=0 | w=106
  891. en:white substance -- r_associated #0: 106 / 0.876 -> en:dystonic writer's cramp
    n1=en:white substance | n2=en:dystonic writer's cramp | rel=r_associated | relid=0 | w=106
  892. en:white substance -- r_associated #0: 106 / 0.876 -> en:earlier sleep-offset time (earlier awakening)
    n1=en:white substance | n2=en:earlier sleep-offset time (earlier awakening) | rel=r_associated | relid=0 | w=106
  893. en:white substance -- r_associated #0: 106 / 0.876 -> en:early and severe foot extensor muscle involvement
    n1=en:white substance | n2=en:early and severe foot extensor muscle involvement | rel=r_associated | relid=0 | w=106
  894. en:white substance -- r_associated #0: 106 / 0.876 -> en:early severe fetal akinesia sequence
    n1=en:white substance | n2=en:early severe fetal akinesia sequence | rel=r_associated | relid=0 | w=106
  895. en:white substance -- r_associated #0: 106 / 0.876 -> en:early-onset myoclonic seizures
    n1=en:white substance | n2=en:early-onset myoclonic seizures | rel=r_associated | relid=0 | w=106
  896. en:white substance -- r_associated #0: 106 / 0.876 -> en:ectopic posterior pituitary (in some patients)
    n1=en:white substance | n2=en:ectopic posterior pituitary (in some patients) | rel=r_associated | relid=0 | w=106
  897. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg - alpha abolished, continuous spike waves, intense myoclonus on photic stimulation (stage 3)
    n1=en:white substance | n2=en:eeg - alpha abolished, continuous spike waves, intense myoclonus on photic stimulation (stage 3) | rel=r_associated | relid=0 | w=106
  898. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg - alpha slowing, 4-6 hz spike waves, myoclonus on photic stimulation (stage 2)
    n1=en:white substance | n2=en:eeg - alpha slowing, 4-6 hz spike waves, myoclonus on photic stimulation (stage 2) | rel=r_associated | relid=0 | w=106
  899. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg - polyspike on photic stimulation (stage 1)
    n1=en:white substance | n2=en:eeg - polyspike on photic stimulation (stage 1) | rel=r_associated | relid=0 | w=106
  900. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg abnormalities - slow waking background, intermittent rhythmical slowing (3-5hz), epileptiform discharges
    n1=en:white substance | n2=en:eeg abnormalities - slow waking background, intermittent rhythmical slowing (3-5hz), epileptiform discharges | rel=r_associated | relid=0 | w=106
  901. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg abnormalities in 20-50% impaired language development
    n1=en:white substance | n2=en:eeg abnormalities in 20-50% impaired language development | rel=r_associated | relid=0 | w=106
  902. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg and symptomatology suggest mesial temporal origin
    n1=en:white substance | n2=en:eeg and symptomatology suggest mesial temporal origin | rel=r_associated | relid=0 | w=106
  903. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg during episodes shows desynchronization
    n1=en:white substance | n2=en:eeg during episodes shows desynchronization | rel=r_associated | relid=0 | w=106
  904. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg is slowed with polyspike wave discharges
    n1=en:white substance | n2=en:eeg is slowed with polyspike wave discharges | rel=r_associated | relid=0 | w=106
  905. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg is usually normal
    n1=en:white substance | n2=en:eeg is usually normal | rel=r_associated | relid=0 | w=106
  906. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg later shows generalized spike or polyspike waves and focal spikes
    n1=en:white substance | n2=en:eeg later shows generalized spike or polyspike waves and focal spikes | rel=r_associated | relid=0 | w=106
  907. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg may be normal at first
    n1=en:white substance | n2=en:eeg may be normal at first | rel=r_associated | relid=0 | w=106
  908. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg may show migrating focal or multifocal origin (in severe cases)
    n1=en:white substance | n2=en:eeg may show migrating focal or multifocal origin (in severe cases) | rel=r_associated | relid=0 | w=106
  909. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows 3-4-hz spike and multispike slow wave complexes
    n1=en:white substance | n2=en:eeg shows 3-4-hz spike and multispike slow wave complexes | rel=r_associated | relid=0 | w=106
  910. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows centrotemporal spike-wave discharges
    n1=en:white substance | n2=en:eeg shows centrotemporal spike-wave discharges | rel=r_associated | relid=0 | w=106
  911. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows epileptiform activity
    n1=en:white substance | n2=en:eeg shows epileptiform activity | rel=r_associated | relid=0 | w=106
  912. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows epileptiform discharges
    n1=en:white substance | n2=en:eeg shows epileptiform discharges | rel=r_associated | relid=0 | w=106
  913. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows generalized polyspike and wave discharges (4-5 hz)
    n1=en:white substance | n2=en:eeg shows generalized polyspike and wave discharges (4-5 hz) | rel=r_associated | relid=0 | w=106
  914. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows generalized polyspike and wave discharges (4-6 hz)
    n1=en:white substance | n2=en:eeg shows generalized polyspike and wave discharges (4-6 hz) | rel=r_associated | relid=0 | w=106
  915. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows generalized, bilateral, synchronous, symmetrical discharge
    n1=en:white substance | n2=en:eeg shows generalized, bilateral, synchronous, symmetrical discharge | rel=r_associated | relid=0 | w=106
  916. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows hypsarrhythmia
    n1=en:white substance | n2=en:eeg shows hypsarrhythmia | rel=r_associated | relid=0 | w=106
  917. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows hypsarrhythmia (in 1 of 6 patients)
    n1=en:white substance | n2=en:eeg shows hypsarrhythmia (in 1 of 6 patients) | rel=r_associated | relid=0 | w=106
  918. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows multifocal discharges
    n1=en:white substance | n2=en:eeg shows multifocal discharges | rel=r_associated | relid=0 | w=106
  919. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows nonspecific slow-wave paroxysms
    n1=en:white substance | n2=en:eeg shows nonspecific slow-wave paroxysms | rel=r_associated | relid=0 | w=106
  920. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows photosensitivity
    n1=en:white substance | n2=en:eeg shows photosensitivity | rel=r_associated | relid=0 | w=106
  921. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows slow frequency high amplitude waves with high frequency polyspikes
    n1=en:white substance | n2=en:eeg shows slow frequency high amplitude waves with high frequency polyspikes | rel=r_associated | relid=0 | w=106
  922. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows spike and multispike waves, 3-4 hz
    n1=en:white substance | n2=en:eeg shows spike and multispike waves, 3-4 hz | rel=r_associated | relid=0 | w=106
  923. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows suppression with ictal burst activities
    n1=en:white substance | n2=en:eeg shows suppression with ictal burst activities | rel=r_associated | relid=0 | w=106
  924. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows suppression-burst pattern
    n1=en:white substance | n2=en:eeg shows suppression-burst pattern | rel=r_associated | relid=0 | w=106
  925. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows unilateral centrotemporal spikes
    n1=en:white substance | n2=en:eeg shows unilateral centrotemporal spikes | rel=r_associated | relid=0 | w=106
  926. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg shows with a multifocal pattern with spikes and sharp waves
    n1=en:white substance | n2=en:eeg shows with a multifocal pattern with spikes and sharp waves | rel=r_associated | relid=0 | w=106
  927. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg with burst suppression
    n1=en:white substance | n2=en:eeg with burst suppression | rel=r_associated | relid=0 | w=106
  928. en:white substance -- r_associated #0: 106 / 0.876 -> en:eeg with focal discharge
    n1=en:white substance | n2=en:eeg with focal discharge | rel=r_associated | relid=0 | w=106
  929. en:white substance -- r_associated #0: 106 / 0.876 -> en:electroencephalogram abnormal
    n1=en:white substance | n2=en:electroencephalogram abnormal | rel=r_associated | relid=0 | w=106
  930. en:white substance -- r_associated #0: 106 / 0.876 -> en:electrophysiologic studies indicate cortical origin
    n1=en:white substance | n2=en:electrophysiologic studies indicate cortical origin | rel=r_associated | relid=0 | w=106
  931. en:white substance -- r_associated #0: 106 / 0.876 -> en:elevated interferon levels in cerebrospinal fluid
    n1=en:white substance | n2=en:elevated interferon levels in cerebrospinal fluid | rel=r_associated | relid=0 | w=106
  932. en:white substance -- r_associated #0: 106 / 0.876 -> en:elevated pterin levels (tetrahydrobiopterin, neopterin) in cerebrospinal fluid
    n1=en:white substance | n2=en:elevated pterin levels (tetrahydrobiopterin, neopterin) in cerebrospinal fluid | rel=r_associated | relid=0 | w=106
  933. en:white substance -- r_associated #0: 106 / 0.876 -> en:elevation and splaying of the superior cerebellar peduncles
    n1=en:white substance | n2=en:elevation and splaying of the superior cerebellar peduncles | rel=r_associated | relid=0 | w=106
  934. en:white substance -- r_associated #0: 106 / 0.876 -> en:embryologic
    n1=en:white substance | n2=en:embryologic | rel=r_associated | relid=0 | w=106
  935. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows bursts of activity originating in the masseter muscle and spreading to the orbicularis oris and oculi muscles
    n1=en:white substance | n2=en:emg shows bursts of activity originating in the masseter muscle and spreading to the orbicularis oris and oculi muscles | rel=r_associated | relid=0 | w=106
  936. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows continuous motor unit firing at rest
    n1=en:white substance | n2=en:emg shows continuous motor unit firing at rest | rel=r_associated | relid=0 | w=106
  937. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows fibrillation potentials and mixed myopathic and neurogenic motor unit potentials
    n1=en:white substance | n2=en:emg shows fibrillation potentials and mixed myopathic and neurogenic motor unit potentials | rel=r_associated | relid=0 | w=106
  938. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows fibrillations and fasiculations
    n1=en:white substance | n2=en:emg shows fibrillations and fasiculations | rel=r_associated | relid=0 | w=106
  939. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows involuntary continuous motor activity at rest
    n1=en:white substance | n2=en:emg shows involuntary continuous motor activity at rest | rel=r_associated | relid=0 | w=106
  940. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows neurogenic changes
    n1=en:white substance | n2=en:emg shows neurogenic changes | rel=r_associated | relid=0 | w=106
  941. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows neurogenic changes and denervation
    n1=en:white substance | n2=en:emg shows neurogenic changes and denervation | rel=r_associated | relid=0 | w=106
  942. en:white substance -- r_associated #0: 106 / 0.876 -> en:emg shows neurogenic findings
    n1=en:white substance | n2=en:emg shows neurogenic findings | rel=r_associated | relid=0 | w=106
  943. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalitis
    n1=en:white substance | n2=en:encephalitis | rel=r_associated | relid=0 | w=106
  944. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalocele
    n1=en:white substance | n2=en:encephalocele | rel=r_associated | relid=0 | w=106
  945. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalocele (1 patient)
    n1=en:white substance | n2=en:encephalocele (1 patient) | rel=r_associated | relid=0 | w=106
  946. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalocele (single case)
    n1=en:white substance | n2=en:encephalocele (single case) | rel=r_associated | relid=0 | w=106
  947. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalocele of orbit
    n1=en:white substance | n2=en:encephalocele of orbit | rel=r_associated | relid=0 | w=106
  948. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephaloceles, frontal
    n1=en:white substance | n2=en:encephaloceles, frontal | rel=r_associated | relid=0 | w=106
  949. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalomyopathy
    n1=en:white substance | n2=en:encephalomyopathy | rel=r_associated | relid=0 | w=106
  950. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathic episodes, often associated with infection
    n1=en:white substance | n2=en:encephalopathic episodes, often associated with infection | rel=r_associated | relid=0 | w=106
  951. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy
    n1=en:white substance | n2=en:encephalopathy | rel=r_associated | relid=0 | w=106
  952. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy (in 1 patient)
    n1=en:white substance | n2=en:encephalopathy (in 1 patient) | rel=r_associated | relid=0 | w=106
  953. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy adverse event
    n1=en:white substance | n2=en:encephalopathy adverse event | rel=r_associated | relid=0 | w=106
  954. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy associated with hypoglycemia
    n1=en:white substance | n2=en:encephalopathy associated with hypoglycemia | rel=r_associated | relid=0 | w=106
  955. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy during episodes
    n1=en:white substance | n2=en:encephalopathy during episodes | rel=r_associated | relid=0 | w=106
  956. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy, acute-onset
    n1=en:white substance | n2=en:encephalopathy, acute-onset | rel=r_associated | relid=0 | w=106
  957. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy, episodic
    n1=en:white substance | n2=en:encephalopathy, episodic | rel=r_associated | relid=0 | w=106
  958. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy, episodic, associated with febrile illnesses
    n1=en:white substance | n2=en:encephalopathy, episodic, associated with febrile illnesses | rel=r_associated | relid=0 | w=106
  959. en:white substance -- r_associated #0: 106 / 0.876 -> en:encephalopathy, severe, neonatal
    n1=en:white substance | n2=en:encephalopathy, severe, neonatal | rel=r_associated | relid=0 | w=106
  960. en:white substance -- r_associated #0: 106 / 0.876 -> en:endocrine system
    n1=en:white substance | n2=en:endocrine system | rel=r_associated | relid=0 | w=106
  961. en:white substance -- r_associated #0: 106 / 0.876 -> en:endocrine system subdivision
    n1=en:white substance | n2=en:endocrine system subdivision | rel=r_associated | relid=0 | w=106
  962. en:white substance -- r_associated #0: 106 / 0.876 -> en:endothelial intracytoplasmic globular inclusions
    n1=en:white substance | n2=en:endothelial intracytoplasmic globular inclusions | rel=r_associated | relid=0 | w=106
  963. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged cerebellar cistern
    n1=en:white substance | n2=en:enlarged cerebellar cistern | rel=r_associated | relid=0 | w=106
  964. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged cerebellum
    n1=en:white substance | n2=en:enlarged cerebellum | rel=r_associated | relid=0 | w=106
  965. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged cisterna magna
    n1=en:white substance | n2=en:enlarged cisterna magna | rel=r_associated | relid=0 | w=106
  966. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged cisterna magna (in some patients)
    n1=en:white substance | n2=en:enlarged cisterna magna (in some patients) | rel=r_associated | relid=0 | w=106
  967. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged corpus callosum
    n1=en:white substance | n2=en:enlarged corpus callosum | rel=r_associated | relid=0 | w=106
  968. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged lateral ventricles (occipital>frontal)
    n1=en:white substance | n2=en:enlarged lateral ventricles (occipital>frontal) | rel=r_associated | relid=0 | w=106
  969. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged motor unit action potentials
    n1=en:white substance | n2=en:enlarged motor unit action potentials | rel=r_associated | relid=0 | w=106
  970. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged ventricles (1 patient)
    n1=en:white substance | n2=en:enlarged ventricles (1 patient) | rel=r_associated | relid=0 | w=106
  971. en:white substance -- r_associated #0: 106 / 0.876 -> en:enlarged white matter
    n1=en:white substance | n2=en:enlarged white matter | rel=r_associated | relid=0 | w=106
  972. en:white substance -- r_associated #0: 106 / 0.876 -> en:entire nucleus of brain
    n1=en:white substance | n2=en:entire nucleus of brain | rel=r_associated | relid=0 | w=106
  973. en:white substance -- r_associated #0: 106 / 0.876 -> en:enzymology
    n1=en:white substance | n2=en:enzymology | rel=r_associated | relid=0 | w=106
  974. en:white substance -- r_associated #0: 106 / 0.876 -> en:epilepsies, myoclonic
    n1=en:white substance | n2=en:epilepsies, myoclonic | rel=r_associated | relid=0 | w=106
  975. en:white substance -- r_associated #0: 106 / 0.876 -> en:epilepsy (in 2 of 3 patients)
    n1=en:white substance | n2=en:epilepsy (in 2 of 3 patients) | rel=r_associated | relid=0 | w=106
  976. en:white substance -- r_associated #0: 106 / 0.876 -> en:epilepsy (in some patients)
    n1=en:white substance | n2=en:epilepsy (in some patients) | rel=r_associated | relid=0 | w=106
  977. en:white substance -- r_associated #0: 106 / 0.876 -> en:epilepsy, rolandic
    n1=en:white substance | n2=en:epilepsy, rolandic | rel=r_associated | relid=0 | w=106
  978. en:white substance -- r_associated #0: 106 / 0.876 -> en:epileptic drop attack
    n1=en:white substance | n2=en:epileptic drop attack | rel=r_associated | relid=0 | w=106
  979. en:white substance -- r_associated #0: 106 / 0.876 -> en:epileptic encephalopathy
    n1=en:white substance | n2=en:epileptic encephalopathy | rel=r_associated | relid=0 | w=106
  980. en:white substance -- r_associated #0: 106 / 0.876 -> en:epileptic encephalopathy (in 2 of 3 patients)
    n1=en:white substance | n2=en:epileptic encephalopathy (in 2 of 3 patients) | rel=r_associated | relid=0 | w=106
  981. en:white substance -- r_associated #0: 106 / 0.876 -> en:epileptic encephalopathy (in some patients)
    n1=en:white substance | n2=en:epileptic encephalopathy (in some patients) | rel=r_associated | relid=0 | w=106
  982. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodes begin with muscle tightening
    n1=en:white substance | n2=en:episodes begin with muscle tightening | rel=r_associated | relid=0 | w=106
  983. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodes last up to 2 minutes
    n1=en:white substance | n2=en:episodes last up to 2 minutes | rel=r_associated | relid=0 | w=106
  984. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodes of decreased alertness, hypotonia, and poor respiration requiring mechanical ventilation
    n1=en:white substance | n2=en:episodes of decreased alertness, hypotonia, and poor respiration requiring mechanical ventilation | rel=r_associated | relid=0 | w=106
  985. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodes typically occur several times a week
    n1=en:white substance | n2=en:episodes typically occur several times a week | rel=r_associated | relid=0 | w=106
  986. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodic acute neurologic deterioration/encephalopathy, recurrent
    n1=en:white substance | n2=en:episodic acute neurologic deterioration/encephalopathy, recurrent | rel=r_associated | relid=0 | w=106
  987. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodic hemiplegia
    n1=en:white substance | n2=en:episodic hemiplegia | rel=r_associated | relid=0 | w=106
  988. en:white substance -- r_associated #0: 106 / 0.876 -> en:episodic vomiting
    n1=en:white substance | n2=en:episodic vomiting | rel=r_associated | relid=0 | w=106
  989. en:white substance -- r_associated #0: 106 / 0.876 -> en:equivocal plantar response
    n1=en:white substance | n2=en:equivocal plantar response | rel=r_associated | relid=0 | w=106
  990. en:white substance -- r_associated #0: 106 / 0.876 -> en:essential tremor (1 family)
    n1=en:white substance | n2=en:essential tremor (1 family) | rel=r_associated | relid=0 | w=106
  991. en:white substance -- r_associated #0: 106 / 0.876 -> en:evolution to severe encephalopathy
    n1=en:white substance | n2=en:evolution to severe encephalopathy | rel=r_associated | relid=0 | w=106
  992. en:white substance -- r_associated #0: 106 / 0.876 -> en:exaggerated acoustic startle response
    n1=en:white substance | n2=en:exaggerated acoustic startle response | rel=r_associated | relid=0 | w=106
  993. en:white substance -- r_associated #0: 106 / 0.876 -> en:exaggerated moro reflex
    n1=en:white substance | n2=en:exaggerated moro reflex | rel=r_associated | relid=0 | w=106
  994. en:white substance -- r_associated #0: 106 / 0.876 -> en:exaggerated startle response
    n1=en:white substance | n2=en:exaggerated startle response | rel=r_associated | relid=0 | w=106
  995. en:white substance -- r_associated #0: 106 / 0.876 -> en:exaggerated startle response to tactile or acoustic stimuli
    n1=en:white substance | n2=en:exaggerated startle response to tactile or acoustic stimuli | rel=r_associated | relid=0 | w=106
  996. en:white substance -- r_associated #0: 106 / 0.876 -> en:excessive daytime somnolence
    n1=en:white substance | n2=en:excessive daytime somnolence | rel=r_associated | relid=0 | w=106
  997. en:white substance -- r_associated #0: 106 / 0.876 -> en:exocrine system
    n1=en:white substance | n2=en:exocrine system | rel=r_associated | relid=0 | w=106
  998. en:white substance -- r_associated #0: 106 / 0.876 -> en:expressive language disorder
    n1=en:white substance | n2=en:expressive language disorder | rel=r_associated | relid=0 | w=106
  999. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensive melanosis of leptomeninges, amygdala, and cerebellar hemispheres
    n1=en:white substance | n2=en:extensive melanosis of leptomeninges, amygdala, and cerebellar hemispheres | rel=r_associated | relid=0 | w=106
  1000. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor plantar responses (1 patient)
    n1=en:white substance | n2=en:extensor plantar responses (1 patient) | rel=r_associated | relid=0 | w=106
  1001. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor plantar responses (in some patients)
    n1=en:white substance | n2=en:extensor plantar responses (in some patients) | rel=r_associated | relid=0 | w=106
  1002. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor plantar responses (later)
    n1=en:white substance | n2=en:extensor plantar responses (later) | rel=r_associated | relid=0 | w=106
  1003. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor plantar responses (reported in 1 family)
    n1=en:white substance | n2=en:extensor plantar responses (reported in 1 family) | rel=r_associated | relid=0 | w=106
  1004. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor plantar responses (reported in 1 patient)
    n1=en:white substance | n2=en:extensor plantar responses (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  1005. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor plantar responses (variable)
    n1=en:white substance | n2=en:extensor plantar responses (variable) | rel=r_associated | relid=0 | w=106
  1006. en:white substance -- r_associated #0: 106 / 0.876 -> en:extensor posturing
    n1=en:white substance | n2=en:extensor posturing | rel=r_associated | relid=0 | w=106
  1007. en:white substance -- r_associated #0: 106 / 0.876 -> en:external capsule and claustrum may be involved
    n1=en:white substance | n2=en:external capsule and claustrum may be involved | rel=r_associated | relid=0 | w=106
  1008. en:white substance -- r_associated #0: 106 / 0.876 -> en:extra superior temporal gyrus (female)
    n1=en:white substance | n2=en:extra superior temporal gyrus (female) | rel=r_associated | relid=0 | w=106
  1009. en:white substance -- r_associated #0: 106 / 0.876 -> en:extraneuronal accumulation of autofluorescent pigmented material in various brain regions
    n1=en:white substance | n2=en:extraneuronal accumulation of autofluorescent pigmented material in various brain regions | rel=r_associated | relid=0 | w=106
  1010. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal dyskinesias (1 patient)
    n1=en:white substance | n2=en:extrapyramidal dyskinesias (1 patient) | rel=r_associated | relid=0 | w=106
  1011. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal features
    n1=en:white substance | n2=en:extrapyramidal features | rel=r_associated | relid=0 | w=106
  1012. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal muscular rigidity
    n1=en:white substance | n2=en:extrapyramidal muscular rigidity | rel=r_associated | relid=0 | w=106
  1013. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal signs (in 1 patient)
    n1=en:white substance | n2=en:extrapyramidal signs (in 1 patient) | rel=r_associated | relid=0 | w=106
  1014. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal signs (in some patients) thinning of the corpus callosum
    n1=en:white substance | n2=en:extrapyramidal signs (in some patients) thinning of the corpus callosum | rel=r_associated | relid=0 | w=106
  1015. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal signs (less common)
    n1=en:white substance | n2=en:extrapyramidal signs (less common) | rel=r_associated | relid=0 | w=106
  1016. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal signs, mild
    n1=en:white substance | n2=en:extrapyramidal signs, mild | rel=r_associated | relid=0 | w=106
  1017. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal symptoms may occur
    n1=en:white substance | n2=en:extrapyramidal symptoms may occur | rel=r_associated | relid=0 | w=106
  1018. en:white substance -- r_associated #0: 106 / 0.876 -> en:extrapyramidal tract
    n1=en:white substance | n2=en:extrapyramidal tract | rel=r_associated | relid=0 | w=106
  1019. en:white substance -- r_associated #0: 106 / 0.876 -> en:facial muscle weakness of muscles innervated by cn vii
    n1=en:white substance | n2=en:facial muscle weakness of muscles innervated by cn vii | rel=r_associated | relid=0 | w=106
  1020. en:white substance -- r_associated #0: 106 / 0.876 -> en:facial myokymia, mild
    n1=en:white substance | n2=en:facial myokymia, mild | rel=r_associated | relid=0 | w=106
  1021. en:white substance -- r_associated #0: 106 / 0.876 -> en:facial myokymias
    n1=en:white substance | n2=en:facial myokymias | rel=r_associated | relid=0 | w=106
  1022. en:white substance -- r_associated #0: 106 / 0.876 -> en:facial palsy secondary to cranial hyperostosis
    n1=en:white substance | n2=en:facial palsy secondary to cranial hyperostosis | rel=r_associated | relid=0 | w=106
  1023. en:white substance -- r_associated #0: 106 / 0.876 -> en:facial paralysis
    n1=en:white substance | n2=en:facial paralysis | rel=r_associated | relid=0 | w=106
  1024. en:white substance -- r_associated #0: 106 / 0.876 -> en:facial paresis, congenital bilateral
    n1=en:white substance | n2=en:facial paresis, congenital bilateral | rel=r_associated | relid=0 | w=106
  1025. en:white substance -- r_associated #0: 106 / 0.876 -> en:failure of opercularization of the frontal and temporal lobes on ct
    n1=en:white substance | n2=en:failure of opercularization of the frontal and temporal lobes on ct | rel=r_associated | relid=0 | w=106
  1026. en:white substance -- r_associated #0: 106 / 0.876 -> en:failure to achieve sitting or walking (severe form)
    n1=en:white substance | n2=en:failure to achieve sitting or walking (severe form) | rel=r_associated | relid=0 | w=106
  1027. en:white substance -- r_associated #0: 106 / 0.876 -> en:fall
    n1=en:white substance | n2=en:fall | rel=r_associated | relid=0 | w=106
  1028. en:white substance -- r_associated #0: 106 / 0.876 -> en:fasciculation
    n1=en:white substance | n2=en:fasciculation | rel=r_associated | relid=0 | w=106
  1029. en:white substance -- r_associated #0: 106 / 0.876 -> en:fasciculation-like movements
    n1=en:white substance | n2=en:fasciculation-like movements | rel=r_associated | relid=0 | w=106
  1030. en:white substance -- r_associated #0: 106 / 0.876 -> en:fasciculations (after long disease duration)
    n1=en:white substance | n2=en:fasciculations (after long disease duration) | rel=r_associated | relid=0 | w=106
  1031. en:white substance -- r_associated #0: 106 / 0.876 -> en:fearful expression
    n1=en:white substance | n2=en:fearful expression | rel=r_associated | relid=0 | w=106
  1032. en:white substance -- r_associated #0: 106 / 0.876 -> en:febrile seizure
    n1=en:white substance | n2=en:febrile seizure | rel=r_associated | relid=0 | w=106
  1033. en:white substance -- r_associated #0: 106 / 0.876 -> en:febrile seizures (1 patient)
    n1=en:white substance | n2=en:febrile seizures (1 patient) | rel=r_associated | relid=0 | w=106
  1034. en:white substance -- r_associated #0: 106 / 0.876 -> en:febrile seizures (in some)
    n1=en:white substance | n2=en:febrile seizures (in some) | rel=r_associated | relid=0 | w=106
  1035. en:white substance -- r_associated #0: 106 / 0.876 -> en:febrile seizures (usually remit by age 6 years)
    n1=en:white substance | n2=en:febrile seizures (usually remit by age 6 years) | rel=r_associated | relid=0 | w=106
  1036. en:white substance -- r_associated #0: 106 / 0.876 -> en:febrile seizures in infancy
    n1=en:white substance | n2=en:febrile seizures in infancy | rel=r_associated | relid=0 | w=106
  1037. en:white substance -- r_associated #0: 106 / 0.876 -> en:festinating (parkinsonian) gait
    n1=en:white substance | n2=en:festinating (parkinsonian) gait | rel=r_associated | relid=0 | w=106
  1038. en:white substance -- r_associated #0: 106 / 0.876 -> en:fibrillary plaques in the cerebellar cortex
    n1=en:white substance | n2=en:fibrillary plaques in the cerebellar cortex | rel=r_associated | relid=0 | w=106
  1039. en:white substance -- r_associated #0: 106 / 0.876 -> en:fibrillation
    n1=en:white substance | n2=en:fibrillation | rel=r_associated | relid=0 | w=106
  1040. en:white substance -- r_associated #0: 106 / 0.876 -> en:fibrous astrocyte
    n1=en:white substance | n2=en:fibrous astrocyte | rel=r_associated | relid=0 | w=106
  1041. en:white substance -- r_associated #0: 106 / 0.876 -> en:fine motor impairment
    n1=en:white substance | n2=en:fine motor impairment | rel=r_associated | relid=0 | w=106
  1042. en:white substance -- r_associated #0: 106 / 0.876 -> en:fine motor skills delayed
    n1=en:white substance | n2=en:fine motor skills delayed | rel=r_associated | relid=0 | w=106
  1043. en:white substance -- r_associated #0: 106 / 0.876 -> en:fine rapid hand tremor, 4-12 hz
    n1=en:white substance | n2=en:fine rapid hand tremor, 4-12 hz | rel=r_associated | relid=0 | w=106
  1044. en:white substance -- r_associated #0: 106 / 0.876 -> en:fine tremors
    n1=en:white substance | n2=en:fine tremors | rel=r_associated | relid=0 | w=106
  1045. en:white substance -- r_associated #0: 106 / 0.876 -> en:finger twitching
    n1=en:white substance | n2=en:finger twitching | rel=r_associated | relid=0 | w=106
  1046. en:white substance -- r_associated #0: 106 / 0.876 -> en:flaccidity, episodic
    n1=en:white substance | n2=en:flaccidity, episodic | rel=r_associated | relid=0 | w=106
  1047. en:white substance -- r_associated #0: 106 / 0.876 -> en:flat pons
    n1=en:white substance | n2=en:flat pons | rel=r_associated | relid=0 | w=106
  1048. en:white substance -- r_associated #0: 106 / 0.876 -> en:flattening of the caudate
    n1=en:white substance | n2=en:flattening of the caudate | rel=r_associated | relid=0 | w=106
  1049. en:white substance -- r_associated #0: 106 / 0.876 -> en:flattening of the pons
    n1=en:white substance | n2=en:flattening of the pons | rel=r_associated | relid=0 | w=106
  1050. en:white substance -- r_associated #0: 106 / 0.876 -> en:flexor plantar response
    n1=en:white substance | n2=en:flexor plantar response | rel=r_associated | relid=0 | w=106
  1051. en:white substance -- r_associated #0: 106 / 0.876 -> en:floppy infant
    n1=en:white substance | n2=en:floppy infant | rel=r_associated | relid=0 | w=106
  1052. en:white substance -- r_associated #0: 106 / 0.876 -> en:fluctuations in consciousness
    n1=en:white substance | n2=en:fluctuations in consciousness | rel=r_associated | relid=0 | w=106
  1053. en:white substance -- r_associated #0: 106 / 0.876 -> en:fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (csf) spaces
    n1=en:white substance | n2=en:fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (csf) spaces | rel=r_associated | relid=0 | w=106
  1054. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal cerebellar dysplasia
    n1=en:white substance | n2=en:focal cerebellar dysplasia | rel=r_associated | relid=0 | w=106
  1055. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal cortical dysplasia
    n1=en:white substance | n2=en:focal cortical dysplasia | rel=r_associated | relid=0 | w=106
  1056. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal discharges
    n1=en:white substance | n2=en:focal discharges | rel=r_associated | relid=0 | w=106
  1057. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal dystonia (e.g., writer's cramp)
    n1=en:white substance | n2=en:focal dystonia (e.g., writer's cramp) | rel=r_associated | relid=0 | w=106
  1058. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal dystonias
    n1=en:white substance | n2=en:focal dystonias | rel=r_associated | relid=0 | w=106
  1059. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal hyperplasia of the choroid plexus
    n1=en:white substance | n2=en:focal hyperplasia of the choroid plexus | rel=r_associated | relid=0 | w=106
  1060. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal interhemispheric fusion
    n1=en:white substance | n2=en:focal interhemispheric fusion | rel=r_associated | relid=0 | w=106
  1061. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal lissencephaly
    n1=en:white substance | n2=en:focal lissencephaly | rel=r_associated | relid=0 | w=106
  1062. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal neurologic deficits (i.e., hemiparesis)
    n1=en:white substance | n2=en:focal neurologic deficits (i.e., hemiparesis) | rel=r_associated | relid=0 | w=106
  1063. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal neurologic signs
    n1=en:white substance | n2=en:focal neurologic signs | rel=r_associated | relid=0 | w=106
  1064. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal nodular heterotopia
    n1=en:white substance | n2=en:focal nodular heterotopia | rel=r_associated | relid=0 | w=106
  1065. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal pachygyria
    n1=en:white substance | n2=en:focal pachygyria | rel=r_associated | relid=0 | w=106
  1066. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal paroxysmal discharges
    n1=en:white substance | n2=en:focal paroxysmal discharges | rel=r_associated | relid=0 | w=106
  1067. en:white substance -- r_associated #0: 106 / 0.876 -> en:focal white matter lesions (in type iib)
    n1=en:white substance | n2=en:focal white matter lesions (in type iib) | rel=r_associated | relid=0 | w=106
  1068. en:white substance -- r_associated #0: 106 / 0.876 -> en:foot-drop
    n1=en:white substance | n2=en:foot-drop | rel=r_associated | relid=0 | w=106
  1069. en:white substance -- r_associated #0: 106 / 0.876 -> en:forebrain
    n1=en:white substance | n2=en:forebrain | rel=r_associated | relid=0 | w=106
  1070. en:white substance -- r_associated #0: 106 / 0.876 -> en:four-repeat tau plaques in the striatum
    n1=en:white substance | n2=en:four-repeat tau plaques in the striatum | rel=r_associated | relid=0 | w=106
  1071. en:white substance -- r_associated #0: 106 / 0.876 -> en:frequency 3.5 hz in midline
    n1=en:white substance | n2=en:frequency 3.5 hz in midline | rel=r_associated | relid=0 | w=106
  1072. en:white substance -- r_associated #0: 106 / 0.876 -> en:frequency of 1 to 20 episodes per day
    n1=en:white substance | n2=en:frequency of 1 to 20 episodes per day | rel=r_associated | relid=0 | w=106
  1073. en:white substance -- r_associated #0: 106 / 0.876 -> en:frequent falls
    n1=en:white substance | n2=en:frequent falls | rel=r_associated | relid=0 | w=106
  1074. en:white substance -- r_associated #0: 106 / 0.876 -> en:frequent falls with preservation of consciousness
    n1=en:white substance | n2=en:frequent falls with preservation of consciousness | rel=r_associated | relid=0 | w=106
  1075. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontal cortical atophy
    n1=en:white substance | n2=en:frontal cortical atophy | rel=r_associated | relid=0 | w=106
  1076. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontal lobe atrophy
    n1=en:white substance | n2=en:frontal lobe atrophy | rel=r_associated | relid=0 | w=106
  1077. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontal lobe origin
    n1=en:white substance | n2=en:frontal lobe origin | rel=r_associated | relid=0 | w=106
  1078. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontal lobe syndrome
    n1=en:white substance | n2=en:frontal lobe syndrome | rel=r_associated | relid=0 | w=106
  1079. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontal release signs
    n1=en:white substance | n2=en:frontal release signs | rel=r_associated | relid=0 | w=106
  1080. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontolimbic dementia
    n1=en:white substance | n2=en:frontolimbic dementia | rel=r_associated | relid=0 | w=106
  1081. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontoparietal polymicrogyria
    n1=en:white substance | n2=en:frontoparietal polymicrogyria | rel=r_associated | relid=0 | w=106
  1082. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal atrophy
    n1=en:white substance | n2=en:frontotemporal atrophy | rel=r_associated | relid=0 | w=106
  1083. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal atrophy, mild, seen on mri
    n1=en:white substance | n2=en:frontotemporal atrophy, mild, seen on mri | rel=r_associated | relid=0 | w=106
  1084. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal dementia (1 patient)
    n1=en:white substance | n2=en:frontotemporal dementia (1 patient) | rel=r_associated | relid=0 | w=106
  1085. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal dementia, variable severity
    n1=en:white substance | n2=en:frontotemporal dementia, variable severity | rel=r_associated | relid=0 | w=106
  1086. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal hypoplasia
    n1=en:white substance | n2=en:frontotemporal hypoplasia | rel=r_associated | relid=0 | w=106
  1087. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal lobar atrophy
    n1=en:white substance | n2=en:frontotemporal lobar atrophy | rel=r_associated | relid=0 | w=106
  1088. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal lobar atrophy with 'knife-edge' distinction
    n1=en:white substance | n2=en:frontotemporal lobar atrophy with 'knife-edge' distinction | rel=r_associated | relid=0 | w=106
  1089. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporal polymicrogyria
    n1=en:white substance | n2=en:frontotemporal polymicrogyria | rel=r_associated | relid=0 | w=106
  1090. en:white substance -- r_associated #0: 106 / 0.876 -> en:frontotemporoparietal cortical dysplasia
    n1=en:white substance | n2=en:frontotemporoparietal cortical dysplasia | rel=r_associated | relid=0 | w=106
  1091. en:white substance -- r_associated #0: 106 / 0.876 -> en:funnel-shaped signal tapering from subcortical white matter to ventricle (in some type iib patients)
    n1=en:white substance | n2=en:funnel-shaped signal tapering from subcortical white matter to ventricle (in some type iib patients) | rel=r_associated | relid=0 | w=106
  1092. en:white substance -- r_associated #0: 106 / 0.876 -> en:fused hemispheres (wws)
    n1=en:white substance | n2=en:fused hemispheres (wws) | rel=r_associated | relid=0 | w=106
  1093. en:white substance -- r_associated #0: 106 / 0.876 -> en:fusion of the cerebellar hemispheres
    n1=en:white substance | n2=en:fusion of the cerebellar hemispheres | rel=r_associated | relid=0 | w=106
  1094. en:white substance -- r_associated #0: 106 / 0.876 -> en:fusion of the dentate nuclei and the superior cerebellar peduncles
    n1=en:white substance | n2=en:fusion of the dentate nuclei and the superior cerebellar peduncles | rel=r_associated | relid=0 | w=106
  1095. en:white substance -- r_associated #0: 106 / 0.876 -> en:fusion of the left and right thalami
    n1=en:white substance | n2=en:fusion of the left and right thalami | rel=r_associated | relid=0 | w=106
  1096. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait abnormalities (in some patients)
    n1=en:white substance | n2=en:gait abnormalities (in some patients) | rel=r_associated | relid=0 | w=106
  1097. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait abnormalities due to muscle weakness
    n1=en:white substance | n2=en:gait abnormalities due to muscle weakness | rel=r_associated | relid=0 | w=106
  1098. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait and limb ataxia
    n1=en:white substance | n2=en:gait and limb ataxia | rel=r_associated | relid=0 | w=106
  1099. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait ataxias, cerebellar
    n1=en:white substance | n2=en:gait ataxias, cerebellar | rel=r_associated | relid=0 | w=106
  1100. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait difficulties, late-onset
    n1=en:white substance | n2=en:gait difficulties, late-onset | rel=r_associated | relid=0 | w=106
  1101. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait disability
    n1=en:white substance | n2=en:gait disability | rel=r_associated | relid=0 | w=106
  1102. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait disturbance (ataxia)
    n1=en:white substance | n2=en:gait disturbance (ataxia) | rel=r_associated | relid=0 | w=106
  1103. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait imbalance
    n1=en:white substance | n2=en:gait imbalance | rel=r_associated | relid=0 | w=106
  1104. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait impairment
    n1=en:white substance | n2=en:gait impairment | rel=r_associated | relid=0 | w=106
  1105. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait impairment (55%)
    n1=en:white substance | n2=en:gait impairment (55%) | rel=r_associated | relid=0 | w=106
  1106. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait unsteady
    n1=en:white substance | n2=en:gait unsteady | rel=r_associated | relid=0 | w=106
  1107. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait, drop foot
    n1=en:white substance | n2=en:gait, drop foot | rel=r_associated | relid=0 | w=106
  1108. en:white substance -- r_associated #0: 106 / 0.876 -> en:gait, rigid
    n1=en:white substance | n2=en:gait, rigid | rel=r_associated | relid=0 | w=106
  1109. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized and focal spike and wave complexes seen on eeg
    n1=en:white substance | n2=en:generalized and focal spike and wave complexes seen on eeg | rel=r_associated | relid=0 | w=106
  1110. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized cerebral hypoplasia/atrophy (45%)
    n1=en:white substance | n2=en:generalized cerebral hypoplasia/atrophy (45%) | rel=r_associated | relid=0 | w=106
  1111. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized cerebral, cerebellar, and brainstem atrophy, progressive
    n1=en:white substance | n2=en:generalized cerebral, cerebellar, and brainstem atrophy, progressive | rel=r_associated | relid=0 | w=106
  1112. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized clonic or tonic-clonic seizures
    n1=en:white substance | n2=en:generalized clonic or tonic-clonic seizures | rel=r_associated | relid=0 | w=106
  1113. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized cortical atrophy, most prominent in the frontal and parietal lobes
    n1=en:white substance | n2=en:generalized cortical atrophy, most prominent in the frontal and parietal lobes | rel=r_associated | relid=0 | w=106
  1114. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized dystonia
    n1=en:white substance | n2=en:generalized dystonia | rel=r_associated | relid=0 | w=106
  1115. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized hypotonia
    n1=en:white substance | n2=en:generalized hypotonia | rel=r_associated | relid=0 | w=106
  1116. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized myelin loss
    n1=en:white substance | n2=en:generalized myelin loss | rel=r_associated | relid=0 | w=106
  1117. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized seizures
    n1=en:white substance | n2=en:generalized seizures | rel=r_associated | relid=0 | w=106
  1118. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized spike-wave activity seen on eeg
    n1=en:white substance | n2=en:generalized spike-wave activity seen on eeg | rel=r_associated | relid=0 | w=106
  1119. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized spike-wave discharges see on eeg
    n1=en:white substance | n2=en:generalized spike-wave discharges see on eeg | rel=r_associated | relid=0 | w=106
  1120. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized stiffening
    n1=en:white substance | n2=en:generalized stiffening | rel=r_associated | relid=0 | w=106
  1121. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized tonic-clonic seizures (gtcs) (in most patients)
    n1=en:white substance | n2=en:generalized tonic-clonic seizures (gtcs) (in most patients) | rel=r_associated | relid=0 | w=106
  1122. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized tonic-clonic seizures (gtcs) on awakening
    n1=en:white substance | n2=en:generalized tonic-clonic seizures (gtcs) on awakening | rel=r_associated | relid=0 | w=106
  1123. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized tonic-clonic seizures (often develop in adolescence)
    n1=en:white substance | n2=en:generalized tonic-clonic seizures (often develop in adolescence) | rel=r_associated | relid=0 | w=106
  1124. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized tonic-clonic seizures (rare)
    n1=en:white substance | n2=en:generalized tonic-clonic seizures (rare) | rel=r_associated | relid=0 | w=106
  1125. en:white substance -- r_associated #0: 106 / 0.876 -> en:generalized tonic-clonic seizures (stage 2 and 3)
    n1=en:white substance | n2=en:generalized tonic-clonic seizures (stage 2 and 3) | rel=r_associated | relid=0 | w=106
  1126. en:white substance -- r_associated #0: 106 / 0.876 -> en:germinal cysts over the caudate
    n1=en:white substance | n2=en:germinal cysts over the caudate | rel=r_associated | relid=0 | w=106
  1127. en:white substance -- r_associated #0: 106 / 0.876 -> en:giant granules in schwann cells
    n1=en:white substance | n2=en:giant granules in schwann cells | rel=r_associated | relid=0 | w=106
  1128. en:white substance -- r_associated #0: 106 / 0.876 -> en:gilles de la tourette syndrome (reported in 1 patient)
    n1=en:white substance | n2=en:gilles de la tourette syndrome (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  1129. en:white substance -- r_associated #0: 106 / 0.876 -> en:glial activation
    n1=en:white substance | n2=en:glial activation | rel=r_associated | relid=0 | w=106
  1130. en:white substance -- r_associated #0: 106 / 0.876 -> en:glial cell
    n1=en:white substance | n2=en:glial cell | rel=r_associated | relid=0 | w=106
  1131. en:white substance -- r_associated #0: 106 / 0.876 -> en:glial inclusions
    n1=en:white substance | n2=en:glial inclusions | rel=r_associated | relid=0 | w=106
  1132. en:white substance -- r_associated #0: 106 / 0.876 -> en:gliosis
    n1=en:white substance | n2=en:gliosis | rel=r_associated | relid=0 | w=106
  1133. en:white substance -- r_associated #0: 106 / 0.876 -> en:gliosis (27%)
    n1=en:white substance | n2=en:gliosis (27%) | rel=r_associated | relid=0 | w=106
  1134. en:white substance -- r_associated #0: 106 / 0.876 -> en:gliosis (patient a)
    n1=en:white substance | n2=en:gliosis (patient a) | rel=r_associated | relid=0 | w=106
  1135. en:white substance -- r_associated #0: 106 / 0.876 -> en:gliosis in the striatum, medial thalamic nuclei, and inferior olives
    n1=en:white substance | n2=en:gliosis in the striatum, medial thalamic nuclei, and inferior olives | rel=r_associated | relid=0 | w=106
  1136. en:white substance -- r_associated #0: 106 / 0.876 -> en:global and focal neurologic abnormalities (less than 30%)
    n1=en:white substance | n2=en:global and focal neurologic abnormalities (less than 30%) | rel=r_associated | relid=0 | w=106
  1137. en:white substance -- r_associated #0: 106 / 0.876 -> en:global cerebral atrophy, mild (in some patients)
    n1=en:white substance | n2=en:global cerebral atrophy, mild (in some patients) | rel=r_associated | relid=0 | w=106
  1138. en:white substance -- r_associated #0: 106 / 0.876 -> en:global developmental delay if untreated
    n1=en:white substance | n2=en:global developmental delay if untreated | rel=r_associated | relid=0 | w=106
  1139. en:white substance -- r_associated #0: 106 / 0.876 -> en:global hypotonia
    n1=en:white substance | n2=en:global hypotonia | rel=r_associated | relid=0 | w=106
  1140. en:white substance -- r_associated #0: 106 / 0.876 -> en:global reduction in cerebral blood flow on pet scan
    n1=en:white substance | n2=en:global reduction in cerebral blood flow on pet scan | rel=r_associated | relid=0 | w=106
  1141. en:white substance -- r_associated #0: 106 / 0.876 -> en:globally delayed development
    n1=en:white substance | n2=en:globally delayed development | rel=r_associated | relid=0 | w=106
  1142. en:white substance -- r_associated #0: 106 / 0.876 -> en:globular thalamus (1 patient)
    n1=en:white substance | n2=en:globular thalamus (1 patient) | rel=r_associated | relid=0 | w=106
  1143. en:white substance -- r_associated #0: 106 / 0.876 -> en:glomeruloid vascular proliferation in brain and spinal cord
    n1=en:white substance | n2=en:glomeruloid vascular proliferation in brain and spinal cord | rel=r_associated | relid=0 | w=106
  1144. en:white substance -- r_associated #0: 106 / 0.876 -> en:gowers sign
    n1=en:white substance | n2=en:gowers sign | rel=r_associated | relid=0 | w=106
  1145. en:white substance -- r_associated #0: 106 / 0.876 -> en:grand mal epilepsy
    n1=en:white substance | n2=en:grand mal epilepsy | rel=r_associated | relid=0 | w=106
  1146. en:white substance -- r_associated #0: 106 / 0.876 -> en:granular material in neurons
    n1=en:white substance | n2=en:granular material in neurons | rel=r_associated | relid=0 | w=106
  1147. en:white substance -- r_associated #0: 106 / 0.876 -> en:granular osmiophilic cytoplasmic deposits in schwann cells
    n1=en:white substance | n2=en:granular osmiophilic cytoplasmic deposits in schwann cells | rel=r_associated | relid=0 | w=106
  1148. en:white substance -- r_associated #0: 106 / 0.876 -> en:granulovacuolar degeneration
    n1=en:white substance | n2=en:granulovacuolar degeneration | rel=r_associated | relid=0 | w=106
  1149. en:white substance -- r_associated #0: 106 / 0.876 -> en:gray matter appears relatively unaffected
    n1=en:white substance | n2=en:gray matter appears relatively unaffected | rel=r_associated | relid=0 | w=106
  1150. en:white substance -- r_associated #0: 106 / 0.876 -> en:gray matter heterotopia (in some patients)
    n1=en:white substance | n2=en:gray matter heterotopia (in some patients) | rel=r_associated | relid=0 | w=106
  1151. en:white substance -- r_associated #0: 106 / 0.876 -> en:gray matter structure of central nervous system
    n1=en:white substance | n2=en:gray matter structure of central nervous system | rel=r_associated | relid=0 | w=106
  1152. en:white substance -- r_associated #0: 106 / 0.876 -> en:grimaces
    n1=en:white substance | n2=en:grimaces | rel=r_associated | relid=0 | w=106
  1153. en:white substance -- r_associated #0: 106 / 0.876 -> en:gross motor delay
    n1=en:white substance | n2=en:gross motor delay | rel=r_associated | relid=0 | w=106
  1154. en:white substance -- r_associated #0: 106 / 0.876 -> en:gross motor delay (in one family)
    n1=en:white substance | n2=en:gross motor delay (in one family) | rel=r_associated | relid=0 | w=106
  1155. en:white substance -- r_associated #0: 106 / 0.876 -> en:gross motor skill delay (infancy)
    n1=en:white substance | n2=en:gross motor skill delay (infancy) | rel=r_associated | relid=0 | w=106
  1156. en:white substance -- r_associated #0: 106 / 0.876 -> en:gtcs during 'leisure' time (evening)
    n1=en:white substance | n2=en:gtcs during 'leisure' time (evening) | rel=r_associated | relid=0 | w=106
  1157. en:white substance -- r_associated #0: 106 / 0.876 -> en:gyral disorganization
    n1=en:white substance | n2=en:gyral disorganization | rel=r_associated | relid=0 | w=106
  1158. en:white substance -- r_associated #0: 106 / 0.876 -> en:hallucination
    n1=en:white substance | n2=en:hallucination | rel=r_associated | relid=0 | w=106
  1159. en:white substance -- r_associated #0: 106 / 0.876 -> en:hand muscle atrophy
    n1=en:white substance | n2=en:hand muscle atrophy | rel=r_associated | relid=0 | w=106
  1160. en:white substance -- r_associated #0: 106 / 0.876 -> en:hand muscle weakness
    n1=en:white substance | n2=en:hand muscle weakness | rel=r_associated | relid=0 | w=106
  1161. en:white substance -- r_associated #0: 106 / 0.876 -> en:has tingling sensation
    n1=en:white substance | n2=en:has tingling sensation | rel=r_associated | relid=0 | w=106
  1162. en:white substance -- r_associated #0: 106 / 0.876 -> en:head 'tilt' in infancy
    n1=en:white substance | n2=en:head 'tilt' in infancy | rel=r_associated | relid=0 | w=106
  1163. en:white substance -- r_associated #0: 106 / 0.876 -> en:head bobbing
    n1=en:white substance | n2=en:head bobbing | rel=r_associated | relid=0 | w=106
  1164. en:white substance -- r_associated #0: 106 / 0.876 -> en:head oscillations
    n1=en:white substance | n2=en:head oscillations | rel=r_associated | relid=0 | w=106
  1165. en:white substance -- r_associated #0: 106 / 0.876 -> en:head tremor
    n1=en:white substance | n2=en:head tremor | rel=r_associated | relid=0 | w=106
  1166. en:white substance -- r_associated #0: 106 / 0.876 -> en:head tremor (in some patients)
    n1=en:white substance | n2=en:head tremor (in some patients) | rel=r_associated | relid=0 | w=106
  1167. en:white substance -- r_associated #0: 106 / 0.876 -> en:head tremor, mild
    n1=en:white substance | n2=en:head tremor, mild | rel=r_associated | relid=0 | w=106
  1168. en:white substance -- r_associated #0: 106 / 0.876 -> en:head-rolling movements
    n1=en:white substance | n2=en:head-rolling movements | rel=r_associated | relid=0 | w=106
  1169. en:white substance -- r_associated #0: 106 / 0.876 -> en:headache
    n1=en:white substance | n2=en:headache | rel=r_associated | relid=0 | w=106
  1170. en:white substance -- r_associated #0: 106 / 0.876 -> en:headache (with pheochromocytoma)
    n1=en:white substance | n2=en:headache (with pheochromocytoma) | rel=r_associated | relid=0 | w=106
  1171. en:white substance -- r_associated #0: 106 / 0.876 -> en:headache is usually not a symptom
    n1=en:white substance | n2=en:headache is usually not a symptom | rel=r_associated | relid=0 | w=106
  1172. en:white substance -- r_associated #0: 106 / 0.876 -> en:headache, episodic
    n1=en:white substance | n2=en:headache, episodic | rel=r_associated | relid=0 | w=106
  1173. en:white substance -- r_associated #0: 106 / 0.876 -> en:headache, suboccipital, migraine-like (most common symptom) precipitated by coughing, sneezing, bending forward, lifting, neck extension
    n1=en:white substance | n2=en:headache, suboccipital, migraine-like (most common symptom) precipitated by coughing, sneezing, bending forward, lifting, neck extension | rel=r_associated | relid=0 | w=106
  1174. en:white substance -- r_associated #0: 106 / 0.876 -> en:headaches, severe, unilateral
    n1=en:white substance | n2=en:headaches, severe, unilateral | rel=r_associated | relid=0 | w=106
  1175. en:white substance -- r_associated #0: 106 / 0.876 -> en:heightened sensitivity to external stimuli
    n1=en:white substance | n2=en:heightened sensitivity to external stimuli | rel=r_associated | relid=0 | w=106
  1176. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemihypoasthesia
    n1=en:white substance | n2=en:hemihypoasthesia | rel=r_associated | relid=0 | w=106
  1177. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemiparesis
    n1=en:white substance | n2=en:hemiparesis | rel=r_associated | relid=0 | w=106
  1178. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemiparesis (in some patients)
    n1=en:white substance | n2=en:hemiparesis (in some patients) | rel=r_associated | relid=0 | w=106
  1179. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemiparesis, paroxysmal
    n1=en:white substance | n2=en:hemiparesis, paroxysmal | rel=r_associated | relid=0 | w=106
  1180. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemiplegic migraine in some patients
    n1=en:white substance | n2=en:hemiplegic migraine in some patients | rel=r_associated | relid=0 | w=106
  1181. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemisensory attacks
    n1=en:white substance | n2=en:hemisensory attacks | rel=r_associated | relid=0 | w=106
  1182. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemispheric atrophy
    n1=en:white substance | n2=en:hemispheric atrophy | rel=r_associated | relid=0 | w=106
  1183. en:white substance -- r_associated #0: 106 / 0.876 -> en:hemosiderin deposition
    n1=en:white substance | n2=en:hemosiderin deposition | rel=r_associated | relid=0 | w=106
  1184. en:white substance -- r_associated #0: 106 / 0.876 -> en:hepatic coma
    n1=en:white substance | n2=en:hepatic coma | rel=r_associated | relid=0 | w=106
  1185. en:white substance -- r_associated #0: 106 / 0.876 -> en:hepatic encephalopathy
    n1=en:white substance | n2=en:hepatic encephalopathy | rel=r_associated | relid=0 | w=106
  1186. en:white substance -- r_associated #0: 106 / 0.876 -> en:herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum
    n1=en:white substance | n2=en:herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum | rel=r_associated | relid=0 | w=106
  1187. en:white substance -- r_associated #0: 106 / 0.876 -> en:heterotopic neurons in the white matter (36%)
    n1=en:white substance | n2=en:heterotopic neurons in the white matter (36%) | rel=r_associated | relid=0 | w=106
  1188. en:white substance -- r_associated #0: 106 / 0.876 -> en:high pain threshold
    n1=en:white substance | n2=en:high pain threshold | rel=r_associated | relid=0 | w=106
  1189. en:white substance -- r_associated #0: 106 / 0.876 -> en:high signal intensities at gray/white matter junction
    n1=en:white substance | n2=en:high signal intensities at gray/white matter junction | rel=r_associated | relid=0 | w=106
  1190. en:white substance -- r_associated #0: 106 / 0.876 -> en:high-steppage gait
    n1=en:white substance | n2=en:high-steppage gait | rel=r_associated | relid=0 | w=106
  1191. en:white substance -- r_associated #0: 106 / 0.876 -> en:high-stepping gait
    n1=en:white substance | n2=en:high-stepping gait | rel=r_associated | relid=0 | w=106
  1192. en:white substance -- r_associated #0: 106 / 0.876 -> en:hindbrain and midbrain
    n1=en:white substance | n2=en:hindbrain and midbrain | rel=r_associated | relid=0 | w=106
  1193. en:white substance -- r_associated #0: 106 / 0.876 -> en:hippocampal atrophy (1 patient)
    n1=en:white substance | n2=en:hippocampal atrophy (1 patient) | rel=r_associated | relid=0 | w=106
  1194. en:white substance -- r_associated #0: 106 / 0.876 -> en:hippocampal hypoplasia
    n1=en:white substance | n2=en:hippocampal hypoplasia | rel=r_associated | relid=0 | w=106
  1195. en:white substance -- r_associated #0: 106 / 0.876 -> en:holoprosencephaly
    n1=en:white substance | n2=en:holoprosencephaly | rel=r_associated | relid=0 | w=106
  1196. en:white substance -- r_associated #0: 106 / 0.876 -> en:holoprosencephaly (100%)
    n1=en:white substance | n2=en:holoprosencephaly (100%) | rel=r_associated | relid=0 | w=106
  1197. en:white substance -- r_associated #0: 106 / 0.876 -> en:holoprosencephaly (less common)
    n1=en:white substance | n2=en:holoprosencephaly (less common) | rel=r_associated | relid=0 | w=106
  1198. en:white substance -- r_associated #0: 106 / 0.876 -> en:holoprosencephaly (variable)
    n1=en:white substance | n2=en:holoprosencephaly (variable) | rel=r_associated | relid=0 | w=106
  1199. en:white substance -- r_associated #0: 106 / 0.876 -> en:hooked aspect of the frontal horn of the lateral ventricles due to abnormally shaped basal ganglia
    n1=en:white substance | n2=en:hooked aspect of the frontal horn of the lateral ventricles due to abnormally shaped basal ganglia | rel=r_associated | relid=0 | w=106
  1200. en:white substance -- r_associated #0: 106 / 0.876 -> en:hunger and thirst disturbances (in some patients)
    n1=en:white substance | n2=en:hunger and thirst disturbances (in some patients) | rel=r_associated | relid=0 | w=106
  1201. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydranencephaly
    n1=en:white substance | n2=en:hydranencephaly | rel=r_associated | relid=0 | w=106
  1202. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus
    n1=en:white substance | n2=en:hydrocephalus | rel=r_associated | relid=0 | w=106
  1203. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (11%)
    n1=en:white substance | n2=en:hydrocephalus (11%) | rel=r_associated | relid=0 | w=106
  1204. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (12%)
    n1=en:white substance | n2=en:hydrocephalus (12%) | rel=r_associated | relid=0 | w=106
  1205. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (in 1 patient)
    n1=en:white substance | n2=en:hydrocephalus (in 1 patient) | rel=r_associated | relid=0 | w=106
  1206. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (in some patients)
    n1=en:white substance | n2=en:hydrocephalus (in some patients) | rel=r_associated | relid=0 | w=106
  1207. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (less common)
    n1=en:white substance | n2=en:hydrocephalus (less common) | rel=r_associated | relid=0 | w=106
  1208. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (uncommon)
    n1=en:white substance | n2=en:hydrocephalus (uncommon) | rel=r_associated | relid=0 | w=106
  1209. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus (variable)
    n1=en:white substance | n2=en:hydrocephalus (variable) | rel=r_associated | relid=0 | w=106
  1210. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephalus, occasional
    n1=en:white substance | n2=en:hydrocephalus, occasional | rel=r_associated | relid=0 | w=106
  1211. en:white substance -- r_associated #0: 106 / 0.876 -> en:hydrocephaly, mild
    n1=en:white substance | n2=en:hydrocephaly, mild | rel=r_associated | relid=0 | w=106
  1212. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperactive deep tendon reflexes
    n1=en:white substance | n2=en:hyperactive deep tendon reflexes | rel=r_associated | relid=0 | w=106
  1213. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperactive deep tendon reflexes in early stage
    n1=en:white substance | n2=en:hyperactive deep tendon reflexes in early stage | rel=r_associated | relid=0 | w=106
  1214. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperactive startle reflex
    n1=en:white substance | n2=en:hyperactive startle reflex | rel=r_associated | relid=0 | w=106
  1215. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperactivity
    n1=en:white substance | n2=en:hyperactivity | rel=r_associated | relid=0 | w=106
  1216. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperintense lesions in the basal ganglia on mri
    n1=en:white substance | n2=en:hyperintense lesions in the basal ganglia on mri | rel=r_associated | relid=0 | w=106
  1217. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperintensities in the basal ganglia (rare)
    n1=en:white substance | n2=en:hyperintensities in the basal ganglia (rare) | rel=r_associated | relid=0 | w=106
  1218. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperintensities in the basal ganglia and/or thalamus
    n1=en:white substance | n2=en:hyperintensities in the basal ganglia and/or thalamus | rel=r_associated | relid=0 | w=106
  1219. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperirritability
    n1=en:white substance | n2=en:hyperirritability | rel=r_associated | relid=0 | w=106
  1220. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperkinetic involuntary movements
    n1=en:white substance | n2=en:hyperkinetic involuntary movements | rel=r_associated | relid=0 | w=106
  1221. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypermotor behavior
    n1=en:white substance | n2=en:hypermotor behavior | rel=r_associated | relid=0 | w=106
  1222. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia
    n1=en:white substance | n2=en:hyperreflexia | rel=r_associated | relid=0 | w=106
  1223. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia (2 patients)
    n1=en:white substance | n2=en:hyperreflexia (2 patients) | rel=r_associated | relid=0 | w=106
  1224. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia (33%)
    n1=en:white substance | n2=en:hyperreflexia (33%) | rel=r_associated | relid=0 | w=106
  1225. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia (70%)
    n1=en:white substance | n2=en:hyperreflexia (70%) | rel=r_associated | relid=0 | w=106
  1226. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia (particularly in lower extremities, more prevalent in adolescents and adults)
    n1=en:white substance | n2=en:hyperreflexia (particularly in lower extremities, more prevalent in adolescents and adults) | rel=r_associated | relid=0 | w=106
  1227. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia (some patients)
    n1=en:white substance | n2=en:hyperreflexia (some patients) | rel=r_associated | relid=0 | w=106
  1228. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia (type i)
    n1=en:white substance | n2=en:hyperreflexia (type i) | rel=r_associated | relid=0 | w=106
  1229. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia in some
    n1=en:white substance | n2=en:hyperreflexia in some | rel=r_associated | relid=0 | w=106
  1230. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia in the lower limbs (in some patients)
    n1=en:white substance | n2=en:hyperreflexia in the lower limbs (in some patients) | rel=r_associated | relid=0 | w=106
  1231. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia may occur
    n1=en:white substance | n2=en:hyperreflexia may occur | rel=r_associated | relid=0 | w=106
  1232. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia proximally
    n1=en:white substance | n2=en:hyperreflexia proximally | rel=r_associated | relid=0 | w=106
  1233. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia, lower limbs more than upper limbs
    n1=en:white substance | n2=en:hyperreflexia, lower limbs more than upper limbs | rel=r_associated | relid=0 | w=106
  1234. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyperreflexia, lower limbs, mild
    n1=en:white substance | n2=en:hyperreflexia, lower limbs, mild | rel=r_associated | relid=0 | w=106
  1235. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypersensitive to stimuli
    n1=en:white substance | n2=en:hypersensitive to stimuli | rel=r_associated | relid=0 | w=106
  1236. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypersensitivity to sound
    n1=en:white substance | n2=en:hypersensitivity to sound | rel=r_associated | relid=0 | w=106
  1237. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia
    n1=en:white substance | n2=en:hypertonia | rel=r_associated | relid=0 | w=106
  1238. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia (after age 2 years)
    n1=en:white substance | n2=en:hypertonia (after age 2 years) | rel=r_associated | relid=0 | w=106
  1239. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia (childhood)
    n1=en:white substance | n2=en:hypertonia (childhood) | rel=r_associated | relid=0 | w=106
  1240. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia (older children and adolescents)
    n1=en:white substance | n2=en:hypertonia (older children and adolescents) | rel=r_associated | relid=0 | w=106
  1241. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia (type ii)
    n1=en:white substance | n2=en:hypertonia (type ii) | rel=r_associated | relid=0 | w=106
  1242. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia and rigidity during seizures
    n1=en:white substance | n2=en:hypertonia and rigidity during seizures | rel=r_associated | relid=0 | w=106
  1243. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia in early stage
    n1=en:white substance | n2=en:hypertonia in early stage | rel=r_associated | relid=0 | w=106
  1244. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia of lower limbs, later
    n1=en:white substance | n2=en:hypertonia of lower limbs, later | rel=r_associated | relid=0 | w=106
  1245. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonia, mild, transient
    n1=en:white substance | n2=en:hypertonia, mild, transient | rel=r_associated | relid=0 | w=106
  1246. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonic seizures
    n1=en:white substance | n2=en:hypertonic seizures | rel=r_associated | relid=0 | w=106
  1247. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypertonicity
    n1=en:white substance | n2=en:hypertonicity | rel=r_associated | relid=0 | w=106
  1248. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypnagogic hallucinations
    n1=en:white substance | n2=en:hypnagogic hallucinations | rel=r_associated | relid=0 | w=106
  1249. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypo- and demyelination of the brain
    n1=en:white substance | n2=en:hypo- and demyelination of the brain | rel=r_associated | relid=0 | w=106
  1250. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypocalcemic seizures
    n1=en:white substance | n2=en:hypocalcemic seizures | rel=r_associated | relid=0 | w=106
  1251. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypocalcemic tetany
    n1=en:white substance | n2=en:hypocalcemic tetany | rel=r_associated | relid=0 | w=106
  1252. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypodensity of caudate
    n1=en:white substance | n2=en:hypodensity of caudate | rel=r_associated | relid=0 | w=106
  1253. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypodensity of cerebral white matter seen on mri
    n1=en:white substance | n2=en:hypodensity of cerebral white matter seen on mri | rel=r_associated | relid=0 | w=106
  1254. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypodensity of lenticular nuclei
    n1=en:white substance | n2=en:hypodensity of lenticular nuclei | rel=r_associated | relid=0 | w=106
  1255. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypodensity of the white matter
    n1=en:white substance | n2=en:hypodensity of the white matter | rel=r_associated | relid=0 | w=106
  1256. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypogenesis of the corpus callosum
    n1=en:white substance | n2=en:hypogenesis of the corpus callosum | rel=r_associated | relid=0 | w=106
  1257. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoglycemia-related seizures
    n1=en:white substance | n2=en:hypoglycemia-related seizures | rel=r_associated | relid=0 | w=106
  1258. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoglycemic coma
    n1=en:white substance | n2=en:hypoglycemic coma | rel=r_associated | relid=0 | w=106
  1259. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypokinesia
    n1=en:white substance | n2=en:hypokinesia | rel=r_associated | relid=0 | w=106
  1260. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypokinesia in infancy
    n1=en:white substance | n2=en:hypokinesia in infancy | rel=r_associated | relid=0 | w=106
  1261. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypokinetic movements
    n1=en:white substance | n2=en:hypokinetic movements | rel=r_associated | relid=0 | w=106
  1262. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypometabolism of the frontal lobe and thalamic regions
    n1=en:white substance | n2=en:hypometabolism of the frontal lobe and thalamic regions | rel=r_associated | relid=0 | w=106
  1263. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypomimia
    n1=en:white substance | n2=en:hypomimia | rel=r_associated | relid=0 | w=106
  1264. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypomyelinating leukoencephalopathy
    n1=en:white substance | n2=en:hypomyelinating leukoencephalopathy | rel=r_associated | relid=0 | w=106
  1265. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypomyelination (1 patient)
    n1=en:white substance | n2=en:hypomyelination (1 patient) | rel=r_associated | relid=0 | w=106
  1266. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypomyelination (patient a) metabolic : hypochloremia metabolic alkalosis (patient a)
    n1=en:white substance | n2=en:hypomyelination (patient a) metabolic : hypochloremia metabolic alkalosis (patient a) | rel=r_associated | relid=0 | w=106
  1267. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypomyelination of the brain white matter, diffuse
    n1=en:white substance | n2=en:hypomyelination of the brain white matter, diffuse | rel=r_associated | relid=0 | w=106
  1268. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia and displacement of the corticospinal fibers within the brainstem
    n1=en:white substance | n2=en:hypoplasia and displacement of the corticospinal fibers within the brainstem | rel=r_associated | relid=0 | w=106
  1269. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of anterior or entire pituitary gland (frequent)
    n1=en:white substance | n2=en:hypoplasia of anterior or entire pituitary gland (frequent) | rel=r_associated | relid=0 | w=106
  1270. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of septum pellucidum
    n1=en:white substance | n2=en:hypoplasia of septum pellucidum | rel=r_associated | relid=0 | w=106
  1271. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the brainstem
    n1=en:white substance | n2=en:hypoplasia of the brainstem | rel=r_associated | relid=0 | w=106
  1272. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the corpus callosum (2 patients)
    n1=en:white substance | n2=en:hypoplasia of the corpus callosum (2 patients) | rel=r_associated | relid=0 | w=106
  1273. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the hypothalamus
    n1=en:white substance | n2=en:hypoplasia of the hypothalamus | rel=r_associated | relid=0 | w=106
  1274. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the mesencephalic tectum
    n1=en:white substance | n2=en:hypoplasia of the mesencephalic tectum | rel=r_associated | relid=0 | w=106
  1275. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the optic chiasm
    n1=en:white substance | n2=en:hypoplasia of the optic chiasm | rel=r_associated | relid=0 | w=106
  1276. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the optic tract
    n1=en:white substance | n2=en:hypoplasia of the optic tract | rel=r_associated | relid=0 | w=106
  1277. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the pyramidal tract
    n1=en:white substance | n2=en:hypoplasia of the pyramidal tract | rel=r_associated | relid=0 | w=106
  1278. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplasia of the ventral pons
    n1=en:white substance | n2=en:hypoplasia of the ventral pons | rel=r_associated | relid=0 | w=106
  1279. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic anterior pituitary (in some patients)
    n1=en:white substance | n2=en:hypoplastic anterior pituitary (in some patients) | rel=r_associated | relid=0 | w=106
  1280. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic brainstem with loss of demarcation at the pontomedullary junction
    n1=en:white substance | n2=en:hypoplastic brainstem with loss of demarcation at the pontomedullary junction | rel=r_associated | relid=0 | w=106
  1281. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic cerebellar vermis (rare)
    n1=en:white substance | n2=en:hypoplastic cerebellar vermis (rare) | rel=r_associated | relid=0 | w=106
  1282. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic corpus callosum (1 patient)
    n1=en:white substance | n2=en:hypoplastic corpus callosum (1 patient) | rel=r_associated | relid=0 | w=106
  1283. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic corpus callosum (in some patients)
    n1=en:white substance | n2=en:hypoplastic corpus callosum (in some patients) | rel=r_associated | relid=0 | w=106
  1284. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic corpus callosum (in some)
    n1=en:white substance | n2=en:hypoplastic corpus callosum (in some) | rel=r_associated | relid=0 | w=106
  1285. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic corpus callosum (rare)
    n1=en:white substance | n2=en:hypoplastic corpus callosum (rare) | rel=r_associated | relid=0 | w=106
  1286. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic olfactory lobes
    n1=en:white substance | n2=en:hypoplastic olfactory lobes | rel=r_associated | relid=0 | w=106
  1287. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic or absent middle cerebellar peduncles
    n1=en:white substance | n2=en:hypoplastic or absent middle cerebellar peduncles | rel=r_associated | relid=0 | w=106
  1288. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic or absent optic chiasm
    n1=en:white substance | n2=en:hypoplastic or absent optic chiasm | rel=r_associated | relid=0 | w=106
  1289. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic pituitary gland (in some patients)
    n1=en:white substance | n2=en:hypoplastic pituitary gland (in some patients) | rel=r_associated | relid=0 | w=106
  1290. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic pons
    n1=en:white substance | n2=en:hypoplastic pons | rel=r_associated | relid=0 | w=106
  1291. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoplastic/atrophic corpus callosum (55%)
    n1=en:white substance | n2=en:hypoplastic/atrophic corpus callosum (55%) | rel=r_associated | relid=0 | w=106
  1292. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyporeflexia
    n1=en:white substance | n2=en:hyporeflexia | rel=r_associated | relid=0 | w=106
  1293. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyporeflexia (early)
    n1=en:white substance | n2=en:hyporeflexia (early) | rel=r_associated | relid=0 | w=106
  1294. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyporeflexia (occurs later)
    n1=en:white substance | n2=en:hyporeflexia (occurs later) | rel=r_associated | relid=0 | w=106
  1295. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyporeflexia to hyperreflexia
    n1=en:white substance | n2=en:hyporeflexia to hyperreflexia | rel=r_associated | relid=0 | w=106
  1296. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyposmia/anosmia
    n1=en:white substance | n2=en:hyposmia/anosmia | rel=r_associated | relid=0 | w=106
  1297. en:white substance -- r_associated #0: 106 / 0.876 -> en:hyposmia/anosmia (in some patients)
    n1=en:white substance | n2=en:hyposmia/anosmia (in some patients) | rel=r_associated | relid=0 | w=106
  1298. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (1 patient)
    n1=en:white substance | n2=en:hypotonia (1 patient) | rel=r_associated | relid=0 | w=106
  1299. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (93%)
    n1=en:white substance | n2=en:hypotonia (93%) | rel=r_associated | relid=0 | w=106
  1300. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (96%)
    n1=en:white substance | n2=en:hypotonia (96%) | rel=r_associated | relid=0 | w=106
  1301. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (congenital form)
    n1=en:white substance | n2=en:hypotonia (congenital form) | rel=r_associated | relid=0 | w=106
  1302. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (hcs and 2p21del)
    n1=en:white substance | n2=en:hypotonia (hcs and 2p21del) | rel=r_associated | relid=0 | w=106
  1303. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (in 1/4 patients)
    n1=en:white substance | n2=en:hypotonia (in 1/4 patients) | rel=r_associated | relid=0 | w=106
  1304. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (in some patients)
    n1=en:white substance | n2=en:hypotonia (in some patients) | rel=r_associated | relid=0 | w=106
  1305. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (less common)
    n1=en:white substance | n2=en:hypotonia (less common) | rel=r_associated | relid=0 | w=106
  1306. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (newborn)
    n1=en:white substance | n2=en:hypotonia (newborn) | rel=r_associated | relid=0 | w=106
  1307. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (rare)
    n1=en:white substance | n2=en:hypotonia (rare) | rel=r_associated | relid=0 | w=106
  1308. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia (type i and type ii, infantile)
    n1=en:white substance | n2=en:hypotonia (type i and type ii, infantile) | rel=r_associated | relid=0 | w=106
  1309. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia at birth
    n1=en:white substance | n2=en:hypotonia at birth | rel=r_associated | relid=0 | w=106
  1310. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia changing to hypertonia
    n1=en:white substance | n2=en:hypotonia changing to hypertonia | rel=r_associated | relid=0 | w=106
  1311. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia in infancy and early childhood
    n1=en:white substance | n2=en:hypotonia in infancy and early childhood | rel=r_associated | relid=0 | w=106
  1312. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia in later stages
    n1=en:white substance | n2=en:hypotonia in later stages | rel=r_associated | relid=0 | w=106
  1313. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia progressing to hypertonia
    n1=en:white substance | n2=en:hypotonia progressing to hypertonia | rel=r_associated | relid=0 | w=106
  1314. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia, axial, severe
    n1=en:white substance | n2=en:hypotonia, axial, severe | rel=r_associated | relid=0 | w=106
  1315. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia, mild
    n1=en:white substance | n2=en:hypotonia, mild | rel=r_associated | relid=0 | w=106
  1316. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia, mild, transient
    n1=en:white substance | n2=en:hypotonia, mild, transient | rel=r_associated | relid=0 | w=106
  1317. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia, neonatal (> 90%)
    n1=en:white substance | n2=en:hypotonia, neonatal (> 90%) | rel=r_associated | relid=0 | w=106
  1318. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia, proximal, severe
    n1=en:white substance | n2=en:hypotonia, proximal, severe | rel=r_associated | relid=0 | w=106
  1319. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonia, severe (rare)
    n1=en:white substance | n2=en:hypotonia, severe (rare) | rel=r_associated | relid=0 | w=106
  1320. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonic
    n1=en:white substance | n2=en:hypotonic | rel=r_associated | relid=0 | w=106
  1321. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonic seizures
    n1=en:white substance | n2=en:hypotonic seizures | rel=r_associated | relid=0 | w=106
  1322. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotonicity (in some patients)
    n1=en:white substance | n2=en:hypotonicity (in some patients) | rel=r_associated | relid=0 | w=106
  1323. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypotrophic brainstem
    n1=en:white substance | n2=en:hypotrophic brainstem | rel=r_associated | relid=0 | w=106
  1324. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypoxic convulsions
    n1=en:white substance | n2=en:hypoxic convulsions | rel=r_associated | relid=0 | w=106
  1325. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypperreflexia
    n1=en:white substance | n2=en:hypperreflexia | rel=r_associated | relid=0 | w=106
  1326. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypsarrhythmia
    n1=en:white substance | n2=en:hypsarrhythmia | rel=r_associated | relid=0 | w=106
  1327. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypsarrhythmia (1 patient)
    n1=en:white substance | n2=en:hypsarrhythmia (1 patient) | rel=r_associated | relid=0 | w=106
  1328. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypsarrhythmia (in some patients)
    n1=en:white substance | n2=en:hypsarrhythmia (in some patients) | rel=r_associated | relid=0 | w=106
  1329. en:white substance -- r_associated #0: 106 / 0.876 -> en:hypsarrhythmia or severe multifocal epileptic abnormalities with poor background activity on eeg
    n1=en:white substance | n2=en:hypsarrhythmia or severe multifocal epileptic abnormalities with poor background activity on eeg | rel=r_associated | relid=0 | w=106
  1330. en:white substance -- r_associated #0: 106 / 0.876 -> en:hysteria
    n1=en:white substance | n2=en:hysteria | rel=r_associated | relid=0 | w=106
  1331. en:white substance -- r_associated #0: 106 / 0.876 -> en:ictal eeg showed partial seizures with frontal lobe origin
    n1=en:white substance | n2=en:ictal eeg showed partial seizures with frontal lobe origin | rel=r_associated | relid=0 | w=106
  1332. en:white substance -- r_associated #0: 106 / 0.876 -> en:ictal eeg shows diffuse slow delta and theta activity
    n1=en:white substance | n2=en:ictal eeg shows diffuse slow delta and theta activity | rel=r_associated | relid=0 | w=106
  1333. en:white substance -- r_associated #0: 106 / 0.876 -> en:ictal eeg shows focal onset in central, parietal, or temporal regions
    n1=en:white substance | n2=en:ictal eeg shows focal onset in central, parietal, or temporal regions | rel=r_associated | relid=0 | w=106
  1334. en:white substance -- r_associated #0: 106 / 0.876 -> en:ictal eeg shows focal, temporal, unilateral, rhythmic slow wave activity of high amplitude
    n1=en:white substance | n2=en:ictal eeg shows focal, temporal, unilateral, rhythmic slow wave activity of high amplitude | rel=r_associated | relid=0 | w=106
  1335. en:white substance -- r_associated #0: 106 / 0.876 -> en:ictal eeg with bisynchronous spike waves
    n1=en:white substance | n2=en:ictal eeg with bisynchronous spike waves | rel=r_associated | relid=0 | w=106
  1336. en:white substance -- r_associated #0: 106 / 0.876 -> en:idiopathic torsion dystonia
    n1=en:white substance | n2=en:idiopathic torsion dystonia | rel=r_associated | relid=0 | w=106
  1337. en:white substance -- r_associated #0: 106 / 0.876 -> en:illegible handwriting
    n1=en:white substance | n2=en:illegible handwriting | rel=r_associated | relid=0 | w=106
  1338. en:white substance -- r_associated #0: 106 / 0.876 -> en:imaging shows noncalcified subependymal periventricular heterotopic nodules of gray matter
    n1=en:white substance | n2=en:imaging shows noncalcified subependymal periventricular heterotopic nodules of gray matter | rel=r_associated | relid=0 | w=106
  1339. en:white substance -- r_associated #0: 106 / 0.876 -> en:imaging shows signal abnormalities in basal ganglia
    n1=en:white substance | n2=en:imaging shows signal abnormalities in basal ganglia | rel=r_associated | relid=0 | w=106
  1340. en:white substance -- r_associated #0: 106 / 0.876 -> en:imbalance
    n1=en:white substance | n2=en:imbalance | rel=r_associated | relid=0 | w=106
  1341. en:white substance -- r_associated #0: 106 / 0.876 -> en:immature brain with no gyral development
    n1=en:white substance | n2=en:immature brain with no gyral development | rel=r_associated | relid=0 | w=106
  1342. en:white substance -- r_associated #0: 106 / 0.876 -> en:immature myelination
    n1=en:white substance | n2=en:immature myelination | rel=r_associated | relid=0 | w=106
  1343. en:white substance -- r_associated #0: 106 / 0.876 -> en:immobile
    n1=en:white substance | n2=en:immobile | rel=r_associated | relid=0 | w=106
  1344. en:white substance -- r_associated #0: 106 / 0.876 -> en:immune system
    n1=en:white substance | n2=en:immune system | rel=r_associated | relid=0 | w=106
  1345. en:white substance -- r_associated #0: 106 / 0.876 -> en:immunology aspects
    n1=en:white substance | n2=en:immunology aspects | rel=r_associated | relid=0 | w=106
  1346. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired balance (2 patients)
    n1=en:white substance | n2=en:impaired balance (2 patients) | rel=r_associated | relid=0 | w=106
  1347. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired executive function (in some patients)
    n1=en:white substance | n2=en:impaired executive function (in some patients) | rel=r_associated | relid=0 | w=106
  1348. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired expression of language
    n1=en:white substance | n2=en:impaired expression of language | rel=r_associated | relid=0 | w=106
  1349. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired fine motor skills
    n1=en:white substance | n2=en:impaired fine motor skills | rel=r_associated | relid=0 | w=106
  1350. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired long-term verbal memory
    n1=en:white substance | n2=en:impaired long-term verbal memory | rel=r_associated | relid=0 | w=106
  1351. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired processing of language
    n1=en:white substance | n2=en:impaired processing of language | rel=r_associated | relid=0 | w=106
  1352. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired proprioception
    n1=en:white substance | n2=en:impaired proprioception | rel=r_associated | relid=0 | w=106
  1353. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired psychomotor development
    n1=en:white substance | n2=en:impaired psychomotor development | rel=r_associated | relid=0 | w=106
  1354. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired vertical visual pursuit
    n1=en:white substance | n2=en:impaired vertical visual pursuit | rel=r_associated | relid=0 | w=106
  1355. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired vibration sensation at ankles
    n1=en:white substance | n2=en:impaired vibration sensation at ankles | rel=r_associated | relid=0 | w=106
  1356. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired vibration sensation in the lower limbs
    n1=en:white substance | n2=en:impaired vibration sensation in the lower limbs | rel=r_associated | relid=0 | w=106
  1357. en:white substance -- r_associated #0: 106 / 0.876 -> en:impaired visuospatial skills
    n1=en:white substance | n2=en:impaired visuospatial skills | rel=r_associated | relid=0 | w=106
  1358. en:white substance -- r_associated #0: 106 / 0.876 -> en:impairment of gross and fine motor coordination
    n1=en:white substance | n2=en:impairment of gross and fine motor coordination | rel=r_associated | relid=0 | w=106
  1359. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to communicate
    n1=en:white substance | n2=en:inability to communicate | rel=r_associated | relid=0 | w=106
  1360. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to hold head up
    n1=en:white substance | n2=en:inability to hold head up | rel=r_associated | relid=0 | w=106
  1361. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to hold neck up ('limber neck') onset at 6 months
    n1=en:white substance | n2=en:inability to hold neck up ('limber neck') onset at 6 months | rel=r_associated | relid=0 | w=106
  1362. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to reach
    n1=en:white substance | n2=en:inability to reach | rel=r_associated | relid=0 | w=106
  1363. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to run
    n1=en:white substance | n2=en:inability to run | rel=r_associated | relid=0 | w=106
  1364. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to run (in some patients)
    n1=en:white substance | n2=en:inability to run (in some patients) | rel=r_associated | relid=0 | w=106
  1365. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to sit
    n1=en:white substance | n2=en:inability to sit | rel=r_associated | relid=0 | w=106
  1366. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to sit or control head
    n1=en:white substance | n2=en:inability to sit or control head | rel=r_associated | relid=0 | w=106
  1367. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to walk independently
    n1=en:white substance | n2=en:inability to walk independently | rel=r_associated | relid=0 | w=106
  1368. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to walk unaided
    n1=en:white substance | n2=en:inability to walk unaided | rel=r_associated | relid=0 | w=106
  1369. en:white substance -- r_associated #0: 106 / 0.876 -> en:inability to walk unsupported
    n1=en:white substance | n2=en:inability to walk unsupported | rel=r_associated | relid=0 | w=106
  1370. en:white substance -- r_associated #0: 106 / 0.876 -> en:inarticulate speech delayed gross motor skills
    n1=en:white substance | n2=en:inarticulate speech delayed gross motor skills | rel=r_associated | relid=0 | w=106
  1371. en:white substance -- r_associated #0: 106 / 0.876 -> en:increased csf lactate
    n1=en:white substance | n2=en:increased csf lactate | rel=r_associated | relid=0 | w=106
  1372. en:white substance -- r_associated #0: 106 / 0.876 -> en:increased intracranial pressure preoperatively (in some patients)
    n1=en:white substance | n2=en:increased intracranial pressure preoperatively (in some patients) | rel=r_associated | relid=0 | w=106
  1373. en:white substance -- r_associated #0: 106 / 0.876 -> en:increased iron deposition in the basal ganglia (40%)
    n1=en:white substance | n2=en:increased iron deposition in the basal ganglia (40%) | rel=r_associated | relid=0 | w=106
  1374. en:white substance -- r_associated #0: 106 / 0.876 -> en:increased neurologic sequelae of infections (rare)
    n1=en:white substance | n2=en:increased neurologic sequelae of infections (rare) | rel=r_associated | relid=0 | w=106
  1375. en:white substance -- r_associated #0: 106 / 0.876 -> en:increased risk of seizures in childhood or adulthood (11-16%)
    n1=en:white substance | n2=en:increased risk of seizures in childhood or adulthood (11-16%) | rel=r_associated | relid=0 | w=106
  1376. en:white substance -- r_associated #0: 106 / 0.876 -> en:increased white matter abnormalities on t2 signalling (in type iib)
    n1=en:white substance | n2=en:increased white matter abnormalities on t2 signalling (in type iib) | rel=r_associated | relid=0 | w=106
  1377. en:white substance -- r_associated #0: 106 / 0.876 -> en:independent walking never achieved
    n1=en:white substance | n2=en:independent walking never achieved | rel=r_associated | relid=0 | w=106
  1378. en:white substance -- r_associated #0: 106 / 0.876 -> en:individuals can stand or walk with support by 4 to 6 years of age
    n1=en:white substance | n2=en:individuals can stand or walk with support by 4 to 6 years of age | rel=r_associated | relid=0 | w=106
  1379. en:white substance -- r_associated #0: 106 / 0.876 -> en:individuals require less sleep in a 24-hour period compared to age-matched controls
    n1=en:white substance | n2=en:individuals require less sleep in a 24-hour period compared to age-matched controls | rel=r_associated | relid=0 | w=106
  1380. en:white substance -- r_associated #0: 106 / 0.876 -> en:infantile encephalopathy, progressive
    n1=en:white substance | n2=en:infantile encephalopathy, progressive | rel=r_associated | relid=0 | w=106
  1381. en:white substance -- r_associated #0: 106 / 0.876 -> en:infantile hemiplegias
    n1=en:white substance | n2=en:infantile hemiplegias | rel=r_associated | relid=0 | w=106
  1382. en:white substance -- r_associated #0: 106 / 0.876 -> en:infantile irritability (if left untreated)
    n1=en:white substance | n2=en:infantile irritability (if left untreated) | rel=r_associated | relid=0 | w=106
  1383. en:white substance -- r_associated #0: 106 / 0.876 -> en:infantile nystagmus
    n1=en:white substance | n2=en:infantile nystagmus | rel=r_associated | relid=0 | w=106
  1384. en:white substance -- r_associated #0: 106 / 0.876 -> en:infantile seizures
    n1=en:white substance | n2=en:infantile seizures | rel=r_associated | relid=0 | w=106
  1385. en:white substance -- r_associated #0: 106 / 0.876 -> en:infantile spasm
    n1=en:white substance | n2=en:infantile spasm | rel=r_associated | relid=0 | w=106
  1386. en:white substance -- r_associated #0: 106 / 0.876 -> en:inferior olivary nuclei show fetal pattern
    n1=en:white substance | n2=en:inferior olivary nuclei show fetal pattern | rel=r_associated | relid=0 | w=106
  1387. en:white substance -- r_associated #0: 106 / 0.876 -> en:inferior vermis hypoplasia
    n1=en:white substance | n2=en:inferior vermis hypoplasia | rel=r_associated | relid=0 | w=106
  1388. en:white substance -- r_associated #0: 106 / 0.876 -> en:infrequent generalized seizures
    n1=en:white substance | n2=en:infrequent generalized seizures | rel=r_associated | relid=0 | w=106
  1389. en:white substance -- r_associated #0: 106 / 0.876 -> en:initial normal development
    n1=en:white substance | n2=en:initial normal development | rel=r_associated | relid=0 | w=106
  1390. en:white substance -- r_associated #0: 106 / 0.876 -> en:insomnia
    n1=en:white substance | n2=en:insomnia | rel=r_associated | relid=0 | w=106
  1391. en:white substance -- r_associated #0: 106 / 0.876 -> en:insomnia adverse event
    n1=en:white substance | n2=en:insomnia adverse event | rel=r_associated | relid=0 | w=106
  1392. en:white substance -- r_associated #0: 106 / 0.876 -> en:insomnia, refractory
    n1=en:white substance | n2=en:insomnia, refractory | rel=r_associated | relid=0 | w=106
  1393. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellect high (in some patients)
    n1=en:white substance | n2=en:intellect high (in some patients) | rel=r_associated | relid=0 | w=106
  1394. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual delay
    n1=en:white substance | n2=en:intellectual delay | rel=r_associated | relid=0 | w=106
  1395. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability
    n1=en:white substance | n2=en:intellectual disability | rel=r_associated | relid=0 | w=106
  1396. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability (in 1 ashkenazi patient)
    n1=en:white substance | n2=en:intellectual disability (in 1 ashkenazi patient) | rel=r_associated | relid=0 | w=106
  1397. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability (in most patients)
    n1=en:white substance | n2=en:intellectual disability (in most patients) | rel=r_associated | relid=0 | w=106
  1398. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability (in some patients)
    n1=en:white substance | n2=en:intellectual disability (in some patients) | rel=r_associated | relid=0 | w=106
  1399. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability, mild (in some patients)
    n1=en:white substance | n2=en:intellectual disability, mild (in some patients) | rel=r_associated | relid=0 | w=106
  1400. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability, mild to moderate
    n1=en:white substance | n2=en:intellectual disability, mild to moderate | rel=r_associated | relid=0 | w=106
  1401. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability, mild to moderate (in homozygotes)
    n1=en:white substance | n2=en:intellectual disability, mild to moderate (in homozygotes) | rel=r_associated | relid=0 | w=106
  1402. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability, mild to severe
    n1=en:white substance | n2=en:intellectual disability, mild to severe | rel=r_associated | relid=0 | w=106
  1403. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual disability, moderate to severe
    n1=en:white substance | n2=en:intellectual disability, moderate to severe | rel=r_associated | relid=0 | w=106
  1404. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual function may be high in milder cases
    n1=en:white substance | n2=en:intellectual function may be high in milder cases | rel=r_associated | relid=0 | w=106
  1405. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual impairment (rare)
    n1=en:white substance | n2=en:intellectual impairment (rare) | rel=r_associated | relid=0 | w=106
  1406. en:white substance -- r_associated #0: 106 / 0.876 -> en:intellectual impairment, mild (in some patients)
    n1=en:white substance | n2=en:intellectual impairment, mild (in some patients) | rel=r_associated | relid=0 | w=106
  1407. en:white substance -- r_associated #0: 106 / 0.876 -> en:intention tremor (1 patient)
    n1=en:white substance | n2=en:intention tremor (1 patient) | rel=r_associated | relid=0 | w=106
  1408. en:white substance -- r_associated #0: 106 / 0.876 -> en:intention tremor (in some patients)
    n1=en:white substance | n2=en:intention tremor (in some patients) | rel=r_associated | relid=0 | w=106
  1409. en:white substance -- r_associated #0: 106 / 0.876 -> en:intention tremor in those who survive
    n1=en:white substance | n2=en:intention tremor in those who survive | rel=r_associated | relid=0 | w=106
  1410. en:white substance -- r_associated #0: 106 / 0.876 -> en:interhemispheric cysts
    n1=en:white substance | n2=en:interhemispheric cysts | rel=r_associated | relid=0 | w=106
  1411. en:white substance -- r_associated #0: 106 / 0.876 -> en:interhemispheric lipoma
    n1=en:white substance | n2=en:interhemispheric lipoma | rel=r_associated | relid=0 | w=106
  1412. en:white substance -- r_associated #0: 106 / 0.876 -> en:interictal ataxia may occur later in disease course
    n1=en:white substance | n2=en:interictal ataxia may occur later in disease course | rel=r_associated | relid=0 | w=106
  1413. en:white substance -- r_associated #0: 106 / 0.876 -> en:interictal dystonia may occur later in disease course
    n1=en:white substance | n2=en:interictal dystonia may occur later in disease course | rel=r_associated | relid=0 | w=106
  1414. en:white substance -- r_associated #0: 106 / 0.876 -> en:interictal periods of normal health
    n1=en:white substance | n2=en:interictal periods of normal health | rel=r_associated | relid=0 | w=106
  1415. en:white substance -- r_associated #0: 106 / 0.876 -> en:intermittent migraine headaches
    n1=en:white substance | n2=en:intermittent migraine headaches | rel=r_associated | relid=0 | w=106
  1416. en:white substance -- r_associated #0: 106 / 0.876 -> en:intermittent wheelchair dependence (stage 3)
    n1=en:white substance | n2=en:intermittent wheelchair dependence (stage 3) | rel=r_associated | relid=0 | w=106
  1417. en:white substance -- r_associated #0: 106 / 0.876 -> en:intermittent, transient episodes of worsening of ataxia
    n1=en:white substance | n2=en:intermittent, transient episodes of worsening of ataxia | rel=r_associated | relid=0 | w=106
  1418. en:white substance -- r_associated #0: 106 / 0.876 -> en:interosseus muscle atrophy
    n1=en:white substance | n2=en:interosseus muscle atrophy | rel=r_associated | relid=0 | w=106
  1419. en:white substance -- r_associated #0: 106 / 0.876 -> en:interventricular cysts
    n1=en:white substance | n2=en:interventricular cysts | rel=r_associated | relid=0 | w=106
  1420. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracellular accumulation of material resulting in curvilinear profiles on ultrastructural analysis
    n1=en:white substance | n2=en:intracellular accumulation of material resulting in curvilinear profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=106
  1421. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracellular accumulation of material resulting in fingerprint profiles on ultrastructural analysis
    n1=en:white substance | n2=en:intracellular accumulation of material resulting in fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=106
  1422. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracellular accumulation of material resulting in rectilinear profiles on ultrastructural analysis
    n1=en:white substance | n2=en:intracellular accumulation of material resulting in rectilinear profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=106
  1423. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracellular lewy bodies
    n1=en:white substance | n2=en:intracellular lewy bodies | rel=r_associated | relid=0 | w=106
  1424. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies)
    n1=en:white substance | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) | rel=r_associated | relid=0 | w=106
  1425. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracerebral calcifications (in some patients)
    n1=en:white substance | n2=en:intracerebral calcifications (in some patients) | rel=r_associated | relid=0 | w=106
  1426. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracerebral periventricular calcifications
    n1=en:white substance | n2=en:intracerebral periventricular calcifications | rel=r_associated | relid=0 | w=106
  1427. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial calcification by x-ray or ct
    n1=en:white substance | n2=en:intracranial calcification by x-ray or ct | rel=r_associated | relid=0 | w=106
  1428. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial calcifications (in some patients)
    n1=en:white substance | n2=en:intracranial calcifications (in some patients) | rel=r_associated | relid=0 | w=106
  1429. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial calcifications in the anterior mesial temporal lobes
    n1=en:white substance | n2=en:intracranial calcifications in the anterior mesial temporal lobes | rel=r_associated | relid=0 | w=106
  1430. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial calcifications, band-like, particularly periventricular and in the basal ganglia and thalamus
    n1=en:white substance | n2=en:intracranial calcifications, band-like, particularly periventricular and in the basal ganglia and thalamus | rel=r_associated | relid=0 | w=106
  1431. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial cysts
    n1=en:white substance | n2=en:intracranial cysts | rel=r_associated | relid=0 | w=106
  1432. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial hemorrhage
    n1=en:white substance | n2=en:intracranial hemorrhage | rel=r_associated | relid=0 | w=106
  1433. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial hypertension
    n1=en:white substance | n2=en:intracranial hypertension | rel=r_associated | relid=0 | w=106
  1434. en:white substance -- r_associated #0: 106 / 0.876 -> en:intracranial lipoma (cerebello-pontine)
    n1=en:white substance | n2=en:intracranial lipoma (cerebello-pontine) | rel=r_associated | relid=0 | w=106
  1435. en:white substance -- r_associated #0: 106 / 0.876 -> en:intractable epilepsy
    n1=en:white substance | n2=en:intractable epilepsy | rel=r_associated | relid=0 | w=106
  1436. en:white substance -- r_associated #0: 106 / 0.876 -> en:intraparenchymal brain hemorrhage, multifocal
    n1=en:white substance | n2=en:intraparenchymal brain hemorrhage, multifocal | rel=r_associated | relid=0 | w=106
  1437. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary dystonic or choreiform movements
    n1=en:white substance | n2=en:involuntary dystonic or choreiform movements | rel=r_associated | relid=0 | w=106
  1438. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary movements may be precipitated by exertion or anxiety
    n1=en:white substance | n2=en:involuntary movements may be precipitated by exertion or anxiety | rel=r_associated | relid=0 | w=106
  1439. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary movements of extremities, neck, trunk, and/or face
    n1=en:white substance | n2=en:involuntary movements of extremities, neck, trunk, and/or face | rel=r_associated | relid=0 | w=106
  1440. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary movements, asymmetric
    n1=en:white substance | n2=en:involuntary movements, asymmetric | rel=r_associated | relid=0 | w=106
  1441. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary repetitive movements
    n1=en:white substance | n2=en:involuntary repetitive movements | rel=r_associated | relid=0 | w=106
  1442. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers
    n1=en:white substance | n2=en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers | rel=r_associated | relid=0 | w=106
  1443. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary rhythmic myoclonic movements ('tremor'), upper extremities
    n1=en:white substance | n2=en:involuntary rhythmic myoclonic movements ('tremor'), upper extremities | rel=r_associated | relid=0 | w=106
  1444. en:white substance -- r_associated #0: 106 / 0.876 -> en:involuntary writhing movements
    n1=en:white substance | n2=en:involuntary writhing movements | rel=r_associated | relid=0 | w=106
  1445. en:white substance -- r_associated #0: 106 / 0.876 -> en:ipsilateral brain hypoplasia
    n1=en:white substance | n2=en:ipsilateral brain hypoplasia | rel=r_associated | relid=0 | w=106
  1446. en:white substance -- r_associated #0: 106 / 0.876 -> en:ipsilateral cranial nerve hypoplasia
    n1=en:white substance | n2=en:ipsilateral cranial nerve hypoplasia | rel=r_associated | relid=0 | w=106
  1447. en:white substance -- r_associated #0: 106 / 0.876 -> en:iron deposition in pallidal nuclei
    n1=en:white substance | n2=en:iron deposition in pallidal nuclei | rel=r_associated | relid=0 | w=106
  1448. en:white substance -- r_associated #0: 106 / 0.876 -> en:iron deposition in the globus pallidus (variable)
    n1=en:white substance | n2=en:iron deposition in the globus pallidus (variable) | rel=r_associated | relid=0 | w=106
  1449. en:white substance -- r_associated #0: 106 / 0.876 -> en:iron deposits in the globus pallidus, caudate, and substantia nigra
    n1=en:white substance | n2=en:iron deposits in the globus pallidus, caudate, and substantia nigra | rel=r_associated | relid=0 | w=106
  1450. en:white substance -- r_associated #0: 106 / 0.876 -> en:iron-containing deposits in various brain regions
    n1=en:white substance | n2=en:iron-containing deposits in various brain regions | rel=r_associated | relid=0 | w=106
  1451. en:white substance -- r_associated #0: 106 / 0.876 -> en:irregular cortical ribbon
    n1=en:white substance | n2=en:irregular cortical ribbon | rel=r_associated | relid=0 | w=106
  1452. en:white substance -- r_associated #0: 106 / 0.876 -> en:irregular folding of the cortex
    n1=en:white substance | n2=en:irregular folding of the cortex | rel=r_associated | relid=0 | w=106
  1453. en:white substance -- r_associated #0: 106 / 0.876 -> en:irregular spike and slow waves
    n1=en:white substance | n2=en:irregular spike and slow waves | rel=r_associated | relid=0 | w=106
  1454. en:white substance -- r_associated #0: 106 / 0.876 -> en:irresistible desire to move the legs
    n1=en:white substance | n2=en:irresistible desire to move the legs | rel=r_associated | relid=0 | w=106
  1455. en:white substance -- r_associated #0: 106 / 0.876 -> en:irritation
    n1=en:white substance | n2=en:irritation | rel=r_associated | relid=0 | w=106
  1456. en:white substance -- r_associated #0: 106 / 0.876 -> en:ischemic cerebrovascular accident
    n1=en:white substance | n2=en:ischemic cerebrovascular accident | rel=r_associated | relid=0 | w=106
  1457. en:white substance -- r_associated #0: 106 / 0.876 -> en:ischemic infarction (rare)
    n1=en:white substance | n2=en:ischemic infarction (rare) | rel=r_associated | relid=0 | w=106
  1458. en:white substance -- r_associated #0: 106 / 0.876 -> en:ischemic stroke (in some patients)
    n1=en:white substance | n2=en:ischemic stroke (in some patients) | rel=r_associated | relid=0 | w=106
  1459. en:white substance -- r_associated #0: 106 / 0.876 -> en:ischemic stroke in the basal ganglia (rare)
    n1=en:white substance | n2=en:ischemic stroke in the basal ganglia (rare) | rel=r_associated | relid=0 | w=106
  1460. en:white substance -- r_associated #0: 106 / 0.876 -> en:isolated absence of pain sensation
    n1=en:white substance | n2=en:isolated absence of pain sensation | rel=r_associated | relid=0 | w=106
  1461. en:white substance -- r_associated #0: 106 / 0.876 -> en:jacksonian seizure
    n1=en:white substance | n2=en:jacksonian seizure | rel=r_associated | relid=0 | w=106
  1462. en:white substance -- r_associated #0: 106 / 0.876 -> en:jerk-locked premyoclonus spikes
    n1=en:white substance | n2=en:jerk-locked premyoclonus spikes | rel=r_associated | relid=0 | w=106
  1463. en:white substance -- r_associated #0: 106 / 0.876 -> en:jerking may be unidirectional, periodically alternating, or mixed pendular and jerk-like
    n1=en:white substance | n2=en:jerking may be unidirectional, periodically alternating, or mixed pendular and jerk-like | rel=r_associated | relid=0 | w=106
  1464. en:white substance -- r_associated #0: 106 / 0.876 -> en:jerky head movements
    n1=en:white substance | n2=en:jerky head movements | rel=r_associated | relid=0 | w=106
  1465. en:white substance -- r_associated #0: 106 / 0.876 -> en:joubert syndrome
    n1=en:white substance | n2=en:joubert syndrome | rel=r_associated | relid=0 | w=106
  1466. en:white substance -- r_associated #0: 106 / 0.876 -> en:kernicterus
    n1=en:white substance | n2=en:kernicterus | rel=r_associated | relid=0 | w=106
  1467. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of development
    n1=en:white substance | n2=en:lack of development | rel=r_associated | relid=0 | w=106
  1468. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of developmental development
    n1=en:white substance | n2=en:lack of developmental development | rel=r_associated | relid=0 | w=106
  1469. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of developmental milestones
    n1=en:white substance | n2=en:lack of developmental milestones | rel=r_associated | relid=0 | w=106
  1470. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of ependymal cells
    n1=en:white substance | n2=en:lack of ependymal cells | rel=r_associated | relid=0 | w=106
  1471. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of expressive speech
    n1=en:white substance | n2=en:lack of expressive speech | rel=r_associated | relid=0 | w=106
  1472. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of head control
    n1=en:white substance | n2=en:lack of head control | rel=r_associated | relid=0 | w=106
  1473. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of head or postural control (in severe cases)
    n1=en:white substance | n2=en:lack of head or postural control (in severe cases) | rel=r_associated | relid=0 | w=106
  1474. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of independent sitting or walking
    n1=en:white substance | n2=en:lack of independent sitting or walking | rel=r_associated | relid=0 | w=106
  1475. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of independent walking (in some patients)
    n1=en:white substance | n2=en:lack of independent walking (in some patients) | rel=r_associated | relid=0 | w=106
  1476. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of inflammatory infiltrate
    n1=en:white substance | n2=en:lack of inflammatory infiltrate | rel=r_associated | relid=0 | w=106
  1477. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of motor development
    n1=en:white substance | n2=en:lack of motor development | rel=r_associated | relid=0 | w=106
  1478. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of motor development (wws)
    n1=en:white substance | n2=en:lack of motor development (wws) | rel=r_associated | relid=0 | w=106
  1479. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of neurologic development
    n1=en:white substance | n2=en:lack of neurologic development | rel=r_associated | relid=0 | w=106
  1480. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of peer relationships
    n1=en:white substance | n2=en:lack of peer relationships | rel=r_associated | relid=0 | w=106
  1481. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of psychomotor development (1 patient)
    n1=en:white substance | n2=en:lack of psychomotor development (1 patient) | rel=r_associated | relid=0 | w=106
  1482. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of psychomotor development (severe connatal form)
    n1=en:white substance | n2=en:lack of psychomotor development (severe connatal form) | rel=r_associated | relid=0 | w=106
  1483. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of skein-like inclusions
    n1=en:white substance | n2=en:lack of skein-like inclusions | rel=r_associated | relid=0 | w=106
  1484. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of speech development
    n1=en:white substance | n2=en:lack of speech development | rel=r_associated | relid=0 | w=106
  1485. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of speech development (some patients)
    n1=en:white substance | n2=en:lack of speech development (some patients) | rel=r_associated | relid=0 | w=106
  1486. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of speech or only a few words
    n1=en:white substance | n2=en:lack of speech or only a few words | rel=r_associated | relid=0 | w=106
  1487. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of speech or poor speech
    n1=en:white substance | n2=en:lack of speech or poor speech | rel=r_associated | relid=0 | w=106
  1488. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of spontaneous play
    n1=en:white substance | n2=en:lack of spontaneous play | rel=r_associated | relid=0 | w=106
  1489. en:white substance -- r_associated #0: 106 / 0.876 -> en:lack of volitional movement
    n1=en:white substance | n2=en:lack of volitional movement | rel=r_associated | relid=0 | w=106
  1490. en:white substance -- r_associated #0: 106 / 0.876 -> en:lacunar infarcts develop after age 40 years
    n1=en:white substance | n2=en:lacunar infarcts develop after age 40 years | rel=r_associated | relid=0 | w=106
  1491. en:white substance -- r_associated #0: 106 / 0.876 -> en:language acquisition difficulties (in some patients)
    n1=en:white substance | n2=en:language acquisition difficulties (in some patients) | rel=r_associated | relid=0 | w=106
  1492. en:white substance -- r_associated #0: 106 / 0.876 -> en:language delay
    n1=en:white substance | n2=en:language delay | rel=r_associated | relid=0 | w=106
  1493. en:white substance -- r_associated #0: 106 / 0.876 -> en:language delay (55%)
    n1=en:white substance | n2=en:language delay (55%) | rel=r_associated | relid=0 | w=106
  1494. en:white substance -- r_associated #0: 106 / 0.876 -> en:language delay/disorder
    n1=en:white substance | n2=en:language delay/disorder | rel=r_associated | relid=0 | w=106
  1495. en:white substance -- r_associated #0: 106 / 0.876 -> en:large cerebellum, progressive
    n1=en:white substance | n2=en:large cerebellum, progressive | rel=r_associated | relid=0 | w=106
  1496. en:white substance -- r_associated #0: 106 / 0.876 -> en:large sella turcica
    n1=en:white substance | n2=en:large sella turcica | rel=r_associated | relid=0 | w=106
  1497. en:white substance -- r_associated #0: 106 / 0.876 -> en:large subcortical cysts in frontal and temporal lobes
    n1=en:white substance | n2=en:large subcortical cysts in frontal and temporal lobes | rel=r_associated | relid=0 | w=106
  1498. en:white substance -- r_associated #0: 106 / 0.876 -> en:late ambulation
    n1=en:white substance | n2=en:late ambulation | rel=r_associated | relid=0 | w=106
  1499. en:white substance -- r_associated #0: 106 / 0.876 -> en:late diaphragmatic involvement
    n1=en:white substance | n2=en:late diaphragmatic involvement | rel=r_associated | relid=0 | w=106
  1500. en:white substance -- r_associated #0: 106 / 0.876 -> en:late-onset spinocerebellar degeneration
    n1=en:white substance | n2=en:late-onset spinocerebellar degeneration | rel=r_associated | relid=0 | w=106
  1501. en:white substance -- r_associated #0: 106 / 0.876 -> en:lateral corticospinal tracts show atrophy, pallor, and degeneration
    n1=en:white substance | n2=en:lateral corticospinal tracts show atrophy, pallor, and degeneration | rel=r_associated | relid=0 | w=106
  1502. en:white substance -- r_associated #0: 106 / 0.876 -> en:lateral horn of the spinal cord
    n1=en:white substance | n2=en:lateral horn of the spinal cord | rel=r_associated | relid=0 | w=106
  1503. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning and developmental delay (in some patients)
    n1=en:white substance | n2=en:learning and developmental delay (in some patients) | rel=r_associated | relid=0 | w=106
  1504. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning difficulties
    n1=en:white substance | n2=en:learning difficulties | rel=r_associated | relid=0 | w=106
  1505. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning difficulties (in 1 patient)
    n1=en:white substance | n2=en:learning difficulties (in 1 patient) | rel=r_associated | relid=0 | w=106
  1506. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning difficulties (less common)
    n1=en:white substance | n2=en:learning difficulties (less common) | rel=r_associated | relid=0 | w=106
  1507. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning difficulties (seen in recessive form)
    n1=en:white substance | n2=en:learning difficulties (seen in recessive form) | rel=r_associated | relid=0 | w=106
  1508. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning difficulties, mild (1 family)
    n1=en:white substance | n2=en:learning difficulties, mild (1 family) | rel=r_associated | relid=0 | w=106
  1509. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning disabilities
    n1=en:white substance | n2=en:learning disabilities | rel=r_associated | relid=0 | w=106
  1510. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning disabilities (in some)
    n1=en:white substance | n2=en:learning disabilities (in some) | rel=r_associated | relid=0 | w=106
  1511. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning disability (90% patients)
    n1=en:white substance | n2=en:learning disability (90% patients) | rel=r_associated | relid=0 | w=106
  1512. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning disability (early in life)
    n1=en:white substance | n2=en:learning disability (early in life) | rel=r_associated | relid=0 | w=106
  1513. en:white substance -- r_associated #0: 106 / 0.876 -> en:learning problems
    n1=en:white substance | n2=en:learning problems | rel=r_associated | relid=0 | w=106
  1514. en:white substance -- r_associated #0: 106 / 0.876 -> en:leg cramp
    n1=en:white substance | n2=en:leg cramp | rel=r_associated | relid=0 | w=106
  1515. en:white substance -- r_associated #0: 106 / 0.876 -> en:leg pain
    n1=en:white substance | n2=en:leg pain | rel=r_associated | relid=0 | w=106
  1516. en:white substance -- r_associated #0: 106 / 0.876 -> en:leg stiffness
    n1=en:white substance | n2=en:leg stiffness | rel=r_associated | relid=0 | w=106
  1517. en:white substance -- r_associated #0: 106 / 0.876 -> en:leigh syndrome (in some patients)
    n1=en:white substance | n2=en:leigh syndrome (in some patients) | rel=r_associated | relid=0 | w=106
  1518. en:white substance -- r_associated #0: 106 / 0.876 -> en:leptomeningeal thickening
    n1=en:white substance | n2=en:leptomeningeal thickening | rel=r_associated | relid=0 | w=106
  1519. en:white substance -- r_associated #0: 106 / 0.876 -> en:lesions are symmetrical
    n1=en:white substance | n2=en:lesions are symmetrical | rel=r_associated | relid=0 | w=106
  1520. en:white substance -- r_associated #0: 106 / 0.876 -> en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation
    n1=en:white substance | n2=en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation | rel=r_associated | relid=0 | w=106
  1521. en:white substance -- r_associated #0: 106 / 0.876 -> en:lesions in the anterior pituitary (less common)
    n1=en:white substance | n2=en:lesions in the anterior pituitary (less common) | rel=r_associated | relid=0 | w=106
  1522. en:white substance -- r_associated #0: 106 / 0.876 -> en:lethargy
    n1=en:white substance | n2=en:lethargy | rel=r_associated | relid=0 | w=106
  1523. en:white substance -- r_associated #0: 106 / 0.876 -> en:lethargy associated with hypoglycemia
    n1=en:white substance | n2=en:lethargy associated with hypoglycemia | rel=r_associated | relid=0 | w=106
  1524. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukoaraiosis
    n1=en:white substance | n2=en:leukoaraiosis | rel=r_associated | relid=0 | w=106
  1525. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukodystrophy
    n1=en:white substance | n2=en:leukodystrophy | rel=r_associated | relid=0 | w=106
  1526. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukodystrophy (in 1 of 2 patients)
    n1=en:white substance | n2=en:leukodystrophy (in 1 of 2 patients) | rel=r_associated | relid=0 | w=106
  1527. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukodystrophy and white matter changes, which improve with age
    n1=en:white substance | n2=en:leukodystrophy and white matter changes, which improve with age | rel=r_associated | relid=0 | w=106
  1528. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts
    n1=en:white substance | n2=en:leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts | rel=r_associated | relid=0 | w=106
  1529. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukoencephalopathy, severe
    n1=en:white substance | n2=en:leukoencephalopathy, severe | rel=r_associated | relid=0 | w=106
  1530. en:white substance -- r_associated #0: 106 / 0.876 -> en:leukomalacia (rare)
    n1=en:white substance | n2=en:leukomalacia (rare) | rel=r_associated | relid=0 | w=106
  1531. en:white substance -- r_associated #0: 106 / 0.876 -> en:lewy bodies (not always present)
    n1=en:white substance | n2=en:lewy bodies (not always present) | rel=r_associated | relid=0 | w=106
  1532. en:white substance -- r_associated #0: 106 / 0.876 -> en:lewy bodies throughout the brain
    n1=en:white substance | n2=en:lewy bodies throughout the brain | rel=r_associated | relid=0 | w=106
  1533. en:white substance -- r_associated #0: 106 / 0.876 -> en:light-induced sneezing
    n1=en:white substance | n2=en:light-induced sneezing | rel=r_associated | relid=0 | w=106
  1534. en:white substance -- r_associated #0: 106 / 0.876 -> en:lightheadedness
    n1=en:white substance | n2=en:lightheadedness | rel=r_associated | relid=0 | w=106
  1535. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb ataxia, progressive
    n1=en:white substance | n2=en:limb ataxia, progressive | rel=r_associated | relid=0 | w=106
  1536. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb dysmetria
    n1=en:white substance | n2=en:limb dysmetria | rel=r_associated | relid=0 | w=106
  1537. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb fasciculations
    n1=en:white substance | n2=en:limb fasciculations | rel=r_associated | relid=0 | w=106
  1538. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb hypertonia
    n1=en:white substance | n2=en:limb hypertonia | rel=r_associated | relid=0 | w=106
  1539. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb hypertonia (in some patients)
    n1=en:white substance | n2=en:limb hypertonia (in some patients) | rel=r_associated | relid=0 | w=106
  1540. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb incoordination (in some patients)
    n1=en:white substance | n2=en:limb incoordination (in some patients) | rel=r_associated | relid=0 | w=106
  1541. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb muscle stiffness is often asymmetric
    n1=en:white substance | n2=en:limb muscle stiffness is often asymmetric | rel=r_associated | relid=0 | w=106
  1542. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb muscle weakness (distal greater than proximal)
    n1=en:white substance | n2=en:limb muscle weakness (distal greater than proximal) | rel=r_associated | relid=0 | w=106
  1543. en:white substance -- r_associated #0: 106 / 0.876 -> en:limb posturing (if left untreated)
    n1=en:white substance | n2=en:limb posturing (if left untreated) | rel=r_associated | relid=0 | w=106
  1544. en:white substance -- r_associated #0: 106 / 0.876 -> en:limbic system
    n1=en:white substance | n2=en:limbic system | rel=r_associated | relid=0 | w=106
  1545. en:white substance -- r_associated #0: 106 / 0.876 -> en:limited expressive language
    n1=en:white substance | n2=en:limited expressive language | rel=r_associated | relid=0 | w=106
  1546. en:white substance -- r_associated #0: 106 / 0.876 -> en:lingual-facial-buccal dyskinesia
    n1=en:white substance | n2=en:lingual-facial-buccal dyskinesia | rel=r_associated | relid=0 | w=106
  1547. en:white substance -- r_associated #0: 106 / 0.876 -> en:lipoma, anterior sacral
    n1=en:white substance | n2=en:lipoma, anterior sacral | rel=r_associated | relid=0 | w=106
  1548. en:white substance -- r_associated #0: 106 / 0.876 -> en:lissencephaly (reported in 1 patient)
    n1=en:white substance | n2=en:lissencephaly (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  1549. en:white substance -- r_associated #0: 106 / 0.876 -> en:little or no speech acquisition
    n1=en:white substance | n2=en:little or no speech acquisition | rel=r_associated | relid=0 | w=106
  1550. en:white substance -- r_associated #0: 106 / 0.876 -> en:little spontaneous movement
    n1=en:white substance | n2=en:little spontaneous movement | rel=r_associated | relid=0 | w=106
  1551. en:white substance -- r_associated #0: 106 / 0.876 -> en:lobar holoprosencephalies
    n1=en:white substance | n2=en:lobar holoprosencephalies | rel=r_associated | relid=0 | w=106
  1552. en:white substance -- r_associated #0: 106 / 0.876 -> en:lobar hpe shows clear interhemispheric fissure and 2 lateral ventricles
    n1=en:white substance | n2=en:lobar hpe shows clear interhemispheric fissure and 2 lateral ventricles | rel=r_associated | relid=0 | w=106
  1553. en:white substance -- r_associated #0: 106 / 0.876 -> en:locomotor delay (early-onset form)
    n1=en:white substance | n2=en:locomotor delay (early-onset form) | rel=r_associated | relid=0 | w=106
  1554. en:white substance -- r_associated #0: 106 / 0.876 -> en:long-tract signs
    n1=en:white substance | n2=en:long-tract signs | rel=r_associated | relid=0 | w=106
  1555. en:white substance -- r_associated #0: 106 / 0.876 -> en:long, thickened cerebellar peduncles
    n1=en:white substance | n2=en:long, thickened cerebellar peduncles | rel=r_associated | relid=0 | w=106
  1556. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of ability to walk
    n1=en:white substance | n2=en:loss of ability to walk | rel=r_associated | relid=0 | w=106
  1557. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of ability to walk in first decade
    n1=en:white substance | n2=en:loss of ability to walk in first decade | rel=r_associated | relid=0 | w=106
  1558. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of ambulation
    n1=en:white substance | n2=en:loss of ambulation | rel=r_associated | relid=0 | w=106
  1559. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of anterior horn cells and gliosis in the spinal cord
    n1=en:white substance | n2=en:loss of anterior horn cells and gliosis in the spinal cord | rel=r_associated | relid=0 | w=106
  1560. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of any acquired abilities in early childhood
    n1=en:white substance | n2=en:loss of any acquired abilities in early childhood | rel=r_associated | relid=0 | w=106
  1561. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of balance may occur
    n1=en:white substance | n2=en:loss of balance may occur | rel=r_associated | relid=0 | w=106
  1562. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of cerebellar purkinje cells
    n1=en:white substance | n2=en:loss of cerebellar purkinje cells | rel=r_associated | relid=0 | w=106
  1563. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of dopaminergic neurons
    n1=en:white substance | n2=en:loss of dopaminergic neurons | rel=r_associated | relid=0 | w=106
  1564. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of executive functions
    n1=en:white substance | n2=en:loss of executive functions | rel=r_associated | relid=0 | w=106
  1565. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of fine motor skills
    n1=en:white substance | n2=en:loss of fine motor skills | rel=r_associated | relid=0 | w=106
  1566. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of gait (in some)
    n1=en:white substance | n2=en:loss of gait (in some) | rel=r_associated | relid=0 | w=106
  1567. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of hypocretin (orexin)-secreting neurons in the hypothalamus
    n1=en:white substance | n2=en:loss of hypocretin (orexin)-secreting neurons in the hypothalamus | rel=r_associated | relid=0 | w=106
  1568. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of independent ambulation (in some patients)
    n1=en:white substance | n2=en:loss of independent ambulation (in some patients) | rel=r_associated | relid=0 | w=106
  1569. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of independent ambulation approximately 30 years after onset
    n1=en:white substance | n2=en:loss of independent ambulation approximately 30 years after onset | rel=r_associated | relid=0 | w=106
  1570. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of independent ambulation by age 10 years
    n1=en:white substance | n2=en:loss of independent ambulation by age 10 years | rel=r_associated | relid=0 | w=106
  1571. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of motor neurons in the anterior horn of the spinal cord
    n1=en:white substance | n2=en:loss of motor neurons in the anterior horn of the spinal cord | rel=r_associated | relid=0 | w=106
  1572. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of motor skills
    n1=en:white substance | n2=en:loss of motor skills | rel=r_associated | relid=0 | w=106
  1573. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of myelin
    n1=en:white substance | n2=en:loss of myelin | rel=r_associated | relid=0 | w=106
  1574. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of myelin in the cerebral and cerebellar white matter
    n1=en:white substance | n2=en:loss of myelin in the cerebral and cerebellar white matter | rel=r_associated | relid=0 | w=106
  1575. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of myelin in the pyramidal tracts
    n1=en:white substance | n2=en:loss of myelin in the pyramidal tracts | rel=r_associated | relid=0 | w=106
  1576. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of myelinated fibers in spinal cord roots
    n1=en:white substance | n2=en:loss of myelinated fibers in spinal cord roots | rel=r_associated | relid=0 | w=106
  1577. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of myelinated fibers with regenerative clusters on biopsy
    n1=en:white substance | n2=en:loss of myelinated fibers with regenerative clusters on biopsy | rel=r_associated | relid=0 | w=106
  1578. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of neurons affecting all cortical layers
    n1=en:white substance | n2=en:loss of neurons affecting all cortical layers | rel=r_associated | relid=0 | w=106
  1579. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of pain and temperature in a cape-like distribution
    n1=en:white substance | n2=en:loss of pain and temperature in a cape-like distribution | rel=r_associated | relid=0 | w=106
  1580. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of pigmented neurons in the substantia nigra
    n1=en:white substance | n2=en:loss of pigmented neurons in the substantia nigra | rel=r_associated | relid=0 | w=106
  1581. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of primary reflexes
    n1=en:white substance | n2=en:loss of primary reflexes | rel=r_associated | relid=0 | w=106
  1582. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of purkinje cells
    n1=en:white substance | n2=en:loss of purkinje cells | rel=r_associated | relid=0 | w=106
  1583. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of purkinje cells in the cerebellar vermis
    n1=en:white substance | n2=en:loss of purkinje cells in the cerebellar vermis | rel=r_associated | relid=0 | w=106
  1584. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of purkinje cells in the cerebellum
    n1=en:white substance | n2=en:loss of purkinje cells in the cerebellum | rel=r_associated | relid=0 | w=106
  1585. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of purposeful hand movements
    n1=en:white substance | n2=en:loss of purposeful hand movements | rel=r_associated | relid=0 | w=106
  1586. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of reflexes due to myopathy
    n1=en:white substance | n2=en:loss of reflexes due to myopathy | rel=r_associated | relid=0 | w=106
  1587. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of speech
    n1=en:white substance | n2=en:loss of speech | rel=r_associated | relid=0 | w=106
  1588. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of speech (1 patient)
    n1=en:white substance | n2=en:loss of speech (1 patient) | rel=r_associated | relid=0 | w=106
  1589. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of spontaneous movements
    n1=en:white substance | n2=en:loss of spontaneous movements | rel=r_associated | relid=0 | w=106
  1590. en:white substance -- r_associated #0: 106 / 0.876 -> en:loss of very early milestones
    n1=en:white substance | n2=en:loss of very early milestones | rel=r_associated | relid=0 | w=106
  1591. en:white substance -- r_associated #0: 106 / 0.876 -> en:low apparent diffusion coefficient (adc) values
    n1=en:white substance | n2=en:low apparent diffusion coefficient (adc) values | rel=r_associated | relid=0 | w=106
  1592. en:white substance -- r_associated #0: 106 / 0.876 -> en:low densities in the basal ganglia similar to leigh syndrome (256000)
    n1=en:white substance | n2=en:low densities in the basal ganglia similar to leigh syndrome (256000) | rel=r_associated | relid=0 | w=106
  1593. en:white substance -- r_associated #0: 106 / 0.876 -> en:low density white matter on ct scan
    n1=en:white substance | n2=en:low density white matter on ct scan | rel=r_associated | relid=0 | w=106
  1594. en:white substance -- r_associated #0: 106 / 0.876 -> en:low-lying cerebellar tonsils
    n1=en:white substance | n2=en:low-lying cerebellar tonsils | rel=r_associated | relid=0 | w=106
  1595. en:white substance -- r_associated #0: 106 / 0.876 -> en:low-normal intelligence
    n1=en:white substance | n2=en:low-normal intelligence | rel=r_associated | relid=0 | w=106
  1596. en:white substance -- r_associated #0: 106 / 0.876 -> en:low-normal iq
    n1=en:white substance | n2=en:low-normal iq | rel=r_associated | relid=0 | w=106
  1597. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower extremity weakness with febrile episodes (rare)
    n1=en:white substance | n2=en:lower extremity weakness with febrile episodes (rare) | rel=r_associated | relid=0 | w=106
  1598. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb atrophy
    n1=en:white substance | n2=en:lower limb atrophy | rel=r_associated | relid=0 | w=106
  1599. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb hypertonia
    n1=en:white substance | n2=en:lower limb hypertonia | rel=r_associated | relid=0 | w=106
  1600. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb muscle atrophy
    n1=en:white substance | n2=en:lower limb muscle atrophy | rel=r_associated | relid=0 | w=106
  1601. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb muscle weakness (occurs later)
    n1=en:white substance | n2=en:lower limb muscle weakness (occurs later) | rel=r_associated | relid=0 | w=106
  1602. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb spasticity
    n1=en:white substance | n2=en:lower limb spasticity | rel=r_associated | relid=0 | w=106
  1603. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb spasticity, mild
    n1=en:white substance | n2=en:lower limb spasticity, mild | rel=r_associated | relid=0 | w=106
  1604. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower limb weakness, proximal
    n1=en:white substance | n2=en:lower limb weakness, proximal | rel=r_associated | relid=0 | w=106
  1605. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron degeneration
    n1=en:white substance | n2=en:lower motor neuron degeneration | rel=r_associated | relid=0 | w=106
  1606. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron disease affecting upper and lower limbs
    n1=en:white substance | n2=en:lower motor neuron disease affecting upper and lower limbs | rel=r_associated | relid=0 | w=106
  1607. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron dysfunction
    n1=en:white substance | n2=en:lower motor neuron dysfunction | rel=r_associated | relid=0 | w=106
  1608. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron dysfunction involving upper and lower limbs
    n1=en:white substance | n2=en:lower motor neuron dysfunction involving upper and lower limbs | rel=r_associated | relid=0 | w=106
  1609. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron involvement after long disease duration
    n1=en:white substance | n2=en:lower motor neuron involvement after long disease duration | rel=r_associated | relid=0 | w=106
  1610. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron involvement, mild, seen on emg (in some patients)
    n1=en:white substance | n2=en:lower motor neuron involvement, mild, seen on emg (in some patients) | rel=r_associated | relid=0 | w=106
  1611. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor neuron signs, later
    n1=en:white substance | n2=en:lower motor neuron signs, later | rel=r_associated | relid=0 | w=106
  1612. en:white substance -- r_associated #0: 106 / 0.876 -> en:lower motor signs
    n1=en:white substance | n2=en:lower motor signs | rel=r_associated | relid=0 | w=106
  1613. en:white substance -- r_associated #0: 106 / 0.876 -> en:lumbosacral meningocele
    n1=en:white substance | n2=en:lumbosacral meningocele | rel=r_associated | relid=0 | w=106
  1614. en:white substance -- r_associated #0: 106 / 0.876 -> en:macroencephaly
    n1=en:white substance | n2=en:macroencephaly | rel=r_associated | relid=0 | w=106
  1615. en:white substance -- r_associated #0: 106 / 0.876 -> en:magnetic resonance spectroscopy (mrs) shows decreased n-acetylaspartic acid in unaffected white matter
    n1=en:white substance | n2=en:magnetic resonance spectroscopy (mrs) shows decreased n-acetylaspartic acid in unaffected white matter | rel=r_associated | relid=0 | w=106
  1616. en:white substance -- r_associated #0: 106 / 0.876 -> en:magnetic resonance spectroscopy shows increased lactate in white matter
    n1=en:white substance | n2=en:magnetic resonance spectroscopy shows increased lactate in white matter | rel=r_associated | relid=0 | w=106
  1617. en:white substance -- r_associated #0: 106 / 0.876 -> en:major developmental delay
    n1=en:white substance | n2=en:major developmental delay | rel=r_associated | relid=0 | w=106
  1618. en:white substance -- r_associated #0: 106 / 0.876 -> en:major developmental milestones are not attained
    n1=en:white substance | n2=en:major developmental milestones are not attained | rel=r_associated | relid=0 | w=106
  1619. en:white substance -- r_associated #0: 106 / 0.876 -> en:malformation, cerebral arteriovenous
    n1=en:white substance | n2=en:malformation, cerebral arteriovenous | rel=r_associated | relid=0 | w=106
  1620. en:white substance -- r_associated #0: 106 / 0.876 -> en:malformations of cortical development
    n1=en:white substance | n2=en:malformations of cortical development | rel=r_associated | relid=0 | w=106
  1621. en:white substance -- r_associated #0: 106 / 0.876 -> en:mandibular dental arcade
    n1=en:white substance | n2=en:mandibular dental arcade | rel=r_associated | relid=0 | w=106
  1622. en:white substance -- r_associated #0: 106 / 0.876 -> en:manic psychosis
    n1=en:white substance | n2=en:manic psychosis | rel=r_associated | relid=0 | w=106
  1623. en:white substance -- r_associated #0: 106 / 0.876 -> en:markedly delayed nerve conduction velocities
    n1=en:white substance | n2=en:markedly delayed nerve conduction velocities | rel=r_associated | relid=0 | w=106
  1624. en:white substance -- r_associated #0: 106 / 0.876 -> en:mask-like facies
    n1=en:white substance | n2=en:mask-like facies | rel=r_associated | relid=0 | w=106
  1625. en:white substance -- r_associated #0: 106 / 0.876 -> en:maxillary dental arcade
    n1=en:white substance | n2=en:maxillary dental arcade | rel=r_associated | relid=0 | w=106
  1626. en:white substance -- r_associated #0: 106 / 0.876 -> en:mean sleep latency is less than 5 to 8 minutes
    n1=en:white substance | n2=en:mean sleep latency is less than 5 to 8 minutes | rel=r_associated | relid=0 | w=106
  1627. en:white substance -- r_associated #0: 106 / 0.876 -> en:medulloblastoma
    n1=en:white substance | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=106
  1628. en:white substance -- r_associated #0: 106 / 0.876 -> en:mega cisterna magna
    n1=en:white substance | n2=en:mega cisterna magna | rel=r_associated | relid=0 | w=106
  1629. en:white substance -- r_associated #0: 106 / 0.876 -> en:megacisterna magna (rare)
    n1=en:white substance | n2=en:megacisterna magna (rare) | rel=r_associated | relid=0 | w=106
  1630. en:white substance -- r_associated #0: 106 / 0.876 -> en:memory impairment
    n1=en:white substance | n2=en:memory impairment | rel=r_associated | relid=0 | w=106
  1631. en:white substance -- r_associated #0: 106 / 0.876 -> en:memory impairment, progressive
    n1=en:white substance | n2=en:memory impairment, progressive | rel=r_associated | relid=0 | w=106
  1632. en:white substance -- r_associated #0: 106 / 0.876 -> en:meninges
    n1=en:white substance | n2=en:meninges | rel=r_associated | relid=0 | w=106
  1633. en:white substance -- r_associated #0: 106 / 0.876 -> en:meningioma (in some patients)
    n1=en:white substance | n2=en:meningioma (in some patients) | rel=r_associated | relid=0 | w=106
  1634. en:white substance -- r_associated #0: 106 / 0.876 -> en:meningoceles, multiple, lateral
    n1=en:white substance | n2=en:meningoceles, multiple, lateral | rel=r_associated | relid=0 | w=106
  1635. en:white substance -- r_associated #0: 106 / 0.876 -> en:meningoencephalitis
    n1=en:white substance | n2=en:meningoencephalitis | rel=r_associated | relid=0 | w=106
  1636. en:white substance -- r_associated #0: 106 / 0.876 -> en:meningoencephalocele (wws)
    n1=en:white substance | n2=en:meningoencephalocele (wws) | rel=r_associated | relid=0 | w=106
  1637. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental delay or retardation (uncommon)
    n1=en:white substance | n2=en:mental delay or retardation (uncommon) | rel=r_associated | relid=0 | w=106
  1638. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental deterioration
    n1=en:white substance | n2=en:mental deterioration | rel=r_associated | relid=0 | w=106
  1639. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental deterioration in a subset of patients
    n1=en:white substance | n2=en:mental deterioration in a subset of patients | rel=r_associated | relid=0 | w=106
  1640. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental deterioration in childhood
    n1=en:white substance | n2=en:mental deterioration in childhood | rel=r_associated | relid=0 | w=106
  1641. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental impairment may develop with repeated acute episodes
    n1=en:white substance | n2=en:mental impairment may develop with repeated acute episodes | rel=r_associated | relid=0 | w=106
  1642. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental lethargy
    n1=en:white substance | n2=en:mental lethargy | rel=r_associated | relid=0 | w=106
  1643. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation
    n1=en:white substance | n2=en:mental retardation | rel=r_associated | relid=0 | w=106
  1644. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (1 family)
    n1=en:white substance | n2=en:mental retardation (1 family) | rel=r_associated | relid=0 | w=106
  1645. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (15%)
    n1=en:white substance | n2=en:mental retardation (15%) | rel=r_associated | relid=0 | w=106
  1646. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (18% of patients)
    n1=en:white substance | n2=en:mental retardation (18% of patients) | rel=r_associated | relid=0 | w=106
  1647. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (3 patients)
    n1=en:white substance | n2=en:mental retardation (3 patients) | rel=r_associated | relid=0 | w=106
  1648. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (30%)
    n1=en:white substance | n2=en:mental retardation (30%) | rel=r_associated | relid=0 | w=106
  1649. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (31%)
    n1=en:white substance | n2=en:mental retardation (31%) | rel=r_associated | relid=0 | w=106
  1650. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (38%)
    n1=en:white substance | n2=en:mental retardation (38%) | rel=r_associated | relid=0 | w=106
  1651. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (50% patients)
    n1=en:white substance | n2=en:mental retardation (50% patients) | rel=r_associated | relid=0 | w=106
  1652. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (6%)
    n1=en:white substance | n2=en:mental retardation (6%) | rel=r_associated | relid=0 | w=106
  1653. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (7%)
    n1=en:white substance | n2=en:mental retardation (7%) | rel=r_associated | relid=0 | w=106
  1654. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (70%)
    n1=en:white substance | n2=en:mental retardation (70%) | rel=r_associated | relid=0 | w=106
  1655. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (about 40%)
    n1=en:white substance | n2=en:mental retardation (about 40%) | rel=r_associated | relid=0 | w=106
  1656. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (average iq 56)
    n1=en:white substance | n2=en:mental retardation (average iq 56) | rel=r_associated | relid=0 | w=106
  1657. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (cvs+)
    n1=en:white substance | n2=en:mental retardation (cvs+) | rel=r_associated | relid=0 | w=106
  1658. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (develops later)
    n1=en:white substance | n2=en:mental retardation (develops later) | rel=r_associated | relid=0 | w=106
  1659. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (early-onset form)
    n1=en:white substance | n2=en:mental retardation (early-onset form) | rel=r_associated | relid=0 | w=106
  1660. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (if left untreated)
    n1=en:white substance | n2=en:mental retardation (if left untreated) | rel=r_associated | relid=0 | w=106
  1661. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (if untreated in infancy)
    n1=en:white substance | n2=en:mental retardation (if untreated in infancy) | rel=r_associated | relid=0 | w=106
  1662. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in 2 patients) learning disability (in 1 patient)
    n1=en:white substance | n2=en:mental retardation (in 2 patients) learning disability (in 1 patient) | rel=r_associated | relid=0 | w=106
  1663. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in a subset of patients)
    n1=en:white substance | n2=en:mental retardation (in a subset of patients) | rel=r_associated | relid=0 | w=106
  1664. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in most patients)
    n1=en:white substance | n2=en:mental retardation (in most patients) | rel=r_associated | relid=0 | w=106
  1665. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in most)
    n1=en:white substance | n2=en:mental retardation (in most) | rel=r_associated | relid=0 | w=106
  1666. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in some cases)
    n1=en:white substance | n2=en:mental retardation (in some cases) | rel=r_associated | relid=0 | w=106
  1667. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in some patients)
    n1=en:white substance | n2=en:mental retardation (in some patients) | rel=r_associated | relid=0 | w=106
  1668. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (in type iia)
    n1=en:white substance | n2=en:mental retardation (in type iia) | rel=r_associated | relid=0 | w=106
  1669. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (iq 20-78)
    n1=en:white substance | n2=en:mental retardation (iq 20-78) | rel=r_associated | relid=0 | w=106
  1670. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (iq 50-60 combined griffiths and stanford-binet scale)
    n1=en:white substance | n2=en:mental retardation (iq 50-60 combined griffiths and stanford-binet scale) | rel=r_associated | relid=0 | w=106
  1671. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (less common)
    n1=en:white substance | n2=en:mental retardation (less common) | rel=r_associated | relid=0 | w=106
  1672. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (males)
    n1=en:white substance | n2=en:mental retardation (males) | rel=r_associated | relid=0 | w=106
  1673. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (moderate to severe in males)
    n1=en:white substance | n2=en:mental retardation (moderate to severe in males) | rel=r_associated | relid=0 | w=106
  1674. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (rare less than 1% of cases)
    n1=en:white substance | n2=en:mental retardation (rare less than 1% of cases) | rel=r_associated | relid=0 | w=106
  1675. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (rare)
    n1=en:white substance | n2=en:mental retardation (rare) | rel=r_associated | relid=0 | w=106
  1676. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (seen in hhs variant)
    n1=en:white substance | n2=en:mental retardation (seen in hhs variant) | rel=r_associated | relid=0 | w=106
  1677. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (sometimes)
    n1=en:white substance | n2=en:mental retardation (sometimes) | rel=r_associated | relid=0 | w=106
  1678. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (type i)
    n1=en:white substance | n2=en:mental retardation (type i) | rel=r_associated | relid=0 | w=106
  1679. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (uncommon)
    n1=en:white substance | n2=en:mental retardation (uncommon) | rel=r_associated | relid=0 | w=106
  1680. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (untreated hypothyroidism)
    n1=en:white substance | n2=en:mental retardation (untreated hypothyroidism) | rel=r_associated | relid=0 | w=106
  1681. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation (variable expression)
    n1=en:white substance | n2=en:mental retardation (variable expression) | rel=r_associated | relid=0 | w=106
  1682. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation by age 30 years
    n1=en:white substance | n2=en:mental retardation by age 30 years | rel=r_associated | relid=0 | w=106
  1683. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation due to repeated episodes of hypoglycemia
    n1=en:white substance | n2=en:mental retardation due to repeated episodes of hypoglycemia | rel=r_associated | relid=0 | w=106
  1684. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation has been reported
    n1=en:white substance | n2=en:mental retardation has been reported | rel=r_associated | relid=0 | w=106
  1685. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation in 5-13%
    n1=en:white substance | n2=en:mental retardation in 5-13% | rel=r_associated | relid=0 | w=106
  1686. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation may occur
    n1=en:white substance | n2=en:mental retardation may occur | rel=r_associated | relid=0 | w=106
  1687. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, borderline (1 patient)
    n1=en:white substance | n2=en:mental retardation, borderline (1 patient) | rel=r_associated | relid=0 | w=106
  1688. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, borderline-mild in carrier females
    n1=en:white substance | n2=en:mental retardation, borderline-mild in carrier females | rel=r_associated | relid=0 | w=106
  1689. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (1 family)
    n1=en:white substance | n2=en:mental retardation, mild (1 family) | rel=r_associated | relid=0 | w=106
  1690. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (1 patient)
    n1=en:white substance | n2=en:mental retardation, mild (1 patient) | rel=r_associated | relid=0 | w=106
  1691. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (18%)
    n1=en:white substance | n2=en:mental retardation, mild (18%) | rel=r_associated | relid=0 | w=106
  1692. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (20% have more severe mental retardation)
    n1=en:white substance | n2=en:mental retardation, mild (20% have more severe mental retardation) | rel=r_associated | relid=0 | w=106
  1693. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (carrier females)
    n1=en:white substance | n2=en:mental retardation, mild (carrier females) | rel=r_associated | relid=0 | w=106
  1694. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (in some females)
    n1=en:white substance | n2=en:mental retardation, mild (in some females) | rel=r_associated | relid=0 | w=106
  1695. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (iq range from 50 to 70)
    n1=en:white substance | n2=en:mental retardation, mild (iq range from 50 to 70) | rel=r_associated | relid=0 | w=106
  1696. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild (rare)
    n1=en:white substance | n2=en:mental retardation, mild (rare) | rel=r_associated | relid=0 | w=106
  1697. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild to moderate (20% of patients)
    n1=en:white substance | n2=en:mental retardation, mild to moderate (20% of patients) | rel=r_associated | relid=0 | w=106
  1698. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild to moderate (in some patients)
    n1=en:white substance | n2=en:mental retardation, mild to moderate (in some patients) | rel=r_associated | relid=0 | w=106
  1699. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild-moderate (28%, usually in males)
    n1=en:white substance | n2=en:mental retardation, mild-moderate (28%, usually in males) | rel=r_associated | relid=0 | w=106
  1700. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild, in most carrier females
    n1=en:white substance | n2=en:mental retardation, mild, in most carrier females | rel=r_associated | relid=0 | w=106
  1701. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, mild, some patients (iq 70-80)
    n1=en:white substance | n2=en:mental retardation, mild, some patients (iq 70-80) | rel=r_associated | relid=0 | w=106
  1702. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate (apparent by age 4 years)
    n1=en:white substance | n2=en:mental retardation, moderate (apparent by age 4 years) | rel=r_associated | relid=0 | w=106
  1703. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate (in sister)
    n1=en:white substance | n2=en:mental retardation, moderate (in sister) | rel=r_associated | relid=0 | w=106
  1704. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate (in some patients)
    n1=en:white substance | n2=en:mental retardation, moderate (in some patients) | rel=r_associated | relid=0 | w=106
  1705. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate to profound
    n1=en:white substance | n2=en:mental retardation, moderate to profound | rel=r_associated | relid=0 | w=106
  1706. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate to severe
    n1=en:white substance | n2=en:mental retardation, moderate to severe | rel=r_associated | relid=0 | w=106
  1707. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate to severe (in some patients)
    n1=en:white substance | n2=en:mental retardation, moderate to severe (in some patients) | rel=r_associated | relid=0 | w=106
  1708. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate to severe (iq 35-50)
    n1=en:white substance | n2=en:mental retardation, moderate to severe (iq 35-50) | rel=r_associated | relid=0 | w=106
  1709. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate to severe (iq 40 to 60)
    n1=en:white substance | n2=en:mental retardation, moderate to severe (iq 40 to 60) | rel=r_associated | relid=0 | w=106
  1710. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, moderate to severe (type ii, infantile and juvenile)
    n1=en:white substance | n2=en:mental retardation, moderate to severe (type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=106
  1711. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, profound (wws)
    n1=en:white substance | n2=en:mental retardation, profound (wws) | rel=r_associated | relid=0 | w=106
  1712. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, progressive (50% of patients)
    n1=en:white substance | n2=en:mental retardation, progressive (50% of patients) | rel=r_associated | relid=0 | w=106
  1713. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, residual mild-to-severe (in some patients)
    n1=en:white substance | n2=en:mental retardation, residual mild-to-severe (in some patients) | rel=r_associated | relid=0 | w=106
  1714. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, severe (if untreated)
    n1=en:white substance | n2=en:mental retardation, severe (if untreated) | rel=r_associated | relid=0 | w=106
  1715. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, severe in some patients
    n1=en:white substance | n2=en:mental retardation, severe in some patients | rel=r_associated | relid=0 | w=106
  1716. en:white substance -- r_associated #0: 106 / 0.876 -> en:mental retardation, variable degree (in some patients)
    n1=en:white substance | n2=en:mental retardation, variable degree (in some patients) | rel=r_associated | relid=0 | w=106
  1717. en:white substance -- r_associated #0: 106 / 0.876 -> en:mesial temporal brain malformations
    n1=en:white substance | n2=en:mesial temporal brain malformations | rel=r_associated | relid=0 | w=106
  1718. en:white substance -- r_associated #0: 106 / 0.876 -> en:metabolic aspects
    n1=en:white substance | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=106
  1719. en:white substance -- r_associated #0: 106 / 0.876 -> en:microbleeds
    n1=en:white substance | n2=en:microbleeds | rel=r_associated | relid=0 | w=106
  1720. en:white substance -- r_associated #0: 106 / 0.876 -> en:micrographia
    n1=en:white substance | n2=en:micrographia | rel=r_associated | relid=0 | w=106
  1721. en:white substance -- r_associated #0: 106 / 0.876 -> en:microlissencephalies
    n1=en:white substance | n2=en:microlissencephalies | rel=r_associated | relid=0 | w=106
  1722. en:white substance -- r_associated #0: 106 / 0.876 -> en:microvacuolation
    n1=en:white substance | n2=en:microvacuolation | rel=r_associated | relid=0 | w=106
  1723. en:white substance -- r_associated #0: 106 / 0.876 -> en:microvascular spaces, dilated
    n1=en:white substance | n2=en:microvascular spaces, dilated | rel=r_associated | relid=0 | w=106
  1724. en:white substance -- r_associated #0: 106 / 0.876 -> en:midbrain atrophy
    n1=en:white substance | n2=en:midbrain atrophy | rel=r_associated | relid=0 | w=106
  1725. en:white substance -- r_associated #0: 106 / 0.876 -> en:midline brain calcifications
    n1=en:white substance | n2=en:midline brain calcifications | rel=r_associated | relid=0 | w=106
  1726. en:white substance -- r_associated #0: 106 / 0.876 -> en:midline forebrain defects
    n1=en:white substance | n2=en:midline forebrain defects | rel=r_associated | relid=0 | w=106
  1727. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine
    n1=en:white substance | n2=en:migraine | rel=r_associated | relid=0 | w=106
  1728. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine (40% of patients)
    n1=en:white substance | n2=en:migraine (40% of patients) | rel=r_associated | relid=0 | w=106
  1729. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine (in affected males)
    n1=en:white substance | n2=en:migraine (in affected males) | rel=r_associated | relid=0 | w=106
  1730. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine (in some patients)
    n1=en:white substance | n2=en:migraine (in some patients) | rel=r_associated | relid=0 | w=106
  1731. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine (uncommon)
    n1=en:white substance | n2=en:migraine (uncommon) | rel=r_associated | relid=0 | w=106
  1732. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine headaches (cvs+)
    n1=en:white substance | n2=en:migraine headaches (cvs+) | rel=r_associated | relid=0 | w=106
  1733. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine headaches (onset in adolescence)
    n1=en:white substance | n2=en:migraine headaches (onset in adolescence) | rel=r_associated | relid=0 | w=106
  1734. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine with aura
    n1=en:white substance | n2=en:migraine with aura | rel=r_associated | relid=0 | w=106
  1735. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine with aura, usually visual (in 50% of patients)
    n1=en:white substance | n2=en:migraine with aura, usually visual (in 50% of patients) | rel=r_associated | relid=0 | w=106
  1736. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine without aura
    n1=en:white substance | n2=en:migraine without aura | rel=r_associated | relid=0 | w=106
  1737. en:white substance -- r_associated #0: 106 / 0.876 -> en:migraine, with or without aura
    n1=en:white substance | n2=en:migraine, with or without aura | rel=r_associated | relid=0 | w=106
  1738. en:white substance -- r_associated #0: 106 / 0.876 -> en:migrating focal discharges from one cortical region to another seen on eeg
    n1=en:white substance | n2=en:migrating focal discharges from one cortical region to another seen on eeg | rel=r_associated | relid=0 | w=106
  1739. en:white substance -- r_associated #0: 106 / 0.876 -> en:migrating partial seizures
    n1=en:white substance | n2=en:migrating partial seizures | rel=r_associated | relid=0 | w=106
  1740. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild brain anomalies on mri (e.g., dilated ventricles) (in some patients)
    n1=en:white substance | n2=en:mild brain anomalies on mri (e.g., dilated ventricles) (in some patients) | rel=r_associated | relid=0 | w=106
  1741. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild cognitive decline (1 patient)
    n1=en:white substance | n2=en:mild cognitive decline (1 patient) | rel=r_associated | relid=0 | w=106
  1742. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild cognitive impairment (in 2 patients)
    n1=en:white substance | n2=en:mild cognitive impairment (in 2 patients) | rel=r_associated | relid=0 | w=106
  1743. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild cortical atrophy (in 1 patient)
    n1=en:white substance | n2=en:mild cortical atrophy (in 1 patient) | rel=r_associated | relid=0 | w=106
  1744. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild cortical atrophy on ct or mri
    n1=en:white substance | n2=en:mild cortical atrophy on ct or mri | rel=r_associated | relid=0 | w=106
  1745. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild global developmental delay
    n1=en:white substance | n2=en:mild global developmental delay | rel=r_associated | relid=0 | w=106
  1746. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild loss of neurons in the cerebellum
    n1=en:white substance | n2=en:mild loss of neurons in the cerebellum | rel=r_associated | relid=0 | w=106
  1747. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild memory loss
    n1=en:white substance | n2=en:mild memory loss | rel=r_associated | relid=0 | w=106
  1748. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild mental decline
    n1=en:white substance | n2=en:mild mental decline | rel=r_associated | relid=0 | w=106
  1749. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild mental retardation
    n1=en:white substance | n2=en:mild mental retardation | rel=r_associated | relid=0 | w=106
  1750. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild pyramidal signs (variable expression)
    n1=en:white substance | n2=en:mild pyramidal signs (variable expression) | rel=r_associated | relid=0 | w=106
  1751. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild sensorimotor neuropathy
    n1=en:white substance | n2=en:mild sensorimotor neuropathy | rel=r_associated | relid=0 | w=106
  1752. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild upper limb involvement
    n1=en:white substance | n2=en:mild upper limb involvement | rel=r_associated | relid=0 | w=106
  1753. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild-moderate mental retardation (80% affected males)
    n1=en:white substance | n2=en:mild-moderate mental retardation (80% affected males) | rel=r_associated | relid=0 | w=106
  1754. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild-moderate ventricular dilatation
    n1=en:white substance | n2=en:mild-moderate ventricular dilatation | rel=r_associated | relid=0 | w=106
  1755. en:white substance -- r_associated #0: 106 / 0.876 -> en:mild-severe mental retardation (20%)
    n1=en:white substance | n2=en:mild-severe mental retardation (20%) | rel=r_associated | relid=0 | w=106
  1756. en:white substance -- r_associated #0: 106 / 0.876 -> en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy
    n1=en:white substance | n2=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | rel=r_associated | relid=0 | w=106
  1757. en:white substance -- r_associated #0: 106 / 0.876 -> en:mildly delayed motor development
    n1=en:white substance | n2=en:mildly delayed motor development | rel=r_associated | relid=0 | w=106
  1758. en:white substance -- r_associated #0: 106 / 0.876 -> en:mildly enlarged ventricles
    n1=en:white substance | n2=en:mildly enlarged ventricles | rel=r_associated | relid=0 | w=106
  1759. en:white substance -- r_associated #0: 106 / 0.876 -> en:minimal gliosis
    n1=en:white substance | n2=en:minimal gliosis | rel=r_associated | relid=0 | w=106
  1760. en:white substance -- r_associated #0: 106 / 0.876 -> en:minimal to absent speech
    n1=en:white substance | n2=en:minimal to absent speech | rel=r_associated | relid=0 | w=106
  1761. en:white substance -- r_associated #0: 106 / 0.876 -> en:minor motor impairment (stage 2)
    n1=en:white substance | n2=en:minor motor impairment (stage 2) | rel=r_associated | relid=0 | w=106
  1762. en:white substance -- r_associated #0: 106 / 0.876 -> en:mirror hand movements (bimanual synkinesis, in some patients)
    n1=en:white substance | n2=en:mirror hand movements (bimanual synkinesis, in some patients) | rel=r_associated | relid=0 | w=106
  1763. en:white substance -- r_associated #0: 106 / 0.876 -> en:mirror movements disorder
    n1=en:white substance | n2=en:mirror movements disorder | rel=r_associated | relid=0 | w=106
  1764. en:white substance -- r_associated #0: 106 / 0.876 -> en:mirror movements, involuntary, affecting the hand and fingers
    n1=en:white substance | n2=en:mirror movements, involuntary, affecting the hand and fingers | rel=r_associated | relid=0 | w=106
  1765. en:white substance -- r_associated #0: 106 / 0.876 -> en:mirror movements, involuntary, usually of the upper limb and hand
    n1=en:white substance | n2=en:mirror movements, involuntary, usually of the upper limb and hand | rel=r_associated | relid=0 | w=106
  1766. en:white substance -- r_associated #0: 106 / 0.876 -> en:misshapen posterior fossa
    n1=en:white substance | n2=en:misshapen posterior fossa | rel=r_associated | relid=0 | w=106
  1767. en:white substance -- r_associated #0: 106 / 0.876 -> en:mitochondrial dna depletion in brain tissue
    n1=en:white substance | n2=en:mitochondrial dna depletion in brain tissue | rel=r_associated | relid=0 | w=106
  1768. en:white substance -- r_associated #0: 106 / 0.876 -> en:mixed cerebellar/pseudobulbar dysarthria
    n1=en:white substance | n2=en:mixed cerebellar/pseudobulbar dysarthria | rel=r_associated | relid=0 | w=106
  1769. en:white substance -- r_associated #0: 106 / 0.876 -> en:mobility poor
    n1=en:white substance | n2=en:mobility poor | rel=r_associated | relid=0 | w=106
  1770. en:white substance -- r_associated #0: 106 / 0.876 -> en:moderate cortical atrophy (in some patients)
    n1=en:white substance | n2=en:moderate cortical atrophy (in some patients) | rel=r_associated | relid=0 | w=106
  1771. en:white substance -- r_associated #0: 106 / 0.876 -> en:moderate mental retardation (i.q. 35-49)
    n1=en:white substance | n2=en:moderate mental retardation (i.q. 35-49) | rel=r_associated | relid=0 | w=106
  1772. en:white substance -- r_associated #0: 106 / 0.876 -> en:moderately thickened cortex
    n1=en:white substance | n2=en:moderately thickened cortex | rel=r_associated | relid=0 | w=106
  1773. en:white substance -- r_associated #0: 106 / 0.876 -> en:molar tooth sign on mri
    n1=en:white substance | n2=en:molar tooth sign on mri | rel=r_associated | relid=0 | w=106
  1774. en:white substance -- r_associated #0: 106 / 0.876 -> en:molar tooth sign seen on mri
    n1=en:white substance | n2=en:molar tooth sign seen on mri | rel=r_associated | relid=0 | w=106
  1775. en:white substance -- r_associated #0: 106 / 0.876 -> en:monotone speech
    n1=en:white substance | n2=en:monotone speech | rel=r_associated | relid=0 | w=106
  1776. en:white substance -- r_associated #0: 106 / 0.876 -> en:mood lability
    n1=en:white substance | n2=en:mood lability | rel=r_associated | relid=0 | w=106
  1777. en:white substance -- r_associated #0: 106 / 0.876 -> en:moro reflex absent
    n1=en:white substance | n2=en:moro reflex absent | rel=r_associated | relid=0 | w=106
  1778. en:white substance -- r_associated #0: 106 / 0.876 -> en:most patients achieve walking with aid
    n1=en:white substance | n2=en:most patients achieve walking with aid | rel=r_associated | relid=0 | w=106
  1779. en:white substance -- r_associated #0: 106 / 0.876 -> en:most patients are wheelchair-bound
    n1=en:white substance | n2=en:most patients are wheelchair-bound | rel=r_associated | relid=0 | w=106
  1780. en:white substance -- r_associated #0: 106 / 0.876 -> en:most patients do not achieve independent sitting or walking
    n1=en:white substance | n2=en:most patients do not achieve independent sitting or walking | rel=r_associated | relid=0 | w=106
  1781. en:white substance -- r_associated #0: 106 / 0.876 -> en:mosy patients become wheelchair-bound after 10 years
    n1=en:white substance | n2=en:mosy patients become wheelchair-bound after 10 years | rel=r_associated | relid=0 | w=106
  1782. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor and vocal tics
    n1=en:white substance | n2=en:motor and vocal tics | rel=r_associated | relid=0 | w=106
  1783. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor automatisms
    n1=en:white substance | n2=en:motor automatisms | rel=r_associated | relid=0 | w=106
  1784. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor deterioration in second decade
    n1=en:white substance | n2=en:motor deterioration in second decade | rel=r_associated | relid=0 | w=106
  1785. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor development delayed (in some patients)
    n1=en:white substance | n2=en:motor development delayed (in some patients) | rel=r_associated | relid=0 | w=106
  1786. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor developmental delay, severe
    n1=en:white substance | n2=en:motor developmental delay, severe | rel=r_associated | relid=0 | w=106
  1787. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor disturbances
    n1=en:white substance | n2=en:motor disturbances | rel=r_associated | relid=0 | w=106
  1788. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor dyspraxia
    n1=en:white substance | n2=en:motor dyspraxia | rel=r_associated | relid=0 | w=106
  1789. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor neuron disease (less common)
    n1=en:white substance | n2=en:motor neuron disease (less common) | rel=r_associated | relid=0 | w=106
  1790. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor retardation, mild
    n1=en:white substance | n2=en:motor retardation, mild | rel=r_associated | relid=0 | w=106
  1791. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor symptoms may be present
    n1=en:white substance | n2=en:motor symptoms may be present | rel=r_associated | relid=0 | w=106
  1792. en:white substance -- r_associated #0: 106 / 0.876 -> en:motor tic
    n1=en:white substance | n2=en:motor tic | rel=r_associated | relid=0 | w=106
  1793. en:white substance -- r_associated #0: 106 / 0.876 -> en:mouth movements
    n1=en:white substance | n2=en:mouth movements | rel=r_associated | relid=0 | w=106
  1794. en:white substance -- r_associated #0: 106 / 0.876 -> en:movement abnormalities of the extremities
    n1=en:white substance | n2=en:movement abnormalities of the extremities | rel=r_associated | relid=0 | w=106
  1795. en:white substance -- r_associated #0: 106 / 0.876 -> en:movement disorder
    n1=en:white substance | n2=en:movement disorder | rel=r_associated | relid=0 | w=106
  1796. en:white substance -- r_associated #0: 106 / 0.876 -> en:movement of visual image - finding
    n1=en:white substance | n2=en:movement of visual image - finding | rel=r_associated | relid=0 | w=106
  1797. en:white substance -- r_associated #0: 106 / 0.876 -> en:movements ('tremors') characterized by 8 to 10-hz discharges
    n1=en:white substance | n2=en:movements ('tremors') characterized by 8 to 10-hz discharges | rel=r_associated | relid=0 | w=106
  1798. en:white substance -- r_associated #0: 106 / 0.876 -> en:mr spectroscopy shows decreased n-acetyl aspartate
    n1=en:white substance | n2=en:mr spectroscopy shows decreased n-acetyl aspartate | rel=r_associated | relid=0 | w=106
  1799. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri - diffuse or focal cerebral and cerebellar white matter disease
    n1=en:white substance | n2=en:mri - diffuse or focal cerebral and cerebellar white matter disease | rel=r_associated | relid=0 | w=106
  1800. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri imaging shows cavitation of the basal ganglia
    n1=en:white substance | n2=en:mri imaging shows cavitation of the basal ganglia | rel=r_associated | relid=0 | w=106
  1801. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri is best imaging modality to detect lesions
    n1=en:white substance | n2=en:mri is best imaging modality to detect lesions | rel=r_associated | relid=0 | w=106
  1802. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri may show atrophy of the cerebrum
    n1=en:white substance | n2=en:mri may show atrophy of the cerebrum | rel=r_associated | relid=0 | w=106
  1803. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows atretic occipital cephalocele with bony skull defect
    n1=en:white substance | n2=en:mri shows atretic occipital cephalocele with bony skull defect | rel=r_associated | relid=0 | w=106
  1804. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows brain asymmetry
    n1=en:white substance | n2=en:mri shows brain asymmetry | rel=r_associated | relid=0 | w=106
  1805. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows brainstem hypoplasia
    n1=en:white substance | n2=en:mri shows brainstem hypoplasia | rel=r_associated | relid=0 | w=106
  1806. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows cerebellar atrophy
    n1=en:white substance | n2=en:mri shows cerebellar atrophy | rel=r_associated | relid=0 | w=106
  1807. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows cerebral atrophy
    n1=en:white substance | n2=en:mri shows cerebral atrophy | rel=r_associated | relid=0 | w=106
  1808. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows diffuse white matter hyperintensities on t2-weighted imaging
    n1=en:white substance | n2=en:mri shows diffuse white matter hyperintensities on t2-weighted imaging | rel=r_associated | relid=0 | w=106
  1809. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows dysmyelination
    n1=en:white substance | n2=en:mri shows dysmyelination | rel=r_associated | relid=0 | w=106
  1810. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows frontal and temporal cortical atrophy
    n1=en:white substance | n2=en:mri shows frontal and temporal cortical atrophy | rel=r_associated | relid=0 | w=106
  1811. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows generalized atrophy
    n1=en:white substance | n2=en:mri shows generalized atrophy | rel=r_associated | relid=0 | w=106
  1812. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows globus pallidus signal abnormalities
    n1=en:white substance | n2=en:mri shows globus pallidus signal abnormalities | rel=r_associated | relid=0 | w=106
  1813. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows high signal intensity of the white matter later
    n1=en:white substance | n2=en:mri shows high signal intensity of the white matter later | rel=r_associated | relid=0 | w=106
  1814. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows hypointensity of the thalami early-on
    n1=en:white substance | n2=en:mri shows hypointensity of the thalami early-on | rel=r_associated | relid=0 | w=106
  1815. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows increased t2-weighted signals in the globus pallidi
    n1=en:white substance | n2=en:mri shows increased t2-weighted signals in the globus pallidi | rel=r_associated | relid=0 | w=106
  1816. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows no normal myelination
    n1=en:white substance | n2=en:mri shows no normal myelination | rel=r_associated | relid=0 | w=106
  1817. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows short, thick corpus callosum
    n1=en:white substance | n2=en:mri shows short, thick corpus callosum | rel=r_associated | relid=0 | w=106
  1818. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows subcortical leukoencephalopathy with cavitation
    n1=en:white substance | n2=en:mri shows subcortical leukoencephalopathy with cavitation | rel=r_associated | relid=0 | w=106
  1819. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows symmetric lesions of the basal ganglia (particularly caudate and putamen)
    n1=en:white substance | n2=en:mri shows symmetric lesions of the basal ganglia (particularly caudate and putamen) | rel=r_associated | relid=0 | w=106
  1820. en:white substance -- r_associated #0: 106 / 0.876 -> en:mri shows white matter lesions
    n1=en:white substance | n2=en:mri shows white matter lesions | rel=r_associated | relid=0 | w=106
  1821. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal areas of laminar dysmorphic neurons (in type iia)
    n1=en:white substance | n2=en:multifocal areas of laminar dysmorphic neurons (in type iia) | rel=r_associated | relid=0 | w=106
  1822. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal discharges associated with contralateral jerky movements
    n1=en:white substance | n2=en:multifocal discharges associated with contralateral jerky movements | rel=r_associated | relid=0 | w=106
  1823. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal epileptic activity
    n1=en:white substance | n2=en:multifocal epileptic activity | rel=r_associated | relid=0 | w=106
  1824. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal epileptiform discharges on diffuse slow background
    n1=en:white substance | n2=en:multifocal epileptiform discharges on diffuse slow background | rel=r_associated | relid=0 | w=106
  1825. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal epileptiform spikes seen on eeg
    n1=en:white substance | n2=en:multifocal epileptiform spikes seen on eeg | rel=r_associated | relid=0 | w=106
  1826. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal intractable seizures
    n1=en:white substance | n2=en:multifocal intractable seizures | rel=r_associated | relid=0 | w=106
  1827. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal spike and wave activity
    n1=en:white substance | n2=en:multifocal spike and wave activity | rel=r_associated | relid=0 | w=106
  1828. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal spikes
    n1=en:white substance | n2=en:multifocal spikes | rel=r_associated | relid=0 | w=106
  1829. en:white substance -- r_associated #0: 106 / 0.876 -> en:multifocal spikes and progressive slowing of background activity seen on eeg
    n1=en:white substance | n2=en:multifocal spikes and progressive slowing of background activity seen on eeg | rel=r_associated | relid=0 | w=106
  1830. en:white substance -- r_associated #0: 106 / 0.876 -> en:multiple aneurysms
    n1=en:white substance | n2=en:multiple aneurysms | rel=r_associated | relid=0 | w=106
  1831. en:white substance -- r_associated #0: 106 / 0.876 -> en:multiple independent spike foci
    n1=en:white substance | n2=en:multiple independent spike foci | rel=r_associated | relid=0 | w=106
  1832. en:white substance -- r_associated #0: 106 / 0.876 -> en:multiple lesions in the white matter
    n1=en:white substance | n2=en:multiple lesions in the white matter | rel=r_associated | relid=0 | w=106
  1833. en:white substance -- r_associated #0: 106 / 0.876 -> en:multiple sclerosis-like illness (516003.0001)
    n1=en:white substance | n2=en:multiple sclerosis-like illness (516003.0001) | rel=r_associated | relid=0 | w=106
  1834. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle atrophy
    n1=en:white substance | n2=en:muscle atrophy | rel=r_associated | relid=0 | w=106
  1835. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle biopsy shows neurogenic changes
    n1=en:white substance | n2=en:muscle biopsy shows neurogenic changes | rel=r_associated | relid=0 | w=106
  1836. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle stiffness and rigidity, chronic, fluctuating
    n1=en:white substance | n2=en:muscle stiffness and rigidity, chronic, fluctuating | rel=r_associated | relid=0 | w=106
  1837. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness
    n1=en:white substance | n2=en:muscle weakness | rel=r_associated | relid=0 | w=106
  1838. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness lower limb
    n1=en:white substance | n2=en:muscle weakness lower limb | rel=r_associated | relid=0 | w=106
  1839. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness of limb
    n1=en:white substance | n2=en:muscle weakness of limb | rel=r_associated | relid=0 | w=106
  1840. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness, distal (lower limbs more affected than upper limbs), due to motor neuronopathy
    n1=en:white substance | n2=en:muscle weakness, distal (lower limbs more affected than upper limbs), due to motor neuronopathy | rel=r_associated | relid=0 | w=106
  1841. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness, distal, upper and lower
    n1=en:white substance | n2=en:muscle weakness, distal, upper and lower | rel=r_associated | relid=0 | w=106
  1842. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs
    n1=en:white substance | n2=en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs | rel=r_associated | relid=0 | w=106
  1843. en:white substance -- r_associated #0: 106 / 0.876 -> en:muscle weakness, proximal, symmetric (lower limbs more affected than upper limbs) due to motor neuronopathy
    n1=en:white substance | n2=en:muscle weakness, proximal, symmetric (lower limbs more affected than upper limbs) due to motor neuronopathy | rel=r_associated | relid=0 | w=106
  1844. en:white substance -- r_associated #0: 106 / 0.876 -> en:mutism
    n1=en:white substance | n2=en:mutism | rel=r_associated | relid=0 | w=106
  1845. en:white substance -- r_associated #0: 106 / 0.876 -> en:myclonus (rare)
    n1=en:white substance | n2=en:myclonus (rare) | rel=r_associated | relid=0 | w=106
  1846. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelin loss in the corticospinal tracts
    n1=en:white substance | n2=en:myelin loss in the corticospinal tracts | rel=r_associated | relid=0 | w=106
  1847. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelin microvacuolation
    n1=en:white substance | n2=en:myelin microvacuolation | rel=r_associated | relid=0 | w=106
  1848. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelin sheath
    n1=en:white substance | n2=en:myelin sheath | rel=r_associated | relid=0 | w=106
  1849. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelin-like lamellar structures in schwann cells
    n1=en:white substance | n2=en:myelin-like lamellar structures in schwann cells | rel=r_associated | relid=0 | w=106
  1850. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelinated nerve fiber
    n1=en:white substance | n2=en:myelinated nerve fiber | rel=r_associated | relid=0 | w=106
  1851. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelination defects (type ii)
    n1=en:white substance | n2=en:myelination defects (type ii) | rel=r_associated | relid=0 | w=106
  1852. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelomeningocele
    n1=en:white substance | n2=en:myelomeningocele | rel=r_associated | relid=0 | w=106
  1853. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelomeningocele (less common)
    n1=en:white substance | n2=en:myelomeningocele (less common) | rel=r_associated | relid=0 | w=106
  1854. en:white substance -- r_associated #0: 106 / 0.876 -> en:myelomeningocele (rare)
    n1=en:white substance | n2=en:myelomeningocele (rare) | rel=r_associated | relid=0 | w=106
  1855. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic jerk
    n1=en:white substance | n2=en:myoclonic jerk | rel=r_associated | relid=0 | w=106
  1856. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic jerks (less common)
    n1=en:white substance | n2=en:myoclonic jerks (less common) | rel=r_associated | relid=0 | w=106
  1857. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic jerks (rare)
    n1=en:white substance | n2=en:myoclonic jerks (rare) | rel=r_associated | relid=0 | w=106
  1858. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic seizure, refractory
    n1=en:white substance | n2=en:myoclonic seizure, refractory | rel=r_associated | relid=0 | w=106
  1859. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic seizures (1 patient)
    n1=en:white substance | n2=en:myoclonic seizures (1 patient) | rel=r_associated | relid=0 | w=106
  1860. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic seizures, frequent, long-lasting (many hours)
    n1=en:white substance | n2=en:myoclonic seizures, frequent, long-lasting (many hours) | rel=r_associated | relid=0 | w=106
  1861. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic seizures, progressive
    n1=en:white substance | n2=en:myoclonic seizures, progressive | rel=r_associated | relid=0 | w=106
  1862. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles)
    n1=en:white substance | n2=en:myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles) | rel=r_associated | relid=0 | w=106
  1863. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonus (in 1 family)
    n1=en:white substance | n2=en:myoclonus (in 1 family) | rel=r_associated | relid=0 | w=106
  1864. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture)
    n1=en:white substance | n2=en:myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture) | rel=r_associated | relid=0 | w=106
  1865. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonus, cortical, multifocal
    n1=en:white substance | n2=en:myoclonus, cortical, multifocal | rel=r_associated | relid=0 | w=106
  1866. en:white substance -- r_associated #0: 106 / 0.876 -> en:myoclonus, paroxysmal
    n1=en:white substance | n2=en:myoclonus, paroxysmal | rel=r_associated | relid=0 | w=106
  1867. en:white substance -- r_associated #0: 106 / 0.876 -> en:myokymia
    n1=en:white substance | n2=en:myokymia | rel=r_associated | relid=0 | w=106
  1868. en:white substance -- r_associated #0: 106 / 0.876 -> en:myokymia (in some patients)
    n1=en:white substance | n2=en:myokymia (in some patients) | rel=r_associated | relid=0 | w=106
  1869. en:white substance -- r_associated #0: 106 / 0.876 -> en:myotonia
    n1=en:white substance | n2=en:myotonia | rel=r_associated | relid=0 | w=106
  1870. en:white substance -- r_associated #0: 106 / 0.876 -> en:myotonia (in 1 patient)
    n1=en:white substance | n2=en:myotonia (in 1 patient) | rel=r_associated | relid=0 | w=106
  1871. en:white substance -- r_associated #0: 106 / 0.876 -> en:narcolepsy
    n1=en:white substance | n2=en:narcolepsy | rel=r_associated | relid=0 | w=106
  1872. en:white substance -- r_associated #0: 106 / 0.876 -> en:neck drop
    n1=en:white substance | n2=en:neck drop | rel=r_associated | relid=0 | w=106
  1873. en:white substance -- r_associated #0: 106 / 0.876 -> en:neck pain
    n1=en:white substance | n2=en:neck pain | rel=r_associated | relid=0 | w=106
  1874. en:white substance -- r_associated #0: 106 / 0.876 -> en:necrotic process
    n1=en:white substance | n2=en:necrotic process | rel=r_associated | relid=0 | w=106
  1875. en:white substance -- r_associated #0: 106 / 0.876 -> en:neocortical atrophy
    n1=en:white substance | n2=en:neocortical atrophy | rel=r_associated | relid=0 | w=106
  1876. en:white substance -- r_associated #0: 106 / 0.876 -> en:neonatal irresponsiveness
    n1=en:white substance | n2=en:neonatal irresponsiveness | rel=r_associated | relid=0 | w=106
  1877. en:white substance -- r_associated #0: 106 / 0.876 -> en:neonatal irritability
    n1=en:white substance | n2=en:neonatal irritability | rel=r_associated | relid=0 | w=106
  1878. en:white substance -- r_associated #0: 106 / 0.876 -> en:neonatal/early-infantile onset encephalopathy
    n1=en:white substance | n2=en:neonatal/early-infantile onset encephalopathy | rel=r_associated | relid=0 | w=106
  1879. en:white substance -- r_associated #0: 106 / 0.876 -> en:nerve cells show ballooning with membrane-bound vesicles with reticulogranular pattern
    n1=en:white substance | n2=en:nerve cells show ballooning with membrane-bound vesicles with reticulogranular pattern | rel=r_associated | relid=0 | w=106
  1880. en:white substance -- r_associated #0: 106 / 0.876 -> en:nerve degeneration
    n1=en:white substance | n2=en:nerve degeneration | rel=r_associated | relid=0 | w=106
  1881. en:white substance -- r_associated #0: 106 / 0.876 -> en:nerve fasciculus
    n1=en:white substance | n2=en:nerve fasciculus | rel=r_associated | relid=0 | w=106
  1882. en:white substance -- r_associated #0: 106 / 0.876 -> en:nervousness
    n1=en:white substance | n2=en:nervousness | rel=r_associated | relid=0 | w=106
  1883. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural ganglion or nucleus
    n1=en:white substance | n2=en:neural ganglion or nucleus | rel=r_associated | relid=0 | w=106
  1884. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of brain
    n1=en:white substance | n2=en:neural tissue of brain | rel=r_associated | relid=0 | w=106
  1885. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of nerve
    n1=en:white substance | n2=en:neural tissue of nerve | rel=r_associated | relid=0 | w=106
  1886. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of neural tree organ
    n1=en:white substance | n2=en:neural tissue of neural tree organ | rel=r_associated | relid=0 | w=106
  1887. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of neuraxis
    n1=en:white substance | n2=en:neural tissue of neuraxis | rel=r_associated | relid=0 | w=106
  1888. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of peripheral ganglion
    n1=en:white substance | n2=en:neural tissue of peripheral ganglion | rel=r_associated | relid=0 | w=106
  1889. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of segment of spinal cord
    n1=en:white substance | n2=en:neural tissue of segment of spinal cord | rel=r_associated | relid=0 | w=106
  1890. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of spinal cord
    n1=en:white substance | n2=en:neural tissue of spinal cord | rel=r_associated | relid=0 | w=106
  1891. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tissue of subsegment of spinal cord
    n1=en:white substance | n2=en:neural tissue of subsegment of spinal cord | rel=r_associated | relid=0 | w=106
  1892. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tube defect (in some patients)
    n1=en:white substance | n2=en:neural tube defect (in some patients) | rel=r_associated | relid=0 | w=106
  1893. en:white substance -- r_associated #0: 106 / 0.876 -> en:neural tube defects may occur
    n1=en:white substance | n2=en:neural tube defects may occur | rel=r_associated | relid=0 | w=106
  1894. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuroaxonal abnormalities
    n1=en:white substance | n2=en:neuroaxonal abnormalities | rel=r_associated | relid=0 | w=106
  1895. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuroaxonal dystrophies
    n1=en:white substance | n2=en:neuroaxonal dystrophies | rel=r_associated | relid=0 | w=106
  1896. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurobehavioral changes associated with hyperammonemia
    n1=en:white substance | n2=en:neurobehavioral changes associated with hyperammonemia | rel=r_associated | relid=0 | w=106
  1897. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurodegeneration (patient a)
    n1=en:white substance | n2=en:neurodegeneration (patient a) | rel=r_associated | relid=0 | w=106
  1898. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurodegeneration in the basal ganglia
    n1=en:white substance | n2=en:neurodegeneration in the basal ganglia | rel=r_associated | relid=0 | w=106
  1899. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurodegeneration in the cerebellum
    n1=en:white substance | n2=en:neurodegeneration in the cerebellum | rel=r_associated | relid=0 | w=106
  1900. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurodegeneration in the substantia nigra
    n1=en:white substance | n2=en:neurodegeneration in the substantia nigra | rel=r_associated | relid=0 | w=106
  1901. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurofibrillary degeneration (morphologic abnormality)
    n1=en:white substance | n2=en:neurofibrillary degeneration (morphologic abnormality) | rel=r_associated | relid=0 | w=106
  1902. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurofibrillary tangles composed of disordered microtubules
    n1=en:white substance | n2=en:neurofibrillary tangles composed of disordered microtubules | rel=r_associated | relid=0 | w=106
  1903. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurofibrillary tangles may be present
    n1=en:white substance | n2=en:neurofibrillary tangles may be present | rel=r_associated | relid=0 | w=106
  1904. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels
    n1=en:white substance | n2=en:neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels | rel=r_associated | relid=0 | w=106
  1905. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurogenic bladder
    n1=en:white substance | n2=en:neurogenic bladder | rel=r_associated | relid=0 | w=106
  1906. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurogenic muscle atrophy, especially in the lower limbs
    n1=en:white substance | n2=en:neurogenic muscle atrophy, especially in the lower limbs | rel=r_associated | relid=0 | w=106
  1907. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuroimaging shows cortical atrophy
    n1=en:white substance | n2=en:neuroimaging shows cortical atrophy | rel=r_associated | relid=0 | w=106
  1908. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic degeneration
    n1=en:white substance | n2=en:neurologic degeneration | rel=r_associated | relid=0 | w=106
  1909. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic deterioration in longterm survivors
    n1=en:white substance | n2=en:neurologic deterioration in longterm survivors | rel=r_associated | relid=0 | w=106
  1910. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic dysfunction, progressive
    n1=en:white substance | n2=en:neurologic dysfunction, progressive | rel=r_associated | relid=0 | w=106
  1911. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic involvement (in some patients)
    n1=en:white substance | n2=en:neurologic involvement (in some patients) | rel=r_associated | relid=0 | w=106
  1912. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic regression
    n1=en:white substance | n2=en:neurologic regression | rel=r_associated | relid=0 | w=106
  1913. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic regression after age 2 years
    n1=en:white substance | n2=en:neurologic regression after age 2 years | rel=r_associated | relid=0 | w=106
  1914. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic regression after prolonged episodes
    n1=en:white substance | n2=en:neurologic regression after prolonged episodes | rel=r_associated | relid=0 | w=106
  1915. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic sequelae not always present
    n1=en:white substance | n2=en:neurologic sequelae not always present | rel=r_associated | relid=0 | w=106
  1916. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic sequelae of stroke
    n1=en:white substance | n2=en:neurologic sequelae of stroke | rel=r_associated | relid=0 | w=106
  1917. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurologic symptoms, if present, usually result from associated syringomyelia
    n1=en:white substance | n2=en:neurologic symptoms, if present, usually result from associated syringomyelia | rel=r_associated | relid=0 | w=106
  1918. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuromuscular disturbances, progressive
    n1=en:white substance | n2=en:neuromuscular disturbances, progressive | rel=r_associated | relid=0 | w=106
  1919. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuron apoptotic process
    n1=en:white substance | n2=en:neuron apoptotic process | rel=r_associated | relid=0 | w=106
  1920. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuron covering
    n1=en:white substance | n2=en:neuron covering | rel=r_associated | relid=0 | w=106
  1921. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuron loss
    n1=en:white substance | n2=en:neuron loss | rel=r_associated | relid=0 | w=106
  1922. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal inclusion bodies stain for neuroserpin
    n1=en:white substance | n2=en:neuronal inclusion bodies stain for neuroserpin | rel=r_associated | relid=0 | w=106
  1923. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss (patient a)
    n1=en:white substance | n2=en:neuronal loss (patient a) | rel=r_associated | relid=0 | w=106
  1924. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss and gliosis in caudate and putamen
    n1=en:white substance | n2=en:neuronal loss and gliosis in caudate and putamen | rel=r_associated | relid=0 | w=106
  1925. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss and gliosis in the cerebral cortex
    n1=en:white substance | n2=en:neuronal loss and gliosis in the cerebral cortex | rel=r_associated | relid=0 | w=106
  1926. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss and gliosis in the dentate nucleus
    n1=en:white substance | n2=en:neuronal loss and gliosis in the dentate nucleus | rel=r_associated | relid=0 | w=106
  1927. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss and gliosis in the inferior olives
    n1=en:white substance | n2=en:neuronal loss and gliosis in the inferior olives | rel=r_associated | relid=0 | w=106
  1928. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in basal ganglia
    n1=en:white substance | n2=en:neuronal loss in basal ganglia | rel=r_associated | relid=0 | w=106
  1929. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in central nervous system
    n1=en:white substance | n2=en:neuronal loss in central nervous system | rel=r_associated | relid=0 | w=106
  1930. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the brainstem
    n1=en:white substance | n2=en:neuronal loss in the brainstem | rel=r_associated | relid=0 | w=106
  1931. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the cerebral cortex
    n1=en:white substance | n2=en:neuronal loss in the cerebral cortex | rel=r_associated | relid=0 | w=106
  1932. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the cerebrum and cerebellum
    n1=en:white substance | n2=en:neuronal loss in the cerebrum and cerebellum | rel=r_associated | relid=0 | w=106
  1933. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the dentate nuclei
    n1=en:white substance | n2=en:neuronal loss in the dentate nuclei | rel=r_associated | relid=0 | w=106
  1934. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the locus ceruleus
    n1=en:white substance | n2=en:neuronal loss in the locus ceruleus | rel=r_associated | relid=0 | w=106
  1935. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients)
    n1=en:white substance | n2=en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients) | rel=r_associated | relid=0 | w=106
  1936. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss in the substantia nigra
    n1=en:white substance | n2=en:neuronal loss in the substantia nigra | rel=r_associated | relid=0 | w=106
  1937. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal loss, diffuse
    n1=en:white substance | n2=en:neuronal loss, diffuse | rel=r_associated | relid=0 | w=106
  1938. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuronal migration defect
    n1=en:white substance | n2=en:neuronal migration defect | rel=r_associated | relid=0 | w=106
  1939. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathologic examination shows calcification of the small brain vessels
    n1=en:white substance | n2=en:neuropathologic examination shows calcification of the small brain vessels | rel=r_associated | relid=0 | w=106
  1940. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathologic examination shows extensive spongiosis and gliosis
    n1=en:white substance | n2=en:neuropathologic examination shows extensive spongiosis and gliosis | rel=r_associated | relid=0 | w=106
  1941. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathologic examination shows severe demyelination
    n1=en:white substance | n2=en:neuropathologic examination shows severe demyelination | rel=r_associated | relid=0 | w=106
  1942. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially)
    n1=en:white substance | n2=en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially) | rel=r_associated | relid=0 | w=106
  1943. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathology shows diffuse demyelination of the cerebral white matter
    n1=en:white substance | n2=en:neuropathology shows diffuse demyelination of the cerebral white matter | rel=r_associated | relid=0 | w=106
  1944. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathology shows fmr1 mrna-positive inclusions in neurons and astrocytes
    n1=en:white substance | n2=en:neuropathology shows fmr1 mrna-positive inclusions in neurons and astrocytes | rel=r_associated | relid=0 | w=106
  1945. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathology shows neuronal degeneration
    n1=en:white substance | n2=en:neuropathology shows neuronal degeneration | rel=r_associated | relid=0 | w=106
  1946. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum
    n1=en:white substance | n2=en:neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum | rel=r_associated | relid=0 | w=106
  1947. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum
    n1=en:white substance | n2=en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum | rel=r_associated | relid=0 | w=106
  1948. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurophysiologic abnormalities (eeg, sep, vep)
    n1=en:white substance | n2=en:neurophysiologic abnormalities (eeg, sep, vep) | rel=r_associated | relid=0 | w=106
  1949. en:white substance -- r_associated #0: 106 / 0.876 -> en:neuropsychologic impairment
    n1=en:white substance | n2=en:neuropsychologic impairment | rel=r_associated | relid=0 | w=106
  1950. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurosarcoidosis (5-16% of patients)
    n1=en:white substance | n2=en:neurosarcoidosis (5-16% of patients) | rel=r_associated | relid=0 | w=106
  1951. en:white substance -- r_associated #0: 106 / 0.876 -> en:neurosis
    n1=en:white substance | n2=en:neurosis | rel=r_associated | relid=0 | w=106
  1952. en:white substance -- r_associated #0: 106 / 0.876 -> en:never able to walk
    n1=en:white substance | n2=en:never able to walk | rel=r_associated | relid=0 | w=106
  1953. en:white substance -- r_associated #0: 106 / 0.876 -> en:never learn to walk (some patients)
    n1=en:white substance | n2=en:never learn to walk (some patients) | rel=r_associated | relid=0 | w=106
  1954. en:white substance -- r_associated #0: 106 / 0.876 -> en:nigrostriatal degeneration
    n1=en:white substance | n2=en:nigrostriatal degeneration | rel=r_associated | relid=0 | w=106
  1955. en:white substance -- r_associated #0: 106 / 0.876 -> en:no amyloid plaques
    n1=en:white substance | n2=en:no amyloid plaques | rel=r_associated | relid=0 | w=106
  1956. en:white substance -- r_associated #0: 106 / 0.876 -> en:no bulbar involvement
    n1=en:white substance | n2=en:no bulbar involvement | rel=r_associated | relid=0 | w=106
  1957. en:white substance -- r_associated #0: 106 / 0.876 -> en:no central nervous system abnormalities
    n1=en:white substance | n2=en:no central nervous system abnormalities | rel=r_associated | relid=0 | w=106
  1958. en:white substance -- r_associated #0: 106 / 0.876 -> en:no cerebellar signs
    n1=en:white substance | n2=en:no cerebellar signs | rel=r_associated | relid=0 | w=106
  1959. en:white substance -- r_associated #0: 106 / 0.876 -> en:no dementia
    n1=en:white substance | n2=en:no dementia | rel=r_associated | relid=0 | w=106
  1960. en:white substance -- r_associated #0: 106 / 0.876 -> en:no development
    n1=en:white substance | n2=en:no development | rel=r_associated | relid=0 | w=106
  1961. en:white substance -- r_associated #0: 106 / 0.876 -> en:no gaze contact
    n1=en:white substance | n2=en:no gaze contact | rel=r_associated | relid=0 | w=106
  1962. en:white substance -- r_associated #0: 106 / 0.876 -> en:no head control
    n1=en:white substance | n2=en:no head control | rel=r_associated | relid=0 | w=106
  1963. en:white substance -- r_associated #0: 106 / 0.876 -> en:no hippocampal sclerosis
    n1=en:white substance | n2=en:no hippocampal sclerosis | rel=r_associated | relid=0 | w=106
  1964. en:white substance -- r_associated #0: 106 / 0.876 -> en:no hydrocephalus
    n1=en:white substance | n2=en:no hydrocephalus | rel=r_associated | relid=0 | w=106
  1965. en:white substance -- r_associated #0: 106 / 0.876 -> en:no language
    n1=en:white substance | n2=en:no language | rel=r_associated | relid=0 | w=106
  1966. en:white substance -- r_associated #0: 106 / 0.876 -> en:no language development
    n1=en:white substance | n2=en:no language development | rel=r_associated | relid=0 | w=106
  1967. en:white substance -- r_associated #0: 106 / 0.876 -> en:no lewy bodies
    n1=en:white substance | n2=en:no lewy bodies | rel=r_associated | relid=0 | w=106
  1968. en:white substance -- r_associated #0: 106 / 0.876 -> en:no motor skills acquired (in some)
    n1=en:white substance | n2=en:no motor skills acquired (in some) | rel=r_associated | relid=0 | w=106
  1969. en:white substance -- r_associated #0: 106 / 0.876 -> en:no neurofibrillary tangles
    n1=en:white substance | n2=en:no neurofibrillary tangles | rel=r_associated | relid=0 | w=106
  1970. en:white substance -- r_associated #0: 106 / 0.876 -> en:no other neurologic deficits
    n1=en:white substance | n2=en:no other neurologic deficits | rel=r_associated | relid=0 | w=106
  1971. en:white substance -- r_associated #0: 106 / 0.876 -> en:no other neurologic disorder
    n1=en:white substance | n2=en:no other neurologic disorder | rel=r_associated | relid=0 | w=106
  1972. en:white substance -- r_associated #0: 106 / 0.876 -> en:no overt seizures
    n1=en:white substance | n2=en:no overt seizures | rel=r_associated | relid=0 | w=106
  1973. en:white substance -- r_associated #0: 106 / 0.876 -> en:no response to l-dopa treatment
    n1=en:white substance | n2=en:no response to l-dopa treatment | rel=r_associated | relid=0 | w=106
  1974. en:white substance -- r_associated #0: 106 / 0.876 -> en:no seizures
    n1=en:white substance | n2=en:no seizures | rel=r_associated | relid=0 | w=106
  1975. en:white substance -- r_associated #0: 106 / 0.876 -> en:no seizures (hcs)
    n1=en:white substance | n2=en:no seizures (hcs) | rel=r_associated | relid=0 | w=106
  1976. en:white substance -- r_associated #0: 106 / 0.876 -> en:no sensory symptoms
    n1=en:white substance | n2=en:no sensory symptoms | rel=r_associated | relid=0 | w=106
  1977. en:white substance -- r_associated #0: 106 / 0.876 -> en:no speech development (in most patients)
    n1=en:white substance | n2=en:no speech development (in most patients) | rel=r_associated | relid=0 | w=106
  1978. en:white substance -- r_associated #0: 106 / 0.876 -> en:no speech problem
    n1=en:white substance | n2=en:no speech problem | rel=r_associated | relid=0 | w=106
  1979. en:white substance -- r_associated #0: 106 / 0.876 -> en:no spontaneous movements
    n1=en:white substance | n2=en:no spontaneous movements | rel=r_associated | relid=0 | w=106
  1980. en:white substance -- r_associated #0: 106 / 0.876 -> en:no tau pathology
    n1=en:white substance | n2=en:no tau pathology | rel=r_associated | relid=0 | w=106
  1981. en:white substance -- r_associated #0: 106 / 0.876 -> en:no tremor
    n1=en:white substance | n2=en:no tremor | rel=r_associated | relid=0 | w=106
  1982. en:white substance -- r_associated #0: 106 / 0.876 -> en:no visual fixation
    n1=en:white substance | n2=en:no visual fixation | rel=r_associated | relid=0 | w=106
  1983. en:white substance -- r_associated #0: 106 / 0.876 -> en:nocturnal seizures
    n1=en:white substance | n2=en:nocturnal seizures | rel=r_associated | relid=0 | w=106
  1984. en:white substance -- r_associated #0: 106 / 0.876 -> en:nocturnal seizures (in some patients)
    n1=en:white substance | n2=en:nocturnal seizures (in some patients) | rel=r_associated | relid=0 | w=106
  1985. en:white substance -- r_associated #0: 106 / 0.876 -> en:nodding of head
    n1=en:white substance | n2=en:nodding of head | rel=r_associated | relid=0 | w=106
  1986. en:white substance -- r_associated #0: 106 / 0.876 -> en:nodular heterotopia
    n1=en:white substance | n2=en:nodular heterotopia | rel=r_associated | relid=0 | w=106
  1987. en:white substance -- r_associated #0: 106 / 0.876 -> en:nodular heterotopia (in some patients)
    n1=en:white substance | n2=en:nodular heterotopia (in some patients) | rel=r_associated | relid=0 | w=106
  1988. en:white substance -- r_associated #0: 106 / 0.876 -> en:nodular heterotopia (rare)
    n1=en:white substance | n2=en:nodular heterotopia (rare) | rel=r_associated | relid=0 | w=106
  1989. en:white substance -- r_associated #0: 106 / 0.876 -> en:non-febrile seizures later
    n1=en:white substance | n2=en:non-febrile seizures later | rel=r_associated | relid=0 | w=106
  1990. en:white substance -- r_associated #0: 106 / 0.876 -> en:non-purposeful arm movements, choreoathetoid-like
    n1=en:white substance | n2=en:non-purposeful arm movements, choreoathetoid-like | rel=r_associated | relid=0 | w=106
  1991. en:white substance -- r_associated #0: 106 / 0.876 -> en:nonspecific leukoencephalopathy (52%)
    n1=en:white substance | n2=en:nonspecific leukoencephalopathy (52%) | rel=r_associated | relid=0 | w=106
  1992. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal cognition (reported in 1 patient who survived to age 20 years)
    n1=en:white substance | n2=en:normal cognition (reported in 1 patient who survived to age 20 years) | rel=r_associated | relid=0 | w=106
  1993. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal cognition (reported in some patients)
    n1=en:white substance | n2=en:normal cognition (reported in some patients) | rel=r_associated | relid=0 | w=106
  1994. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal early development
    n1=en:white substance | n2=en:normal early development | rel=r_associated | relid=0 | w=106
  1995. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal early development, up to 8 to 15 months of age
    n1=en:white substance | n2=en:normal early development, up to 8 to 15 months of age | rel=r_associated | relid=0 | w=106
  1996. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal early developmental milestones
    n1=en:white substance | n2=en:normal early developmental milestones | rel=r_associated | relid=0 | w=106
  1997. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal early psychomotor development
    n1=en:white substance | n2=en:normal early psychomotor development | rel=r_associated | relid=0 | w=106
  1998. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal fine motor activity
    n1=en:white substance | n2=en:normal fine motor activity | rel=r_associated | relid=0 | w=106
  1999. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal initial psychomotor development
    n1=en:white substance | n2=en:normal initial psychomotor development | rel=r_associated | relid=0 | w=106
  2000. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intellectual development
    n1=en:white substance | n2=en:normal intellectual development | rel=r_associated | relid=0 | w=106
  2001. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intelligence (in some patients)
    n1=en:white substance | n2=en:normal intelligence (in some patients) | rel=r_associated | relid=0 | w=106
  2002. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intelligence (majority)
    n1=en:white substance | n2=en:normal intelligence (majority) | rel=r_associated | relid=0 | w=106
  2003. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intelligence in iib
    n1=en:white substance | n2=en:normal intelligence in iib | rel=r_associated | relid=0 | w=106
  2004. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intelligence in majority
    n1=en:white substance | n2=en:normal intelligence in majority | rel=r_associated | relid=0 | w=106
  2005. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intelligence in most cases
    n1=en:white substance | n2=en:normal intelligence in most cases | rel=r_associated | relid=0 | w=106
  2006. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal intelligence to mild or moderate mental retardation
    n1=en:white substance | n2=en:normal intelligence to mild or moderate mental retardation | rel=r_associated | relid=0 | w=106
  2007. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal interictal eeg
    n1=en:white substance | n2=en:normal interictal eeg | rel=r_associated | relid=0 | w=106
  2008. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal interictal neurologic examination
    n1=en:white substance | n2=en:normal interictal neurologic examination | rel=r_associated | relid=0 | w=106
  2009. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal iq in infancy, then iq drops with age
    n1=en:white substance | n2=en:normal iq in infancy, then iq drops with age | rel=r_associated | relid=0 | w=106
  2010. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal mental development
    n1=en:white substance | n2=en:normal mental development | rel=r_associated | relid=0 | w=106
  2011. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal motor conduction studies (initially)
    n1=en:white substance | n2=en:normal motor conduction studies (initially) | rel=r_associated | relid=0 | w=106
  2012. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal motor development
    n1=en:white substance | n2=en:normal motor development | rel=r_associated | relid=0 | w=106
  2013. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal muscle strength
    n1=en:white substance | n2=en:normal muscle strength | rel=r_associated | relid=0 | w=106
  2014. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal neurological development is possible
    n1=en:white substance | n2=en:normal neurological development is possible | rel=r_associated | relid=0 | w=106
  2015. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal neuromuscular studies
    n1=en:white substance | n2=en:normal neuromuscular studies | rel=r_associated | relid=0 | w=106
  2016. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal psychomotor development in most
    n1=en:white substance | n2=en:normal psychomotor development in most | rel=r_associated | relid=0 | w=106
  2017. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal psychomotor development until age 2 to 3 years
    n1=en:white substance | n2=en:normal psychomotor development until age 2 to 3 years | rel=r_associated | relid=0 | w=106
  2018. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal to mildly delayed development
    n1=en:white substance | n2=en:normal to mildly delayed development | rel=r_associated | relid=0 | w=106
  2019. en:white substance -- r_associated #0: 106 / 0.876 -> en:normal, timely language development
    n1=en:white substance | n2=en:normal, timely language development | rel=r_associated | relid=0 | w=106
  2020. en:white substance -- r_associated #0: 106 / 0.876 -> en:nuclear magnetic resonance imaging brain normal
    n1=en:white substance | n2=en:nuclear magnetic resonance imaging brain normal | rel=r_associated | relid=0 | w=106
  2021. en:white substance -- r_associated #0: 106 / 0.876 -> en:numbness
    n1=en:white substance | n2=en:numbness | rel=r_associated | relid=0 | w=106
  2022. en:white substance -- r_associated #0: 106 / 0.876 -> en:nystagmus
    n1=en:white substance | n2=en:nystagmus | rel=r_associated | relid=0 | w=106
  2023. en:white substance -- r_associated #0: 106 / 0.876 -> en:nystagmus decreases on convergence
    n1=en:white substance | n2=en:nystagmus decreases on convergence | rel=r_associated | relid=0 | w=106
  2024. en:white substance -- r_associated #0: 106 / 0.876 -> en:nystagmus is accentuated by fixation, lateral gaze, smooth pursuit
    n1=en:white substance | n2=en:nystagmus is accentuated by fixation, lateral gaze, smooth pursuit | rel=r_associated | relid=0 | w=106
  2025. en:white substance -- r_associated #0: 106 / 0.876 -> en:nystagmus, horizontal
    n1=en:white substance | n2=en:nystagmus, horizontal | rel=r_associated | relid=0 | w=106
  2026. en:white substance -- r_associated #0: 106 / 0.876 -> en:nystagmus, jerky, horizontal, congenital
    n1=en:white substance | n2=en:nystagmus, jerky, horizontal, congenital | rel=r_associated | relid=0 | w=106
  2027. en:white substance -- r_associated #0: 106 / 0.876 -> en:obsessive compulsive behavior
    n1=en:white substance | n2=en:obsessive compulsive behavior | rel=r_associated | relid=0 | w=106
  2028. en:white substance -- r_associated #0: 106 / 0.876 -> en:obstruction of the foramen of monro (variable)
    n1=en:white substance | n2=en:obstruction of the foramen of monro (variable) | rel=r_associated | relid=0 | w=106
  2029. en:white substance -- r_associated #0: 106 / 0.876 -> en:obtundation
    n1=en:white substance | n2=en:obtundation | rel=r_associated | relid=0 | w=106
  2030. en:white substance -- r_associated #0: 106 / 0.876 -> en:occasional degeneration of the globus pallidus
    n1=en:white substance | n2=en:occasional degeneration of the globus pallidus | rel=r_associated | relid=0 | w=106
  2031. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital encephalocele (in some patients)
    n1=en:white substance | n2=en:occipital encephalocele (in some patients) | rel=r_associated | relid=0 | w=106
  2032. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital encephalocele (wws)
    n1=en:white substance | n2=en:occipital encephalocele (wws) | rel=r_associated | relid=0 | w=106
  2033. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital encephaloceles
    n1=en:white substance | n2=en:occipital encephaloceles | rel=r_associated | relid=0 | w=106
  2034. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital lobe
    n1=en:white substance | n2=en:occipital lobe | rel=r_associated | relid=0 | w=106
  2035. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital lobe atrophy
    n1=en:white substance | n2=en:occipital lobe atrophy | rel=r_associated | relid=0 | w=106
  2036. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital lobe infarct (rare)
    n1=en:white substance | n2=en:occipital lobe infarct (rare) | rel=r_associated | relid=0 | w=106
  2037. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital meningocele
    n1=en:white substance | n2=en:occipital meningocele | rel=r_associated | relid=0 | w=106
  2038. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital meningocele (less common)
    n1=en:white substance | n2=en:occipital meningocele (less common) | rel=r_associated | relid=0 | w=106
  2039. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital myelomeningocele (less common)
    n1=en:white substance | n2=en:occipital myelomeningocele (less common) | rel=r_associated | relid=0 | w=106
  2040. en:white substance -- r_associated #0: 106 / 0.876 -> en:occipital neural tube defects
    n1=en:white substance | n2=en:occipital neural tube defects | rel=r_associated | relid=0 | w=106
  2041. en:white substance -- r_associated #0: 106 / 0.876 -> en:occurs most often during the night or early morning
    n1=en:white substance | n2=en:occurs most often during the night or early morning | rel=r_associated | relid=0 | w=106
  2042. en:white substance -- r_associated #0: 106 / 0.876 -> en:ocular motility spared
    n1=en:white substance | n2=en:ocular motility spared | rel=r_associated | relid=0 | w=106
  2043. en:white substance -- r_associated #0: 106 / 0.876 -> en:ocular muscle abnormalities
    n1=en:white substance | n2=en:ocular muscle abnormalities | rel=r_associated | relid=0 | w=106
  2044. en:white substance -- r_associated #0: 106 / 0.876 -> en:ocular palsies
    n1=en:white substance | n2=en:ocular palsies | rel=r_associated | relid=0 | w=106
  2045. en:white substance -- r_associated #0: 106 / 0.876 -> en:oculogyric crisis
    n1=en:white substance | n2=en:oculogyric crisis | rel=r_associated | relid=0 | w=106
  2046. en:white substance -- r_associated #0: 106 / 0.876 -> en:oligodendrocytes with foamy cytoplasm
    n1=en:white substance | n2=en:oligodendrocytes with foamy cytoplasm | rel=r_associated | relid=0 | w=106
  2047. en:white substance -- r_associated #0: 106 / 0.876 -> en:olivopontocerebellar atrophy
    n1=en:white substance | n2=en:olivopontocerebellar atrophy | rel=r_associated | relid=0 | w=106
  2048. en:white substance -- r_associated #0: 106 / 0.876 -> en:olivopontocerebellar hypoplasia, fetal-onset
    n1=en:white substance | n2=en:olivopontocerebellar hypoplasia, fetal-onset | rel=r_associated | relid=0 | w=106
  2049. en:white substance -- r_associated #0: 106 / 0.876 -> en:olivopontocerebellar hypoplasia, severe
    n1=en:white substance | n2=en:olivopontocerebellar hypoplasia, severe | rel=r_associated | relid=0 | w=106
  2050. en:white substance -- r_associated #0: 106 / 0.876 -> en:only some achieve rolling or sitting
    n1=en:white substance | n2=en:only some achieve rolling or sitting | rel=r_associated | relid=0 | w=106
  2051. en:white substance -- r_associated #0: 106 / 0.876 -> en:only walking achieved
    n1=en:white substance | n2=en:only walking achieved | rel=r_associated | relid=0 | w=106
  2052. en:white substance -- r_associated #0: 106 / 0.876 -> en:opisthotonic posturing
    n1=en:white substance | n2=en:opisthotonic posturing | rel=r_associated | relid=0 | w=106
  2053. en:white substance -- r_associated #0: 106 / 0.876 -> en:opisthotonos (type ii)
    n1=en:white substance | n2=en:opisthotonos (type ii) | rel=r_associated | relid=0 | w=106
  2054. en:white substance -- r_associated #0: 106 / 0.876 -> en:opsoclonus
    n1=en:white substance | n2=en:opsoclonus | rel=r_associated | relid=0 | w=106
  2055. en:white substance -- r_associated #0: 106 / 0.876 -> en:optic nerve hypoplasia
    n1=en:white substance | n2=en:optic nerve hypoplasia | rel=r_associated | relid=0 | w=106
  2056. en:white substance -- r_associated #0: 106 / 0.876 -> en:optic tract and chiasm hypoplasia
    n1=en:white substance | n2=en:optic tract and chiasm hypoplasia | rel=r_associated | relid=0 | w=106
  2057. en:white substance -- r_associated #0: 106 / 0.876 -> en:organic writer's cramp
    n1=en:white substance | n2=en:organic writer's cramp | rel=r_associated | relid=0 | w=106
  2058. en:white substance -- r_associated #0: 106 / 0.876 -> en:orofacial dyspraxia, linguistic and nonlinguistic
    n1=en:white substance | n2=en:orofacial dyspraxia, linguistic and nonlinguistic | rel=r_associated | relid=0 | w=106
  2059. en:white substance -- r_associated #0: 106 / 0.876 -> en:other auras may occur
    n1=en:white substance | n2=en:other auras may occur | rel=r_associated | relid=0 | w=106
  2060. en:white substance -- r_associated #0: 106 / 0.876 -> en:other cranial nerves may be involved
    n1=en:white substance | n2=en:other cranial nerves may be involved | rel=r_associated | relid=0 | w=106
  2061. en:white substance -- r_associated #0: 106 / 0.876 -> en:other seizure types (in some patients)
    n1=en:white substance | n2=en:other seizure types (in some patients) | rel=r_associated | relid=0 | w=106
  2062. en:white substance -- r_associated #0: 106 / 0.876 -> en:over time, white matter vanishes and is replaced by csf
    n1=en:white substance | n2=en:over time, white matter vanishes and is replaced by csf | rel=r_associated | relid=0 | w=106
  2063. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria (1 patient)
    n1=en:white substance | n2=en:pachygyria (1 patient) | rel=r_associated | relid=0 | w=106
  2064. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria (less common)
    n1=en:white substance | n2=en:pachygyria (less common) | rel=r_associated | relid=0 | w=106
  2065. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria (posterior-to-anterior gradient)
    n1=en:white substance | n2=en:pachygyria (posterior-to-anterior gradient) | rel=r_associated | relid=0 | w=106
  2066. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria (rare)
    n1=en:white substance | n2=en:pachygyria (rare) | rel=r_associated | relid=0 | w=106
  2067. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria with preferential frontoparietal involvement (meb)
    n1=en:white substance | n2=en:pachygyria with preferential frontoparietal involvement (meb) | rel=r_associated | relid=0 | w=106
  2068. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria, most prominent in the frontal lobes
    n1=en:white substance | n2=en:pachygyria, most prominent in the frontal lobes | rel=r_associated | relid=0 | w=106
  2069. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria, occipital
    n1=en:white substance | n2=en:pachygyria, occipital | rel=r_associated | relid=0 | w=106
  2070. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyria, usually posterior
    n1=en:white substance | n2=en:pachygyria, usually posterior | rel=r_associated | relid=0 | w=106
  2071. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachygyrias
    n1=en:white substance | n2=en:pachygyrias | rel=r_associated | relid=0 | w=106
  2072. en:white substance -- r_associated #0: 106 / 0.876 -> en:pachymeningitis cervicalis (cervical cord compression due to thickened dura)
    n1=en:white substance | n2=en:pachymeningitis cervicalis (cervical cord compression due to thickened dura) | rel=r_associated | relid=0 | w=106
  2073. en:white substance -- r_associated #0: 106 / 0.876 -> en:pain (sharp, boring, drilling, piercing)
    n1=en:white substance | n2=en:pain (sharp, boring, drilling, piercing) | rel=r_associated | relid=0 | w=106
  2074. en:white substance -- r_associated #0: 106 / 0.876 -> en:palatal myoclonus
    n1=en:white substance | n2=en:palatal myoclonus | rel=r_associated | relid=0 | w=106
  2075. en:white substance -- r_associated #0: 106 / 0.876 -> en:pallor of dorsal columns of the spinal cord
    n1=en:white substance | n2=en:pallor of dorsal columns of the spinal cord | rel=r_associated | relid=0 | w=106
  2076. en:white substance -- r_associated #0: 106 / 0.876 -> en:paralysis
    n1=en:white substance | n2=en:paralysis | rel=r_associated | relid=0 | w=106
  2077. en:white substance -- r_associated #0: 106 / 0.876 -> en:paraparesis
    n1=en:white substance | n2=en:paraparesis | rel=r_associated | relid=0 | w=106
  2078. en:white substance -- r_associated #0: 106 / 0.876 -> en:paraplegia secondary to spinal cord compression due to severe kyphosis
    n1=en:white substance | n2=en:paraplegia secondary to spinal cord compression due to severe kyphosis | rel=r_associated | relid=0 | w=106
  2079. en:white substance -- r_associated #0: 106 / 0.876 -> en:paraventricular cysts
    n1=en:white substance | n2=en:paraventricular cysts | rel=r_associated | relid=0 | w=106
  2080. en:white substance -- r_associated #0: 106 / 0.876 -> en:parenchymal neuromelanosis
    n1=en:white substance | n2=en:parenchymal neuromelanosis | rel=r_associated | relid=0 | w=106
  2081. en:white substance -- r_associated #0: 106 / 0.876 -> en:paresis (hcp)
    n1=en:white substance | n2=en:paresis (hcp) | rel=r_associated | relid=0 | w=106
  2082. en:white substance -- r_associated #0: 106 / 0.876 -> en:paresis of extensor muscles of the big toe is presenting symptom
    n1=en:white substance | n2=en:paresis of extensor muscles of the big toe is presenting symptom | rel=r_associated | relid=0 | w=106
  2083. en:white substance -- r_associated #0: 106 / 0.876 -> en:paresthesia
    n1=en:white substance | n2=en:paresthesia | rel=r_associated | relid=0 | w=106
  2084. en:white substance -- r_associated #0: 106 / 0.876 -> en:parietal lobe
    n1=en:white substance | n2=en:parietal lobe | rel=r_associated | relid=0 | w=106
  2085. en:white substance -- r_associated #0: 106 / 0.876 -> en:parietal lobe epilepsy
    n1=en:white substance | n2=en:parietal lobe epilepsy | rel=r_associated | relid=0 | w=106
  2086. en:white substance -- r_associated #0: 106 / 0.876 -> en:parkinsonism
    n1=en:white substance | n2=en:parkinsonism | rel=r_associated | relid=0 | w=106
  2087. en:white substance -- r_associated #0: 106 / 0.876 -> en:parkinsonism (later onset)
    n1=en:white substance | n2=en:parkinsonism (later onset) | rel=r_associated | relid=0 | w=106
  2088. en:white substance -- r_associated #0: 106 / 0.876 -> en:parkinsonism (later)
    n1=en:white substance | n2=en:parkinsonism (later) | rel=r_associated | relid=0 | w=106
  2089. en:white substance -- r_associated #0: 106 / 0.876 -> en:parkinsonism, l-dopa responsive
    n1=en:white substance | n2=en:parkinsonism, l-dopa responsive | rel=r_associated | relid=0 | w=106
  2090. en:white substance -- r_associated #0: 106 / 0.876 -> en:parkinsonism, levodopa-responsive (occurs at later stages, may replace dystonia symptoms)
    n1=en:white substance | n2=en:parkinsonism, levodopa-responsive (occurs at later stages, may replace dystonia symptoms) | rel=r_associated | relid=0 | w=106
  2091. en:white substance -- r_associated #0: 106 / 0.876 -> en:paroxysmal dystonia
    n1=en:white substance | n2=en:paroxysmal dystonia | rel=r_associated | relid=0 | w=106
  2092. en:white substance -- r_associated #0: 106 / 0.876 -> en:paroxysmal lethargy
    n1=en:white substance | n2=en:paroxysmal lethargy | rel=r_associated | relid=0 | w=106
  2093. en:white substance -- r_associated #0: 106 / 0.876 -> en:paroxysmal nonkinesigenic dyskinesia
    n1=en:white substance | n2=en:paroxysmal nonkinesigenic dyskinesia | rel=r_associated | relid=0 | w=106
  2094. en:white substance -- r_associated #0: 106 / 0.876 -> en:paroxysmal oculogyric crises
    n1=en:white substance | n2=en:paroxysmal oculogyric crises | rel=r_associated | relid=0 | w=106
  2095. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial agenesis of the corpus callosum (in 1 of 2 sibs)
    n1=en:white substance | n2=en:partial agenesis of the corpus callosum (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=106
  2096. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial agenesis of the corpus callosum (rare)
    n1=en:white substance | n2=en:partial agenesis of the corpus callosum (rare) | rel=r_associated | relid=0 | w=106
  2097. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial empty sella turcica
    n1=en:white substance | n2=en:partial empty sella turcica | rel=r_associated | relid=0 | w=106
  2098. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial epilepsy
    n1=en:white substance | n2=en:partial epilepsy | rel=r_associated | relid=0 | w=106
  2099. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial or complete absence of the cerebellar vermis consistent with dandy walker malformation
    n1=en:white substance | n2=en:partial or complete absence of the cerebellar vermis consistent with dandy walker malformation | rel=r_associated | relid=0 | w=106
  2100. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial or total agenesis of the corpus callosum (33%)
    n1=en:white substance | n2=en:partial or total agenesis of the corpus callosum (33%) | rel=r_associated | relid=0 | w=106
  2101. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial pachygyria
    n1=en:white substance | n2=en:partial pachygyria | rel=r_associated | relid=0 | w=106
  2102. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial response to pyridoxine
    n1=en:white substance | n2=en:partial response to pyridoxine | rel=r_associated | relid=0 | w=106
  2103. en:white substance -- r_associated #0: 106 / 0.876 -> en:partial seizure
    n1=en:white substance | n2=en:partial seizure | rel=r_associated | relid=0 | w=106
  2104. en:white substance -- r_associated #0: 106 / 0.876 -> en:patchy demyelination of subcortical white matter
    n1=en:white substance | n2=en:patchy demyelination of subcortical white matter | rel=r_associated | relid=0 | w=106
  2105. en:white substance -- r_associated #0: 106 / 0.876 -> en:patchy diffuse hyperintensities on t2-weighted mri
    n1=en:white substance | n2=en:patchy diffuse hyperintensities on t2-weighted mri | rel=r_associated | relid=0 | w=106
  2106. en:white substance -- r_associated #0: 106 / 0.876 -> en:pathologic calcification, calcified structure
    n1=en:white substance | n2=en:pathologic calcification, calcified structure | rel=r_associated | relid=0 | w=106
  2107. en:white substance -- r_associated #0: 106 / 0.876 -> en:pathological aspects
    n1=en:white substance | n2=en:pathological aspects | rel=r_associated | relid=0 | w=106
  2108. en:white substance -- r_associated #0: 106 / 0.876 -> en:patients 20-30 years old have hyperintense lesions on t2-weighted mri in the frontal and anterior temporal lobes
    n1=en:white substance | n2=en:patients 20-30 years old have hyperintense lesions on t2-weighted mri in the frontal and anterior temporal lobes | rel=r_associated | relid=0 | w=106
  2109. en:white substance -- r_associated #0: 106 / 0.876 -> en:patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem
    n1=en:white substance | n2=en:patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem | rel=r_associated | relid=0 | w=106
  2110. en:white substance -- r_associated #0: 106 / 0.876 -> en:patients achieve ambulation
    n1=en:white substance | n2=en:patients achieve ambulation | rel=r_associated | relid=0 | w=106
  2111. en:white substance -- r_associated #0: 106 / 0.876 -> en:patients may only achieve sitting or walking
    n1=en:white substance | n2=en:patients may only achieve sitting or walking | rel=r_associated | relid=0 | w=106
  2112. en:white substance -- r_associated #0: 106 / 0.876 -> en:patients show normal psychomotor development
    n1=en:white substance | n2=en:patients show normal psychomotor development | rel=r_associated | relid=0 | w=106
  2113. en:white substance -- r_associated #0: 106 / 0.876 -> en:peak frequency of vomiting every 10 to 15 minutes
    n1=en:white substance | n2=en:peak frequency of vomiting every 10 to 15 minutes | rel=r_associated | relid=0 | w=106
  2114. en:white substance -- r_associated #0: 106 / 0.876 -> en:peculiar stance and sitting posture (if left untreated)
    n1=en:white substance | n2=en:peculiar stance and sitting posture (if left untreated) | rel=r_associated | relid=0 | w=106
  2115. en:white substance -- r_associated #0: 106 / 0.876 -> en:pericystic abnormal myelination
    n1=en:white substance | n2=en:pericystic abnormal myelination | rel=r_associated | relid=0 | w=106
  2116. en:white substance -- r_associated #0: 106 / 0.876 -> en:periodic paralysis (finding)
    n1=en:white substance | n2=en:periodic paralysis (finding) | rel=r_associated | relid=0 | w=106
  2117. en:white substance -- r_associated #0: 106 / 0.876 -> en:periodic paralysis, usually hypokalemic
    n1=en:white substance | n2=en:periodic paralysis, usually hypokalemic | rel=r_associated | relid=0 | w=106
  2118. en:white substance -- r_associated #0: 106 / 0.876 -> en:peripheral hypertonia
    n1=en:white substance | n2=en:peripheral hypertonia | rel=r_associated | relid=0 | w=106
  2119. en:white substance -- r_associated #0: 106 / 0.876 -> en:peripheral motor neuropathy
    n1=en:white substance | n2=en:peripheral motor neuropathy | rel=r_associated | relid=0 | w=106
  2120. en:white substance -- r_associated #0: 106 / 0.876 -> en:peripheral sensory neuropathy
    n1=en:white substance | n2=en:peripheral sensory neuropathy | rel=r_associated | relid=0 | w=106
  2121. en:white substance -- r_associated #0: 106 / 0.876 -> en:perivascular spaces
    n1=en:white substance | n2=en:perivascular spaces | rel=r_associated | relid=0 | w=106
  2122. en:white substance -- r_associated #0: 106 / 0.876 -> en:periventricular and subcortical white matter abnormalities
    n1=en:white substance | n2=en:periventricular and subcortical white matter abnormalities | rel=r_associated | relid=0 | w=106
  2123. en:white substance -- r_associated #0: 106 / 0.876 -> en:periventricular calcifications
    n1=en:white substance | n2=en:periventricular calcifications | rel=r_associated | relid=0 | w=106
  2124. en:white substance -- r_associated #0: 106 / 0.876 -> en:periventricular gray matter heterotopia
    n1=en:white substance | n2=en:periventricular gray matter heterotopia | rel=r_associated | relid=0 | w=106
  2125. en:white substance -- r_associated #0: 106 / 0.876 -> en:periventricular hemorrhagic infarction
    n1=en:white substance | n2=en:periventricular hemorrhagic infarction | rel=r_associated | relid=0 | w=106
  2126. en:white substance -- r_associated #0: 106 / 0.876 -> en:periventricular leukomalacia (reported in 2 patients)
    n1=en:white substance | n2=en:periventricular leukomalacia (reported in 2 patients) | rel=r_associated | relid=0 | w=106
  2127. en:white substance -- r_associated #0: 106 / 0.876 -> en:periventricular white matter changes
    n1=en:white substance | n2=en:periventricular white matter changes | rel=r_associated | relid=0 | w=106
  2128. en:white substance -- r_associated #0: 106 / 0.876 -> en:perseveration
    n1=en:white substance | n2=en:perseveration | rel=r_associated | relid=0 | w=106
  2129. en:white substance -- r_associated #0: 106 / 0.876 -> en:persistent cavus septum pellucidum
    n1=en:white substance | n2=en:persistent cavus septum pellucidum | rel=r_associated | relid=0 | w=106
  2130. en:white substance -- r_associated #0: 106 / 0.876 -> en:pharyngeal gag reflex negative
    n1=en:white substance | n2=en:pharyngeal gag reflex negative | rel=r_associated | relid=0 | w=106
  2131. en:white substance -- r_associated #0: 106 / 0.876 -> en:phonology deficits
    n1=en:white substance | n2=en:phonology deficits | rel=r_associated | relid=0 | w=106
  2132. en:white substance -- r_associated #0: 106 / 0.876 -> en:phonophobia
    n1=en:white substance | n2=en:phonophobia | rel=r_associated | relid=0 | w=106
  2133. en:white substance -- r_associated #0: 106 / 0.876 -> en:photophobia
    n1=en:white substance | n2=en:photophobia | rel=r_associated | relid=0 | w=106
  2134. en:white substance -- r_associated #0: 106 / 0.876 -> en:photosensitive tonic-clonic seizures
    n1=en:white substance | n2=en:photosensitive tonic-clonic seizures | rel=r_associated | relid=0 | w=106
  2135. en:white substance -- r_associated #0: 106 / 0.876 -> en:photosensitivity in one-third of patients
    n1=en:white substance | n2=en:photosensitivity in one-third of patients | rel=r_associated | relid=0 | w=106
  2136. en:white substance -- r_associated #0: 106 / 0.876 -> en:physiopathological
    n1=en:white substance | n2=en:physiopathological | rel=r_associated | relid=0 | w=106
  2137. en:white substance -- r_associated #0: 106 / 0.876 -> en:pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus
    n1=en:white substance | n2=en:pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus | rel=r_associated | relid=0 | w=106
  2138. en:white substance -- r_associated #0: 106 / 0.876 -> en:pigmentary loss in the substantia nigra
    n1=en:white substance | n2=en:pigmentary loss in the substantia nigra | rel=r_associated | relid=0 | w=106
  2139. en:white substance -- r_associated #0: 106 / 0.876 -> en:pineal gland
    n1=en:white substance | n2=en:pineal gland | rel=r_associated | relid=0 | w=106
  2140. en:white substance -- r_associated #0: 106 / 0.876 -> en:pineal hypertrophy
    n1=en:white substance | n2=en:pineal hypertrophy | rel=r_associated | relid=0 | w=106
  2141. en:white substance -- r_associated #0: 106 / 0.876 -> en:pituitary agenesis
    n1=en:white substance | n2=en:pituitary agenesis | rel=r_associated | relid=0 | w=106
  2142. en:white substance -- r_associated #0: 106 / 0.876 -> en:pituitary gland adenoma
    n1=en:white substance | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=106
  2143. en:white substance -- r_associated #0: 106 / 0.876 -> en:pituitary gland hypoplasia
    n1=en:white substance | n2=en:pituitary gland hypoplasia | rel=r_associated | relid=0 | w=106
  2144. en:white substance -- r_associated #0: 106 / 0.876 -> en:plaque, amyloid
    n1=en:white substance | n2=en:plaque, amyloid | rel=r_associated | relid=0 | w=106
  2145. en:white substance -- r_associated #0: 106 / 0.876 -> en:polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes
    n1=en:white substance | n2=en:polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes | rel=r_associated | relid=0 | w=106
  2146. en:white substance -- r_associated #0: 106 / 0.876 -> en:polygyria
    n1=en:white substance | n2=en:polygyria | rel=r_associated | relid=0 | w=106
  2147. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria (rare)
    n1=en:white substance | n2=en:polymicrogyria (rare) | rel=r_associated | relid=0 | w=106
  2148. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, anterior to posterior gradient
    n1=en:white substance | n2=en:polymicrogyria, anterior to posterior gradient | rel=r_associated | relid=0 | w=106
  2149. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, bilateral frontoparietal
    n1=en:white substance | n2=en:polymicrogyria, bilateral frontoparietal | rel=r_associated | relid=0 | w=106
  2150. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, diffuse, asymmetric
    n1=en:white substance | n2=en:polymicrogyria, diffuse, asymmetric | rel=r_associated | relid=0 | w=106
  2151. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, frontal
    n1=en:white substance | n2=en:polymicrogyria, frontal | rel=r_associated | relid=0 | w=106
  2152. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, most severe in the frontoparietal regions
    n1=en:white substance | n2=en:polymicrogyria, most severe in the frontoparietal regions | rel=r_associated | relid=0 | w=106
  2153. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, temporo-occipital
    n1=en:white substance | n2=en:polymicrogyria, temporo-occipital | rel=r_associated | relid=0 | w=106
  2154. en:white substance -- r_associated #0: 106 / 0.876 -> en:polymicrogyria, usually frontal (in some patients)
    n1=en:white substance | n2=en:polymicrogyria, usually frontal (in some patients) | rel=r_associated | relid=0 | w=106
  2155. en:white substance -- r_associated #0: 106 / 0.876 -> en:pontine atrophy
    n1=en:white substance | n2=en:pontine atrophy | rel=r_associated | relid=0 | w=106
  2156. en:white substance -- r_associated #0: 106 / 0.876 -> en:pontine dysraphia
    n1=en:white substance | n2=en:pontine dysraphia | rel=r_associated | relid=0 | w=106
  2157. en:white substance -- r_associated #0: 106 / 0.876 -> en:pontine hypoplasia (1 family)
    n1=en:white substance | n2=en:pontine hypoplasia (1 family) | rel=r_associated | relid=0 | w=106
  2158. en:white substance -- r_associated #0: 106 / 0.876 -> en:pontine hypoplasia, mild
    n1=en:white substance | n2=en:pontine hypoplasia, mild | rel=r_associated | relid=0 | w=106
  2159. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor adaptive skills
    n1=en:white substance | n2=en:poor adaptive skills | rel=r_associated | relid=0 | w=106
  2160. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor balance (finding)
    n1=en:white substance | n2=en:poor balance (finding) | rel=r_associated | relid=0 | w=106
  2161. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor concentration
    n1=en:white substance | n2=en:poor concentration | rel=r_associated | relid=0 | w=106
  2162. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor coordination
    n1=en:white substance | n2=en:poor coordination | rel=r_associated | relid=0 | w=106
  2163. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor coordination (83%)
    n1=en:white substance | n2=en:poor coordination (83%) | rel=r_associated | relid=0 | w=106
  2164. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor delineation of cerebral cortical regions
    n1=en:white substance | n2=en:poor delineation of cerebral cortical regions | rel=r_associated | relid=0 | w=106
  2165. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor eye contact
    n1=en:white substance | n2=en:poor eye contact | rel=r_associated | relid=0 | w=106
  2166. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor fine and gross motor coordination
    n1=en:white substance | n2=en:poor fine and gross motor coordination | rel=r_associated | relid=0 | w=106
  2167. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor fine motor coordination
    n1=en:white substance | n2=en:poor fine motor coordination | rel=r_associated | relid=0 | w=106
  2168. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor gross motor coordination
    n1=en:white substance | n2=en:poor gross motor coordination | rel=r_associated | relid=0 | w=106
  2169. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor language and speech development
    n1=en:white substance | n2=en:poor language and speech development | rel=r_associated | relid=0 | w=106
  2170. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor motor coordination
    n1=en:white substance | n2=en:poor motor coordination | rel=r_associated | relid=0 | w=106
  2171. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor neonatal suck and swallow reflexes
    n1=en:white substance | n2=en:poor neonatal suck and swallow reflexes | rel=r_associated | relid=0 | w=106
  2172. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor or absent independent walking
    n1=en:white substance | n2=en:poor or absent independent walking | rel=r_associated | relid=0 | w=106
  2173. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor or absent speech
    n1=en:white substance | n2=en:poor or absent speech | rel=r_associated | relid=0 | w=106
  2174. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor or absent speech acquisition
    n1=en:white substance | n2=en:poor or absent speech acquisition | rel=r_associated | relid=0 | w=106
  2175. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor responsiveness
    n1=en:white substance | n2=en:poor responsiveness | rel=r_associated | relid=0 | w=106
  2176. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor spontaneous movements
    n1=en:white substance | n2=en:poor spontaneous movements | rel=r_associated | relid=0 | w=106
  2177. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor visual-spatial construction
    n1=en:white substance | n2=en:poor visual-spatial construction | rel=r_associated | relid=0 | w=106
  2178. en:white substance -- r_associated #0: 106 / 0.876 -> en:poor-absent neurologic development
    n1=en:white substance | n2=en:poor-absent neurologic development | rel=r_associated | relid=0 | w=106
  2179. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior column
    n1=en:white substance | n2=en:posterior column | rel=r_associated | relid=0 | w=106
  2180. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior column degeneration
    n1=en:white substance | n2=en:posterior column degeneration | rel=r_associated | relid=0 | w=106
  2181. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior column sensory loss
    n1=en:white substance | n2=en:posterior column sensory loss | rel=r_associated | relid=0 | w=106
  2182. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior fossa compression syndrome
    n1=en:white substance | n2=en:posterior fossa compression syndrome | rel=r_associated | relid=0 | w=106
  2183. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior fossa crowding, progressive
    n1=en:white substance | n2=en:posterior fossa crowding, progressive | rel=r_associated | relid=0 | w=106
  2184. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior fossa cyst
    n1=en:white substance | n2=en:posterior fossa cyst | rel=r_associated | relid=0 | w=106
  2185. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior fossa cyst (in 1 of 2 patients)
    n1=en:white substance | n2=en:posterior fossa cyst (in 1 of 2 patients) | rel=r_associated | relid=0 | w=106
  2186. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior fossa malformations
    n1=en:white substance | n2=en:posterior fossa malformations | rel=r_associated | relid=0 | w=106
  2187. en:white substance -- r_associated #0: 106 / 0.876 -> en:posterior pachygyria
    n1=en:white substance | n2=en:posterior pachygyria | rel=r_associated | relid=0 | w=106
  2188. en:white substance -- r_associated #0: 106 / 0.876 -> en:postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia)
    n1=en:white substance | n2=en:postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia) | rel=r_associated | relid=0 | w=106
  2189. en:white substance -- r_associated #0: 106 / 0.876 -> en:postural instability
    n1=en:white substance | n2=en:postural instability | rel=r_associated | relid=0 | w=106
  2190. en:white substance -- r_associated #0: 106 / 0.876 -> en:postural instability (63%)
    n1=en:white substance | n2=en:postural instability (63%) | rel=r_associated | relid=0 | w=106
  2191. en:white substance -- r_associated #0: 106 / 0.876 -> en:postural tremor (later onset, spreads to all limbs and neck)
    n1=en:white substance | n2=en:postural tremor (later onset, spreads to all limbs and neck) | rel=r_associated | relid=0 | w=106
  2192. en:white substance -- r_associated #0: 106 / 0.876 -> en:postural tremor, slow, irregular (in some patients)
    n1=en:white substance | n2=en:postural tremor, slow, irregular (in some patients) | rel=r_associated | relid=0 | w=106
  2193. en:white substance -- r_associated #0: 106 / 0.876 -> en:pre-senile dementia
    n1=en:white substance | n2=en:pre-senile dementia | rel=r_associated | relid=0 | w=106
  2194. en:white substance -- r_associated #0: 106 / 0.876 -> en:premature stroke
    n1=en:white substance | n2=en:premature stroke | rel=r_associated | relid=0 | w=106
  2195. en:white substance -- r_associated #0: 106 / 0.876 -> en:primarily affects distal lower limbs
    n1=en:white substance | n2=en:primarily affects distal lower limbs | rel=r_associated | relid=0 | w=106
  2196. en:white substance -- r_associated #0: 106 / 0.876 -> en:primitive reflexes (in some patients)
    n1=en:white substance | n2=en:primitive reflexes (in some patients) | rel=r_associated | relid=0 | w=106
  2197. en:white substance -- r_associated #0: 106 / 0.876 -> en:primitive sylvian fissures
    n1=en:white substance | n2=en:primitive sylvian fissures | rel=r_associated | relid=0 | w=106
  2198. en:white substance -- r_associated #0: 106 / 0.876 -> en:prion protein-positive senile plaques
    n1=en:white substance | n2=en:prion protein-positive senile plaques | rel=r_associated | relid=0 | w=106
  2199. en:white substance -- r_associated #0: 106 / 0.876 -> en:prnp-immunoreactive cerebral amyloid angiopathy (in some patients)
    n1=en:white substance | n2=en:prnp-immunoreactive cerebral amyloid angiopathy (in some patients) | rel=r_associated | relid=0 | w=106
  2200. en:white substance -- r_associated #0: 106 / 0.876 -> en:profound global developmental delay
    n1=en:white substance | n2=en:profound global developmental delay | rel=r_associated | relid=0 | w=106
  2201. en:white substance -- r_associated #0: 106 / 0.876 -> en:profound intellectual disabilities
    n1=en:white substance | n2=en:profound intellectual disabilities | rel=r_associated | relid=0 | w=106
  2202. en:white substance -- r_associated #0: 106 / 0.876 -> en:progression to paralysis and atrophy of distal lower limb muscles
    n1=en:white substance | n2=en:progression to paralysis and atrophy of distal lower limb muscles | rel=r_associated | relid=0 | w=106
  2203. en:white substance -- r_associated #0: 106 / 0.876 -> en:progression to tetraplegia and decerebrate state
    n1=en:white substance | n2=en:progression to tetraplegia and decerebrate state | rel=r_associated | relid=0 | w=106
  2204. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive ataxia (onset second year of life)
    n1=en:white substance | n2=en:progressive ataxia (onset second year of life) | rel=r_associated | relid=0 | w=106
  2205. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive bulbar palsy
    n1=en:white substance | n2=en:progressive bulbar palsy | rel=r_associated | relid=0 | w=106
  2206. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive cerebellar degeneration
    n1=en:white substance | n2=en:progressive cerebellar degeneration | rel=r_associated | relid=0 | w=106
  2207. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive choreoathetosis
    n1=en:white substance | n2=en:progressive choreoathetosis | rel=r_associated | relid=0 | w=106
  2208. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive cns degeneration
    n1=en:white substance | n2=en:progressive cns degeneration | rel=r_associated | relid=0 | w=106
  2209. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive cognitive decline following normal development in childhood (in some patients)
    n1=en:white substance | n2=en:progressive cognitive decline following normal development in childhood (in some patients) | rel=r_associated | relid=0 | w=106
  2210. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive gait ataxia
    n1=en:white substance | n2=en:progressive gait ataxia | rel=r_associated | relid=0 | w=106
  2211. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive inability to walk
    n1=en:white substance | n2=en:progressive inability to walk | rel=r_associated | relid=0 | w=106
  2212. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive intellectual decline
    n1=en:white substance | n2=en:progressive intellectual decline | rel=r_associated | relid=0 | w=106
  2213. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive language deterioration
    n1=en:white substance | n2=en:progressive language deterioration | rel=r_associated | relid=0 | w=106
  2214. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive neurologic deterioration
    n1=en:white substance | n2=en:progressive neurologic deterioration | rel=r_associated | relid=0 | w=106
  2215. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive spastic diplegia to quadriplegia
    n1=en:white substance | n2=en:progressive spastic diplegia to quadriplegia | rel=r_associated | relid=0 | w=106
  2216. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive spastic paraplegia
    n1=en:white substance | n2=en:progressive spastic paraplegia | rel=r_associated | relid=0 | w=106
  2217. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive spastic quadriplegia
    n1=en:white substance | n2=en:progressive spastic quadriplegia | rel=r_associated | relid=0 | w=106
  2218. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive spasticity
    n1=en:white substance | n2=en:progressive spasticity | rel=r_associated | relid=0 | w=106
  2219. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive truncal ataxia
    n1=en:white substance | n2=en:progressive truncal ataxia | rel=r_associated | relid=0 | w=106
  2220. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive ventriculomegaly
    n1=en:white substance | n2=en:progressive ventriculomegaly | rel=r_associated | relid=0 | w=106
  2221. en:white substance -- r_associated #0: 106 / 0.876 -> en:progressive, symmetric degeneration of the caudate and putamen
    n1=en:white substance | n2=en:progressive, symmetric degeneration of the caudate and putamen | rel=r_associated | relid=0 | w=106
  2222. en:white substance -- r_associated #0: 106 / 0.876 -> en:prolonged seizure
    n1=en:white substance | n2=en:prolonged seizure | rel=r_associated | relid=0 | w=106
  2223. en:white substance -- r_associated #0: 106 / 0.876 -> en:prolonged somatosensory evoked potentials (seps)
    n1=en:white substance | n2=en:prolonged somatosensory evoked potentials (seps) | rel=r_associated | relid=0 | w=106
  2224. en:white substance -- r_associated #0: 106 / 0.876 -> en:prominent perivascular spaces
    n1=en:white substance | n2=en:prominent perivascular spaces | rel=r_associated | relid=0 | w=106
  2225. en:white substance -- r_associated #0: 106 / 0.876 -> en:prominent sulci
    n1=en:white substance | n2=en:prominent sulci | rel=r_associated | relid=0 | w=106
  2226. en:white substance -- r_associated #0: 106 / 0.876 -> en:prominent ventricles (in some patients)
    n1=en:white substance | n2=en:prominent ventricles (in some patients) | rel=r_associated | relid=0 | w=106
  2227. en:white substance -- r_associated #0: 106 / 0.876 -> en:proximal limb muscle stiffness
    n1=en:white substance | n2=en:proximal limb muscle stiffness | rel=r_associated | relid=0 | w=106
  2228. en:white substance -- r_associated #0: 106 / 0.876 -> en:proximal muscle weakness in lower limbs
    n1=en:white substance | n2=en:proximal muscle weakness in lower limbs | rel=r_associated | relid=0 | w=106
  2229. en:white substance -- r_associated #0: 106 / 0.876 -> en:proximal weakness occurs first
    n1=en:white substance | n2=en:proximal weakness occurs first | rel=r_associated | relid=0 | w=106
  2230. en:white substance -- r_associated #0: 106 / 0.876 -> en:prp immunoreactivity limited to cerebellum and putamen
    n1=en:white substance | n2=en:prp immunoreactivity limited to cerebellum and putamen | rel=r_associated | relid=0 | w=106
  2231. en:white substance -- r_associated #0: 106 / 0.876 -> en:pseudobulbar palsy
    n1=en:white substance | n2=en:pseudobulbar palsy | rel=r_associated | relid=0 | w=106
  2232. en:white substance -- r_associated #0: 106 / 0.876 -> en:pseudobulbar palsy (e.g. involuntary weeping or laughter)
    n1=en:white substance | n2=en:pseudobulbar palsy (e.g. involuntary weeping or laughter) | rel=r_associated | relid=0 | w=106
  2233. en:white substance -- r_associated #0: 106 / 0.876 -> en:pseudobulbar signs
    n1=en:white substance | n2=en:pseudobulbar signs | rel=r_associated | relid=0 | w=106
  2234. en:white substance -- r_associated #0: 106 / 0.876 -> en:pseudolaminar spongiform changes
    n1=en:white substance | n2=en:pseudolaminar spongiform changes | rel=r_associated | relid=0 | w=106
  2235. en:white substance -- r_associated #0: 106 / 0.876 -> en:pseudotumor
    n1=en:white substance | n2=en:pseudotumor | rel=r_associated | relid=0 | w=106
  2236. en:white substance -- r_associated #0: 106 / 0.876 -> en:pseudotumor cerebri
    n1=en:white substance | n2=en:pseudotumor cerebri | rel=r_associated | relid=0 | w=106
  2237. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychiatric disorder
    n1=en:white substance | n2=en:psychiatric disorder | rel=r_associated | relid=0 | w=106
  2238. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychiatric symptoms (delusions, hallucinations)
    n1=en:white substance | n2=en:psychiatric symptoms (delusions, hallucinations) | rel=r_associated | relid=0 | w=106
  2239. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor delay (evident at 3 months)
    n1=en:white substance | n2=en:psychomotor delay (evident at 3 months) | rel=r_associated | relid=0 | w=106
  2240. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor delay (in one family)
    n1=en:white substance | n2=en:psychomotor delay (in one family) | rel=r_associated | relid=0 | w=106
  2241. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor delay, severe
    n1=en:white substance | n2=en:psychomotor delay, severe | rel=r_associated | relid=0 | w=106
  2242. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor deterioration (classical form)
    n1=en:white substance | n2=en:psychomotor deterioration (classical form) | rel=r_associated | relid=0 | w=106
  2243. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor impairments
    n1=en:white substance | n2=en:psychomotor impairments | rel=r_associated | relid=0 | w=106
  2244. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression
    n1=en:white substance | n2=en:psychomotor regression | rel=r_associated | relid=0 | w=106
  2245. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression (in milder cases)
    n1=en:white substance | n2=en:psychomotor regression (in milder cases) | rel=r_associated | relid=0 | w=106
  2246. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression (onset within first year of life)
    n1=en:white substance | n2=en:psychomotor regression (onset within first year of life) | rel=r_associated | relid=0 | w=106
  2247. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression in infants
    n1=en:white substance | n2=en:psychomotor regression in infants | rel=r_associated | relid=0 | w=106
  2248. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression may occur
    n1=en:white substance | n2=en:psychomotor regression may occur | rel=r_associated | relid=0 | w=106
  2249. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression, episodic, often associated with common childhood infections
    n1=en:white substance | n2=en:psychomotor regression, episodic, often associated with common childhood infections | rel=r_associated | relid=0 | w=106
  2250. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor regression, progressive
    n1=en:white substance | n2=en:psychomotor regression, progressive | rel=r_associated | relid=0 | w=106
  2251. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation
    n1=en:white substance | n2=en:psychomotor retardation | rel=r_associated | relid=0 | w=106
  2252. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation (2/4 patients)
    n1=en:white substance | n2=en:psychomotor retardation (2/4 patients) | rel=r_associated | relid=0 | w=106
  2253. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation in those that survive
    n1=en:white substance | n2=en:psychomotor retardation in those that survive | rel=r_associated | relid=0 | w=106
  2254. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation, mild to moderate
    n1=en:white substance | n2=en:psychomotor retardation, mild to moderate | rel=r_associated | relid=0 | w=106
  2255. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation, moderate
    n1=en:white substance | n2=en:psychomotor retardation, moderate | rel=r_associated | relid=0 | w=106
  2256. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation, profound, in those who survive
    n1=en:white substance | n2=en:psychomotor retardation, profound, in those who survive | rel=r_associated | relid=0 | w=106
  2257. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation, severe to profound
    n1=en:white substance | n2=en:psychomotor retardation, severe to profound | rel=r_associated | relid=0 | w=106
  2258. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychomotor retardation, variable
    n1=en:white substance | n2=en:psychomotor retardation, variable | rel=r_associated | relid=0 | w=106
  2259. en:white substance -- r_associated #0: 106 / 0.876 -> en:psychosis
    n1=en:white substance | n2=en:psychosis | rel=r_associated | relid=0 | w=106
  2260. en:white substance -- r_associated #0: 106 / 0.876 -> en:pulsating quality
    n1=en:white substance | n2=en:pulsating quality | rel=r_associated | relid=0 | w=106
  2261. en:white substance -- r_associated #0: 106 / 0.876 -> en:purposeless movements (if left untreated)
    n1=en:white substance | n2=en:purposeless movements (if left untreated) | rel=r_associated | relid=0 | w=106
  2262. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal features (rare)
    n1=en:white substance | n2=en:pyramidal features (rare) | rel=r_associated | relid=0 | w=106
  2263. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal hypertonia
    n1=en:white substance | n2=en:pyramidal hypertonia | rel=r_associated | relid=0 | w=106
  2264. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal sign
    n1=en:white substance | n2=en:pyramidal sign | rel=r_associated | relid=0 | w=106
  2265. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal signs (21% of patients)
    n1=en:white substance | n2=en:pyramidal signs (21% of patients) | rel=r_associated | relid=0 | w=106
  2266. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal signs (in some patients)
    n1=en:white substance | n2=en:pyramidal signs (in some patients) | rel=r_associated | relid=0 | w=106
  2267. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal signs (in some)
    n1=en:white substance | n2=en:pyramidal signs (in some) | rel=r_associated | relid=0 | w=106
  2268. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal signs (less common)
    n1=en:white substance | n2=en:pyramidal signs (less common) | rel=r_associated | relid=0 | w=106
  2269. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal signs, mild
    n1=en:white substance | n2=en:pyramidal signs, mild | rel=r_associated | relid=0 | w=106
  2270. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal signs, mild (uncommon)
    n1=en:white substance | n2=en:pyramidal signs, mild (uncommon) | rel=r_associated | relid=0 | w=106
  2271. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal syndrome of the lower limbs
    n1=en:white substance | n2=en:pyramidal syndrome of the lower limbs | rel=r_associated | relid=0 | w=106
  2272. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal system
    n1=en:white substance | n2=en:pyramidal system | rel=r_associated | relid=0 | w=106
  2273. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal tetraparesis
    n1=en:white substance | n2=en:pyramidal tetraparesis | rel=r_associated | relid=0 | w=106
  2274. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal tract dysfunction (juvenile-onset, less common)
    n1=en:white substance | n2=en:pyramidal tract dysfunction (juvenile-onset, less common) | rel=r_associated | relid=0 | w=106
  2275. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal tract involvement
    n1=en:white substance | n2=en:pyramidal tract involvement | rel=r_associated | relid=0 | w=106
  2276. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal tract signs (in some patients)
    n1=en:white substance | n2=en:pyramidal tract signs (in some patients) | rel=r_associated | relid=0 | w=106
  2277. en:white substance -- r_associated #0: 106 / 0.876 -> en:pyramidal tracts
    n1=en:white substance | n2=en:pyramidal tracts | rel=r_associated | relid=0 | w=106
  2278. en:white substance -- r_associated #0: 106 / 0.876 -> en:quadriplegia
    n1=en:white substance | n2=en:quadriplegia | rel=r_associated | relid=0 | w=106
  2279. en:white substance -- r_associated #0: 106 / 0.876 -> en:quadriplegia, episodic
    n1=en:white substance | n2=en:quadriplegia, episodic | rel=r_associated | relid=0 | w=106
  2280. en:white substance -- r_associated #0: 106 / 0.876 -> en:quadriplegic dyskinesia
    n1=en:white substance | n2=en:quadriplegic dyskinesia | rel=r_associated | relid=0 | w=106
  2281. en:white substance -- r_associated #0: 106 / 0.876 -> en:quadrupedal gait
    n1=en:white substance | n2=en:quadrupedal gait | rel=r_associated | relid=0 | w=106
  2282. en:white substance -- r_associated #0: 106 / 0.876 -> en:quadrupedal gait (in some)
    n1=en:white substance | n2=en:quadrupedal gait (in some) | rel=r_associated | relid=0 | w=106
  2283. en:white substance -- r_associated #0: 106 / 0.876 -> en:rapid complete resolution of symptoms
    n1=en:white substance | n2=en:rapid complete resolution of symptoms | rel=r_associated | relid=0 | w=106
  2284. en:white substance -- r_associated #0: 106 / 0.876 -> en:rapid initial onset of symptoms (hours to weeks)
    n1=en:white substance | n2=en:rapid initial onset of symptoms (hours to weeks) | rel=r_associated | relid=0 | w=106
  2285. en:white substance -- r_associated #0: 106 / 0.876 -> en:rapid onset
    n1=en:white substance | n2=en:rapid onset | rel=r_associated | relid=0 | w=106
  2286. en:white substance -- r_associated #0: 106 / 0.876 -> en:rapid regression
    n1=en:white substance | n2=en:rapid regression | rel=r_associated | relid=0 | w=106
  2287. en:white substance -- r_associated #0: 106 / 0.876 -> en:rapid, jerky movements
    n1=en:white substance | n2=en:rapid, jerky movements | rel=r_associated | relid=0 | w=106
  2288. en:white substance -- r_associated #0: 106 / 0.876 -> en:rapidly progressive brainstem degeneration
    n1=en:white substance | n2=en:rapidly progressive brainstem degeneration | rel=r_associated | relid=0 | w=106
  2289. en:white substance -- r_associated #0: 106 / 0.876 -> en:rare secondary generalization
    n1=en:white substance | n2=en:rare secondary generalization | rel=r_associated | relid=0 | w=106
  2290. en:white substance -- r_associated #0: 106 / 0.876 -> en:recurrent encephalopathy
    n1=en:white substance | n2=en:recurrent encephalopathy | rel=r_associated | relid=0 | w=106
  2291. en:white substance -- r_associated #0: 106 / 0.876 -> en:recurrent meningitis
    n1=en:white substance | n2=en:recurrent meningitis | rel=r_associated | relid=0 | w=106
  2292. en:white substance -- r_associated #0: 106 / 0.876 -> en:recurrent seizures nos
    n1=en:white substance | n2=en:recurrent seizures nos | rel=r_associated | relid=0 | w=106
  2293. en:white substance -- r_associated #0: 106 / 0.876 -> en:recurrent subcortical infarcts (strokes)
    n1=en:white substance | n2=en:recurrent subcortical infarcts (strokes) | rel=r_associated | relid=0 | w=106
  2294. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced brain gyri
    n1=en:white substance | n2=en:reduced brain gyri | rel=r_associated | relid=0 | w=106
  2295. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced brain size
    n1=en:white substance | n2=en:reduced brain size | rel=r_associated | relid=0 | w=106
  2296. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced consciousness
    n1=en:white substance | n2=en:reduced consciousness | rel=r_associated | relid=0 | w=106
  2297. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced consciousness, hypoglycemia-related
    n1=en:white substance | n2=en:reduced consciousness, hypoglycemia-related | rel=r_associated | relid=0 | w=106
  2298. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced numbers of neurons
    n1=en:white substance | n2=en:reduced numbers of neurons | rel=r_associated | relid=0 | w=106
  2299. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced posterior white matter volume (in some patients)
    n1=en:white substance | n2=en:reduced posterior white matter volume (in some patients) | rel=r_associated | relid=0 | w=106
  2300. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced size of the pituitary gland
    n1=en:white substance | n2=en:reduced size of the pituitary gland | rel=r_associated | relid=0 | w=106
  2301. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced tendon reflexes
    n1=en:white substance | n2=en:reduced tendon reflexes | rel=r_associated | relid=0 | w=106
  2302. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced white matter
    n1=en:white substance | n2=en:reduced white matter | rel=r_associated | relid=0 | w=106
  2303. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduced white matter volume
    n1=en:white substance | n2=en:reduced white matter volume | rel=r_associated | relid=0 | w=106
  2304. en:white substance -- r_associated #0: 106 / 0.876 -> en:reduction or loss of acquired skills (e.g., purposeful hand use, speech)
    n1=en:white substance | n2=en:reduction or loss of acquired skills (e.g., purposeful hand use, speech) | rel=r_associated | relid=0 | w=106
  2305. en:white substance -- r_associated #0: 106 / 0.876 -> en:region of cell part cluster of neuraxis
    n1=en:white substance | n2=en:region of cell part cluster of neuraxis | rel=r_associated | relid=0 | w=106
  2306. en:white substance -- r_associated #0: 106 / 0.876 -> en:region of gray matter of neuraxis
    n1=en:white substance | n2=en:region of gray matter of neuraxis | rel=r_associated | relid=0 | w=106
  2307. en:white substance -- r_associated #0: 106 / 0.876 -> en:regression of early motor skills
    n1=en:white substance | n2=en:regression of early motor skills | rel=r_associated | relid=0 | w=106
  2308. en:white substance -- r_associated #0: 106 / 0.876 -> en:regression of motor development
    n1=en:white substance | n2=en:regression of motor development | rel=r_associated | relid=0 | w=106
  2309. en:white substance -- r_associated #0: 106 / 0.876 -> en:relative preservation of purkinje cells, but they are deformed and disaligned
    n1=en:white substance | n2=en:relative preservation of purkinje cells, but they are deformed and disaligned | rel=r_associated | relid=0 | w=106
  2310. en:white substance -- r_associated #0: 106 / 0.876 -> en:relative preservation of the cerebellum
    n1=en:white substance | n2=en:relative preservation of the cerebellum | rel=r_associated | relid=0 | w=106
  2311. en:white substance -- r_associated #0: 106 / 0.876 -> en:relative sparing of language
    n1=en:white substance | n2=en:relative sparing of language | rel=r_associated | relid=0 | w=106
  2312. en:white substance -- r_associated #0: 106 / 0.876 -> en:renal medulla
    n1=en:white substance | n2=en:renal medulla | rel=r_associated | relid=0 | w=106
  2313. en:white substance -- r_associated #0: 106 / 0.876 -> en:response to pyridoxal phosphate
    n1=en:white substance | n2=en:response to pyridoxal phosphate | rel=r_associated | relid=0 | w=106
  2314. en:white substance -- r_associated #0: 106 / 0.876 -> en:resting myoclonus
    n1=en:white substance | n2=en:resting myoclonus | rel=r_associated | relid=0 | w=106
  2315. en:white substance -- r_associated #0: 106 / 0.876 -> en:restrictive behavior, interests, and activities
    n1=en:white substance | n2=en:restrictive behavior, interests, and activities | rel=r_associated | relid=0 | w=106
  2316. en:white substance -- r_associated #0: 106 / 0.876 -> en:results in nocturnal insomnia and chronic sleep deprivation
    n1=en:white substance | n2=en:results in nocturnal insomnia and chronic sleep deprivation | rel=r_associated | relid=0 | w=106
  2317. en:white substance -- r_associated #0: 106 / 0.876 -> en:retrocerebellar cyst (rare)
    n1=en:white substance | n2=en:retrocerebellar cyst (rare) | rel=r_associated | relid=0 | w=106
  2318. en:white substance -- r_associated #0: 106 / 0.876 -> en:reversal sign
    n1=en:white substance | n2=en:reversal sign | rel=r_associated | relid=0 | w=106
  2319. en:white substance -- r_associated #0: 106 / 0.876 -> en:reye syndrome
    n1=en:white substance | n2=en:reye syndrome | rel=r_associated | relid=0 | w=106
  2320. en:white substance -- r_associated #0: 106 / 0.876 -> en:rhombencephalosynapsis
    n1=en:white substance | n2=en:rhombencephalosynapsis | rel=r_associated | relid=0 | w=106
  2321. en:white substance -- r_associated #0: 106 / 0.876 -> en:rigidity (juvenile form)
    n1=en:white substance | n2=en:rigidity (juvenile form) | rel=r_associated | relid=0 | w=106
  2322. en:white substance -- r_associated #0: 106 / 0.876 -> en:rigidity of limbs
    n1=en:white substance | n2=en:rigidity of limbs | rel=r_associated | relid=0 | w=106
  2323. en:white substance -- r_associated #0: 106 / 0.876 -> en:rigidity, axial and limb
    n1=en:white substance | n2=en:rigidity, axial and limb | rel=r_associated | relid=0 | w=106
  2324. en:white substance -- r_associated #0: 106 / 0.876 -> en:sagittal sinus thrombosis
    n1=en:white substance | n2=en:sagittal sinus thrombosis | rel=r_associated | relid=0 | w=106
  2325. en:white substance -- r_associated #0: 106 / 0.876 -> en:salaam seizures
    n1=en:white substance | n2=en:salaam seizures | rel=r_associated | relid=0 | w=106
  2326. en:white substance -- r_associated #0: 106 / 0.876 -> en:scanning speech
    n1=en:white substance | n2=en:scanning speech | rel=r_associated | relid=0 | w=106
  2327. en:white substance -- r_associated #0: 106 / 0.876 -> en:scant iron deposition in the brain (1 family)
    n1=en:white substance | n2=en:scant iron deposition in the brain (1 family) | rel=r_associated | relid=0 | w=106
  2328. en:white substance -- r_associated #0: 106 / 0.876 -> en:scattered cns demyelination
    n1=en:white substance | n2=en:scattered cns demyelination | rel=r_associated | relid=0 | w=106
  2329. en:white substance -- r_associated #0: 106 / 0.876 -> en:schizencephaly
    n1=en:white substance | n2=en:schizencephaly | rel=r_associated | relid=0 | w=106
  2330. en:white substance -- r_associated #0: 106 / 0.876 -> en:schizophrenic reaction
    n1=en:white substance | n2=en:schizophrenic reaction | rel=r_associated | relid=0 | w=106
  2331. en:white substance -- r_associated #0: 106 / 0.876 -> en:school problem (finding)
    n1=en:white substance | n2=en:school problem (finding) | rel=r_associated | relid=0 | w=106
  2332. en:white substance -- r_associated #0: 106 / 0.876 -> en:scissoring
    n1=en:white substance | n2=en:scissoring | rel=r_associated | relid=0 | w=106
  2333. en:white substance -- r_associated #0: 106 / 0.876 -> en:secondary generalization may occur
    n1=en:white substance | n2=en:secondary generalization may occur | rel=r_associated | relid=0 | w=106
  2334. en:white substance -- r_associated #0: 106 / 0.876 -> en:secondary generalization occurs in about 33% of patients
    n1=en:white substance | n2=en:secondary generalization occurs in about 33% of patients | rel=r_associated | relid=0 | w=106
  2335. en:white substance -- r_associated #0: 106 / 0.876 -> en:secondary hypertonia
    n1=en:white substance | n2=en:secondary hypertonia | rel=r_associated | relid=0 | w=106
  2336. en:white substance -- r_associated #0: 106 / 0.876 -> en:secondary involvement of proximal and trunk muscles
    n1=en:white substance | n2=en:secondary involvement of proximal and trunk muscles | rel=r_associated | relid=0 | w=106
  2337. en:white substance -- r_associated #0: 106 / 0.876 -> en:secondary motor complications develop in 50% of those on levodopa therapy
    n1=en:white substance | n2=en:secondary motor complications develop in 50% of those on levodopa therapy | rel=r_associated | relid=0 | w=106
  2338. en:white substance -- r_associated #0: 106 / 0.876 -> en:secondary seizures (in some patients)
    n1=en:white substance | n2=en:secondary seizures (in some patients) | rel=r_associated | relid=0 | w=106
  2339. en:white substance -- r_associated #0: 106 / 0.876 -> en:see juvenile myoclonic epilepsy (606904)
    n1=en:white substance | n2=en:see juvenile myoclonic epilepsy (606904) | rel=r_associated | relid=0 | w=106
  2340. en:white substance -- r_associated #0: 106 / 0.876 -> en:see spg5a (270800)
    n1=en:white substance | n2=en:see spg5a (270800) | rel=r_associated | relid=0 | w=106
  2341. en:white substance -- r_associated #0: 106 / 0.876 -> en:segment of metencephalon
    n1=en:white substance | n2=en:segment of metencephalon | rel=r_associated | relid=0 | w=106
  2342. en:white substance -- r_associated #0: 106 / 0.876 -> en:segment of spinal cord
    n1=en:white substance | n2=en:segment of spinal cord | rel=r_associated | relid=0 | w=106
  2343. en:white substance -- r_associated #0: 106 / 0.876 -> en:segmental sensory loss, especially of pain and temperature
    n1=en:white substance | n2=en:segmental sensory loss, especially of pain and temperature | rel=r_associated | relid=0 | w=106
  2344. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizure
    n1=en:white substance | n2=en:seizure | rel=r_associated | relid=0 | w=106
  2345. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizure disorder
    n1=en:white substance | n2=en:seizure disorder | rel=r_associated | relid=0 | w=106
  2346. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizure disorder (homozygote)
    n1=en:white substance | n2=en:seizure disorder (homozygote) | rel=r_associated | relid=0 | w=106
  2347. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizure including seizure-like activity in utero starting around 18 weeks gestation
    n1=en:white substance | n2=en:seizure including seizure-like activity in utero starting around 18 weeks gestation | rel=r_associated | relid=0 | w=106
  2348. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizure, febrile (2/3 children)
    n1=en:white substance | n2=en:seizure, febrile (2/3 children) | rel=r_associated | relid=0 | w=106
  2349. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizure, focal or multifocal onset
    n1=en:white substance | n2=en:seizure, focal or multifocal onset | rel=r_associated | relid=0 | w=106
  2350. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (> 90%)
    n1=en:white substance | n2=en:seizures (> 90%) | rel=r_associated | relid=0 | w=106
  2351. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (1 patient)
    n1=en:white substance | n2=en:seizures (1 patient) | rel=r_associated | relid=0 | w=106
  2352. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (50% of patients)
    n1=en:white substance | n2=en:seizures (50% of patients) | rel=r_associated | relid=0 | w=106
  2353. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (about 50% of patients)
    n1=en:white substance | n2=en:seizures (about 50% of patients) | rel=r_associated | relid=0 | w=106
  2354. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (adult)
    n1=en:white substance | n2=en:seizures (adult) | rel=r_associated | relid=0 | w=106
  2355. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (eclampsia)
    n1=en:white substance | n2=en:seizures (eclampsia) | rel=r_associated | relid=0 | w=106
  2356. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (if left untreated)
    n1=en:white substance | n2=en:seizures (if left untreated) | rel=r_associated | relid=0 | w=106
  2357. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (in 1 of 2 sibs)
    n1=en:white substance | n2=en:seizures (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=106
  2358. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (in 1 of 3 patients)
    n1=en:white substance | n2=en:seizures (in 1 of 3 patients) | rel=r_associated | relid=0 | w=106
  2359. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (in 2 of 9 patients)
    n1=en:white substance | n2=en:seizures (in 2 of 9 patients) | rel=r_associated | relid=0 | w=106
  2360. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (in 35%)
    n1=en:white substance | n2=en:seizures (in 35%) | rel=r_associated | relid=0 | w=106
  2361. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (in some patients)
    n1=en:white substance | n2=en:seizures (in some patients) | rel=r_associated | relid=0 | w=106
  2362. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (juvenile form)
    n1=en:white substance | n2=en:seizures (juvenile form) | rel=r_associated | relid=0 | w=106
  2363. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (less common)
    n1=en:white substance | n2=en:seizures (less common) | rel=r_associated | relid=0 | w=106
  2364. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (may be difficult to control)
    n1=en:white substance | n2=en:seizures (may be difficult to control) | rel=r_associated | relid=0 | w=106
  2365. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (mean onset 4-5 months)
    n1=en:white substance | n2=en:seizures (mean onset 4-5 months) | rel=r_associated | relid=0 | w=106
  2366. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (meb)
    n1=en:white substance | n2=en:seizures (meb) | rel=r_associated | relid=0 | w=106
  2367. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (onset <2 years)
    n1=en:white substance | n2=en:seizures (onset <2 years) | rel=r_associated | relid=0 | w=106
  2368. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (rare, in males)
    n1=en:white substance | n2=en:seizures (rare, in males) | rel=r_associated | relid=0 | w=106
  2369. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures (type i and type ii, juvenile)
    n1=en:white substance | n2=en:seizures (type i and type ii, juvenile) | rel=r_associated | relid=0 | w=106
  2370. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures affect the vocal cords, lips, mouth, and face
    n1=en:white substance | n2=en:seizures affect the vocal cords, lips, mouth, and face | rel=r_associated | relid=0 | w=106
  2371. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures are poorly controlled
    n1=en:white substance | n2=en:seizures are poorly controlled | rel=r_associated | relid=0 | w=106
  2372. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures in 15-30%
    n1=en:white substance | n2=en:seizures in 15-30% | rel=r_associated | relid=0 | w=106
  2373. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures in the newborn, refractory
    n1=en:white substance | n2=en:seizures in the newborn, refractory | rel=r_associated | relid=0 | w=106
  2374. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures occur multiple times per day
    n1=en:white substance | n2=en:seizures occur multiple times per day | rel=r_associated | relid=0 | w=106
  2375. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures often associated with infections
    n1=en:white substance | n2=en:seizures often associated with infections | rel=r_associated | relid=0 | w=106
  2376. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures often begin focally with head and eye deviation
    n1=en:white substance | n2=en:seizures often begin focally with head and eye deviation | rel=r_associated | relid=0 | w=106
  2377. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures often begin with head and eye deviation
    n1=en:white substance | n2=en:seizures often begin with head and eye deviation | rel=r_associated | relid=0 | w=106
  2378. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures provoked by tactile stimulation or extreme emotion
    n1=en:white substance | n2=en:seizures provoked by tactile stimulation or extreme emotion | rel=r_associated | relid=0 | w=106
  2379. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures recur in 33% of patients
    n1=en:white substance | n2=en:seizures recur in 33% of patients | rel=r_associated | relid=0 | w=106
  2380. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures usually last 1 to 5 minutes (less commonly up to 10 minutes)
    n1=en:white substance | n2=en:seizures usually last 1 to 5 minutes (less commonly up to 10 minutes) | rel=r_associated | relid=0 | w=106
  2381. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures usually last less than 15 minutes
    n1=en:white substance | n2=en:seizures usually last less than 15 minutes | rel=r_associated | relid=0 | w=106
  2382. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, complex, myoclonic
    n1=en:white substance | n2=en:seizures, complex, myoclonic | rel=r_associated | relid=0 | w=106
  2383. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, early onset
    n1=en:white substance | n2=en:seizures, early onset | rel=r_associated | relid=0 | w=106
  2384. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, early-onset (1 family)
    n1=en:white substance | n2=en:seizures, early-onset (1 family) | rel=r_associated | relid=0 | w=106
  2385. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, focal, partial, motor
    n1=en:white substance | n2=en:seizures, focal, partial, motor | rel=r_associated | relid=0 | w=106
  2386. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, generalized tonic/clonic, myoclonic, atonic, or atypical absence, aggravated by fatigue and fasting with frequency ranges from daily to monthly (in some patients)
    n1=en:white substance | n2=en:seizures, generalized tonic/clonic, myoclonic, atonic, or atypical absence, aggravated by fatigue and fasting with frequency ranges from daily to monthly (in some patients) | rel=r_associated | relid=0 | w=106
  2387. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, generalized, afebrile
    n1=en:white substance | n2=en:seizures, generalized, afebrile | rel=r_associated | relid=0 | w=106
  2388. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, generalized, may occur
    n1=en:white substance | n2=en:seizures, generalized, may occur | rel=r_associated | relid=0 | w=106
  2389. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, hypoglycemic (in some patients)
    n1=en:white substance | n2=en:seizures, hypoglycemic (in some patients) | rel=r_associated | relid=0 | w=106
  2390. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, intractable
    n1=en:white substance | n2=en:seizures, intractable | rel=r_associated | relid=0 | w=106
  2391. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, juvenile myoclonic
    n1=en:white substance | n2=en:seizures, juvenile myoclonic | rel=r_associated | relid=0 | w=106
  2392. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, mild
    n1=en:white substance | n2=en:seizures, mild | rel=r_associated | relid=0 | w=106
  2393. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, neonatal (2p21del)
    n1=en:white substance | n2=en:seizures, neonatal (2p21del) | rel=r_associated | relid=0 | w=106
  2394. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, nocturnal, usually occur in daily clusters
    n1=en:white substance | n2=en:seizures, nocturnal, usually occur in daily clusters | rel=r_associated | relid=0 | w=106
  2395. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, partial with secondary generalization, focal at onset, usually motor
    n1=en:white substance | n2=en:seizures, partial with secondary generalization, focal at onset, usually motor | rel=r_associated | relid=0 | w=106
  2396. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, partial, unilateral
    n1=en:white substance | n2=en:seizures, partial, unilateral | rel=r_associated | relid=0 | w=106
  2397. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, recurrent, refractory
    n1=en:white substance | n2=en:seizures, recurrent, refractory | rel=r_associated | relid=0 | w=106
  2398. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, refractory to treatment
    n1=en:white substance | n2=en:seizures, refractory to treatment | rel=r_associated | relid=0 | w=106
  2399. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, severe, drug-resistant, intractable
    n1=en:white substance | n2=en:seizures, severe, drug-resistant, intractable | rel=r_associated | relid=0 | w=106
  2400. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, tonic-clonic (rare)
    n1=en:white substance | n2=en:seizures, tonic-clonic (rare) | rel=r_associated | relid=0 | w=106
  2401. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, tonic-clonic or absence (in some patients)
    n1=en:white substance | n2=en:seizures, tonic-clonic or absence (in some patients) | rel=r_associated | relid=0 | w=106
  2402. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, tonic, clonic, focal
    n1=en:white substance | n2=en:seizures, tonic, clonic, focal | rel=r_associated | relid=0 | w=106
  2403. en:white substance -- r_associated #0: 106 / 0.876 -> en:seizures, tonic, hyperekplectic
    n1=en:white substance | n2=en:seizures, tonic, hyperekplectic | rel=r_associated | relid=0 | w=106
  2404. en:white substance -- r_associated #0: 106 / 0.876 -> en:selective loss of cerebellar purkinje cells
    n1=en:white substance | n2=en:selective loss of cerebellar purkinje cells | rel=r_associated | relid=0 | w=106
  2405. en:white substance -- r_associated #0: 106 / 0.876 -> en:self mutilation
    n1=en:white substance | n2=en:self mutilation | rel=r_associated | relid=0 | w=106
  2406. en:white substance -- r_associated #0: 106 / 0.876 -> en:self-injurious behavior, median onset age 2 years
    n1=en:white substance | n2=en:self-injurious behavior, median onset age 2 years | rel=r_associated | relid=0 | w=106
  2407. en:white substance -- r_associated #0: 106 / 0.876 -> en:semilobar hpe shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle
    n1=en:white substance | n2=en:semilobar hpe shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle | rel=r_associated | relid=0 | w=106
  2408. en:white substance -- r_associated #0: 106 / 0.876 -> en:sensitivity to neuroleptic medication
    n1=en:white substance | n2=en:sensitivity to neuroleptic medication | rel=r_associated | relid=0 | w=106
  2409. en:white substance -- r_associated #0: 106 / 0.876 -> en:sensory aura may occur
    n1=en:white substance | n2=en:sensory aura may occur | rel=r_associated | relid=0 | w=106
  2410. en:white substance -- r_associated #0: 106 / 0.876 -> en:septum of neuraxis
    n1=en:white substance | n2=en:septum of neuraxis | rel=r_associated | relid=0 | w=106
  2411. en:white substance -- r_associated #0: 106 / 0.876 -> en:septum pellucidum deficient or cavum
    n1=en:white substance | n2=en:septum pellucidum deficient or cavum | rel=r_associated | relid=0 | w=106
  2412. en:white substance -- r_associated #0: 106 / 0.876 -> en:set of accessory visual structures
    n1=en:white substance | n2=en:set of accessory visual structures | rel=r_associated | relid=0 | w=106
  2413. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe behavioral problems at age 3-4
    n1=en:white substance | n2=en:severe behavioral problems at age 3-4 | rel=r_associated | relid=0 | w=106
  2414. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe brain damage
    n1=en:white substance | n2=en:severe brain damage | rel=r_associated | relid=0 | w=106
  2415. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe cognitive deficits (develop later)
    n1=en:white substance | n2=en:severe cognitive deficits (develop later) | rel=r_associated | relid=0 | w=106
  2416. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe cognitive impairment
    n1=en:white substance | n2=en:severe cognitive impairment | rel=r_associated | relid=0 | w=106
  2417. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe delay in myelination
    n1=en:white substance | n2=en:severe delay in myelination | rel=r_associated | relid=0 | w=106
  2418. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe demyelination of the white matter
    n1=en:white substance | n2=en:severe demyelination of the white matter | rel=r_associated | relid=0 | w=106
  2419. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe expressive language delay
    n1=en:white substance | n2=en:severe expressive language delay | rel=r_associated | relid=0 | w=106
  2420. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe form may never achieve sitting or walking
    n1=en:white substance | n2=en:severe form may never achieve sitting or walking | rel=r_associated | relid=0 | w=106
  2421. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe global developmental delay
    n1=en:white substance | n2=en:severe global developmental delay | rel=r_associated | relid=0 | w=106
  2422. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe mental retardation (congenital form)
    n1=en:white substance | n2=en:severe mental retardation (congenital form) | rel=r_associated | relid=0 | w=106
  2423. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe mental retardation (i.q. 20-34)
    n1=en:white substance | n2=en:severe mental retardation (i.q. 20-34) | rel=r_associated | relid=0 | w=106
  2424. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe mental retardation (iq 10-40)
    n1=en:white substance | n2=en:severe mental retardation (iq 10-40) | rel=r_associated | relid=0 | w=106
  2425. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe muscular hypotonia
    n1=en:white substance | n2=en:severe muscular hypotonia | rel=r_associated | relid=0 | w=106
  2426. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe neonatal hypotonia improving with age
    n1=en:white substance | n2=en:severe neonatal hypotonia improving with age | rel=r_associated | relid=0 | w=106
  2427. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe psychomotor retardation (iq 35-65)
    n1=en:white substance | n2=en:severe psychomotor retardation (iq 35-65) | rel=r_associated | relid=0 | w=106
  2428. en:white substance -- r_associated #0: 106 / 0.876 -> en:severe psychomotor retardation from birth
    n1=en:white substance | n2=en:severe psychomotor retardation from birth | rel=r_associated | relid=0 | w=106
  2429. en:white substance -- r_associated #0: 106 / 0.876 -> en:severely delayed psychomotor development
    n1=en:white substance | n2=en:severely delayed psychomotor development | rel=r_associated | relid=0 | w=106
  2430. en:white substance -- r_associated #0: 106 / 0.876 -> en:sheath of schwann
    n1=en:white substance | n2=en:sheath of schwann | rel=r_associated | relid=0 | w=106
  2431. en:white substance -- r_associated #0: 106 / 0.876 -> en:shivering sensation
    n1=en:white substance | n2=en:shivering sensation | rel=r_associated | relid=0 | w=106
  2432. en:white substance -- r_associated #0: 106 / 0.876 -> en:short pons
    n1=en:white substance | n2=en:short pons | rel=r_associated | relid=0 | w=106
  2433. en:white substance -- r_associated #0: 106 / 0.876 -> en:shuffling gaits
    n1=en:white substance | n2=en:shuffling gaits | rel=r_associated | relid=0 | w=106
  2434. en:white substance -- r_associated #0: 106 / 0.876 -> en:signal abnormalities in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles seen on mri
    n1=en:white substance | n2=en:signal abnormalities in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles seen on mri | rel=r_associated | relid=0 | w=106
  2435. en:white substance -- r_associated #0: 106 / 0.876 -> en:signal changes in the caudate and putamen
    n1=en:white substance | n2=en:signal changes in the caudate and putamen | rel=r_associated | relid=0 | w=106
  2436. en:white substance -- r_associated #0: 106 / 0.876 -> en:simple partial seizures with secondary generalization
    n1=en:white substance | n2=en:simple partial seizures with secondary generalization | rel=r_associated | relid=0 | w=106
  2437. en:white substance -- r_associated #0: 106 / 0.876 -> en:simplified cortical gyral pattern
    n1=en:white substance | n2=en:simplified cortical gyral pattern | rel=r_associated | relid=0 | w=106
  2438. en:white substance -- r_associated #0: 106 / 0.876 -> en:simplified cortical gyration pattern
    n1=en:white substance | n2=en:simplified cortical gyration pattern | rel=r_associated | relid=0 | w=106
  2439. en:white substance -- r_associated #0: 106 / 0.876 -> en:simplified gyral pattern (1 patient)
    n1=en:white substance | n2=en:simplified gyral pattern (1 patient) | rel=r_associated | relid=0 | w=106
  2440. en:white substance -- r_associated #0: 106 / 0.876 -> en:simplified gyral pattern (in one patient)
    n1=en:white substance | n2=en:simplified gyral pattern (in one patient) | rel=r_associated | relid=0 | w=106
  2441. en:white substance -- r_associated #0: 106 / 0.876 -> en:simplified gyration in the frontal cortex (less common)
    n1=en:white substance | n2=en:simplified gyration in the frontal cortex (less common) | rel=r_associated | relid=0 | w=106
  2442. en:white substance -- r_associated #0: 106 / 0.876 -> en:skin photosensitivity
    n1=en:white substance | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=106
  2443. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep abnormalities
    n1=en:white substance | n2=en:sleep abnormalities | rel=r_associated | relid=0 | w=106
  2444. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep disorder (rare)
    n1=en:white substance | n2=en:sleep disorder (rare) | rel=r_associated | relid=0 | w=106
  2445. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep disorder with severe insomnia (in adulthood)
    n1=en:white substance | n2=en:sleep disorder with severe insomnia (in adulthood) | rel=r_associated | relid=0 | w=106
  2446. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep disturbances
    n1=en:white substance | n2=en:sleep disturbances | rel=r_associated | relid=0 | w=106
  2447. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep impairment, progressive
    n1=en:white substance | n2=en:sleep impairment, progressive | rel=r_associated | relid=0 | w=106
  2448. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep paralysis at beginning or end of sleep period (in 60% of patients)
    n1=en:white substance | n2=en:sleep paralysis at beginning or end of sleep period (in 60% of patients) | rel=r_associated | relid=0 | w=106
  2449. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep pattern disturbance
    n1=en:white substance | n2=en:sleep pattern disturbance | rel=r_associated | relid=0 | w=106
  2450. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep-onset rem
    n1=en:white substance | n2=en:sleep-onset rem | rel=r_associated | relid=0 | w=106
  2451. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleep-wake cycle disturbance
    n1=en:white substance | n2=en:sleep-wake cycle disturbance | rel=r_associated | relid=0 | w=106
  2452. en:white substance -- r_associated #0: 106 / 0.876 -> en:sleepiness
    n1=en:white substance | n2=en:sleepiness | rel=r_associated | relid=0 | w=106
  2453. en:white substance -- r_associated #0: 106 / 0.876 -> en:slow gait
    n1=en:white substance | n2=en:slow gait | rel=r_associated | relid=0 | w=106
  2454. en:white substance -- r_associated #0: 106 / 0.876 -> en:slow gross motor activity
    n1=en:white substance | n2=en:slow gross motor activity | rel=r_associated | relid=0 | w=106
  2455. en:white substance -- r_associated #0: 106 / 0.876 -> en:slow speech
    n1=en:white substance | n2=en:slow speech | rel=r_associated | relid=0 | w=106
  2456. en:white substance -- r_associated #0: 106 / 0.876 -> en:slow spike-wave discharges
    n1=en:white substance | n2=en:slow spike-wave discharges | rel=r_associated | relid=0 | w=106
  2457. en:white substance -- r_associated #0: 106 / 0.876 -> en:slowed background activity
    n1=en:white substance | n2=en:slowed background activity | rel=r_associated | relid=0 | w=106
  2458. en:white substance -- r_associated #0: 106 / 0.876 -> en:slowing mental development by 1.5 to 3 years of age
    n1=en:white substance | n2=en:slowing mental development by 1.5 to 3 years of age | rel=r_associated | relid=0 | w=106
  2459. en:white substance -- r_associated #0: 106 / 0.876 -> en:slowly progressive neurologic deterioration
    n1=en:white substance | n2=en:slowly progressive neurologic deterioration | rel=r_associated | relid=0 | w=106
  2460. en:white substance -- r_associated #0: 106 / 0.876 -> en:slurred speech
    n1=en:white substance | n2=en:slurred speech | rel=r_associated | relid=0 | w=106
  2461. en:white substance -- r_associated #0: 106 / 0.876 -> en:small brain
    n1=en:white substance | n2=en:small brain | rel=r_associated | relid=0 | w=106
  2462. en:white substance -- r_associated #0: 106 / 0.876 -> en:small brain size (some patients)
    n1=en:white substance | n2=en:small brain size (some patients) | rel=r_associated | relid=0 | w=106
  2463. en:white substance -- r_associated #0: 106 / 0.876 -> en:small cavum septum
    n1=en:white substance | n2=en:small cavum septum | rel=r_associated | relid=0 | w=106
  2464. en:white substance -- r_associated #0: 106 / 0.876 -> en:small frontal lobes (in one patient)
    n1=en:white substance | n2=en:small frontal lobes (in one patient) | rel=r_associated | relid=0 | w=106
  2465. en:white substance -- r_associated #0: 106 / 0.876 -> en:small hippocampi (1 patient)
    n1=en:white substance | n2=en:small hippocampi (1 patient) | rel=r_associated | relid=0 | w=106
  2466. en:white substance -- r_associated #0: 106 / 0.876 -> en:small midbrain
    n1=en:white substance | n2=en:small midbrain | rel=r_associated | relid=0 | w=106
  2467. en:white substance -- r_associated #0: 106 / 0.876 -> en:small rotary component may be present
    n1=en:white substance | n2=en:small rotary component may be present | rel=r_associated | relid=0 | w=106
  2468. en:white substance -- r_associated #0: 106 / 0.876 -> en:small sella
    n1=en:white substance | n2=en:small sella | rel=r_associated | relid=0 | w=106
  2469. en:white substance -- r_associated #0: 106 / 0.876 -> en:small shrunken brain
    n1=en:white substance | n2=en:small shrunken brain | rel=r_associated | relid=0 | w=106
  2470. en:white substance -- r_associated #0: 106 / 0.876 -> en:small, smooth cerebellum
    n1=en:white substance | n2=en:small, smooth cerebellum | rel=r_associated | relid=0 | w=106
  2471. en:white substance -- r_associated #0: 106 / 0.876 -> en:small, thin cerebellum
    n1=en:white substance | n2=en:small, thin cerebellum | rel=r_associated | relid=0 | w=106
  2472. en:white substance -- r_associated #0: 106 / 0.876 -> en:smooth, thin cortical mantle (wws)
    n1=en:white substance | n2=en:smooth, thin cortical mantle (wws) | rel=r_associated | relid=0 | w=106
  2473. en:white substance -- r_associated #0: 106 / 0.876 -> en:somatosensory evoked potentials show prolonged latency
    n1=en:white substance | n2=en:somatosensory evoked potentials show prolonged latency | rel=r_associated | relid=0 | w=106
  2474. en:white substance -- r_associated #0: 106 / 0.876 -> en:some may not achieve ambulation
    n1=en:white substance | n2=en:some may not achieve ambulation | rel=r_associated | relid=0 | w=106
  2475. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients do not achieve ability to walk
    n1=en:white substance | n2=en:some patients do not achieve ability to walk | rel=r_associated | relid=0 | w=106
  2476. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients have neurologic involvement
    n1=en:white substance | n2=en:some patients have neurologic involvement | rel=r_associated | relid=0 | w=106
  2477. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients have no structural brain abnormalities
    n1=en:white substance | n2=en:some patients have no structural brain abnormalities | rel=r_associated | relid=0 | w=106
  2478. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients may develop afebrile seizures later in life
    n1=en:white substance | n2=en:some patients may develop afebrile seizures later in life | rel=r_associated | relid=0 | w=106
  2479. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients may show normal early development
    n1=en:white substance | n2=en:some patients may show normal early development | rel=r_associated | relid=0 | w=106
  2480. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients never achieve independent ambulation
    n1=en:white substance | n2=en:some patients never achieve independent ambulation | rel=r_associated | relid=0 | w=106
  2481. en:white substance -- r_associated #0: 106 / 0.876 -> en:some patients only achieve sitting
    n1=en:white substance | n2=en:some patients only achieve sitting | rel=r_associated | relid=0 | w=106
  2482. en:white substance -- r_associated #0: 106 / 0.876 -> en:somnolence
    n1=en:white substance | n2=en:somnolence | rel=r_associated | relid=0 | w=106
  2483. en:white substance -- r_associated #0: 106 / 0.876 -> en:sparing of central white matter structures
    n1=en:white substance | n2=en:sparing of central white matter structures | rel=r_associated | relid=0 | w=106
  2484. en:white substance -- r_associated #0: 106 / 0.876 -> en:sparing of the inferior olives
    n1=en:white substance | n2=en:sparing of the inferior olives | rel=r_associated | relid=0 | w=106
  2485. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasmodic dysphonia
    n1=en:white substance | n2=en:spasmodic dysphonia | rel=r_associated | relid=0 | w=106
  2486. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic ataxia
    n1=en:white substance | n2=en:spastic ataxia | rel=r_associated | relid=0 | w=106
  2487. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic diplegia (1 patient)
    n1=en:white substance | n2=en:spastic diplegia (1 patient) | rel=r_associated | relid=0 | w=106
  2488. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic diplegia (in some patients)
    n1=en:white substance | n2=en:spastic diplegia (in some patients) | rel=r_associated | relid=0 | w=106
  2489. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic diplegia, progressive
    n1=en:white substance | n2=en:spastic diplegia, progressive | rel=r_associated | relid=0 | w=106
  2490. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic diplegia, symmetric
    n1=en:white substance | n2=en:spastic diplegia, symmetric | rel=r_associated | relid=0 | w=106
  2491. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic gait
    n1=en:white substance | n2=en:spastic gait | rel=r_associated | relid=0 | w=106
  2492. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic paralysis
    n1=en:white substance | n2=en:spastic paralysis | rel=r_associated | relid=0 | w=106
  2493. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic paraparesis (1 patient)
    n1=en:white substance | n2=en:spastic paraparesis (1 patient) | rel=r_associated | relid=0 | w=106
  2494. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic paraplegia (in some patients)
    n1=en:white substance | n2=en:spastic paraplegia (in some patients) | rel=r_associated | relid=0 | w=106
  2495. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic paraplegia, later onset (in one patient)
    n1=en:white substance | n2=en:spastic paraplegia, later onset (in one patient) | rel=r_associated | relid=0 | w=106
  2496. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic paraplegia, pure
    n1=en:white substance | n2=en:spastic paraplegia, pure | rel=r_associated | relid=0 | w=106
  2497. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic quadriplegia
    n1=en:white substance | n2=en:spastic quadriplegia | rel=r_associated | relid=0 | w=106
  2498. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic quadriplegia (in one patient)
    n1=en:white substance | n2=en:spastic quadriplegia (in one patient) | rel=r_associated | relid=0 | w=106
  2499. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic quadriplegia, residual mild-to-severe (in some patients)
    n1=en:white substance | n2=en:spastic quadriplegia, residual mild-to-severe (in some patients) | rel=r_associated | relid=0 | w=106
  2500. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic tetraparesis
    n1=en:white substance | n2=en:spastic tetraparesis | rel=r_associated | relid=0 | w=106
  2501. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic tetraparesis (in severe cases)
    n1=en:white substance | n2=en:spastic tetraparesis (in severe cases) | rel=r_associated | relid=0 | w=106
  2502. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic tetraplegia (in some patients)
    n1=en:white substance | n2=en:spastic tetraplegia (in some patients) | rel=r_associated | relid=0 | w=106
  2503. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic tetraplegia (onset in the second decade)
    n1=en:white substance | n2=en:spastic tetraplegia (onset in the second decade) | rel=r_associated | relid=0 | w=106
  2504. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic-ataxic gait
    n1=en:white substance | n2=en:spastic-ataxic gait | rel=r_associated | relid=0 | w=106
  2505. en:white substance -- r_associated #0: 106 / 0.876 -> en:spastic-ataxic tetraparesis
    n1=en:white substance | n2=en:spastic-ataxic tetraparesis | rel=r_associated | relid=0 | w=106
  2506. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity
    n1=en:white substance | n2=en:spasticity | rel=r_associated | relid=0 | w=106
  2507. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (1 family)
    n1=en:white substance | n2=en:spasticity (1 family) | rel=r_associated | relid=0 | w=106
  2508. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (in some patients)
    n1=en:white substance | n2=en:spasticity (in some patients) | rel=r_associated | relid=0 | w=106
  2509. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (later)
    n1=en:white substance | n2=en:spasticity (later) | rel=r_associated | relid=0 | w=106
  2510. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (less common)
    n1=en:white substance | n2=en:spasticity (less common) | rel=r_associated | relid=0 | w=106
  2511. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (patient a)
    n1=en:white substance | n2=en:spasticity (patient a) | rel=r_associated | relid=0 | w=106
  2512. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (reported in 1 patient)
    n1=en:white substance | n2=en:spasticity (reported in 1 patient) | rel=r_associated | relid=0 | w=106
  2513. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity (type ii)
    n1=en:white substance | n2=en:spasticity (type ii) | rel=r_associated | relid=0 | w=106
  2514. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity in infancy (1 patient)
    n1=en:white substance | n2=en:spasticity in infancy (1 patient) | rel=r_associated | relid=0 | w=106
  2515. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity may be present
    n1=en:white substance | n2=en:spasticity may be present | rel=r_associated | relid=0 | w=106
  2516. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity may occur
    n1=en:white substance | n2=en:spasticity may occur | rel=r_associated | relid=0 | w=106
  2517. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity of facial muscles
    n1=en:white substance | n2=en:spasticity of facial muscles | rel=r_associated | relid=0 | w=106
  2518. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity of lower and upper limbs
    n1=en:white substance | n2=en:spasticity of lower and upper limbs | rel=r_associated | relid=0 | w=106
  2519. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity of pharyngeal muscles
    n1=en:white substance | n2=en:spasticity of pharyngeal muscles | rel=r_associated | relid=0 | w=106
  2520. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity, hyperreflexia
    n1=en:white substance | n2=en:spasticity, hyperreflexia | rel=r_associated | relid=0 | w=106
  2521. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity, mild (in some patients)
    n1=en:white substance | n2=en:spasticity, mild (in some patients) | rel=r_associated | relid=0 | w=106
  2522. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity, more apparent in the lower limbs
    n1=en:white substance | n2=en:spasticity, more apparent in the lower limbs | rel=r_associated | relid=0 | w=106
  2523. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity, progressive, develops in childhood
    n1=en:white substance | n2=en:spasticity, progressive, develops in childhood | rel=r_associated | relid=0 | w=106
  2524. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity, severe
    n1=en:white substance | n2=en:spasticity, severe | rel=r_associated | relid=0 | w=106
  2525. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity, severe, affecting lower limbs
    n1=en:white substance | n2=en:spasticity, severe, affecting lower limbs | rel=r_associated | relid=0 | w=106
  2526. en:white substance -- r_associated #0: 106 / 0.876 -> en:spasticity/paresis (rare)
    n1=en:white substance | n2=en:spasticity/paresis (rare) | rel=r_associated | relid=0 | w=106
  2527. en:white substance -- r_associated #0: 106 / 0.876 -> en:spect scan may show hypermetabolism of the temporal lobe
    n1=en:white substance | n2=en:spect scan may show hypermetabolism of the temporal lobe | rel=r_associated | relid=0 | w=106
  2528. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech abnormalities (palilalia)
    n1=en:white substance | n2=en:speech abnormalities (palilalia) | rel=r_associated | relid=0 | w=106
  2529. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech and language delay, severe
    n1=en:white substance | n2=en:speech and language delay, severe | rel=r_associated | relid=0 | w=106
  2530. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech and language disorder
    n1=en:white substance | n2=en:speech and language disorder | rel=r_associated | relid=0 | w=106
  2531. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech articulation problems
    n1=en:white substance | n2=en:speech articulation problems | rel=r_associated | relid=0 | w=106
  2532. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech delay (10%)
    n1=en:white substance | n2=en:speech delay (10%) | rel=r_associated | relid=0 | w=106
  2533. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech delay (59%)
    n1=en:white substance | n2=en:speech delay (59%) | rel=r_associated | relid=0 | w=106
  2534. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech delay (in all patients)
    n1=en:white substance | n2=en:speech delay (in all patients) | rel=r_associated | relid=0 | w=106
  2535. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech difficulties (48%)
    n1=en:white substance | n2=en:speech difficulties (48%) | rel=r_associated | relid=0 | w=106
  2536. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech difficulties due to hypoglossia
    n1=en:white substance | n2=en:speech difficulties due to hypoglossia | rel=r_associated | relid=0 | w=106
  2537. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech disability
    n1=en:white substance | n2=en:speech disability | rel=r_associated | relid=0 | w=106
  2538. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech disorder
    n1=en:white substance | n2=en:speech disorder | rel=r_associated | relid=0 | w=106
  2539. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech disorders (rare)
    n1=en:white substance | n2=en:speech disorders (rare) | rel=r_associated | relid=0 | w=106
  2540. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech hesitancy
    n1=en:white substance | n2=en:speech hesitancy | rel=r_associated | relid=0 | w=106
  2541. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech impairment
    n1=en:white substance | n2=en:speech impairment | rel=r_associated | relid=0 | w=106
  2542. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech limited
    n1=en:white substance | n2=en:speech limited | rel=r_associated | relid=0 | w=106
  2543. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech limited to single word or no words
    n1=en:white substance | n2=en:speech limited to single word or no words | rel=r_associated | relid=0 | w=106
  2544. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech never acquired
    n1=en:white substance | n2=en:speech never acquired | rel=r_associated | relid=0 | w=106
  2545. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech severely limited or absent
    n1=en:white substance | n2=en:speech severely limited or absent | rel=r_associated | relid=0 | w=106
  2546. en:white substance -- r_associated #0: 106 / 0.876 -> en:speech, limited or nonverbal
    n1=en:white substance | n2=en:speech, limited or nonverbal | rel=r_associated | relid=0 | w=106
  2547. en:white substance -- r_associated #0: 106 / 0.876 -> en:spina bifida
    n1=en:white substance | n2=en:spina bifida | rel=r_associated | relid=0 | w=106
  2548. en:white substance -- r_associated #0: 106 / 0.876 -> en:spina bifida occulta
    n1=en:white substance | n2=en:spina bifida occulta | rel=r_associated | relid=0 | w=106
  2549. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord
    n1=en:white substance | n2=en:spinal cord | rel=r_associated | relid=0 | w=106
  2550. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord atrophy (1 family)
    n1=en:white substance | n2=en:spinal cord atrophy (1 family) | rel=r_associated | relid=0 | w=106
  2551. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord atrophy (rare)
    n1=en:white substance | n2=en:spinal cord atrophy (rare) | rel=r_associated | relid=0 | w=106
  2552. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord disorder
    n1=en:white substance | n2=en:spinal cord disorder | rel=r_associated | relid=0 | w=106
  2553. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord dorsal median sulcus
    n1=en:white substance | n2=en:spinal cord dorsal median sulcus | rel=r_associated | relid=0 | w=106
  2554. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord paresis
    n1=en:white substance | n2=en:spinal cord paresis | rel=r_associated | relid=0 | w=106
  2555. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cord syrinx (in 2 patients)
    n1=en:white substance | n2=en:spinal cord syrinx (in 2 patients) | rel=r_associated | relid=0 | w=106
  2556. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal cysts (in some patients)
    n1=en:white substance | n2=en:spinal cysts (in some patients) | rel=r_associated | relid=0 | w=106
  2557. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal muscular atrophy
    n1=en:white substance | n2=en:spinal muscular atrophy | rel=r_associated | relid=0 | w=106
  2558. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal nerve root
    n1=en:white substance | n2=en:spinal nerve root | rel=r_associated | relid=0 | w=106
  2559. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal neurofibromas (64%)
    n1=en:white substance | n2=en:spinal neurofibromas (64%) | rel=r_associated | relid=0 | w=106
  2560. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal neuropathy
    n1=en:white substance | n2=en:spinal neuropathy | rel=r_associated | relid=0 | w=106
  2561. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal stenosis
    n1=en:white substance | n2=en:spinal stenosis | rel=r_associated | relid=0 | w=106
  2562. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinal tract degeneration
    n1=en:white substance | n2=en:spinal tract degeneration | rel=r_associated | relid=0 | w=106
  2563. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinocerebellar ataxia (upper and lower limb involvement)
    n1=en:white substance | n2=en:spinocerebellar ataxia (upper and lower limb involvement) | rel=r_associated | relid=0 | w=106
  2564. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinocerebellar tract degeneration
    n1=en:white substance | n2=en:spinocerebellar tract degeneration | rel=r_associated | relid=0 | w=106
  2565. en:white substance -- r_associated #0: 106 / 0.876 -> en:spinothalamic tracts
    n1=en:white substance | n2=en:spinothalamic tracts | rel=r_associated | relid=0 | w=106
  2566. en:white substance -- r_associated #0: 106 / 0.876 -> en:spongiform changes are mild or may not be present
    n1=en:white substance | n2=en:spongiform changes are mild or may not be present | rel=r_associated | relid=0 | w=106
  2567. en:white substance -- r_associated #0: 106 / 0.876 -> en:spongiform degeneration
    n1=en:white substance | n2=en:spongiform degeneration | rel=r_associated | relid=0 | w=106
  2568. en:white substance -- r_associated #0: 106 / 0.876 -> en:spongy degeneration
    n1=en:white substance | n2=en:spongy degeneration | rel=r_associated | relid=0 | w=106
  2569. en:white substance -- r_associated #0: 106 / 0.876 -> en:spongy gliosis
    n1=en:white substance | n2=en:spongy gliosis | rel=r_associated | relid=0 | w=106
  2570. en:white substance -- r_associated #0: 106 / 0.876 -> en:stance ataxia
    n1=en:white substance | n2=en:stance ataxia | rel=r_associated | relid=0 | w=106
  2571. en:white substance -- r_associated #0: 106 / 0.876 -> en:staring
    n1=en:white substance | n2=en:staring | rel=r_associated | relid=0 | w=106
  2572. en:white substance -- r_associated #0: 106 / 0.876 -> en:staring episodes during seizures
    n1=en:white substance | n2=en:staring episodes during seizures | rel=r_associated | relid=0 | w=106
  2573. en:white substance -- r_associated #0: 106 / 0.876 -> en:staring spells
    n1=en:white substance | n2=en:staring spells | rel=r_associated | relid=0 | w=106
  2574. en:white substance -- r_associated #0: 106 / 0.876 -> en:start with tonic posturing
    n1=en:white substance | n2=en:start with tonic posturing | rel=r_associated | relid=0 | w=106
  2575. en:white substance -- r_associated #0: 106 / 0.876 -> en:status epilepticus
    n1=en:white substance | n2=en:status epilepticus | rel=r_associated | relid=0 | w=106
  2576. en:white substance -- r_associated #0: 106 / 0.876 -> en:status epilepticus (in some patients)
    n1=en:white substance | n2=en:status epilepticus (in some patients) | rel=r_associated | relid=0 | w=106
  2577. en:white substance -- r_associated #0: 106 / 0.876 -> en:status epilepticus (in some)
    n1=en:white substance | n2=en:status epilepticus (in some) | rel=r_associated | relid=0 | w=106
  2578. en:white substance -- r_associated #0: 106 / 0.876 -> en:stenosis of the jugular foramen
    n1=en:white substance | n2=en:stenosis of the jugular foramen | rel=r_associated | relid=0 | w=106
  2579. en:white substance -- r_associated #0: 106 / 0.876 -> en:stereotypic movements
    n1=en:white substance | n2=en:stereotypic movements | rel=r_associated | relid=0 | w=106
  2580. en:white substance -- r_associated #0: 106 / 0.876 -> en:stiff gait
    n1=en:white substance | n2=en:stiff gait | rel=r_associated | relid=0 | w=106
  2581. en:white substance -- r_associated #0: 106 / 0.876 -> en:stiff limbs
    n1=en:white substance | n2=en:stiff limbs | rel=r_associated | relid=0 | w=106
  2582. en:white substance -- r_associated #0: 106 / 0.876 -> en:stiffness
    n1=en:white substance | n2=en:stiffness | rel=r_associated | relid=0 | w=106
  2583. en:white substance -- r_associated #0: 106 / 0.876 -> en:stiffness while walking
    n1=en:white substance | n2=en:stiffness while walking | rel=r_associated | relid=0 | w=106
  2584. en:white substance -- r_associated #0: 106 / 0.876 -> en:stimulation sensitive generalized myoclonus (stage 3)
    n1=en:white substance | n2=en:stimulation sensitive generalized myoclonus (stage 3) | rel=r_associated | relid=0 | w=106
  2585. en:white substance -- r_associated #0: 106 / 0.876 -> en:striatal lesions
    n1=en:white substance | n2=en:striatal lesions | rel=r_associated | relid=0 | w=106
  2586. en:white substance -- r_associated #0: 106 / 0.876 -> en:striatal necrosis
    n1=en:white substance | n2=en:striatal necrosis | rel=r_associated | relid=0 | w=106
  2587. en:white substance -- r_associated #0: 106 / 0.876 -> en:stroke (rare)
    n1=en:white substance | n2=en:stroke (rare) | rel=r_associated | relid=0 | w=106
  2588. en:white substance -- r_associated #0: 106 / 0.876 -> en:stroke (uncommon)
    n1=en:white substance | n2=en:stroke (uncommon) | rel=r_associated | relid=0 | w=106
  2589. en:white substance -- r_associated #0: 106 / 0.876 -> en:stroke-like episodes (in some patients)
    n1=en:white substance | n2=en:stroke-like episodes (in some patients) | rel=r_associated | relid=0 | w=106
  2590. en:white substance -- r_associated #0: 106 / 0.876 -> en:structural abnormalities of cerebellum
    n1=en:white substance | n2=en:structural abnormalities of cerebellum | rel=r_associated | relid=0 | w=106
  2591. en:white substance -- r_associated #0: 106 / 0.876 -> en:structural changes in the temporal lobe
    n1=en:white substance | n2=en:structural changes in the temporal lobe | rel=r_associated | relid=0 | w=106
  2592. en:white substance -- r_associated #0: 106 / 0.876 -> en:structure of anterior median fissure of medulla oblongata
    n1=en:white substance | n2=en:structure of anterior median fissure of medulla oblongata | rel=r_associated | relid=0 | w=106
  2593. en:white substance -- r_associated #0: 106 / 0.876 -> en:structure of central sensory visual system
    n1=en:white substance | n2=en:structure of central sensory visual system | rel=r_associated | relid=0 | w=106
  2594. en:white substance -- r_associated #0: 106 / 0.876 -> en:structure of cervical spinal cord ventral horn
    n1=en:white substance | n2=en:structure of cervical spinal cord ventral horn | rel=r_associated | relid=0 | w=106
  2595. en:white substance -- r_associated #0: 106 / 0.876 -> en:structure of decussation of superior cerebellar peduncles
    n1=en:white substance | n2=en:structure of decussation of superior cerebellar peduncles | rel=r_associated | relid=0 | w=106
  2596. en:white substance -- r_associated #0: 106 / 0.876 -> en:structure of spinal cord ventral lateral sulcus
    n1=en:white substance | n2=en:structure of spinal cord ventral lateral sulcus | rel=r_associated | relid=0 | w=106
  2597. en:white substance -- r_associated #0: 106 / 0.876 -> en:subacute neurologic deterioration
    n1=en:white substance | n2=en:subacute neurologic deterioration | rel=r_associated | relid=0 | w=106
  2598. en:white substance -- r_associated #0: 106 / 0.876 -> en:subarachnoid hemorrhage
    n1=en:white substance | n2=en:subarachnoid hemorrhage | rel=r_associated | relid=0 | w=106
  2599. en:white substance -- r_associated #0: 106 / 0.876 -> en:subarachnoid hemorrhage (rare)
    n1=en:white substance | n2=en:subarachnoid hemorrhage (rare) | rel=r_associated | relid=0 | w=106
  2600. en:white substance -- r_associated #0: 106 / 0.876 -> en:subclinical absence seizures
    n1=en:white substance | n2=en:subclinical absence seizures | rel=r_associated | relid=0 | w=106
  2601. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical band or laminar heterotopia (in female carriers)
    n1=en:white substance | n2=en:subcortical band or laminar heterotopia (in female carriers) | rel=r_associated | relid=0 | w=106
  2602. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical cysts in frontal and temporal lobes
    n1=en:white substance | n2=en:subcortical cysts in frontal and temporal lobes | rel=r_associated | relid=0 | w=106
  2603. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical cysts may occur elsewhere
    n1=en:white substance | n2=en:subcortical cysts may occur elsewhere | rel=r_associated | relid=0 | w=106
  2604. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical gliosis
    n1=en:white substance | n2=en:subcortical gliosis | rel=r_associated | relid=0 | w=106
  2605. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical heterotopia
    n1=en:white substance | n2=en:subcortical heterotopia | rel=r_associated | relid=0 | w=106
  2606. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical hypomyelination
    n1=en:white substance | n2=en:subcortical hypomyelination | rel=r_associated | relid=0 | w=106
  2607. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical lacunar lesions seen early in disease
    n1=en:white substance | n2=en:subcortical lacunar lesions seen early in disease | rel=r_associated | relid=0 | w=106
  2608. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical leukodystrophy
    n1=en:white substance | n2=en:subcortical leukodystrophy | rel=r_associated | relid=0 | w=106
  2609. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical nodular grey matter heterotopia
    n1=en:white substance | n2=en:subcortical nodular grey matter heterotopia | rel=r_associated | relid=0 | w=106
  2610. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical temporal white matter disease, moderate
    n1=en:white substance | n2=en:subcortical temporal white matter disease, moderate | rel=r_associated | relid=0 | w=106
  2611. en:white substance -- r_associated #0: 106 / 0.876 -> en:subcortical white matter calcifications
    n1=en:white substance | n2=en:subcortical white matter calcifications | rel=r_associated | relid=0 | w=106
  2612. en:white substance -- r_associated #0: 106 / 0.876 -> en:subdivision of genital system
    n1=en:white substance | n2=en:subdivision of genital system | rel=r_associated | relid=0 | w=106
  2613. en:white substance -- r_associated #0: 106 / 0.876 -> en:subdivision of nervous system
    n1=en:white substance | n2=en:subdivision of nervous system | rel=r_associated | relid=0 | w=106
  2614. en:white substance -- r_associated #0: 106 / 0.876 -> en:subependymal calcifications
    n1=en:white substance | n2=en:subependymal calcifications | rel=r_associated | relid=0 | w=106
  2615. en:white substance -- r_associated #0: 106 / 0.876 -> en:subependymal hemorrhage
    n1=en:white substance | n2=en:subependymal hemorrhage | rel=r_associated | relid=0 | w=106
  2616. en:white substance -- r_associated #0: 106 / 0.876 -> en:subependymal heterotopias
    n1=en:white substance | n2=en:subependymal heterotopias | rel=r_associated | relid=0 | w=106
  2617. en:white substance -- r_associated #0: 106 / 0.876 -> en:subependymal heterotopic nodules
    n1=en:white substance | n2=en:subependymal heterotopic nodules | rel=r_associated | relid=0 | w=106
  2618. en:white substance -- r_associated #0: 106 / 0.876 -> en:subnormal cognition
    n1=en:white substance | n2=en:subnormal cognition | rel=r_associated | relid=0 | w=106
  2619. en:white substance -- r_associated #0: 106 / 0.876 -> en:subnormal intelligence (62%)
    n1=en:white substance | n2=en:subnormal intelligence (62%) | rel=r_associated | relid=0 | w=106
  2620. en:white substance -- r_associated #0: 106 / 0.876 -> en:substance withdrawal syndrome
    n1=en:white substance | n2=en:substance withdrawal syndrome | rel=r_associated | relid=0 | w=106
  2621. en:white substance -- r_associated #0: 106 / 0.876 -> en:sudden arousal from slow-wave sleep with screaming, autonomic, and behavioral manifestations of intense fear (sleep terrors)
    n1=en:white substance | n2=en:sudden arousal from slow-wave sleep with screaming, autonomic, and behavioral manifestations of intense fear (sleep terrors) | rel=r_associated | relid=0 | w=106
  2622. en:white substance -- r_associated #0: 106 / 0.876 -> en:sudden onset of neuropsychiatric symptoms
    n1=en:white substance | n2=en:sudden onset of neuropsychiatric symptoms | rel=r_associated | relid=0 | w=106
  2623. en:white substance -- r_associated #0: 106 / 0.876 -> en:suppression-burst pattern
    n1=en:white substance | n2=en:suppression-burst pattern | rel=r_associated | relid=0 | w=106
  2624. en:white substance -- r_associated #0: 106 / 0.876 -> en:suppression-burst pattern see on eeg
    n1=en:white substance | n2=en:suppression-burst pattern see on eeg | rel=r_associated | relid=0 | w=106
  2625. en:white substance -- r_associated #0: 106 / 0.876 -> en:surgical aspects
    n1=en:white substance | n2=en:surgical aspects | rel=r_associated | relid=0 | w=106
  2626. en:white substance -- r_associated #0: 106 / 0.876 -> en:sweating problem
    n1=en:white substance | n2=en:sweating problem | rel=r_associated | relid=0 | w=106
  2627. en:white substance -- r_associated #0: 106 / 0.876 -> en:swelling of the cerebral white matter
    n1=en:white substance | n2=en:swelling of the cerebral white matter | rel=r_associated | relid=0 | w=106
  2628. en:white substance -- r_associated #0: 106 / 0.876 -> en:swollen achromatic cells (pick cells)
    n1=en:white substance | n2=en:swollen achromatic cells (pick cells) | rel=r_associated | relid=0 | w=106
  2629. en:white substance -- r_associated #0: 106 / 0.876 -> en:symmetric lesions in the basal ganglia consistent with leigh syndrome (256000), in a subset of patients
    n1=en:white substance | n2=en:symmetric lesions in the basal ganglia consistent with leigh syndrome (256000), in a subset of patients | rel=r_associated | relid=0 | w=106
  2630. en:white substance -- r_associated #0: 106 / 0.876 -> en:symmetric ventriculomegaly
    n1=en:white substance | n2=en:symmetric ventriculomegaly | rel=r_associated | relid=0 | w=106
  2631. en:white substance -- r_associated #0: 106 / 0.876 -> en:symptoms are exacerbated during pregnancy
    n1=en:white substance | n2=en:symptoms are exacerbated during pregnancy | rel=r_associated | relid=0 | w=106
  2632. en:white substance -- r_associated #0: 106 / 0.876 -> en:symptoms occur at rest
    n1=en:white substance | n2=en:symptoms occur at rest | rel=r_associated | relid=0 | w=106
  2633. en:white substance -- r_associated #0: 106 / 0.876 -> en:symptoms of hypothalamic disturbances (in some patients)
    n1=en:white substance | n2=en:symptoms of hypothalamic disturbances (in some patients) | rel=r_associated | relid=0 | w=106
  2634. en:white substance -- r_associated #0: 106 / 0.876 -> en:symptoms stabilize within 4 weeks
    n1=en:white substance | n2=en:symptoms stabilize within 4 weeks | rel=r_associated | relid=0 | w=106
  2635. en:white substance -- r_associated #0: 106 / 0.876 -> en:syncope
    n1=en:white substance | n2=en:syncope | rel=r_associated | relid=0 | w=106
  2636. en:white substance -- r_associated #0: 106 / 0.876 -> en:syndrome screaming
    n1=en:white substance | n2=en:syndrome screaming | rel=r_associated | relid=0 | w=106
  2637. en:white substance -- r_associated #0: 106 / 0.876 -> en:synkinesia (rare)
    n1=en:white substance | n2=en:synkinesia (rare) | rel=r_associated | relid=0 | w=106
  2638. en:white substance -- r_associated #0: 106 / 0.876 -> en:syringomyelia
    n1=en:white substance | n2=en:syringomyelia | rel=r_associated | relid=0 | w=106
  2639. en:white substance -- r_associated #0: 106 / 0.876 -> en:syringomyelia (in some patients)
    n1=en:white substance | n2=en:syringomyelia (in some patients) | rel=r_associated | relid=0 | w=106
  2640. en:white substance -- r_associated #0: 106 / 0.876 -> en:syringomyelia, noncommunicating (80% of cases)
    n1=en:white substance | n2=en:syringomyelia, noncommunicating (80% of cases) | rel=r_associated | relid=0 | w=106
  2641. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in deep brain regions
    n1=en:white substance | n2=en:t2-weighted hyperintensities in deep brain regions | rel=r_associated | relid=0 | w=106
  2642. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in deep cerebral white matter, brainstem, and cerebellar white matter with sparing of the periventricular rim
    n1=en:white substance | n2=en:t2-weighted hyperintensities in deep cerebral white matter, brainstem, and cerebellar white matter with sparing of the periventricular rim | rel=r_associated | relid=0 | w=106
  2643. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in subcortical brain regions seen on mri
    n1=en:white substance | n2=en:t2-weighted hyperintensities in subcortical brain regions seen on mri | rel=r_associated | relid=0 | w=106
  2644. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem seen on mri
    n1=en:white substance | n2=en:t2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem seen on mri | rel=r_associated | relid=0 | w=106
  2645. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in the corticospinal tracts and posterior arms of the internal capsule in older patients seen on mri
    n1=en:white substance | n2=en:t2-weighted hyperintensities in the corticospinal tracts and posterior arms of the internal capsule in older patients seen on mri | rel=r_associated | relid=0 | w=106
  2646. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in the periventricular and deep subcortical white matter
    n1=en:white substance | n2=en:t2-weighted hyperintensities in the periventricular and deep subcortical white matter | rel=r_associated | relid=0 | w=106
  2647. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hyperintensities in the putamen and caudate nuclei
    n1=en:white substance | n2=en:t2-weighted hyperintensities in the putamen and caudate nuclei | rel=r_associated | relid=0 | w=106
  2648. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted hypodensities in the basal ganglia
    n1=en:white substance | n2=en:t2-weighted hypodensities in the basal ganglia | rel=r_associated | relid=0 | w=106
  2649. en:white substance -- r_associated #0: 106 / 0.876 -> en:t2-weighted signal abnormalities in the deep white matter
    n1=en:white substance | n2=en:t2-weighted signal abnormalities in the deep white matter | rel=r_associated | relid=0 | w=106
  2650. en:white substance -- r_associated #0: 106 / 0.876 -> en:tardive dyskinesia
    n1=en:white substance | n2=en:tardive dyskinesia | rel=r_associated | relid=0 | w=106
  2651. en:white substance -- r_associated #0: 106 / 0.876 -> en:tau immunreactivity
    n1=en:white substance | n2=en:tau immunreactivity | rel=r_associated | relid=0 | w=106
  2652. en:white substance -- r_associated #0: 106 / 0.876 -> en:tau inclusions are 'flame-shaped' or 'tuft-like'
    n1=en:white substance | n2=en:tau inclusions are 'flame-shaped' or 'tuft-like' | rel=r_associated | relid=0 | w=106
  2653. en:white substance -- r_associated #0: 106 / 0.876 -> en:tau-containing inclusions
    n1=en:white substance | n2=en:tau-containing inclusions | rel=r_associated | relid=0 | w=106
  2654. en:white substance -- r_associated #0: 106 / 0.876 -> en:tau-immunoreactive inclusions in neurons and astrocytes
    n1=en:white substance | n2=en:tau-immunoreactive inclusions in neurons and astrocytes | rel=r_associated | relid=0 | w=106
  2655. en:white substance -- r_associated #0: 106 / 0.876 -> en:tau-positive inclusions may be found
    n1=en:white substance | n2=en:tau-positive inclusions may be found | rel=r_associated | relid=0 | w=106
  2656. en:white substance -- r_associated #0: 106 / 0.876 -> en:tbp- and 1c2-immunoreactive neuronal inclusions
    n1=en:white substance | n2=en:tbp- and 1c2-immunoreactive neuronal inclusions | rel=r_associated | relid=0 | w=106
  2657. en:white substance -- r_associated #0: 106 / 0.876 -> en:tdp43-positive inclusions
    n1=en:white substance | n2=en:tdp43-positive inclusions | rel=r_associated | relid=0 | w=106
  2658. en:white substance -- r_associated #0: 106 / 0.876 -> en:tdp43-positive neuronal and glial cytoplasmic inclusions
    n1=en:white substance | n2=en:tdp43-positive neuronal and glial cytoplasmic inclusions | rel=r_associated | relid=0 | w=106
  2659. en:white substance -- r_associated #0: 106 / 0.876 -> en:tdp43-positive neuronal inclusions
    n1=en:white substance | n2=en:tdp43-positive neuronal inclusions | rel=r_associated | relid=0 | w=106
  2660. en:white substance -- r_associated #0: 106 / 0.876 -> en:tectal enlargement
    n1=en:white substance | n2=en:tectal enlargement | rel=r_associated | relid=0 | w=106
  2661. en:white substance -- r_associated #0: 106 / 0.876 -> en:temporal epileptiform discharges seen on eeg
    n1=en:white substance | n2=en:temporal epileptiform discharges seen on eeg | rel=r_associated | relid=0 | w=106
  2662. en:white substance -- r_associated #0: 106 / 0.876 -> en:temporal lobe
    n1=en:white substance | n2=en:temporal lobe | rel=r_associated | relid=0 | w=106
  2663. en:white substance -- r_associated #0: 106 / 0.876 -> en:temporal lobe epilepsy (1 patient)
    n1=en:white substance | n2=en:temporal lobe epilepsy (1 patient) | rel=r_associated | relid=0 | w=106
  2664. en:white substance -- r_associated #0: 106 / 0.876 -> en:temporal lobe infarct (rare)
    n1=en:white substance | n2=en:temporal lobe infarct (rare) | rel=r_associated | relid=0 | w=106
  2665. en:white substance -- r_associated #0: 106 / 0.876 -> en:temporal lobe seizures (in 1 patient)
    n1=en:white substance | n2=en:temporal lobe seizures (in 1 patient) | rel=r_associated | relid=0 | w=106
  2666. en:white substance -- r_associated #0: 106 / 0.876 -> en:tendency to walk on toes
    n1=en:white substance | n2=en:tendency to walk on toes | rel=r_associated | relid=0 | w=106
  2667. en:white substance -- r_associated #0: 106 / 0.876 -> en:tetany, hypocalcemic, episodic
    n1=en:white substance | n2=en:tetany, hypocalcemic, episodic | rel=r_associated | relid=0 | w=106
  2668. en:white substance -- r_associated #0: 106 / 0.876 -> en:tethered spinal cord
    n1=en:white substance | n2=en:tethered spinal cord | rel=r_associated | relid=0 | w=106
  2669. en:white substance -- r_associated #0: 106 / 0.876 -> en:tethered spinal cord syndrome
    n1=en:white substance | n2=en:tethered spinal cord syndrome | rel=r_associated | relid=0 | w=106
  2670. en:white substance -- r_associated #0: 106 / 0.876 -> en:tetraplegic spasticity
    n1=en:white substance | n2=en:tetraplegic spasticity | rel=r_associated | relid=0 | w=106
  2671. en:white substance -- r_associated #0: 106 / 0.876 -> en:tfg- and tdp43-positive intraneuronal inclusions in some sensory and motor spinal cord neurons
    n1=en:white substance | n2=en:tfg- and tdp43-positive intraneuronal inclusions in some sensory and motor spinal cord neurons | rel=r_associated | relid=0 | w=106
  2672. en:white substance -- r_associated #0: 106 / 0.876 -> en:thalamic hypoplasia
    n1=en:white substance | n2=en:thalamic hypoplasia | rel=r_associated | relid=0 | w=106
  2673. en:white substance -- r_associated #0: 106 / 0.876 -> en:thalamic neuronal loss, especially in the medial dorsal nucleus
    n1=en:white substance | n2=en:thalamic neuronal loss, especially in the medial dorsal nucleus | rel=r_associated | relid=0 | w=106
  2674. en:white substance -- r_associated #0: 106 / 0.876 -> en:thenar muscle atrophy
    n1=en:white substance | n2=en:thenar muscle atrophy | rel=r_associated | relid=0 | w=106
  2675. en:white substance -- r_associated #0: 106 / 0.876 -> en:thenar muscle weakness
    n1=en:white substance | n2=en:thenar muscle weakness | rel=r_associated | relid=0 | w=106
  2676. en:white substance -- r_associated #0: 106 / 0.876 -> en:thick corpus callosum
    n1=en:white substance | n2=en:thick corpus callosum | rel=r_associated | relid=0 | w=106
  2677. en:white substance -- r_associated #0: 106 / 0.876 -> en:thick cortex
    n1=en:white substance | n2=en:thick cortex | rel=r_associated | relid=0 | w=106
  2678. en:white substance -- r_associated #0: 106 / 0.876 -> en:thick, maloriented superior cerebellar peduncles
    n1=en:white substance | n2=en:thick, maloriented superior cerebellar peduncles | rel=r_associated | relid=0 | w=106
  2679. en:white substance -- r_associated #0: 106 / 0.876 -> en:thick, short corpus callosum
    n1=en:white substance | n2=en:thick, short corpus callosum | rel=r_associated | relid=0 | w=106
  2680. en:white substance -- r_associated #0: 106 / 0.876 -> en:thickened cortices
    n1=en:white substance | n2=en:thickened cortices | rel=r_associated | relid=0 | w=106
  2681. en:white substance -- r_associated #0: 106 / 0.876 -> en:thickened optic nerve sheath
    n1=en:white substance | n2=en:thickened optic nerve sheath | rel=r_associated | relid=0 | w=106
  2682. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin bony cortex
    n1=en:white substance | n2=en:thin bony cortex | rel=r_associated | relid=0 | w=106
  2683. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin brainstem
    n1=en:white substance | n2=en:thin brainstem | rel=r_associated | relid=0 | w=106
  2684. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin cerebral cortex
    n1=en:white substance | n2=en:thin cerebral cortex | rel=r_associated | relid=0 | w=106
  2685. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin corpus callosum (1 family)
    n1=en:white substance | n2=en:thin corpus callosum (1 family) | rel=r_associated | relid=0 | w=106
  2686. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin corpus callosum (1 patient)
    n1=en:white substance | n2=en:thin corpus callosum (1 patient) | rel=r_associated | relid=0 | w=106
  2687. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin corpus callosum (1/4 patients)
    n1=en:white substance | n2=en:thin corpus callosum (1/4 patients) | rel=r_associated | relid=0 | w=106
  2688. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin corpus callosum (in some patients)
    n1=en:white substance | n2=en:thin corpus callosum (in some patients) | rel=r_associated | relid=0 | w=106
  2689. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin corpus callosum enlarged ventricles
    n1=en:white substance | n2=en:thin corpus callosum enlarged ventricles | rel=r_associated | relid=0 | w=106
  2690. en:white substance -- r_associated #0: 106 / 0.876 -> en:thin cortical mantle (wws)
    n1=en:white substance | n2=en:thin cortical mantle (wws) | rel=r_associated | relid=0 | w=106
  2691. en:white substance -- r_associated #0: 106 / 0.876 -> en:toe-walking gait
    n1=en:white substance | n2=en:toe-walking gait | rel=r_associated | relid=0 | w=106
  2692. en:white substance -- r_associated #0: 106 / 0.876 -> en:toe-walking in early childhood
    n1=en:white substance | n2=en:toe-walking in early childhood | rel=r_associated | relid=0 | w=106
  2693. en:white substance -- r_associated #0: 106 / 0.876 -> en:tonic clonic seizures, infrequent (in one patient)
    n1=en:white substance | n2=en:tonic clonic seizures, infrequent (in one patient) | rel=r_associated | relid=0 | w=106
  2694. en:white substance -- r_associated #0: 106 / 0.876 -> en:tonic convulsion
    n1=en:white substance | n2=en:tonic convulsion | rel=r_associated | relid=0 | w=106
  2695. en:white substance -- r_associated #0: 106 / 0.876 -> en:tonic head extension
    n1=en:white substance | n2=en:tonic head extension | rel=r_associated | relid=0 | w=106
  2696. en:white substance -- r_associated #0: 106 / 0.876 -> en:tonic posturing
    n1=en:white substance | n2=en:tonic posturing | rel=r_associated | relid=0 | w=106
  2697. en:white substance -- r_associated #0: 106 / 0.876 -> en:tonic spasms
    n1=en:white substance | n2=en:tonic spasms | rel=r_associated | relid=0 | w=106
  2698. en:white substance -- r_associated #0: 106 / 0.876 -> en:tonus dysregulation
    n1=en:white substance | n2=en:tonus dysregulation | rel=r_associated | relid=0 | w=106
  2699. en:white substance -- r_associated #0: 106 / 0.876 -> en:total body paralysis, paroxysmal
    n1=en:white substance | n2=en:total body paralysis, paroxysmal | rel=r_associated | relid=0 | w=106
  2700. en:white substance -- r_associated #0: 106 / 0.876 -> en:touch, vibration, and limb position may or may not be affected
    n1=en:white substance | n2=en:touch, vibration, and limb position may or may not be affected | rel=r_associated | relid=0 | w=106
  2701. en:white substance -- r_associated #0: 106 / 0.876 -> en:transient ataxia
    n1=en:white substance | n2=en:transient ataxia | rel=r_associated | relid=0 | w=106
  2702. en:white substance -- r_associated #0: 106 / 0.876 -> en:transient ischemic attack
    n1=en:white substance | n2=en:transient ischemic attack | rel=r_associated | relid=0 | w=106
  2703. en:white substance -- r_associated #0: 106 / 0.876 -> en:transient, reversible neurologic deficits
    n1=en:white substance | n2=en:transient, reversible neurologic deficits | rel=r_associated | relid=0 | w=106
  2704. en:white substance -- r_associated #0: 106 / 0.876 -> en:transitional facial palsy (15%)
    n1=en:white substance | n2=en:transitional facial palsy (15%) | rel=r_associated | relid=0 | w=106
  2705. en:white substance -- r_associated #0: 106 / 0.876 -> en:transplantation aspects
    n1=en:white substance | n2=en:transplantation aspects | rel=r_associated | relid=0 | w=106
  2706. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor
    n1=en:white substance | n2=en:tremor | rel=r_associated | relid=0 | w=106
  2707. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor (30%)
    n1=en:white substance | n2=en:tremor (30%) | rel=r_associated | relid=0 | w=106
  2708. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor (later-onset)
    n1=en:white substance | n2=en:tremor (later-onset) | rel=r_associated | relid=0 | w=106
  2709. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor (less common)
    n1=en:white substance | n2=en:tremor (less common) | rel=r_associated | relid=0 | w=106
  2710. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor is exacerbated by stress and exercise
    n1=en:white substance | n2=en:tremor is exacerbated by stress and exercise | rel=r_associated | relid=0 | w=106
  2711. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor of hands
    n1=en:white substance | n2=en:tremor of hands | rel=r_associated | relid=0 | w=106
  2712. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor of the upper limb
    n1=en:white substance | n2=en:tremor of the upper limb | rel=r_associated | relid=0 | w=106
  2713. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor, postural (arms, tongue, head, legs and trunk)
    n1=en:white substance | n2=en:tremor, postural (arms, tongue, head, legs and trunk) | rel=r_associated | relid=0 | w=106
  2714. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor, postural, upper limb, onset in fourth decade (reported in 1 family)
    n1=en:white substance | n2=en:tremor, postural, upper limb, onset in fourth decade (reported in 1 family) | rel=r_associated | relid=0 | w=106
  2715. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor, small-amplitude, high-frequency, restricted to the hands
    n1=en:white substance | n2=en:tremor, small-amplitude, high-frequency, restricted to the hands | rel=r_associated | relid=0 | w=106
  2716. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremor, static
    n1=en:white substance | n2=en:tremor, static | rel=r_associated | relid=0 | w=106
  2717. en:white substance -- r_associated #0: 106 / 0.876 -> en:tremors, limb
    n1=en:white substance | n2=en:tremors, limb | rel=r_associated | relid=0 | w=106
  2718. en:white substance -- r_associated #0: 106 / 0.876 -> en:trigeminal neuralgia
    n1=en:white substance | n2=en:trigeminal neuralgia | rel=r_associated | relid=0 | w=106
  2719. en:white substance -- r_associated #0: 106 / 0.876 -> en:trismus
    n1=en:white substance | n2=en:trismus | rel=r_associated | relid=0 | w=106
  2720. en:white substance -- r_associated #0: 106 / 0.876 -> en:trismus (rare)
    n1=en:white substance | n2=en:trismus (rare) | rel=r_associated | relid=0 | w=106
  2721. en:white substance -- r_associated #0: 106 / 0.876 -> en:truncal arching
    n1=en:white substance | n2=en:truncal arching | rel=r_associated | relid=0 | w=106
  2722. en:white substance -- r_associated #0: 106 / 0.876 -> en:truncal ataxia, severe
    n1=en:white substance | n2=en:truncal ataxia, severe | rel=r_associated | relid=0 | w=106
  2723. en:white substance -- r_associated #0: 106 / 0.876 -> en:truncal titubation
    n1=en:white substance | n2=en:truncal titubation | rel=r_associated | relid=0 | w=106
  2724. en:white substance -- r_associated #0: 106 / 0.876 -> en:tussive syncopes
    n1=en:white substance | n2=en:tussive syncopes | rel=r_associated | relid=0 | w=106
  2725. en:white substance -- r_associated #0: 106 / 0.876 -> en:twitching of the fingers and toes
    n1=en:white substance | n2=en:twitching of the fingers and toes | rel=r_associated | relid=0 | w=106
  2726. en:white substance -- r_associated #0: 106 / 0.876 -> en:type i arnold chiari malformation
    n1=en:white substance | n2=en:type i arnold chiari malformation | rel=r_associated | relid=0 | w=106
  2727. en:white substance -- r_associated #0: 106 / 0.876 -> en:type i eeg response is occipital spikes
    n1=en:white substance | n2=en:type i eeg response is occipital spikes | rel=r_associated | relid=0 | w=106
  2728. en:white substance -- r_associated #0: 106 / 0.876 -> en:type ii eeg response is parietooccipital spikes followed by biphasic slow waves
    n1=en:white substance | n2=en:type ii eeg response is parietooccipital spikes followed by biphasic slow waves | rel=r_associated | relid=0 | w=106
  2729. en:white substance -- r_associated #0: 106 / 0.876 -> en:type iii eeg response is parietooccipital spikes followed by biphasic slow waves and spreading to the frontal region
    n1=en:white substance | n2=en:type iii eeg response is parietooccipital spikes followed by biphasic slow waves and spreading to the frontal region | rel=r_associated | relid=0 | w=106
  2730. en:white substance -- r_associated #0: 106 / 0.876 -> en:ubiquitin-positive cytoplasmic and intranuclear neuronal inclusions
    n1=en:white substance | n2=en:ubiquitin-positive cytoplasmic and intranuclear neuronal inclusions | rel=r_associated | relid=0 | w=106
  2731. en:white substance -- r_associated #0: 106 / 0.876 -> en:ubiquitin-positive intranuclear neuronal inclusions
    n1=en:white substance | n2=en:ubiquitin-positive intranuclear neuronal inclusions | rel=r_associated | relid=0 | w=106
  2732. en:white substance -- r_associated #0: 106 / 0.876 -> en:ubqln2- and tdp43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons
    n1=en:white substance | n2=en:ubqln2- and tdp43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons | rel=r_associated | relid=0 | w=106
  2733. en:white substance -- r_associated #0: 106 / 0.876 -> en:ultrastructure
    n1=en:white substance | n2=en:ultrastructure | rel=r_associated | relid=0 | w=106
  2734. en:white substance -- r_associated #0: 106 / 0.876 -> en:unable to grasp objects
    n1=en:white substance | n2=en:unable to grasp objects | rel=r_associated | relid=0 | w=106
  2735. en:white substance -- r_associated #0: 106 / 0.876 -> en:unable to stand
    n1=en:white substance | n2=en:unable to stand | rel=r_associated | relid=0 | w=106
  2736. en:white substance -- r_associated #0: 106 / 0.876 -> en:unable to walk
    n1=en:white substance | n2=en:unable to walk | rel=r_associated | relid=0 | w=106
  2737. en:white substance -- r_associated #0: 106 / 0.876 -> en:uncoordinated movements
    n1=en:white substance | n2=en:uncoordinated movements | rel=r_associated | relid=0 | w=106
  2738. en:white substance -- r_associated #0: 106 / 0.876 -> en:underdeveloped corpus callosum (3 patients)
    n1=en:white substance | n2=en:underdeveloped corpus callosum (3 patients) | rel=r_associated | relid=0 | w=106
  2739. en:white substance -- r_associated #0: 106 / 0.876 -> en:unidentified bright objects on brain mri
    n1=en:white substance | n2=en:unidentified bright objects on brain mri | rel=r_associated | relid=0 | w=106
  2740. en:white substance -- r_associated #0: 106 / 0.876 -> en:unilateral cerebellar hypoplasia
    n1=en:white substance | n2=en:unilateral cerebellar hypoplasia | rel=r_associated | relid=0 | w=106
  2741. en:white substance -- r_associated #0: 106 / 0.876 -> en:unilateral headache location
    n1=en:white substance | n2=en:unilateral headache location | rel=r_associated | relid=0 | w=106
  2742. en:white substance -- r_associated #0: 106 / 0.876 -> en:unresponsive to stimuli
    n1=en:white substance | n2=en:unresponsive to stimuli | rel=r_associated | relid=0 | w=106
  2743. en:white substance -- r_associated #0: 106 / 0.876 -> en:unresponsiveness
    n1=en:white substance | n2=en:unresponsiveness | rel=r_associated | relid=0 | w=106
  2744. en:white substance -- r_associated #0: 106 / 0.876 -> en:unstable, ataxic gait
    n1=en:white substance | n2=en:unstable, ataxic gait | rel=r_associated | relid=0 | w=106
  2745. en:white substance -- r_associated #0: 106 / 0.876 -> en:unsteadiness, episodic
    n1=en:white substance | n2=en:unsteadiness, episodic | rel=r_associated | relid=0 | w=106
  2746. en:white substance -- r_associated #0: 106 / 0.876 -> en:unsteady gait due to muscle weakness
    n1=en:white substance | n2=en:unsteady gait due to muscle weakness | rel=r_associated | relid=0 | w=106
  2747. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper and lower motor neuron degeneration
    n1=en:white substance | n2=en:upper and lower motor neuron degeneration | rel=r_associated | relid=0 | w=106
  2748. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper and lower neuron manifestations
    n1=en:white substance | n2=en:upper and lower neuron manifestations | rel=r_associated | relid=0 | w=106
  2749. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper body involvement
    n1=en:white substance | n2=en:upper body involvement | rel=r_associated | relid=0 | w=106
  2750. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper extremity action tremor
    n1=en:white substance | n2=en:upper extremity action tremor | rel=r_associated | relid=0 | w=106
  2751. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb ataxia
    n1=en:white substance | n2=en:upper limb ataxia | rel=r_associated | relid=0 | w=106
  2752. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb dysmetria
    n1=en:white substance | n2=en:upper limb dysmetria | rel=r_associated | relid=0 | w=106
  2753. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb hyperreflexia (in some patients)
    n1=en:white substance | n2=en:upper limb hyperreflexia (in some patients) | rel=r_associated | relid=0 | w=106
  2754. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb hyperreflexia (some)
    n1=en:white substance | n2=en:upper limb hyperreflexia (some) | rel=r_associated | relid=0 | w=106
  2755. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb involvement
    n1=en:white substance | n2=en:upper limb involvement | rel=r_associated | relid=0 | w=106
  2756. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb involvement (in some patients)
    n1=en:white substance | n2=en:upper limb involvement (in some patients) | rel=r_associated | relid=0 | w=106
  2757. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb involvement (onset in the first decade)
    n1=en:white substance | n2=en:upper limb involvement (onset in the first decade) | rel=r_associated | relid=0 | w=106
  2758. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb involvement may occur
    n1=en:white substance | n2=en:upper limb involvement may occur | rel=r_associated | relid=0 | w=106
  2759. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb spasticity
    n1=en:white substance | n2=en:upper limb spasticity | rel=r_associated | relid=0 | w=106
  2760. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb weakness
    n1=en:white substance | n2=en:upper limb weakness | rel=r_associated | relid=0 | w=106
  2761. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limb weakness may occur later
    n1=en:white substance | n2=en:upper limb weakness may occur later | rel=r_associated | relid=0 | w=106
  2762. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limbs affected
    n1=en:white substance | n2=en:upper limbs affected | rel=r_associated | relid=0 | w=106
  2763. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limbs may be affected
    n1=en:white substance | n2=en:upper limbs may be affected | rel=r_associated | relid=0 | w=106
  2764. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limbs may show hyperreflexia
    n1=en:white substance | n2=en:upper limbs may show hyperreflexia | rel=r_associated | relid=0 | w=106
  2765. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limbs may show mild involvement
    n1=en:white substance | n2=en:upper limbs may show mild involvement | rel=r_associated | relid=0 | w=106
  2766. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper limbs more often affected than lower limbs
    n1=en:white substance | n2=en:upper limbs more often affected than lower limbs | rel=r_associated | relid=0 | w=106
  2767. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper motor involvement (some patient)
    n1=en:white substance | n2=en:upper motor involvement (some patient) | rel=r_associated | relid=0 | w=106
  2768. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper motor neuron dysfunction
    n1=en:white substance | n2=en:upper motor neuron dysfunction | rel=r_associated | relid=0 | w=106
  2769. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper motor neuron signs, early
    n1=en:white substance | n2=en:upper motor neuron signs, early | rel=r_associated | relid=0 | w=106
  2770. en:white substance -- r_associated #0: 106 / 0.876 -> en:upper motor signs (in some patients)
    n1=en:white substance | n2=en:upper motor signs (in some patients) | rel=r_associated | relid=0 | w=106
  2771. en:white substance -- r_associated #0: 106 / 0.876 -> en:uremic coma
    n1=en:white substance | n2=en:uremic coma | rel=r_associated | relid=0 | w=106
  2772. en:white substance -- r_associated #0: 106 / 0.876 -> en:use of ultrasonography
    n1=en:white substance | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=106
  2773. en:white substance -- r_associated #0: 106 / 0.876 -> en:vacuolated neurons
    n1=en:white substance | n2=en:vacuolated neurons | rel=r_associated | relid=0 | w=106
  2774. en:white substance -- r_associated #0: 106 / 0.876 -> en:vacuolizing myelinopathy
    n1=en:white substance | n2=en:vacuolizing myelinopathy | rel=r_associated | relid=0 | w=106
  2775. en:white substance -- r_associated #0: 106 / 0.876 -> en:variable delay (iq range 52-104)
    n1=en:white substance | n2=en:variable delay (iq range 52-104) | rel=r_associated | relid=0 | w=106
  2776. en:white substance -- r_associated #0: 106 / 0.876 -> en:variable intracranial abnormalities
    n1=en:white substance | n2=en:variable intracranial abnormalities | rel=r_associated | relid=0 | w=106
  2777. en:white substance -- r_associated #0: 106 / 0.876 -> en:variable mental retardation
    n1=en:white substance | n2=en:variable mental retardation | rel=r_associated | relid=0 | w=106
  2778. en:white substance -- r_associated #0: 106 / 0.876 -> en:variable mental retardation (40%)
    n1=en:white substance | n2=en:variable mental retardation (40%) | rel=r_associated | relid=0 | w=106
  2779. en:white substance -- r_associated #0: 106 / 0.876 -> en:variable mental retardation ranging from severe neurodegeneration to mild mental retardation
    n1=en:white substance | n2=en:variable mental retardation ranging from severe neurodegeneration to mild mental retardation | rel=r_associated | relid=0 | w=106
  2780. en:white substance -- r_associated #0: 106 / 0.876 -> en:variable neurologic deterioration (likely result of hemophagocytic syndrome)
    n1=en:white substance | n2=en:variable neurologic deterioration (likely result of hemophagocytic syndrome) | rel=r_associated | relid=0 | w=106
  2781. en:white substance -- r_associated #0: 106 / 0.876 -> en:vasculopathy of the small arteries penetrating the white matter
    n1=en:white substance | n2=en:vasculopathy of the small arteries penetrating the white matter | rel=r_associated | relid=0 | w=106
  2782. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventral funiculus
    n1=en:white substance | n2=en:ventral funiculus | rel=r_associated | relid=0 | w=106
  2783. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventral nerve root
    n1=en:white substance | n2=en:ventral nerve root | rel=r_associated | relid=0 | w=106
  2784. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventricular anomalies
    n1=en:white substance | n2=en:ventricular anomalies | rel=r_associated | relid=0 | w=106
  2785. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventricular asymmetry
    n1=en:white substance | n2=en:ventricular asymmetry | rel=r_associated | relid=0 | w=106
  2786. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventricular dilatation (29%)
    n1=en:white substance | n2=en:ventricular dilatation (29%) | rel=r_associated | relid=0 | w=106
  2787. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventricular dilatation (rare)
    n1=en:white substance | n2=en:ventricular dilatation (rare) | rel=r_associated | relid=0 | w=106
  2788. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventricular enlargement, mild
    n1=en:white substance | n2=en:ventricular enlargement, mild | rel=r_associated | relid=0 | w=106
  2789. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventriculomegaly (in some patients)
    n1=en:white substance | n2=en:ventriculomegaly (in some patients) | rel=r_associated | relid=0 | w=106
  2790. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventriculomegaly, mild (rare)
    n1=en:white substance | n2=en:ventriculomegaly, mild (rare) | rel=r_associated | relid=0 | w=106
  2791. en:white substance -- r_associated #0: 106 / 0.876 -> en:ventriculomeglia
    n1=en:white substance | n2=en:ventriculomeglia | rel=r_associated | relid=0 | w=106
  2792. en:white substance -- r_associated #0: 106 / 0.876 -> en:verbal delay (in some patients)
    n1=en:white substance | n2=en:verbal delay (in some patients) | rel=r_associated | relid=0 | w=106
  2793. en:white substance -- r_associated #0: 106 / 0.876 -> en:vermian hypoplasia
    n1=en:white substance | n2=en:vermian hypoplasia | rel=r_associated | relid=0 | w=106
  2794. en:white substance -- r_associated #0: 106 / 0.876 -> en:vertical orientation of hippocampus
    n1=en:white substance | n2=en:vertical orientation of hippocampus | rel=r_associated | relid=0 | w=106
  2795. en:white substance -- r_associated #0: 106 / 0.876 -> en:very poor expressive speech
    n1=en:white substance | n2=en:very poor expressive speech | rel=r_associated | relid=0 | w=106
  2796. en:white substance -- r_associated #0: 106 / 0.876 -> en:vestibular diseases
    n1=en:white substance | n2=en:vestibular diseases | rel=r_associated | relid=0 | w=106
  2797. en:white substance -- r_associated #0: 106 / 0.876 -> en:vestibular dysfunction
    n1=en:white substance | n2=en:vestibular dysfunction | rel=r_associated | relid=0 | w=106
  2798. en:white substance -- r_associated #0: 106 / 0.876 -> en:vestibulopathy, bilateral, progressive (onset in fourth or fifth decade)
    n1=en:white substance | n2=en:vestibulopathy, bilateral, progressive (onset in fourth or fifth decade) | rel=r_associated | relid=0 | w=106
  2799. en:white substance -- r_associated #0: 106 / 0.876 -> en:virtual absence of pyramidal tracts (wws)
    n1=en:white substance | n2=en:virtual absence of pyramidal tracts (wws) | rel=r_associated | relid=0 | w=106
  2800. en:white substance -- r_associated #0: 106 / 0.876 -> en:viruses
    n1=en:white substance | n2=en:viruses | rel=r_associated | relid=0 | w=106
  2801. en:white substance -- r_associated #0: 106 / 0.876 -> en:visceroautonomic dysfunction
    n1=en:white substance | n2=en:visceroautonomic dysfunction | rel=r_associated | relid=0 | w=106
  2802. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual acuity is normal
    n1=en:white substance | n2=en:visual acuity is normal | rel=r_associated | relid=0 | w=106
  2803. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual auras
    n1=en:white substance | n2=en:visual auras | rel=r_associated | relid=0 | w=106
  2804. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual blackouts (stage 1)
    n1=en:white substance | n2=en:visual blackouts (stage 1) | rel=r_associated | relid=0 | w=106
  2805. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual hallucination
    n1=en:white substance | n2=en:visual hallucination | rel=r_associated | relid=0 | w=106
  2806. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual hallucinations may occur
    n1=en:white substance | n2=en:visual hallucinations may occur | rel=r_associated | relid=0 | w=106
  2807. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual impairment
    n1=en:white substance | n2=en:visual impairment | rel=r_associated | relid=0 | w=106
  2808. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual inattention
    n1=en:white substance | n2=en:visual inattention | rel=r_associated | relid=0 | w=106
  2809. en:white substance -- r_associated #0: 106 / 0.876 -> en:visual symptoms (in 60% of patients)
    n1=en:white substance | n2=en:visual symptoms (in 60% of patients) | rel=r_associated | relid=0 | w=106
  2810. en:white substance -- r_associated #0: 106 / 0.876 -> en:visuospatial agnosia (in a subset of patients)
    n1=en:white substance | n2=en:visuospatial agnosia (in a subset of patients) | rel=r_associated | relid=0 | w=106
  2811. en:white substance -- r_associated #0: 106 / 0.876 -> en:vocalization (finding)
    n1=en:white substance | n2=en:vocalization (finding) | rel=r_associated | relid=0 | w=106
  2812. en:white substance -- r_associated #0: 106 / 0.876 -> en:walking delay
    n1=en:white substance | n2=en:walking delay | rel=r_associated | relid=0 | w=106
  2813. en:white substance -- r_associated #0: 106 / 0.876 -> en:walking during slow-wave sleep (sleepwalking)
    n1=en:white substance | n2=en:walking during slow-wave sleep (sleepwalking) | rel=r_associated | relid=0 | w=106
  2814. en:white substance -- r_associated #0: 106 / 0.876 -> en:weakness
    n1=en:white substance | n2=en:weakness | rel=r_associated | relid=0 | w=106
  2815. en:white substance -- r_associated #0: 106 / 0.876 -> en:weakness of hip and ankle flexion
    n1=en:white substance | n2=en:weakness of hip and ankle flexion | rel=r_associated | relid=0 | w=106
  2816. en:white substance -- r_associated #0: 106 / 0.876 -> en:west syndrome
    n1=en:white substance | n2=en:west syndrome | rel=r_associated | relid=0 | w=106
  2817. en:white substance -- r_associated #0: 106 / 0.876 -> en:white mater abnormalities in the posterior periventricular region
    n1=en:white substance | n2=en:white mater abnormalities in the posterior periventricular region | rel=r_associated | relid=0 | w=106
  2818. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter abnormalities (1 patient)
    n1=en:white substance | n2=en:white matter abnormalities (1 patient) | rel=r_associated | relid=0 | w=106
  2819. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter abnormalities (in some)
    n1=en:white substance | n2=en:white matter abnormalities (in some) | rel=r_associated | relid=0 | w=106
  2820. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter abnormalities (uncommon)
    n1=en:white substance | n2=en:white matter abnormalities (uncommon) | rel=r_associated | relid=0 | w=106
  2821. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter abnormalities on mri
    n1=en:white substance | n2=en:white matter abnormalities on mri | rel=r_associated | relid=0 | w=106
  2822. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter abnormalities seen on mri
    n1=en:white substance | n2=en:white matter abnormalities seen on mri | rel=r_associated | relid=0 | w=106
  2823. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter abnormalities seen on mri which resolve over time
    n1=en:white substance | n2=en:white matter abnormalities seen on mri which resolve over time | rel=r_associated | relid=0 | w=106
  2824. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter alterations (in one family)
    n1=en:white substance | n2=en:white matter alterations (in one family) | rel=r_associated | relid=0 | w=106
  2825. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter degeneration
    n1=en:white substance | n2=en:white matter degeneration | rel=r_associated | relid=0 | w=106
  2826. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter dysmyelination/demyelination (71%)
    n1=en:white substance | n2=en:white matter dysmyelination/demyelination (71%) | rel=r_associated | relid=0 | w=106
  2827. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter hyperintensities
    n1=en:white substance | n2=en:white matter hyperintensities | rel=r_associated | relid=0 | w=106
  2828. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter hyperintensities in t2 imaging
    n1=en:white substance | n2=en:white matter hyperintensities in t2 imaging | rel=r_associated | relid=0 | w=106
  2829. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter hypodensities seen on mri
    n1=en:white substance | n2=en:white matter hypodensities seen on mri | rel=r_associated | relid=0 | w=106
  2830. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter immaturity
    n1=en:white substance | n2=en:white matter immaturity | rel=r_associated | relid=0 | w=106
  2831. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter lesions (1 patient)
    n1=en:white substance | n2=en:white matter lesions (1 patient) | rel=r_associated | relid=0 | w=106
  2832. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter lesions in the basal ganglia
    n1=en:white substance | n2=en:white matter lesions in the basal ganglia | rel=r_associated | relid=0 | w=106
  2833. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter lesions may occur in the thalami, basal ganglia, and periventricular white matter (see leigh syndrome, 256000)
    n1=en:white substance | n2=en:white matter lesions may occur in the thalami, basal ganglia, and periventricular white matter (see leigh syndrome, 256000) | rel=r_associated | relid=0 | w=106
  2834. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter lesions seen on brain imaging
    n1=en:white substance | n2=en:white matter lesions seen on brain imaging | rel=r_associated | relid=0 | w=106
  2835. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter neuronal heterotopia
    n1=en:white substance | n2=en:white matter neuronal heterotopia | rel=r_associated | relid=0 | w=106
  2836. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter signal abnormalities in the deep white matter and periventricular regions
    n1=en:white substance | n2=en:white matter signal abnormalities in the deep white matter and periventricular regions | rel=r_associated | relid=0 | w=106
  2837. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter signal abnormalities in various brain regions
    n1=en:white substance | n2=en:white matter signal abnormalities in various brain regions | rel=r_associated | relid=0 | w=106
  2838. en:white substance -- r_associated #0: 106 / 0.876 -> en:white matter streaks
    n1=en:white substance | n2=en:white matter streaks | rel=r_associated | relid=0 | w=106
  2839. en:white substance -- r_associated #0: 106 / 0.876 -> en:wide subarachnoid spaces
    n1=en:white substance | n2=en:wide subarachnoid spaces | rel=r_associated | relid=0 | w=106
  2840. en:white substance -- r_associated #0: 106 / 0.876 -> en:wide sylvian fissures with incomplete opercularization
    n1=en:white substance | n2=en:wide sylvian fissures with incomplete opercularization | rel=r_associated | relid=0 | w=106
  2841. en:white substance -- r_associated #0: 106 / 0.876 -> en:widened lateral ventricles
    n1=en:white substance | n2=en:widened lateral ventricles | rel=r_associated | relid=0 | w=106
  2842. en:white substance -- r_associated #0: 106 / 0.876 -> en:widened subarachnoid spaces
    n1=en:white substance | n2=en:widened subarachnoid spaces | rel=r_associated | relid=0 | w=106
  2843. en:white substance -- r_associated #0: 106 / 0.876 -> en:widening of cortical sulci
    n1=en:white substance | n2=en:widening of cortical sulci | rel=r_associated | relid=0 | w=106
  2844. en:white substance -- r_associated #0: 106 / 0.876 -> en:widening of the spinal canal
    n1=en:white substance | n2=en:widening of the spinal canal | rel=r_associated | relid=0 | w=106
  2845. en:white substance -- r_associated #0: 106 / 0.876 -> en:widening of the ventricles
    n1=en:white substance | n2=en:widening of the ventricles | rel=r_associated | relid=0 | w=106
  2846. en:white substance -- r_associated #0: 106 / 0.876 -> en:widespread brain atrophy
    n1=en:white substance | n2=en:widespread brain atrophy | rel=r_associated | relid=0 | w=106
  2847. en:white substance -- r_associated #0: 106 / 0.876 -> en:widespread brain calcifications
    n1=en:white substance | n2=en:widespread brain calcifications | rel=r_associated | relid=0 | w=106
  2848. en:white substance -- r_associated #0: 106 / 0.876 -> en:word finding difficulty (disorder)
    n1=en:white substance | n2=en:word finding difficulty (disorder) | rel=r_associated | relid=0 | w=106
  2849. en:white substance -- r_associated #0: 99 / 0.818 -> matière blanche
    n1=en:white substance | n2=matière blanche | rel=r_associated | relid=0 | w=99
  2850. en:white substance -- r_associated #0: 91 / 0.752 -> en:abnormal gait due to muscle weakness
    n1=en:white substance | n2=en:abnormal gait due to muscle weakness | rel=r_associated | relid=0 | w=91
  2851. en:white substance -- r_associated #0: 91 / 0.752 -> en:abnormal hippocampus
    n1=en:white substance | n2=en:abnormal hippocampus | rel=r_associated | relid=0 | w=91
  2852. en:white substance -- r_associated #0: 91 / 0.752 -> en:abnormal sleep pattern
    n1=en:white substance | n2=en:abnormal sleep pattern | rel=r_associated | relid=0 | w=91
  2853. en:white substance -- r_associated #0: 91 / 0.752 -> en:abnormal spike waves
    n1=en:white substance | n2=en:abnormal spike waves | rel=r_associated | relid=0 | w=91
  2854. en:white substance -- r_associated #0: 91 / 0.752 -> en:abnormal t2-weighted signals in the occipital white and gray matter
    n1=en:white substance | n2=en:abnormal t2-weighted signals in the occipital white and gray matter | rel=r_associated | relid=0 | w=91
  2855. en:white substance -- r_associated #0: 91 / 0.752 -> en:absence of vestibular schwannomas at age greater than 18 years
    n1=en:white substance | n2=en:absence of vestibular schwannomas at age greater than 18 years | rel=r_associated | relid=0 | w=91
  2856. en:white substance -- r_associated #0: 91 / 0.752 -> en:absence seizures (in some)
    n1=en:white substance | n2=en:absence seizures (in some) | rel=r_associated | relid=0 | w=91
  2857. en:white substance -- r_associated #0: 91 / 0.752 -> en:absent cisterna magna
    n1=en:white substance | n2=en:absent cisterna magna | rel=r_associated | relid=0 | w=91
  2858. en:white substance -- r_associated #0: 91 / 0.752 -> en:absent development
    n1=en:white substance | n2=en:absent development | rel=r_associated | relid=0 | w=91
  2859. en:white substance -- r_associated #0: 91 / 0.752 -> en:accumulation of pas-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (collins bodies)
    n1=en:white substance | n2=en:accumulation of pas-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (collins bodies) | rel=r_associated | relid=0 | w=91
  2860. en:white substance -- r_associated #0: 91 / 0.752 -> en:actin- and actin depolymerizing factor/cofilin-immunoreactive eosinophilic spherical structures in the striatum
    n1=en:white substance | n2=en:actin- and actin depolymerizing factor/cofilin-immunoreactive eosinophilic spherical structures in the striatum | rel=r_associated | relid=0 | w=91
  2861. en:white substance -- r_associated #0: 91 / 0.752 -> en:agenesis of the occipital lobes (1 patient)
    n1=en:white substance | n2=en:agenesis of the occipital lobes (1 patient) | rel=r_associated | relid=0 | w=91
  2862. en:white substance -- r_associated #0: 91 / 0.752 -> en:agenesis or hypogenesis of the cerebellar vermis
    n1=en:white substance | n2=en:agenesis or hypogenesis of the cerebellar vermis | rel=r_associated | relid=0 | w=91
  2863. en:white substance -- r_associated #0: 91 / 0.752 -> en:aggression
    n1=en:white substance | n2=en:aggression | rel=r_associated | relid=0 | w=91
  2864. en:white substance -- r_associated #0: 91 / 0.752 -> en:agnosia
    n1=en:white substance | n2=en:agnosia | rel=r_associated | relid=0 | w=91
  2865. en:white substance -- r_associated #0: 91 / 0.752 -> en:akinetic mutism (in some patients)
    n1=en:white substance | n2=en:akinetic mutism (in some patients) | rel=r_associated | relid=0 | w=91
  2866. en:white substance -- r_associated #0: 91 / 0.752 -> en:all nervous tissue
    n1=en:white substance | n2=en:all nervous tissue | rel=r_associated | relid=0 | w=91
  2867. en:white substance -- r_associated #0: 91 / 0.752 -> en:alpha-synuclein-immunreactive lewy bodies
    n1=en:white substance | n2=en:alpha-synuclein-immunreactive lewy bodies | rel=r_associated | relid=0 | w=91
  2868. en:white substance -- r_associated #0: 91 / 0.752 -> en:alzheimer disease, early onset
    n1=en:white substance | n2=en:alzheimer disease, early onset | rel=r_associated | relid=0 | w=91
  2869. en:white substance -- r_associated #0: 91 / 0.752 -> en:amyotrophy, distal, severe
    n1=en:white substance | n2=en:amyotrophy, distal, severe | rel=r_associated | relid=0 | w=91
  2870. en:white substance -- r_associated #0: 91 / 0.752 -> en:angiographically 'silent'
    n1=en:white substance | n2=en:angiographically 'silent' | rel=r_associated | relid=0 | w=91
  2871. en:white substance -- r_associated #0: 91 / 0.752 -> en:angulation of the frontal horns
    n1=en:white substance | n2=en:angulation of the frontal horns | rel=r_associated | relid=0 | w=91
  2872. en:white substance -- r_associated #0: 91 / 0.752 -> en:anisocoria
    n1=en:white substance | n2=en:anisocoria | rel=r_associated | relid=0 | w=91
  2873. en:white substance -- r_associated #0: 91 / 0.752 -> en:ankle or knee clonus
    n1=en:white substance | n2=en:ankle or knee clonus | rel=r_associated | relid=0 | w=91
  2874. en:white substance -- r_associated #0: 91 / 0.752 -> en:anterior commissure not evident
    n1=en:white substance | n2=en:anterior commissure not evident | rel=r_associated | relid=0 | w=91
  2875. en:white substance -- r_associated #0: 91 / 0.752 -> en:anterior horn cell impairment
    n1=en:white substance | n2=en:anterior horn cell impairment | rel=r_associated | relid=0 | w=91
  2876. en:white substance -- r_associated #0: 91 / 0.752 -> en:anterior pachygyria and posterior agyria
    n1=en:white substance | n2=en:anterior pachygyria and posterior agyria | rel=r_associated | relid=0 | w=91
  2877. en:white substance -- r_associated #0: 91 / 0.752 -> en:anterior temporal lobe subcortical cysts
    n1=en:white substance | n2=en:anterior temporal lobe subcortical cysts | rel=r_associated | relid=0 | w=91
  2878. en:white substance -- r_associated #0: 91 / 0.752 -> en:aphasia
    n1=en:white substance | n2=en:aphasia | rel=r_associated | relid=0 | w=91
  2879. en:white substance -- r_associated #0: 91 / 0.752 -> en:aplasia of the vermis
    n1=en:white substance | n2=en:aplasia of the vermis | rel=r_associated | relid=0 | w=91
  2880. en:white substance -- r_associated #0: 91 / 0.752 -> en:apoptotic neurons
    n1=en:white substance | n2=en:apoptotic neurons | rel=r_associated | relid=0 | w=91
  2881. en:white substance -- r_associated #0: 91 / 0.752 -> en:appendage of the uterus
    n1=en:white substance | n2=en:appendage of the uterus | rel=r_associated | relid=0 | w=91
  2882. en:white substance -- r_associated #0: 91 / 0.752 -> en:apraxia, verbal
    n1=en:white substance | n2=en:apraxia, verbal | rel=r_associated | relid=0 | w=91
  2883. en:white substance -- r_associated #0: 91 / 0.752 -> en:areflexia of lower limbs
    n1=en:white substance | n2=en:areflexia of lower limbs | rel=r_associated | relid=0 | w=91
  2884. en:white substance -- r_associated #0: 91 / 0.752 -> en:arhinencephaly (1 patient)
    n1=en:white substance | n2=en:arhinencephaly (1 patient) | rel=r_associated | relid=0 | w=91
  2885. en:white substance -- r_associated #0: 91 / 0.752 -> en:arm flexion
    n1=en:white substance | n2=en:arm flexion | rel=r_associated | relid=0 | w=91
  2886. en:white substance -- r_associated #0: 91 / 0.752 -> en:aspects of radiation effects
    n1=en:white substance | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=91
  2887. en:white substance -- r_associated #0: 91 / 0.752 -> en:associated with syringomyelia (186700)
    n1=en:white substance | n2=en:associated with syringomyelia (186700) | rel=r_associated | relid=0 | w=91
  2888. en:white substance -- r_associated #0: 91 / 0.752 -> en:astrocytes show reactive changes
    n1=en:white substance | n2=en:astrocytes show reactive changes | rel=r_associated | relid=0 | w=91
  2889. en:white substance -- r_associated #0: 91 / 0.752 -> en:asymmetric brain development
    n1=en:white substance | n2=en:asymmetric brain development | rel=r_associated | relid=0 | w=91
  2890. en:white substance -- r_associated #0: 91 / 0.752 -> en:asymmetry at onset (74%)
    n1=en:white substance | n2=en:asymmetry at onset (74%) | rel=r_associated | relid=0 | w=91
  2891. en:white substance -- r_associated #0: 91 / 0.752 -> en:ataxia
    n1=en:white substance | n2=en:ataxia | rel=r_associated | relid=0 | w=91
  2892. en:white substance -- r_associated #0: 91 / 0.752 -> en:ataxia (early-onset form)
    n1=en:white substance | n2=en:ataxia (early-onset form) | rel=r_associated | relid=0 | w=91
  2893. en:white substance -- r_associated #0: 91 / 0.752 -> en:ataxias, truncal
    n1=en:white substance | n2=en:ataxias, truncal | rel=r_associated | relid=0 | w=91
  2894. en:white substance -- r_associated #0: 91 / 0.752 -> en:atrophy may be more severe in the left hemisphere
    n1=en:white substance | n2=en:atrophy may be more severe in the left hemisphere | rel=r_associated | relid=0 | w=91
  2895. en:white substance -- r_associated #0: 91 / 0.752 -> en:atrophy of corpus callosum
    n1=en:white substance | n2=en:atrophy of corpus callosum | rel=r_associated | relid=0 | w=91
  2896. en:white substance -- r_associated #0: 91 / 0.752 -> en:atrophy of the pons (in some patients)
    n1=en:white substance | n2=en:atrophy of the pons (in some patients) | rel=r_associated | relid=0 | w=91
  2897. en:white substance -- r_associated #0: 91 / 0.752 -> en:atrophy, thin hemisphere
    n1=en:white substance | n2=en:atrophy, thin hemisphere | rel=r_associated | relid=0 | w=91
  2898. en:white substance -- r_associated #0: 91 / 0.752 -> en:autism or autistic features
    n1=en:white substance | n2=en:autism or autistic features | rel=r_associated | relid=0 | w=91
  2899. en:white substance -- r_associated #0: 91 / 0.752 -> en:autonomic disturbances
    n1=en:white substance | n2=en:autonomic disturbances | rel=r_associated | relid=0 | w=91
  2900. en:white substance -- r_associated #0: 91 / 0.752 -> en:autonomic dysfunction may occur
    n1=en:white substance | n2=en:autonomic dysfunction may occur | rel=r_associated | relid=0 | w=91
  2901. en:white substance -- r_associated #0: 91 / 0.752 -> en:autonomic features may occur (diaphoresis, tachycardia, hyperthermia, hypertension)
    n1=en:white substance | n2=en:autonomic features may occur (diaphoresis, tachycardia, hyperthermia, hypertension) | rel=r_associated | relid=0 | w=91
  2902. en:white substance -- r_associated #0: 91 / 0.752 -> en:autonomic nervous system disorders
    n1=en:white substance | n2=en:autonomic nervous system disorders | rel=r_associated | relid=0 | w=91
  2903. en:white substance -- r_associated #0: 91 / 0.752 -> en:axon bundle
    n1=en:white substance | n2=en:axon bundle | rel=r_associated | relid=0 | w=91
  2904. en:white substance -- r_associated #0: 91 / 0.752 -> en:axonal dystrophy
    n1=en:white substance | n2=en:axonal dystrophy | rel=r_associated | relid=0 | w=91
  2905. en:white substance -- r_associated #0: 91 / 0.752 -> en:axonal spheroids
    n1=en:white substance | n2=en:axonal spheroids | rel=r_associated | relid=0 | w=91
  2906. en:white substance -- r_associated #0: 91 / 0.752 -> en:basal ganglion degeneration
    n1=en:white substance | n2=en:basal ganglion degeneration | rel=r_associated | relid=0 | w=91
  2907. en:white substance -- r_associated #0: 91 / 0.752 -> en:biopsy in both types shows neuronal cytomegaly (large, bizarre, maloriented neurons) in the laminar cortex
    n1=en:white substance | n2=en:biopsy in both types shows neuronal cytomegaly (large, bizarre, maloriented neurons) in the laminar cortex | rel=r_associated | relid=0 | w=91
  2908. en:white substance -- r_associated #0: 91 / 0.752 -> en:board and poorly defined gyri
    n1=en:white substance | n2=en:board and poorly defined gyri | rel=r_associated | relid=0 | w=91
  2909. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain
    n1=en:white substance | n2=en:brain | rel=r_associated | relid=0 | w=91
  2910. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain atrophy, particularly of the frontal and temporal lobes
    n1=en:white substance | n2=en:brain atrophy, particularly of the frontal and temporal lobes | rel=r_associated | relid=0 | w=91
  2911. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain imaging shows cortical atrophy
    n1=en:white substance | n2=en:brain imaging shows cortical atrophy | rel=r_associated | relid=0 | w=91
  2912. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain mri shows diffusion abnormalities
    n1=en:white substance | n2=en:brain mri shows diffusion abnormalities | rel=r_associated | relid=0 | w=91
  2913. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain mri shows hyperintensities in the basal ganglia
    n1=en:white substance | n2=en:brain mri shows hyperintensities in the basal ganglia | rel=r_associated | relid=0 | w=91
  2914. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain mri shows hypoplastic pituitary
    n1=en:white substance | n2=en:brain mri shows hypoplastic pituitary | rel=r_associated | relid=0 | w=91
  2915. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain mri shows t2-weighted hyperintensities (17%)
    n1=en:white substance | n2=en:brain mri shows t2-weighted hyperintensities (17%) | rel=r_associated | relid=0 | w=91
  2916. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain part
    n1=en:white substance | n2=en:brain part | rel=r_associated | relid=0 | w=91
  2917. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain pathway
    n1=en:white substance | n2=en:brain pathway | rel=r_associated | relid=0 | w=91
  2918. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain subcortex
    n1=en:white substance | n2=en:brain subcortex | rel=r_associated | relid=0 | w=91
  2919. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain ventricle
    n1=en:white substance | n2=en:brain ventricle | rel=r_associated | relid=0 | w=91
  2920. en:white substance -- r_associated #0: 91 / 0.752 -> en:brain white matter hyperintensities on mri
    n1=en:white substance | n2=en:brain white matter hyperintensities on mri | rel=r_associated | relid=0 | w=91
  2921. en:white substance -- r_associated #0: 91 / 0.752 -> en:brainstem atrophy
    n1=en:white substance | n2=en:brainstem atrophy | rel=r_associated | relid=0 | w=91
  2922. en:white substance -- r_associated #0: 91 / 0.752 -> en:brainstem hypoplasia (1 patient)
    n1=en:white substance | n2=en:brainstem hypoplasia (1 patient) | rel=r_associated | relid=0 | w=91
  2923. en:white substance -- r_associated #0: 91 / 0.752 -> en:bulbar dysfunction
    n1=en:white substance | n2=en:bulbar dysfunction | rel=r_associated | relid=0 | w=91
  2924. en:white substance -- r_associated #0: 91 / 0.752 -> en:bulbar weakness
    n1=en:white substance | n2=en:bulbar weakness | rel=r_associated | relid=0 | w=91
  2925. en:white substance -- r_associated #0: 91 / 0.752 -> en:burst suppression pattern on neonatal eeg
    n1=en:white substance | n2=en:burst suppression pattern on neonatal eeg | rel=r_associated | relid=0 | w=91
  2926. en:white substance -- r_associated #0: 91 / 0.752 -> en:cataplexy, paroxysmal weakness or paralysis
    n1=en:white substance | n2=en:cataplexy, paroxysmal weakness or paralysis | rel=r_associated | relid=0 | w=91
  2927. en:white substance -- r_associated #0: 91 / 0.752 -> en:central nervous system depression (disorder)
    n1=en:white substance | n2=en:central nervous system depression (disorder) | rel=r_associated | relid=0 | w=91
  2928. en:white substance -- r_associated #0: 91 / 0.752 -> en:central nervous system tract structure
    n1=en:white substance | n2=en:central nervous system tract structure | rel=r_associated | relid=0 | w=91
  2929. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar ataxia (may be permanent in 50% of patients)
    n1=en:white substance | n2=en:cerebellar ataxia (may be permanent in 50% of patients) | rel=r_associated | relid=0 | w=91
  2930. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar ataxia during episodes
    n1=en:white substance | n2=en:cerebellar ataxia during episodes | rel=r_associated | relid=0 | w=91
  2931. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar ataxia, severe
    n1=en:white substance | n2=en:cerebellar ataxia, severe | rel=r_associated | relid=0 | w=91
  2932. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar atrophy in most cases
    n1=en:white substance | n2=en:cerebellar atrophy in most cases | rel=r_associated | relid=0 | w=91
  2933. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar atrophy, mild (1 patient)
    n1=en:white substance | n2=en:cerebellar atrophy, mild (1 patient) | rel=r_associated | relid=0 | w=91
  2934. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar atrophy, progressive
    n1=en:white substance | n2=en:cerebellar atrophy, progressive | rel=r_associated | relid=0 | w=91
  2935. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar atrophy, severe
    n1=en:white substance | n2=en:cerebellar atrophy, severe | rel=r_associated | relid=0 | w=91
  2936. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar cortical degeneration
    n1=en:white substance | n2=en:cerebellar cortical degeneration | rel=r_associated | relid=0 | w=91
  2937. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar cyst
    n1=en:white substance | n2=en:cerebellar cyst | rel=r_associated | relid=0 | w=91
  2938. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar cysts (meb)
    n1=en:white substance | n2=en:cerebellar cysts (meb) | rel=r_associated | relid=0 | w=91
  2939. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar dysarthria
    n1=en:white substance | n2=en:cerebellar dysarthria | rel=r_associated | relid=0 | w=91
  2940. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar hypoplasia (1 patient)
    n1=en:white substance | n2=en:cerebellar hypoplasia (1 patient) | rel=r_associated | relid=0 | w=91
  2941. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar hypoplasia (reported in 1 family)
    n1=en:white substance | n2=en:cerebellar hypoplasia (reported in 1 family) | rel=r_associated | relid=0 | w=91
  2942. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar hypoplasia (seen in recessive form)
    n1=en:white substance | n2=en:cerebellar hypoplasia (seen in recessive form) | rel=r_associated | relid=0 | w=91
  2943. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar hypoplasia, mild (in some patients)
    n1=en:white substance | n2=en:cerebellar hypoplasia, mild (in some patients) | rel=r_associated | relid=0 | w=91
  2944. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar hypoplasia, mild asymmetric (rare)
    n1=en:white substance | n2=en:cerebellar hypoplasia, mild asymmetric (rare) | rel=r_associated | relid=0 | w=91
  2945. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar signs, mild (in 1 of 3 families)
    n1=en:white substance | n2=en:cerebellar signs, mild (in 1 of 3 families) | rel=r_associated | relid=0 | w=91
  2946. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar vermis hypoplasia (in some patients)
    n1=en:white substance | n2=en:cerebellar vermis hypoplasia (in some patients) | rel=r_associated | relid=0 | w=91
  2947. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebellar white matter lesions on mri
    n1=en:white substance | n2=en:cerebellar white matter lesions on mri | rel=r_associated | relid=0 | w=91
  2948. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebral atrophy (in 1 family)
    n1=en:white substance | n2=en:cerebral atrophy (in 1 family) | rel=r_associated | relid=0 | w=91
  2949. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebral atrophy (reported in 1 patient)
    n1=en:white substance | n2=en:cerebral atrophy (reported in 1 patient) | rel=r_associated | relid=0 | w=91
  2950. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebral cavernous malformation
    n1=en:white substance | n2=en:cerebral cavernous malformation | rel=r_associated | relid=0 | w=91
  2951. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebral cortex with spongiform changes
    n1=en:white substance | n2=en:cerebral cortex with spongiform changes | rel=r_associated | relid=0 | w=91
  2952. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebral hypoplasia
    n1=en:white substance | n2=en:cerebral hypoplasia | rel=r_associated | relid=0 | w=91
  2953. en:white substance -- r_associated #0: 91 / 0.752 -> en:cerebrovascular disorder
    n1=en:white substance | n2=en:cerebrovascular disorder | rel=r_associated | relid=0 | w=91
  2954. en:white substance -- r_associated #0: 91 / 0.752 -> en:chiari i malformation of the cerebellum (in some patients)
    n1=en:white substance | n2=en:chiari i malformation of the cerebellum (in some patients) | rel=r_associated | relid=0 | w=91
  2955. en:white substance -- r_associated #0: 91 / 0.752 -> en:chiari i malformation on mri (some)
    n1=en:white substance | n2=en:chiari i malformation on mri (some) | rel=r_associated | relid=0 | w=91
  2956. en:white substance -- r_associated #0: 91 / 0.752 -> en:chiari malformation (uncommon)
    n1=en:white substance | n2=en:chiari malformation (uncommon) | rel=r_associated | relid=0 | w=91
  2957. en:white substance -- r_associated #0: 91 / 0.752 -> en:chiari type i
    n1=en:white substance | n2=en:chiari type i | rel=r_associated | relid=0 | w=91
  2958. en:white substance -- r_associated #0: 91 / 0.752 -> en:chorea-ballism
    n1=en:white substance | n2=en:chorea-ballism | rel=r_associated | relid=0 | w=91
  2959. en:white substance -- r_associated #0: 91 / 0.752 -> en:choreoathetosis (in 79%), more frequent at disease onset
    n1=en:white substance | n2=en:choreoathetosis (in 79%), more frequent at disease onset | rel=r_associated | relid=0 | w=91
  2960. en:white substance -- r_associated #0: 91 / 0.752 -> en:choreoathetosis (in a subset of patients)
    n1=en:white substance | n2=en:choreoathetosis (in a subset of patients) | rel=r_associated | relid=0 | w=91
  2961. en:white substance -- r_associated #0: 91 / 0.752 -> en:choreoathetosis (in some patients)
    n1=en:white substance | n2=en:choreoathetosis (in some patients) | rel=r_associated | relid=0 | w=91
  2962. en:white substance -- r_associated #0: 91 / 0.752 -> en:choroid plexus calcification
    n1=en:white substance | n2=en:choroid plexus calcification | rel=r_associated | relid=0 | w=91
  2963. en:white substance -- r_associated #0: 91 / 0.752 -> en:chronic lymphocytic meningitis
    n1=en:white substance | n2=en:chronic lymphocytic meningitis | rel=r_associated | relid=0 | w=91
  2964. en:white substance -- r_associated #0: 91 / 0.752 -> en:cobblestone lissencephaly, type ii (wws)
    n1=en:white substance | n2=en:cobblestone lissencephaly, type ii (wws) | rel=r_associated | relid=0 | w=91
  2965. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive decline (1 patient)
    n1=en:white substance | n2=en:cognitive decline (1 patient) | rel=r_associated | relid=0 | w=91
  2966. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive decline (in some patients)
    n1=en:white substance | n2=en:cognitive decline (in some patients) | rel=r_associated | relid=0 | w=91
  2967. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive decline (later in life)
    n1=en:white substance | n2=en:cognitive decline (later in life) | rel=r_associated | relid=0 | w=91
  2968. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive decline, rapid
    n1=en:white substance | n2=en:cognitive decline, rapid | rel=r_associated | relid=0 | w=91
  2969. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive delay, mild (1 patient)
    n1=en:white substance | n2=en:cognitive delay, mild (1 patient) | rel=r_associated | relid=0 | w=91
  2970. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive deterioration
    n1=en:white substance | n2=en:cognitive deterioration | rel=r_associated | relid=0 | w=91
  2971. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive impairment (rare)
    n1=en:white substance | n2=en:cognitive impairment (rare) | rel=r_associated | relid=0 | w=91
  2972. en:white substance -- r_associated #0: 91 / 0.752 -> en:cognitive regression, mild
    n1=en:white substance | n2=en:cognitive regression, mild | rel=r_associated | relid=0 | w=91
  2973. en:white substance -- r_associated #0: 91 / 0.752 -> en:complex motor behavior such as sleep walking
    n1=en:white substance | n2=en:complex motor behavior such as sleep walking | rel=r_associated | relid=0 | w=91
  2974. en:white substance -- r_associated #0: 91 / 0.752 -> en:conducting tissue of heart
    n1=en:white substance | n2=en:conducting tissue of heart | rel=r_associated | relid=0 | w=91
  2975. en:white substance -- r_associated #0: 91 / 0.752 -> en:confusion
    n1=en:white substance | n2=en:confusion | rel=r_associated | relid=0 | w=91
  2976. en:white substance -- r_associated #0: 91 / 0.752 -> en:confusion, paroxysmal
    n1=en:white substance | n2=en:confusion, paroxysmal | rel=r_associated | relid=0 | w=91
  2977. en:white substance -- r_associated #0: 91 / 0.752 -> en:congenital hyperextension of limb
    n1=en:white substance | n2=en:congenital hyperextension of limb | rel=r_associated | relid=0 | w=91
  2978. en:white substance -- r_associated #0: 91 / 0.752 -> en:corprolalia
    n1=en:white substance | n2=en:corprolalia | rel=r_associated | relid=0 | w=91
  2979. en:white substance -- r_associated #0: 91 / 0.752 -> en:cortical dysgenesis
    n1=en:white substance | n2=en:cortical dysgenesis | rel=r_associated | relid=0 | w=91
  2980. en:white substance -- r_associated #0: 91 / 0.752 -> en:cortical dysplasia, focal (in some patients)
    n1=en:white substance | n2=en:cortical dysplasia, focal (in some patients) | rel=r_associated | relid=0 | w=91
  2981. en:white substance -- r_associated #0: 91 / 0.752 -> en:corticospinal tract disease in lower limbs (in adulthood)
    n1=en:white substance | n2=en:corticospinal tract disease in lower limbs (in adulthood) | rel=r_associated | relid=0 | w=91
  2982. en:white substance -- r_associated #0: 91 / 0.752 -> en:cranial nerve palsy
    n1=en:white substance | n2=en:cranial nerve palsy | rel=r_associated | relid=0 | w=91
  2983. en:white substance -- r_associated #0: 91 / 0.752 -> en:cyst of septum pellucidum
    n1=en:white substance | n2=en:cyst of septum pellucidum | rel=r_associated | relid=0 | w=91
  2984. en:white substance -- r_associated #0: 91 / 0.752 -> en:cystic lesions consistent with leigh syndrome (256000)
    n1=en:white substance | n2=en:cystic lesions consistent with leigh syndrome (256000) | rel=r_associated | relid=0 | w=91
  2985. en:white substance -- r_associated #0: 91 / 0.752 -> en:cystic lysis of the deep white matter
    n1=en:white substance | n2=en:cystic lysis of the deep white matter | rel=r_associated | relid=0 | w=91
  2986. en:white substance -- r_associated #0: 91 / 0.752 -> en:cysts tend to enlarge with age
    n1=en:white substance | n2=en:cysts tend to enlarge with age | rel=r_associated | relid=0 | w=91
  2987. en:white substance -- r_associated #0: 91 / 0.752 -> en:dandy-walker malformation (rare)
    n1=en:white substance | n2=en:dandy-walker malformation (rare) | rel=r_associated | relid=0 | w=91
  2988. en:white substance -- r_associated #0: 91 / 0.752 -> en:decerebrate posturings
    n1=en:white substance | n2=en:decerebrate posturings | rel=r_associated | relid=0 | w=91
  2989. en:white substance -- r_associated #0: 91 / 0.752 -> en:decorticate posture
    n1=en:white substance | n2=en:decorticate posture | rel=r_associated | relid=0 | w=91
  2990. en:white substance -- r_associated #0: 91 / 0.752 -> en:decreased active movements
    n1=en:white substance | n2=en:decreased active movements | rel=r_associated | relid=0 | w=91
  2991. en:white substance -- r_associated #0: 91 / 0.752 -> en:decreased creatine signal seen on magnetic resonance spectroscopy
    n1=en:white substance | n2=en:decreased creatine signal seen on magnetic resonance spectroscopy | rel=r_associated | relid=0 | w=91
  2992. en:white substance -- r_associated #0: 91 / 0.752 -> en:decreased mitochondrial respiratory chain complex activity
    n1=en:white substance | n2=en:decreased mitochondrial respiratory chain complex activity | rel=r_associated | relid=0 | w=91
  2993. en:white substance -- r_associated #0: 91 / 0.752 -> en:decreased or absent gyri (in some patients)
    n1=en:white substance | n2=en:decreased or absent gyri (in some patients) | rel=r_associated | relid=0 | w=91
  2994. en:white substance -- r_associated #0: 91 / 0.752 -> en:decreased upper extremity reflexes
    n1=en:white substance | n2=en:decreased upper extremity reflexes | rel=r_associated | relid=0 | w=91
  2995. en:white substance -- r_associated #0: 91 / 0.752 -> en:deep hypointensities (mri, t2) suggestive of past microbleeds
    n1=en:white substance | n2=en:deep hypointensities (mri, t2) suggestive of past microbleeds | rel=r_associated | relid=0 | w=91
  2996. en:white substance -- r_associated #0: 91 / 0.752 -> en:deep white matter changes
    n1=en:white substance | n2=en:deep white matter changes | rel=r_associated | relid=0 | w=91
  2997. en:white substance -- r_associated #0: 91 / 0.752 -> en:deep white matter hypodensities
    n1=en:white substance | n2=en:deep white matter hypodensities | rel=r_associated | relid=0 | w=91
  2998. en:white substance -- r_associated #0: 91 / 0.752 -> en:deficits in abstraction
    n1=en:white substance | n2=en:deficits in abstraction | rel=r_associated | relid=0 | w=91
  2999. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed brainstem development (in some patients)
    n1=en:white substance | n2=en:delayed brainstem development (in some patients) | rel=r_associated | relid=0 | w=91
  3000. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed development (1 family)
    n1=en:white substance | n2=en:delayed development (1 family) | rel=r_associated | relid=0 | w=91
  3001. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed development (in some patients)
    n1=en:white substance | n2=en:delayed development (in some patients) | rel=r_associated | relid=0 | w=91
  3002. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed development if untreated
    n1=en:white substance | n2=en:delayed development if untreated | rel=r_associated | relid=0 | w=91
  3003. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed development, ranging from mild to severe
    n1=en:white substance | n2=en:delayed development, ranging from mild to severe | rel=r_associated | relid=0 | w=91
  3004. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed development, variable severity, from birth in some patients
    n1=en:white substance | n2=en:delayed development, variable severity, from birth in some patients | rel=r_associated | relid=0 | w=91
  3005. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed gross motor development (in some patients)
    n1=en:white substance | n2=en:delayed gross motor development (in some patients) | rel=r_associated | relid=0 | w=91
  3006. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed independent walking
    n1=en:white substance | n2=en:delayed independent walking | rel=r_associated | relid=0 | w=91
  3007. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed myelination (1/4 patients)
    n1=en:white substance | n2=en:delayed myelination (1/4 patients) | rel=r_associated | relid=0 | w=91
  3008. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed psychomotor development (in 1 family)
    n1=en:white substance | n2=en:delayed psychomotor development (in 1 family) | rel=r_associated | relid=0 | w=91
  3009. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed psychomotor development (in some patients)
    n1=en:white substance | n2=en:delayed psychomotor development (in some patients) | rel=r_associated | relid=0 | w=91
  3010. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed psychomotor development (stops at development levels of 1-2 years)
    n1=en:white substance | n2=en:delayed psychomotor development (stops at development levels of 1-2 years) | rel=r_associated | relid=0 | w=91
  3011. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed psychomotor development, moderate to severe
    n1=en:white substance | n2=en:delayed psychomotor development, moderate to severe | rel=r_associated | relid=0 | w=91
  3012. en:white substance -- r_associated #0: 91 / 0.752 -> en:delayed psychomotor development, severe to profound
    n1=en:white substance | n2=en:delayed psychomotor development, severe to profound | rel=r_associated | relid=0 | w=91
  3013. en:white substance -- r_associated #0: 91 / 0.752 -> en:dementia
    n1=en:white substance | n2=en:dementia | rel=r_associated | relid=0 | w=91
  3014. en:white substance -- r_associated #0: 91 / 0.752 -> en:demyelination of the posterior and lateral columns of the spinal cord
    n1=en:white substance | n2=en:demyelination of the posterior and lateral columns of the spinal cord | rel=r_associated | relid=0 | w=91
  3015. en:white substance -- r_associated #0: 91 / 0.752 -> en:demyelinization
    n1=en:white substance | n2=en:demyelinization | rel=r_associated | relid=0 | w=91
  3016. en:white substance -- r_associated #0: 91 / 0.752 -> en:deterioration of motor development
    n1=en:white substance | n2=en:deterioration of motor development | rel=r_associated | relid=0 | w=91
  3017. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental arrest, 2nd year of life
    n1=en:white substance | n2=en:developmental arrest, 2nd year of life | rel=r_associated | relid=0 | w=91
  3018. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay (female)
    n1=en:white substance | n2=en:developmental delay (female) | rel=r_associated | relid=0 | w=91
  3019. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay (homozygote)
    n1=en:white substance | n2=en:developmental delay (homozygote) | rel=r_associated | relid=0 | w=91
  3020. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay (in some patients)
    n1=en:white substance | n2=en:developmental delay (in some patients) | rel=r_associated | relid=0 | w=91
  3021. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay (mild-severe)
    n1=en:white substance | n2=en:developmental delay (mild-severe) | rel=r_associated | relid=0 | w=91
  3022. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay, primarily motor, resolves in childhood
    n1=en:white substance | n2=en:developmental delay, primarily motor, resolves in childhood | rel=r_associated | relid=0 | w=91
  3023. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay, progressive
    n1=en:white substance | n2=en:developmental delay, progressive | rel=r_associated | relid=0 | w=91
  3024. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental delay, variable
    n1=en:white substance | n2=en:developmental delay, variable | rel=r_associated | relid=0 | w=91
  3025. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental regression (in some patients)
    n1=en:white substance | n2=en:developmental regression (in some patients) | rel=r_associated | relid=0 | w=91
  3026. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental regression before age 6 months
    n1=en:white substance | n2=en:developmental regression before age 6 months | rel=r_associated | relid=0 | w=91
  3027. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental regression in about 50% of patients
    n1=en:white substance | n2=en:developmental regression in about 50% of patients | rel=r_associated | relid=0 | w=91
  3028. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental retardation (in some patients)
    n1=en:white substance | n2=en:developmental retardation (in some patients) | rel=r_associated | relid=0 | w=91
  3029. en:white substance -- r_associated #0: 91 / 0.752 -> en:developmental stagnation at onset of seizures
    n1=en:white substance | n2=en:developmental stagnation at onset of seizures | rel=r_associated | relid=0 | w=91
  3030. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse brain swelling occurs during coma
    n1=en:white substance | n2=en:diffuse brain swelling occurs during coma | rel=r_associated | relid=0 | w=91
  3031. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse cerebellar atrophy
    n1=en:white substance | n2=en:diffuse cerebellar atrophy | rel=r_associated | relid=0 | w=91
  3032. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse fibrillar astrocytosis (in type iib)
    n1=en:white substance | n2=en:diffuse fibrillar astrocytosis (in type iib) | rel=r_associated | relid=0 | w=91
  3033. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse hyperintense signal abnormalities in the white matter (in children)
    n1=en:white substance | n2=en:diffuse hyperintense signal abnormalities in the white matter (in children) | rel=r_associated | relid=0 | w=91
  3034. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse hypomyelination
    n1=en:white substance | n2=en:diffuse hypomyelination | rel=r_associated | relid=0 | w=91
  3035. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse lewy bodies throughout the brain (cortical and subcortical regions)
    n1=en:white substance | n2=en:diffuse lewy bodies throughout the brain (cortical and subcortical regions) | rel=r_associated | relid=0 | w=91
  3036. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse spongiform leukoencephalopathy
    n1=en:white substance | n2=en:diffuse spongiform leukoencephalopathy | rel=r_associated | relid=0 | w=91
  3037. en:white substance -- r_associated #0: 91 / 0.752 -> en:diffuse, severe neuronal loss
    n1=en:white substance | n2=en:diffuse, severe neuronal loss | rel=r_associated | relid=0 | w=91
  3038. en:white substance -- r_associated #0: 91 / 0.752 -> en:dilated fourth ventricle
    n1=en:white substance | n2=en:dilated fourth ventricle | rel=r_associated | relid=0 | w=91
  3039. en:white substance -- r_associated #0: 91 / 0.752 -> en:dilated perivascular spaces
    n1=en:white substance | n2=en:dilated perivascular spaces | rel=r_associated | relid=0 | w=91
  3040. en:white substance -- r_associated #0: 91 / 0.752 -> en:diminished visual activity
    n1=en:white substance | n2=en:diminished visual activity | rel=r_associated | relid=0 | w=91
  3041. en:white substance -- r_associated #0: 91 / 0.752 -> en:disdiadochokinesia
    n1=en:white substance | n2=en:disdiadochokinesia | rel=r_associated | relid=0 | w=91
  3042. en:white substance -- r_associated #0: 91 / 0.752 -> en:disturbance of attention
    n1=en:white substance | n2=en:disturbance of attention | rel=r_associated | relid=0 | w=91
  3043. en:white substance -- r_associated #0: 91 / 0.752 -> en:disturbed equilibrium
    n1=en:white substance | n2=en:disturbed equilibrium | rel=r_associated | relid=0 | w=91
  3044. en:white substance -- r_associated #0: 91 / 0.752 -> en:diurnal fluctuations of symptoms (in a subset of patients)
    n1=en:white substance | n2=en:diurnal fluctuations of symptoms (in a subset of patients) | rel=r_associated | relid=0 | w=91
  3045. en:white substance -- r_associated #0: 91 / 0.752 -> en:drooling
    n1=en:white substance | n2=en:drooling | rel=r_associated | relid=0 | w=91
  3046. en:white substance -- r_associated #0: 91 / 0.752 -> en:drug-resistent seizures (rare)
    n1=en:white substance | n2=en:drug-resistent seizures (rare) | rel=r_associated | relid=0 | w=91
  3047. en:white substance -- r_associated #0: 91 / 0.752 -> en:dural ectasia
    n1=en:white substance | n2=en:dural ectasia | rel=r_associated | relid=0 | w=91
  3048. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysarthria (in some patients)
    n1=en:white substance | n2=en:dysarthria (in some patients) | rel=r_associated | relid=0 | w=91
  3049. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysarthria, mild (1 family)
    n1=en:white substance | n2=en:dysarthria, mild (1 family) | rel=r_associated | relid=0 | w=91
  3050. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysdiadochokinesis (63%)
    n1=en:white substance | n2=en:dysdiadochokinesis (63%) | rel=r_associated | relid=0 | w=91
  3051. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysfunction of lateral corticospinal tracts
    n1=en:white substance | n2=en:dysfunction of lateral corticospinal tracts | rel=r_associated | relid=0 | w=91
  3052. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysgenesis or agenesis of the corpus callosum (in some)
    n1=en:white substance | n2=en:dysgenesis or agenesis of the corpus callosum (in some) | rel=r_associated | relid=0 | w=91
  3053. en:white substance -- r_associated #0: 91 / 0.752 -> en:dyskinesia, episodic
    n1=en:white substance | n2=en:dyskinesia, episodic | rel=r_associated | relid=0 | w=91
  3054. en:white substance -- r_associated #0: 91 / 0.752 -> en:dyskinesia, limb, exertion-induced
    n1=en:white substance | n2=en:dyskinesia, limb, exertion-induced | rel=r_associated | relid=0 | w=91
  3055. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysmetria (in some patients)
    n1=en:white substance | n2=en:dysmetria (in some patients) | rel=r_associated | relid=0 | w=91
  3056. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysphasia
    n1=en:white substance | n2=en:dysphasia | rel=r_associated | relid=0 | w=91
  3057. en:white substance -- r_associated #0: 91 / 0.752 -> en:dysplastic cerebellar vermis
    n1=en:white substance | n2=en:dysplastic cerebellar vermis | rel=r_associated | relid=0 | w=91
  3058. en:white substance -- r_associated #0: 91 / 0.752 -> en:dystonia
    n1=en:white substance | n2=en:dystonia | rel=r_associated | relid=0 | w=91
  3059. en:white substance -- r_associated #0: 91 / 0.752 -> en:dystonia may become generalized
    n1=en:white substance | n2=en:dystonia may become generalized | rel=r_associated | relid=0 | w=91
  3060. en:white substance -- r_associated #0: 91 / 0.752 -> en:dystonia, focal, limited to orbicularis oculi muscle (blepharospasm)
    n1=en:white substance | n2=en:dystonia, focal, limited to orbicularis oculi muscle (blepharospasm) | rel=r_associated | relid=0 | w=91
  3061. en:white substance -- r_associated #0: 91 / 0.752 -> en:dystonia, severe (in all limbs)
    n1=en:white substance | n2=en:dystonia, severe (in all limbs) | rel=r_associated | relid=0 | w=91
  3062. en:white substance -- r_associated #0: 91 / 0.752 -> en:dystonic posture
    n1=en:white substance | n2=en:dystonic posture | rel=r_associated | relid=0 | w=91
  3063. en:white substance -- r_associated #0: 91 / 0.752 -> en:early involvement of the corticospinal pathways
    n1=en:white substance | n2=en:early involvement of the corticospinal pathways | rel=r_associated | relid=0 | w=91
  3064. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows 3-4-hz spike waves
    n1=en:white substance | n2=en:eeg shows 3-4-hz spike waves | rel=r_associated | relid=0 | w=91
  3065. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows 3-hz spike-wave discharges
    n1=en:white substance | n2=en:eeg shows 3-hz spike-wave discharges | rel=r_associated | relid=0 | w=91
  3066. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows abundant slow waves and fast spike activity
    n1=en:white substance | n2=en:eeg shows abundant slow waves and fast spike activity | rel=r_associated | relid=0 | w=91
  3067. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows active generalized spike and wave and polyspike pattern
    n1=en:white substance | n2=en:eeg shows active generalized spike and wave and polyspike pattern | rel=r_associated | relid=0 | w=91
  3068. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows multifocal epileptic activity
    n1=en:white substance | n2=en:eeg shows multifocal epileptic activity | rel=r_associated | relid=0 | w=91
  3069. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows rolandic sharp waves and spikes
    n1=en:white substance | n2=en:eeg shows rolandic sharp waves and spikes | rel=r_associated | relid=0 | w=91
  3070. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows slowed dysrhythmia and multifocal discharges
    n1=en:white substance | n2=en:eeg shows slowed dysrhythmia and multifocal discharges | rel=r_associated | relid=0 | w=91
  3071. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg shows spike and wave or polyspike and wave discharges
    n1=en:white substance | n2=en:eeg shows spike and wave or polyspike and wave discharges | rel=r_associated | relid=0 | w=91
  3072. en:white substance -- r_associated #0: 91 / 0.752 -> en:eeg with photoparoxysmal response
    n1=en:white substance | n2=en:eeg with photoparoxysmal response | rel=r_associated | relid=0 | w=91
  3073. en:white substance -- r_associated #0: 91 / 0.752 -> en:electroencephalogram (eeg) abnormalities
    n1=en:white substance | n2=en:electroencephalogram (eeg) abnormalities | rel=r_associated | relid=0 | w=91
  3074. en:white substance -- r_associated #0: 91 / 0.752 -> en:elongated superior cerebellar peduncles
    n1=en:white substance | n2=en:elongated superior cerebellar peduncles | rel=r_associated | relid=0 | w=91
  3075. en:white substance -- r_associated #0: 91 / 0.752 -> en:emg shows evidence of denervation
    n1=en:white substance | n2=en:emg shows evidence of denervation | rel=r_associated | relid=0 | w=91
  3076. en:white substance -- r_associated #0: 91 / 0.752 -> en:emg shows neurogenic abnormalities
    n1=en:white substance | n2=en:emg shows neurogenic abnormalities | rel=r_associated | relid=0 | w=91
  3077. en:white substance -- r_associated #0: 91 / 0.752 -> en:empty sella syndrome
    n1=en:white substance | n2=en:empty sella syndrome | rel=r_associated | relid=0 | w=91
  3078. en:white substance -- r_associated #0: 91 / 0.752 -> en:encephalomyelopathy
    n1=en:white substance | n2=en:encephalomyelopathy | rel=r_associated | relid=0 | w=91
  3079. en:white substance -- r_associated #0: 91 / 0.752 -> en:encephalopathic attacks, episodic, associated with infection
    n1=en:white substance | n2=en:encephalopathic attacks, episodic, associated with infection | rel=r_associated | relid=0 | w=91
  3080. en:white substance -- r_associated #0: 91 / 0.752 -> en:encephalopathy (in some patients)
    n1=en:white substance | n2=en:encephalopathy (in some patients) | rel=r_associated | relid=0 | w=91
  3081. en:white substance -- r_associated #0: 91 / 0.752 -> en:encephalopathy, acute, sudden-onset during febrile illness
    n1=en:white substance | n2=en:encephalopathy, acute, sudden-onset during febrile illness | rel=r_associated | relid=0 | w=91
  3082. en:white substance -- r_associated #0: 91 / 0.752 -> en:end-position nystagmus
    n1=en:white substance | n2=en:end-position nystagmus | rel=r_associated | relid=0 | w=91
  3083. en:white substance -- r_associated #0: 91 / 0.752 -> en:enhancement of the c-reflex
    n1=en:white substance | n2=en:enhancement of the c-reflex | rel=r_associated | relid=0 | w=91
  3084. en:white substance -- r_associated #0: 91 / 0.752 -> en:enlarged fourth ventricle, mild
    n1=en:white substance | n2=en:enlarged fourth ventricle, mild | rel=r_associated | relid=0 | w=91
  3085. en:white substance -- r_associated #0: 91 / 0.752 -> en:enlarged lateral and third ventricles
    n1=en:white substance | n2=en:enlarged lateral and third ventricles | rel=r_associated | relid=0 | w=91
  3086. en:white substance -- r_associated #0: 91 / 0.752 -> en:enlarged ventricles (in some patients)
    n1=en:white substance | n2=en:enlarged ventricles (in some patients) | rel=r_associated | relid=0 | w=91
  3087. en:white substance -- r_associated #0: 91 / 0.752 -> en:entire central nervous system
    n1=en:white substance | n2=en:entire central nervous system | rel=r_associated | relid=0 | w=91
  3088. en:white substance -- r_associated #0: 91 / 0.752 -> en:entire spinal cord
    n1=en:white substance | n2=en:entire spinal cord | rel=r_associated | relid=0 | w=91
  3089. en:white substance -- r_associated #0: 91 / 0.752 -> en:eosinophilic 'cotton wool' plaques without dense congophilic core in various brain regions
    n1=en:white substance | n2=en:eosinophilic 'cotton wool' plaques without dense congophilic core in various brain regions | rel=r_associated | relid=0 | w=91
  3090. en:white substance -- r_associated #0: 91 / 0.752 -> en:ependyma
    n1=en:white substance | n2=en:ependyma | rel=r_associated | relid=0 | w=91
  3091. en:white substance -- r_associated #0: 91 / 0.752 -> en:ependymitis
    n1=en:white substance | n2=en:ependymitis | rel=r_associated | relid=0 | w=91
  3092. en:white substance -- r_associated #0: 91 / 0.752 -> en:epilepsia partialis continua
    n1=en:white substance | n2=en:epilepsia partialis continua | rel=r_associated | relid=0 | w=91
  3093. en:white substance -- r_associated #0: 91 / 0.752 -> en:epilepsy, multifocal, intractable
    n1=en:white substance | n2=en:epilepsy, multifocal, intractable | rel=r_associated | relid=0 | w=91
  3094. en:white substance -- r_associated #0: 91 / 0.752 -> en:epilepsy, myoclonic astatic
    n1=en:white substance | n2=en:epilepsy, myoclonic astatic | rel=r_associated | relid=0 | w=91
  3095. en:white substance -- r_associated #0: 91 / 0.752 -> en:epilepsy, refractory (onset in adolescence or young adulthood)
    n1=en:white substance | n2=en:epilepsy, refractory (onset in adolescence or young adulthood) | rel=r_associated | relid=0 | w=91
  3096. en:white substance -- r_associated #0: 91 / 0.752 -> en:epilepsy, temporal lobe
    n1=en:white substance | n2=en:epilepsy, temporal lobe | rel=r_associated | relid=0 | w=91
  3097. en:white substance -- r_associated #0: 91 / 0.752 -> en:episodes may last less than 30 minutes or greater than several hours
    n1=en:white substance | n2=en:episodes may last less than 30 minutes or greater than several hours | rel=r_associated | relid=0 | w=91
  3098. en:white substance -- r_associated #0: 91 / 0.752 -> en:episodic absence-like spells
    n1=en:white substance | n2=en:episodic absence-like spells | rel=r_associated | relid=0 | w=91
  3099. en:white substance -- r_associated #0: 91 / 0.752 -> en:episodic ataxia
    n1=en:white substance | n2=en:episodic ataxia | rel=r_associated | relid=0 | w=91
  3100. en:white substance -- r_associated #0: 91 / 0.752 -> en:euphoric mood
    n1=en:white substance | n2=en:euphoric mood | rel=r_associated | relid=0 | w=91
  3101. en:white substance -- r_associated #0: 91 / 0.752 -> en:expressive speech absent
    n1=en:white substance | n2=en:expressive speech absent | rel=r_associated | relid=0 | w=91
  3102. en:white substance -- r_associated #0: 91 / 0.752 -> en:extensor plantar responses (1 family)
    n1=en:white substance | n2=en:extensor plantar responses (1 family) | rel=r_associated | relid=0 | w=91
  3103. en:white substance -- r_associated #0: 91 / 0.752 -> en:extrapyramidal dyskinesia
    n1=en:white substance | n2=en:extrapyramidal dyskinesia | rel=r_associated | relid=0 | w=91
  3104. en:white substance -- r_associated #0: 91 / 0.752 -> en:extrapyramidal signs may develop
    n1=en:white substance | n2=en:extrapyramidal signs may develop | rel=r_associated | relid=0 | w=91
  3105. en:white substance -- r_associated #0: 91 / 0.752 -> en:extrapyramidal symptoms (later-onset)
    n1=en:white substance | n2=en:extrapyramidal symptoms (later-onset) | rel=r_associated | relid=0 | w=91
  3106. en:white substance -- r_associated #0: 91 / 0.752 -> en:extremity ataxia
    n1=en:white substance | n2=en:extremity ataxia | rel=r_associated | relid=0 | w=91
  3107. en:white substance -- r_associated #0: 91 / 0.752 -> en:eye
    n1=en:white substance | n2=en:eye | rel=r_associated | relid=0 | w=91
  3108. en:white substance -- r_associated #0: 91 / 0.752 -> en:facial muscle sparing
    n1=en:white substance | n2=en:facial muscle sparing | rel=r_associated | relid=0 | w=91
  3109. en:white substance -- r_associated #0: 91 / 0.752 -> en:facial nerve weakness
    n1=en:white substance | n2=en:facial nerve weakness | rel=r_associated | relid=0 | w=91
  3110. en:white substance -- r_associated #0: 91 / 0.752 -> en:facial-faucial-finger mini-myoclonus (fff)
    n1=en:white substance | n2=en:facial-faucial-finger mini-myoclonus (fff) | rel=r_associated | relid=0 | w=91
  3111. en:white substance -- r_associated #0: 91 / 0.752 -> en:facial-lingual fasciculations
    n1=en:white substance | n2=en:facial-lingual fasciculations | rel=r_associated | relid=0 | w=91
  3112. en:white substance -- r_associated #0: 91 / 0.752 -> en:falx cerebri, precocious calcification of
    n1=en:white substance | n2=en:falx cerebri, precocious calcification of | rel=r_associated | relid=0 | w=91
  3113. en:white substance -- r_associated #0: 91 / 0.752 -> en:fascicle
    n1=en:white substance | n2=en:fascicle | rel=r_associated | relid=0 | w=91
  3114. en:white substance -- r_associated #0: 91 / 0.752 -> en:fatal subacute encephalopathy (1 family)
    n1=en:white substance | n2=en:fatal subacute encephalopathy (1 family) | rel=r_associated | relid=0 | w=91
  3115. en:white substance -- r_associated #0: 91 / 0.752 -> en:febrile seizures (reported in 1 patient)
    n1=en:white substance | n2=en:febrile seizures (reported in 1 patient) | rel=r_associated | relid=0 | w=91
  3116. en:white substance -- r_associated #0: 91 / 0.752 -> en:febrile seizures may occur
    n1=en:white substance | n2=en:febrile seizures may occur | rel=r_associated | relid=0 | w=91
  3117. en:white substance -- r_associated #0: 91 / 0.752 -> en:fenestrated basilar artery
    n1=en:white substance | n2=en:fenestrated basilar artery | rel=r_associated | relid=0 | w=91
  3118. en:white substance -- r_associated #0: 91 / 0.752 -> en:fifth ventricle
    n1=en:white substance | n2=en:fifth ventricle | rel=r_associated | relid=0 | w=91
  3119. en:white substance -- r_associated #0: 91 / 0.752 -> en:fine motor delay
    n1=en:white substance | n2=en:fine motor delay | rel=r_associated | relid=0 | w=91
  3120. en:white substance -- r_associated #0: 91 / 0.752 -> en:fine motor/coordination problems (12%)
    n1=en:white substance | n2=en:fine motor/coordination problems (12%) | rel=r_associated | relid=0 | w=91
  3121. en:white substance -- r_associated #0: 91 / 0.752 -> en:first dorsal interossei muscle weakness
    n1=en:white substance | n2=en:first dorsal interossei muscle weakness | rel=r_associated | relid=0 | w=91
  3122. en:white substance -- r_associated #0: 91 / 0.752 -> en:fluctuating neurologic signs
    n1=en:white substance | n2=en:fluctuating neurologic signs | rel=r_associated | relid=0 | w=91
  3123. en:white substance -- r_associated #0: 91 / 0.752 -> en:fluid filled posterior fossa
    n1=en:white substance | n2=en:fluid filled posterior fossa | rel=r_associated | relid=0 | w=91
  3124. en:white substance -- r_associated #0: 91 / 0.752 -> en:focal dystonia (adult onset)
    n1=en:white substance | n2=en:focal dystonia (adult onset) | rel=r_associated | relid=0 | w=91
  3125. en:white substance -- r_associated #0: 91 / 0.752 -> en:focal thickening of the cortex on mri (in type iib)
    n1=en:white substance | n2=en:focal thickening of the cortex on mri (in type iib) | rel=r_associated | relid=0 | w=91
  3126. en:white substance -- r_associated #0: 91 / 0.752 -> en:forebrain defects
    n1=en:white substance | n2=en:forebrain defects | rel=r_associated | relid=0 | w=91
  3127. en:white substance -- r_associated #0: 91 / 0.752 -> en:frightening sensation
    n1=en:white substance | n2=en:frightening sensation | rel=r_associated | relid=0 | w=91
  3128. en:white substance -- r_associated #0: 91 / 0.752 -> en:frontal lobe
    n1=en:white substance | n2=en:frontal lobe | rel=r_associated | relid=0 | w=91
  3129. en:white substance -- r_associated #0: 91 / 0.752 -> en:frontotemporal dementia
    n1=en:white substance | n2=en:frontotemporal dementia | rel=r_associated | relid=0 | w=91
  3130. en:white substance -- r_associated #0: 91 / 0.752 -> en:frontotemporal leukoencephalopathy
    n1=en:white substance | n2=en:frontotemporal leukoencephalopathy | rel=r_associated | relid=0 | w=91
  3131. en:white substance -- r_associated #0: 91 / 0.752 -> en:frontotemporal/subcortical dementia
    n1=en:white substance | n2=en:frontotemporal/subcortical dementia | rel=r_associated | relid=0 | w=91
  3132. en:white substance -- r_associated #0: 91 / 0.752 -> en:gait ataxia (in some patients)
    n1=en:white substance | n2=en:gait ataxia (in some patients) | rel=r_associated | relid=0 | w=91
  3133. en:white substance -- r_associated #0: 91 / 0.752 -> en:gait instability, worse in the dark
    n1=en:white substance | n2=en:gait instability, worse in the dark | rel=r_associated | relid=0 | w=91
  3134. en:white substance -- r_associated #0: 91 / 0.752 -> en:generalized amyotrophy
    n1=en:white substance | n2=en:generalized amyotrophy | rel=r_associated | relid=0 | w=91
  3135. en:white substance -- r_associated #0: 91 / 0.752 -> en:generalized spike wave discharges
    n1=en:white substance | n2=en:generalized spike wave discharges | rel=r_associated | relid=0 | w=91
  3136. en:white substance -- r_associated #0: 91 / 0.752 -> en:gliosis in the brainstem
    n1=en:white substance | n2=en:gliosis in the brainstem | rel=r_associated | relid=0 | w=91
  3137. en:white substance -- r_associated #0: 91 / 0.752 -> en:grand mal seizure
    n1=en:white substance | n2=en:grand mal seizure | rel=r_associated | relid=0 | w=91
  3138. en:white substance -- r_associated #0: 91 / 0.752 -> en:gyral simplification
    n1=en:white substance | n2=en:gyral simplification | rel=r_associated | relid=0 | w=91
  3139. en:white substance -- r_associated #0: 91 / 0.752 -> en:head lag
    n1=en:white substance | n2=en:head lag | rel=r_associated | relid=0 | w=91
  3140. en:white substance -- r_associated #0: 91 / 0.752 -> en:head titubations
    n1=en:white substance | n2=en:head titubations | rel=r_associated | relid=0 | w=91
  3141. en:white substance -- r_associated #0: 91 / 0.752 -> en:headache is unilateral
    n1=en:white substance | n2=en:headache is unilateral | rel=r_associated | relid=0 | w=91
  3142. en:white substance -- r_associated #0: 91 / 0.752 -> en:hemiclonic seizures
    n1=en:white substance | n2=en:hemiclonic seizures | rel=r_associated | relid=0 | w=91
  3143. en:white substance -- r_associated #0: 91 / 0.752 -> en:hemiplegia (rare)
    n1=en:white substance | n2=en:hemiplegia (rare) | rel=r_associated | relid=0 | w=91
  3144. en:white substance -- r_associated #0: 91 / 0.752 -> en:hiccough
    n1=en:white substance | n2=en:hiccough | rel=r_associated | relid=0 | w=91
  3145. en:white substance -- r_associated #0: 91 / 0.752 -> en:high intensity area in white matter on head mri
    n1=en:white substance | n2=en:high intensity area in white matter on head mri | rel=r_associated | relid=0 | w=91
  3146. en:white substance -- r_associated #0: 91 / 0.752 -> en:hippocampal atrophy (in 2 siblings)
    n1=en:white substance | n2=en:hippocampal atrophy (in 2 siblings) | rel=r_associated | relid=0 | w=91
  3147. en:white substance -- r_associated #0: 91 / 0.752 -> en:holoprosencephaly (1 patient)
    n1=en:white substance | n2=en:holoprosencephaly (1 patient) | rel=r_associated | relid=0 | w=91
  3148. en:white substance -- r_associated #0: 91 / 0.752 -> en:horner syndrome
    n1=en:white substance | n2=en:horner syndrome | rel=r_associated | relid=0 | w=91
  3149. en:white substance -- r_associated #0: 91 / 0.752 -> en:hydrocephalus (in 2 patients)
    n1=en:white substance | n2=en:hydrocephalus (in 2 patients) | rel=r_associated | relid=0 | w=91
  3150. en:white substance -- r_associated #0: 91 / 0.752 -> en:hyperkinesia
    n1=en:white substance | n2=en:hyperkinesia | rel=r_associated | relid=0 | w=91
  3151. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypermetric saccades
    n1=en:white substance | n2=en:hypermetric saccades | rel=r_associated | relid=0 | w=91
  3152. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypermotor automatisms
    n1=en:white substance | n2=en:hypermotor automatisms | rel=r_associated | relid=0 | w=91
  3153. en:white substance -- r_associated #0: 91 / 0.752 -> en:hyperreflexia (early)
    n1=en:white substance | n2=en:hyperreflexia (early) | rel=r_associated | relid=0 | w=91
  3154. en:white substance -- r_associated #0: 91 / 0.752 -> en:hyperreflexia, especially of the lower limbs
    n1=en:white substance | n2=en:hyperreflexia, especially of the lower limbs | rel=r_associated | relid=0 | w=91
  3155. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypertensive encephalopathy
    n1=en:white substance | n2=en:hypertensive encephalopathy | rel=r_associated | relid=0 | w=91
  3156. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypertonia late
    n1=en:white substance | n2=en:hypertonia late | rel=r_associated | relid=0 | w=91
  3157. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypoplasia of corpus callosum and cerebellar vermis
    n1=en:white substance | n2=en:hypoplasia of corpus callosum and cerebellar vermis | rel=r_associated | relid=0 | w=91
  3158. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypoplasia of olfactory tract
    n1=en:white substance | n2=en:hypoplasia of olfactory tract | rel=r_associated | relid=0 | w=91
  3159. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypoplasia of the medulla oblongata
    n1=en:white substance | n2=en:hypoplasia of the medulla oblongata | rel=r_associated | relid=0 | w=91
  3160. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypoplasia or dysgenesis of the corpus callosum (in some patients)
    n1=en:white substance | n2=en:hypoplasia or dysgenesis of the corpus callosum (in some patients) | rel=r_associated | relid=0 | w=91
  3161. en:white substance -- r_associated #0: 91 / 0.752 -> en:hyporeflexia of lower limbs
    n1=en:white substance | n2=en:hyporeflexia of lower limbs | rel=r_associated | relid=0 | w=91
  3162. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypothalamic hamartoma
    n1=en:white substance | n2=en:hypothalamic hamartoma | rel=r_associated | relid=0 | w=91
  3163. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypothalamus
    n1=en:white substance | n2=en:hypothalamus | rel=r_associated | relid=0 | w=91
  3164. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypotonia
    n1=en:white substance | n2=en:hypotonia | rel=r_associated | relid=0 | w=91
  3165. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypotonia (early-onset form)
    n1=en:white substance | n2=en:hypotonia (early-onset form) | rel=r_associated | relid=0 | w=91
  3166. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypotonia, profound muscular (in some patients)
    n1=en:white substance | n2=en:hypotonia, profound muscular (in some patients) | rel=r_associated | relid=0 | w=91
  3167. en:white substance -- r_associated #0: 91 / 0.752 -> en:hypsarrhythmia seen on eeg
    n1=en:white substance | n2=en:hypsarrhythmia seen on eeg | rel=r_associated | relid=0 | w=91
  3168. en:white substance -- r_associated #0: 91 / 0.752 -> en:ictal eeg shows focal onset, often posterior region of brain
    n1=en:white substance | n2=en:ictal eeg shows focal onset, often posterior region of brain | rel=r_associated | relid=0 | w=91
  3169. en:white substance -- r_associated #0: 91 / 0.752 -> en:idiopathic generalized epilepsy in childhood (homozygous patient)
    n1=en:white substance | n2=en:idiopathic generalized epilepsy in childhood (homozygous patient) | rel=r_associated | relid=0 | w=91
  3170. en:white substance -- r_associated #0: 91 / 0.752 -> en:impaired expressive speech
    n1=en:white substance | n2=en:impaired expressive speech | rel=r_associated | relid=0 | w=91
  3171. en:white substance -- r_associated #0: 91 / 0.752 -> en:impaired gait due to peripheral neuropathy
    n1=en:white substance | n2=en:impaired gait due to peripheral neuropathy | rel=r_associated | relid=0 | w=91
  3172. en:white substance -- r_associated #0: 91 / 0.752 -> en:impaired horizontal smooth pursuit
    n1=en:white substance | n2=en:impaired horizontal smooth pursuit | rel=r_associated | relid=0 | w=91
  3173. en:white substance -- r_associated #0: 91 / 0.752 -> en:impaired tandem gait
    n1=en:white substance | n2=en:impaired tandem gait | rel=r_associated | relid=0 | w=91
  3174. en:white substance -- r_associated #0: 91 / 0.752 -> en:impaired walking ability (in some patients)
    n1=en:white substance | n2=en:impaired walking ability (in some patients) | rel=r_associated | relid=0 | w=91
  3175. en:white substance -- r_associated #0: 91 / 0.752 -> en:inability to hold head
    n1=en:white substance | n2=en:inability to hold head | rel=r_associated | relid=0 | w=91
  3176. en:white substance -- r_associated #0: 91 / 0.752 -> en:inability to sit or stand independently
    n1=en:white substance | n2=en:inability to sit or stand independently | rel=r_associated | relid=0 | w=91
  3177. en:white substance -- r_associated #0: 91 / 0.752 -> en:inability to sit or walk independently
    n1=en:white substance | n2=en:inability to sit or walk independently | rel=r_associated | relid=0 | w=91
  3178. en:white substance -- r_associated #0: 91 / 0.752 -> en:inability to stand without assistance
    n1=en:white substance | n2=en:inability to stand without assistance | rel=r_associated | relid=0 | w=91
  3179. en:white substance -- r_associated #0: 91 / 0.752 -> en:incoordination of trunk and limbs
    n1=en:white substance | n2=en:incoordination of trunk and limbs | rel=r_associated | relid=0 | w=91
  3180. en:white substance -- r_associated #0: 91 / 0.752 -> en:increased activity period
    n1=en:white substance | n2=en:increased activity period | rel=r_associated | relid=0 | w=91
  3181. en:white substance -- r_associated #0: 91 / 0.752 -> en:increased deep tendon reflexes (if left untreated)
    n1=en:white substance | n2=en:increased deep tendon reflexes (if left untreated) | rel=r_associated | relid=0 | w=91
  3182. en:white substance -- r_associated #0: 91 / 0.752 -> en:increased muscle tone in the lower limbs
    n1=en:white substance | n2=en:increased muscle tone in the lower limbs | rel=r_associated | relid=0 | w=91
  3183. en:white substance -- r_associated #0: 91 / 0.752 -> en:increased signal intensity on t(2)-weighted scans in the periventricular and centrum ovale area
    n1=en:white substance | n2=en:increased signal intensity on t(2)-weighted scans in the periventricular and centrum ovale area | rel=r_associated | relid=0 | w=91
  3184. en:white substance -- r_associated #0: 91 / 0.752 -> en:increased subdural space around frontal lobes
    n1=en:white substance | n2=en:increased subdural space around frontal lobes | rel=r_associated | relid=0 | w=91
  3185. en:white substance -- r_associated #0: 91 / 0.752 -> en:increased tone in the upper limbs (occur later)
    n1=en:white substance | n2=en:increased tone in the upper limbs (occur later) | rel=r_associated | relid=0 | w=91
  3186. en:white substance -- r_associated #0: 91 / 0.752 -> en:infantile encephalopathy
    n1=en:white substance | n2=en:infantile encephalopathy | rel=r_associated | relid=0 | w=91
  3187. en:white substance -- r_associated #0: 91 / 0.752 -> en:infarction
    n1=en:white substance | n2=en:infarction | rel=r_associated | relid=0 | w=91
  3188. en:white substance -- r_associated #0: 91 / 0.752 -> en:intellectual disabilities (in 1 family)
    n1=en:white substance | n2=en:intellectual disabilities (in 1 family) | rel=r_associated | relid=0 | w=91
  3189. en:white substance -- r_associated #0: 91 / 0.752 -> en:intellectual disability, mild (1 patient)
    n1=en:white substance | n2=en:intellectual disability, mild (1 patient) | rel=r_associated | relid=0 | w=91
  3190. en:white substance -- r_associated #0: 91 / 0.752 -> en:intellectual disability, moderate (in some patients)
    n1=en:white substance | n2=en:intellectual disability, moderate (in some patients) | rel=r_associated | relid=0 | w=91
  3191. en:white substance -- r_associated #0: 91 / 0.752 -> en:interictal downbeat nystagmus
    n1=en:white substance | n2=en:interictal downbeat nystagmus | rel=r_associated | relid=0 | w=91
  3192. en:white substance -- r_associated #0: 91 / 0.752 -> en:interictal eeg may be normal or abnormal
    n1=en:white substance | n2=en:interictal eeg may be normal or abnormal | rel=r_associated | relid=0 | w=91
  3193. en:white substance -- r_associated #0: 91 / 0.752 -> en:interictal eeg may show nonspecific changes in 15 to 20%
    n1=en:white substance | n2=en:interictal eeg may show nonspecific changes in 15 to 20% | rel=r_associated | relid=0 | w=91
  3194. en:white substance -- r_associated #0: 91 / 0.752 -> en:interictal eeg shows 3-4 hz general spike-wave complexes
    n1=en:white substance | n2=en:interictal eeg shows 3-4 hz general spike-wave complexes | rel=r_associated | relid=0 | w=91
  3195. en:white substance -- r_associated #0: 91 / 0.752 -> en:intracerebral cysts (in some patients)
    n1=en:white substance | n2=en:intracerebral cysts (in some patients) | rel=r_associated | relid=0 | w=91
  3196. en:white substance -- r_associated #0: 91 / 0.752 -> en:intracranial bleeding (1 patient)
    n1=en:white substance | n2=en:intracranial bleeding (1 patient) | rel=r_associated | relid=0 | w=91
  3197. en:white substance -- r_associated #0: 91 / 0.752 -> en:intracranial calcification affecting the basal ganglia (in some patients)
    n1=en:white substance | n2=en:intracranial calcification affecting the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=91
  3198. en:white substance -- r_associated #0: 91 / 0.752 -> en:intraneuronal inclusions
    n1=en:white substance | n2=en:intraneuronal inclusions | rel=r_associated | relid=0 | w=91
  3199. en:white substance -- r_associated #0: 91 / 0.752 -> en:involuntary movements
    n1=en:white substance | n2=en:involuntary movements | rel=r_associated | relid=0 | w=91
  3200. en:white substance -- r_associated #0: 91 / 0.752 -> en:ischemic infarct of brain
    n1=en:white substance | n2=en:ischemic infarct of brain | rel=r_associated | relid=0 | w=91
  3201. en:white substance -- r_associated #0: 91 / 0.752 -> en:jerking movements
    n1=en:white substance | n2=en:jerking movements | rel=r_associated | relid=0 | w=91
  3202. en:white substance -- r_associated #0: 91 / 0.752 -> en:jerky movements in infancy
    n1=en:white substance | n2=en:jerky movements in infancy | rel=r_associated | relid=0 | w=91
  3203. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of communication
    n1=en:white substance | n2=en:lack of communication | rel=r_associated | relid=0 | w=91
  3204. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of motor milestones
    n1=en:white substance | n2=en:lack of motor milestones | rel=r_associated | relid=0 | w=91
  3205. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of speech (in severe cases)
    n1=en:white substance | n2=en:lack of speech (in severe cases) | rel=r_associated | relid=0 | w=91
  3206. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of speech acquisition
    n1=en:white substance | n2=en:lack of speech acquisition | rel=r_associated | relid=0 | w=91
  3207. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of spontaneous movement
    n1=en:white substance | n2=en:lack of spontaneous movement | rel=r_associated | relid=0 | w=91
  3208. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of upper motor neuron signs
    n1=en:white substance | n2=en:lack of upper motor neuron signs | rel=r_associated | relid=0 | w=91
  3209. en:white substance -- r_associated #0: 91 / 0.752 -> en:lack of verbal communication
    n1=en:white substance | n2=en:lack of verbal communication | rel=r_associated | relid=0 | w=91
  3210. en:white substance -- r_associated #0: 91 / 0.752 -> en:lacunar infarcts in the deep-brain nuclei, brainstem, internal capsule seen on imaging
    n1=en:white substance | n2=en:lacunar infarcts in the deep-brain nuclei, brainstem, internal capsule seen on imaging | rel=r_associated | relid=0 | w=91
  3211. en:white substance -- r_associated #0: 91 / 0.752 -> en:laminar necrosis
    n1=en:white substance | n2=en:laminar necrosis | rel=r_associated | relid=0 | w=91
  3212. en:white substance -- r_associated #0: 91 / 0.752 -> en:language disorder
    n1=en:white substance | n2=en:language disorder | rel=r_associated | relid=0 | w=91
  3213. en:white substance -- r_associated #0: 91 / 0.752 -> en:large cavum vergae
    n1=en:white substance | n2=en:large cavum vergae | rel=r_associated | relid=0 | w=91
  3214. en:white substance -- r_associated #0: 91 / 0.752 -> en:learning disabilities (1 family)
    n1=en:white substance | n2=en:learning disabilities (1 family) | rel=r_associated | relid=0 | w=91
  3215. en:white substance -- r_associated #0: 91 / 0.752 -> en:lesions characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation
    n1=en:white substance | n2=en:lesions characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation | rel=r_associated | relid=0 | w=91
  3216. en:white substance -- r_associated #0: 91 / 0.752 -> en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord
    n1=en:white substance | n2=en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord | rel=r_associated | relid=0 | w=91
  3217. en:white substance -- r_associated #0: 91 / 0.752 -> en:lethargy, neonatal
    n1=en:white substance | n2=en:lethargy, neonatal | rel=r_associated | relid=0 | w=91
  3218. en:white substance -- r_associated #0: 91 / 0.752 -> en:leukodystrophy (in some patients)
    n1=en:white substance | n2=en:leukodystrophy (in some patients) | rel=r_associated | relid=0 | w=91
  3219. en:white substance -- r_associated #0: 91 / 0.752 -> en:leukoencephalopathy
    n1=en:white substance | n2=en:leukoencephalopathy | rel=r_associated | relid=0 | w=91
  3220. en:white substance -- r_associated #0: 91 / 0.752 -> en:leukoencephalopathy in the frontal and parietal lobes (later)
    n1=en:white substance | n2=en:leukoencephalopathy in the frontal and parietal lobes (later) | rel=r_associated | relid=0 | w=91
  3221. en:white substance -- r_associated #0: 91 / 0.752 -> en:leukoencephalopathy on ct and mri
    n1=en:white substance | n2=en:leukoencephalopathy on ct and mri | rel=r_associated | relid=0 | w=91
  3222. en:white substance -- r_associated #0: 91 / 0.752 -> en:lewy bodies in the substantia nigra
    n1=en:white substance | n2=en:lewy bodies in the substantia nigra | rel=r_associated | relid=0 | w=91
  3223. en:white substance -- r_associated #0: 91 / 0.752 -> en:limb dystonia (18%)
    n1=en:white substance | n2=en:limb dystonia (18%) | rel=r_associated | relid=0 | w=91
  3224. en:white substance -- r_associated #0: 91 / 0.752 -> en:limbic malformations
    n1=en:white substance | n2=en:limbic malformations | rel=r_associated | relid=0 | w=91
  3225. en:white substance -- r_associated #0: 91 / 0.752 -> en:limited verbal comprehension
    n1=en:white substance | n2=en:limited verbal comprehension | rel=r_associated | relid=0 | w=91
  3226. en:white substance -- r_associated #0: 91 / 0.752 -> en:lissencephaly (anterior to posterior decreasing gradient of severity, more prominent in anterior brain regions)
    n1=en:white substance | n2=en:lissencephaly (anterior to posterior decreasing gradient of severity, more prominent in anterior brain regions) | rel=r_associated | relid=0 | w=91
  3227. en:white substance -- r_associated #0: 91 / 0.752 -> en:lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions)
    n1=en:white substance | n2=en:lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions) | rel=r_associated | relid=0 | w=91
  3228. en:white substance -- r_associated #0: 91 / 0.752 -> en:lissencephaly, posterior to anterior gradient
    n1=en:white substance | n2=en:lissencephaly, posterior to anterior gradient | rel=r_associated | relid=0 | w=91
  3229. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of ability to walk later
    n1=en:white substance | n2=en:loss of ability to walk later | rel=r_associated | relid=0 | w=91
  3230. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of ankle reflexes
    n1=en:white substance | n2=en:loss of ankle reflexes | rel=r_associated | relid=0 | w=91
  3231. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of cerebellar granular cells
    n1=en:white substance | n2=en:loss of cerebellar granular cells | rel=r_associated | relid=0 | w=91
  3232. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of consciousness
    n1=en:white substance | n2=en:loss of consciousness | rel=r_associated | relid=0 | w=91
  3233. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of developmental milestones
    n1=en:white substance | n2=en:loss of developmental milestones | rel=r_associated | relid=0 | w=91
  3234. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of dopaminergic neurons in the substantia nigra
    n1=en:white substance | n2=en:loss of dopaminergic neurons in the substantia nigra | rel=r_associated | relid=0 | w=91
  3235. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of dorsal root ganglion cells
    n1=en:white substance | n2=en:loss of dorsal root ganglion cells | rel=r_associated | relid=0 | w=91
  3236. en:white substance -- r_associated #0: 91 / 0.752 -> en:loss of postural tone
    n1=en:white substance | n2=en:loss of postural tone | rel=r_associated | relid=0 | w=91
  3237. en:white substance -- r_associated #0: 91 / 0.752 -> en:low iq
    n1=en:white substance | n2=en:low iq | rel=r_associated | relid=0 | w=91
  3238. en:white substance -- r_associated #0: 91 / 0.752 -> en:lower limb hypotrophy
    n1=en:white substance | n2=en:lower limb hypotrophy | rel=r_associated | relid=0 | w=91
  3239. en:white substance -- r_associated #0: 91 / 0.752 -> en:lower limbs affected before upper limbs
    n1=en:white substance | n2=en:lower limbs affected before upper limbs | rel=r_associated | relid=0 | w=91
  3240. en:white substance -- r_associated #0: 91 / 0.752 -> en:lower motor neuron symptoms
    n1=en:white substance | n2=en:lower motor neuron symptoms | rel=r_associated | relid=0 | w=91
  3241. en:white substance -- r_associated #0: 91 / 0.752 -> en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis
    n1=en:white substance | n2=en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis | rel=r_associated | relid=0 | w=91
  3242. en:white substance -- r_associated #0: 91 / 0.752 -> en:macrocephaly (due to dandy-walker malformation)
    n1=en:white substance | n2=en:macrocephaly (due to dandy-walker malformation) | rel=r_associated | relid=0 | w=91
  3243. en:white substance -- r_associated #0: 91 / 0.752 -> en:malformations of cortical development, variable
    n1=en:white substance | n2=en:malformations of cortical development, variable | rel=r_associated | relid=0 | w=91
  3244. en:white substance -- r_associated #0: 91 / 0.752 -> en:malformations of the mid- and hindbrain
    n1=en:white substance | n2=en:malformations of the mid- and hindbrain | rel=r_associated | relid=0 | w=91
  3245. en:white substance -- r_associated #0: 91 / 0.752 -> en:meningitis
    n1=en:white substance | n2=en:meningitis | rel=r_associated | relid=0 | w=91
  3246. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental deficiency
    n1=en:white substance | n2=en:mental deficiency | rel=r_associated | relid=0 | w=91
  3247. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental deterioration beginning 2 to 5 years after onset of seizures
    n1=en:white substance | n2=en:mental deterioration beginning 2 to 5 years after onset of seizures | rel=r_associated | relid=0 | w=91
  3248. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental impairment
    n1=en:white substance | n2=en:mental impairment | rel=r_associated | relid=0 | w=91
  3249. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (25%)
    n1=en:white substance | n2=en:mental retardation (25%) | rel=r_associated | relid=0 | w=91
  3250. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (average iq 51)
    n1=en:white substance | n2=en:mental retardation (average iq 51) | rel=r_associated | relid=0 | w=91
  3251. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (in 2 of 6 patients)
    n1=en:white substance | n2=en:mental retardation (in 2 of 6 patients) | rel=r_associated | relid=0 | w=91
  3252. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (iq 24-85) (variable)
    n1=en:white substance | n2=en:mental retardation (iq 24-85) (variable) | rel=r_associated | relid=0 | w=91
  3253. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (one patient)
    n1=en:white substance | n2=en:mental retardation (one patient) | rel=r_associated | relid=0 | w=91
  3254. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (one-third)
    n1=en:white substance | n2=en:mental retardation (one-third) | rel=r_associated | relid=0 | w=91
  3255. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation (reported in 1 family)
    n1=en:white substance | n2=en:mental retardation (reported in 1 family) | rel=r_associated | relid=0 | w=91
  3256. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation by the age of 7 years
    n1=en:white substance | n2=en:mental retardation by the age of 7 years | rel=r_associated | relid=0 | w=91
  3257. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation can occur in patients with repeated episodes of dehydration
    n1=en:white substance | n2=en:mental retardation can occur in patients with repeated episodes of dehydration | rel=r_associated | relid=0 | w=91
  3258. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation in 75%
    n1=en:white substance | n2=en:mental retardation in 75% | rel=r_associated | relid=0 | w=91
  3259. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, borderline to severe
    n1=en:white substance | n2=en:mental retardation, borderline to severe | rel=r_associated | relid=0 | w=91
  3260. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, mild (11%)
    n1=en:white substance | n2=en:mental retardation, mild (11%) | rel=r_associated | relid=0 | w=91
  3261. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, mild to moderate (in 12%)
    n1=en:white substance | n2=en:mental retardation, mild to moderate (in 12%) | rel=r_associated | relid=0 | w=91
  3262. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, mild to profound
    n1=en:white substance | n2=en:mental retardation, mild to profound | rel=r_associated | relid=0 | w=91
  3263. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, mild to severe
    n1=en:white substance | n2=en:mental retardation, mild to severe | rel=r_associated | relid=0 | w=91
  3264. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, mild-moderate (some)
    n1=en:white substance | n2=en:mental retardation, mild-moderate (some) | rel=r_associated | relid=0 | w=91
  3265. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, moderate (in 1 patient)
    n1=en:white substance | n2=en:mental retardation, moderate (in 1 patient) | rel=r_associated | relid=0 | w=91
  3266. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, moderate to severe (10-15% of patients)
    n1=en:white substance | n2=en:mental retardation, moderate to severe (10-15% of patients) | rel=r_associated | relid=0 | w=91
  3267. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, severe (meb)
    n1=en:white substance | n2=en:mental retardation, severe (meb) | rel=r_associated | relid=0 | w=91
  3268. en:white substance -- r_associated #0: 91 / 0.752 -> en:mental retardation, severe to profound
    n1=en:white substance | n2=en:mental retardation, severe to profound | rel=r_associated | relid=0 | w=91
  3269. en:white substance -- r_associated #0: 91 / 0.752 -> en:mesial temporal sclerosis (in 1 patient)
    n1=en:white substance | n2=en:mesial temporal sclerosis (in 1 patient) | rel=r_associated | relid=0 | w=91
  3270. en:white substance -- r_associated #0: 91 / 0.752 -> en:microbiological
    n1=en:white substance | n2=en:microbiological | rel=r_associated | relid=0 | w=91
  3271. en:white substance -- r_associated #0: 91 / 0.752 -> en:microcystic degeneration
    n1=en:white substance | n2=en:microcystic degeneration | rel=r_associated | relid=0 | w=91
  3272. en:white substance -- r_associated #0: 91 / 0.752 -> en:microgyria
    n1=en:white substance | n2=en:microgyria | rel=r_associated | relid=0 | w=91
  3273. en:white substance -- r_associated #0: 91 / 0.752 -> en:migraine headache (less common)
    n1=en:white substance | n2=en:migraine headache (less common) | rel=r_associated | relid=0 | w=91
  3274. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild cognitive deterioration in adults
    n1=en:white substance | n2=en:mild cognitive deterioration in adults | rel=r_associated | relid=0 | w=91
  3275. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild cognitive impairment (in some patients)
    n1=en:white substance | n2=en:mild cognitive impairment (in some patients) | rel=r_associated | relid=0 | w=91
  3276. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild mental deterioration
    n1=en:white substance | n2=en:mild mental deterioration | rel=r_associated | relid=0 | w=91
  3277. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild mental retardation (39%) feeding problems/weak suck (43%)
    n1=en:white substance | n2=en:mild mental retardation (39%) feeding problems/weak suck (43%) | rel=r_associated | relid=0 | w=91
  3278. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild mental retardation (some)
    n1=en:white substance | n2=en:mild mental retardation (some) | rel=r_associated | relid=0 | w=91
  3279. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild motor development delay
    n1=en:white substance | n2=en:mild motor development delay | rel=r_associated | relid=0 | w=91
  3280. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild structural abnormalities seen mri (in some patients)
    n1=en:white substance | n2=en:mild structural abnormalities seen mri (in some patients) | rel=r_associated | relid=0 | w=91
  3281. en:white substance -- r_associated #0: 91 / 0.752 -> en:mild to moderate learning difficulties
    n1=en:white substance | n2=en:mild to moderate learning difficulties | rel=r_associated | relid=0 | w=91
  3282. en:white substance -- r_associated #0: 91 / 0.752 -> en:mildly decreased intelligence has been reported
    n1=en:white substance | n2=en:mildly decreased intelligence has been reported | rel=r_associated | relid=0 | w=91
  3283. en:white substance -- r_associated #0: 91 / 0.752 -> en:mildly delayed motor development due to vestibular dysfunction
    n1=en:white substance | n2=en:mildly delayed motor development due to vestibular dysfunction | rel=r_associated | relid=0 | w=91
  3284. en:white substance -- r_associated #0: 91 / 0.752 -> en:misorientation of pyramidal fibers
    n1=en:white substance | n2=en:misorientation of pyramidal fibers | rel=r_associated | relid=0 | w=91
  3285. en:white substance -- r_associated #0: 91 / 0.752 -> en:moderate learning difficulties
    n1=en:white substance | n2=en:moderate learning difficulties | rel=r_associated | relid=0 | w=91
  3286. en:white substance -- r_associated #0: 91 / 0.752 -> en:molar tooth sign on brain mri
    n1=en:white substance | n2=en:molar tooth sign on brain mri | rel=r_associated | relid=0 | w=91
  3287. en:white substance -- r_associated #0: 91 / 0.752 -> en:molar tooth sign on brain mri (subset of patients)
    n1=en:white substance | n2=en:molar tooth sign on brain mri (subset of patients) | rel=r_associated | relid=0 | w=91
  3288. en:white substance -- r_associated #0: 91 / 0.752 -> en:monotonous speech
    n1=en:white substance | n2=en:monotonous speech | rel=r_associated | relid=0 | w=91
  3289. en:white substance -- r_associated #0: 91 / 0.752 -> en:morning myoclonic jerks
    n1=en:white substance | n2=en:morning myoclonic jerks | rel=r_associated | relid=0 | w=91
  3290. en:white substance -- r_associated #0: 91 / 0.752 -> en:most never acquire independent ambulation
    n1=en:white substance | n2=en:most never acquire independent ambulation | rel=r_associated | relid=0 | w=91
  3291. en:white substance -- r_associated #0: 91 / 0.752 -> en:most patients remain stable or improve in years after the abrupt onset of symptoms
    n1=en:white substance | n2=en:most patients remain stable or improve in years after the abrupt onset of symptoms | rel=r_associated | relid=0 | w=91
  3292. en:white substance -- r_associated #0: 91 / 0.752 -> en:motor delay (in one patient)
    n1=en:white substance | n2=en:motor delay (in one patient) | rel=r_associated | relid=0 | w=91
  3293. en:white substance -- r_associated #0: 91 / 0.752 -> en:motor development delay (83%)
    n1=en:white substance | n2=en:motor development delay (83%) | rel=r_associated | relid=0 | w=91
  3294. en:white substance -- r_associated #0: 91 / 0.752 -> en:motor developmental delay
    n1=en:white substance | n2=en:motor developmental delay | rel=r_associated | relid=0 | w=91
  3295. en:white substance -- r_associated #0: 91 / 0.752 -> en:motor dysfunction
    n1=en:white substance | n2=en:motor dysfunction | rel=r_associated | relid=0 | w=91
  3296. en:white substance -- r_associated #0: 91 / 0.752 -> en:motor regression
    n1=en:white substance | n2=en:motor regression | rel=r_associated | relid=0 | w=91
  3297. en:white substance -- r_associated #0: 91 / 0.752 -> en:motor stereotypy
    n1=en:white substance | n2=en:motor stereotypy | rel=r_associated | relid=0 | w=91
  3298. en:white substance -- r_associated #0: 91 / 0.752 -> en:moyamoya disease
    n1=en:white substance | n2=en:moyamoya disease | rel=r_associated | relid=0 | w=91
  3299. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows absence of the facial nerve
    n1=en:white substance | n2=en:mri shows absence of the facial nerve | rel=r_associated | relid=0 | w=91
  3300. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows decreased signal intensity in the pallidal nuclei with central hyperintensity ('eye of the tiger' sign)
    n1=en:white substance | n2=en:mri shows decreased signal intensity in the pallidal nuclei with central hyperintensity ('eye of the tiger' sign) | rel=r_associated | relid=0 | w=91
  3301. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows defects of the corpus callosum
    n1=en:white substance | n2=en:mri shows defects of the corpus callosum | rel=r_associated | relid=0 | w=91
  3302. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows delayed myelination (1 of 6 patients)
    n1=en:white substance | n2=en:mri shows delayed myelination (1 of 6 patients) | rel=r_associated | relid=0 | w=91
  3303. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows leukoencephalopathy
    n1=en:white substance | n2=en:mri shows leukoencephalopathy | rel=r_associated | relid=0 | w=91
  3304. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows symmetric, diffuse lesions with csf-like signal intensity
    n1=en:white substance | n2=en:mri shows symmetric, diffuse lesions with csf-like signal intensity | rel=r_associated | relid=0 | w=91
  3305. en:white substance -- r_associated #0: 91 / 0.752 -> en:mri shows t2-weighted signals in the basal ganglia
    n1=en:white substance | n2=en:mri shows t2-weighted signals in the basal ganglia | rel=r_associated | relid=0 | w=91
  3306. en:white substance -- r_associated #0: 91 / 0.752 -> en:multifocal cerebral white matter abnormalities
    n1=en:white substance | n2=en:multifocal cerebral white matter abnormalities | rel=r_associated | relid=0 | w=91
  3307. en:white substance -- r_associated #0: 91 / 0.752 -> en:multifocal discharges
    n1=en:white substance | n2=en:multifocal discharges | rel=r_associated | relid=0 | w=91
  3308. en:white substance -- r_associated #0: 91 / 0.752 -> en:muscular rigidity
    n1=en:white substance | n2=en:muscular rigidity | rel=r_associated | relid=0 | w=91
  3309. en:white substance -- r_associated #0: 91 / 0.752 -> en:musician's cramp
    n1=en:white substance | n2=en:musician's cramp | rel=r_associated | relid=0 | w=91
  3310. en:white substance -- r_associated #0: 91 / 0.752 -> en:myoclonic epilepsy (1 patient)
    n1=en:white substance | n2=en:myoclonic epilepsy (1 patient) | rel=r_associated | relid=0 | w=91
  3311. en:white substance -- r_associated #0: 91 / 0.752 -> en:myoclonic seizures (subtype 3a)
    n1=en:white substance | n2=en:myoclonic seizures (subtype 3a) | rel=r_associated | relid=0 | w=91
  3312. en:white substance -- r_associated #0: 91 / 0.752 -> en:myoclonus (in a subset of patients)
    n1=en:white substance | n2=en:myoclonus (in a subset of patients) | rel=r_associated | relid=0 | w=91
  3313. en:white substance -- r_associated #0: 91 / 0.752 -> en:necrotic white matter lesions throughout the brain and brainstem
    n1=en:white substance | n2=en:necrotic white matter lesions throughout the brain and brainstem | rel=r_associated | relid=0 | w=91
  3314. en:white substance -- r_associated #0: 91 / 0.752 -> en:neocortical dysplasia (27%)
    n1=en:white substance | n2=en:neocortical dysplasia (27%) | rel=r_associated | relid=0 | w=91
  3315. en:white substance -- r_associated #0: 91 / 0.752 -> en:neonatal hypotonia
    n1=en:white substance | n2=en:neonatal hypotonia | rel=r_associated | relid=0 | w=91
  3316. en:white substance -- r_associated #0: 91 / 0.752 -> en:neurodegeneration leading to profound mental retardation
    n1=en:white substance | n2=en:neurodegeneration leading to profound mental retardation | rel=r_associated | relid=0 | w=91
  3317. en:white substance -- r_associated #0: 91 / 0.752 -> en:neurologic abnormalities in about 7%
    n1=en:white substance | n2=en:neurologic abnormalities in about 7% | rel=r_associated | relid=0 | w=91
  3318. en:white substance -- r_associated #0: 91 / 0.752 -> en:neurologic crises with coma (in some patients)
    n1=en:white substance | n2=en:neurologic crises with coma (in some patients) | rel=r_associated | relid=0 | w=91
  3319. en:white substance -- r_associated #0: 91 / 0.752 -> en:neurologic regression following seizure onset
    n1=en:white substance | n2=en:neurologic regression following seizure onset | rel=r_associated | relid=0 | w=91
  3320. en:white substance -- r_associated #0: 91 / 0.752 -> en:neuronal and vascular calcifications
    n1=en:white substance | n2=en:neuronal and vascular calcifications | rel=r_associated | relid=0 | w=91
  3321. en:white substance -- r_associated #0: 91 / 0.752 -> en:neuronal loss and gliosis in the substantia nigra pars compacta
    n1=en:white substance | n2=en:neuronal loss and gliosis in the substantia nigra pars compacta | rel=r_associated | relid=0 | w=91
  3322. en:white substance -- r_associated #0: 91 / 0.752 -> en:neuronal loss in the purkinje cell layer of the cerebellar vermis
    n1=en:white substance | n2=en:neuronal loss in the purkinje cell layer of the cerebellar vermis | rel=r_associated | relid=0 | w=91
  3323. en:white substance -- r_associated #0: 91 / 0.752 -> en:neuronal loss in the striatum, medial thalamic nuclei, and inferior olives
    n1=en:white substance | n2=en:neuronal loss in the striatum, medial thalamic nuclei, and inferior olives | rel=r_associated | relid=0 | w=91
  3324. en:white substance -- r_associated #0: 91 / 0.752 -> en:neuronal migration disorder
    n1=en:white substance | n2=en:neuronal migration disorder | rel=r_associated | relid=0 | w=91
  3325. en:white substance -- r_associated #0: 91 / 0.752 -> en:neuropsychologic cognitive abnormalities
    n1=en:white substance | n2=en:neuropsychologic cognitive abnormalities | rel=r_associated | relid=0 | w=91
  3326. en:white substance -- r_associated #0: 91 / 0.752 -> en:no cognitive decline
    n1=en:white substance | n2=en:no cognitive decline | rel=r_associated | relid=0 | w=91
  3327. en:white substance -- r_associated #0: 91 / 0.752 -> en:no pick bodies or lewy bodies
    n1=en:white substance | n2=en:no pick bodies or lewy bodies | rel=r_associated | relid=0 | w=91
  3328. en:white substance -- r_associated #0: 91 / 0.752 -> en:no speech acquisition
    n1=en:white substance | n2=en:no speech acquisition | rel=r_associated | relid=0 | w=91
  3329. en:white substance -- r_associated #0: 91 / 0.752 -> en:no voluntary movement
    n1=en:white substance | n2=en:no voluntary movement | rel=r_associated | relid=0 | w=91
  3330. en:white substance -- r_associated #0: 91 / 0.752 -> en:nodular heterotopia (less common)
    n1=en:white substance | n2=en:nodular heterotopia (less common) | rel=r_associated | relid=0 | w=91
  3331. en:white substance -- r_associated #0: 91 / 0.752 -> en:nonspecific spongiform degeneration
    n1=en:white substance | n2=en:nonspecific spongiform degeneration | rel=r_associated | relid=0 | w=91
  3332. en:white substance -- r_associated #0: 91 / 0.752 -> en:normal brain mri or ct scan
    n1=en:white substance | n2=en:normal brain mri or ct scan | rel=r_associated | relid=0 | w=91
  3333. en:white substance -- r_associated #0: 91 / 0.752 -> en:normal cognition and intellectual function
    n1=en:white substance | n2=en:normal cognition and intellectual function | rel=r_associated | relid=0 | w=91
  3334. en:white substance -- r_associated #0: 91 / 0.752 -> en:normal development
    n1=en:white substance | n2=en:normal development | rel=r_associated | relid=0 | w=91
  3335. en:white substance -- r_associated #0: 91 / 0.752 -> en:normal development in some patients
    n1=en:white substance | n2=en:normal development in some patients | rel=r_associated | relid=0 | w=91
  3336. en:white substance -- r_associated #0: 91 / 0.752 -> en:normal intelligence in carrier females
    n1=en:white substance | n2=en:normal intelligence in carrier females | rel=r_associated | relid=0 | w=91
  3337. en:white substance -- r_associated #0: 91 / 0.752 -> en:normal neurologic development in most cases
    n1=en:white substance | n2=en:normal neurologic development in most cases | rel=r_associated | relid=0 | w=91
  3338. en:white substance -- r_associated #0: 91 / 0.752 -> en:nystagmus, mild
    n1=en:white substance | n2=en:nystagmus, mild | rel=r_associated | relid=0 | w=91
  3339. en:white substance -- r_associated #0: 91 / 0.752 -> en:occipital headache
    n1=en:white substance | n2=en:occipital headache | rel=r_associated | relid=0 | w=91
  3340. en:white substance -- r_associated #0: 91 / 0.752 -> en:oculomotor apraxia
    n1=en:white substance | n2=en:oculomotor apraxia | rel=r_associated | relid=0 | w=91
  3341. en:white substance -- r_associated #0: 91 / 0.752 -> en:olfactory or auditory hallucinations
    n1=en:white substance | n2=en:olfactory or auditory hallucinations | rel=r_associated | relid=0 | w=91
  3342. en:white substance -- r_associated #0: 91 / 0.752 -> en:onset may be triggered by emotional stress, fever, exercise, exposure to heat
    n1=en:white substance | n2=en:onset may be triggered by emotional stress, fever, exercise, exposure to heat | rel=r_associated | relid=0 | w=91
  3343. en:white substance -- r_associated #0: 91 / 0.752 -> en:open sylvian fissures
    n1=en:white substance | n2=en:open sylvian fissures | rel=r_associated | relid=0 | w=91
  3344. en:white substance -- r_associated #0: 91 / 0.752 -> en:opisthotonus
    n1=en:white substance | n2=en:opisthotonus | rel=r_associated | relid=0 | w=91
  3345. en:white substance -- r_associated #0: 91 / 0.752 -> en:pachymacrogyria
    n1=en:white substance | n2=en:pachymacrogyria | rel=r_associated | relid=0 | w=91
  3346. en:white substance -- r_associated #0: 91 / 0.752 -> en:pain
    n1=en:white substance | n2=en:pain | rel=r_associated | relid=0 | w=91
  3347. en:white substance -- r_associated #0: 91 / 0.752 -> en:pallidal degeneration
    n1=en:white substance | n2=en:pallidal degeneration | rel=r_associated | relid=0 | w=91
  3348. en:white substance -- r_associated #0: 91 / 0.752 -> en:paralysis, episodic, after strenuous exercise
    n1=en:white substance | n2=en:paralysis, episodic, after strenuous exercise | rel=r_associated | relid=0 | w=91
  3349. en:white substance -- r_associated #0: 91 / 0.752 -> en:paranoid reaction
    n1=en:white substance | n2=en:paranoid reaction | rel=r_associated | relid=0 | w=91
  3350. en:white substance -- r_associated #0: 91 / 0.752 -> en:paraparesis, spastic
    n1=en:white substance | n2=en:paraparesis, spastic | rel=r_associated | relid=0 | w=91
  3351. en:white substance -- r_associated #0: 91 / 0.752 -> en:parasitology
    n1=en:white substance | n2=en:parasitology | rel=r_associated | relid=0 | w=91
  3352. en:white substance -- r_associated #0: 91 / 0.752 -> en:paraspinal masses
    n1=en:white substance | n2=en:paraspinal masses | rel=r_associated | relid=0 | w=91
  3353. en:white substance -- r_associated #0: 91 / 0.752 -> en:parkinsonism (in some patients)
    n1=en:white substance | n2=en:parkinsonism (in some patients) | rel=r_associated | relid=0 | w=91
  3354. en:white substance -- r_associated #0: 91 / 0.752 -> en:parkinsonism (in some)
    n1=en:white substance | n2=en:parkinsonism (in some) | rel=r_associated | relid=0 | w=91
  3355. en:white substance -- r_associated #0: 91 / 0.752 -> en:parkinsonism has been described in 1 family
    n1=en:white substance | n2=en:parkinsonism has been described in 1 family | rel=r_associated | relid=0 | w=91
  3356. en:white substance -- r_associated #0: 91 / 0.752 -> en:paroxysmal choreoathetosis
    n1=en:white substance | n2=en:paroxysmal choreoathetosis | rel=r_associated | relid=0 | w=91
  3357. en:white substance -- r_associated #0: 91 / 0.752 -> en:partial absence of the corpus callosum (in one patient)
    n1=en:white substance | n2=en:partial absence of the corpus callosum (in one patient) | rel=r_associated | relid=0 | w=91
  3358. en:white substance -- r_associated #0: 91 / 0.752 -> en:partial migrating seizures seen on eeg (in some patients)
    n1=en:white substance | n2=en:partial migrating seizures seen on eeg (in some patients) | rel=r_associated | relid=0 | w=91
  3359. en:white substance -- r_associated #0: 91 / 0.752 -> en:patellar and ankle clonus
    n1=en:white substance | n2=en:patellar and ankle clonus | rel=r_associated | relid=0 | w=91
  3360. en:white substance -- r_associated #0: 91 / 0.752 -> en:pathologic changes in anterior horn cells and lateral corticospinal tracts
    n1=en:white substance | n2=en:pathologic changes in anterior horn cells and lateral corticospinal tracts | rel=r_associated | relid=0 | w=91
  3361. en:white substance -- r_associated #0: 91 / 0.752 -> en:pathology includes spongiform changes, diffuse nerve cell degeneration and glial proliferation
    n1=en:white substance | n2=en:pathology includes spongiform changes, diffuse nerve cell degeneration and glial proliferation | rel=r_associated | relid=0 | w=91
  3362. en:white substance -- r_associated #0: 91 / 0.752 -> en:peripheral nervous system disorder
    n1=en:white substance | n2=en:peripheral nervous system disorder | rel=r_associated | relid=0 | w=91
  3363. en:white substance -- r_associated #0: 91 / 0.752 -> en:perisylvian polymicrogyria
    n1=en:white substance | n2=en:perisylvian polymicrogyria | rel=r_associated | relid=0 | w=91
  3364. en:white substance -- r_associated #0: 91 / 0.752 -> en:periventricular nodular heterotopia seen on mri
    n1=en:white substance | n2=en:periventricular nodular heterotopia seen on mri | rel=r_associated | relid=0 | w=91
  3365. en:white substance -- r_associated #0: 91 / 0.752 -> en:periventricular white matter gliosis (in some patients)
    n1=en:white substance | n2=en:periventricular white matter gliosis (in some patients) | rel=r_associated | relid=0 | w=91
  3366. en:white substance -- r_associated #0: 91 / 0.752 -> en:periventricular white matter lesions
    n1=en:white substance | n2=en:periventricular white matter lesions | rel=r_associated | relid=0 | w=91
  3367. en:white substance -- r_associated #0: 91 / 0.752 -> en:persistent cavum septum pellucidum
    n1=en:white substance | n2=en:persistent cavum septum pellucidum | rel=r_associated | relid=0 | w=91
  3368. en:white substance -- r_associated #0: 91 / 0.752 -> en:personality disorder
    n1=en:white substance | n2=en:personality disorder | rel=r_associated | relid=0 | w=91
  3369. en:white substance -- r_associated #0: 91 / 0.752 -> en:photoparoxysmal and photomyoclonic responses
    n1=en:white substance | n2=en:photoparoxysmal and photomyoclonic responses | rel=r_associated | relid=0 | w=91
  3370. en:white substance -- r_associated #0: 91 / 0.752 -> en:photoparoxysmal response (in some)
    n1=en:white substance | n2=en:photoparoxysmal response (in some) | rel=r_associated | relid=0 | w=91
  3371. en:white substance -- r_associated #0: 91 / 0.752 -> en:physiological aspects
    n1=en:white substance | n2=en:physiological aspects | rel=r_associated | relid=0 | w=91
  3372. en:white substance -- r_associated #0: 91 / 0.752 -> en:pituitary aplasia or dysplasia
    n1=en:white substance | n2=en:pituitary aplasia or dysplasia | rel=r_associated | relid=0 | w=91
  3373. en:white substance -- r_associated #0: 91 / 0.752 -> en:pituitary hypoplasia (in some patients)
    n1=en:white substance | n2=en:pituitary hypoplasia (in some patients) | rel=r_associated | relid=0 | w=91
  3374. en:white substance -- r_associated #0: 91 / 0.752 -> en:platybasia
    n1=en:white substance | n2=en:platybasia | rel=r_associated | relid=0 | w=91
  3375. en:white substance -- r_associated #0: 91 / 0.752 -> en:polymicrogyria
    n1=en:white substance | n2=en:polymicrogyria | rel=r_associated | relid=0 | w=91
  3376. en:white substance -- r_associated #0: 91 / 0.752 -> en:polymicrogyria (reported in 1 patient)
    n1=en:white substance | n2=en:polymicrogyria (reported in 1 patient) | rel=r_associated | relid=0 | w=91
  3377. en:white substance -- r_associated #0: 91 / 0.752 -> en:polymicrogyria, occipital
    n1=en:white substance | n2=en:polymicrogyria, occipital | rel=r_associated | relid=0 | w=91
  3378. en:white substance -- r_associated #0: 91 / 0.752 -> en:polymicrogyria, predominantly frontal and perisylvian
    n1=en:white substance | n2=en:polymicrogyria, predominantly frontal and perisylvian | rel=r_associated | relid=0 | w=91
  3379. en:white substance -- r_associated #0: 91 / 0.752 -> en:polyneuropathies, motor
    n1=en:white substance | n2=en:polyneuropathies, motor | rel=r_associated | relid=0 | w=91
  3380. en:white substance -- r_associated #0: 91 / 0.752 -> en:polyneuropathy
    n1=en:white substance | n2=en:polyneuropathy | rel=r_associated | relid=0 | w=91
  3381. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor communication
    n1=en:white substance | n2=en:poor communication | rel=r_associated | relid=0 | w=91
  3382. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor hand-eye coordination
    n1=en:white substance | n2=en:poor hand-eye coordination | rel=r_associated | relid=0 | w=91
  3383. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor motor development
    n1=en:white substance | n2=en:poor motor development | rel=r_associated | relid=0 | w=91
  3384. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor myelination
    n1=en:white substance | n2=en:poor myelination | rel=r_associated | relid=0 | w=91
  3385. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor or absent speech development
    n1=en:white substance | n2=en:poor or absent speech development | rel=r_associated | relid=0 | w=91
  3386. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor speech or lack of speech development
    n1=en:white substance | n2=en:poor speech or lack of speech development | rel=r_associated | relid=0 | w=91
  3387. en:white substance -- r_associated #0: 91 / 0.752 -> en:poor visual-motor integration (range 41-80)
    n1=en:white substance | n2=en:poor visual-motor integration (range 41-80) | rel=r_associated | relid=0 | w=91
  3388. en:white substance -- r_associated #0: 91 / 0.752 -> en:porencephaly (in some patients)
    n1=en:white substance | n2=en:porencephaly (in some patients) | rel=r_associated | relid=0 | w=91
  3389. en:white substance -- r_associated #0: 91 / 0.752 -> en:posterior fossa abnormalities (rare)
    n1=en:white substance | n2=en:posterior fossa abnormalities (rare) | rel=r_associated | relid=0 | w=91
  3390. en:white substance -- r_associated #0: 91 / 0.752 -> en:posterior fossa arachnoid cyst
    n1=en:white substance | n2=en:posterior fossa arachnoid cyst | rel=r_associated | relid=0 | w=91
  3391. en:white substance -- r_associated #0: 91 / 0.752 -> en:posterior slow-wave activity on eeg
    n1=en:white substance | n2=en:posterior slow-wave activity on eeg | rel=r_associated | relid=0 | w=91
  3392. en:white substance -- r_associated #0: 91 / 0.752 -> en:praxis
    n1=en:white substance | n2=en:praxis | rel=r_associated | relid=0 | w=91
  3393. en:white substance -- r_associated #0: 91 / 0.752 -> en:presenile and senile dementia
    n1=en:white substance | n2=en:presenile and senile dementia | rel=r_associated | relid=0 | w=91
  3394. en:white substance -- r_associated #0: 91 / 0.752 -> en:profound mental retardation and hypotonia in survivors
    n1=en:white substance | n2=en:profound mental retardation and hypotonia in survivors | rel=r_associated | relid=0 | w=91
  3395. en:white substance -- r_associated #0: 91 / 0.752 -> en:progressive cerebellar ataxia
    n1=en:white substance | n2=en:progressive cerebellar ataxia | rel=r_associated | relid=0 | w=91
  3396. en:white substance -- r_associated #0: 91 / 0.752 -> en:progressive impairment of gait
    n1=en:white substance | n2=en:progressive impairment of gait | rel=r_associated | relid=0 | w=91
  3397. en:white substance -- r_associated #0: 91 / 0.752 -> en:progressive leukoencephalopathy
    n1=en:white substance | n2=en:progressive leukoencephalopathy | rel=r_associated | relid=0 | w=91
  3398. en:white substance -- r_associated #0: 91 / 0.752 -> en:progressive loss of movement control
    n1=en:white substance | n2=en:progressive loss of movement control | rel=r_associated | relid=0 | w=91
  3399. en:white substance -- r_associated #0: 91 / 0.752 -> en:progressive myoclonus epilepsy
    n1=en:white substance | n2=en:progressive myoclonus epilepsy | rel=r_associated | relid=0 | w=91
  3400. en:white substance -- r_associated #0: 91 / 0.752 -> en:progressive pyramidal and cerebellar signs
    n1=en:white substance | n2=en:progressive pyramidal and cerebellar signs | rel=r_associated | relid=0 | w=91
  3401. en:white substance -- r_associated #0: 91 / 0.752 -> en:prominent cortical sulci
    n1=en:white substance | n2=en:prominent cortical sulci | rel=r_associated | relid=0 | w=91
  3402. en:white substance -- r_associated #0: 91 / 0.752 -> en:prominent csf spaces (in some patients)
    n1=en:white substance | n2=en:prominent csf spaces (in some patients) | rel=r_associated | relid=0 | w=91
  3403. en:white substance -- r_associated #0: 91 / 0.752 -> en:proximal weakness occurs later
    n1=en:white substance | n2=en:proximal weakness occurs later | rel=r_associated | relid=0 | w=91
  3404. en:white substance -- r_associated #0: 91 / 0.752 -> en:proximal weakness of the lower extremities
    n1=en:white substance | n2=en:proximal weakness of the lower extremities | rel=r_associated | relid=0 | w=91
  3405. en:white substance -- r_associated #0: 91 / 0.752 -> en:pseudobulbar symptoms (uncontrolled laughter, weeping)
    n1=en:white substance | n2=en:pseudobulbar symptoms (uncontrolled laughter, weeping) | rel=r_associated | relid=0 | w=91
  3406. en:white substance -- r_associated #0: 91 / 0.752 -> en:psychomotor delay after second year
    n1=en:white substance | n2=en:psychomotor delay after second year | rel=r_associated | relid=0 | w=91
  3407. en:white substance -- r_associated #0: 91 / 0.752 -> en:psychomotor delay, mild to moderate
    n1=en:white substance | n2=en:psychomotor delay, mild to moderate | rel=r_associated | relid=0 | w=91
  3408. en:white substance -- r_associated #0: 91 / 0.752 -> en:psychomotor regression (in some patients)
    n1=en:white substance | n2=en:psychomotor regression (in some patients) | rel=r_associated | relid=0 | w=91
  3409. en:white substance -- r_associated #0: 91 / 0.752 -> en:psychomotor regression beginning in infancy
    n1=en:white substance | n2=en:psychomotor regression beginning in infancy | rel=r_associated | relid=0 | w=91
  3410. en:white substance -- r_associated #0: 91 / 0.752 -> en:psychomotor retardation, mild
    n1=en:white substance | n2=en:psychomotor retardation, mild | rel=r_associated | relid=0 | w=91
  3411. en:white substance -- r_associated #0: 91 / 0.752 -> en:putamen atrophy
    n1=en:white substance | n2=en:putamen atrophy | rel=r_associated | relid=0 | w=91
  3412. en:white substance -- r_associated #0: 91 / 0.752 -> en:pyramidal syndrome
    n1=en:white substance | n2=en:pyramidal syndrome | rel=r_associated | relid=0 | w=91
  3413. en:white substance -- r_associated #0: 91 / 0.752 -> en:quadriplegia, flaccid
    n1=en:white substance | n2=en:quadriplegia, flaccid | rel=r_associated | relid=0 | w=91
  3414. en:white substance -- r_associated #0: 91 / 0.752 -> en:quadrupedal gait (palm of hands, legs straight) with diagonal walking
    n1=en:white substance | n2=en:quadrupedal gait (palm of hands, legs straight) with diagonal walking | rel=r_associated | relid=0 | w=91
  3415. en:white substance -- r_associated #0: 91 / 0.752 -> en:quadrupedal locomotion (in some patients)
    n1=en:white substance | n2=en:quadrupedal locomotion (in some patients) | rel=r_associated | relid=0 | w=91
  3416. en:white substance -- r_associated #0: 91 / 0.752 -> en:rapid, instantaneous neurologic decline may occur after fright
    n1=en:white substance | n2=en:rapid, instantaneous neurologic decline may occur after fright | rel=r_associated | relid=0 | w=91
  3417. en:white substance -- r_associated #0: 91 / 0.752 -> en:recurrent muscle twitches (symptom)
    n1=en:white substance | n2=en:recurrent muscle twitches (symptom) | rel=r_associated | relid=0 | w=91
  3418. en:white substance -- r_associated #0: 91 / 0.752 -> en:reduced concentration span
    n1=en:white substance | n2=en:reduced concentration span | rel=r_associated | relid=0 | w=91
  3419. en:white substance -- r_associated #0: 91 / 0.752 -> en:reduced sleep latency
    n1=en:white substance | n2=en:reduced sleep latency | rel=r_associated | relid=0 | w=91
  3420. en:white substance -- r_associated #0: 91 / 0.752 -> en:reflex epilepsy, photosensitive
    n1=en:white substance | n2=en:reflex epilepsy, photosensitive | rel=r_associated | relid=0 | w=91
  3421. en:white substance -- r_associated #0: 91 / 0.752 -> en:reflex, deep tendon, absent
    n1=en:white substance | n2=en:reflex, deep tendon, absent | rel=r_associated | relid=0 | w=91
  3422. en:white substance -- r_associated #0: 91 / 0.752 -> en:regression of development
    n1=en:white substance | n2=en:regression of development | rel=r_associated | relid=0 | w=91
  3423. en:white substance -- r_associated #0: 91 / 0.752 -> en:rem sleep behavior disorder
    n1=en:white substance | n2=en:rem sleep behavior disorder | rel=r_associated | relid=0 | w=91
  3424. en:white substance -- r_associated #0: 91 / 0.752 -> en:restlessness at birth
    n1=en:white substance | n2=en:restlessness at birth | rel=r_associated | relid=0 | w=91
  3425. en:white substance -- r_associated #0: 91 / 0.752 -> en:retroflexion of the neck
    n1=en:white substance | n2=en:retroflexion of the neck | rel=r_associated | relid=0 | w=91
  3426. en:white substance -- r_associated #0: 91 / 0.752 -> en:romberg's sign positive
    n1=en:white substance | n2=en:romberg's sign positive | rel=r_associated | relid=0 | w=91
  3427. en:white substance -- r_associated #0: 91 / 0.752 -> en:scissors gait
    n1=en:white substance | n2=en:scissors gait | rel=r_associated | relid=0 | w=91
  3428. en:white substance -- r_associated #0: 91 / 0.752 -> en:secondary generalization
    n1=en:white substance | n2=en:secondary generalization | rel=r_associated | relid=0 | w=91
  3429. en:white substance -- r_associated #0: 91 / 0.752 -> en:secondary generalized tonic-clonic seizures may occur
    n1=en:white substance | n2=en:secondary generalized tonic-clonic seizures may occur | rel=r_associated | relid=0 | w=91
  3430. en:white substance -- r_associated #0: 91 / 0.752 -> en:secondary hand muscle weakness predominating at the wrist and finger extensor muscles
    n1=en:white substance | n2=en:secondary hand muscle weakness predominating at the wrist and finger extensor muscles | rel=r_associated | relid=0 | w=91
  3431. en:white substance -- r_associated #0: 91 / 0.752 -> en:segment of cerebellar medulla
    n1=en:white substance | n2=en:segment of cerebellar medulla | rel=r_associated | relid=0 | w=91
  3432. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizure (in a subset of patients in infancy)
    n1=en:white substance | n2=en:seizure (in a subset of patients in infancy) | rel=r_associated | relid=0 | w=91
  3433. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures (1 family)
    n1=en:white substance | n2=en:seizures (1 family) | rel=r_associated | relid=0 | w=91
  3434. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures (3 patients)
    n1=en:white substance | n2=en:seizures (3 patients) | rel=r_associated | relid=0 | w=91
  3435. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures (in one patient)
    n1=en:white substance | n2=en:seizures (in one patient) | rel=r_associated | relid=0 | w=91
  3436. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures (uncommon)
    n1=en:white substance | n2=en:seizures (uncommon) | rel=r_associated | relid=0 | w=91
  3437. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures (variable)
    n1=en:white substance | n2=en:seizures (variable) | rel=r_associated | relid=0 | w=91
  3438. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures may occur during hypotensive episodes
    n1=en:white substance | n2=en:seizures may occur during hypotensive episodes | rel=r_associated | relid=0 | w=91
  3439. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures occur in clusters over 1 or several days
    n1=en:white substance | n2=en:seizures occur in clusters over 1 or several days | rel=r_associated | relid=0 | w=91
  3440. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures, complex partial, episodic
    n1=en:white substance | n2=en:seizures, complex partial, episodic | rel=r_associated | relid=0 | w=91
  3441. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures, continuous, refractory
    n1=en:white substance | n2=en:seizures, continuous, refractory | rel=r_associated | relid=0 | w=91
  3442. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures, intractable (in 1 family)
    n1=en:white substance | n2=en:seizures, intractable (in 1 family) | rel=r_associated | relid=0 | w=91
  3443. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures, multiple types
    n1=en:white substance | n2=en:seizures, multiple types | rel=r_associated | relid=0 | w=91
  3444. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures, refractory
    n1=en:white substance | n2=en:seizures, refractory | rel=r_associated | relid=0 | w=91
  3445. en:white substance -- r_associated #0: 91 / 0.752 -> en:seizures, refractory, infantile-onset
    n1=en:white substance | n2=en:seizures, refractory, infantile-onset | rel=r_associated | relid=0 | w=91
  3446. en:white substance -- r_associated #0: 91 / 0.752 -> en:semilobar holoprosencephalies
    n1=en:white substance | n2=en:semilobar holoprosencephalies | rel=r_associated | relid=0 | w=91
  3447. en:white substance -- r_associated #0: 91 / 0.752 -> en:sensorineural hearing loss
    n1=en:white substance | n2=en:sensorineural hearing loss | rel=r_associated | relid=0 | w=91
  3448. en:white substance -- r_associated #0: 91 / 0.752 -> en:sensory ataxia (less common)
    n1=en:white substance | n2=en:sensory ataxia (less common) | rel=r_associated | relid=0 | w=91
  3449. en:white substance -- r_associated #0: 91 / 0.752 -> en:set of eye and related structures
    n1=en:white substance | n2=en:set of eye and related structures | rel=r_associated | relid=0 | w=91
  3450. en:white substance -- r_associated #0: 91 / 0.752 -> en:set of laryngeal cartilages and joints
    n1=en:white substance | n2=en:set of laryngeal cartilages and joints | rel=r_associated | relid=0 | w=91
  3451. en:white substance -- r_associated #0: 91 / 0.752 -> en:severe expressive speech delay
    n1=en:white substance | n2=en:severe expressive speech delay | rel=r_associated | relid=0 | w=91
  3452. en:white substance -- r_associated #0: 91 / 0.752 -> en:severe hydrocephalus
    n1=en:white substance | n2=en:severe hydrocephalus | rel=r_associated | relid=0 | w=91
  3453. en:white substance -- r_associated #0: 91 / 0.752 -> en:severe involvement of globus pallidus
    n1=en:white substance | n2=en:severe involvement of globus pallidus | rel=r_associated | relid=0 | w=91
  3454. en:white substance -- r_associated #0: 91 / 0.752 -> en:severe prenatal onset hydrocephalus
    n1=en:white substance | n2=en:severe prenatal onset hydrocephalus | rel=r_associated | relid=0 | w=91
  3455. en:white substance -- r_associated #0: 91 / 0.752 -> en:severe psychomotor retardation
    n1=en:white substance | n2=en:severe psychomotor retardation | rel=r_associated | relid=0 | w=91
  3456. en:white substance -- r_associated #0: 91 / 0.752 -> en:severe speech impairment
    n1=en:white substance | n2=en:severe speech impairment | rel=r_associated | relid=0 | w=91
  3457. en:white substance -- r_associated #0: 91 / 0.752 -> en:severity of symptoms peak in the second decade and do not progress
    n1=en:white substance | n2=en:severity of symptoms peak in the second decade and do not progress | rel=r_associated | relid=0 | w=91
  3458. en:white substance -- r_associated #0: 91 / 0.752 -> en:shorter daily total sleep times compared to age-matched controls
    n1=en:white substance | n2=en:shorter daily total sleep times compared to age-matched controls | rel=r_associated | relid=0 | w=91
  3459. en:white substance -- r_associated #0: 91 / 0.752 -> en:simple partial seizures
    n1=en:white substance | n2=en:simple partial seizures | rel=r_associated | relid=0 | w=91
  3460. en:white substance -- r_associated #0: 91 / 0.752 -> en:simplified gyral pattern (in some patients)
    n1=en:white substance | n2=en:simplified gyral pattern (in some patients) | rel=r_associated | relid=0 | w=91
  3461. en:white substance -- r_associated #0: 91 / 0.752 -> en:simplified gyration pattern
    n1=en:white substance | n2=en:simplified gyration pattern | rel=r_associated | relid=0 | w=91
  3462. en:white substance -- r_associated #0: 91 / 0.752 -> en:sleep apnea
    n1=en:white substance | n2=en:sleep apnea | rel=r_associated | relid=0 | w=91
  3463. en:white substance -- r_associated #0: 91 / 0.752 -> en:sleep disturbances (in some patients)
    n1=en:white substance | n2=en:sleep disturbances (in some patients) | rel=r_associated | relid=0 | w=91
  3464. en:white substance -- r_associated #0: 91 / 0.752 -> en:sleep talking
    n1=en:white substance | n2=en:sleep talking | rel=r_associated | relid=0 | w=91
  3465. en:white substance -- r_associated #0: 91 / 0.752 -> en:slow reactions
    n1=en:white substance | n2=en:slow reactions | rel=r_associated | relid=0 | w=91
  3466. en:white substance -- r_associated #0: 91 / 0.752 -> en:slurred speech, episodic
    n1=en:white substance | n2=en:slurred speech, episodic | rel=r_associated | relid=0 | w=91
  3467. en:white substance -- r_associated #0: 91 / 0.752 -> en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration
    n1=en:white substance | n2=en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration | rel=r_associated | relid=0 | w=91
  3468. en:white substance -- r_associated #0: 91 / 0.752 -> en:small brain with no other malformation see on mri
    n1=en:white substance | n2=en:small brain with no other malformation see on mri | rel=r_associated | relid=0 | w=91
  3469. en:white substance -- r_associated #0: 91 / 0.752 -> en:small but structurally normal cerebral cortex
    n1=en:white substance | n2=en:small but structurally normal cerebral cortex | rel=r_associated | relid=0 | w=91
  3470. en:white substance -- r_associated #0: 91 / 0.752 -> en:small pituitary gland (in some patients)
    n1=en:white substance | n2=en:small pituitary gland (in some patients) | rel=r_associated | relid=0 | w=91
  3471. en:white substance -- r_associated #0: 91 / 0.752 -> en:small thalami
    n1=en:white substance | n2=en:small thalami | rel=r_associated | relid=0 | w=91
  3472. en:white substance -- r_associated #0: 91 / 0.752 -> en:social and occupational deterioration
    n1=en:white substance | n2=en:social and occupational deterioration | rel=r_associated | relid=0 | w=91
  3473. en:white substance -- r_associated #0: 91 / 0.752 -> en:some patients have periodic wave complexes on eeg
    n1=en:white substance | n2=en:some patients have periodic wave complexes on eeg | rel=r_associated | relid=0 | w=91
  3474. en:white substance -- r_associated #0: 91 / 0.752 -> en:sparing of optic tracts
    n1=en:white substance | n2=en:sparing of optic tracts | rel=r_associated | relid=0 | w=91
  3475. en:white substance -- r_associated #0: 91 / 0.752 -> en:spastic cerebral palsy
    n1=en:white substance | n2=en:spastic cerebral palsy | rel=r_associated | relid=0 | w=91
  3476. en:white substance -- r_associated #0: 91 / 0.752 -> en:spastic paraplegia
    n1=en:white substance | n2=en:spastic paraplegia | rel=r_associated | relid=0 | w=91
  3477. en:white substance -- r_associated #0: 91 / 0.752 -> en:spastic paraplegia, severe
    n1=en:white substance | n2=en:spastic paraplegia, severe | rel=r_associated | relid=0 | w=91
  3478. en:white substance -- r_associated #0: 91 / 0.752 -> en:spasticity (1 of 4 patients)
    n1=en:white substance | n2=en:spasticity (1 of 4 patients) | rel=r_associated | relid=0 | w=91
  3479. en:white substance -- r_associated #0: 91 / 0.752 -> en:spasticity, distal
    n1=en:white substance | n2=en:spasticity, distal | rel=r_associated | relid=0 | w=91
  3480. en:white substance -- r_associated #0: 91 / 0.752 -> en:spasticity, mainly in the lower limbs
    n1=en:white substance | n2=en:spasticity, mainly in the lower limbs | rel=r_associated | relid=0 | w=91
  3481. en:white substance -- r_associated #0: 91 / 0.752 -> en:spasticity, primarily lower limbs, but upper limbs may be involved
    n1=en:white substance | n2=en:spasticity, primarily lower limbs, but upper limbs may be involved | rel=r_associated | relid=0 | w=91
  3482. en:white substance -- r_associated #0: 91 / 0.752 -> en:speech delay
    n1=en:white substance | n2=en:speech delay | rel=r_associated | relid=0 | w=91
  3483. en:white substance -- r_associated #0: 91 / 0.752 -> en:speech development delayed (in some patients)
    n1=en:white substance | n2=en:speech development delayed (in some patients) | rel=r_associated | relid=0 | w=91
  3484. en:white substance -- r_associated #0: 91 / 0.752 -> en:spinal cord glial hyperplasia
    n1=en:white substance | n2=en:spinal cord glial hyperplasia | rel=r_associated | relid=0 | w=91
  3485. en:white substance -- r_associated #0: 91 / 0.752 -> en:spinal cord part
    n1=en:white substance | n2=en:spinal cord part | rel=r_associated | relid=0 | w=91
  3486. en:white substance -- r_associated #0: 91 / 0.752 -> en:spinocerebellar ataxia
    n1=en:white substance | n2=en:spinocerebellar ataxia | rel=r_associated | relid=0 | w=91
  3487. en:white substance -- r_associated #0: 91 / 0.752 -> en:spinocerebellar degeneration
    n1=en:white substance | n2=en:spinocerebellar degeneration | rel=r_associated | relid=0 | w=91
  3488. en:white substance -- r_associated #0: 91 / 0.752 -> en:startle myoclonus
    n1=en:white substance | n2=en:startle myoclonus | rel=r_associated | relid=0 | w=91
  3489. en:white substance -- r_associated #0: 91 / 0.752 -> en:status epilepticus (in 1 of 6 patients)
    n1=en:white substance | n2=en:status epilepticus (in 1 of 6 patients) | rel=r_associated | relid=0 | w=91
  3490. en:white substance -- r_associated #0: 91 / 0.752 -> en:stiffness of the lower limbs
    n1=en:white substance | n2=en:stiffness of the lower limbs | rel=r_associated | relid=0 | w=91
  3491. en:white substance -- r_associated #0: 91 / 0.752 -> en:stoke-like lesions
    n1=en:white substance | n2=en:stoke-like lesions | rel=r_associated | relid=0 | w=91
  3492. en:white substance -- r_associated #0: 91 / 0.752 -> en:stretched cerebellar peduncles
    n1=en:white substance | n2=en:stretched cerebellar peduncles | rel=r_associated | relid=0 | w=91
  3493. en:white substance -- r_associated #0: 91 / 0.752 -> en:striatal atrophy
    n1=en:white substance | n2=en:striatal atrophy | rel=r_associated | relid=0 | w=91
  3494. en:white substance -- r_associated #0: 91 / 0.752 -> en:stroke (in some patients)
    n1=en:white substance | n2=en:stroke (in some patients) | rel=r_associated | relid=0 | w=91
  3495. en:white substance -- r_associated #0: 91 / 0.752 -> en:stroke-like episodes
    n1=en:white substance | n2=en:stroke-like episodes | rel=r_associated | relid=0 | w=91
  3496. en:white substance -- r_associated #0: 91 / 0.752 -> en:stroke-like symptoms
    n1=en:white substance | n2=en:stroke-like symptoms | rel=r_associated | relid=0 | w=91
  3497. en:white substance -- r_associated #0: 91 / 0.752 -> en:structural abnormalities in the basal ganglia (especially caudate)
    n1=en:white substance | n2=en:structural abnormalities in the basal ganglia (especially caudate) | rel=r_associated | relid=0 | w=91
  3498. en:white substance -- r_associated #0: 91 / 0.752 -> en:structural brain abnormalities
    n1=en:white substance | n2=en:structural brain abnormalities | rel=r_associated | relid=0 | w=91
  3499. en:white substance -- r_associated #0: 91 / 0.752 -> en:structure of central auditory system
    n1=en:white substance | n2=en:structure of central auditory system | rel=r_associated | relid=0 | w=91
  3500. en:white substance -- r_associated #0: 91 / 0.752 -> en:subcortical and periventricular white matter abnormalities seen on mri (in some patients)
    n1=en:white substance | n2=en:subcortical and periventricular white matter abnormalities seen on mri (in some patients) | rel=r_associated | relid=0 | w=91
  3501. en:white substance -- r_associated #0: 91 / 0.752 -> en:subcortical cysts temporal lobe
    n1=en:white substance | n2=en:subcortical cysts temporal lobe | rel=r_associated | relid=0 | w=91
  3502. en:white substance -- r_associated #0: 91 / 0.752 -> en:subcortical dementia, progressive (6% of patients)
    n1=en:white substance | n2=en:subcortical dementia, progressive (6% of patients) | rel=r_associated | relid=0 | w=91
  3503. en:white substance -- r_associated #0: 91 / 0.752 -> en:subcortical white matter abnormalities (rare)
    n1=en:white substance | n2=en:subcortical white matter abnormalities (rare) | rel=r_associated | relid=0 | w=91
  3504. en:white substance -- r_associated #0: 91 / 0.752 -> en:subcortical white matter abnormalities seen on mri
    n1=en:white substance | n2=en:subcortical white matter abnormalities seen on mri | rel=r_associated | relid=0 | w=91
  3505. en:white substance -- r_associated #0: 91 / 0.752 -> en:subcortical white matter lesions in the temporal lobes seen on brain mri
    n1=en:white substance | n2=en:subcortical white matter lesions in the temporal lobes seen on brain mri | rel=r_associated | relid=0 | w=91
  3506. en:white substance -- r_associated #0: 91 / 0.752 -> en:subependymal nodules
    n1=en:white substance | n2=en:subependymal nodules | rel=r_associated | relid=0 | w=91
  3507. en:white substance -- r_associated #0: 91 / 0.752 -> en:subependymal pseudocyst
    n1=en:white substance | n2=en:subependymal pseudocyst | rel=r_associated | relid=0 | w=91
  3508. en:white substance -- r_associated #0: 91 / 0.752 -> en:substantia nigra gliosis
    n1=en:white substance | n2=en:substantia nigra gliosis | rel=r_associated | relid=0 | w=91
  3509. en:white substance -- r_associated #0: 91 / 0.752 -> en:superficial laminar spongiosis
    n1=en:white substance | n2=en:superficial laminar spongiosis | rel=r_associated | relid=0 | w=91
  3510. en:white substance -- r_associated #0: 91 / 0.752 -> en:supratentorial structures unformed or regressed
    n1=en:white substance | n2=en:supratentorial structures unformed or regressed | rel=r_associated | relid=0 | w=91
  3511. en:white substance -- r_associated #0: 91 / 0.752 -> en:symmetric spinal nerve root neurofibromas
    n1=en:white substance | n2=en:symmetric spinal nerve root neurofibromas | rel=r_associated | relid=0 | w=91
  3512. en:white substance -- r_associated #0: 91 / 0.752 -> en:synkinesis
    n1=en:white substance | n2=en:synkinesis | rel=r_associated | relid=0 | w=91
  3513. en:white substance -- r_associated #0: 91 / 0.752 -> en:t1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra
    n1=en:white substance | n2=en:t1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra | rel=r_associated | relid=0 | w=91
  3514. en:white substance -- r_associated #0: 91 / 0.752 -> en:t2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem
    n1=en:white substance | n2=en:t2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem | rel=r_associated | relid=0 | w=91
  3515. en:white substance -- r_associated #0: 91 / 0.752 -> en:t2-weighted mri shows hyperintensities in the thalamus, basal ganglia, and brainstem during acute illness (may later resolve)
    n1=en:white substance | n2=en:t2-weighted mri shows hyperintensities in the thalamus, basal ganglia, and brainstem during acute illness (may later resolve) | rel=r_associated | relid=0 | w=91
  3516. en:white substance -- r_associated #0: 91 / 0.752 -> en:teratologic
    n1=en:white substance | n2=en:teratologic | rel=r_associated | relid=0 | w=91
  3517. en:white substance -- r_associated #0: 91 / 0.752 -> en:tetany
    n1=en:white substance | n2=en:tetany | rel=r_associated | relid=0 | w=91
  3518. en:white substance -- r_associated #0: 91 / 0.752 -> en:tetany, hypocalcemic (in some patients)
    n1=en:white substance | n2=en:tetany, hypocalcemic (in some patients) | rel=r_associated | relid=0 | w=91
  3519. en:white substance -- r_associated #0: 91 / 0.752 -> en:tethered cord (uncommon)
    n1=en:white substance | n2=en:tethered cord (uncommon) | rel=r_associated | relid=0 | w=91
  3520. en:white substance -- r_associated #0: 91 / 0.752 -> en:thick and elongated superior cerebellar peduncles
    n1=en:white substance | n2=en:thick and elongated superior cerebellar peduncles | rel=r_associated | relid=0 | w=91
  3521. en:white substance -- r_associated #0: 91 / 0.752 -> en:thickened frontal cortex
    n1=en:white substance | n2=en:thickened frontal cortex | rel=r_associated | relid=0 | w=91
  3522. en:white substance -- r_associated #0: 91 / 0.752 -> en:thickening of the skull (less common)
    n1=en:white substance | n2=en:thickening of the skull (less common) | rel=r_associated | relid=0 | w=91
  3523. en:white substance -- r_associated #0: 91 / 0.752 -> en:thin pituitary stalk
    n1=en:white substance | n2=en:thin pituitary stalk | rel=r_associated | relid=0 | w=91
  3524. en:white substance -- r_associated #0: 91 / 0.752 -> en:thrombosis of cerebral veins
    n1=en:white substance | n2=en:thrombosis of cerebral veins | rel=r_associated | relid=0 | w=91
  3525. en:white substance -- r_associated #0: 91 / 0.752 -> en:tonic seizures, refractory
    n1=en:white substance | n2=en:tonic seizures, refractory | rel=r_associated | relid=0 | w=91
  3526. en:white substance -- r_associated #0: 91 / 0.752 -> en:torticollis
    n1=en:white substance | n2=en:torticollis | rel=r_associated | relid=0 | w=91
  3527. en:white substance -- r_associated #0: 91 / 0.752 -> en:tow-walking
    n1=en:white substance | n2=en:tow-walking | rel=r_associated | relid=0 | w=91
  3528. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremor (1 patient)
    n1=en:white substance | n2=en:tremor (1 patient) | rel=r_associated | relid=0 | w=91
  3529. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremor (rare)
    n1=en:white substance | n2=en:tremor (rare) | rel=r_associated | relid=0 | w=91
  3530. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremor adverse event
    n1=en:white substance | n2=en:tremor adverse event | rel=r_associated | relid=0 | w=91
  3531. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremor with febrile episodes (rare)
    n1=en:white substance | n2=en:tremor with febrile episodes (rare) | rel=r_associated | relid=0 | w=91
  3532. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremor, action (arms, tongue, head, legs and trunk)
    n1=en:white substance | n2=en:tremor, action (arms, tongue, head, legs and trunk) | rel=r_associated | relid=0 | w=91
  3533. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremor, variable
    n1=en:white substance | n2=en:tremor, variable | rel=r_associated | relid=0 | w=91
  3534. en:white substance -- r_associated #0: 91 / 0.752 -> en:tremors, action
    n1=en:white substance | n2=en:tremors, action | rel=r_associated | relid=0 | w=91
  3535. en:white substance -- r_associated #0: 91 / 0.752 -> en:truncal ataxia, mild
    n1=en:white substance | n2=en:truncal ataxia, mild | rel=r_associated | relid=0 | w=91
  3536. en:white substance -- r_associated #0: 91 / 0.752 -> en:truncal instability
    n1=en:white substance | n2=en:truncal instability | rel=r_associated | relid=0 | w=91
  3537. en:white substance -- r_associated #0: 91 / 0.752 -> en:type iv eeg response is generalized spike-wave discharges
    n1=en:white substance | n2=en:type iv eeg response is generalized spike-wave discharges | rel=r_associated | relid=0 | w=91
  3538. en:white substance -- r_associated #0: 91 / 0.752 -> en:ubiquitin-positive inclusions
    n1=en:white substance | n2=en:ubiquitin-positive inclusions | rel=r_associated | relid=0 | w=91
  3539. en:white substance -- r_associated #0: 91 / 0.752 -> en:unable to talk
    n1=en:white substance | n2=en:unable to talk | rel=r_associated | relid=0 | w=91
  3540. en:white substance -- r_associated #0: 91 / 0.752 -> en:undersulcation of the frontal lobes
    n1=en:white substance | n2=en:undersulcation of the frontal lobes | rel=r_associated | relid=0 | w=91
  3541. en:white substance -- r_associated #0: 91 / 0.752 -> en:unintelligible speech, vocalizations, grunting
    n1=en:white substance | n2=en:unintelligible speech, vocalizations, grunting | rel=r_associated | relid=0 | w=91
  3542. en:white substance -- r_associated #0: 91 / 0.752 -> en:upper limb dystonia
    n1=en:white substance | n2=en:upper limb dystonia | rel=r_associated | relid=0 | w=91
  3543. en:white substance -- r_associated #0: 91 / 0.752 -> en:upper limb spasticity (in some patients)
    n1=en:white substance | n2=en:upper limb spasticity (in some patients) | rel=r_associated | relid=0 | w=91
  3544. en:white substance -- r_associated #0: 91 / 0.752 -> en:upper motor neuron signs (in some patients)
    n1=en:white substance | n2=en:upper motor neuron signs (in some patients) | rel=r_associated | relid=0 | w=91
  3545. en:white substance -- r_associated #0: 91 / 0.752 -> en:upper motor signs
    n1=en:white substance | n2=en:upper motor signs | rel=r_associated | relid=0 | w=91
  3546. en:white substance -- r_associated #0: 91 / 0.752 -> en:usually occurs at night
    n1=en:white substance | n2=en:usually occurs at night | rel=r_associated | relid=0 | w=91
  3547. en:white substance -- r_associated #0: 91 / 0.752 -> en:ventricles slightly enlarged
    n1=en:white substance | n2=en:ventricles slightly enlarged | rel=r_associated | relid=0 | w=91
  3548. en:white substance -- r_associated #0: 91 / 0.752 -> en:ventricular dilatation (in some patients)
    n1=en:white substance | n2=en:ventricular dilatation (in some patients) | rel=r_associated | relid=0 | w=91
  3549. en:white substance -- r_associated #0: 91 / 0.752 -> en:ventriculomegaly (38%)
    n1=en:white substance | n2=en:ventriculomegaly (38%) | rel=r_associated | relid=0 | w=91
  3550. en:white substance -- r_associated #0: 91 / 0.752 -> en:ventriculomegaly (variable)
    n1=en:white substance | n2=en:ventriculomegaly (variable) | rel=r_associated | relid=0 | w=91
  3551. en:white substance -- r_associated #0: 91 / 0.752 -> en:vertigo
    n1=en:white substance | n2=en:vertigo | rel=r_associated | relid=0 | w=91
  3552. en:white substance -- r_associated #0: 91 / 0.752 -> en:vertigo, episodic (onset in second or third decade)
    n1=en:white substance | n2=en:vertigo, episodic (onset in second or third decade) | rel=r_associated | relid=0 | w=91
  3553. en:white substance -- r_associated #0: 91 / 0.752 -> en:visual changes
    n1=en:white substance | n2=en:visual changes | rel=r_associated | relid=0 | w=91
  3554. en:white substance -- r_associated #0: 91 / 0.752 -> en:walking impairment due to myoclonus late in disease
    n1=en:white substance | n2=en:walking impairment due to myoclonus late in disease | rel=r_associated | relid=0 | w=91
  3555. en:white substance -- r_associated #0: 91 / 0.752 -> en:weak or absent tendon reflexes of knees and ankles (in some patients)
    n1=en:white substance | n2=en:weak or absent tendon reflexes of knees and ankles (in some patients) | rel=r_associated | relid=0 | w=91
  3556. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter abnormalities (rare)
    n1=en:white substance | n2=en:white matter abnormalities (rare) | rel=r_associated | relid=0 | w=91
  3557. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter buckling sign
    n1=en:white substance | n2=en:white matter buckling sign | rel=r_associated | relid=0 | w=91
  3558. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter hyperintensities (mri, t2 images) suggestive of old infarcts
    n1=en:white substance | n2=en:white matter hyperintensities (mri, t2 images) suggestive of old infarcts | rel=r_associated | relid=0 | w=91
  3559. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter hyperintensities in various brain regions
    n1=en:white substance | n2=en:white matter hyperintensities in various brain regions | rel=r_associated | relid=0 | w=91
  3560. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter hypodensities on brain imaging
    n1=en:white substance | n2=en:white matter hypodensities on brain imaging | rel=r_associated | relid=0 | w=91
  3561. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter lesion
    n1=en:white substance | n2=en:white matter lesion | rel=r_associated | relid=0 | w=91
  3562. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter lesions in the brainstem may occur
    n1=en:white substance | n2=en:white matter lesions in the brainstem may occur | rel=r_associated | relid=0 | w=91
  3563. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter rarefaction and cystic degeneration
    n1=en:white substance | n2=en:white matter rarefaction and cystic degeneration | rel=r_associated | relid=0 | w=91
  3564. en:white substance -- r_associated #0: 91 / 0.752 -> en:white matter vacuolization
    n1=en:white substance | n2=en:white matter vacuolization | rel=r_associated | relid=0 | w=91
  3565. en:white substance -- r_associated #0: 91 / 0.752 -> en:widening of the operculum
    n1=en:white substance | n2=en:widening of the operculum | rel=r_associated | relid=0 | w=91
  3566. en:white substance -- r_associated #0: 91 / 0.752 -> en:widespread neuronal loss
    n1=en:white substance | n2=en:widespread neuronal loss | rel=r_associated | relid=0 | w=91
  3567. en:white substance -- r_associated #0: 91 / 0.752 -> en:widespread tau (mapt)-positive glial and neuronal inclusions
    n1=en:white substance | n2=en:widespread tau (mapt)-positive glial and neuronal inclusions | rel=r_associated | relid=0 | w=91
  3568. en:white substance -- r_associated #0: 91 / 0.752 -> en:writing fatigability
    n1=en:white substance | n2=en:writing fatigability | rel=r_associated | relid=0 | w=91
  3569. en:white substance -- r_associated #0: 91 / 0.752 -> en:zone of neuraxis
    n1=en:white substance | n2=en:zone of neuraxis | rel=r_associated | relid=0 | w=91
  3570. en:white substance -- r_associated #0: 90 / 0.744 -> cerveau
    n1=en:white substance | n2=cerveau | rel=r_associated | relid=0 | w=90
  3571. en:white substance -- r_associated #0: 90 / 0.744 -> cerveau
    (anatomie)
    n1=en:white substance | n2=cerveau
    (anatomie)
    | rel=r_associated | relid=0 | w=90
  3572. en:white substance -- r_associated #0: 90 / 0.744 -> en:white matter of thalamus
    n1=en:white substance | n2=en:white matter of thalamus | rel=r_associated | relid=0 | w=90
  3573. en:white substance -- r_associated #0: 90 / 0.744 -> fibre
    (biologie)
    n1=en:white substance | n2=fibre
    (biologie)
    | rel=r_associated | relid=0 | w=90
  3574. en:white substance -- r_associated #0: 90 / 0.744 -> neurologie
    n1=en:white substance | n2=neurologie | rel=r_associated | relid=0 | w=90
  3575. en:white substance -- r_associated #0: 86 / 0.711 -> axone
    n1=en:white substance | n2=axone | rel=r_associated | relid=0 | w=86
  3576. en:white substance -- r_associated #0: 85 / 0.702 -> axone
    (biologie)
    n1=en:white substance | n2=axone
    (biologie)
    | rel=r_associated | relid=0 | w=85
  3577. en:white substance -- r_associated #0: 85 / 0.702 -> biologie
    n1=en:white substance | n2=biologie | rel=r_associated | relid=0 | w=85
  3578. en:white substance -- r_associated #0: 85 / 0.702 -> substance
    n1=en:white substance | n2=substance | rel=r_associated | relid=0 | w=85
  3579. en:white substance -- r_associated #0: 85 / 0.702 -> substance blanche hémisphérique
    n1=en:white substance | n2=substance blanche hémisphérique | rel=r_associated | relid=0 | w=85
  3580. en:white substance -- r_associated #0: 85 / 0.702 -> tissu
    n1=en:white substance | n2=tissu | rel=r_associated | relid=0 | w=85
  3581. en:white substance -- r_associated #0: 85 / 0.702 -> tissu
    (tissu cellulaire)
    n1=en:white substance | n2=tissu
    (tissu cellulaire)
    | rel=r_associated | relid=0 | w=85
  3582. en:white substance -- r_associated #0: 81 / 0.669 -> en:'globoid multinucleated cells' in brain tissue
    n1=en:white substance | n2=en:'globoid multinucleated cells' in brain tissue | rel=r_associated | relid=0 | w=81
  3583. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormal cortical gyration
    n1=en:white substance | n2=en:abnormal cortical gyration | rel=r_associated | relid=0 | w=81
  3584. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormal gyral pattern
    n1=en:white substance | n2=en:abnormal gyral pattern | rel=r_associated | relid=0 | w=81
  3585. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormal hypothalamo-pituitary axis
    n1=en:white substance | n2=en:abnormal hypothalamo-pituitary axis | rel=r_associated | relid=0 | w=81
  3586. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormal movement
    n1=en:white substance | n2=en:abnormal movement | rel=r_associated | relid=0 | w=81
  3587. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormal myelination
    n1=en:white substance | n2=en:abnormal myelination | rel=r_associated | relid=0 | w=81
  3588. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormal signals in the thalami seen on mri
    n1=en:white substance | n2=en:abnormal signals in the thalami seen on mri | rel=r_associated | relid=0 | w=81
  3589. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormality of brainstem morphology
    n1=en:white substance | n2=en:abnormality of brainstem morphology | rel=r_associated | relid=0 | w=81
  3590. en:white substance -- r_associated #0: 81 / 0.669 -> en:abnormality of the cerebellum
    n1=en:white substance | n2=en:abnormality of the cerebellum | rel=r_associated | relid=0 | w=81
  3591. en:white substance -- r_associated #0: 81 / 0.669 -> en:absence of septum pellucidum
    n1=en:white substance | n2=en:absence of septum pellucidum | rel=r_associated | relid=0 | w=81
  3592. en:white substance -- r_associated #0: 81 / 0.669 -> en:agenesis of the corpus callosum (in 1 of 2 patients)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (in 1 of 2 patients) | rel=r_associated | relid=0 | w=81
  3593. en:white substance -- r_associated #0: 81 / 0.669 -> en:agenesis of the corpus callosum (patient a)
    n1=en:white substance | n2=en:agenesis of the corpus callosum (patient a) | rel=r_associated | relid=0 | w=81
  3594. en:white substance -- r_associated #0: 81 / 0.669 -> en:aggregation of snca-immunopositive inclusions
    n1=en:white substance | n2=en:aggregation of snca-immunopositive inclusions | rel=r_associated | relid=0 | w=81
  3595. en:white substance -- r_associated #0: 81 / 0.669 -> en:alobar hpe shows absence of interhemispheric cleavage and single ventricle
    n1=en:white substance | n2=en:alobar hpe shows absence of interhemispheric cleavage and single ventricle | rel=r_associated | relid=0 | w=81
  3596. en:white substance -- r_associated #0: 81 / 0.669 -> en:anencephaly
    n1=en:white substance | n2=en:anencephaly | rel=r_associated | relid=0 | w=81
  3597. en:white substance -- r_associated #0: 81 / 0.669 -> en:anosmia
    n1=en:white substance | n2=en:anosmia | rel=r_associated | relid=0 | w=81
  3598. en:white substance -- r_associated #0: 81 / 0.669 -> en:anterior pituitary hypoplasia
    n1=en:white substance | n2=en:anterior pituitary hypoplasia | rel=r_associated | relid=0 | w=81
  3599. en:white substance -- r_associated #0: 81 / 0.669 -> en:arnold-chiari malformation
    n1=en:white substance | n2=en:arnold-chiari malformation | rel=r_associated | relid=0 | w=81
  3600. en:white substance -- r_associated #0: 81 / 0.669 -> en:ataxia (if untreated)
    n1=en:white substance | n2=en:ataxia (if untreated) | rel=r_associated | relid=0 | w=81
  3601. en:white substance -- r_associated #0: 81 / 0.669 -> en:ataxia (less common)
    n1=en:white substance | n2=en:ataxia (less common) | rel=r_associated | relid=0 | w=81
  3602. en:white substance -- r_associated #0: 81 / 0.669 -> en:ataxia may develop in middle age (less common)
    n1=en:white substance | n2=en:ataxia may develop in middle age (less common) | rel=r_associated | relid=0 | w=81
  3603. en:white substance -- r_associated #0: 81 / 0.669 -> en:attenuated gyri
    n1=en:white substance | n2=en:attenuated gyri | rel=r_associated | relid=0 | w=81
  3604. en:white substance -- r_associated #0: 81 / 0.669 -> en:autonomic involvement
    n1=en:white substance | n2=en:autonomic involvement | rel=r_associated | relid=0 | w=81
  3605. en:white substance -- r_associated #0: 81 / 0.669 -> en:axonal dystrophy (in some patients)
    n1=en:white substance | n2=en:axonal dystrophy (in some patients) | rel=r_associated | relid=0 | w=81
  3606. en:white substance -- r_associated #0: 81 / 0.669 -> en:axonal spheroids in the dorsal column
    n1=en:white substance | n2=en:axonal spheroids in the dorsal column | rel=r_associated | relid=0 | w=81
  3607. en:white substance -- r_associated #0: 81 / 0.669 -> en:balloon cells (in type iib)
    n1=en:white substance | n2=en:balloon cells (in type iib) | rel=r_associated | relid=0 | w=81
  3608. en:white substance -- r_associated #0: 81 / 0.669 -> en:basal ganglia lesions seen on mri
    n1=en:white substance | n2=en:basal ganglia lesions seen on mri | rel=r_associated | relid=0 | w=81
  3609. en:white substance -- r_associated #0: 81 / 0.669 -> en:bipolar disorder
    n1=en:white substance | n2=en:bipolar disorder | rel=r_associated | relid=0 | w=81
  3610. en:white substance -- r_associated #0: 81 / 0.669 -> en:blood-brain barrier
    n1=en:white substance | n2=en:blood-brain barrier | rel=r_associated | relid=0 | w=81
  3611. en:white substance -- r_associated #0: 81 / 0.669 -> en:brain abscess
    n1=en:white substance | n2=en:brain abscess | rel=r_associated | relid=0 | w=81
  3612. en:white substance -- r_associated #0: 81 / 0.669 -> en:brain mri shows cortical atrophy
    n1=en:white substance | n2=en:brain mri shows cortical atrophy | rel=r_associated | relid=0 | w=81
  3613. en:white substance -- r_associated #0: 81 / 0.669 -> en:brain stem
    n1=en:white substance | n2=en:brain stem | rel=r_associated | relid=0 | w=81
  3614. en:white substance -- r_associated #0: 81 / 0.669 -> en:brainstem hypoplasia (in some patients)
    n1=en:white substance | n2=en:brainstem hypoplasia (in some patients) | rel=r_associated | relid=0 | w=81
  3615. en:white substance -- r_associated #0: 81 / 0.669 -> en:brief involuntary movements of upper extremities
    n1=en:white substance | n2=en:brief involuntary movements of upper extremities | rel=r_associated | relid=0 | w=81
  3616. en:white substance -- r_associated #0: 81 / 0.669 -> en:brisk reflexes
    n1=en:white substance | n2=en:brisk reflexes | rel=r_associated | relid=0 | w=81
  3617. en:white substance -- r_associated #0: 81 / 0.669 -> en:broca's aphasia
    n1=en:white substance | n2=en:broca's aphasia | rel=r_associated | relid=0 | w=81
  3618. en:white substance -- r_associated #0: 81 / 0.669 -> en:bulbar dysfunction (e.g. dysarthria and dysphagia)
    n1=en:white substance | n2=en:bulbar dysfunction (e.g. dysarthria and dysphagia) | rel=r_associated | relid=0 | w=81
  3619. en:white substance -- r_associated #0: 81 / 0.669 -> en:bulbar spasticity
    n1=en:white substance | n2=en:bulbar spasticity | rel=r_associated | relid=0 | w=81
  3620. en:white substance -- r_associated #0: 81 / 0.669 -> en:burning or tingling of plantar surface of foot (in some patients)
    n1=en:white substance | n2=en:burning or tingling of plantar surface of foot (in some patients) | rel=r_associated | relid=0 | w=81
  3621. en:white substance -- r_associated #0: 81 / 0.669 -> en:burning pain in the limbs
    n1=en:white substance | n2=en:burning pain in the limbs | rel=r_associated | relid=0 | w=81
  3622. en:white substance -- r_associated #0: 81 / 0.669 -> en:calcification of the amygdala and the amygdala-hippocampal transition area
    n1=en:white substance | n2=en:calcification of the amygdala and the amygdala-hippocampal transition area | rel=r_associated | relid=0 | w=81
  3623. en:white substance -- r_associated #0: 81 / 0.669 -> en:calcification of the falx
    n1=en:white substance | n2=en:calcification of the falx | rel=r_associated | relid=0 | w=81
  3624. en:white substance -- r_associated #0: 81 / 0.669 -> en:cauda equina syndrome
    n1=en:white substance | n2=en:cauda equina syndrome | rel=r_associated | relid=0 | w=81
  3625. en:white substance -- r_associated #0: 81 / 0.669 -> en:caudate atrophy
    n1=en:white substance | n2=en:caudate atrophy | rel=r_associated | relid=0 | w=81
  3626. en:white substance -- r_associated #0: 81 / 0.669 -> en:central canal malformation
    n1=en:white substance | n2=en:central canal malformation | rel=r_associated | relid=0 | w=81
  3627. en:white substance -- r_associated #0: 81 / 0.669 -> en:central nervous system involvement in approximately 50% of patients
    n1=en:white substance | n2=en:central nervous system involvement in approximately 50% of patients | rel=r_associated | relid=0 | w=81
  3628. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar ataxia (in 1 of 3 families)
    n1=en:white substance | n2=en:cerebellar ataxia (in 1 of 3 families) | rel=r_associated | relid=0 | w=81
  3629. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar ataxia, limb and trunk
    n1=en:white substance | n2=en:cerebellar ataxia, limb and trunk | rel=r_associated | relid=0 | w=81
  3630. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar atrophy (especially of the vermis)
    n1=en:white substance | n2=en:cerebellar atrophy (especially of the vermis) | rel=r_associated | relid=0 | w=81
  3631. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar atrophy seen on mri
    n1=en:white substance | n2=en:cerebellar atrophy seen on mri | rel=r_associated | relid=0 | w=81
  3632. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar calcifications
    n1=en:white substance | n2=en:cerebellar calcifications | rel=r_associated | relid=0 | w=81
  3633. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar diseases
    n1=en:white substance | n2=en:cerebellar diseases | rel=r_associated | relid=0 | w=81
  3634. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar dysplasia
    n1=en:white substance | n2=en:cerebellar dysplasia | rel=r_associated | relid=0 | w=81
  3635. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar hypoplasia (in some patients)
    n1=en:white substance | n2=en:cerebellar hypoplasia (in some patients) | rel=r_associated | relid=0 | w=81
  3636. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar hypoplasia, severe (wws)
    n1=en:white substance | n2=en:cerebellar hypoplasia, severe (wws) | rel=r_associated | relid=0 | w=81
  3637. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar medulloblastoma (rare)
    n1=en:white substance | n2=en:cerebellar medulloblastoma (rare) | rel=r_associated | relid=0 | w=81
  3638. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebellar tonsil herniation
    n1=en:white substance | n2=en:cerebellar tonsil herniation | rel=r_associated | relid=0 | w=81
  3639. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebral atrophy, mild, diffuse
    n1=en:white substance | n2=en:cerebral atrophy, mild, diffuse | rel=r_associated | relid=0 | w=81
  3640. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebral cyst
    n1=en:white substance | n2=en:cerebral cyst | rel=r_associated | relid=0 | w=81
  3641. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebral degeneration
    n1=en:white substance | n2=en:cerebral degeneration | rel=r_associated | relid=0 | w=81
  3642. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebral hypomyelination
    n1=en:white substance | n2=en:cerebral hypomyelination | rel=r_associated | relid=0 | w=81
  3643. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebral malformations
    n1=en:white substance | n2=en:cerebral malformations | rel=r_associated | relid=0 | w=81
  3644. en:white substance -- r_associated #0: 81 / 0.669 -> en:cerebral white matter lesions (1 patient)
    n1=en:white substance | n2=en:cerebral white matter lesions (1 patient) | rel=r_associated | relid=0 | w=81
  3645. en:white substance -- r_associated #0: 81 / 0.669 -> en:characteristic electroencephalogram (eeg) discharges
    n1=en:white substance | n2=en:characteristic electroencephalogram (eeg) discharges | rel=r_associated | relid=0 | w=81
  3646. en:white substance -- r_associated #0: 81 / 0.669 -> en:chorea, prominent (in some patients)
    n1=en:white substance | n2=en:chorea, prominent (in some patients) | rel=r_associated | relid=0 | w=81
  3647. en:white substance -- r_associated #0: 81 / 0.669 -> en:choreic movements, episodic
    n1=en:white substance | n2=en:choreic movements, episodic | rel=r_associated | relid=0 | w=81
  3648. en:white substance -- r_associated #0: 81 / 0.669 -> en:choristoma
    n1=en:white substance | n2=en:choristoma | rel=r_associated | relid=0 | w=81
  3649. en:white substance -- r_associated #0: 81 / 0.669 -> en:choroid plexus papilloma (in some patients)
    n1=en:white substance | n2=en:choroid plexus papilloma (in some patients) | rel=r_associated | relid=0 | w=81
  3650. en:white substance -- r_associated #0: 81 / 0.669 -> en:clumsiness (82%)
    n1=en:white substance | n2=en:clumsiness (82%) | rel=r_associated | relid=0 | w=81
  3651. en:white substance -- r_associated #0: 81 / 0.669 -> en:clumsiness (mild)
    n1=en:white substance | n2=en:clumsiness (mild) | rel=r_associated | relid=0 | w=81
  3652. en:white substance -- r_associated #0: 81 / 0.669 -> en:coarsened pattern of sulci and gyri
    n1=en:white substance | n2=en:coarsened pattern of sulci and gyri | rel=r_associated | relid=0 | w=81
  3653. en:white substance -- r_associated #0: 81 / 0.669 -> en:cobblestone lissencephaly, posterior frontal and parietal regions
    n1=en:white substance | n2=en:cobblestone lissencephaly, posterior frontal and parietal regions | rel=r_associated | relid=0 | w=81
  3654. en:white substance -- r_associated #0: 81 / 0.669 -> en:cognitive decline (1 family)
    n1=en:white substance | n2=en:cognitive decline (1 family) | rel=r_associated | relid=0 | w=81
  3655. en:white substance -- r_associated #0: 81 / 0.669 -> en:cognitive impairment (1 family)
    n1=en:white substance | n2=en:cognitive impairment (1 family) | rel=r_associated | relid=0 | w=81
  3656. en:white substance -- r_associated #0: 81 / 0.669 -> en:contralateral hemiparesis, congenital
    n1=en:white substance | n2=en:contralateral hemiparesis, congenital | rel=r_associated | relid=0 | w=81
  3657. en:white substance -- r_associated #0: 81 / 0.669 -> en:conus medullaris
    n1=en:white substance | n2=en:conus medullaris | rel=r_associated | relid=0 | w=81
  3658. en:white substance -- r_associated #0: 81 / 0.669 -> en:corpus callosum agenesis
    n1=en:white substance | n2=en:corpus callosum agenesis | rel=r_associated | relid=0 | w=81
  3659. en:white substance -- r_associated #0: 81 / 0.669 -> en:cortical atrophy (in some patients)
    n1=en:white substance | n2=en:cortical atrophy (in some patients) | rel=r_associated | relid=0 | w=81
  3660. en:white substance -- r_associated #0: 81 / 0.669 -> en:cortical dysgenesis, complex
    n1=en:white substance | n2=en:cortical dysgenesis, complex | rel=r_associated | relid=0 | w=81
  3661. en:white substance -- r_associated #0: 81 / 0.669 -> en:cranial nerve palsy, intermittent, transient
    n1=en:white substance | n2=en:cranial nerve palsy, intermittent, transient | rel=r_associated | relid=0 | w=81
  3662. en:white substance -- r_associated #0: 81 / 0.669 -> en:dandy walker variant
    n1=en:white substance | n2=en:dandy walker variant | rel=r_associated | relid=0 | w=81
  3663. en:white substance -- r_associated #0: 81 / 0.669 -> en:dandy-walker malformation (in some patients)
    n1=en:white substance | n2=en:dandy-walker malformation (in some patients) | rel=r_associated | relid=0 | w=81
  3664. en:white substance -- r_associated #0: 81 / 0.669 -> en:decrease in abstract thinking
    n1=en:white substance | n2=en:decrease in abstract thinking | rel=r_associated | relid=0 | w=81
  3665. en:white substance -- r_associated #0: 81 / 0.669 -> en:decreased pain response
    n1=en:white substance | n2=en:decreased pain response | rel=r_associated | relid=0 | w=81
  3666. en:white substance -- r_associated #0: 81 / 0.669 -> en:decreased volume of the cerebral white matter
    n1=en:white substance | n2=en:decreased volume of the cerebral white matter | rel=r_associated | relid=0 | w=81
  3667. en:white substance -- r_associated #0: 81 / 0.669 -> en:deep interpeduncular fossa
    n1=en:white substance | n2=en:deep interpeduncular fossa | rel=r_associated | relid=0 | w=81
  3668. en:white substance -- r_associated #0: 81 / 0.669 -> en:deficit in phonologic short-term memory
    n1=en:white substance | n2=en:deficit in phonologic short-term memory | rel=r_associated | relid=0 | w=81
  3669. en:white substance -- r_associated #0: 81 / 0.669 -> en:deformed temporal lobes
    n1=en:white substance | n2=en:deformed temporal lobes | rel=r_associated | relid=0 | w=81
  3670. en:white substance -- r_associated #0: 81 / 0.669 -> en:degeneration of anterior horn cells
    n1=en:white substance | n2=en:degeneration of anterior horn cells | rel=r_associated | relid=0 | w=81
  3671. en:white substance -- r_associated #0: 81 / 0.669 -> en:delayed myelination seen on mri
    n1=en:white substance | n2=en:delayed myelination seen on mri | rel=r_associated | relid=0 | w=81
  3672. en:white substance -- r_associated #0: 81 / 0.669 -> en:delayed psychomotor development (in severe cases)
    n1=en:white substance | n2=en:delayed psychomotor development (in severe cases) | rel=r_associated | relid=0 | w=81
  3673. en:white substance -- r_associated #0: 81 / 0.669 -> en:delayed psychomotor development (mild to severe)
    n1=en:white substance | n2=en:delayed psychomotor development (mild to severe) | rel=r_associated | relid=0 | w=81
  3674. en:white substance -- r_associated #0: 81 / 0.669 -> en:delayed walking (1 family)
    n1=en:white substance | n2=en:delayed walking (1 family) | rel=r_associated | relid=0 | w=81
  3675. en:white substance -- r_associated #0: 81 / 0.669 -> en:demyelination with white matter disease in internal capsule, external capsule, genu of corpus callosum, subcortical white matter, and posterior fossa
    n1=en:white substance | n2=en:demyelination with white matter disease in internal capsule, external capsule, genu of corpus callosum, subcortical white matter, and posterior fossa | rel=r_associated | relid=0 | w=81
  3676. en:white substance -- r_associated #0: 81 / 0.669 -> en:development varies from normal to retarded
    n1=en:white substance | n2=en:development varies from normal to retarded | rel=r_associated | relid=0 | w=81
  3677. en:white substance -- r_associated #0: 81 / 0.669 -> en:developmental delay (1 family)
    n1=en:white substance | n2=en:developmental delay (1 family) | rel=r_associated | relid=0 | w=81
  3678. en:white substance -- r_associated #0: 81 / 0.669 -> en:developmental delay (20%)
    n1=en:white substance | n2=en:developmental delay (20%) | rel=r_associated | relid=0 | w=81
  3679. en:white substance -- r_associated #0: 81 / 0.669 -> en:developmental delay (rare)
    n1=en:white substance | n2=en:developmental delay (rare) | rel=r_associated | relid=0 | w=81
  3680. en:white substance -- r_associated #0: 81 / 0.669 -> en:developmental delay, mild (in some)
    n1=en:white substance | n2=en:developmental delay, mild (in some) | rel=r_associated | relid=0 | w=81
  3681. en:white substance -- r_associated #0: 81 / 0.669 -> en:diabetes with coma (disorder)
    n1=en:white substance | n2=en:diabetes with coma (disorder) | rel=r_associated | relid=0 | w=81
  3682. en:white substance -- r_associated #0: 81 / 0.669 -> en:difficulty speaking during seizures
    n1=en:white substance | n2=en:difficulty speaking during seizures | rel=r_associated | relid=0 | w=81
  3683. en:white substance -- r_associated #0: 81 / 0.669 -> en:difficulty walking in childhood
    n1=en:white substance | n2=en:difficulty walking in childhood | rel=r_associated | relid=0 | w=81
  3684. en:white substance -- r_associated #0: 81 / 0.669 -> en:diffuse lewy body pathology
    n1=en:white substance | n2=en:diffuse lewy body pathology | rel=r_associated | relid=0 | w=81
  3685. en:white substance -- r_associated #0: 81 / 0.669 -> en:disordered thinking
    n1=en:white substance | n2=en:disordered thinking | rel=r_associated | relid=0 | w=81
  3686. en:white substance -- r_associated #0: 81 / 0.669 -> en:disorganization of the anterior cerebellar vermis
    n1=en:white substance | n2=en:disorganization of the anterior cerebellar vermis | rel=r_associated | relid=0 | w=81
  3687. en:white substance -- r_associated #0: 81 / 0.669 -> en:disorganized eeg
    n1=en:white substance | n2=en:disorganized eeg | rel=r_associated | relid=0 | w=81
  3688. en:white substance -- r_associated #0: 81 / 0.669 -> en:distal muscle weakness, upper and lower limbs
    n1=en:white substance | n2=en:distal muscle weakness, upper and lower limbs | rel=r_associated | relid=0 | w=81
  3689. en:white substance -- r_associated #0: 81 / 0.669 -> en:distal tapering of the carotid, cerebellar, and meningeal arteries
    n1=en:white substance | n2=en:distal tapering of the carotid, cerebellar, and meningeal arteries | rel=r_associated | relid=0 | w=81
  3690. en:white substance -- r_associated #0: 81 / 0.669 -> en:dizziness, episodic
    n1=en:white substance | n2=en:dizziness, episodic | rel=r_associated | relid=0 | w=81
  3691. en:white substance -- r_associated #0: 81 / 0.669 -> en:dopamine-responsive parkinsonism
    n1=en:white substance | n2=en:dopamine-responsive parkinsonism | rel=r_associated | relid=0 | w=81
  3692. en:white substance -- r_associated #0: 81 / 0.669 -> en:dysarthria (1 patient)
    n1=en:white substance | n2=en:dysarthria (1 patient) | rel=r_associated | relid=0 | w=81
  3693. en:white substance -- r_associated #0: 81 / 0.669 -> en:dysarthria (mild)
    n1=en:white substance | n2=en:dysarthria (mild) | rel=r_associated | relid=0 | w=81
  3694. en:white substance -- r_associated #0: 81 / 0.669 -> en:dysarthria (most common presenting symptom)
    n1=en:white substance | n2=en:dysarthria (most common presenting symptom) | rel=r_associated | relid=0 | w=81
  3695. en:white substance -- r_associated #0: 81 / 0.669 -> en:dysgenesis or agenesis of the cerebellar vermis
    n1=en:white substance | n2=en:dysgenesis or agenesis of the cerebellar vermis | rel=r_associated | relid=0 | w=81
  3696. en:white substance -- r_associated #0: 81 / 0.669 -> en:dyslexia
    n1=en:white substance | n2=en:dyslexia | rel=r_associated | relid=0 | w=81
  3697. en:white substance -- r_associated #0: 81 / 0.669 -> en:dystonia (1 family)
    n1=en:white substance | n2=en:dystonia (1 family) | rel=r_associated | relid=0 | w=81
  3698. en:white substance -- r_associated #0: 81 / 0.669 -> en:dystonia, focal (at onset)
    n1=en:white substance | n2=en:dystonia, focal (at onset) | rel=r_associated | relid=0 | w=81
  3699. en:white substance -- r_associated #0: 81 / 0.669 -> en:dystonic movements (in 1 of 6 patients)
    n1=en:white substance | n2=en:dystonic movements (in 1 of 6 patients) | rel=r_associated | relid=0 | w=81
  3700. en:white substance -- r_associated #0: 81 / 0.669 -> en:dystrophic neurites
    n1=en:white substance | n2=en:dystrophic neurites | rel=r_associated | relid=0 | w=81
  3701. en:white substance -- r_associated #0: 81 / 0.669 -> en:ectopic posterior pituitary
    n1=en:white substance | n2=en:ectopic posterior pituitary | rel=r_associated | relid=0 | w=81
  3702. en:white substance -- r_associated #0: 81 / 0.669 -> en:eeg abnormalities in 20-50%
    n1=en:white substance | n2=en:eeg abnormalities in 20-50% | rel=r_associated | relid=0 | w=81
  3703. en:white substance -- r_associated #0: 81 / 0.669 -> en:elevated white cell count in cerebrospinal fluid
    n1=en:white substance | n2=en:elevated white cell count in cerebrospinal fluid | rel=r_associated | relid=0 | w=81
  3704. en:white substance -- r_associated #0: 81 / 0.669 -> en:emg with spontaneous discharge of normal motor unit potentials
    n1=en:white substance | n2=en:emg with spontaneous discharge of normal motor unit potentials | rel=r_associated | relid=0 | w=81
  3705. en:white substance -- r_associated #0: 81 / 0.669 -> en:encephalocele (uncommon)
    n1=en:white substance | n2=en:encephalocele (uncommon) | rel=r_associated | relid=0 | w=81
  3706. en:white substance -- r_associated #0: 81 / 0.669 -> en:encephalopathy, acute, episodic
    n1=en:white substance | n2=en:encephalopathy, acute, episodic | rel=r_associated | relid=0 | w=81
  3707. en:white substance -- r_associated #0: 81 / 0.669 -> en:encephalopathy, acute, sudden-onset after febrile illness
    n1=en:white substance | n2=en:encephalopathy, acute, sudden-onset after febrile illness | rel=r_associated | relid=0 | w=81
  3708. en:white substance -- r_associated #0: 81 / 0.669 -> en:enlarged extraaxial space on brain imaging
    n1=en:white substance | n2=en:enlarged extraaxial space on brain imaging | rel=r_associated | relid=0 | w=81
  3709. en:white substance -- r_associated #0: 81 / 0.669 -> en:enlarged or prominent ventricles (in some patients)
    n1=en:white substance | n2=en:enlarged or prominent ventricles (in some patients) | rel=r_associated | relid=0 | w=81
  3710. en:white substance -- r_associated #0: 81 / 0.669 -> en:entire brain
    n1=en:white substance | n2=en:entire brain | rel=r_associated | relid=0 | w=81
  3711. en:white substance -- r_associated #0: 81 / 0.669 -> en:episodic generalized skeletal muscle contractions
    n1=en:white substance | n2=en:episodic generalized skeletal muscle contractions | rel=r_associated | relid=0 | w=81
  3712. en:white substance -- r_associated #0: 81 / 0.669 -> en:episodic subtype, headaches occur in clusters
    n1=en:white substance | n2=en:episodic subtype, headaches occur in clusters | rel=r_associated | relid=0 | w=81
  3713. en:white substance -- r_associated #0: 81 / 0.669 -> en:episodic sudden headache
    n1=en:white substance | n2=en:episodic sudden headache | rel=r_associated | relid=0 | w=81
  3714. en:white substance -- r_associated #0: 81 / 0.669 -> en:essential tremor
    n1=en:white substance | n2=en:essential tremor | rel=r_associated | relid=0 | w=81
  3715. en:white substance -- r_associated #0: 81 / 0.669 -> en:expressive aphasia
    n1=en:white substance | n2=en:expressive aphasia | rel=r_associated | relid=0 | w=81
  3716. en:white substance -- r_associated #0: 81 / 0.669 -> en:expressive language delay
    n1=en:white substance | n2=en:expressive language delay | rel=r_associated | relid=0 | w=81
  3717. en:white substance -- r_associated #0: 81 / 0.669 -> en:expressive speech deficit
    n1=en:white substance | n2=en:expressive speech deficit | rel=r_associated | relid=0 | w=81
  3718. en:white substance -- r_associated #0: 81 / 0.669 -> en:extensor plantar responses (early-on)
    n1=en:white substance | n2=en:extensor plantar responses (early-on) | rel=r_associated | relid=0 | w=81
  3719. en:white substance -- r_associated #0: 81 / 0.669 -> en:facial muscle weakness
    n1=en:white substance | n2=en:facial muscle weakness | rel=r_associated | relid=0 | w=81
  3720. en:white substance -- r_associated #0: 81 / 0.669 -> en:facial nerve palsy
    n1=en:white substance | n2=en:facial nerve palsy | rel=r_associated | relid=0 | w=81
  3721. en:white substance -- r_associated #0: 81 / 0.669 -> en:faciomandibular myoclonus, nocturnal
    n1=en:white substance | n2=en:faciomandibular myoclonus, nocturnal | rel=r_associated | relid=0 | w=81
  3722. en:white substance -- r_associated #0: 81 / 0.669 -> en:favorable response to levodopa
    n1=en:white substance | n2=en:favorable response to levodopa | rel=r_associated | relid=0 | w=81
  3723. en:white substance -- r_associated #0: 81 / 0.669 -> en:finger dysmetria
    n1=en:white substance | n2=en:finger dysmetria | rel=r_associated | relid=0 | w=81
  3724. en:white substance -- r_associated #0: 81 / 0.669 -> en:first dorsal interossei muscle atrophy
    n1=en:white substance | n2=en:first dorsal interossei muscle atrophy | rel=r_associated | relid=0 | w=81
  3725. en:white substance -- r_associated #0: 81 / 0.669 -> en:floppiness
    n1=en:white substance | n2=en:floppiness | rel=r_associated | relid=0 | w=81
  3726. en:white substance -- r_associated #0: 81 / 0.669 -> en:focal dystonia (rare)
    n1=en:white substance | n2=en:focal dystonia (rare) | rel=r_associated | relid=0 | w=81
  3727. en:white substance -- r_associated #0: 81 / 0.669 -> en:focal neurologic deficit
    n1=en:white substance | n2=en:focal neurologic deficit | rel=r_associated | relid=0 | w=81
  3728. en:white substance -- r_associated #0: 81 / 0.669 -> en:focal parietal pachygyria
    n1=en:white substance | n2=en:focal parietal pachygyria | rel=r_associated | relid=0 | w=81
  3729. en:white substance -- r_associated #0: 81 / 0.669 -> en:fontanelle
    n1=en:white substance | n2=en:fontanelle | rel=r_associated | relid=0 | w=81
  3730. en:white substance -- r_associated #0: 81 / 0.669 -> en:frontal lobe hypoplasia
    n1=en:white substance | n2=en:frontal lobe hypoplasia | rel=r_associated | relid=0 | w=81
  3731. en:white substance -- r_associated #0: 81 / 0.669 -> en:fusion of the basal ganglia
    n1=en:white substance | n2=en:fusion of the basal ganglia | rel=r_associated | relid=0 | w=81
  3732. en:white substance -- r_associated #0: 81 / 0.669 -> en:gait abnormalities may occur
    n1=en:white substance | n2=en:gait abnormalities may occur | rel=r_associated | relid=0 | w=81
  3733. en:white substance -- r_associated #0: 81 / 0.669 -> en:generalized slowing
    n1=en:white substance | n2=en:generalized slowing | rel=r_associated | relid=0 | w=81
  3734. en:white substance -- r_associated #0: 81 / 0.669 -> en:generalized slowing seen on eeg
    n1=en:white substance | n2=en:generalized slowing seen on eeg | rel=r_associated | relid=0 | w=81
  3735. en:white substance -- r_associated #0: 81 / 0.669 -> en:giant cortical somatosensory evoked potentials (seps)
    n1=en:white substance | n2=en:giant cortical somatosensory evoked potentials (seps) | rel=r_associated | relid=0 | w=81
  3736. en:white substance -- r_associated #0: 81 / 0.669 -> en:gliosis of the white matter
    n1=en:white substance | n2=en:gliosis of the white matter | rel=r_associated | relid=0 | w=81
  3737. en:white substance -- r_associated #0: 81 / 0.669 -> en:gliosis, necrosis, neuronal loss in basal ganglia, brainstem, and spinal cord
    n1=en:white substance | n2=en:gliosis, necrosis, neuronal loss in basal ganglia, brainstem, and spinal cord | rel=r_associated | relid=0 | w=81
  3738. en:white substance -- r_associated #0: 81 / 0.669 -> en:gray matter
    n1=en:white substance | n2=en:gray matter | rel=r_associated | relid=0 | w=81
  3739. en:white substance -- r_associated #0: 81 / 0.669 -> en:gurgling or drooling during seizures
    n1=en:white substance | n2=en:gurgling or drooling during seizures | rel=r_associated | relid=0 | w=81
  3740. en:white substance -- r_associated #0: 81 / 0.669 -> en:hand tremor (in some patients)
    n1=en:white substance | n2=en:hand tremor (in some patients) | rel=r_associated | relid=0 | w=81
  3741. en:white substance -- r_associated #0: 81 / 0.669 -> en:head tremor (14% of patients)
    n1=en:white substance | n2=en:head tremor (14% of patients) | rel=r_associated | relid=0 | w=81
  3742. en:white substance -- r_associated #0: 81 / 0.669 -> en:headache recurrent
    n1=en:white substance | n2=en:headache recurrent | rel=r_associated | relid=0 | w=81
  3743. en:white substance -- r_associated #0: 81 / 0.669 -> en:hemiplegia
    n1=en:white substance | n2=en:hemiplegia | rel=r_associated | relid=0 | w=81
  3744. en:white substance -- r_associated #0: 81 / 0.669 -> en:hemiplegic migraine
    n1=en:white substance | n2=en:hemiplegic migraine | rel=r_associated | relid=0 | w=81
  3745. en:white substance -- r_associated #0: 81 / 0.669 -> en:hemorrhage
    n1=en:white substance | n2=en:hemorrhage | rel=r_associated | relid=0 | w=81
  3746. en:white substance -- r_associated #0: 81 / 0.669 -> en:hostility
    n1=en:white substance | n2=en:hostility | rel=r_associated | relid=0 | w=81
  3747. en:white substance -- r_associated #0: 81 / 0.669 -> en:hyperekplexia (rare)
    n1=en:white substance | n2=en:hyperekplexia (rare) | rel=r_associated | relid=0 | w=81
  3748. en:white substance -- r_associated #0: 81 / 0.669 -> en:hyperexplexia
    n1=en:white substance | n2=en:hyperexplexia | rel=r_associated | relid=0 | w=81
  3749. en:white substance -- r_associated #0: 81 / 0.669 -> en:hyperextension of the neck
    n1=en:white substance | n2=en:hyperextension of the neck | rel=r_associated | relid=0 | w=81
  3750. en:white substance -- r_associated #0: 81 / 0.669 -> en:hyperreflexia (less common)
    n1=en:white substance | n2=en:hyperreflexia (less common) | rel=r_associated | relid=0 | w=81
  3751. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypertonia (in some patients)
    n1=en:white substance | n2=en:hypertonia (in some patients) | rel=r_associated | relid=0 | w=81
  3752. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypertonia of the extremities
    n1=en:white substance | n2=en:hypertonia of the extremities | rel=r_associated | relid=0 | w=81
  3753. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypertonia, peripheral dystonia
    n1=en:white substance | n2=en:hypertonia, peripheral dystonia | rel=r_associated | relid=0 | w=81
  3754. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypoglycemic encephalopathy
    n1=en:white substance | n2=en:hypoglycemic encephalopathy | rel=r_associated | relid=0 | w=81
  3755. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypomyelination
    n1=en:white substance | n2=en:hypomyelination | rel=r_associated | relid=0 | w=81
  3756. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypoplasia of corpus callosum
    n1=en:white substance | n2=en:hypoplasia of corpus callosum | rel=r_associated | relid=0 | w=81
  3757. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypoplasia of dentate nucleus
    n1=en:white substance | n2=en:hypoplasia of dentate nucleus | rel=r_associated | relid=0 | w=81
  3758. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypoplasia of the posterior corpus callosum (in some patients)
    n1=en:white substance | n2=en:hypoplasia of the posterior corpus callosum (in some patients) | rel=r_associated | relid=0 | w=81
  3759. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypoplastic anterior pituitary gland
    n1=en:white substance | n2=en:hypoplastic anterior pituitary gland | rel=r_associated | relid=0 | w=81
  3760. en:white substance -- r_associated #0: 81 / 0.669 -> en:hypoplastic internal capsule (in some)
    n1=en:white substance | n2=en:hypoplastic internal capsule (in some) | rel=r_associated | relid=0 | w=81
  3761. en:white substance -- r_associated #0: 81 / 0.669 -> en:hyporeflexia or areflexia
    n1=en:white substance | n2=en:hyporeflexia or areflexia | rel=r_associated | relid=0 | w=81
  3762. en:white substance -- r_associated #0: 81 / 0.669 -> en:impaired voluntary movement
    n1=en:white substance | n2=en:impaired voluntary movement | rel=r_associated | relid=0 | w=81
  3763. en:white substance -- r_associated #0: 81 / 0.669 -> en:inability to generate syntactic grammar rules (i.e., tense, gender, number)
    n1=en:white substance | n2=en:inability to generate syntactic grammar rules (i.e., tense, gender, number) | rel=r_associated | relid=0 | w=81
  3764. en:white substance -- r_associated #0: 81 / 0.669 -> en:incomplete myelination
    n1=en:white substance | n2=en:incomplete myelination | rel=r_associated | relid=0 | w=81
  3765. en:white substance -- r_associated #0: 81 / 0.669 -> en:incomprehensible speech
    n1=en:white substance | n2=en:incomprehensible speech | rel=r_associated | relid=0 | w=81
  3766. en:white substance -- r_associated #0: 81 / 0.669 -> en:increased cerebral lactate
    n1=en:white substance | n2=en:increased cerebral lactate | rel=r_associated | relid=0 | w=81
  3767. en:white substance -- r_associated #0: 81 / 0.669 -> en:increased csf protein
    n1=en:white substance | n2=en:increased csf protein | rel=r_associated | relid=0 | w=81
  3768. en:white substance -- r_associated #0: 81 / 0.669 -> en:increased csf protein with normal cell count
    n1=en:white substance | n2=en:increased csf protein with normal cell count | rel=r_associated | relid=0 | w=81
  3769. en:white substance -- r_associated #0: 81 / 0.669 -> en:increased lactate in the brain
    n1=en:white substance | n2=en:increased lactate in the brain | rel=r_associated | relid=0 | w=81
  3770. en:white substance -- r_associated #0: 81 / 0.669 -> en:increased startle response
    n1=en:white substance | n2=en:increased startle response | rel=r_associated | relid=0 | w=81
  3771. en:white substance -- r_associated #0: 81 / 0.669 -> en:increased t2 signal intensities in the middle cerebellar peduncles
    n1=en:white substance | n2=en:increased t2 signal intensities in the middle cerebellar peduncles | rel=r_associated | relid=0 | w=81
  3772. en:white substance -- r_associated #0: 81 / 0.669 -> en:infantile seizures, afebrile, with no neurologic sequelae (in 40% of patients)
    n1=en:white substance | n2=en:infantile seizures, afebrile, with no neurologic sequelae (in 40% of patients) | rel=r_associated | relid=0 | w=81
  3773. en:white substance -- r_associated #0: 81 / 0.669 -> en:initial hypotonia, followed by spasticity
    n1=en:white substance | n2=en:initial hypotonia, followed by spasticity | rel=r_associated | relid=0 | w=81
  3774. en:white substance -- r_associated #0: 81 / 0.669 -> en:intellectual disability, mild (uncommon)
    n1=en:white substance | n2=en:intellectual disability, mild (uncommon) | rel=r_associated | relid=0 | w=81
  3775. en:white substance -- r_associated #0: 81 / 0.669 -> en:intellectual impairment, mild
    n1=en:white substance | n2=en:intellectual impairment, mild | rel=r_associated | relid=0 | w=81
  3776. en:white substance -- r_associated #0: 81 / 0.669 -> en:interictal neurologic impairment
    n1=en:white substance | n2=en:interictal neurologic impairment | rel=r_associated | relid=0 | w=81
  3777. en:white substance -- r_associated #0: 81 / 0.669 -> en:intermittent episodes associated with lethargy, vomiting
    n1=en:white substance | n2=en:intermittent episodes associated with lethargy, vomiting | rel=r_associated | relid=0 | w=81
  3778. en:white substance -- r_associated #0: 81 / 0.669 -> en:involuntary jerking movements
    n1=en:white substance | n2=en:involuntary jerking movements | rel=r_associated | relid=0 | w=81
  3779. en:white substance -- r_associated #0: 81 / 0.669 -> en:iron accumulation in the globus pallidus and substantia nigra seen on mri
    n1=en:white substance | n2=en:iron accumulation in the globus pallidus and substantia nigra seen on mri | rel=r_associated | relid=0 | w=81
  3780. en:white substance -- r_associated #0: 81 / 0.669 -> en:iron deposition in the basal ganglia (in some patients)
    n1=en:white substance | n2=en:iron deposition in the basal ganglia (in some patients) | rel=r_associated | relid=0 | w=81
  3781. en:white substance -- r_associated #0: 81 / 0.669 -> en:isolated focal dystonia may occur
    n1=en:white substance | n2=en:isolated focal dystonia may occur | rel=r_associated | relid=0 | w=81
  3782. en:white substance -- r_associated #0: 81 / 0.669 -> en:jerky limb movements
    n1=en:white substance | n2=en:jerky limb movements | rel=r_associated | relid=0 | w=81
  3783. en:white substance -- r_associated #0: 81 / 0.669 -> en:lack of bunina bodies
    n1=en:white substance | n2=en:lack of bunina bodies | rel=r_associated | relid=0 | w=81
  3784. en:white substance -- r_associated #0: 81 / 0.669 -> en:lack of independent ambulation
    n1=en:white substance | n2=en:lack of independent ambulation | rel=r_associated | relid=0 | w=81
  3785. en:white substance -- r_associated #0: 81 / 0.669 -> en:lack of independent ambulation (1 patient)
    n1=en:white substance | n2=en:lack of independent ambulation (1 patient) | rel=r_associated | relid=0 | w=81
  3786. en:white substance -- r_associated #0: 81 / 0.669 -> en:lack of visual attention
    n1=en:white substance | n2=en:lack of visual attention | rel=r_associated | relid=0 | w=81
  3787. en:white substance -- r_associated #0: 81 / 0.669 -> en:learning difficulties (in some patients)
    n1=en:white substance | n2=en:learning difficulties (in some patients) | rel=r_associated | relid=0 | w=81
  3788. en:white substance -- r_associated #0: 81 / 0.669 -> en:learning disabilities (30%)
    n1=en:white substance | n2=en:learning disabilities (30%) | rel=r_associated | relid=0 | w=81
  3789. en:white substance -- r_associated #0: 81 / 0.669 -> en:learning disabilities (in females)
    n1=en:white substance | n2=en:learning disabilities (in females) | rel=r_associated | relid=0 | w=81
  3790. en:white substance -- r_associated #0: 81 / 0.669 -> en:learning disabilities (in some patients)
    n1=en:white substance | n2=en:learning disabilities (in some patients) | rel=r_associated | relid=0 | w=81
  3791. en:white substance -- r_associated #0: 81 / 0.669 -> en:leigh disease
    n1=en:white substance | n2=en:leigh disease | rel=r_associated | relid=0 | w=81
  3792. en:white substance -- r_associated #0: 81 / 0.669 -> en:leigh syndrome (245000), in a subset of patients
    n1=en:white substance | n2=en:leigh syndrome (245000), in a subset of patients | rel=r_associated | relid=0 | w=81
  3793. en:white substance -- r_associated #0: 81 / 0.669 -> en:leptomeningeal melanocytosis (in some patients)
    n1=en:white substance | n2=en:leptomeningeal melanocytosis (in some patients) | rel=r_associated | relid=0 | w=81
  3794. en:white substance -- r_associated #0: 81 / 0.669 -> en:lesions in the caudate and putamen
    n1=en:white substance | n2=en:lesions in the caudate and putamen | rel=r_associated | relid=0 | w=81
  3795. en:white substance -- r_associated #0: 81 / 0.669 -> en:leukodystrophy, demyelinating
    n1=en:white substance | n2=en:leukodystrophy, demyelinating | rel=r_associated | relid=0 | w=81
  3796. en:white substance -- r_associated #0: 81 / 0.669 -> en:lewy bodies
    n1=en:white substance | n2=en:lewy bodies | rel=r_associated | relid=0 | w=81
  3797. en:white substance -- r_associated #0: 81 / 0.669 -> en:limb dystonia
    n1=en:white substance | n2=en:limb dystonia | rel=r_associated | relid=0 | w=81
  3798. en:white substance -- r_associated #0: 81 / 0.669 -> en:limb spasticity
    n1=en:white substance | n2=en:limb spasticity | rel=r_associated | relid=0 | w=81
  3799. en:white substance -- r_associated #0: 81 / 0.669 -> en:limited memory, attention, language
    n1=en:white substance | n2=en:limited memory, attention, language | rel=r_associated | relid=0 | w=81
  3800. en:white substance -- r_associated #0: 81 / 0.669 -> en:little polarity in remaining neurons
    n1=en:white substance | n2=en:little polarity in remaining neurons | rel=r_associated | relid=0 | w=81
  3801. en:white substance -- r_associated #0: 81 / 0.669 -> en:long perforating arteries of the brain are affected
    n1=en:white substance | n2=en:long perforating arteries of the brain are affected | rel=r_associated | relid=0 | w=81
  3802. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of consciousness (1 patient)
    n1=en:white substance | n2=en:loss of consciousness (1 patient) | rel=r_associated | relid=0 | w=81
  3803. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of coordination
    n1=en:white substance | n2=en:loss of coordination | rel=r_associated | relid=0 | w=81
  3804. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of independent ambulation within a few years
    n1=en:white substance | n2=en:loss of independent ambulation within a few years | rel=r_associated | relid=0 | w=81
  3805. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of lower alpha-motor neurons in the anterior horn of the spinal cord and lower brainstem
    n1=en:white substance | n2=en:loss of lower alpha-motor neurons in the anterior horn of the spinal cord and lower brainstem | rel=r_associated | relid=0 | w=81
  3806. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of motor functions
    n1=en:white substance | n2=en:loss of motor functions | rel=r_associated | relid=0 | w=81
  3807. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of motor milestones
    n1=en:white substance | n2=en:loss of motor milestones | rel=r_associated | relid=0 | w=81
  3808. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of motor neurons in the spinal cord
    n1=en:white substance | n2=en:loss of motor neurons in the spinal cord | rel=r_associated | relid=0 | w=81
  3809. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of neurons and gliosis in basal ganglia, cranial nerve nuclei, and spinal cord
    n1=en:white substance | n2=en:loss of neurons and gliosis in basal ganglia, cranial nerve nuclei, and spinal cord | rel=r_associated | relid=0 | w=81
  3810. en:white substance -- r_associated #0: 81 / 0.669 -> en:loss of speech development
    n1=en:white substance | n2=en:loss of speech development | rel=r_associated | relid=0 | w=81
  3811. en:white substance -- r_associated #0: 81 / 0.669 -> en:lower limb hyperreflexia
    n1=en:white substance | n2=en:lower limb hyperreflexia | rel=r_associated | relid=0 | w=81
  3812. en:white substance -- r_associated #0: 81 / 0.669 -> en:memory loss
    n1=en:white substance | n2=en:memory loss | rel=r_associated | relid=0 | w=81
  3813. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation (2/3 patients)
    n1=en:white substance | n2=en:mental retardation (2/3 patients) | rel=r_associated | relid=0 | w=81
  3814. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation (47%)
    n1=en:white substance | n2=en:mental retardation (47%) | rel=r_associated | relid=0 | w=81
  3815. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation (in some)
    n1=en:white substance | n2=en:mental retardation (in some) | rel=r_associated | relid=0 | w=81
  3816. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation (iq 45-75)
    n1=en:white substance | n2=en:mental retardation (iq 45-75) | rel=r_associated | relid=0 | w=81
  3817. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation from rapid mental regression
    n1=en:white substance | n2=en:mental retardation from rapid mental regression | rel=r_associated | relid=0 | w=81
  3818. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation, mild (10%)
    n1=en:white substance | n2=en:mental retardation, mild (10%) | rel=r_associated | relid=0 | w=81
  3819. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation, mild-borderline, nonprogressive
    n1=en:white substance | n2=en:mental retardation, mild-borderline, nonprogressive | rel=r_associated | relid=0 | w=81
  3820. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation, severe, profound
    n1=en:white substance | n2=en:mental retardation, severe, profound | rel=r_associated | relid=0 | w=81
  3821. en:white substance -- r_associated #0: 81 / 0.669 -> en:mental retardation, variable severity
    n1=en:white substance | n2=en:mental retardation, variable severity | rel=r_associated | relid=0 | w=81
  3822. en:white substance -- r_associated #0: 81 / 0.669 -> en:microcephaly
    n1=en:white substance | n2=en:microcephaly | rel=r_associated | relid=0 | w=81
  3823. en:white substance -- r_associated #0: 81 / 0.669 -> en:mild mental retardation (in 1/4 patients)
    n1=en:white substance | n2=en:mild mental retardation (in 1/4 patients) | rel=r_associated | relid=0 | w=81
  3824. en:white substance -- r_associated #0: 81 / 0.669 -> en:mild spasticity
    n1=en:white substance | n2=en:mild spasticity | rel=r_associated | relid=0 | w=81
  3825. en:white substance -- r_associated #0: 81 / 0.669 -> en:minimal or lack of speech
    n1=en:white substance | n2=en:minimal or lack of speech | rel=r_associated | relid=0 | w=81
  3826. en:white substance -- r_associated #0: 81 / 0.669 -> en:mobius syndrome
    n1=en:white substance | n2=en:mobius syndrome | rel=r_associated | relid=0 | w=81
  3827. en:white substance -- r_associated #0: 81 / 0.669 -> en:motor abnormalities
    n1=en:white substance | n2=en:motor abnormalities | rel=r_associated | relid=0 | w=81
  3828. en:white substance -- r_associated #0: 81 / 0.669 -> en:motor and intellectual disability, severe
    n1=en:white substance | n2=en:motor and intellectual disability, severe | rel=r_associated | relid=0 | w=81
  3829. en:white substance -- r_associated #0: 81 / 0.669 -> en:motor deterioration
    n1=en:white substance | n2=en:motor deterioration | rel=r_associated | relid=0 | w=81
  3830. en:white substance -- r_associated #0: 81 / 0.669 -> en:motor incoordination
    n1=en:white substance | n2=en:motor incoordination | rel=r_associated | relid=0 | w=81
  3831. en:white substance -- r_associated #0: 81 / 0.669 -> en:motor neuron disease
    n1=en:white substance | n2=en:motor neuron disease | rel=r_associated | relid=0 | w=81
  3832. en:white substance -- r_associated #0: 81 / 0.669 -> en:motor neuron disease, lower
    n1=en:white substance | n2=en:motor neuron disease, lower | rel=r_associated | relid=0 | w=81
  3833. en:white substance -- r_associated #0: 81 / 0.669 -> en:mri may be normal, especially in type iib
    n1=en:white substance | n2=en:mri may be normal, especially in type iib | rel=r_associated | relid=0 | w=81
  3834. en:white substance -- r_associated #0: 81 / 0.669 -> en:mri shows decreased signal intensities in the basal ganglia
    n1=en:white substance | n2=en:mri shows decreased signal intensities in the basal ganglia | rel=r_associated | relid=0 | w=81
  3835. en:white substance -- r_associated #0: 81 / 0.669 -> en:mrs shows decreased choline in affected white matter
    n1=en:white substance | n2=en:mrs shows decreased choline in affected white matter | rel=r_associated | relid=0 | w=81
  3836. en:white substance -- r_associated #0: 81 / 0.669 -> en:multifocal seizure
    n1=en:white substance | n2=en:multifocal seizure | rel=r_associated | relid=0 | w=81
  3837. en:white substance -- r_associated #0: 81 / 0.669 -> en:multifocal spike waves
    n1=en:white substance | n2=en:multifocal spike waves | rel=r_associated | relid=0 | w=81
  3838. en:white substance -- r_associated #0: 81 / 0.669 -> en:myelination defect
    n1=en:white substance | n2=en:myelination defect | rel=r_associated | relid=0 | w=81
  3839. en:white substance -- r_associated #0: 81 / 0.669 -> en:myoclonus (less common)
    n1=en:white substance | n2=en:myoclonus (less common) | rel=r_associated | relid=0 | w=81
  3840. en:white substance -- r_associated #0: 81 / 0.669 -> en:myoclonus (subtype 3a)
    n1=en:white substance | n2=en:myoclonus (subtype 3a) | rel=r_associated | relid=0 | w=81
  3841. en:white substance -- r_associated #0: 81 / 0.669 -> en:myokymia, especially facial
    n1=en:white substance | n2=en:myokymia, especially facial | rel=r_associated | relid=0 | w=81
  3842. en:white substance -- r_associated #0: 81 / 0.669 -> en:myotonic seizures
    n1=en:white substance | n2=en:myotonic seizures | rel=r_associated | relid=0 | w=81
  3843. en:white substance -- r_associated #0: 81 / 0.669 -> en:nerve paralysis
    n1=en:white substance | n2=en:nerve paralysis | rel=r_associated | relid=0 | w=81
  3844. en:white substance -- r_associated #0: 81 / 0.669 -> en:neural tube defects (4%)
    n1=en:white substance | n2=en:neural tube defects (4%) | rel=r_associated | relid=0 | w=81
  3845. en:white substance -- r_associated #0: 81 / 0.669 -> en:neuroaxonal spheroids
    n1=en:white substance | n2=en:neuroaxonal spheroids | rel=r_associated | relid=0 | w=81
  3846. en:white substance -- r_associated #0: 81 / 0.669 -> en:neurocognitive impairment, mild (homozygous patient)
    n1=en:white substance | n2=en:neurocognitive impairment, mild (homozygous patient) | rel=r_associated | relid=0 | w=81
  3847. en:white substance -- r_associated #0: 81 / 0.669 -> en:neurofibrillary mapt (tau)-positive tangles
    n1=en:white substance | n2=en:neurofibrillary mapt (tau)-positive tangles | rel=r_associated | relid=0 | w=81
  3848. en:white substance -- r_associated #0: 81 / 0.669 -> en:neurologic decompensation
    n1=en:white substance | n2=en:neurologic decompensation | rel=r_associated | relid=0 | w=81
  3849. en:white substance -- r_associated #0: 81 / 0.669 -> en:neuronal loss in the inferior olives
    n1=en:white substance | n2=en:neuronal loss in the inferior olives | rel=r_associated | relid=0 | w=81
  3850. en:white substance -- r_associated #0: 81 / 0.669 -> en:neuronal loss, particularly of cerebellar purkinje cells
    n1=en:white substance | n2=en:neuronal loss, particularly of cerebellar purkinje cells | rel=r_associated | relid=0 | w=81
  3851. en:white substance -- r_associated #0: 81 / 0.669 -> en:neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells
    n1=en:white substance | n2=en:neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells | rel=r_associated | relid=0 | w=81
  3852. en:white substance -- r_associated #0: 81 / 0.669 -> en:neurophysiologic abnormalities (eeg, vep, sep)
    n1=en:white substance | n2=en:neurophysiologic abnormalities (eeg, vep, sep) | rel=r_associated | relid=0 | w=81
  3853. en:white substance -- r_associated #0: 81 / 0.669 -> en:neuropil
    n1=en:white substance | n2=en:neuropil | rel=r_associated | relid=0 | w=81
  3854. en:white substance -- r_associated #0: 81 / 0.669 -> en:no developmental progress
    n1=en:white substance | n2=en:no developmental progress | rel=r_associated | relid=0 | w=81
  3855. en:white substance -- r_associated #0: 81 / 0.669 -> en:no myoclonus
    n1=en:white substance | n2=en:no myoclonus | rel=r_associated | relid=0 | w=81
  3856. en:white substance -- r_associated #0: 81 / 0.669 -> en:nocturnal occurrence
    n1=en:white substance | n2=en:nocturnal occurrence | rel=r_associated | relid=0 | w=81
  3857. en:white substance -- r_associated #0: 81 / 0.669 -> en:nocturnal occurrence, usually during light sleep
    n1=en:white substance | n2=en:nocturnal occurrence, usually during light sleep | rel=r_associated | relid=0 | w=81
  3858. en:white substance -- r_associated #0: 81 / 0.669 -> en:nonprogressive cerebellar ataxia
    n1=en:white substance | n2=en:nonprogressive cerebellar ataxia | rel=r_associated | relid=0 | w=81
  3859. en:white substance -- r_associated #0: 81 / 0.669 -> en:normal cognition (1 patient)
    n1=en:white substance | n2=en:normal cognition (1 patient) | rel=r_associated | relid=0 | w=81
  3860. en:white substance -- r_associated #0: 81 / 0.669 -> en:normal development until 6-18 months
    n1=en:white substance | n2=en:normal development until 6-18 months | rel=r_associated | relid=0 | w=81
  3861. en:white substance -- r_associated #0: 81 / 0.669 -> en:normal sleep-onset time (normal time of falling asleep)
    n1=en:white substance | n2=en:normal sleep-onset time (normal time of falling asleep) | rel=r_associated | relid=0 | w=81
  3862. en:white substance -- r_associated #0: 81 / 0.669 -> en:normal to mild mental retardation
    n1=en:white substance | n2=en:normal to mild mental retardation | rel=r_associated | relid=0 | w=81
  3863. en:white substance -- r_associated #0: 81 / 0.669 -> en:orthostatic hypotension
    n1=en:white substance | n2=en:orthostatic hypotension | rel=r_associated | relid=0 | w=81
  3864. en:white substance -- r_associated #0: 81 / 0.669 -> en:ossification of the faux cerebri (less common)
    n1=en:white substance | n2=en:ossification of the faux cerebri (less common) | rel=r_associated | relid=0 | w=81
  3865. en:white substance -- r_associated #0: 81 / 0.669 -> en:pachygyria, bilateral frontotemporal
    n1=en:white substance | n2=en:pachygyria, bilateral frontotemporal | rel=r_associated | relid=0 | w=81
  3866. en:white substance -- r_associated #0: 81 / 0.669 -> en:pain, episodic
    n1=en:white substance | n2=en:pain, episodic | rel=r_associated | relid=0 | w=81
  3867. en:white substance -- r_associated #0: 81 / 0.669 -> en:parkinsonism (less common)
    n1=en:white substance | n2=en:parkinsonism (less common) | rel=r_associated | relid=0 | w=81
  3868. en:white substance -- r_associated #0: 81 / 0.669 -> en:partial agenesis of corpus callosum
    n1=en:white substance | n2=en:partial agenesis of corpus callosum | rel=r_associated | relid=0 | w=81
  3869. en:white substance -- r_associated #0: 81 / 0.669 -> en:partial or complete agenesis of corpus callosum
    n1=en:white substance | n2=en:partial or complete agenesis of corpus callosum | rel=r_associated | relid=0 | w=81
  3870. en:white substance -- r_associated #0: 81 / 0.669 -> en:partial seizures, simple and complex
    n1=en:white substance | n2=en:partial seizures, simple and complex | rel=r_associated | relid=0 | w=81
  3871. en:white substance -- r_associated #0: 81 / 0.669 -> en:patellar tendon reflexes hyperactive
    n1=en:white substance | n2=en:patellar tendon reflexes hyperactive | rel=r_associated | relid=0 | w=81
  3872. en:white substance -- r_associated #0: 81 / 0.669 -> en:patients may have no structural abnormalities in the central nervous system
    n1=en:white substance | n2=en:patients may have no structural abnormalities in the central nervous system | rel=r_associated | relid=0 | w=81
  3873. en:white substance -- r_associated #0: 81 / 0.669 -> en:periventricular cysts
    n1=en:white substance | n2=en:periventricular cysts | rel=r_associated | relid=0 | w=81
  3874. en:white substance -- r_associated #0: 81 / 0.669 -> en:periventricular nodular heterotopia
    n1=en:white substance | n2=en:periventricular nodular heterotopia | rel=r_associated | relid=0 | w=81
  3875. en:white substance -- r_associated #0: 81 / 0.669 -> en:periventricular white matter changes (meb)
    n1=en:white substance | n2=en:periventricular white matter changes (meb) | rel=r_associated | relid=0 | w=81
  3876. en:white substance -- r_associated #0: 81 / 0.669 -> en:personality change
    n1=en:white substance | n2=en:personality change | rel=r_associated | relid=0 | w=81
  3877. en:white substance -- r_associated #0: 81 / 0.669 -> en:polymicrogyria (64%)
    n1=en:white substance | n2=en:polymicrogyria (64%) | rel=r_associated | relid=0 | w=81
  3878. en:white substance -- r_associated #0: 81 / 0.669 -> en:polymicrogyria (meb)
    n1=en:white substance | n2=en:polymicrogyria (meb) | rel=r_associated | relid=0 | w=81
  3879. en:white substance -- r_associated #0: 81 / 0.669 -> en:pontoneocerebellar hypoplasia
    n1=en:white substance | n2=en:pontoneocerebellar hypoplasia | rel=r_associated | relid=0 | w=81
  3880. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor cognition
    n1=en:white substance | n2=en:poor cognition | rel=r_associated | relid=0 | w=81
  3881. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor dendritic maturation
    n1=en:white substance | n2=en:poor dendritic maturation | rel=r_associated | relid=0 | w=81
  3882. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor differentiation of gray and white matter on t2-weighted mri
    n1=en:white substance | n2=en:poor differentiation of gray and white matter on t2-weighted mri | rel=r_associated | relid=0 | w=81
  3883. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor feeding (congenital form form)
    n1=en:white substance | n2=en:poor feeding (congenital form form) | rel=r_associated | relid=0 | w=81
  3884. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor head and trunk control in infancy
    n1=en:white substance | n2=en:poor head and trunk control in infancy | rel=r_associated | relid=0 | w=81
  3885. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor or absent smooth pursuit
    n1=en:white substance | n2=en:poor or absent smooth pursuit | rel=r_associated | relid=0 | w=81
  3886. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor school performance
    n1=en:white substance | n2=en:poor school performance | rel=r_associated | relid=0 | w=81
  3887. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor speech
    n1=en:white substance | n2=en:poor speech | rel=r_associated | relid=0 | w=81
  3888. en:white substance -- r_associated #0: 81 / 0.669 -> en:poor speech or no speech
    n1=en:white substance | n2=en:poor speech or no speech | rel=r_associated | relid=0 | w=81
  3889. en:white substance -- r_associated #0: 81 / 0.669 -> en:posterior fossa cyst continuous with the fourth ventricle
    n1=en:white substance | n2=en:posterior fossa cyst continuous with the fourth ventricle | rel=r_associated | relid=0 | w=81
  3890. en:white substance -- r_associated #0: 81 / 0.669 -> en:posterior fossa cysts (wws)
    n1=en:white substance | n2=en:posterior fossa cysts (wws) | rel=r_associated | relid=0 | w=81
  3891. en:white substance -- r_associated #0: 81 / 0.669 -> en:postnatal development of hypertonic extremities
    n1=en:white substance | n2=en:postnatal development of hypertonic extremities | rel=r_associated | relid=0 | w=81
  3892. en:white substance -- r_associated #0: 81 / 0.669 -> en:posturing
    n1=en:white substance | n2=en:posturing | rel=r_associated | relid=0 | w=81
  3893. en:white substance -- r_associated #0: 81 / 0.669 -> en:primitive reflex
    n1=en:white substance | n2=en:primitive reflex | rel=r_associated | relid=0 | w=81
  3894. en:white substance -- r_associated #0: 81 / 0.669 -> en:progressive cerebral atrophy seen on mri
    n1=en:white substance | n2=en:progressive cerebral atrophy seen on mri | rel=r_associated | relid=0 | w=81
  3895. en:white substance -- r_associated #0: 81 / 0.669 -> en:progressive encephalopathy
    n1=en:white substance | n2=en:progressive encephalopathy | rel=r_associated | relid=0 | w=81
  3896. en:white substance -- r_associated #0: 81 / 0.669 -> en:progressive extrapyramidal movement disorder
    n1=en:white substance | n2=en:progressive extrapyramidal movement disorder | rel=r_associated | relid=0 | w=81
  3897. en:white substance -- r_associated #0: 81 / 0.669 -> en:prominent perivascular spaces with surrounding gliosis in periatrial white matter
    n1=en:white substance | n2=en:prominent perivascular spaces with surrounding gliosis in periatrial white matter | rel=r_associated | relid=0 | w=81
  3898. en:white substance -- r_associated #0: 81 / 0.669 -> en:proximal muscle weakness
    n1=en:white substance | n2=en:proximal muscle weakness | rel=r_associated | relid=0 | w=81
  3899. en:white substance -- r_associated #0: 81 / 0.669 -> en:psychomotor retardation (in some patients)
    n1=en:white substance | n2=en:psychomotor retardation (in some patients) | rel=r_associated | relid=0 | w=81
  3900. en:white substance -- r_associated #0: 81 / 0.669 -> en:psychomotor retardation, profound
    n1=en:white substance | n2=en:psychomotor retardation, profound | rel=r_associated | relid=0 | w=81
  3901. en:white substance -- r_associated #0: 81 / 0.669 -> en:psychosis (rare)
    n1=en:white substance | n2=en:psychosis (rare) | rel=r_associated | relid=0 | w=81
  3902. en:white substance -- r_associated #0: 81 / 0.669 -> en:pyramidal signs (1 family)
    n1=en:white substance | n2=en:pyramidal signs (1 family) | rel=r_associated | relid=0 | w=81
  3903. en:white substance -- r_associated #0: 81 / 0.669 -> en:pyramidal signs (1 patient)
    n1=en:white substance | n2=en:pyramidal signs (1 patient) | rel=r_associated | relid=0 | w=81
  3904. en:white substance -- r_associated #0: 81 / 0.669 -> en:quadriparesis
    n1=en:white substance | n2=en:quadriparesis | rel=r_associated | relid=0 | w=81
  3905. en:white substance -- r_associated #0: 81 / 0.669 -> en:reduction of white matter, generalized
    n1=en:white substance | n2=en:reduction of white matter, generalized | rel=r_associated | relid=0 | w=81
  3906. en:white substance -- r_associated #0: 81 / 0.669 -> en:relief with motor activation
    n1=en:white substance | n2=en:relief with motor activation | rel=r_associated | relid=0 | w=81
  3907. en:white substance -- r_associated #0: 81 / 0.669 -> en:resting tremor (in some patients)
    n1=en:white substance | n2=en:resting tremor (in some patients) | rel=r_associated | relid=0 | w=81
  3908. en:white substance -- r_associated #0: 81 / 0.669 -> en:retrocerebellar cyst (in some patients)
    n1=en:white substance | n2=en:retrocerebellar cyst (in some patients) | rel=r_associated | relid=0 | w=81
  3909. en:white substance -- r_associated #0: 81 / 0.669 -> en:retrocollis
    n1=en:white substance | n2=en:retrocollis | rel=r_associated | relid=0 | w=81
  3910. en:white substance -- r_associated #0: 81 / 0.669 -> en:schizophrenia
    n1=en:white substance | n2=en:schizophrenia | rel=r_associated | relid=0 | w=81
  3911. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures (2-10% of patients)
    n1=en:white substance | n2=en:seizures (2-10% of patients) | rel=r_associated | relid=0 | w=81
  3912. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures (in 2 of 6 patients)
    n1=en:white substance | n2=en:seizures (in 2 of 6 patients) | rel=r_associated | relid=0 | w=81
  3913. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures (rare)
    n1=en:white substance | n2=en:seizures (rare) | rel=r_associated | relid=0 | w=81
  3914. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures occur in clusters
    n1=en:white substance | n2=en:seizures occur in clusters | rel=r_associated | relid=0 | w=81
  3915. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures, infantile-onset
    n1=en:white substance | n2=en:seizures, infantile-onset | rel=r_associated | relid=0 | w=81
  3916. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures, onset age 5 to 10 years
    n1=en:white substance | n2=en:seizures, onset age 5 to 10 years | rel=r_associated | relid=0 | w=81
  3917. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures, poorly controlled
    n1=en:white substance | n2=en:seizures, poorly controlled | rel=r_associated | relid=0 | w=81
  3918. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures, sudden-onset, drug-resistant
    n1=en:white substance | n2=en:seizures, sudden-onset, drug-resistant | rel=r_associated | relid=0 | w=81
  3919. en:white substance -- r_associated #0: 81 / 0.669 -> en:seizures, tonic-clonic (1 patient)
    n1=en:white substance | n2=en:seizures, tonic-clonic (1 patient) | rel=r_associated | relid=0 | w=81
  3920. en:white substance -- r_associated #0: 81 / 0.669 -> en:severe developmental delay in survivors
    n1=en:white substance | n2=en:severe developmental delay in survivors | rel=r_associated | relid=0 | w=81
  3921. en:white substance -- r_associated #0: 81 / 0.669 -> en:severe speech delay
    n1=en:white substance | n2=en:severe speech delay | rel=r_associated | relid=0 | w=81
  3922. en:white substance -- r_associated #0: 81 / 0.669 -> en:shrunken inferior olivary nuclei
    n1=en:white substance | n2=en:shrunken inferior olivary nuclei | rel=r_associated | relid=0 | w=81
  3923. en:white substance -- r_associated #0: 81 / 0.669 -> en:sinus pericranii (rare)
    n1=en:white substance | n2=en:sinus pericranii (rare) | rel=r_associated | relid=0 | w=81
  3924. en:white substance -- r_associated #0: 81 / 0.669 -> en:sleep apnea (in 1/4 patients)
    n1=en:white substance | n2=en:sleep apnea (in 1/4 patients) | rel=r_associated | relid=0 | w=81
  3925. en:white substance -- r_associated #0: 81 / 0.669 -> en:sleep disorder
    n1=en:white substance | n2=en:sleep disorder | rel=r_associated | relid=0 | w=81
  3926. en:white substance -- r_associated #0: 81 / 0.669 -> en:sleep disturbances common
    n1=en:white substance | n2=en:sleep disturbances common | rel=r_associated | relid=0 | w=81
  3927. en:white substance -- r_associated #0: 81 / 0.669 -> en:slowing mental development by 1.5 to 3 years
    n1=en:white substance | n2=en:slowing mental development by 1.5 to 3 years | rel=r_associated | relid=0 | w=81
  3928. en:white substance -- r_associated #0: 81 / 0.669 -> en:small caudate
    n1=en:white substance | n2=en:small caudate | rel=r_associated | relid=0 | w=81
  3929. en:white substance -- r_associated #0: 81 / 0.669 -> en:small cerebral cortex
    n1=en:white substance | n2=en:small cerebral cortex | rel=r_associated | relid=0 | w=81
  3930. en:white substance -- r_associated #0: 81 / 0.669 -> en:small size of the left hippocampus gyri
    n1=en:white substance | n2=en:small size of the left hippocampus gyri | rel=r_associated | relid=0 | w=81
  3931. en:white substance -- r_associated #0: 81 / 0.669 -> en:spasmodic torticollis
    n1=en:white substance | n2=en:spasmodic torticollis | rel=r_associated | relid=0 | w=81
  3932. en:white substance -- r_associated #0: 81 / 0.669 -> en:spastic diplegia
    n1=en:white substance | n2=en:spastic diplegia | rel=r_associated | relid=0 | w=81
  3933. en:white substance -- r_associated #0: 81 / 0.669 -> en:spastic dystonia
    n1=en:white substance | n2=en:spastic dystonia | rel=r_associated | relid=0 | w=81
  3934. en:white substance -- r_associated #0: 81 / 0.669 -> en:spastic paraplegia, slowly progressive
    n1=en:white substance | n2=en:spastic paraplegia, slowly progressive | rel=r_associated | relid=0 | w=81
  3935. en:white substance -- r_associated #0: 81 / 0.669 -> en:spastic quadriplegia, severe
    n1=en:white substance | n2=en:spastic quadriplegia, severe | rel=r_associated | relid=0 | w=81
  3936. en:white substance -- r_associated #0: 81 / 0.669 -> en:spasticity (in some)
    n1=en:white substance | n2=en:spasticity (in some) | rel=r_associated | relid=0 | w=81
  3937. en:white substance -- r_associated #0: 81 / 0.669 -> en:spasticity (later onset)
    n1=en:white substance | n2=en:spasticity (later onset) | rel=r_associated | relid=0 | w=81
  3938. en:white substance -- r_associated #0: 81 / 0.669 -> en:specific visual spatial processing defect
    n1=en:white substance | n2=en:specific visual spatial processing defect | rel=r_associated | relid=0 | w=81
  3939. en:white substance -- r_associated #0: 81 / 0.669 -> en:speech and language regression
    n1=en:white substance | n2=en:speech and language regression | rel=r_associated | relid=0 | w=81
  3940. en:white substance -- r_associated #0: 81 / 0.669 -> en:speech articulation defects
    n1=en:white substance | n2=en:speech articulation defects | rel=r_associated | relid=0 | w=81
  3941. en:white substance -- r_associated #0: 81 / 0.669 -> en:speech deficits
    n1=en:white substance | n2=en:speech deficits | rel=r_associated | relid=0 | w=81
  3942. en:white substance -- r_associated #0: 81 / 0.669 -> en:speech delay (1 patient)
    n1=en:white substance | n2=en:speech delay (1 patient) | rel=r_associated | relid=0 | w=81
  3943. en:white substance -- r_associated #0: 81 / 0.669 -> en:spina bifida (less common)
    n1=en:white substance | n2=en:spina bifida (less common) | rel=r_associated | relid=0 | w=81
  3944. en:white substance -- r_associated #0: 81 / 0.669 -> en:spinal cord compression by tumor infiltration
    n1=en:white substance | n2=en:spinal cord compression by tumor infiltration | rel=r_associated | relid=0 | w=81
  3945. en:white substance -- r_associated #0: 81 / 0.669 -> en:spinocerebellar ataxia (in some patients)
    n1=en:white substance | n2=en:spinocerebellar ataxia (in some patients) | rel=r_associated | relid=0 | w=81
  3946. en:white substance -- r_associated #0: 81 / 0.669 -> en:spinocerebellar tract disease in lower limbs (in adulthood)
    n1=en:white substance | n2=en:spinocerebellar tract disease in lower limbs (in adulthood) | rel=r_associated | relid=0 | w=81
  3947. en:white substance -- r_associated #0: 81 / 0.669 -> en:spongiosis, mild
    n1=en:white substance | n2=en:spongiosis, mild | rel=r_associated | relid=0 | w=81
  3948. en:white substance -- r_associated #0: 81 / 0.669 -> en:status dystonicus
    n1=en:white substance | n2=en:status dystonicus | rel=r_associated | relid=0 | w=81
  3949. en:white substance -- r_associated #0: 81 / 0.669 -> en:stenosis of the aqueduct of sylvius (rare)
    n1=en:white substance | n2=en:stenosis of the aqueduct of sylvius (rare) | rel=r_associated | relid=0 | w=81
  3950. en:white substance -- r_associated #0: 81 / 0.669 -> en:stimulation sensitive segmental myoclonus (stage 2)
    n1=en:white substance | n2=en:stimulation sensitive segmental myoclonus (stage 2) | rel=r_associated | relid=0 | w=81
  3951. en:white substance -- r_associated #0: 81 / 0.669 -> en:structural brain anomalies
    n1=en:white substance | n2=en:structural brain anomalies | rel=r_associated | relid=0 | w=81
  3952. en:white substance -- r_associated #0: 81 / 0.669 -> en:structure of spinal sensory afferent system
    n1=en:white substance | n2=en:structure of spinal sensory afferent system | rel=r_associated | relid=0 | w=81
  3953. en:white substance -- r_associated #0: 81 / 0.669 -> en:sturge-weber syndrome
    n1=en:white substance | n2=en:sturge-weber syndrome | rel=r_associated | relid=0 | w=81
  3954. en:white substance -- r_associated #0: 81 / 0.669 -> en:subcortical lesions with edema
    n1=en:white substance | n2=en:subcortical lesions with edema | rel=r_associated | relid=0 | w=81
  3955. en:white substance -- r_associated #0: 81 / 0.669 -> en:subcortical origin of the myoclonus based on neurophysiologic studies
    n1=en:white substance | n2=en:subcortical origin of the myoclonus based on neurophysiologic studies | rel=r_associated | relid=0 | w=81
  3956. en:white substance -- r_associated #0: 81 / 0.669 -> en:subdivision of hemolymphoid system
    n1=en:white substance | n2=en:subdivision of hemolymphoid system | rel=r_associated | relid=0 | w=81
  3957. en:white substance -- r_associated #0: 81 / 0.669 -> en:sudden awakening
    n1=en:white substance | n2=en:sudden awakening | rel=r_associated | relid=0 | w=81
  3958. en:white substance -- r_associated #0: 81 / 0.669 -> en:symmetrical progressive demyelination
    n1=en:white substance | n2=en:symmetrical progressive demyelination | rel=r_associated | relid=0 | w=81
  3959. en:white substance -- r_associated #0: 81 / 0.669 -> en:temporal lobe heterotopias
    n1=en:white substance | n2=en:temporal lobe heterotopias | rel=r_associated | relid=0 | w=81
  3960. en:white substance -- r_associated #0: 81 / 0.669 -> en:thalamic lesions
    n1=en:white substance | n2=en:thalamic lesions | rel=r_associated | relid=0 | w=81
  3961. en:white substance -- r_associated #0: 81 / 0.669 -> en:third ventricle subependymal focal gliosis
    n1=en:white substance | n2=en:third ventricle subependymal focal gliosis | rel=r_associated | relid=0 | w=81
  3962. en:white substance -- r_associated #0: 81 / 0.669 -> en:tip-toe gait
    n1=en:white substance | n2=en:tip-toe gait | rel=r_associated | relid=0 | w=81
  3963. en:white substance -- r_associated #0: 81 / 0.669 -> en:trauma qualifier
    n1=en:white substance | n2=en:trauma qualifier | rel=r_associated | relid=0 | w=81
  3964. en:white substance -- r_associated #0: 81 / 0.669 -> en:tremor (3 patients)
    n1=en:white substance | n2=en:tremor (3 patients) | rel=r_associated | relid=0 | w=81
  3965. en:white substance -- r_associated #0: 81 / 0.669 -> en:tremor (57% of patients)
    n1=en:white substance | n2=en:tremor (57% of patients) | rel=r_associated | relid=0 | w=81
  3966. en:white substance -- r_associated #0: 81 / 0.669 -> en:tremor (in some patients)
    n1=en:white substance | n2=en:tremor (in some patients) | rel=r_associated | relid=0 | w=81
  3967. en:white substance -- r_associated #0: 81 / 0.669 -> en:unsteady standing
    n1=en:white substance | n2=en:unsteady standing | rel=r_associated | relid=0 | w=81
  3968. en:white substance -- r_associated #0: 81 / 0.669 -> en:unusual aura symptoms include alien limb phenomenon, diplopia, apraxia, dysarthria, impaired hearing, vertigo
    n1=en:white substance | n2=en:unusual aura symptoms include alien limb phenomenon, diplopia, apraxia, dysarthria, impaired hearing, vertigo | rel=r_associated | relid=0 | w=81
  3969. en:white substance -- r_associated #0: 81 / 0.669 -> en:upbeat central vestibular nystagmus
    n1=en:white substance | n2=en:upbeat central vestibular nystagmus | rel=r_associated | relid=0 | w=81
  3970. en:white substance -- r_associated #0: 81 / 0.669 -> en:vacuolization (patient a)
    n1=en:white substance | n2=en:vacuolization (patient a) | rel=r_associated | relid=0 | w=81
  3971. en:white substance -- r_associated #0: 81 / 0.669 -> en:variable outcome after acute illness
    n1=en:white substance | n2=en:variable outcome after acute illness | rel=r_associated | relid=0 | w=81
  3972. en:white substance -- r_associated #0: 81 / 0.669 -> en:varying degree of mental retardation
    n1=en:white substance | n2=en:varying degree of mental retardation | rel=r_associated | relid=0 | w=81
  3973. en:white substance -- r_associated #0: 81 / 0.669 -> en:vasovagal syncope
    n1=en:white substance | n2=en:vasovagal syncope | rel=r_associated | relid=0 | w=81
  3974. en:white substance -- r_associated #0: 81 / 0.669 -> en:ventricular enlargement
    n1=en:white substance | n2=en:ventricular enlargement | rel=r_associated | relid=0 | w=81
  3975. en:white substance -- r_associated #0: 81 / 0.669 -> en:vestibular anomalies (less common)
    n1=en:white substance | n2=en:vestibular anomalies (less common) | rel=r_associated | relid=0 | w=81
  3976. en:white substance -- r_associated #0: 81 / 0.669 -> en:walking independently at 2.5 years to 4 years of age
    n1=en:white substance | n2=en:walking independently at 2.5 years to 4 years of age | rel=r_associated | relid=0 | w=81
  3977. en:white substance -- r_associated #0: 81 / 0.669 -> en:white matter abnormalities in the periventricular regions (1 patient)
    n1=en:white substance | n2=en:white matter abnormalities in the periventricular regions (1 patient) | rel=r_associated | relid=0 | w=81
  3978. en:white substance -- r_associated #0: 81 / 0.669 -> en:white matter changes may occur (in adulthood)
    n1=en:white substance | n2=en:white matter changes may occur (in adulthood) | rel=r_associated | relid=0 | w=81
  3979. en:white substance -- r_associated #0: 80 / 0.661 -> tissu nerveux
    n1=en:white substance | n2=tissu nerveux | rel=r_associated | relid=0 | w=80
  3980. en:white substance -- r_associated #0: 76 / 0.628 -> en:'eye of the tiger' sign on mri
    n1=en:white substance | n2=en:'eye of the tiger' sign on mri | rel=r_associated | relid=0 | w=76
  3981. en:white substance -- r_associated #0: 76 / 0.628 -> en:3-6 hz polyspike eeg
    n1=en:white substance | n2=en:3-6 hz polyspike eeg | rel=r_associated | relid=0 | w=76
  3982. en:white substance -- r_associated #0: 76 / 0.628 -> en:abnormal brain myelination
    n1=en:white substance | n2=en:abnormal brain myelination | rel=r_associated | relid=0 | w=76
  3983. en:white substance -- r_associated #0: 76 / 0.628 -> en:abnormal sulci
    n1=en:white substance | n2=en:abnormal sulci | rel=r_associated | relid=0 | w=76
  3984. en:white substance -- r_associated #0: 76 / 0.628 -> en:abnormal visual evoked potential (vep)
    n1=en:white substance | n2=en:abnormal visual evoked potential (vep) | rel=r_associated | relid=0 | w=76
  3985. en:white substance -- r_associated #0: 76 / 0.628 -> en:abnormality of ocular smooth pursuit
    n1=en:white substance | n2=en:abnormality of ocular smooth pursuit | rel=r_associated | relid=0 | w=76
  3986. en:white substance -- r_associated #0: 76 / 0.628 -> en:absence of cerebral aneurysms
    n1=en:white substance | n2=en:absence of cerebral aneurysms | rel=r_associated | relid=0 | w=76
  3987. en:white substance -- r_associated #0: 76 / 0.628 -> en:absence of neurologic manifestations
    n1=en:white substance | n2=en:absence of neurologic manifestations | rel=r_associated | relid=0 | w=76
  3988. en:white substance -- r_associated #0: 76 / 0.628 -> en:absence of the basal ganglia
    n1=en:white substance | n2=en:absence of the basal ganglia | rel=r_associated | relid=0 | w=76
  3989. en:white substance -- r_associated #0: 76 / 0.628 -> en:absence seizures may occur
    n1=en:white substance | n2=en:absence seizures may occur | rel=r_associated | relid=0 | w=76
  3990. en:white substance -- r_associated #0: 76 / 0.628 -> en:absent myelination of the brain (severe connatal form)
    n1=en:white substance | n2=en:absent myelination of the brain (severe connatal form) | rel=r_associated | relid=0 | w=76
  3991. en:white substance -- r_associated #0: 76 / 0.628 -> en:absent posterior pituitary bright spot
    n1=en:white substance | n2=en:absent posterior pituitary bright spot | rel=r_associated | relid=0 | w=76
  3992. en:white substance -- r_associated #0: 76 / 0.628 -> en:absent superior division of oculomotor nerve and corresponding alpha motor neurons
    n1=en:white substance | n2=en:absent superior division of oculomotor nerve and corresponding alpha motor neurons | rel=r_associated | relid=0 | w=76
  3993. en:white substance -- r_associated #0: 76 / 0.628 -> en:actin depolymerizing factor/cofilin-immunoreactive eosinophilic rod-like cytoplasmic inclusions in neocortical and thalamic neurons
    n1=en:white substance | n2=en:actin depolymerizing factor/cofilin-immunoreactive eosinophilic rod-like cytoplasmic inclusions in neocortical and thalamic neurons | rel=r_associated | relid=0 | w=76
  3994. en:white substance -- r_associated #0: 76 / 0.628 -> en:acute encephalopathy
    n1=en:white substance | n2=en:acute encephalopathy | rel=r_associated | relid=0 | w=76
  3995. en:white substance -- r_associated #0: 76 / 0.628 -> en:acute episodes of neuropathic symptoms (hcp)
    n1=en:white substance | n2=en:acute episodes of neuropathic symptoms (hcp) | rel=r_associated | relid=0 | w=76
  3996. en:white substance -- r_associated #0: 76 / 0.628 -> en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes
    n1=en:white substance | n2=en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes | rel=r_associated | relid=0 | w=76
  3997. en:white substance -- r_associated #0: 76 / 0.628 -> en:affected arteries show loss of smooth muscle cells
    n1=en:white substance | n2=en:affected arteries show loss of smooth muscle cells | rel=r_associated | relid=0 | w=76
  3998. en:white substance -- r_associated #0: 76 / 0.628 -> en:akinesia
    n1=en:white substance | n2=en:akinesia | rel=r_associated | relid=0 | w=76
  3999. en:white substance -- r_associated #0: 76 / 0.628 -> en:alpha-b-crystallin expression in oligodendrocytes
    n1=en:white substance | n2=en:alpha-b-crystallin expression in oligodendrocytes | rel=r_associated | relid=0 | w=76
  4000. en:white substance -- r_associated #0: 76 / 0.628 -> en:ambulation difficulty
    n1=en:white substance | n2=en:ambulation difficulty | rel=r_associated | relid=0 | w=76
  4001. en:white substance -- r_associated #0: 76 / 0.628 -> en:amyloid plaques may be present
    n1=en:white substance | n2=en:amyloid plaques may be present | rel=r_associated | relid=0 | w=76
  4002. en:white substance -- r_associated #0: 76 / 0.628 -> en:ankle reflex absent
    n1=en:white substance | n2=en:ankle reflex absent | rel=r_associated | relid=0 | w=76
  4003. en:white substance -- r_associated #0: 76 / 0.628 -> en:antisocial behavior
    n1=en:white substance | n2=en:antisocial behavior | rel=r_associated | relid=0 | w=76
  4004. en:white substance -- r_associated #0: 76 / 0.628 -> en:aplasia/hypoplasia of the corpus callosum
    n1=en:white substance | n2=en:aplasia/hypoplasia of the corpus callosum | rel=r_associated | relid=0 | w=76
  4005. en:white substance -- r_associated #0: 76 / 0.628 -> en:arachnoid cysts (in one family)
    n1=en:white substance | n2=en:arachnoid cysts (in one family) | rel=r_associated | relid=0 | w=76
  4006. en:white substance -- r_associated #0: 76 / 0.628 -> en:ataxia (type i and type ii, infantile and juvenile)
    n1=en:white substance | n2=en:ataxia (type i and type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=76
  4007. en:white substance -- r_associated #0: 76 / 0.628 -> en:ataxic movements
    n1=en:white substance | n2=en:ataxic movements | rel=r_associated | relid=0 | w=76
  4008. en:white substance -- r_associated #0: 76 / 0.628 -> en:atlantoaxial instability
    n1=en:white substance | n2=en:atlantoaxial instability | rel=r_associated | relid=0 | w=76
  4009. en:white substance -- r_associated #0: 76 / 0.628 -> en:atrophy of the cerebellar vermis seen on mri
    n1=en:white substance | n2=en:atrophy of the cerebellar vermis seen on mri | rel=r_associated | relid=0 | w=76
  4010. en:white substance -- r_associated #0: 76 / 0.628 -> en:atrophy of the dentate nucleus
    n1=en:white substance | n2=en:atrophy of the dentate nucleus | rel=r_associated | relid=0 | w=76
  4011. en:white substance -- r_associated #0: 76 / 0.628 -> en:attacks of disabling daytime drowsiness and low alertness
    n1=en:white substance | n2=en:attacks of disabling daytime drowsiness and low alertness | rel=r_associated | relid=0 | w=76
  4012. en:white substance -- r_associated #0: 76 / 0.628 -> en:aura (in some instances)
    n1=en:white substance | n2=en:aura (in some instances) | rel=r_associated | relid=0 | w=76
  4013. en:white substance -- r_associated #0: 76 / 0.628 -> en:aura may occur
    n1=en:white substance | n2=en:aura may occur | rel=r_associated | relid=0 | w=76
  4014. en:white substance -- r_associated #0: 76 / 0.628 -> en:autism
    n1=en:white substance | n2=en:autism | rel=r_associated | relid=0 | w=76
  4015. en:white substance -- r_associated #0: 76 / 0.628 -> en:axonal swelling of spinal nerve roots and cranial nerves
    n1=en:white substance | n2=en:axonal swelling of spinal nerve roots and cranial nerves | rel=r_associated | relid=0 | w=76
  4016. en:white substance -- r_associated #0: 76 / 0.628 -> en:bilateral striatal lucencies on imaging
    n1=en:white substance | n2=en:bilateral striatal lucencies on imaging | rel=r_associated | relid=0 | w=76
  4017. en:white substance -- r_associated #0: 76 / 0.628 -> en:blake's pouch (rare)
    n1=en:white substance | n2=en:blake's pouch (rare) | rel=r_associated | relid=0 | w=76
  4018. en:white substance -- r_associated #0: 76 / 0.628 -> en:blurry cortical-white matter junction due to spillover of abnormal neurons (in type iib)
    n1=en:white substance | n2=en:blurry cortical-white matter junction due to spillover of abnormal neurons (in type iib) | rel=r_associated | relid=0 | w=76
  4019. en:white substance -- r_associated #0: 76 / 0.628 -> en:bradykinesia
    n1=en:white substance | n2=en:bradykinesia | rel=r_associated | relid=0 | w=76
  4020. en:white substance -- r_associated #0: 76 / 0.628 -> en:brain atrophy (1 family)
    n1=en:white substance | n2=en:brain atrophy (1 family) | rel=r_associated | relid=0 | w=76
  4021. en:white substance -- r_associated #0: 76 / 0.628 -> en:brain imaging shows lesions in the thalami, brainstem, and cerebellum
    n1=en:white substance | n2=en:brain imaging shows lesions in the thalami, brainstem, and cerebellum | rel=r_associated | relid=0 | w=76
  4022. en:white substance -- r_associated #0: 76 / 0.628 -> en:brain iron accumulation (in some patients)
    n1=en:white substance | n2=en:brain iron accumulation (in some patients) | rel=r_associated | relid=0 | w=76
  4023. en:white substance -- r_associated #0: 76 / 0.628 -> en:brain mri shows abnormal gyral pattern in frontal lobes
    n1=en:white substance | n2=en:brain mri shows abnormal gyral pattern in frontal lobes | rel=r_associated | relid=0 | w=76
  4024. en:white substance -- r_associated #0: 76 / 0.628 -> en:brain prp-immunoreactive amyloid plaques (in 10% if patients with sporadic cjd and in variant cjd)
    n1=en:white substance | n2=en:brain prp-immunoreactive amyloid plaques (in 10% if patients with sporadic cjd and in variant cjd) | rel=r_associated | relid=0 | w=76
  4025. en:white substance -- r_associated #0: 76 / 0.628 -> en:brain small vessel disease with hemorrhage
    n1=en:white substance | n2=en:brain small vessel disease with hemorrhage | rel=r_associated | relid=0 | w=76
  4026. en:white substance -- r_associated #0: 76 / 0.628 -> en:bulbar symptoms may occur (less common)
    n1=en:white substance | n2=en:bulbar symptoms may occur (less common) | rel=r_associated | relid=0 | w=76
  4027. en:white substance -- r_associated #0: 76 / 0.628 -> en:calcification may occur in other brain regions, including cerebellum, thalamus, white matter
    n1=en:white substance | n2=en:calcification may occur in other brain regions, including cerebellum, thalamus, white matter | rel=r_associated | relid=0 | w=76
  4028. en:white substance -- r_associated #0: 76 / 0.628 -> en:calcifications of cerebral ventricles
    n1=en:white substance | n2=en:calcifications of cerebral ventricles | rel=r_associated | relid=0 | w=76
  4029. en:white substance -- r_associated #0: 76 / 0.628 -> en:central facial nerve paralysis (rare)
    n1=en:white substance | n2=en:central facial nerve paralysis (rare) | rel=r_associated | relid=0 | w=76
  4030. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebellar atrophy (especially in the superior cerebellar vermis)
    n1=en:white substance | n2=en:cerebellar atrophy (especially in the superior cerebellar vermis) | rel=r_associated | relid=0 | w=76
  4031. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebellar atrophy (in adulthood)
    n1=en:white substance | n2=en:cerebellar atrophy (in adulthood) | rel=r_associated | relid=0 | w=76
  4032. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebellar hemorrhage (rare)
    n1=en:white substance | n2=en:cerebellar hemorrhage (rare) | rel=r_associated | relid=0 | w=76
  4033. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebellar hypoplasia (variable)
    n1=en:white substance | n2=en:cerebellar hypoplasia (variable) | rel=r_associated | relid=0 | w=76
  4034. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebellar hypoplasia, particularly of the hemispheres
    n1=en:white substance | n2=en:cerebellar hypoplasia, particularly of the hemispheres | rel=r_associated | relid=0 | w=76
  4035. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebellum white matter
    n1=en:white substance | n2=en:cerebellum white matter | rel=r_associated | relid=0 | w=76
  4036. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral and cerebellar atrophy
    n1=en:white substance | n2=en:cerebral and cerebellar atrophy | rel=r_associated | relid=0 | w=76
  4037. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral atrophy, diffuse, severe
    n1=en:white substance | n2=en:cerebral atrophy, diffuse, severe | rel=r_associated | relid=0 | w=76
  4038. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral atrophy, progressive
    n1=en:white substance | n2=en:cerebral atrophy, progressive | rel=r_associated | relid=0 | w=76
  4039. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral atrophy, severe
    n1=en:white substance | n2=en:cerebral atrophy, severe | rel=r_associated | relid=0 | w=76
  4040. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral cortical atrophy, especially frontal lobes
    n1=en:white substance | n2=en:cerebral cortical atrophy, especially frontal lobes | rel=r_associated | relid=0 | w=76
  4041. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral demyelination and inflammation
    n1=en:white substance | n2=en:cerebral demyelination and inflammation | rel=r_associated | relid=0 | w=76
  4042. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebral thrombosis (e.g. 612283.0014 protein c deficiency)
    n1=en:white substance | n2=en:cerebral thrombosis (e.g. 612283.0014 protein c deficiency) | rel=r_associated | relid=0 | w=76
  4043. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebrospinal fluid
    n1=en:white substance | n2=en:cerebrospinal fluid | rel=r_associated | relid=0 | w=76
  4044. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebrospinal fluid glucose decreased
    n1=en:white substance | n2=en:cerebrospinal fluid glucose decreased | rel=r_associated | relid=0 | w=76
  4045. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebrospinal fluid may show decreased levels of homovanillic acid (hva)
    n1=en:white substance | n2=en:cerebrospinal fluid may show decreased levels of homovanillic acid (hva) | rel=r_associated | relid=0 | w=76
  4046. en:white substance -- r_associated #0: 76 / 0.628 -> en:cerebrovascular accident (in some patients)
    n1=en:white substance | n2=en:cerebrovascular accident (in some patients) | rel=r_associated | relid=0 | w=76
  4047. en:white substance -- r_associated #0: 76 / 0.628 -> en:cns component
    n1=en:white substance | n2=en:cns component | rel=r_associated | relid=0 | w=76
  4048. en:white substance -- r_associated #0: 76 / 0.628 -> en:cns stimulation (finding)
    n1=en:white substance | n2=en:cns stimulation (finding) | rel=r_associated | relid=0 | w=76
  4049. en:white substance -- r_associated #0: 76 / 0.628 -> en:cns tissue
    n1=en:white substance | n2=en:cns tissue | rel=r_associated | relid=0 | w=76
  4050. en:white substance -- r_associated #0: 76 / 0.628 -> en:cognitive defects develop later in the disease
    n1=en:white substance | n2=en:cognitive defects develop later in the disease | rel=r_associated | relid=0 | w=76
  4051. en:white substance -- r_associated #0: 76 / 0.628 -> en:cognitive deficits may occur
    n1=en:white substance | n2=en:cognitive deficits may occur | rel=r_associated | relid=0 | w=76
  4052. en:white substance -- r_associated #0: 76 / 0.628 -> en:cognitive deficits, mild (in some patients)
    n1=en:white substance | n2=en:cognitive deficits, mild (in some patients) | rel=r_associated | relid=0 | w=76
  4053. en:white substance -- r_associated #0: 76 / 0.628 -> en:cognitive impairment (1 patient)
    n1=en:white substance | n2=en:cognitive impairment (1 patient) | rel=r_associated | relid=0 | w=76
  4054. en:white substance -- r_associated #0: 76 / 0.628 -> en:cogwheel rigidity (in some patients)
    n1=en:white substance | n2=en:cogwheel rigidity (in some patients) | rel=r_associated | relid=0 | w=76
  4055. en:white substance -- r_associated #0: 76 / 0.628 -> en:coma during episodes (in some patients)
    n1=en:white substance | n2=en:coma during episodes (in some patients) | rel=r_associated | relid=0 | w=76
  4056. en:white substance -- r_associated #0: 76 / 0.628 -> en:communicating hydrocephalus
    n1=en:white substance | n2=en:communicating hydrocephalus | rel=r_associated | relid=0 | w=76
  4057. en:white substance -- r_associated #0: 76 / 0.628 -> en:complete or partial absence of the corpus callosum (wws)
    n1=en:white substance | n2=en:complete or partial absence of the corpus callosum (wws) | rel=r_associated | relid=0 | w=76
  4058. en:white substance -- r_associated #0: 76 / 0.628 -> en:compromised expressive language development, severe
    n1=en:white substance | n2=en:compromised expressive language development, severe | rel=r_associated | relid=0 | w=76
  4059. en:white substance -- r_associated #0: 76 / 0.628 -> en:congenital anomaly of brain
    n1=en:white substance | n2=en:congenital anomaly of brain | rel=r_associated | relid=0 | w=76
  4060. en:white substance -- r_associated #0: 76 / 0.628 -> en:cortical atrophy with loss of pyramidal neurons in the motor cortex
    n1=en:white substance | n2=en:cortical atrophy with loss of pyramidal neurons in the motor cortex | rel=r_associated | relid=0 | w=76
  4061. en:white substance -- r_associated #0: 76 / 0.628 -> en:corticospinal tracts with decreased myelin staining
    n1=en:white substance | n2=en:corticospinal tracts with decreased myelin staining | rel=r_associated | relid=0 | w=76
  4062. en:white substance -- r_associated #0: 76 / 0.628 -> en:crowding of the posterior fossa
    n1=en:white substance | n2=en:crowding of the posterior fossa | rel=r_associated | relid=0 | w=76
  4063. en:white substance -- r_associated #0: 76 / 0.628 -> en:cyst of septum pellucidum (in some patients)
    n1=en:white substance | n2=en:cyst of septum pellucidum (in some patients) | rel=r_associated | relid=0 | w=76
  4064. en:white substance -- r_associated #0: 76 / 0.628 -> en:dandy-walker malformation (1 patient)
    n1=en:white substance | n2=en:dandy-walker malformation (1 patient) | rel=r_associated | relid=0 | w=76
  4065. en:white substance -- r_associated #0: 76 / 0.628 -> en:decreased motor nerve conduction velocity
    n1=en:white substance | n2=en:decreased motor nerve conduction velocity | rel=r_associated | relid=0 | w=76
  4066. en:white substance -- r_associated #0: 76 / 0.628 -> en:decreased need for sleep
    n1=en:white substance | n2=en:decreased need for sleep | rel=r_associated | relid=0 | w=76
  4067. en:white substance -- r_associated #0: 76 / 0.628 -> en:defects in fine motor skills
    n1=en:white substance | n2=en:defects in fine motor skills | rel=r_associated | relid=0 | w=76
  4068. en:white substance -- r_associated #0: 76 / 0.628 -> en:defects in visual cue processing
    n1=en:white substance | n2=en:defects in visual cue processing | rel=r_associated | relid=0 | w=76
  4069. en:white substance -- r_associated #0: 76 / 0.628 -> en:deficient myelination
    n1=en:white substance | n2=en:deficient myelination | rel=r_associated | relid=0 | w=76
  4070. en:white substance -- r_associated #0: 76 / 0.628 -> en:degeneration of the lateral corticospinal tracts
    n1=en:white substance | n2=en:degeneration of the lateral corticospinal tracts | rel=r_associated | relid=0 | w=76
  4071. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed adaptive hand use
    n1=en:white substance | n2=en:delayed adaptive hand use | rel=r_associated | relid=0 | w=76
  4072. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed cognitive development, mild (reported in 1 family)
    n1=en:white substance | n2=en:delayed cognitive development, mild (reported in 1 family) | rel=r_associated | relid=0 | w=76
  4073. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed developmental milestones
    n1=en:white substance | n2=en:delayed developmental milestones | rel=r_associated | relid=0 | w=76
  4074. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed gyration
    n1=en:white substance | n2=en:delayed gyration | rel=r_associated | relid=0 | w=76
  4075. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed motor development (secondary to skeletal abnormalities)
    n1=en:white substance | n2=en:delayed motor development (secondary to skeletal abnormalities) | rel=r_associated | relid=0 | w=76
  4076. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed motor development, severe
    n1=en:white substance | n2=en:delayed motor development, severe | rel=r_associated | relid=0 | w=76
  4077. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed motor milestones due to muscle weakness
    n1=en:white substance | n2=en:delayed motor milestones due to muscle weakness | rel=r_associated | relid=0 | w=76
  4078. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed myelination
    n1=en:white substance | n2=en:delayed myelination | rel=r_associated | relid=0 | w=76
  4079. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed myelination (in some patients)
    n1=en:white substance | n2=en:delayed myelination (in some patients) | rel=r_associated | relid=0 | w=76
  4080. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed psychomotor development, mild
    n1=en:white substance | n2=en:delayed psychomotor development, mild | rel=r_associated | relid=0 | w=76
  4081. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed psychomotor development, profound
    n1=en:white substance | n2=en:delayed psychomotor development, profound | rel=r_associated | relid=0 | w=76
  4082. en:white substance -- r_associated #0: 76 / 0.628 -> en:delayed psychomotor development, profound (patient a)
    n1=en:white substance | n2=en:delayed psychomotor development, profound (patient a) | rel=r_associated | relid=0 | w=76
  4083. en:white substance -- r_associated #0: 76 / 0.628 -> en:denervation seen on emg
    n1=en:white substance | n2=en:denervation seen on emg | rel=r_associated | relid=0 | w=76
  4084. en:white substance -- r_associated #0: 76 / 0.628 -> en:dermoid cyst
    n1=en:white substance | n2=en:dermoid cyst | rel=r_associated | relid=0 | w=76
  4085. en:white substance -- r_associated #0: 76 / 0.628 -> en:developmental delay, mild to moderate
    n1=en:white substance | n2=en:developmental delay, mild to moderate | rel=r_associated | relid=0 | w=76
  4086. en:white substance -- r_associated #0: 76 / 0.628 -> en:developmental delay, profound
    n1=en:white substance | n2=en:developmental delay, profound | rel=r_associated | relid=0 | w=76
  4087. en:white substance -- r_associated #0: 76 / 0.628 -> en:difficulties with equilibrium
    n1=en:white substance | n2=en:difficulties with equilibrium | rel=r_associated | relid=0 | w=76
  4088. en:white substance -- r_associated #0: 76 / 0.628 -> en:difficulty with writing and drawing
    n1=en:white substance | n2=en:difficulty with writing and drawing | rel=r_associated | relid=0 | w=76
  4089. en:white substance -- r_associated #0: 76 / 0.628 -> en:diffuse cerebral gliosis
    n1=en:white substance | n2=en:diffuse cerebral gliosis | rel=r_associated | relid=0 | w=76
  4090. en:white substance -- r_associated #0: 76 / 0.628 -> en:diffuse hyporeflexia (later)
    n1=en:white substance | n2=en:diffuse hyporeflexia (later) | rel=r_associated | relid=0 | w=76
  4091. en:white substance -- r_associated #0: 76 / 0.628 -> en:diffuse hypotonia
    n1=en:white substance | n2=en:diffuse hypotonia | rel=r_associated | relid=0 | w=76
  4092. en:white substance -- r_associated #0: 76 / 0.628 -> en:diffuse paroxysmal discharges
    n1=en:white substance | n2=en:diffuse paroxysmal discharges | rel=r_associated | relid=0 | w=76
  4093. en:white substance -- r_associated #0: 76 / 0.628 -> en:diffuse signal abnormality of central white matter
    n1=en:white substance | n2=en:diffuse signal abnormality of central white matter | rel=r_associated | relid=0 | w=76
  4094. en:white substance -- r_associated #0: 76 / 0.628 -> en:disordered myelination
    n1=en:white substance | n2=en:disordered myelination | rel=r_associated | relid=0 | w=76
  4095. en:white substance -- r_associated #0: 76 / 0.628 -> en:distal muscle weakness and atrophy due to motor neuronopathy
    n1=en:white substance | n2=en:distal muscle weakness and atrophy due to motor neuronopathy | rel=r_associated | relid=0 | w=76
  4096. en:white substance -- r_associated #0: 76 / 0.628 -> en:disturbed myelination affecting the periventricular and subcortical white matter
    n1=en:white substance | n2=en:disturbed myelination affecting the periventricular and subcortical white matter | rel=r_associated | relid=0 | w=76
  4097. en:white substance -- r_associated #0: 76 / 0.628 -> en:dorsolateral sulcus of spinal cord
    n1=en:white substance | n2=en:dorsolateral sulcus of spinal cord | rel=r_associated | relid=0 | w=76
  4098. en:white substance -- r_associated #0: 76 / 0.628 -> en:dysarthria, slowly progressive
    n1=en:white substance | n2=en:dysarthria, slowly progressive | rel=r_associated | relid=0 | w=76
  4099. en:white substance -- r_associated #0: 76 / 0.628 -> en:dysautonomia
    n1=en:white substance | n2=en:dysautonomia | rel=r_associated | relid=0 | w=76
  4100. en:white substance -- r_associated #0: 76 / 0.628 -> en:dysmetria (type i)
    n1=en:white substance | n2=en:dysmetria (type i) | rel=r_associated | relid=0 | w=76
  4101. en:white substance -- r_associated #0: 76 / 0.628 -> en:dysmetric saccades
    n1=en:white substance | n2=en:dysmetric saccades | rel=r_associated | relid=0 | w=76
  4102. en:white substance -- r_associated #0: 76 / 0.628 -> en:dysphonia
    n1=en:white substance | n2=en:dysphonia | rel=r_associated | relid=0 | w=76
  4103. en:white substance -- r_associated #0: 76 / 0.628 -> en:dysplastic superior cerebellar vermis
    n1=en:white substance | n2=en:dysplastic superior cerebellar vermis | rel=r_associated | relid=0 | w=76
  4104. en:white substance -- r_associated #0: 76 / 0.628 -> en:dystonia (<20%) (finding)
    n1=en:white substance | n2=en:dystonia (<20%) (finding) | rel=r_associated | relid=0 | w=76
  4105. en:white substance -- r_associated #0: 76 / 0.628 -> en:dystonia (14% of patients)
    n1=en:white substance | n2=en:dystonia (14% of patients) | rel=r_associated | relid=0 | w=76
  4106. en:white substance -- r_associated #0: 76 / 0.628 -> en:dystonia (in 2 patients)
    n1=en:white substance | n2=en:dystonia (in 2 patients) | rel=r_associated | relid=0 | w=76
  4107. en:white substance -- r_associated #0: 76 / 0.628 -> en:dystonia (in severe cases)
    n1=en:white substance | n2=en:dystonia (in severe cases) | rel=r_associated | relid=0 | w=76
  4108. en:white substance -- r_associated #0: 76 / 0.628 -> en:dystonia disorders
    n1=en:white substance | n2=en:dystonia disorders | rel=r_associated | relid=0 | w=76
  4109. en:white substance -- r_associated #0: 76 / 0.628 -> en:echolalia
    n1=en:white substance | n2=en:echolalia | rel=r_associated | relid=0 | w=76
  4110. en:white substance -- r_associated #0: 76 / 0.628 -> en:ectopic dorsal pontine transverse bundle of fibers forms the 'cap'
    n1=en:white substance | n2=en:ectopic dorsal pontine transverse bundle of fibers forms the 'cap' | rel=r_associated | relid=0 | w=76
  4111. en:white substance -- r_associated #0: 76 / 0.628 -> en:eeg shows burst suppression
    n1=en:white substance | n2=en:eeg shows burst suppression | rel=r_associated | relid=0 | w=76
  4112. en:white substance -- r_associated #0: 76 / 0.628 -> en:eeg with paroxysmal activity
    n1=en:white substance | n2=en:eeg with paroxysmal activity | rel=r_associated | relid=0 | w=76
  4113. en:white substance -- r_associated #0: 76 / 0.628 -> en:effaced gyral pattern
    n1=en:white substance | n2=en:effaced gyral pattern | rel=r_associated | relid=0 | w=76
  4114. en:white substance -- r_associated #0: 76 / 0.628 -> en:encephalocele (rare)
    n1=en:white substance | n2=en:encephalocele (rare) | rel=r_associated | relid=0 | w=76
  4115. en:white substance -- r_associated #0: 76 / 0.628 -> en:enlarged ventricles (in some)
    n1=en:white substance | n2=en:enlarged ventricles (in some) | rel=r_associated | relid=0 | w=76
  4116. en:white substance -- r_associated #0: 76 / 0.628 -> en:epileptic encephalopathy with psychomotor retardation (rare)
    n1=en:white substance | n2=en:epileptic encephalopathy with psychomotor retardation (rare) | rel=r_associated | relid=0 | w=76
  4117. en:white substance -- r_associated #0: 76 / 0.628 -> en:episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month
    n1=en:white substance | n2=en:episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month | rel=r_associated | relid=0 | w=76
  4118. en:white substance -- r_associated #0: 76 / 0.628 -> en:episodic confusion
    n1=en:white substance | n2=en:episodic confusion | rel=r_associated | relid=0 | w=76
  4119. en:white substance -- r_associated #0: 76 / 0.628 -> en:facial, pharyngeal, and masticatory muscle diplegia
    n1=en:white substance | n2=en:facial, pharyngeal, and masticatory muscle diplegia | rel=r_associated | relid=0 | w=76
  4120. en:white substance -- r_associated #0: 76 / 0.628 -> en:fasciculations, tongue
    n1=en:white substance | n2=en:fasciculations, tongue | rel=r_associated | relid=0 | w=76
  4121. en:white substance -- r_associated #0: 76 / 0.628 -> en:fatigue
    n1=en:white substance | n2=en:fatigue | rel=r_associated | relid=0 | w=76
  4122. en:white substance -- r_associated #0: 76 / 0.628 -> en:feeding problem
    n1=en:white substance | n2=en:feeding problem | rel=r_associated | relid=0 | w=76
  4123. en:white substance -- r_associated #0: 76 / 0.628 -> en:fetal akinesia deformation sequence
    n1=en:white substance | n2=en:fetal akinesia deformation sequence | rel=r_associated | relid=0 | w=76
  4124. en:white substance -- r_associated #0: 76 / 0.628 -> en:focal clonic seizure
    n1=en:white substance | n2=en:focal clonic seizure | rel=r_associated | relid=0 | w=76
  4125. en:white substance -- r_associated #0: 76 / 0.628 -> en:focal dyscognitive seizures
    n1=en:white substance | n2=en:focal dyscognitive seizures | rel=r_associated | relid=0 | w=76
  4126. en:white substance -- r_associated #0: 76 / 0.628 -> en:focal dystonia, usually of the hands
    n1=en:white substance | n2=en:focal dystonia, usually of the hands | rel=r_associated | relid=0 | w=76
  4127. en:white substance -- r_associated #0: 76 / 0.628 -> en:frontotemporal dementia (in 30% of patients)
    n1=en:white substance | n2=en:frontotemporal dementia (in 30% of patients) | rel=r_associated | relid=0 | w=76
  4128. en:white substance -- r_associated #0: 76 / 0.628 -> en:gait abnormalities (less common)
    n1=en:white substance | n2=en:gait abnormalities (less common) | rel=r_associated | relid=0 | w=76
  4129. en:white substance -- r_associated #0: 76 / 0.628 -> en:gait apraxia
    n1=en:white substance | n2=en:gait apraxia | rel=r_associated | relid=0 | w=76
  4130. en:white substance -- r_associated #0: 76 / 0.628 -> en:gait difficulties due to contractures of the lower limbs
    n1=en:white substance | n2=en:gait difficulties due to contractures of the lower limbs | rel=r_associated | relid=0 | w=76
  4131. en:white substance -- r_associated #0: 76 / 0.628 -> en:gait disturbance
    n1=en:white substance | n2=en:gait disturbance | rel=r_associated | relid=0 | w=76
  4132. en:white substance -- r_associated #0: 76 / 0.628 -> en:gaze deviation
    n1=en:white substance | n2=en:gaze deviation | rel=r_associated | relid=0 | w=76
  4133. en:white substance -- r_associated #0: 76 / 0.628 -> en:generalized cortical atrophy (in one patient)
    n1=en:white substance | n2=en:generalized cortical atrophy (in one patient) | rel=r_associated | relid=0 | w=76
  4134. en:white substance -- r_associated #0: 76 / 0.628 -> en:global brain atrophy
    n1=en:white substance | n2=en:global brain atrophy | rel=r_associated | relid=0 | w=76
  4135. en:white substance -- r_associated #0: 76 / 0.628 -> en:global developmental delay
    n1=en:white substance | n2=en:global developmental delay | rel=r_associated | relid=0 | w=76
  4136. en:white substance -- r_associated #0: 76 / 0.628 -> en:global developmental delay, variable severity
    n1=en:white substance | n2=en:global developmental delay, variable severity | rel=r_associated | relid=0 | w=76
  4137. en:white substance -- r_associated #0: 76 / 0.628 -> en:hallucinations (rare)
    n1=en:white substance | n2=en:hallucinations (rare) | rel=r_associated | relid=0 | w=76
  4138. en:white substance -- r_associated #0: 76 / 0.628 -> en:head movements abnormal
    n1=en:white substance | n2=en:head movements abnormal | rel=r_associated | relid=0 | w=76
  4139. en:white substance -- r_associated #0: 76 / 0.628 -> en:head titubation
    n1=en:white substance | n2=en:head titubation | rel=r_associated | relid=0 | w=76
  4140. en:white substance -- r_associated #0: 76 / 0.628 -> en:hemimegalencephaly
    n1=en:white substance | n2=en:hemimegalencephaly | rel=r_associated | relid=0 | w=76
  4141. en:white substance -- r_associated #0: 76 / 0.628 -> en:hemorrhagic cerebrovascular accident
    n1=en:white substance | n2=en:hemorrhagic cerebrovascular accident | rel=r_associated | relid=0 | w=76
  4142. en:white substance -- r_associated #0: 76 / 0.628 -> en:herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater
    n1=en:white substance | n2=en:herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater | rel=r_associated | relid=0 | w=76
  4143. en:white substance -- r_associated #0: 76 / 0.628 -> en:high signal intensities in periventricular white matter
    n1=en:white substance | n2=en:high signal intensities in periventricular white matter | rel=r_associated | relid=0 | w=76
  4144. en:white substance -- r_associated #0: 76 / 0.628 -> en:high voltage spikes over the temporal and central regions seen on eeg
    n1=en:white substance | n2=en:high voltage spikes over the temporal and central regions seen on eeg | rel=r_associated | relid=0 | w=76
  4145. en:white substance -- r_associated #0: 76 / 0.628 -> en:high voltage, fast rhythms seen on eeg
    n1=en:white substance | n2=en:high voltage, fast rhythms seen on eeg | rel=r_associated | relid=0 | w=76
  4146. en:white substance -- r_associated #0: 76 / 0.628 -> en:hydrocephalus (rare)
    n1=en:white substance | n2=en:hydrocephalus (rare) | rel=r_associated | relid=0 | w=76
  4147. en:white substance -- r_associated #0: 76 / 0.628 -> en:hydrocephalus, normal pressure
    n1=en:white substance | n2=en:hydrocephalus, normal pressure | rel=r_associated | relid=0 | w=76
  4148. en:white substance -- r_associated #0: 76 / 0.628 -> en:hyperactive brainstem reflexes (head retraction, palmomental, snout)
    n1=en:white substance | n2=en:hyperactive brainstem reflexes (head retraction, palmomental, snout) | rel=r_associated | relid=0 | w=76
  4149. en:white substance -- r_associated #0: 76 / 0.628 -> en:hyperintense lesions of the globi pallidi
    n1=en:white substance | n2=en:hyperintense lesions of the globi pallidi | rel=r_associated | relid=0 | w=76
  4150. en:white substance -- r_associated #0: 76 / 0.628 -> en:hyperreflexia (later)
    n1=en:white substance | n2=en:hyperreflexia (later) | rel=r_associated | relid=0 | w=76
  4151. en:white substance -- r_associated #0: 76 / 0.628 -> en:hypersomnolent
    n1=en:white substance | n2=en:hypersomnolent | rel=r_associated | relid=0 | w=76
  4152. en:white substance -- r_associated #0: 76 / 0.628 -> en:hyperthermia
    n1=en:white substance | n2=en:hyperthermia | rel=r_associated | relid=0 | w=76
  4153. en:white substance -- r_associated #0: 76 / 0.628 -> en:hypertonia in neonatal period
    n1=en:white substance | n2=en:hypertonia in neonatal period | rel=r_associated | relid=0 | w=76
  4154. en:white substance -- r_associated #0: 76 / 0.628 -> en:hypnapompic hallucinations
    n1=en:white substance | n2=en:hypnapompic hallucinations | rel=r_associated | relid=0 | w=76
  4155. en:white substance -- r_associated #0: 76 / 0.628 -> en:hypoglycemic seizures
    n1=en:white substance | n2=en:hypoglycemic seizures | rel=r_associated | relid=0 | w=76
  4156. en:white substance -- r_associated #0: 76 / 0.628 -> en:hypoplastic cerebrum
    n1=en:white substance | n2=en:hypoplastic cerebrum | rel=r_associated | relid=0 | w=76
  4157. en:white substance -- r_associated #0: 76 / 0.628 -> en:hypotonia (in males)
    n1=en:white substance | n2=en:hypotonia (in males) | rel=r_associated | relid=0 | w=76
  4158. en:white substance -- r_associated #0: 76 / 0.628 -> en:impaired ambulation due to muscle weakness
    n1=en:white substance | n2=en:impaired ambulation due to muscle weakness | rel=r_associated | relid=0 | w=76
  4159. en:white substance -- r_associated #0: 76 / 0.628 -> en:impaired balance
    n1=en:white substance | n2=en:impaired balance | rel=r_associated | relid=0 | w=76
  4160. en:white substance -- r_associated #0: 76 / 0.628 -> en:impaired cognition (in some patients)
    n1=en:white substance | n2=en:impaired cognition (in some patients) | rel=r_associated | relid=0 | w=76
  4161. en:white substance -- r_associated #0: 76 / 0.628 -> en:impaired motor control, mild
    n1=en:white substance | n2=en:impaired motor control, mild | rel=r_associated | relid=0 | w=76
  4162. en:white substance -- r_associated #0: 76 / 0.628 -> en:impairment of balance
    n1=en:white substance | n2=en:impairment of balance | rel=r_associated | relid=0 | w=76
  4163. en:white substance -- r_associated #0: 76 / 0.628 -> en:inability to stand on toes
    n1=en:white substance | n2=en:inability to stand on toes | rel=r_associated | relid=0 | w=76
  4164. en:white substance -- r_associated #0: 76 / 0.628 -> en:incoordination of the hands
    n1=en:white substance | n2=en:incoordination of the hands | rel=r_associated | relid=0 | w=76
  4165. en:white substance -- r_associated #0: 76 / 0.628 -> en:increased falls
    n1=en:white substance | n2=en:increased falls | rel=r_associated | relid=0 | w=76
  4166. en:white substance -- r_associated #0: 76 / 0.628 -> en:infantile muscular hypotonia
    n1=en:white substance | n2=en:infantile muscular hypotonia | rel=r_associated | relid=0 | w=76
  4167. en:white substance -- r_associated #0: 76 / 0.628 -> en:infantile seizures (approximately 80% of patients)
    n1=en:white substance | n2=en:infantile seizures (approximately 80% of patients) | rel=r_associated | relid=0 | w=76
  4168. en:white substance -- r_associated #0: 76 / 0.628 -> en:interictal eeg is usually normal
    n1=en:white substance | n2=en:interictal eeg is usually normal | rel=r_associated | relid=0 | w=76
  4169. en:white substance -- r_associated #0: 76 / 0.628 -> en:intracranial calcifications (1 patient)
    n1=en:white substance | n2=en:intracranial calcifications (1 patient) | rel=r_associated | relid=0 | w=76
  4170. en:white substance -- r_associated #0: 76 / 0.628 -> en:intracranial thin-walled sinusoidal vessel (cavernous) malformations
    n1=en:white substance | n2=en:intracranial thin-walled sinusoidal vessel (cavernous) malformations | rel=r_associated | relid=0 | w=76
  4171. en:white substance -- r_associated #0: 76 / 0.628 -> en:intraspinal neoplasm
    n1=en:white substance | n2=en:intraspinal neoplasm | rel=r_associated | relid=0 | w=76
  4172. en:white substance -- r_associated #0: 76 / 0.628 -> en:iron accumulation in the basal ganglia seen on mri
    n1=en:white substance | n2=en:iron accumulation in the basal ganglia seen on mri | rel=r_associated | relid=0 | w=76
  4173. en:white substance -- r_associated #0: 76 / 0.628 -> en:iron deposition in the globus pallidus and substantia nigra seen on mri
    n1=en:white substance | n2=en:iron deposition in the globus pallidus and substantia nigra seen on mri | rel=r_associated | relid=0 | w=76
  4174. en:white substance -- r_associated #0: 76 / 0.628 -> en:ischemic necrotic lesions
    n1=en:white substance | n2=en:ischemic necrotic lesions | rel=r_associated | relid=0 | w=76
  4175. en:white substance -- r_associated #0: 76 / 0.628 -> en:language development limited to a few words
    n1=en:white substance | n2=en:language development limited to a few words | rel=r_associated | relid=0 | w=76
  4176. en:white substance -- r_associated #0: 76 / 0.628 -> en:learning difficulties in affected females
    n1=en:white substance | n2=en:learning difficulties in affected females | rel=r_associated | relid=0 | w=76
  4177. en:white substance -- r_associated #0: 76 / 0.628 -> en:learning disabilities (major)
    n1=en:white substance | n2=en:learning disabilities (major) | rel=r_associated | relid=0 | w=76
  4178. en:white substance -- r_associated #0: 76 / 0.628 -> en:lesions in the basal ganglia
    n1=en:white substance | n2=en:lesions in the basal ganglia | rel=r_associated | relid=0 | w=76
  4179. en:white substance -- r_associated #0: 76 / 0.628 -> en:lesions in the caudate and putamen seen on mri
    n1=en:white substance | n2=en:lesions in the caudate and putamen seen on mri | rel=r_associated | relid=0 | w=76
  4180. en:white substance -- r_associated #0: 76 / 0.628 -> en:leukodystrophy, hypomyelinating
    n1=en:white substance | n2=en:leukodystrophy, hypomyelinating | rel=r_associated | relid=0 | w=76
  4181. en:white substance -- r_associated #0: 76 / 0.628 -> en:limited walking ability
    n1=en:white substance | n2=en:limited walking ability | rel=r_associated | relid=0 | w=76
  4182. en:white substance -- r_associated #0: 76 / 0.628 -> en:lipomyelocystoceles
    n1=en:white substance | n2=en:lipomyelocystoceles | rel=r_associated | relid=0 | w=76
  4183. en:white substance -- r_associated #0: 76 / 0.628 -> en:lissencephaly
    n1=en:white substance | n2=en:lissencephaly | rel=r_associated | relid=0 | w=76
  4184. en:white substance -- r_associated #0: 76 / 0.628 -> en:little spontaneous limb movement
    n1=en:white substance | n2=en:little spontaneous limb movement | rel=r_associated | relid=0 | w=76
  4185. en:white substance -- r_associated #0: 76 / 0.628 -> en:loss of language ability
    n1=en:white substance | n2=en:loss of language ability | rel=r_associated | relid=0 | w=76
  4186. en:white substance -- r_associated #0: 76 / 0.628 -> en:loss of myelin in the descending lateral spinal cord tracts
    n1=en:white substance | n2=en:loss of myelin in the descending lateral spinal cord tracts | rel=r_associated | relid=0 | w=76
  4187. en:white substance -- r_associated #0: 76 / 0.628 -> en:loss of white matter
    n1=en:white substance | n2=en:loss of white matter | rel=r_associated | relid=0 | w=76
  4188. en:white substance -- r_associated #0: 76 / 0.628 -> en:lower limb dystonia
    n1=en:white substance | n2=en:lower limb dystonia | rel=r_associated | relid=0 | w=76
  4189. en:white substance -- r_associated #0: 76 / 0.628 -> en:lower limb hyperreflexia (reported in 1 patient)
    n1=en:white substance | n2=en:lower limb hyperreflexia (reported in 1 patient) | rel=r_associated | relid=0 | w=76
  4190. en:white substance -- r_associated #0: 76 / 0.628 -> en:lower limbs weakness and atrophy, distal
    n1=en:white substance | n2=en:lower limbs weakness and atrophy, distal | rel=r_associated | relid=0 | w=76
  4191. en:white substance -- r_associated #0: 76 / 0.628 -> en:lymphocytic infiltration of the brain
    n1=en:white substance | n2=en:lymphocytic infiltration of the brain | rel=r_associated | relid=0 | w=76
  4192. en:white substance -- r_associated #0: 76 / 0.628 -> en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system
    n1=en:white substance | n2=en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system | rel=r_associated | relid=0 | w=76
  4193. en:white substance -- r_associated #0: 76 / 0.628 -> en:megacisterna magna (in some patients)
    n1=en:white substance | n2=en:megacisterna magna (in some patients) | rel=r_associated | relid=0 | w=76
  4194. en:white substance -- r_associated #0: 76 / 0.628 -> en:meningioma
    n1=en:white substance | n2=en:meningioma | rel=r_associated | relid=0 | w=76
  4195. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental handicap
    n1=en:white substance | n2=en:mental handicap | rel=r_associated | relid=0 | w=76
  4196. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental impairment, mild to moderate
    n1=en:white substance | n2=en:mental impairment, mild to moderate | rel=r_associated | relid=0 | w=76
  4197. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation (2 patients)
    n1=en:white substance | n2=en:mental retardation (2 patients) | rel=r_associated | relid=0 | w=76
  4198. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation (rarely noted)
    n1=en:white substance | n2=en:mental retardation (rarely noted) | rel=r_associated | relid=0 | w=76
  4199. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation (reported in 1 patient)
    n1=en:white substance | n2=en:mental retardation (reported in 1 patient) | rel=r_associated | relid=0 | w=76
  4200. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation (secondary to intracranial bleed)
    n1=en:white substance | n2=en:mental retardation (secondary to intracranial bleed) | rel=r_associated | relid=0 | w=76
  4201. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation (some)
    n1=en:white substance | n2=en:mental retardation (some) | rel=r_associated | relid=0 | w=76
  4202. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation if untreated
    n1=en:white substance | n2=en:mental retardation if untreated | rel=r_associated | relid=0 | w=76
  4203. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation in survivors
    n1=en:white substance | n2=en:mental retardation in survivors | rel=r_associated | relid=0 | w=76
  4204. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, in subgroup of patients
    n1=en:white substance | n2=en:mental retardation, in subgroup of patients | rel=r_associated | relid=0 | w=76
  4205. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, mild (2 families)
    n1=en:white substance | n2=en:mental retardation, mild (2 families) | rel=r_associated | relid=0 | w=76
  4206. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, mild (in some patients)
    n1=en:white substance | n2=en:mental retardation, mild (in some patients) | rel=r_associated | relid=0 | w=76
  4207. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, mild to moderate
    n1=en:white substance | n2=en:mental retardation, mild to moderate | rel=r_associated | relid=0 | w=76
  4208. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, mild to moderate (iq 30-76)
    n1=en:white substance | n2=en:mental retardation, mild to moderate (iq 30-76) | rel=r_associated | relid=0 | w=76
  4209. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, moderate-severe (2p21del)
    n1=en:white substance | n2=en:mental retardation, moderate-severe (2p21del) | rel=r_associated | relid=0 | w=76
  4210. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, occasional
    n1=en:white substance | n2=en:mental retardation, occasional | rel=r_associated | relid=0 | w=76
  4211. en:white substance -- r_associated #0: 76 / 0.628 -> en:mental retardation, variable (in some patients)
    n1=en:white substance | n2=en:mental retardation, variable (in some patients) | rel=r_associated | relid=0 | w=76
  4212. en:white substance -- r_associated #0: 76 / 0.628 -> en:microbleeds (most smaller than 5 mm) occur after age 40 years
    n1=en:white substance | n2=en:microbleeds (most smaller than 5 mm) occur after age 40 years | rel=r_associated | relid=0 | w=76
  4213. en:white substance -- r_associated #0: 76 / 0.628 -> en:migraines (less common)
    n1=en:white substance | n2=en:migraines (less common) | rel=r_associated | relid=0 | w=76
  4214. en:white substance -- r_associated #0: 76 / 0.628 -> en:migrating clonic jerks (in some patients)
    n1=en:white substance | n2=en:migrating clonic jerks (in some patients) | rel=r_associated | relid=0 | w=76
  4215. en:white substance -- r_associated #0: 76 / 0.628 -> en:migrating discharges from one cortical region to another seen on eeg (in some patients)
    n1=en:white substance | n2=en:migrating discharges from one cortical region to another seen on eeg (in some patients) | rel=r_associated | relid=0 | w=76
  4216. en:white substance -- r_associated #0: 76 / 0.628 -> en:mild cerebellar hypoplasia
    n1=en:white substance | n2=en:mild cerebellar hypoplasia | rel=r_associated | relid=0 | w=76
  4217. en:white substance -- r_associated #0: 76 / 0.628 -> en:mild cognitive disorder
    n1=en:white substance | n2=en:mild cognitive disorder | rel=r_associated | relid=0 | w=76
  4218. en:white substance -- r_associated #0: 76 / 0.628 -> en:mild cognitive impairment (less common)
    n1=en:white substance | n2=en:mild cognitive impairment (less common) | rel=r_associated | relid=0 | w=76
  4219. en:white substance -- r_associated #0: 76 / 0.628 -> en:mild psychomotor delay
    n1=en:white substance | n2=en:mild psychomotor delay | rel=r_associated | relid=0 | w=76
  4220. en:white substance -- r_associated #0: 76 / 0.628 -> en:mild to severe mental retardation (24%)
    n1=en:white substance | n2=en:mild to severe mental retardation (24%) | rel=r_associated | relid=0 | w=76
  4221. en:white substance -- r_associated #0: 76 / 0.628 -> en:mildly thin corpus callosum
    n1=en:white substance | n2=en:mildly thin corpus callosum | rel=r_associated | relid=0 | w=76
  4222. en:white substance -- r_associated #0: 76 / 0.628 -> en:mitochondrial encephalopathy
    n1=en:white substance | n2=en:mitochondrial encephalopathy | rel=r_associated | relid=0 | w=76
  4223. en:white substance -- r_associated #0: 76 / 0.628 -> en:moderate to severe hypotonia
    n1=en:white substance | n2=en:moderate to severe hypotonia | rel=r_associated | relid=0 | w=76
  4224. en:white substance -- r_associated #0: 76 / 0.628 -> en:monopareses
    n1=en:white substance | n2=en:monopareses | rel=r_associated | relid=0 | w=76
  4225. en:white substance -- r_associated #0: 76 / 0.628 -> en:motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening
    n1=en:white substance | n2=en:motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening | rel=r_associated | relid=0 | w=76
  4226. en:white substance -- r_associated #0: 76 / 0.628 -> en:movements are exacerbated by anxiety
    n1=en:white substance | n2=en:movements are exacerbated by anxiety | rel=r_associated | relid=0 | w=76
  4227. en:white substance -- r_associated #0: 76 / 0.628 -> en:mri may show lesions in basal ganglia, thalamus, and white matter
    n1=en:white substance | n2=en:mri may show lesions in basal ganglia, thalamus, and white matter | rel=r_associated | relid=0 | w=76
  4228. en:white substance -- r_associated #0: 76 / 0.628 -> en:mri shows congenital abnormalities of the posterior fossa
    n1=en:white substance | n2=en:mri shows congenital abnormalities of the posterior fossa | rel=r_associated | relid=0 | w=76
  4229. en:white substance -- r_associated #0: 76 / 0.628 -> en:mri shows global lack of myelination in the cerebral hemispheres
    n1=en:white substance | n2=en:mri shows global lack of myelination in the cerebral hemispheres | rel=r_associated | relid=0 | w=76
  4230. en:white substance -- r_associated #0: 76 / 0.628 -> en:mrs shows decreased creatine in white matter
    n1=en:white substance | n2=en:mrs shows decreased creatine in white matter | rel=r_associated | relid=0 | w=76
  4231. en:white substance -- r_associated #0: 76 / 0.628 -> en:multifocal discharges seen on eeg (in some patients)
    n1=en:white substance | n2=en:multifocal discharges seen on eeg (in some patients) | rel=r_associated | relid=0 | w=76
  4232. en:white substance -- r_associated #0: 76 / 0.628 -> en:muscle weakness, symmetric, proximal due to motor neuronopathy
    n1=en:white substance | n2=en:muscle weakness, symmetric, proximal due to motor neuronopathy | rel=r_associated | relid=0 | w=76
  4233. en:white substance -- r_associated #0: 76 / 0.628 -> en:muscular hypotonia of the trunk
    n1=en:white substance | n2=en:muscular hypotonia of the trunk | rel=r_associated | relid=0 | w=76
  4234. en:white substance -- r_associated #0: 76 / 0.628 -> en:myoclonic seizures may occur
    n1=en:white substance | n2=en:myoclonic seizures may occur | rel=r_associated | relid=0 | w=76
  4235. en:white substance -- r_associated #0: 76 / 0.628 -> en:myoclonic-astatic seizures
    n1=en:white substance | n2=en:myoclonic-astatic seizures | rel=r_associated | relid=0 | w=76
  4236. en:white substance -- r_associated #0: 76 / 0.628 -> en:myopathy
    n1=en:white substance | n2=en:myopathy | rel=r_associated | relid=0 | w=76
  4237. en:white substance -- r_associated #0: 76 / 0.628 -> en:neonatal epileptic encephalopathy (nee)
    n1=en:white substance | n2=en:neonatal epileptic encephalopathy (nee) | rel=r_associated | relid=0 | w=76
  4238. en:white substance -- r_associated #0: 76 / 0.628 -> en:neural tissue of segment of brain
    n1=en:white substance | n2=en:neural tissue of segment of brain | rel=r_associated | relid=0 | w=76
  4239. en:white substance -- r_associated #0: 76 / 0.628 -> en:neurodevelopmental regression
    n1=en:white substance | n2=en:neurodevelopmental regression | rel=r_associated | relid=0 | w=76
  4240. en:white substance -- r_associated #0: 76 / 0.628 -> en:neuronal heterotopia
    n1=en:white substance | n2=en:neuronal heterotopia | rel=r_associated | relid=0 | w=76
  4241. en:white substance -- r_associated #0: 76 / 0.628 -> en:neuronal loss in the hippocampus
    n1=en:white substance | n2=en:neuronal loss in the hippocampus | rel=r_associated | relid=0 | w=76
  4242. en:white substance -- r_associated #0: 76 / 0.628 -> en:neurophysiologic studies show evidence of denervation and renervation
    n1=en:white substance | n2=en:neurophysiologic studies show evidence of denervation and renervation | rel=r_associated | relid=0 | w=76
  4243. en:white substance -- r_associated #0: 76 / 0.628 -> en:no autistic features
    n1=en:white substance | n2=en:no autistic features | rel=r_associated | relid=0 | w=76
  4244. en:white substance -- r_associated #0: 76 / 0.628 -> en:no mental retardation
    n1=en:white substance | n2=en:no mental retardation | rel=r_associated | relid=0 | w=76
  4245. en:white substance -- r_associated #0: 76 / 0.628 -> en:no neurofibromas
    n1=en:white substance | n2=en:no neurofibromas | rel=r_associated | relid=0 | w=76
  4246. en:white substance -- r_associated #0: 76 / 0.628 -> en:no structural brain abnormalities seen on mri
    n1=en:white substance | n2=en:no structural brain abnormalities seen on mri | rel=r_associated | relid=0 | w=76
  4247. en:white substance -- r_associated #0: 76 / 0.628 -> en:nocturnal sleep disruption
    n1=en:white substance | n2=en:nocturnal sleep disruption | rel=r_associated | relid=0 | w=76
  4248. en:white substance -- r_associated #0: 76 / 0.628 -> en:nodular heterotopia of the grey matter
    n1=en:white substance | n2=en:nodular heterotopia of the grey matter | rel=r_associated | relid=0 | w=76
  4249. en:white substance -- r_associated #0: 76 / 0.628 -> en:nonverbal (in some patients)
    n1=en:white substance | n2=en:nonverbal (in some patients) | rel=r_associated | relid=0 | w=76
  4250. en:white substance -- r_associated #0: 76 / 0.628 -> en:normal development (in 2 of 6 patients)
    n1=en:white substance | n2=en:normal development (in 2 of 6 patients) | rel=r_associated | relid=0 | w=76
  4251. en:white substance -- r_associated #0: 76 / 0.628 -> en:normal intellectual function
    n1=en:white substance | n2=en:normal intellectual function | rel=r_associated | relid=0 | w=76
  4252. en:white substance -- r_associated #0: 76 / 0.628 -> en:normal psychomotor development
    n1=en:white substance | n2=en:normal psychomotor development | rel=r_associated | relid=0 | w=76
  4253. en:white substance -- r_associated #0: 76 / 0.628 -> en:occipital dermal sinus tract
    n1=en:white substance | n2=en:occipital dermal sinus tract | rel=r_associated | relid=0 | w=76
  4254. en:white substance -- r_associated #0: 76 / 0.628 -> en:occlusive hydrocephalus, congenital
    n1=en:white substance | n2=en:occlusive hydrocephalus, congenital | rel=r_associated | relid=0 | w=76
  4255. en:white substance -- r_associated #0: 76 / 0.628 -> en:olfactory lobe agenesis
    n1=en:white substance | n2=en:olfactory lobe agenesis | rel=r_associated | relid=0 | w=76
  4256. en:white substance -- r_associated #0: 76 / 0.628 -> en:open spina bifida (myelomeningocele, 182940)
    n1=en:white substance | n2=en:open spina bifida (myelomeningocele, 182940) | rel=r_associated | relid=0 | w=76
  4257. en:white substance -- r_associated #0: 76 / 0.628 -> en:optic ataxia (in a subset of patients)
    n1=en:white substance | n2=en:optic ataxia (in a subset of patients) | rel=r_associated | relid=0 | w=76
  4258. en:white substance -- r_associated #0: 76 / 0.628 -> en:optic tract agenesis
    n1=en:white substance | n2=en:optic tract agenesis | rel=r_associated | relid=0 | w=76
  4259. en:white substance -- r_associated #0: 76 / 0.628 -> en:orofacial dystonia
    n1=en:white substance | n2=en:orofacial dystonia | rel=r_associated | relid=0 | w=76
  4260. en:white substance -- r_associated #0: 76 / 0.628 -> en:oromandibular dystonia
    n1=en:white substance | n2=en:oromandibular dystonia | rel=r_associated | relid=0 | w=76
  4261. en:white substance -- r_associated #0: 76 / 0.628 -> en:overlapping lesion of brain
    n1=en:white substance | n2=en:overlapping lesion of brain | rel=r_associated | relid=0 | w=76
  4262. en:white substance -- r_associated #0: 76 / 0.628 -> en:pain affects upper body
    n1=en:white substance | n2=en:pain affects upper body | rel=r_associated | relid=0 | w=76
  4263. en:white substance -- r_associated #0: 76 / 0.628 -> en:paraneoplastic syndrome
    n1=en:white substance | n2=en:paraneoplastic syndrome | rel=r_associated | relid=0 | w=76
  4264. en:white substance -- r_associated #0: 76 / 0.628 -> en:parkinsonism may occur
    n1=en:white substance | n2=en:parkinsonism may occur | rel=r_associated | relid=0 | w=76
  4265. en:white substance -- r_associated #0: 76 / 0.628 -> en:parkinsonism, early-onset
    n1=en:white substance | n2=en:parkinsonism, early-onset | rel=r_associated | relid=0 | w=76
  4266. en:white substance -- r_associated #0: 76 / 0.628 -> en:partial agenesis of corpus callosum (rare, in males)
    n1=en:white substance | n2=en:partial agenesis of corpus callosum (rare, in males) | rel=r_associated | relid=0 | w=76
  4267. en:white substance -- r_associated #0: 76 / 0.628 -> en:patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds
    n1=en:white substance | n2=en:patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds | rel=r_associated | relid=0 | w=76
  4268. en:white substance -- r_associated #0: 76 / 0.628 -> en:paucity of anterior horn motor neurons
    n1=en:white substance | n2=en:paucity of anterior horn motor neurons | rel=r_associated | relid=0 | w=76
  4269. en:white substance -- r_associated #0: 76 / 0.628 -> en:peculiar gait (if left untreated)
    n1=en:white substance | n2=en:peculiar gait (if left untreated) | rel=r_associated | relid=0 | w=76
  4270. en:white substance -- r_associated #0: 76 / 0.628 -> en:periodic stiffness
    n1=en:white substance | n2=en:periodic stiffness | rel=r_associated | relid=0 | w=76
  4271. en:white substance -- r_associated #0: 76 / 0.628 -> en:periventricular white matter abnormalities
    n1=en:white substance | n2=en:periventricular white matter abnormalities | rel=r_associated | relid=0 | w=76
  4272. en:white substance -- r_associated #0: 76 / 0.628 -> en:periventricular white matter abnormalities (in some patients)
    n1=en:white substance | n2=en:periventricular white matter abnormalities (in some patients) | rel=r_associated | relid=0 | w=76
  4273. en:white substance -- r_associated #0: 76 / 0.628 -> en:periventricular white matter hyperintensities, bilateral
    n1=en:white substance | n2=en:periventricular white matter hyperintensities, bilateral | rel=r_associated | relid=0 | w=76
  4274. en:white substance -- r_associated #0: 76 / 0.628 -> en:persistent falcine venous sinus
    n1=en:white substance | n2=en:persistent falcine venous sinus | rel=r_associated | relid=0 | w=76
  4275. en:white substance -- r_associated #0: 76 / 0.628 -> en:petit mal epilepsy
    n1=en:white substance | n2=en:petit mal epilepsy | rel=r_associated | relid=0 | w=76
  4276. en:white substance -- r_associated #0: 76 / 0.628 -> en:pituitary agenesis (rare)
    n1=en:white substance | n2=en:pituitary agenesis (rare) | rel=r_associated | relid=0 | w=76
  4277. en:white substance -- r_associated #0: 76 / 0.628 -> en:polymicrogyria, asymmetric or symmetric
    n1=en:white substance | n2=en:polymicrogyria, asymmetric or symmetric | rel=r_associated | relid=0 | w=76
  4278. en:white substance -- r_associated #0: 76 / 0.628 -> en:pontocerebellar arachnoid cyst (reported in 2 patients)
    n1=en:white substance | n2=en:pontocerebellar arachnoid cyst (reported in 2 patients) | rel=r_associated | relid=0 | w=76
  4279. en:white substance -- r_associated #0: 76 / 0.628 -> en:pontocerebellar atrophy
    n1=en:white substance | n2=en:pontocerebellar atrophy | rel=r_associated | relid=0 | w=76
  4280. en:white substance -- r_associated #0: 76 / 0.628 -> en:poor fine motor skills
    n1=en:white substance | n2=en:poor fine motor skills | rel=r_associated | relid=0 | w=76
  4281. en:white substance -- r_associated #0: 76 / 0.628 -> en:poor head control
    n1=en:white substance | n2=en:poor head control | rel=r_associated | relid=0 | w=76
  4282. en:white substance -- r_associated #0: 76 / 0.628 -> en:poor vestibuloocular reflex
    n1=en:white substance | n2=en:poor vestibuloocular reflex | rel=r_associated | relid=0 | w=76
  4283. en:white substance -- r_associated #0: 76 / 0.628 -> en:porencephalic cyst
    n1=en:white substance | n2=en:porencephalic cyst | rel=r_associated | relid=0 | w=76
  4284. en:white substance -- r_associated #0: 76 / 0.628 -> en:postural hand tremor
    n1=en:white substance | n2=en:postural hand tremor | rel=r_associated | relid=0 | w=76
  4285. en:white substance -- r_associated #0: 76 / 0.628 -> en:presence of rosenthal fibers (eosinophilic bodies near astrocyte filaments)
    n1=en:white substance | n2=en:presence of rosenthal fibers (eosinophilic bodies near astrocyte filaments) | rel=r_associated | relid=0 | w=76
  4286. en:white substance -- r_associated #0: 76 / 0.628 -> en:preservation of u fibers
    n1=en:white substance | n2=en:preservation of u fibers | rel=r_associated | relid=0 | w=76
  4287. en:white substance -- r_associated #0: 76 / 0.628 -> en:primitive reflexes (palmomental, snout, glabellar)
    n1=en:white substance | n2=en:primitive reflexes (palmomental, snout, glabellar) | rel=r_associated | relid=0 | w=76
  4288. en:white substance -- r_associated #0: 76 / 0.628 -> en:progressive forgetfulness
    n1=en:white substance | n2=en:progressive forgetfulness | rel=r_associated | relid=0 | w=76
  4289. en:white substance -- r_associated #0: 76 / 0.628 -> en:progressive psychomotor deterioration
    n1=en:white substance | n2=en:progressive psychomotor deterioration | rel=r_associated | relid=0 | w=76
  4290. en:white substance -- r_associated #0: 76 / 0.628 -> en:prominent trigone and occipital horns
    n1=en:white substance | n2=en:prominent trigone and occipital horns | rel=r_associated | relid=0 | w=76
  4291. en:white substance -- r_associated #0: 76 / 0.628 -> en:proximal amyotrophy
    n1=en:white substance | n2=en:proximal amyotrophy | rel=r_associated | relid=0 | w=76
  4292. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychomotor agitation
    n1=en:white substance | n2=en:psychomotor agitation | rel=r_associated | relid=0 | w=76
  4293. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychomotor delay (rare)
    n1=en:white substance | n2=en:psychomotor delay (rare) | rel=r_associated | relid=0 | w=76
  4294. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychomotor deterioration
    n1=en:white substance | n2=en:psychomotor deterioration | rel=r_associated | relid=0 | w=76
  4295. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychomotor regression (in some)
    n1=en:white substance | n2=en:psychomotor regression (in some) | rel=r_associated | relid=0 | w=76
  4296. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychomotor regression, severe
    n1=en:white substance | n2=en:psychomotor regression, severe | rel=r_associated | relid=0 | w=76
  4297. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychomotor retardation (in 1 patient)
    n1=en:white substance | n2=en:psychomotor retardation (in 1 patient) | rel=r_associated | relid=0 | w=76
  4298. en:white substance -- r_associated #0: 76 / 0.628 -> en:psychotic episodes
    n1=en:white substance | n2=en:psychotic episodes | rel=r_associated | relid=0 | w=76
  4299. en:white substance -- r_associated #0: 76 / 0.628 -> en:pyramidal symptoms
    n1=en:white substance | n2=en:pyramidal symptoms | rel=r_associated | relid=0 | w=76
  4300. en:white substance -- r_associated #0: 76 / 0.628 -> en:rare dementia
    n1=en:white substance | n2=en:rare dementia | rel=r_associated | relid=0 | w=76
  4301. en:white substance -- r_associated #0: 76 / 0.628 -> en:reactive gliosis
    n1=en:white substance | n2=en:reactive gliosis | rel=r_associated | relid=0 | w=76
  4302. en:white substance -- r_associated #0: 76 / 0.628 -> en:recurrent bacterial meningitis
    n1=en:white substance | n2=en:recurrent bacterial meningitis | rel=r_associated | relid=0 | w=76
  4303. en:white substance -- r_associated #0: 76 / 0.628 -> en:reduced cerebral white matter
    n1=en:white substance | n2=en:reduced cerebral white matter | rel=r_associated | relid=0 | w=76
  4304. en:white substance -- r_associated #0: 76 / 0.628 -> en:resting tremors
    n1=en:white substance | n2=en:resting tremors | rel=r_associated | relid=0 | w=76
  4305. en:white substance -- r_associated #0: 76 / 0.628 -> en:rigidity (later)
    n1=en:white substance | n2=en:rigidity (later) | rel=r_associated | relid=0 | w=76
  4306. en:white substance -- r_associated #0: 76 / 0.628 -> en:rigidity during seizures
    n1=en:white substance | n2=en:rigidity during seizures | rel=r_associated | relid=0 | w=76
  4307. en:white substance -- r_associated #0: 76 / 0.628 -> en:roentgenographic
    n1=en:white substance | n2=en:roentgenographic | rel=r_associated | relid=0 | w=76
  4308. en:white substance -- r_associated #0: 76 / 0.628 -> en:rotary head movements ('rolling,' 'tremor')
    n1=en:white substance | n2=en:rotary head movements ('rolling,' 'tremor') | rel=r_associated | relid=0 | w=76
  4309. en:white substance -- r_associated #0: 76 / 0.628 -> en:roving eye movements (infancy)
    n1=en:white substance | n2=en:roving eye movements (infancy) | rel=r_associated | relid=0 | w=76
  4310. en:white substance -- r_associated #0: 76 / 0.628 -> en:rudimentary white matter
    n1=en:white substance | n2=en:rudimentary white matter | rel=r_associated | relid=0 | w=76
  4311. en:white substance -- r_associated #0: 76 / 0.628 -> en:secondary spinal cord compression may occur
    n1=en:white substance | n2=en:secondary spinal cord compression may occur | rel=r_associated | relid=0 | w=76
  4312. en:white substance -- r_associated #0: 76 / 0.628 -> en:segmental callosal hypoplasia, mild
    n1=en:white substance | n2=en:segmental callosal hypoplasia, mild | rel=r_associated | relid=0 | w=76
  4313. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures (50%)
    n1=en:white substance | n2=en:seizures (50%) | rel=r_associated | relid=0 | w=76
  4314. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures (cvs+)
    n1=en:white substance | n2=en:seizures (cvs+) | rel=r_associated | relid=0 | w=76
  4315. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures (in some)
    n1=en:white substance | n2=en:seizures (in some) | rel=r_associated | relid=0 | w=76
  4316. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures (tetany)
    n1=en:white substance | n2=en:seizures (tetany) | rel=r_associated | relid=0 | w=76
  4317. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures, diurnal partial, rare (in some patients)
    n1=en:white substance | n2=en:seizures, diurnal partial, rare (in some patients) | rel=r_associated | relid=0 | w=76
  4318. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures, partial complex (rare)
    n1=en:white substance | n2=en:seizures, partial complex (rare) | rel=r_associated | relid=0 | w=76
  4319. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures, partial, often hemifacial
    n1=en:white substance | n2=en:seizures, partial, often hemifacial | rel=r_associated | relid=0 | w=76
  4320. en:white substance -- r_associated #0: 76 / 0.628 -> en:seizures, particularly absence (in some patients)
    n1=en:white substance | n2=en:seizures, particularly absence (in some patients) | rel=r_associated | relid=0 | w=76
  4321. en:white substance -- r_associated #0: 76 / 0.628 -> en:severely impaired or absent speech
    n1=en:white substance | n2=en:severely impaired or absent speech | rel=r_associated | relid=0 | w=76
  4322. en:white substance -- r_associated #0: 76 / 0.628 -> en:simplified gyral pattern (in 1 of 2 sibs)
    n1=en:white substance | n2=en:simplified gyral pattern (in 1 of 2 sibs) | rel=r_associated | relid=0 | w=76
  4323. en:white substance -- r_associated #0: 76 / 0.628 -> en:sleep benefit (31%)
    n1=en:white substance | n2=en:sleep benefit (31%) | rel=r_associated | relid=0 | w=76
  4324. en:white substance -- r_associated #0: 76 / 0.628 -> en:slow, broad-based gait
    n1=en:white substance | n2=en:slow, broad-based gait | rel=r_associated | relid=0 | w=76
  4325. en:white substance -- r_associated #0: 76 / 0.628 -> en:small cerebellum (especially vermis)
    n1=en:white substance | n2=en:small cerebellum (especially vermis) | rel=r_associated | relid=0 | w=76
  4326. en:white substance -- r_associated #0: 76 / 0.628 -> en:spasticity (rare)
    n1=en:white substance | n2=en:spasticity (rare) | rel=r_associated | relid=0 | w=76
  4327. en:white substance -- r_associated #0: 76 / 0.628 -> en:spasticity, lower limbs greater than upper limbs
    n1=en:white substance | n2=en:spasticity, lower limbs greater than upper limbs | rel=r_associated | relid=0 | w=76
  4328. en:white substance -- r_associated #0: 76 / 0.628 -> en:speech absent or delayed
    n1=en:white substance | n2=en:speech absent or delayed | rel=r_associated | relid=0 | w=76
  4329. en:white substance -- r_associated #0: 76 / 0.628 -> en:speech delay (in some patients)
    n1=en:white substance | n2=en:speech delay (in some patients) | rel=r_associated | relid=0 | w=76
  4330. en:white substance -- r_associated #0: 76 / 0.628 -> en:speech deterioration
    n1=en:white substance | n2=en:speech deterioration | rel=r_associated | relid=0 | w=76
  4331. en:white substance -- r_associated #0: 76 / 0.628 -> en:spinal arteriovenous malformation
    n1=en:white substance | n2=en:spinal arteriovenous malformation | rel=r_associated | relid=0 | w=76
  4332. en:white substance -- r_associated #0: 76 / 0.628 -> en:spongiform encephalomyelopathy
    n1=en:white substance | n2=en:spongiform encephalomyelopathy | rel=r_associated | relid=0 | w=76
  4333. en:white substance -- r_associated #0: 76 / 0.628 -> en:status epilepticus may occur
    n1=en:white substance | n2=en:status epilepticus may occur | rel=r_associated | relid=0 | w=76
  4334. en:white substance -- r_associated #0: 76 / 0.628 -> en:status epilepticus rarely occurs
    n1=en:white substance | n2=en:status epilepticus rarely occurs | rel=r_associated | relid=0 | w=76
  4335. en:white substance -- r_associated #0: 76 / 0.628 -> en:strokes due to coagulopathy
    n1=en:white substance | n2=en:strokes due to coagulopathy | rel=r_associated | relid=0 | w=76
  4336. en:white substance -- r_associated #0: 76 / 0.628 -> en:subarachnoid cyst
    n1=en:white substance | n2=en:subarachnoid cyst | rel=r_associated | relid=0 | w=76
  4337. en:white substance -- r_associated #0: 76 / 0.628 -> en:subcortical atrophy (in some patients)
    n1=en:white substance | n2=en:subcortical atrophy (in some patients) | rel=r_associated | relid=0 | w=76
  4338. en:white substance -- r_associated #0: 76 / 0.628 -> en:subcortical focal lacunae
    n1=en:white substance | n2=en:subcortical focal lacunae | rel=r_associated | relid=0 | w=76
  4339. en:white substance -- r_associated #0: 76 / 0.628 -> en:subcortical lesions
    n1=en:white substance | n2=en:subcortical lesions | rel=r_associated | relid=0 | w=76
  4340. en:white substance -- r_associated #0: 76 / 0.628 -> en:supranuclear gaze palsy
    n1=en:white substance | n2=en:supranuclear gaze palsy | rel=r_associated | relid=0 | w=76
  4341. en:white substance -- r_associated #0: 76 / 0.628 -> en:swelling of the deep white matter seen on mri
    n1=en:white substance | n2=en:swelling of the deep white matter seen on mri | rel=r_associated | relid=0 | w=76
  4342. en:white substance -- r_associated #0: 76 / 0.628 -> en:t2-weighted hyperintensities in the basal ganglia
    n1=en:white substance | n2=en:t2-weighted hyperintensities in the basal ganglia | rel=r_associated | relid=0 | w=76
  4343. en:white substance -- r_associated #0: 76 / 0.628 -> en:t2-weighted hyperintensities in the supratentorial white matter seen on brain mri
    n1=en:white substance | n2=en:t2-weighted hyperintensities in the supratentorial white matter seen on brain mri | rel=r_associated | relid=0 | w=76
  4344. en:white substance -- r_associated #0: 76 / 0.628 -> en:tethered cord (rare)
    n1=en:white substance | n2=en:tethered cord (rare) | rel=r_associated | relid=0 | w=76
  4345. en:white substance -- r_associated #0: 76 / 0.628 -> en:thin optic chiasm
    n1=en:white substance | n2=en:thin optic chiasm | rel=r_associated | relid=0 | w=76
  4346. en:white substance -- r_associated #0: 76 / 0.628 -> en:tonic-clonic seizures (less common)
    n1=en:white substance | n2=en:tonic-clonic seizures (less common) | rel=r_associated | relid=0 | w=76
  4347. en:white substance -- r_associated #0: 76 / 0.628 -> en:transient mild dystonia may precede abrupt onset of disorder by several years
    n1=en:white substance | n2=en:transient mild dystonia may precede abrupt onset of disorder by several years | rel=r_associated | relid=0 | w=76
  4348. en:white substance -- r_associated #0: 76 / 0.628 -> en:tremor of palate
    n1=en:white substance | n2=en:tremor of palate | rel=r_associated | relid=0 | w=76
  4349. en:white substance -- r_associated #0: 76 / 0.628 -> en:tremor, action, progressive
    n1=en:white substance | n2=en:tremor, action, progressive | rel=r_associated | relid=0 | w=76
  4350. en:white substance -- r_associated #0: 76 / 0.628 -> en:tremor, mild
    n1=en:white substance | n2=en:tremor, mild | rel=r_associated | relid=0 | w=76
  4351. en:white substance -- r_associated #0: 76 / 0.628 -> en:unable to sit unsupported
    n1=en:white substance | n2=en:unable to sit unsupported | rel=r_associated | relid=0 | w=76
  4352. en:white substance -- r_associated #0: 76 / 0.628 -> en:upper extremities may be involved
    n1=en:white substance | n2=en:upper extremities may be involved | rel=r_associated | relid=0 | w=76
  4353. en:white substance -- r_associated #0: 76 / 0.628 -> en:upper limb spasticity (some)
    n1=en:white substance | n2=en:upper limb spasticity (some) | rel=r_associated | relid=0 | w=76
  4354. en:white substance -- r_associated #0: 76 / 0.628 -> en:upper motor neuron degeneration
    n1=en:white substance | n2=en:upper motor neuron degeneration | rel=r_associated | relid=0 | w=76
  4355. en:white substance -- r_associated #0: 76 / 0.628 -> en:upper motor neuron signs
    n1=en:white substance | n2=en:upper motor neuron signs | rel=r_associated | relid=0 | w=76
  4356. en:white substance -- r_associated #0: 76 / 0.628 -> en:vcp-positive inclusions
    n1=en:white substance | n2=en:vcp-positive inclusions | rel=r_associated | relid=0 | w=76
  4357. en:white substance -- r_associated #0: 76 / 0.628 -> en:vertigo, mild
    n1=en:white substance | n2=en:vertigo, mild | rel=r_associated | relid=0 | w=76
  4358. en:white substance -- r_associated #0: 76 / 0.628 -> en:waddling gait
    n1=en:white substance | n2=en:waddling gait | rel=r_associated | relid=0 | w=76
  4359. en:white substance -- r_associated #0: 76 / 0.628 -> en:white matter changes on brain imaging (less common)
    n1=en:white substance | n2=en:white matter changes on brain imaging (less common) | rel=r_associated | relid=0 | w=76
  4360. en:white substance -- r_associated #0: 76 / 0.628 -> en:white matter lacks axons and myelin
    n1=en:white substance | n2=en:white matter lacks axons and myelin | rel=r_associated | relid=0 | w=76
  4361. en:white substance -- r_associated #0: 76 / 0.628 -> en:white matter lesions in the supratentorial white matter, brainstem, cerebellum, and spinal cord
    n1=en:white substance | n2=en:white matter lesions in the supratentorial white matter, brainstem, cerebellum, and spinal cord | rel=r_associated | relid=0 | w=76
  4362. en:white substance -- r_associated #0: 76 / 0.628 -> en:wide sylvian fissures
    n1=en:white substance | n2=en:wide sylvian fissures | rel=r_associated | relid=0 | w=76
  4363. en:white substance -- r_associated #0: 75 / 0.62 -> cellule du tissu nerveux
    n1=en:white substance | n2=cellule du tissu nerveux | rel=r_associated | relid=0 | w=75
  4364. en:white substance -- r_associated #0: 75 / 0.62 -> fibre
    n1=en:white substance | n2=fibre | rel=r_associated | relid=0 | w=75
  4365. en:white substance -- r_associated #0: 75 / 0.62 -> moelle épinière
    n1=en:white substance | n2=moelle épinière | rel=r_associated | relid=0 | w=75
  4366. en:white substance -- r_associated #0: 75 / 0.62 -> myéline
    n1=en:white substance | n2=myéline | rel=r_associated | relid=0 | w=75
  4367. en:white substance -- r_associated #0: 75 / 0.62 -> substance grise
    n1=en:white substance | n2=substance grise | rel=r_associated | relid=0 | w=75
  4368. en:white substance -- r_associated #0: 71 / 0.587 -> en:abnormal gait (67%)
    n1=en:white substance | n2=en:abnormal gait (67%) | rel=r_associated | relid=0 | w=71
  4369. en:white substance -- r_associated #0: 71 / 0.587 -> en:acute neurologic decompensation (in later-onset cases)
    n1=en:white substance | n2=en:acute neurologic decompensation (in later-onset cases) | rel=r_associated | relid=0 | w=71
  4370. en:white substance -- r_associated #0: 71 / 0.587 -> en:brain mri shows signal abnormalities in the basal ganglia
    n1=en:white substance | n2=en:brain mri shows signal abnormalities in the basal ganglia | rel=r_associated | relid=0 | w=71
  4371. en:white substance -- r_associated #0: 71 / 0.587 -> en:central nervous system part
    n1=en:white substance | n2=en:central nervous system part | rel=r_associated | relid=0 | w=71
  4372. en:white substance -- r_associated #0: 71 / 0.587 -> en:cerebellar signs (more common in variant cjd)
    n1=en:white substance | n2=en:cerebellar signs (more common in variant cjd) | rel=r_associated | relid=0 | w=71
  4373. en:white substance -- r_associated #0: 71 / 0.587 -> en:characteristic periodic eeg complexes (only in sporadic and familial cjd, not in variant cjd)
    n1=en:white substance | n2=en:characteristic periodic eeg complexes (only in sporadic and familial cjd, not in variant cjd) | rel=r_associated | relid=0 | w=71
  4374. en:white substance -- r_associated #0: 71 / 0.587 -> en:cognitive impairment
    n1=en:white substance | n2=en:cognitive impairment | rel=r_associated | relid=0 | w=71
  4375. en:white substance -- r_associated #0: 71 / 0.587 -> en:cortical atrophy (rare)
    n1=en:white substance | n2=en:cortical atrophy (rare) | rel=r_associated | relid=0 | w=71
  4376. en:white substance -- r_associated #0: 71 / 0.587 -> en:depression
    n1=en:white substance | n2=en:depression | rel=r_associated | relid=0 | w=71
  4377. en:white substance -- r_associated #0: 71 / 0.587 -> en:diffuse leptomeningeal enhancement seen on mri
    n1=en:white substance | n2=en:diffuse leptomeningeal enhancement seen on mri | rel=r_associated | relid=0 | w=71
  4378. en:white substance -- r_associated #0: 71 / 0.587 -> en:generalized tonic-clonic seizures in 50%
    n1=en:white substance | n2=en:generalized tonic-clonic seizures in 50% | rel=r_associated | relid=0 | w=71
  4379. en:white substance -- r_associated #0: 71 / 0.587 -> en:hypodysplasia of the corpus callosum
    n1=en:white substance | n2=en:hypodysplasia of the corpus callosum | rel=r_associated | relid=0 | w=71
  4380. en:white substance -- r_associated #0: 71 / 0.587 -> en:large basal ganglia
    n1=en:white substance | n2=en:large basal ganglia | rel=r_associated | relid=0 | w=71
  4381. en:white substance -- r_associated #0: 71 / 0.587 -> en:mildly delayed developmental milestones
    n1=en:white substance | n2=en:mildly delayed developmental milestones | rel=r_associated | relid=0 | w=71
  4382. en:white substance -- r_associated #0: 71 / 0.587 -> en:no sensory deficit
    n1=en:white substance | n2=en:no sensory deficit | rel=r_associated | relid=0 | w=71
  4383. en:white substance -- r_associated #0: 71 / 0.587 -> en:no structural brain anomalies
    n1=en:white substance | n2=en:no structural brain anomalies | rel=r_associated | relid=0 | w=71
  4384. en:white substance -- r_associated #0: 71 / 0.587 -> en:residual ataxia
    n1=en:white substance | n2=en:residual ataxia | rel=r_associated | relid=0 | w=71
  4385. en:white substance -- r_associated #0: 71 / 0.587 -> en:seizures (reported in 1 family)
    n1=en:white substance | n2=en:seizures (reported in 1 family) | rel=r_associated | relid=0 | w=71
  4386. en:white substance -- r_associated #0: 71 / 0.587 -> en:seizures (reported in 2 patients)
    n1=en:white substance | n2=en:seizures (reported in 2 patients) | rel=r_associated | relid=0 | w=71
  4387. en:white substance -- r_associated #0: 71 / 0.587 -> en:seizures usually occur less than 3 times
    n1=en:white substance | n2=en:seizures usually occur less than 3 times | rel=r_associated | relid=0 | w=71
  4388. en:white substance -- r_associated #0: 71 / 0.587 -> en:small cerebellum
    n1=en:white substance | n2=en:small cerebellum | rel=r_associated | relid=0 | w=71
  4389. en:white substance -- r_associated #0: 71 / 0.587 -> en:smooth brain surface
    n1=en:white substance | n2=en:smooth brain surface | rel=r_associated | relid=0 | w=71
  4390. en:white substance -- r_associated #0: 71 / 0.587 -> en:social communication disorder
    n1=en:white substance | n2=en:social communication disorder | rel=r_associated | relid=0 | w=71
  4391. en:white substance -- r_associated #0: 71 / 0.587 -> en:spastic paraparesis (rare)
    n1=en:white substance | n2=en:spastic paraparesis (rare) | rel=r_associated | relid=0 | w=71
  4392. en:white substance -- r_associated #0: 71 / 0.587 -> en:tongue movements, protrusions
    n1=en:white substance | n2=en:tongue movements, protrusions | rel=r_associated | relid=0 | w=71
  4393. en:white substance -- r_associated #0: 71 / 0.587 -> en:white matter changes
    n1=en:white substance | n2=en:white matter changes | rel=r_associated | relid=0 | w=71
  4394. en:white substance -- r_associated #0: 70 / 0.579 -> tissu cellulaire
    n1=en:white substance | n2=tissu cellulaire | rel=r_associated | relid=0 | w=70
  4395. en:white substance -- r_associated #0: 70 / 0.579 -> tissu des nerfs
    n1=en:white substance | n2=tissu des nerfs | rel=r_associated | relid=0 | w=70
  4396. en:white substance -- r_associated #0: 67 / 0.554 -> en:white matter
    n1=en:white substance | n2=en:white matter | rel=r_associated | relid=0 | w=67
  4397. en:white substance -- r_associated #0: 66 / 0.545 -> en:agenesis or severe hypoplasia of cerebellar vermis
    n1=en:white substance | n2=en:agenesis or severe hypoplasia of cerebellar vermis | rel=r_associated | relid=0 | w=66
  4398. en:white substance -- r_associated #0: 66 / 0.545 -> en:articulatory defect
    n1=en:white substance | n2=en:articulatory defect | rel=r_associated | relid=0 | w=66
  4399. en:white substance -- r_associated #0: 66 / 0.545 -> en:atrophy of the spinal cord and cerebellar tracts
    n1=en:white substance | n2=en:atrophy of the spinal cord and cerebellar tracts | rel=r_associated | relid=0 | w=66
  4400. en:white substance -- r_associated #0: 66 / 0.545 -> en:axonal 'spheroid' inclusions
    n1=en:white substance | n2=en:axonal 'spheroid' inclusions | rel=r_associated | relid=0 | w=66
  4401. en:white substance -- r_associated #0: 66 / 0.545 -> en:begins in limbs, later generalized (childhood onset)
    n1=en:white substance | n2=en:begins in limbs, later generalized (childhood onset) | rel=r_associated | relid=0 | w=66
  4402. en:white substance -- r_associated #0: 66 / 0.545 -> en:brain stem disorder
    n1=en:white substance | n2=en:brain stem disorder | rel=r_associated | relid=0 | w=66
  4403. en:white substance -- r_associated #0: 66 / 0.545 -> en:cerebellar tonsillar herniation
    n1=en:white substance | n2=en:cerebellar tonsillar herniation | rel=r_associated | relid=0 | w=66
  4404. en:white substance -- r_associated #0: 66 / 0.545 -> en:cerebellum
    n1=en:white substance | n2=en:cerebellum | rel=r_associated | relid=0 | w=66
  4405. en:white substance -- r_associated #0: 66 / 0.545 -> en:cerebral arterial thrombosis
    n1=en:white substance | n2=en:cerebral arterial thrombosis | rel=r_associated | relid=0 | w=66
  4406. en:white substance -- r_associated #0: 66 / 0.545 -> en:complex partial seizure with impairment of consciousness
    n1=en:white substance | n2=en:complex partial seizure with impairment of consciousness | rel=r_associated | relid=0 | w=66
  4407. en:white substance -- r_associated #0: 66 / 0.545 -> en:confusion adverse event
    n1=en:white substance | n2=en:confusion adverse event | rel=r_associated | relid=0 | w=66
  4408. en:white substance -- r_associated #0: 66 / 0.545 -> en:congenital hypotonia, axial or generalized
    n1=en:white substance | n2=en:congenital hypotonia, axial or generalized | rel=r_associated | relid=0 | w=66
  4409. en:white substance -- r_associated #0: 66 / 0.545 -> en:congenital porencephaly
    n1=en:white substance | n2=en:congenital porencephaly | rel=r_associated | relid=0 | w=66
  4410. en:white substance -- r_associated #0: 66 / 0.545 -> en:decreased or absent motor evoked potentials (mep), indicating dysfunction of the corticospinal tracts
    n1=en:white substance | n2=en:decreased or absent motor evoked potentials (mep), indicating dysfunction of the corticospinal tracts | rel=r_associated | relid=0 | w=66
  4411. en:white substance -- r_associated #0: 66 / 0.545 -> en:decreased somatosensory-evoked potentials
    n1=en:white substance | n2=en:decreased somatosensory-evoked potentials | rel=r_associated | relid=0 | w=66
  4412. en:white substance -- r_associated #0: 66 / 0.545 -> en:deep white matter lesions, particularly affecting the frontal and parietal lobes
    n1=en:white substance | n2=en:deep white matter lesions, particularly affecting the frontal and parietal lobes | rel=r_associated | relid=0 | w=66
  4413. en:white substance -- r_associated #0: 66 / 0.545 -> en:delayed psychomotor development, profound (1 patient)
    n1=en:white substance | n2=en:delayed psychomotor development, profound (1 patient) | rel=r_associated | relid=0 | w=66
  4414. en:white substance -- r_associated #0: 66 / 0.545 -> en:delayed walking (rare)
    n1=en:white substance | n2=en:delayed walking (rare) | rel=r_associated | relid=0 | w=66
  4415. en:white substance -- r_associated #0: 66 / 0.545 -> en:dementia, progressive (more common in males)
    n1=en:white substance | n2=en:dementia, progressive (more common in males) | rel=r_associated | relid=0 | w=66
  4416. en:white substance -- r_associated #0: 66 / 0.545 -> en:demyelination
    n1=en:white substance | n2=en:demyelination | rel=r_associated | relid=0 | w=66
  4417. en:white substance -- r_associated #0: 66 / 0.545 -> en:developmental retardation, profound
    n1=en:white substance | n2=en:developmental retardation, profound | rel=r_associated | relid=0 | w=66
  4418. en:white substance -- r_associated #0: 66 / 0.545 -> en:difficulty running
    n1=en:white substance | n2=en:difficulty running | rel=r_associated | relid=0 | w=66
  4419. en:white substance -- r_associated #0: 66 / 0.545 -> en:dysmorphic basal ganglia (1 patient)
    n1=en:white substance | n2=en:dysmorphic basal ganglia (1 patient) | rel=r_associated | relid=0 | w=66
  4420. en:white substance -- r_associated #0: 66 / 0.545 -> en:eeg shows frontal lobe origin
    n1=en:white substance | n2=en:eeg shows frontal lobe origin | rel=r_associated | relid=0 | w=66
  4421. en:white substance -- r_associated #0: 66 / 0.545 -> en:embolism, cerebral
    n1=en:white substance | n2=en:embolism, cerebral | rel=r_associated | relid=0 | w=66
  4422. en:white substance -- r_associated #0: 66 / 0.545 -> en:epilepsy, frontal lobe
    n1=en:white substance | n2=en:epilepsy, frontal lobe | rel=r_associated | relid=0 | w=66
  4423. en:white substance -- r_associated #0: 66 / 0.545 -> en:extrapyramidal disorder
    n1=en:white substance | n2=en:extrapyramidal disorder | rel=r_associated | relid=0 | w=66
  4424. en:white substance -- r_associated #0: 66 / 0.545 -> en:extrapyramidal sign
    n1=en:white substance | n2=en:extrapyramidal sign | rel=r_associated | relid=0 | w=66
  4425. en:white substance -- r_associated #0: 66 / 0.545 -> en:fine motor task disruption
    n1=en:white substance | n2=en:fine motor task disruption | rel=r_associated | relid=0 | w=66
  4426. en:white substance -- r_associated #0: 66 / 0.545 -> en:focal dystonia, upper limb
    n1=en:white substance | n2=en:focal dystonia, upper limb | rel=r_associated | relid=0 | w=66
  4427. en:white substance -- r_associated #0: 66 / 0.545 -> en:focal microgyria
    n1=en:white substance | n2=en:focal microgyria | rel=r_associated | relid=0 | w=66
  4428. en:white substance -- r_associated #0: 66 / 0.545 -> en:focal tremor
    n1=en:white substance | n2=en:focal tremor | rel=r_associated | relid=0 | w=66
  4429. en:white substance -- r_associated #0: 66 / 0.545 -> en:focal, segmental or multifocal dystonia
    n1=en:white substance | n2=en:focal, segmental or multifocal dystonia | rel=r_associated | relid=0 | w=66
  4430. en:white substance -- r_associated #0: 66 / 0.545 -> en:frequency 6 hz in lateral gaze
    n1=en:white substance | n2=en:frequency 6 hz in lateral gaze | rel=r_associated | relid=0 | w=66
  4431. en:white substance -- r_associated #0: 66 / 0.545 -> en:frequent headache
    n1=en:white substance | n2=en:frequent headache | rel=r_associated | relid=0 | w=66
  4432. en:white substance -- r_associated #0: 66 / 0.545 -> en:frontotemporal pachygyria (1 patient)
    n1=en:white substance | n2=en:frontotemporal pachygyria (1 patient) | rel=r_associated | relid=0 | w=66
  4433. en:white substance -- r_associated #0: 66 / 0.545 -> en:generalized tonic-clonic seizures on awakening
    n1=en:white substance | n2=en:generalized tonic-clonic seizures on awakening | rel=r_associated | relid=0 | w=66
  4434. en:white substance -- r_associated #0: 66 / 0.545 -> en:globular basal ganglia (1 patient)
    n1=en:white substance | n2=en:globular basal ganglia (1 patient) | rel=r_associated | relid=0 | w=66
  4435. en:white substance -- r_associated #0: 66 / 0.545 -> en:gross motor delay, mild
    n1=en:white substance | n2=en:gross motor delay, mild | rel=r_associated | relid=0 | w=66
  4436. en:white substance -- r_associated #0: 66 / 0.545 -> en:hamartomatous lesions of the brain
    n1=en:white substance | n2=en:hamartomatous lesions of the brain | rel=r_associated | relid=0 | w=66
  4437. en:white substance -- r_associated #0: 66 / 0.545 -> en:hypoplasia of the pons
    n1=en:white substance | n2=en:hypoplasia of the pons | rel=r_associated | relid=0 | w=66
  4438. en:white substance -- r_associated #0: 66 / 0.545 -> en:hypotonia (early infancy)
    n1=en:white substance | n2=en:hypotonia (early infancy) | rel=r_associated | relid=0 | w=66
  4439. en:white substance -- r_associated #0: 66 / 0.545 -> en:hypotonia, global, severe
    n1=en:white substance | n2=en:hypotonia, global, severe | rel=r_associated | relid=0 | w=66
  4440. en:white substance -- r_associated #0: 66 / 0.545 -> en:hypotonia, poor moro reflex
    n1=en:white substance | n2=en:hypotonia, poor moro reflex | rel=r_associated | relid=0 | w=66
  4441. en:white substance -- r_associated #0: 66 / 0.545 -> en:impaired language development
    n1=en:white substance | n2=en:impaired language development | rel=r_associated | relid=0 | w=66
  4442. en:white substance -- r_associated #0: 66 / 0.545 -> en:impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures
    n1=en:white substance | n2=en:impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures | rel=r_associated | relid=0 | w=66
  4443. en:white substance -- r_associated #0: 66 / 0.545 -> en:increased iron deposition in the basal ganglia
    n1=en:white substance | n2=en:increased iron deposition in the basal ganglia | rel=r_associated | relid=0 | w=66
  4444. en:white substance -- r_associated #0: 66 / 0.545 -> en:inflexible adherence to routines or rituals
    n1=en:white substance | n2=en:inflexible adherence to routines or rituals | rel=r_associated | relid=0 | w=66
  4445. en:white substance -- r_associated #0: 66 / 0.545 -> en:intellectual disability, progressive
    n1=en:white substance | n2=en:intellectual disability, progressive | rel=r_associated | relid=0 | w=66
  4446. en:white substance -- r_associated #0: 66 / 0.545 -> en:iq 85-115 (female)
    n1=en:white substance | n2=en:iq 85-115 (female) | rel=r_associated | relid=0 | w=66
  4447. en:white substance -- r_associated #0: 66 / 0.545 -> en:kearns-sayre syndrome (530000), in a subset of patients
    n1=en:white substance | n2=en:kearns-sayre syndrome (530000), in a subset of patients | rel=r_associated | relid=0 | w=66
  4448. en:white substance -- r_associated #0: 66 / 0.545 -> en:knee and ankle clonus
    n1=en:white substance | n2=en:knee and ankle clonus | rel=r_associated | relid=0 | w=66
  4449. en:white substance -- r_associated #0: 66 / 0.545 -> en:lesions in the internal capsule after age 40 years
    n1=en:white substance | n2=en:lesions in the internal capsule after age 40 years | rel=r_associated | relid=0 | w=66
  4450. en:white substance -- r_associated #0: 66 / 0.545 -> en:lesions show signal increase on t2- and signal decrease on t1-weighted images
    n1=en:white substance | n2=en:lesions show signal increase on t2- and signal decrease on t1-weighted images | rel=r_associated | relid=0 | w=66
  4451. en:white substance -- r_associated #0: 66 / 0.545 -> en:loss of cerebral white matter (in 1 of 3 patients)
    n1=en:white substance | n2=en:loss of cerebral white matter (in 1 of 3 patients) | rel=r_associated | relid=0 | w=66
  4452. en:white substance -- r_associated #0: 66 / 0.545 -> en:loss of deep tendon reflexes (later)
    n1=en:white substance | n2=en:loss of deep tendon reflexes (later) | rel=r_associated | relid=0 | w=66
  4453. en:white substance -- r_associated #0: 66 / 0.545 -> en:loss of independent ambulation
    n1=en:white substance | n2=en:loss of independent ambulation | rel=r_associated | relid=0 | w=66
  4454. en:white substance -- r_associated #0: 66 / 0.545 -> en:loss of myelin and oligodendroglia
    n1=en:white substance | n2=en:loss of myelin and oligodendroglia | rel=r_associated | relid=0 | w=66
  4455. en:white substance -- r_associated #0: 66 / 0.545 -> en:malformation of the insula
    n1=en:white substance | n2=en:malformation of the insula | rel=r_associated | relid=0 | w=66
  4456. en:white substance -- r_associated #0: 66 / 0.545 -> en:memory defects
    n1=en:white substance | n2=en:memory defects | rel=r_associated | relid=0 | w=66
  4457. en:white substance -- r_associated #0: 66 / 0.545 -> en:mental retardation (20%)
    n1=en:white substance | n2=en:mental retardation (20%) | rel=r_associated | relid=0 | w=66
  4458. en:white substance -- r_associated #0: 66 / 0.545 -> en:mental retardation (range mild to severe)
    n1=en:white substance | n2=en:mental retardation (range mild to severe) | rel=r_associated | relid=0 | w=66
  4459. en:white substance -- r_associated #0: 66 / 0.545 -> en:migraine headaches (ipsilateral to facial hemangioma)
    n1=en:white substance | n2=en:migraine headaches (ipsilateral to facial hemangioma) | rel=r_associated | relid=0 | w=66
  4460. en:white substance -- r_associated #0: 66 / 0.545 -> en:mild distal sensory deficits
    n1=en:white substance | n2=en:mild distal sensory deficits | rel=r_associated | relid=0 | w=66
  4461. en:white substance -- r_associated #0: 66 / 0.545 -> en:mild paraparesis
    n1=en:white substance | n2=en:mild paraparesis | rel=r_associated | relid=0 | w=66
  4462. en:white substance -- r_associated #0: 66 / 0.545 -> en:multifocal white matter lesions
    n1=en:white substance | n2=en:multifocal white matter lesions | rel=r_associated | relid=0 | w=66
  4463. en:white substance -- r_associated #0: 66 / 0.545 -> en:muscle cramp
    n1=en:white substance | n2=en:muscle cramp | rel=r_associated | relid=0 | w=66
  4464. en:white substance -- r_associated #0: 66 / 0.545 -> en:myoclonus (type i and type ii, infantile and juvenile)
    n1=en:white substance | n2=en:myoclonus (type i and type ii, infantile and juvenile) | rel=r_associated | relid=0 | w=66
  4465. en:white substance -- r_associated #0: 66 / 0.545 -> en:neurodevelopmental impairment (early-onset form)
    n1=en:white substance | n2=en:neurodevelopmental impairment (early-onset form) | rel=r_associated | relid=0 | w=66
  4466. en:white substance -- r_associated #0: 66 / 0.545 -> en:neurologic involvement is rare
    n1=en:white substance | n2=en:neurologic involvement is rare | rel=r_associated | relid=0 | w=66
  4467. en:white substance -- r_associated #0: 66 / 0.545 -> en:neurologic regression around age 3 months
    n1=en:white substance | n2=en:neurologic regression around age 3 months | rel=r_associated | relid=0 | w=66
  4468. en:white substance -- r_associated #0: 66 / 0.545 -> en:no cerebellar vermis aplasia/hypoplasia
    n1=en:white substance | n2=en:no cerebellar vermis aplasia/hypoplasia | rel=r_associated | relid=0 | w=66
  4469. en:white substance -- r_associated #0: 66 / 0.545 -> en:normal cognition (in some patients)
    n1=en:white substance | n2=en:normal cognition (in some patients) | rel=r_associated | relid=0 | w=66
  4470. en:white substance -- r_associated #0: 66 / 0.545 -> en:open operculum
    n1=en:white substance | n2=en:open operculum | rel=r_associated | relid=0 | w=66
  4471. en:white substance -- r_associated #0: 66 / 0.545 -> en:pachygyria, frontoparietal
    n1=en:white substance | n2=en:pachygyria, frontoparietal | rel=r_associated | relid=0 | w=66
  4472. en:white substance -- r_associated #0: 66 / 0.545 -> en:paradoxical cerebral emboli
    n1=en:white substance | n2=en:paradoxical cerebral emboli | rel=r_associated | relid=0 | w=66
  4473. en:white substance -- r_associated #0: 66 / 0.545 -> en:paraplegia
    n1=en:white substance | n2=en:paraplegia | rel=r_associated | relid=0 | w=66
  4474. en:white substance -- r_associated #0: 66 / 0.545 -> en:patients may develop a seizure disorder later in life
    n1=en:white substance | n2=en:patients may develop a seizure disorder later in life | rel=r_associated | relid=0 | w=66
  4475. en:white substance -- r_associated #0: 66 / 0.545 -> en:periventricular leukomalacia
    n1=en:white substance | n2=en:periventricular leukomalacia | rel=r_associated | relid=0 | w=66
  4476. en:white substance -- r_associated #0: 66 / 0.545 -> en:pons damage
    n1=en:white substance | n2=en:pons damage | rel=r_associated | relid=0 | w=66
  4477. en:white substance -- r_associated #0: 66 / 0.545 -> en:poor language
    n1=en:white substance | n2=en:poor language | rel=r_associated | relid=0 | w=66
  4478. en:white substance -- r_associated #0: 66 / 0.545 -> en:porencephalic changes
    n1=en:white substance | n2=en:porencephalic changes | rel=r_associated | relid=0 | w=66
  4479. en:white substance -- r_associated #0: 66 / 0.545 -> en:progressive white matter lesions in the brain
    n1=en:white substance | n2=en:progressive white matter lesions in the brain | rel=r_associated | relid=0 | w=66
  4480. en:white substance -- r_associated #0: 66 / 0.545 -> en:psychomotor arrest and regression
    n1=en:white substance | n2=en:psychomotor arrest and regression | rel=r_associated | relid=0 | w=66
  4481. en:white substance -- r_associated #0: 66 / 0.545 -> en:relative preservation of the cerebellar folia
    n1=en:white substance | n2=en:relative preservation of the cerebellar folia | rel=r_associated | relid=0 | w=66
  4482. en:white substance -- r_associated #0: 66 / 0.545 -> en:retrocerebellar cyst
    n1=en:white substance | n2=en:retrocerebellar cyst | rel=r_associated | relid=0 | w=66
  4483. en:white substance -- r_associated #0: 66 / 0.545 -> en:seizures (40%)
    n1=en:white substance | n2=en:seizures (40%) | rel=r_associated | relid=0 | w=66
  4484. en:white substance -- r_associated #0: 66 / 0.545 -> en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause
    n1=en:white substance | n2=en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause | rel=r_associated | relid=0 | w=66
  4485. en:white substance -- r_associated #0: 66 / 0.545 -> en:seizures, febrile (1 family)
    n1=en:white substance | n2=en:seizures, febrile (1 family) | rel=r_associated | relid=0 | w=66
  4486. en:white substance -- r_associated #0: 66 / 0.545 -> en:seizures, severe, intractable
    n1=en:white substance | n2=en:seizures, severe, intractable | rel=r_associated | relid=0 | w=66
  4487. en:white substance -- r_associated #0: 66 / 0.545 -> en:slow paraparetic gait
    n1=en:white substance | n2=en:slow paraparetic gait | rel=r_associated | relid=0 | w=66
  4488. en:white substance -- r_associated #0: 66 / 0.545 -> en:small anterior commissure
    n1=en:white substance | n2=en:small anterior commissure | rel=r_associated | relid=0 | w=66
  4489. en:white substance -- r_associated #0: 66 / 0.545 -> en:spasticity, usually of the lower limbs
    n1=en:white substance | n2=en:spasticity, usually of the lower limbs | rel=r_associated | relid=0 | w=66
  4490. en:white substance -- r_associated #0: 66 / 0.545 -> en:speech and language delay (rare)
    n1=en:white substance | n2=en:speech and language delay (rare) | rel=r_associated | relid=0 | w=66
  4491. en:white substance -- r_associated #0: 66 / 0.545 -> en:speech disorder (in 1 of 6 patients)
    n1=en:white substance | n2=en:speech disorder (in 1 of 6 patients) | rel=r_associated | relid=0 | w=66
  4492. en:white substance -- r_associated #0: 66 / 0.545 -> en:spheroids contain neurofilaments
    n1=en:white substance | n2=en:spheroids contain neurofilaments | rel=r_associated | relid=0 | w=66
  4493. en:white substance -- r_associated #0: 66 / 0.545 -> en:subcortical nodular lesions in perivascular white matter
    n1=en:white substance | n2=en:subcortical nodular lesions in perivascular white matter | rel=r_associated | relid=0 | w=66
  4494. en:white substance -- r_associated #0: 66 / 0.545 -> en:thinning of the cerebellopontine tracts
    n1=en:white substance | n2=en:thinning of the cerebellopontine tracts | rel=r_associated | relid=0 | w=66
  4495. en:white substance -- r_associated #0: 66 / 0.545 -> en:torsion dystonia (involuntary sustained muscle contractions, twisting and repetitive movements, abnormal posturing)
    n1=en:white substance | n2=en:torsion dystonia (involuntary sustained muscle contractions, twisting and repetitive movements, abnormal posturing) | rel=r_associated | relid=0 | w=66
  4496. en:white substance -- r_associated #0: 66 / 0.545 -> en:tremor due to hyperthyroidism
    n1=en:white substance | n2=en:tremor due to hyperthyroidism | rel=r_associated | relid=0 | w=66
  4497. en:white substance -- r_associated #0: 66 / 0.545 -> en:trigeminal anesthesia
    n1=en:white substance | n2=en:trigeminal anesthesia | rel=r_associated | relid=0 | w=66
  4498. en:white substance -- r_associated #0: 66 / 0.545 -> en:upper and lower motor neuron disease
    n1=en:white substance | n2=en:upper and lower motor neuron disease | rel=r_associated | relid=0 | w=66
  4499. en:white substance -- r_associated #0: 66 / 0.545 -> en:upper limb spasticity, mild
    n1=en:white substance | n2=en:upper limb spasticity, mild | rel=r_associated | relid=0 | w=66
  4500. en:white substance -- r_associated #0: 66 / 0.545 -> en:vestibular dysfunction, mild
    n1=en:white substance | n2=en:vestibular dysfunction, mild | rel=r_associated | relid=0 | w=66
  4501. en:white substance -- r_associated #0: 66 / 0.545 -> substance blanche
    n1=en:white substance | n2=substance blanche | rel=r_associated | relid=0 | w=66
  4502. en:white substance -- r_associated #0: 65 / 0.537 -> en:white material
    n1=en:white substance | n2=en:white material | rel=r_associated | relid=0 | w=65
  4503. en:white substance -- r_associated #0: 65 / 0.537 -> substance noire
    n1=en:white substance | n2=substance noire | rel=r_associated | relid=0 | w=65
  4504. en:white substance -- r_associated #0: 65 / 0.537 -> système nerveux central
    n1=en:white substance | n2=système nerveux central | rel=r_associated | relid=0 | w=65
  4505. en:white substance -- r_associated #0: 64 / 0.529 -> encéphale
    n1=en:white substance | n2=encéphale | rel=r_associated | relid=0 | w=64
  4506. en:white substance -- r_associated #0: 63 / 0.521 -> en:septum pellucidum
    n1=en:white substance | n2=en:septum pellucidum | rel=r_associated | relid=0 | w=63
  4507. en:white substance -- r_associated #0: 62 / 0.512 -> fibres nerveuses
    n1=en:white substance | n2=fibres nerveuses | rel=r_associated | relid=0 | w=62
  4508. en:white substance -- r_associated #0: 61 / 0.504 -> en:cns infarctions
    n1=en:white substance | n2=en:cns infarctions | rel=r_associated | relid=0 | w=61
  4509. en:white substance -- r_associated #0: 61 / 0.504 -> en:spinal cord compression
    n1=en:white substance | n2=en:spinal cord compression | rel=r_associated | relid=0 | w=61
  4510. en:white substance -- r_associated #0: 60 / 0.496 -> septum pellucidum
    n1=en:white substance | n2=septum pellucidum | rel=r_associated | relid=0 | w=60
  4511. en:white substance -- r_associated #0: 60 / 0.496 -> substance blanche de la moelle spinale
    n1=en:white substance | n2=substance blanche de la moelle spinale | rel=r_associated | relid=0 | w=60
  4512. en:white substance -- r_associated #0: 57 / 0.471 -> en:substantia alba
    n1=en:white substance | n2=en:substantia alba | rel=r_associated | relid=0 | w=57
  4513. en:white substance -- r_associated #0: 45 / 0.372 -> médecine
    n1=en:white substance | n2=médecine | rel=r_associated | relid=0 | w=45
  4514. en:white substance -- r_associated #0: 35 / 0.289 -> substance blanche de la moelle allongée
    n1=en:white substance | n2=substance blanche de la moelle allongée | rel=r_associated | relid=0 | w=35
  4515. en:white substance -- r_associated #0: 33 / 0.273 -> en:medicine
    n1=en:white substance | n2=en:medicine | rel=r_associated | relid=0 | w=33
  4516. en:white substance -- r_associated #0: 27 / 0.223 -> en:neurologia
    n1=en:white substance | n2=en:neurologia | rel=r_associated | relid=0 | w=27
  4517. en:white substance -- r_associated #0: 25 / 0.207 -> en:white
    n1=en:white substance | n2=en:white | rel=r_associated | relid=0 | w=25
  4518. en:white substance -- r_associated #0: 20 / 0.165 -> Substance blanche
    n1=en:white substance | n2=Substance blanche | rel=r_associated | relid=0 | w=20
  4519. en:white substance -- r_associated #0: 15 / 0.124 -> matière grise
    n1=en:white substance | n2=matière grise | rel=r_associated | relid=0 | w=15
  4520. en:white substance -- r_associated #0: 15 / 0.124 -> nerfs
    n1=en:white substance | n2=nerfs | rel=r_associated | relid=0 | w=15
  4521. en:white substance -- r_associated #0: 10 / 0.083 -> abcès cérébral
    n1=en:white substance | n2=abcès cérébral | rel=r_associated | relid=0 | w=10
  4522. en:white substance -- r_associated #0: 10 / 0.083 -> abcès du cerveau
    n1=en:white substance | n2=abcès du cerveau | rel=r_associated | relid=0 | w=10
  4523. en:white substance -- r_associated #0: 10 / 0.083 -> abcès intracérébral
    n1=en:white substance | n2=abcès intracérébral | rel=r_associated | relid=0 | w=10
  4524. en:white substance -- r_associated #0: 10 / 0.083 -> accès fébriles
    n1=en:white substance | n2=accès fébriles | rel=r_associated | relid=0 | w=10
  4525. en:white substance -- r_associated #0: 10 / 0.083 -> accident cérébro-vasculaire
    n1=en:white substance | n2=accident cérébro-vasculaire | rel=r_associated | relid=0 | w=10
  4526. en:white substance -- r_associated #0: 10 / 0.083 -> accident cérébrovasculaire
    n1=en:white substance | n2=accident cérébrovasculaire | rel=r_associated | relid=0 | w=10
  4527. en:white substance -- r_associated #0: 10 / 0.083 -> accident ischémique cérébral
    n1=en:white substance | n2=accident ischémique cérébral | rel=r_associated | relid=0 | w=10
  4528. en:white substance -- r_associated #0: 10 / 0.083 -> accident vasculaire cérébral
    n1=en:white substance | n2=accident vasculaire cérébral | rel=r_associated | relid=0 | w=10
  4529. en:white substance -- r_associated #0: 10 / 0.083 -> Accident Vasculaire Cérébral
    n1=en:white substance | n2=Accident Vasculaire Cérébral | rel=r_associated | relid=0 | w=10
  4530. en:white substance -- r_associated #0: 10 / 0.083 -> accidents vasculaires cérébraux
    n1=en:white substance | n2=accidents vasculaires cérébraux | rel=r_associated | relid=0 | w=10
  4531. en:white substance -- r_associated #0: 10 / 0.083 -> action d'émousser
    n1=en:white substance | n2=action d'émousser | rel=r_associated | relid=0 | w=10
  4532. en:white substance -- r_associated #0: 10 / 0.083 -> ACV
    n1=en:white substance | n2=ACV | rel=r_associated | relid=0 | w=10
  4533. en:white substance -- r_associated #0: 10 / 0.083 -> affection du neurone moteur
    n1=en:white substance | n2=affection du neurone moteur | rel=r_associated | relid=0 | w=10
  4534. en:white substance -- r_associated #0: 10 / 0.083 -> aggression
    n1=en:white substance | n2=aggression | rel=r_associated | relid=0 | w=10
  4535. en:white substance -- r_associated #0: 10 / 0.083 -> agnosie
    n1=en:white substance | n2=agnosie | rel=r_associated | relid=0 | w=10
  4536. en:white substance -- r_associated #0: 10 / 0.083 -> agression
    n1=en:white substance | n2=agression | rel=r_associated | relid=0 | w=10
  4537. en:white substance -- r_associated #0: 10 / 0.083 -> aller au tapis
    n1=en:white substance | n2=aller au tapis | rel=r_associated | relid=0 | w=10
  4538. en:white substance -- r_associated #0: 10 / 0.083 -> altération de la conscience
    n1=en:white substance | n2=altération de la conscience | rel=r_associated | relid=0 | w=10
  4539. en:white substance -- r_associated #0: 10 / 0.083 -> altération mentale
    n1=en:white substance | n2=altération mentale | rel=r_associated | relid=0 | w=10
  4540. en:white substance -- r_associated #0: 10 / 0.083 -> amenuiser [qch]
    n1=en:white substance | n2=amenuiser [qch] | rel=r_associated | relid=0 | w=10
  4541. en:white substance -- r_associated #0: 10 / 0.083 -> amenuiser quelque chose
    n1=en:white substance | n2=amenuiser quelque chose | rel=r_associated | relid=0 | w=10
  4542. en:white substance -- r_associated #0: 10 / 0.083 -> amoindrir
    n1=en:white substance | n2=amoindrir | rel=r_associated | relid=0 | w=10
  4543. en:white substance -- r_associated #0: 10 / 0.083 -> amyotrophie
    n1=en:white substance | n2=amyotrophie | rel=r_associated | relid=0 | w=10
  4544. en:white substance -- r_associated #0: 10 / 0.083 -> anencéphalie
    n1=en:white substance | n2=anencéphalie | rel=r_associated | relid=0 | w=10
  4545. en:white substance -- r_associated #0: 10 / 0.083 -> apoplexie
    n1=en:white substance | n2=apoplexie | rel=r_associated | relid=0 | w=10
  4546. en:white substance -- r_associated #0: 10 / 0.083 -> apoplexie cérébrale
    n1=en:white substance | n2=apoplexie cérébrale | rel=r_associated | relid=0 | w=10
  4547. en:white substance -- r_associated #0: 10 / 0.083 -> aréflexie
    n1=en:white substance | n2=aréflexie | rel=r_associated | relid=0 | w=10
  4548. en:white substance -- r_associated #0: 10 / 0.083 -> arrêt cardio-circulatoire
    n1=en:white substance | n2=arrêt cardio-circulatoire | rel=r_associated | relid=0 | w=10
  4549. en:white substance -- r_associated #0: 10 / 0.083 -> arrêt cardiocirculatoire
    n1=en:white substance | n2=arrêt cardiocirculatoire | rel=r_associated | relid=0 | w=10
  4550. en:white substance -- r_associated #0: 10 / 0.083 -> arrêt des contractions du coeur
    n1=en:white substance | n2=arrêt des contractions du coeur | rel=r_associated | relid=0 | w=10
  4551. en:white substance -- r_associated #0: 10 / 0.083 -> arriération
    n1=en:white substance | n2=arriération | rel=r_associated | relid=0 | w=10
  4552. en:white substance -- r_associated #0: 10 / 0.083 -> arriération mentale
    n1=en:white substance | n2=arriération mentale | rel=r_associated | relid=0 | w=10
  4553. en:white substance -- r_associated #0: 10 / 0.083 -> asphyxia
    n1=en:white substance | n2=asphyxia | rel=r_associated | relid=0 | w=10
  4554. en:white substance -- r_associated #0: 10 / 0.083 -> asphyxie
    n1=en:white substance | n2=asphyxie | rel=r_associated | relid=0 | w=10
  4555. en:white substance -- r_associated #0: 10 / 0.083 -> asthénie neuro-circulatoire
    n1=en:white substance | n2=asthénie neuro-circulatoire | rel=r_associated | relid=0 | w=10
  4556. en:white substance -- r_associated #0: 10 / 0.083 -> asthénie neurocirculatoire
    n1=en:white substance | n2=asthénie neurocirculatoire | rel=r_associated | relid=0 | w=10
  4557. en:white substance -- r_associated #0: 10 / 0.083 -> astrocyte
    n1=en:white substance | n2=astrocyte | rel=r_associated | relid=0 | w=10
  4558. en:white substance -- r_associated #0: 10 / 0.083 -> astroglie
    n1=en:white substance | n2=astroglie | rel=r_associated | relid=0 | w=10
  4559. en:white substance -- r_associated #0: 10 / 0.083 -> astroglies
    n1=en:white substance | n2=astroglies | rel=r_associated | relid=0 | w=10
  4560. en:white substance -- r_associated #0: 10 / 0.083 -> asystole
    n1=en:white substance | n2=asystole | rel=r_associated | relid=0 | w=10
  4561. en:white substance -- r_associated #0: 10 / 0.083 -> asystolie ventriculaire
    n1=en:white substance | n2=asystolie ventriculaire | rel=r_associated | relid=0 | w=10
  4562. en:white substance -- r_associated #0: 10 / 0.083 -> ataxies
    n1=en:white substance | n2=ataxies | rel=r_associated | relid=0 | w=10
  4563. en:white substance -- r_associated #0: 10 / 0.083 -> atrophie des muscles
    n1=en:white substance | n2=atrophie des muscles | rel=r_associated | relid=0 | w=10
  4564. en:white substance -- r_associated #0: 10 / 0.083 -> atrophie musculaire
    n1=en:white substance | n2=atrophie musculaire | rel=r_associated | relid=0 | w=10
  4565. en:white substance -- r_associated #0: 10 / 0.083 -> attaque apoplectique
    n1=en:white substance | n2=attaque apoplectique | rel=r_associated | relid=0 | w=10
  4566. en:white substance -- r_associated #0: 10 / 0.083 -> attaque d'apoplexie
    n1=en:white substance | n2=attaque d'apoplexie | rel=r_associated | relid=0 | w=10
  4567. en:white substance -- r_associated #0: 10 / 0.083 -> au black
    n1=en:white substance | n2=au black | rel=r_associated | relid=0 | w=10
  4568. en:white substance -- r_associated #0: 10 / 0.083 -> au noir
    n1=en:white substance | n2=au noir | rel=r_associated | relid=0 | w=10
  4569. en:white substance -- r_associated #0: 10 / 0.083 -> autisme
    n1=en:white substance | n2=autisme | rel=r_associated | relid=0 | w=10
  4570. en:white substance -- r_associated #0: 10 / 0.083 -> AVC
    n1=en:white substance | n2=AVC | rel=r_associated | relid=0 | w=10
  4571. en:white substance -- r_associated #0: 10 / 0.083 -> AVC
    (médecine)
    n1=en:white substance | n2=AVC
    (médecine)
    | rel=r_associated | relid=0 | w=10
  4572. en:white substance -- r_associated #0: 10 / 0.083 -> barrière hémato-encéphalique
    n1=en:white substance | n2=barrière hémato-encéphalique | rel=r_associated | relid=0 | w=10
  4573. en:white substance -- r_associated #0: 10 / 0.083 -> belligérance
    n1=en:white substance | n2=belligérance | rel=r_associated | relid=0 | w=10
  4574. en:white substance -- r_associated #0: 10 / 0.083 -> black-blanc-beur
    n1=en:white substance | n2=black-blanc-beur | rel=r_associated | relid=0 | w=10
  4575. en:white substance -- r_associated #0: 10 / 0.083 -> black-out
    n1=en:white substance | n2=black-out | rel=r_associated | relid=0 | w=10
  4576. en:white substance -- r_associated #0: 10 / 0.083 -> blindness
    n1=en:white substance | n2=blindness | rel=r_associated | relid=0 | w=10
  4577. en:white substance -- r_associated #0: 10 / 0.083 -> brain
    n1=en:white substance | n2=brain | rel=r_associated | relid=0 | w=10
  4578. en:white substance -- r_associated #0: 10 / 0.083 -> cataplexie
    n1=en:white substance | n2=cataplexie | rel=r_associated | relid=0 | w=10
  4579. en:white substance -- r_associated #0: 10 / 0.083 -> cataracte-atrophie du cervelet-myopathie
    n1=en:white substance | n2=cataracte-atrophie du cervelet-myopathie | rel=r_associated | relid=0 | w=10
  4580. en:white substance -- r_associated #0: 10 / 0.083 -> cécité
    n1=en:white substance | n2=cécité | rel=r_associated | relid=0 | w=10
  4581. en:white substance -- r_associated #0: 10 / 0.083 -> Cellule gliale
    n1=en:white substance | n2=Cellule gliale | rel=r_associated | relid=0 | w=10
  4582. en:white substance -- r_associated #0: 10 / 0.083 -> cellule gliale
    n1=en:white substance | n2=cellule gliale | rel=r_associated | relid=0 | w=10
  4583. en:white substance -- r_associated #0: 10 / 0.083 -> cerveau antérieur
    n1=en:white substance | n2=cerveau antérieur | rel=r_associated | relid=0 | w=10
  4584. en:white substance -- r_associated #0: 10 / 0.083 -> cerveaux
    n1=en:white substance | n2=cerveaux | rel=r_associated | relid=0 | w=10
  4585. en:white substance -- r_associated #0: 10 / 0.083 -> Cerveaux
    n1=en:white substance | n2=Cerveaux | rel=r_associated | relid=0 | w=10
  4586. en:white substance -- r_associated #0: 10 / 0.083 -> choc cardiogène
    n1=en:white substance | n2=choc cardiogène | rel=r_associated | relid=0 | w=10
  4587. en:white substance -- r_associated #0: 10 / 0.083 -> choc cardiogénique
    n1=en:white substance | n2=choc cardiogénique | rel=r_associated | relid=0 | w=10
  4588. en:white substance -- r_associated #0: 10 / 0.083 -> choc compliquant ou consécutif à travail et accouchement
    n1=en:white substance | n2=choc compliquant ou consécutif à travail et accouchement | rel=r_associated | relid=0 | w=10
  4589. en:white substance -- r_associated #0: 10 / 0.083 -> collapsus cardiovasculaire
    n1=en:white substance | n2=collapsus cardiovasculaire | rel=r_associated | relid=0 | w=10
  4590. en:white substance -- r_associated #0: 10 / 0.083 -> colpocéphalie
    n1=en:white substance | n2=colpocéphalie | rel=r_associated | relid=0 | w=10
  4591. en:white substance -- r_associated #0: 10 / 0.083 -> coma hépatique
    n1=en:white substance | n2=coma hépatique | rel=r_associated | relid=0 | w=10
  4592. en:white substance -- r_associated #0: 10 / 0.083 -> coma hypoglycémique
    n1=en:white substance | n2=coma hypoglycémique | rel=r_associated | relid=0 | w=10
  4593. en:white substance -- r_associated #0: 10 / 0.083 -> comportement antisocial
    n1=en:white substance | n2=comportement antisocial | rel=r_associated | relid=0 | w=10
  4594. en:white substance -- r_associated #0: 10 / 0.083 -> conarium
    n1=en:white substance | n2=conarium | rel=r_associated | relid=0 | w=10
  4595. en:white substance -- r_associated #0: 10 / 0.083 -> cône médullaire
    n1=en:white substance | n2=cône médullaire | rel=r_associated | relid=0 | w=10
  4596. en:white substance -- r_associated #0: 10 / 0.083 -> congestion cérébrale
    n1=en:white substance | n2=congestion cérébrale | rel=r_associated | relid=0 | w=10
  4597. en:white substance -- r_associated #0: 10 / 0.083 -> contraction clonique
    n1=en:white substance | n2=contraction clonique | rel=r_associated | relid=0 | w=10
  4598. en:white substance -- r_associated #0: 10 / 0.083 -> convulsions fébriles
    n1=en:white substance | n2=convulsions fébriles | rel=r_associated | relid=0 | w=10
  4599. en:white substance -- r_associated #0: 10 / 0.083 -> cordon médullaire
    n1=en:white substance | n2=cordon médullaire | rel=r_associated | relid=0 | w=10
  4600. en:white substance -- r_associated #0: 10 / 0.083 -> cordon nerveux
    n1=en:white substance | n2=cordon nerveux | rel=r_associated | relid=0 | w=10
  4601. en:white substance -- r_associated #0: 10 / 0.083 -> corps pinéal
    n1=en:white substance | n2=corps pinéal | rel=r_associated | relid=0 | w=10
  4602. en:white substance -- r_associated #0: 10 / 0.083 -> coupure d'alimentation
    n1=en:white substance | n2=coupure d'alimentation | rel=r_associated | relid=0 | w=10
  4603. en:white substance -- r_associated #0: 10 / 0.083 -> coupure d'électricité
    n1=en:white substance | n2=coupure d'électricité | rel=r_associated | relid=0 | w=10
  4604. en:white substance -- r_associated #0: 10 / 0.083 -> coupure de courant
    n1=en:white substance | n2=coupure de courant | rel=r_associated | relid=0 | w=10
  4605. en:white substance -- r_associated #0: 10 / 0.083 -> crise d'épilepsie grand mal
    n1=en:white substance | n2=crise d'épilepsie grand mal | rel=r_associated | relid=0 | w=10
  4606. en:white substance -- r_associated #0: 10 / 0.083 -> crise de grand mal
    n1=en:white substance | n2=crise de grand mal | rel=r_associated | relid=0 | w=10
  4607. en:white substance -- r_associated #0: 10 / 0.083 -> crise épileptique de grand mal
    n1=en:white substance | n2=crise épileptique de grand mal | rel=r_associated | relid=0 | w=10
  4608. en:white substance -- r_associated #0: 10 / 0.083 -> crises fébriles
    n1=en:white substance | n2=crises fébriles | rel=r_associated | relid=0 | w=10
  4609. en:white substance -- r_associated #0: 10 / 0.083 -> cyclothymie
    n1=en:white substance | n2=cyclothymie | rel=r_associated | relid=0 | w=10
  4610. en:white substance -- r_associated #0: 10 / 0.083 -> d'automne
    n1=en:white substance | n2=d'automne | rel=r_associated | relid=0 | w=10
  4611. en:white substance -- r_associated #0: 10 / 0.083 -> débilité mentale
    n1=en:white substance | n2=débilité mentale | rel=r_associated | relid=0 | w=10
  4612. en:white substance -- r_associated #0: 10 / 0.083 -> décroître
    n1=en:white substance | n2=décroître | rel=r_associated | relid=0 | w=10
  4613. en:white substance -- r_associated #0: 10 / 0.083 -> déficience intellectuelle
    n1=en:white substance | n2=déficience intellectuelle | rel=r_associated | relid=0 | w=10
  4614. en:white substance -- r_associated #0: 10 / 0.083 -> déficience mentale
    n1=en:white substance | n2=déficience mentale | rel=r_associated | relid=0 | w=10
  4615. en:white substance -- r_associated #0: 10 / 0.083 -> déficience visuelle
    n1=en:white substance | n2=déficience visuelle | rel=r_associated | relid=0 | w=10
  4616. en:white substance -- r_associated #0: 10 / 0.083 -> dégénérescence granulovacuolaire
    n1=en:white substance | n2=dégénérescence granulovacuolaire | rel=r_associated | relid=0 | w=10
  4617. en:white substance -- r_associated #0: 10 / 0.083 -> dégénérescence spongieuse
    n1=en:white substance | n2=dégénérescence spongieuse | rel=r_associated | relid=0 | w=10
  4618. en:white substance -- r_associated #0: 10 / 0.083 -> demence
    n1=en:white substance | n2=demence | rel=r_associated | relid=0 | w=10
  4619. en:white substance -- r_associated #0: 10 / 0.083 -> démence
    n1=en:white substance | n2=démence | rel=r_associated | relid=0 | w=10
  4620. en:white substance -- r_associated #0: 10 / 0.083 -> démence fronto-temporale
    n1=en:white substance | n2=démence fronto-temporale | rel=r_associated | relid=0 | w=10
  4621. en:white substance -- r_associated #0: 10 / 0.083 -> démence frontotemporale
    n1=en:white substance | n2=démence frontotemporale | rel=r_associated | relid=0 | w=10
  4622. en:white substance -- r_associated #0: 10 / 0.083 -> démence héréditaire et infarctus multiples cérébraux
    n1=en:white substance | n2=démence héréditaire et infarctus multiples cérébraux | rel=r_associated | relid=0 | w=10
  4623. en:white substance -- r_associated #0: 10 / 0.083 -> demi-saison
    n1=en:white substance | n2=demi-saison | rel=r_associated | relid=0 | w=10
  4624. en:white substance -- r_associated #0: 10 / 0.083 -> démyélinisation
    n1=en:white substance | n2=démyélinisation | rel=r_associated | relid=0 | w=10
  4625. en:white substance -- r_associated #0: 10 / 0.083 -> dépression bipolaire
    n1=en:white substance | n2=dépression bipolaire | rel=r_associated | relid=0 | w=10
  4626. en:white substance -- r_associated #0: 10 / 0.083 -> détérioration intellectuelle
    n1=en:white substance | n2=détérioration intellectuelle | rel=r_associated | relid=0 | w=10
  4627. en:white substance -- r_associated #0: 10 / 0.083 -> détérioration mentale
    n1=en:white substance | n2=détérioration mentale | rel=r_associated | relid=0 | w=10
  4628. en:white substance -- r_associated #0: 10 / 0.083 -> diplégie spastique de type infantile
    n1=en:white substance | n2=diplégie spastique de type infantile | rel=r_associated | relid=0 | w=10
  4629. en:white substance -- r_associated #0: 10 / 0.083 -> douleur de la face
    n1=en:white substance | n2=douleur de la face | rel=r_associated | relid=0 | w=10
  4630. en:white substance -- r_associated #0: 10 / 0.083 -> douleur du visage
    n1=en:white substance | n2=douleur du visage | rel=r_associated | relid=0 | w=10
  4631. en:white substance -- r_associated #0: 10 / 0.083 -> douleur faciale
    n1=en:white substance | n2=douleur faciale | rel=r_associated | relid=0 | w=10
  4632. en:white substance -- r_associated #0: 10 / 0.083 -> drop attack
    n1=en:white substance | n2=drop attack | rel=r_associated | relid=0 | w=10
  4633. en:white substance -- r_associated #0: 10 / 0.083 -> dysautonomie
    n1=en:white substance | n2=dysautonomie | rel=r_associated | relid=0 | w=10
  4634. en:white substance -- r_associated #0: 10 / 0.083 -> dysautonomie végétative
    n1=en:white substance | n2=dysautonomie végétative | rel=r_associated | relid=0 | w=10
  4635. en:white substance -- r_associated #0: 10 / 0.083 -> dyskinésie
    n1=en:white substance | n2=dyskinésie | rel=r_associated | relid=0 | w=10
  4636. en:white substance -- r_associated #0: 10 / 0.083 -> dysphagia
    n1=en:white substance | n2=dysphagia | rel=r_associated | relid=0 | w=10
  4637. en:white substance -- r_associated #0: 10 / 0.083 -> dysphagie
    n1=en:white substance | n2=dysphagie | rel=r_associated | relid=0 | w=10
  4638. en:white substance -- r_associated #0: 10 / 0.083 -> dystonie
    n1=en:white substance | n2=dystonie | rel=r_associated | relid=0 | w=10
  4639. en:white substance -- r_associated #0: 10 / 0.083 -> dystrophie choriorétinienne, ataxie spinocérébelleuse, et hypogonadisme hypogonadotrophique
    n1=en:white substance | n2=dystrophie choriorétinienne, ataxie spinocérébelleuse, et hypogonadisme hypogonadotrophique | rel=r_associated | relid=0 | w=10
  4640. en:white substance -- r_associated #0: 10 / 0.083 -> élargissement du polygone de sustentation
    n1=en:white substance | n2=élargissement du polygone de sustentation | rel=r_associated | relid=0 | w=10
  4641. en:white substance -- r_associated #0: 10 / 0.083 -> élévation de la température corporelle
    n1=en:white substance | n2=élévation de la température corporelle | rel=r_associated | relid=0 | w=10
  4642. en:white substance -- r_associated #0: 10 / 0.083 -> en:absent moro response
    n1=en:white substance | n2=en:absent moro response | rel=r_associated | relid=0 | w=10
  4643. en:white substance -- r_associated #0: 10 / 0.083 -> en:aciclovir
    n1=en:white substance | n2=en:aciclovir | rel=r_associated | relid=0 | w=10
  4644. en:white substance -- r_associated #0: 10 / 0.083 -> en:amyotrophy
    n1=en:white substance | n2=en:amyotrophy | rel=r_associated | relid=0 | w=10
  4645. en:white substance -- r_associated #0: 10 / 0.083 -> en:and microgenitalism
    n1=en:white substance | n2=en:and microgenitalism | rel=r_associated | relid=0 | w=10
  4646. en:white substance -- r_associated #0: 10 / 0.083 -> en:and proeminent incisors
    n1=en:white substance | n2=en:and proeminent incisors | rel=r_associated | relid=0 | w=10
  4647. en:white substance -- r_associated #0: 10 / 0.083 -> en:angiomatous meningioma
    n1=en:white substance | n2=en:angiomatous meningioma | rel=r_associated | relid=0 | w=10
  4648. en:white substance -- r_associated #0: 10 / 0.083 -> en:apoplectic stroke
    n1=en:white substance | n2=en:apoplectic stroke | rel=r_associated | relid=0 | w=10
  4649. en:white substance -- r_associated #0: 10 / 0.083 -> en:arnold chiari malformation
    n1=en:white substance | n2=en:arnold chiari malformation | rel=r_associated | relid=0 | w=10
  4650. en:white substance -- r_associated #0: 10 / 0.083 -> en:arnold-chiari deformity
    n1=en:white substance | n2=en:arnold-chiari deformity | rel=r_associated | relid=0 | w=10
  4651. en:white substance -- r_associated #0: 10 / 0.083 -> en:asphyxia
    n1=en:white substance | n2=en:asphyxia | rel=r_associated | relid=0 | w=10
  4652. en:white substance -- r_associated #0: 10 / 0.083 -> en:autumn
    n1=en:white substance | n2=en:autumn | rel=r_associated | relid=0 | w=10
  4653. en:white substance -- r_associated #0: 10 / 0.083 -> en:axial hypertonia
    n1=en:white substance | n2=en:axial hypertonia | rel=r_associated | relid=0 | w=10
  4654. en:white substance -- r_associated #0: 10 / 0.083 -> en:Babinski sign
    n1=en:white substance | n2=en:Babinski sign | rel=r_associated | relid=0 | w=10
  4655. en:white substance -- r_associated #0: 10 / 0.083 -> en:balance problem
    n1=en:white substance | n2=en:balance problem | rel=r_associated | relid=0 | w=10
  4656. en:white substance -- r_associated #0: 10 / 0.083 -> en:be falling
    n1=en:white substance | n2=en:be falling | rel=r_associated | relid=0 | w=10
  4657. en:white substance -- r_associated #0: 10 / 0.083 -> en:be projected
    n1=en:white substance | n2=en:be projected | rel=r_associated | relid=0 | w=10
  4658. en:white substance -- r_associated #0: 10 / 0.083 -> en:be unscrewed
    n1=en:white substance | n2=en:be unscrewed | rel=r_associated | relid=0 | w=10
  4659. en:white substance -- r_associated #0: 10 / 0.083 -> en:belt down
    n1=en:white substance | n2=en:belt down | rel=r_associated | relid=0 | w=10
  4660. en:white substance -- r_associated #0: 10 / 0.083 -> en:bend down
    n1=en:white substance | n2=en:bend down | rel=r_associated | relid=0 | w=10
  4661. en:white substance -- r_associated #0: 10 / 0.083 -> en:bifrontal subdural hygroma
    n1=en:white substance | n2=en:bifrontal subdural hygroma | rel=r_associated | relid=0 | w=10
  4662. en:white substance -- r_associated #0: 10 / 0.083 -> en:black-white-arab
    n1=en:white substance | n2=en:black-white-arab | rel=r_associated | relid=0 | w=10
  4663. en:white substance -- r_associated #0: 10 / 0.083 -> en:blackout
    n1=en:white substance | n2=en:blackout | rel=r_associated | relid=0 | w=10
  4664. en:white substance -- r_associated #0: 10 / 0.083 -> en:blackout - symptom
    n1=en:white substance | n2=en:blackout - symptom | rel=r_associated | relid=0 | w=10
  4665. en:white substance -- r_associated #0: 10 / 0.083 -> en:brain failure
    n1=en:white substance | n2=en:brain failure | rel=r_associated | relid=0 | w=10
  4666. en:white substance -- r_associated #0: 10 / 0.083 -> en:brain haemorrhage
    n1=en:white substance | n2=en:brain haemorrhage | rel=r_associated | relid=0 | w=10
  4667. en:white substance -- r_associated #0: 10 / 0.083 -> en:brain hemorrhage
    n1=en:white substance | n2=en:brain hemorrhage | rel=r_associated | relid=0 | w=10
  4668. en:white substance -- r_associated #0: 10 / 0.083 -> en:brain imaging shows supratentorial and infratentorial atrophy
    n1=en:white substance | n2=en:brain imaging shows supratentorial and infratentorial atrophy | rel=r_associated | relid=0 | w=10
  4669. en:white substance -- r_associated #0: 10 / 0.083 -> en:brains
    n1=en:white substance | n2=en:brains | rel=r_associated | relid=0 | w=10
  4670. en:white substance -- r_associated #0: 10 / 0.083 -> en:brainstem
    n1=en:white substance | n2=en:brainstem | rel=r_associated | relid=0 | w=10
  4671. en:white substance -- r_associated #0: 10 / 0.083 -> en:brainware
    n1=en:white substance | n2=en:brainware | rel=r_associated | relid=0 | w=10
  4672. en:white substance -- r_associated #0: 10 / 0.083 -> en:bucket down
    n1=en:white substance | n2=en:bucket down | rel=r_associated | relid=0 | w=10
  4673. en:white substance -- r_associated #0: 10 / 0.083 -> en:cardiac arrest
    n1=en:white substance | n2=en:cardiac arrest | rel=r_associated | relid=0 | w=10
  4674. en:white substance -- r_associated #0: 10 / 0.083 -> en:cardiac shock
    n1=en:white substance | n2=en:cardiac shock | rel=r_associated | relid=0 | w=10
  4675. en:white substance -- r_associated #0: 10 / 0.083 -> en:cardiogenic shock
    n1=en:white substance | n2=en:cardiogenic shock | rel=r_associated | relid=0 | w=10
  4676. en:white substance -- r_associated #0: 10 / 0.083 -> en:cardioneurosis
    n1=en:white substance | n2=en:cardioneurosis | rel=r_associated | relid=0 | w=10
  4677. en:white substance -- r_associated #0: 10 / 0.083 -> en:cataplexia
    n1=en:white substance | n2=en:cataplexia | rel=r_associated | relid=0 | w=10
  4678. en:white substance -- r_associated #0: 10 / 0.083 -> en:cataplexis
    n1=en:white substance | n2=en:cataplexis | rel=r_associated | relid=0 | w=10
  4679. en:white substance -- r_associated #0: 10 / 0.083 -> en:cerebellar tonsilar ectopia (in some patients)
    n1=en:white substance | n2=en:cerebellar tonsilar ectopia (in some patients) | rel=r_associated | relid=0 | w=10
  4680. en:white substance -- r_associated #0: 10 / 0.083 -> en:cerebral abscess
    n1=en:white substance | n2=en:cerebral abscess | rel=r_associated | relid=0 | w=10
  4681. en:white substance -- r_associated #0: 10 / 0.083 -> en:cerebral haemorrhage
    n1=en:white substance | n2=en:cerebral haemorrhage | rel=r_associated | relid=0 | w=10
  4682. en:white substance -- r_associated #0: 10 / 0.083 -> en:cerebral ventriculomegaly
    n1=en:white substance | n2=en:cerebral ventriculomegaly | rel=r_associated | relid=0 | w=10
  4683. en:white substance -- r_associated #0: 10 / 0.083 -> en:change into second
    n1=en:white substance | n2=en:change into second | rel=r_associated | relid=0 | w=10
  4684. en:white substance -- r_associated #0: 10 / 0.083 -> en:chorioretinal dystrophy
    n1=en:white substance | n2=en:chorioretinal dystrophy | rel=r_associated | relid=0 | w=10
  4685. en:white substance -- r_associated #0: 10 / 0.083 -> en:chuck down
    n1=en:white substance | n2=en:chuck down | rel=r_associated | relid=0 | w=10
  4686. en:white substance -- r_associated #0: 10 / 0.083 -> en:collapse
    n1=en:white substance | n2=en:collapse | rel=r_associated | relid=0 | w=10
  4687. en:white substance -- r_associated #0: 10 / 0.083 -> en:come down in buckets
    n1=en:white substance | n2=en:come down in buckets | rel=r_associated | relid=0 | w=10
  4688. en:white substance -- r_associated #0: 10 / 0.083 -> en:come pelting down
    n1=en:white substance | n2=en:come pelting down | rel=r_associated | relid=0 | w=10
  4689. en:white substance -- r_associated #0: 10 / 0.083 -> en:come pouring down
    n1=en:white substance | n2=en:come pouring down | rel=r_associated | relid=0 | w=10
  4690. en:white substance -- r_associated #0: 10 / 0.083 -> en:communications blackout
    n1=en:white substance | n2=en:communications blackout | rel=r_associated | relid=0 | w=10
  4691. en:white substance -- r_associated #0: 10 / 0.083 -> en:conus terminalis
    n1=en:white substance | n2=en:conus terminalis | rel=r_associated | relid=0 | w=10
  4692. en:white substance -- r_associated #0: 10 / 0.083 -> en:coronary
    n1=en:white substance | n2=en:coronary | rel=r_associated | relid=0 | w=10
  4693. en:white substance -- r_associated #0: 10 / 0.083 -> en:crick in the neck
    n1=en:white substance | n2=en:crick in the neck | rel=r_associated | relid=0 | w=10
  4694. en:white substance -- r_associated #0: 10 / 0.083 -> en:crick in your neck
    n1=en:white substance | n2=en:crick in your neck | rel=r_associated | relid=0 | w=10
  4695. en:white substance -- r_associated #0: 10 / 0.083 -> en:deaf dumbness
    n1=en:white substance | n2=en:deaf dumbness | rel=r_associated | relid=0 | w=10
  4696. en:white substance -- r_associated #0: 10 / 0.083 -> en:deaf muteness
    n1=en:white substance | n2=en:deaf muteness | rel=r_associated | relid=0 | w=10
  4697. en:white substance -- r_associated #0: 10 / 0.083 -> en:deaf-muteness
    n1=en:white substance | n2=en:deaf-muteness | rel=r_associated | relid=0 | w=10
  4698. en:white substance -- r_associated #0: 10 / 0.083 -> en:deaf-mutism
    n1=en:white substance | n2=en:deaf-mutism | rel=r_associated | relid=0 | w=10
  4699. en:white substance -- r_associated #0: 10 / 0.083 -> en:decreased distal strength (in some patients)
    n1=en:white substance | n2=en:decreased distal strength (in some patients) | rel=r_associated | relid=0 | w=10
  4700. en:white substance -- r_associated #0: 10 / 0.083 -> en:delayed myelination (patient c)
    n1=en:white substance | n2=en:delayed myelination (patient c) | rel=r_associated | relid=0 | w=10
  4701. en:white substance -- r_associated #0: 10 / 0.083 -> en:delayed myelination (patients a and c)
    n1=en:white substance | n2=en:delayed myelination (patients a and c) | rel=r_associated | relid=0 | w=10
  4702. en:white substance -- r_associated #0: 10 / 0.083 -> en:delayed myelination endocrine : gonadotropin-dependent precocious puberty (1 patient)
    n1=en:white substance | n2=en:delayed myelination endocrine : gonadotropin-dependent precocious puberty (1 patient) | rel=r_associated | relid=0 | w=10
  4703. en:white substance -- r_associated #0: 10 / 0.083 -> en:demean o.s.
    n1=en:white substance | n2=en:demean o.s. | rel=r_associated | relid=0 | w=10
  4704. en:white substance -- r_associated #0: 10 / 0.083 -> en:descend upon somebody
    n1=en:white substance | n2=en:descend upon somebody | rel=r_associated | relid=0 | w=10
  4705. en:white substance -- r_associated #0: 10 / 0.083 -> en:descend upon something
    n1=en:white substance | n2=en:descend upon something | rel=r_associated | relid=0 | w=10
  4706. en:white substance -- r_associated #0: 10 / 0.083 -> en:diffuse signal hyperintensity of white matter seen on mri
    n1=en:white substance | n2=en:diffuse signal hyperintensity of white matter seen on mri | rel=r_associated | relid=0 | w=10
  4707. en:white substance -- r_associated #0: 10 / 0.083 -> en:diffuse slow background activity seen on eeg
    n1=en:white substance | n2=en:diffuse slow background activity seen on eeg | rel=r_associated | relid=0 | w=10
  4708. en:white substance -- r_associated #0: 10 / 0.083 -> en:diminish
    n1=en:white substance | n2=en:diminish | rel=r_associated | relid=0 | w=10
  4709. en:white substance -- r_associated #0: 10 / 0.083 -> en:disorder of equilibrium
    n1=en:white substance | n2=en:disorder of equilibrium | rel=r_associated | relid=0 | w=10
  4710. en:white substance -- r_associated #0: 10 / 0.083 -> en:dorsal nerve cord
    n1=en:white substance | n2=en:dorsal nerve cord | rel=r_associated | relid=0 | w=10
  4711. en:white substance -- r_associated #0: 10 / 0.083 -> en:drowsiness
    n1=en:white substance | n2=en:drowsiness | rel=r_associated | relid=0 | w=10
  4712. en:white substance -- r_associated #0: 10 / 0.083 -> en:dumbness
    n1=en:white substance | n2=en:dumbness | rel=r_associated | relid=0 | w=10
  4713. en:white substance -- r_associated #0: 10 / 0.083 -> en:dwarfism
    n1=en:white substance | n2=en:dwarfism | rel=r_associated | relid=0 | w=10
  4714. en:white substance -- r_associated #0: 10 / 0.083 -> en:dystonic movements (in some patients)
    n1=en:white substance | n2=en:dystonic movements (in some patients) | rel=r_associated | relid=0 | w=10
  4715. en:white substance -- r_associated #0: 10 / 0.083 -> en:eat dirt
    n1=en:white substance | n2=en:eat dirt | rel=r_associated | relid=0 | w=10
  4716. en:white substance -- r_associated #0: 10 / 0.083 -> en:eat shit
    n1=en:white substance | n2=en:eat shit | rel=r_associated | relid=0 | w=10
  4717. en:white substance -- r_associated #0: 10 / 0.083 -> en:effort syndrome
    n1=en:white substance | n2=en:effort syndrome | rel=r_associated | relid=0 | w=10
  4718. en:white substance -- r_associated #0: 10 / 0.083 -> en:electricity cut
    n1=en:white substance | n2=en:electricity cut | rel=r_associated | relid=0 | w=10
  4719. en:white substance -- r_associated #0: 10 / 0.083 -> en:encephalon
    n1=en:white substance | n2=en:encephalon | rel=r_associated | relid=0 | w=10
  4720. en:white substance -- r_associated #0: 10 / 0.083 -> en:encephalopyosis
    n1=en:white substance | n2=en:encephalopyosis | rel=r_associated | relid=0 | w=10
  4721. en:white substance -- r_associated #0: 10 / 0.083 -> en:enfeeblement of muscle
    n1=en:white substance | n2=en:enfeeblement of muscle | rel=r_associated | relid=0 | w=10
  4722. en:white substance -- r_associated #0: 10 / 0.083 -> en:epileptiform neuralgia
    n1=en:white substance | n2=en:epileptiform neuralgia | rel=r_associated | relid=0 | w=10
  4723. en:white substance -- r_associated #0: 10 / 0.083 -> en:extrapyramidal symptoms (patient a)
    n1=en:white substance | n2=en:extrapyramidal symptoms (patient a) | rel=r_associated | relid=0 | w=10
  4724. en:white substance -- r_associated #0: 10 / 0.083 -> en:facial neuralgia
    n1=en:white substance | n2=en:facial neuralgia | rel=r_associated | relid=0 | w=10
  4725. en:white substance -- r_associated #0: 10 / 0.083 -> en:facial pain
    n1=en:white substance | n2=en:facial pain | rel=r_associated | relid=0 | w=10
  4726. en:white substance -- r_associated #0: 10 / 0.083 -> en:fail at a business
    n1=en:white substance | n2=en:fail at a business | rel=r_associated | relid=0 | w=10
  4727. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall apart
    n1=en:white substance | n2=en:fall apart | rel=r_associated | relid=0 | w=10
  4728. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall down
    n1=en:white substance | n2=en:fall down | rel=r_associated | relid=0 | w=10
  4729. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall flat on one's face
    n1=en:white substance | n2=en:fall flat on one's face | rel=r_associated | relid=0 | w=10
  4730. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall flat on your face
    n1=en:white substance | n2=en:fall flat on your face | rel=r_associated | relid=0 | w=10
  4731. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall into disrepair
    n1=en:white substance | n2=en:fall into disrepair | rel=r_associated | relid=0 | w=10
  4732. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall into ruin
    n1=en:white substance | n2=en:fall into ruin | rel=r_associated | relid=0 | w=10
  4733. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall into ruins
    n1=en:white substance | n2=en:fall into ruins | rel=r_associated | relid=0 | w=10
  4734. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall on the floor
    n1=en:white substance | n2=en:fall on the floor | rel=r_associated | relid=0 | w=10
  4735. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall on the ground
    n1=en:white substance | n2=en:fall on the ground | rel=r_associated | relid=0 | w=10
  4736. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall over
    n1=en:white substance | n2=en:fall over | rel=r_associated | relid=0 | w=10
  4737. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall to earth
    n1=en:white substance | n2=en:fall to earth | rel=r_associated | relid=0 | w=10
  4738. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall to the floor
    n1=en:white substance | n2=en:fall to the floor | rel=r_associated | relid=0 | w=10
  4739. en:white substance -- r_associated #0: 10 / 0.083 -> en:fall to the ground
    n1=en:white substance | n2=en:fall to the ground | rel=r_associated | relid=0 | w=10
  4740. en:white substance -- r_associated #0: 10 / 0.083 -> en:febrile convulsions
    n1=en:white substance | n2=en:febrile convulsions | rel=r_associated | relid=0 | w=10
  4741. en:white substance -- r_associated #0: 10 / 0.083 -> en:fever
    n1=en:white substance | n2=en:fever | rel=r_associated | relid=0 | w=10
  4742. en:white substance -- r_associated #0: 10 / 0.083 -> en:few spontaneous movements
    n1=en:white substance | n2=en:few spontaneous movements | rel=r_associated | relid=0 | w=10
  4743. en:white substance -- r_associated #0: 10 / 0.083 -> en:gasping for breath
    n1=en:white substance | n2=en:gasping for breath | rel=r_associated | relid=0 | w=10
  4744. en:white substance -- r_associated #0: 10 / 0.083 -> en:Gayet-Wernicke's syndrome
    n1=en:white substance | n2=en:Gayet-Wernicke's syndrome | rel=r_associated | relid=0 | w=10
  4745. en:white substance -- r_associated #0: 10 / 0.083 -> en:general paralysis
    n1=en:white substance | n2=en:general paralysis | rel=r_associated | relid=0 | w=10
  4746. en:white substance -- r_associated #0: 10 / 0.083 -> en:general paresis
    n1=en:white substance | n2=en:general paresis | rel=r_associated | relid=0 | w=10
  4747. en:white substance -- r_associated #0: 10 / 0.083 -> en:go arse over tit
    n1=en:white substance | n2=en:go arse over tit | rel=r_associated | relid=0 | w=10
  4748. en:white substance -- r_associated #0: 10 / 0.083 -> en:go down for the count
    n1=en:white substance | n2=en:go down for the count | rel=r_associated | relid=0 | w=10
  4749. en:white substance -- r_associated #0: 10 / 0.083 -> en:go out of business
    n1=en:white substance | n2=en:go out of business | rel=r_associated | relid=0 | w=10
  4750. en:white substance -- r_associated #0: 10 / 0.083 -> en:go to pot
    n1=en:white substance | n2=en:go to pot | rel=r_associated | relid=0 | w=10
  4751. en:white substance -- r_associated #0: 10 / 0.083 -> en:grey matter
    n1=en:white substance | n2=en:grey matter | rel=r_associated | relid=0 | w=10
  4752. en:white substance -- r_associated #0: 10 / 0.083 -> en:gross motor development delay
    n1=en:white substance | n2=en:gross motor development delay | rel=r_associated | relid=0 | w=10
  4753. en:white substance -- r_associated #0: 10 / 0.083 -> en:heat-stroke
    n1=en:white substance | n2=en:heat-stroke | rel=r_associated | relid=0 | w=10
  4754. en:white substance -- r_associated #0: 10 / 0.083 -> en:hydrencephalus
    n1=en:white substance | n2=en:hydrencephalus | rel=r_associated | relid=0 | w=10
  4755. en:white substance -- r_associated #0: 10 / 0.083 -> en:hyperthermy
    n1=en:white substance | n2=en:hyperthermy | rel=r_associated | relid=0 | w=10
  4756. en:white substance -- r_associated #0: 10 / 0.083 -> en:hypothalami
    n1=en:white substance | n2=en:hypothalami | rel=r_associated | relid=0 | w=10
  4757. en:white substance -- r_associated #0: 10 / 0.083 -> en:illicitly
    n1=en:white substance | n2=en:illicitly | rel=r_associated | relid=0 | w=10
  4758. en:white substance -- r_associated #0: 10 / 0.083 -> en:immobility
    n1=en:white substance | n2=en:immobility | rel=r_associated | relid=0 | w=10
  4759. en:white substance -- r_associated #0: 10 / 0.083 -> en:inability to walk (in some patients)
    n1=en:white substance | n2=en:inability to walk (in some patients) | rel=r_associated | relid=0 | w=10
  4760. en:white substance -- r_associated #0: 10 / 0.083 -> en:increased white matter signal
    n1=en:white substance | n2=en:increased white matter signal | rel=r_associated | relid=0 | w=10
  4761. en:white substance -- r_associated #0: 10 / 0.083 -> en:inertness
    n1=en:white substance | n2=en:inertness | rel=r_associated | relid=0 | w=10
  4762. en:white substance -- r_associated #0: 10 / 0.083 -> en:infarct
    n1=en:white substance | n2=en:infarct | rel=r_associated | relid=0 | w=10
  4763. en:white substance -- r_associated #0: 10 / 0.083 -> en:infarctioning
    n1=en:white substance | n2=en:infarctioning | rel=r_associated | relid=0 | w=10
  4764. en:white substance -- r_associated #0: 10 / 0.083 -> en:infarctus
    n1=en:white substance | n2=en:infarctus | rel=r_associated | relid=0 | w=10
  4765. en:white substance -- r_associated #0: 10 / 0.083 -> en:ischemic stroke
    n1=en:white substance | n2=en:ischemic stroke | rel=r_associated | relid=0 | w=10
  4766. en:white substance -- r_associated #0: 10 / 0.083 -> en:juvenile cataract
    n1=en:white substance | n2=en:juvenile cataract | rel=r_associated | relid=0 | w=10
  4767. en:white substance -- r_associated #0: 10 / 0.083 -> en:laryngeal cartilages and joints
    n1=en:white substance | n2=en:laryngeal cartilages and joints | rel=r_associated | relid=0 | w=10
  4768. en:white substance -- r_associated #0: 10 / 0.083 -> en:lash
    n1=en:white substance | n2=en:lash | rel=r_associated | relid=0 | w=10
  4769. en:white substance -- r_associated #0: 10 / 0.083 -> en:learning disability
    n1=en:white substance | n2=en:learning disability | rel=r_associated | relid=0 | w=10
  4770. en:white substance -- r_associated #0: 10 / 0.083 -> en:leukoencéphalopathy
    n1=en:white substance | n2=en:leukoencéphalopathy | rel=r_associated | relid=0 | w=10
  4771. en:white substance -- r_associated #0: 10 / 0.083 -> en:manic depression
    n1=en:white substance | n2=en:manic depression | rel=r_associated | relid=0 | w=10
  4772. en:white substance -- r_associated #0: 10 / 0.083 -> en:media blackout
    n1=en:white substance | n2=en:media blackout | rel=r_associated | relid=0 | w=10
  4773. en:white substance -- r_associated #0: 10 / 0.083 -> en:medulla spinalis
    n1=en:white substance | n2=en:medulla spinalis | rel=r_associated | relid=0 | w=10
  4774. en:white substance -- r_associated #0: 10 / 0.083 -> en:meninx
    n1=en:white substance | n2=en:meninx | rel=r_associated | relid=0 | w=10
  4775. en:white substance -- r_associated #0: 10 / 0.083 -> en:mental dullness
    n1=en:white substance | n2=en:mental dullness | rel=r_associated | relid=0 | w=10
  4776. en:white substance -- r_associated #0: 10 / 0.083 -> en:mental retardation, mild to severe (iq <35 in some patients)
    n1=en:white substance | n2=en:mental retardation, mild to severe (iq <35 in some patients) | rel=r_associated | relid=0 | w=10
  4777. en:white substance -- r_associated #0: 10 / 0.083 -> en:molar tooth sign seen on brain imaging
    n1=en:white substance | n2=en:molar tooth sign seen on brain imaging | rel=r_associated | relid=0 | w=10
  4778. en:white substance -- r_associated #0: 10 / 0.083 -> en:morosis
    n1=en:white substance | n2=en:morosis | rel=r_associated | relid=0 | w=10
  4779. en:white substance -- r_associated #0: 10 / 0.083 -> en:motor deficits (in some patients)
    n1=en:white substance | n2=en:motor deficits (in some patients) | rel=r_associated | relid=0 | w=10
  4780. en:white substance -- r_associated #0: 10 / 0.083 -> en:motor disability
    n1=en:white substance | n2=en:motor disability | rel=r_associated | relid=0 | w=10
  4781. en:white substance -- r_associated #0: 10 / 0.083 -> en:motor handicap
    n1=en:white substance | n2=en:motor handicap | rel=r_associated | relid=0 | w=10
  4782. en:white substance -- r_associated #0: 10 / 0.083 -> en:multiracial
    n1=en:white substance | n2=en:multiracial | rel=r_associated | relid=0 | w=10
  4783. en:white substance -- r_associated #0: 10 / 0.083 -> en:muscle twitch
    n1=en:white substance | n2=en:muscle twitch | rel=r_associated | relid=0 | w=10
  4784. en:white substance -- r_associated #0: 10 / 0.083 -> en:muscle wasting
    n1=en:white substance | n2=en:muscle wasting | rel=r_associated | relid=0 | w=10
  4785. en:white substance -- r_associated #0: 10 / 0.083 -> en:muscular atrophy
    n1=en:white substance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
  4786. en:white substance -- r_associated #0: 10 / 0.083 -> en:muscular fasciculation
    n1=en:white substance | n2=en:muscular fasciculation | rel=r_associated | relid=0 | w=10
  4787. en:white substance -- r_associated #0: 10 / 0.083 -> en:muscular hypotonia
    n1=en:white substance | n2=en:muscular hypotonia | rel=r_associated | relid=0 | w=10
  4788. en:white substance -- r_associated #0: 10 / 0.083 -> en:muscular weakness
    n1=en:white substance | n2=en:muscular weakness | rel=r_associated | relid=0 | w=10
  4789. en:white substance -- r_associated #0: 10 / 0.083 -> en:neonatal distress
    n1=en:white substance | n2=en:neonatal distress | rel=r_associated | relid=0 | w=10
  4790. en:white substance -- r_associated #0: 10 / 0.083 -> en:neurocirculatory astheny
    n1=en:white substance | n2=en:neurocirculatory astheny | rel=r_associated | relid=0 | w=10
  4791. en:white substance -- r_associated #0: 10 / 0.083 -> en:obesity
    n1=en:white substance | n2=en:obesity | rel=r_associated | relid=0 | w=10
  4792. en:white substance -- r_associated #0: 10 / 0.083 -> en:obnubilation
    n1=en:white substance | n2=en:obnubilation | rel=r_associated | relid=0 | w=10
  4793. en:white substance -- r_associated #0: 10 / 0.083 -> en:off the books
    n1=en:white substance | n2=en:off the books | rel=r_associated | relid=0 | w=10
  4794. en:white substance -- r_associated #0: 10 / 0.083 -> en:oligophrenia
    n1=en:white substance | n2=en:oligophrenia | rel=r_associated | relid=0 | w=10
  4795. en:white substance -- r_associated #0: 10 / 0.083 -> en:oligopsychia
    n1=en:white substance | n2=en:oligopsychia | rel=r_associated | relid=0 | w=10
  4796. en:white substance -- r_associated #0: 10 / 0.083 -> en:opisthotonus (patient b)
    n1=en:white substance | n2=en:opisthotonus (patient b) | rel=r_associated | relid=0 | w=10
  4797. en:white substance -- r_associated #0: 10 / 0.083 -> en:optic atrophy
    n1=en:white substance | n2=en:optic atrophy | rel=r_associated | relid=0 | w=10
  4798. en:white substance -- r_associated #0: 10 / 0.083 -> en:orthostatic low blood pressure
    n1=en:white substance | n2=en:orthostatic low blood pressure | rel=r_associated | relid=0 | w=10
  4799. en:white substance -- r_associated #0: 10 / 0.083 -> en:paralytic dementia
    n1=en:white substance | n2=en:paralytic dementia | rel=r_associated | relid=0 | w=10
  4800. en:white substance -- r_associated #0: 10 / 0.083 -> en:paresis
    n1=en:white substance | n2=en:paresis | rel=r_associated | relid=0 | w=10
  4801. en:white substance -- r_associated #0: 10 / 0.083 -> en:pars centralis systemae nervosi
    n1=en:white substance | n2=en:pars centralis systemae nervosi | rel=r_associated | relid=0 | w=10
  4802. en:white substance -- r_associated #0: 10 / 0.083 -> en:pay for itself
    n1=en:white substance | n2=en:pay for itself | rel=r_associated | relid=0 | w=10
  4803. en:white substance -- r_associated #0: 10 / 0.083 -> en:pay for something in installments
    n1=en:white substance | n2=en:pay for something in installments | rel=r_associated | relid=0 | w=10
  4804. en:white substance -- r_associated #0: 10 / 0.083 -> en:pelt
    n1=en:white substance | n2=en:pelt | rel=r_associated | relid=0 | w=10
  4805. en:white substance -- r_associated #0: 10 / 0.083 -> en:pelt down
    n1=en:white substance | n2=en:pelt down | rel=r_associated | relid=0 | w=10
  4806. en:white substance -- r_associated #0: 10 / 0.083 -> en:periventricular calcifications (patient c)
    n1=en:white substance | n2=en:periventricular calcifications (patient c) | rel=r_associated | relid=0 | w=10
  4807. en:white substance -- r_associated #0: 10 / 0.083 -> en:personality problem
    n1=en:white substance | n2=en:personality problem | rel=r_associated | relid=0 | w=10
  4808. en:white substance -- r_associated #0: 10 / 0.083 -> en:photosensitivity of skin
    n1=en:white substance | n2=en:photosensitivity of skin | rel=r_associated | relid=0 | w=10
  4809. en:white substance -- r_associated #0: 10 / 0.083 -> en:physical disability
    n1=en:white substance | n2=en:physical disability | rel=r_associated | relid=0 | w=10
  4810. en:white substance -- r_associated #0: 10 / 0.083 -> en:Pineal gland
    n1=en:white substance | n2=en:Pineal gland | rel=r_associated | relid=0 | w=10
  4811. en:white substance -- r_associated #0: 10 / 0.083 -> en:piss down
    n1=en:white substance | n2=en:piss down | rel=r_associated | relid=0 | w=10
  4812. en:white substance -- r_associated #0: 10 / 0.083 -> en:piss with rain
    n1=en:white substance | n2=en:piss with rain | rel=r_associated | relid=0 | w=10
  4813. en:white substance -- r_associated #0: 10 / 0.083 -> en:portal systemic encephalopathy
    n1=en:white substance | n2=en:portal systemic encephalopathy | rel=r_associated | relid=0 | w=10
  4814. en:white substance -- r_associated #0: 10 / 0.083 -> en:pour down
    n1=en:white substance | n2=en:pour down | rel=r_associated | relid=0 | w=10
  4815. en:white substance -- r_associated #0: 10 / 0.083 -> en:pour down with rain
    n1=en:white substance | n2=en:pour down with rain | rel=r_associated | relid=0 | w=10
  4816. en:white substance -- r_associated #0: 10 / 0.083 -> en:pour with rain
    n1=en:white substance | n2=en:pour with rain | rel=r_associated | relid=0 | w=10
  4817. en:white substance -- r_associated #0: 10 / 0.083 -> en:power black out
    n1=en:white substance | n2=en:power black out | rel=r_associated | relid=0 | w=10
  4818. en:white substance -- r_associated #0: 10 / 0.083 -> en:power cut
    n1=en:white substance | n2=en:power cut | rel=r_associated | relid=0 | w=10
  4819. en:white substance -- r_associated #0: 10 / 0.083 -> en:power failure
    n1=en:white substance | n2=en:power failure | rel=r_associated | relid=0 | w=10
  4820. en:white substance -- r_associated #0: 10 / 0.083 -> en:power outage
    n1=en:white substance | n2=en:power outage | rel=r_associated | relid=0 | w=10
  4821. en:white substance -- r_associated #0: 10 / 0.083 -> en:power shutdown
    n1=en:white substance | n2=en:power shutdown | rel=r_associated | relid=0 | w=10
  4822. en:white substance -- r_associated #0: 10 / 0.083 -> en:problem with balance
    n1=en:white substance | n2=en:problem with balance | rel=r_associated | relid=0 | w=10
  4823. en:white substance -- r_associated #0: 10 / 0.083 -> en:profound deafness
    n1=en:white substance | n2=en:profound deafness | rel=r_associated | relid=0 | w=10
  4824. en:white substance -- r_associated #0: 10 / 0.083 -> en:prosopalgia
    n1=en:white substance | n2=en:prosopalgia | rel=r_associated | relid=0 | w=10
  4825. en:white substance -- r_associated #0: 10 / 0.083 -> en:prosoponeuralgia
    n1=en:white substance | n2=en:prosoponeuralgia | rel=r_associated | relid=0 | w=10
  4826. en:white substance -- r_associated #0: 10 / 0.083 -> en:rain buckets
    n1=en:white substance | n2=en:rain buckets | rel=r_associated | relid=0 | w=10
  4827. en:white substance -- r_associated #0: 10 / 0.083 -> en:rain cats and dogs
    n1=en:white substance | n2=en:rain cats and dogs | rel=r_associated | relid=0 | w=10
  4828. en:white substance -- r_associated #0: 10 / 0.083 -> en:rain heavily
    n1=en:white substance | n2=en:rain heavily | rel=r_associated | relid=0 | w=10
  4829. en:white substance -- r_associated #0: 10 / 0.083 -> en:rain pitchforks
    n1=en:white substance | n2=en:rain pitchforks | rel=r_associated | relid=0 | w=10
  4830. en:white substance -- r_associated #0: 10 / 0.083 -> en:retardation
    n1=en:white substance | n2=en:retardation | rel=r_associated | relid=0 | w=10
  4831. en:white substance -- r_associated #0: 10 / 0.083 -> en:rhaebocrania
    n1=en:white substance | n2=en:rhaebocrania | rel=r_associated | relid=0 | w=10
  4832. en:white substance -- r_associated #0: 10 / 0.083 -> en:rotary vertigo
    n1=en:white substance | n2=en:rotary vertigo | rel=r_associated | relid=0 | w=10
  4833. en:white substance -- r_associated #0: 10 / 0.083 -> en:Schwann's sheath
    n1=en:white substance | n2=en:Schwann's sheath | rel=r_associated | relid=0 | w=10
  4834. en:white substance -- r_associated #0: 10 / 0.083 -> en:set of astrocytes
    n1=en:white substance | n2=en:set of astrocytes | rel=r_associated | relid=0 | w=10
  4835. en:white substance -- r_associated #0: 10 / 0.083 -> en:severe neonatal distress
    n1=en:white substance | n2=en:severe neonatal distress | rel=r_associated | relid=0 | w=10
  4836. en:white substance -- r_associated #0: 10 / 0.083 -> en:speech difficulties due to deafness
    n1=en:white substance | n2=en:speech difficulties due to deafness | rel=r_associated | relid=0 | w=10
  4837. en:white substance -- r_associated #0: 10 / 0.083 -> en:spike-wave discharges
    n1=en:white substance | n2=en:spike-wave discharges | rel=r_associated | relid=0 | w=10
  4838. en:white substance -- r_associated #0: 10 / 0.083 -> en:stiff neck
    n1=en:white substance | n2=en:stiff neck | rel=r_associated | relid=0 | w=10
  4839. en:white substance -- r_associated #0: 10 / 0.083 -> en:stop working
    n1=en:white substance | n2=en:stop working | rel=r_associated | relid=0 | w=10
  4840. en:white substance -- r_associated #0: 10 / 0.083 -> en:stroke
    n1=en:white substance | n2=en:stroke | rel=r_associated | relid=0 | w=10
  4841. en:white substance -- r_associated #0: 10 / 0.083 -> en:stroke syndrome
    n1=en:white substance | n2=en:stroke syndrome | rel=r_associated | relid=0 | w=10
  4842. en:white substance -- r_associated #0: 10 / 0.083 -> en:substantia grisea
    n1=en:white substance | n2=en:substantia grisea | rel=r_associated | relid=0 | w=10
  4843. en:white substance -- r_associated #0: 10 / 0.083 -> en:suffer a fall
    n1=en:white substance | n2=en:suffer a fall | rel=r_associated | relid=0 | w=10
  4844. en:white substance -- r_associated #0: 10 / 0.083 -> en:suffocation
    n1=en:white substance | n2=en:suffocation | rel=r_associated | relid=0 | w=10
  4845. en:white substance -- r_associated #0: 10 / 0.083 -> en:surdimutism
    n1=en:white substance | n2=en:surdimutism | rel=r_associated | relid=0 | w=10
  4846. en:white substance -- r_associated #0: 10 / 0.083 -> en:syphilitic meningoencephalitis
    n1=en:white substance | n2=en:syphilitic meningoencephalitis | rel=r_associated | relid=0 | w=10
  4847. en:white substance -- r_associated #0: 10 / 0.083 -> en:systema nervosum centrale
    n1=en:white substance | n2=en:systema nervosum centrale | rel=r_associated | relid=0 | w=10
  4848. en:white substance -- r_associated #0: 10 / 0.083 -> en:to abase o.s.
    n1=en:white substance | n2=en:to abase o.s. | rel=r_associated | relid=0 | w=10
  4849. en:white substance -- r_associated #0: 10 / 0.083 -> en:to be falling
    n1=en:white substance | n2=en:to be falling | rel=r_associated | relid=0 | w=10
  4850. en:white substance -- r_associated #0: 10 / 0.083 -> en:to come a cropper
    n1=en:white substance | n2=en:to come a cropper | rel=r_associated | relid=0 | w=10
  4851. en:white substance -- r_associated #0: 10 / 0.083 -> en:to fall flat on one's face
    n1=en:white substance | n2=en:to fall flat on one's face | rel=r_associated | relid=0 | w=10
  4852. en:white substance -- r_associated #0: 10 / 0.083 -> en:to fall into disrepair
    n1=en:white substance | n2=en:to fall into disrepair | rel=r_associated | relid=0 | w=10
  4853. en:white substance -- r_associated #0: 10 / 0.083 -> en:to fall into ruins
    n1=en:white substance | n2=en:to fall into ruins | rel=r_associated | relid=0 | w=10
  4854. en:white substance -- r_associated #0: 10 / 0.083 -> en:to fall to bits
    n1=en:white substance | n2=en:to fall to bits | rel=r_associated | relid=0 | w=10
  4855. en:white substance -- r_associated #0: 10 / 0.083 -> en:to go down
    n1=en:white substance | n2=en:to go down | rel=r_associated | relid=0 | w=10
  4856. en:white substance -- r_associated #0: 10 / 0.083 -> en:to piss with rain
    n1=en:white substance | n2=en:to piss with rain | rel=r_associated | relid=0 | w=10
  4857. en:white substance -- r_associated #0: 10 / 0.083 -> en:to rain cats and dogs
    n1=en:white substance | n2=en:to rain cats and dogs | rel=r_associated | relid=0 | w=10
  4858. en:white substance -- r_associated #0: 10 / 0.083 -> en:trifacial neuralgia
    n1=en:white substance | n2=en:trifacial neuralgia | rel=r_associated | relid=0 | w=10
  4859. en:white substance -- r_associated #0: 10 / 0.083 -> en:twitching
    n1=en:white substance | n2=en:twitching | rel=r_associated | relid=0 | w=10
  4860. en:white substance -- r_associated #0: 10 / 0.083 -> en:ventral nerve cord
    n1=en:white substance | n2=en:ventral nerve cord | rel=r_associated | relid=0 | w=10
  4861. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities at corticomedullary junctions
    n1=en:white substance | n2=en:white matter abnormalities at corticomedullary junctions | rel=r_associated | relid=0 | w=10
  4862. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities consistent with leigh syndrome seen on brain imaging
    n1=en:white substance | n2=en:white matter abnormalities consistent with leigh syndrome seen on brain imaging | rel=r_associated | relid=0 | w=10
  4863. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in subcortical regions
    n1=en:white substance | n2=en:white matter abnormalities in subcortical regions | rel=r_associated | relid=0 | w=10
  4864. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in the basal ganglia
    n1=en:white substance | n2=en:white matter abnormalities in the basal ganglia | rel=r_associated | relid=0 | w=10
  4865. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in the cerebellum
    n1=en:white substance | n2=en:white matter abnormalities in the cerebellum | rel=r_associated | relid=0 | w=10
  4866. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in the corpus callosum
    n1=en:white substance | n2=en:white matter abnormalities in the corpus callosum | rel=r_associated | relid=0 | w=10
  4867. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in the periventricular regions
    n1=en:white substance | n2=en:white matter abnormalities in the periventricular regions | rel=r_associated | relid=0 | w=10
  4868. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in the subcortical white matter and cerebellum
    n1=en:white substance | n2=en:white matter abnormalities in the subcortical white matter and cerebellum | rel=r_associated | relid=0 | w=10
  4869. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities in u fibers
    n1=en:white substance | n2=en:white matter abnormalities in u fibers | rel=r_associated | relid=0 | w=10
  4870. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities on brain imaging
    n1=en:white substance | n2=en:white matter abnormalities on brain imaging | rel=r_associated | relid=0 | w=10
  4871. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter abnormalities, periventricular and diffuse
    n1=en:white substance | n2=en:white matter abnormalities, periventricular and diffuse | rel=r_associated | relid=0 | w=10
  4872. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter changes on brain imaging
    n1=en:white substance | n2=en:white matter changes on brain imaging | rel=r_associated | relid=0 | w=10
  4873. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter dysmyelination/demyelination
    n1=en:white substance | n2=en:white matter dysmyelination/demyelination | rel=r_associated | relid=0 | w=10
  4874. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter rarefaction
    n1=en:white substance | n2=en:white matter rarefaction | rel=r_associated | relid=0 | w=10
  4875. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter signal changes
    n1=en:white substance | n2=en:white matter signal changes | rel=r_associated | relid=0 | w=10
  4876. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter signals
    n1=en:white substance | n2=en:white matter signals | rel=r_associated | relid=0 | w=10
  4877. en:white substance -- r_associated #0: 10 / 0.083 -> en:white matter vacuolation
    n1=en:white substance | n2=en:white matter vacuolation | rel=r_associated | relid=0 | w=10
  4878. en:white substance -- r_associated #0: 10 / 0.083 -> en:wide-based gait
    n1=en:white substance | n2=en:wide-based gait | rel=r_associated | relid=0 | w=10
  4879. en:white substance -- r_associated #0: 10 / 0.083 -> en:with growth retardation
    n1=en:white substance | n2=en:with growth retardation | rel=r_associated | relid=0 | w=10
  4880. en:white substance -- r_associated #0: 10 / 0.083 -> en:wry neck
    n1=en:white substance | n2=en:wry neck | rel=r_associated | relid=0 | w=10
  4881. en:white substance -- r_associated #0: 10 / 0.083 -> en:wryneck
    n1=en:white substance | n2=en:wryneck | rel=r_associated | relid=0 | w=10
  4882. en:white substance -- r_associated #0: 10 / 0.083 -> en:X-linked
    n1=en:white substance | n2=en:X-linked | rel=r_associated | relid=0 | w=10
  4883. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalite
    n1=en:white substance | n2=encéphalite | rel=r_associated | relid=0 | w=10
  4884. en:white substance -- r_associated #0: 10 / 0.083 -> encephalitis
    n1=en:white substance | n2=encephalitis | rel=r_associated | relid=0 | w=10
  4885. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalopathie
    n1=en:white substance | n2=encéphalopathie | rel=r_associated | relid=0 | w=10
  4886. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalopathie hépatique
    n1=en:white substance | n2=encéphalopathie hépatique | rel=r_associated | relid=0 | w=10
  4887. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalopathie hépato-cérébrale
    n1=en:white substance | n2=encéphalopathie hépato-cérébrale | rel=r_associated | relid=0 | w=10
  4888. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalopathie hypertensive
    n1=en:white substance | n2=encéphalopathie hypertensive | rel=r_associated | relid=0 | w=10
  4889. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalopathie infantile
    n1=en:white substance | n2=encéphalopathie infantile | rel=r_associated | relid=0 | w=10
  4890. en:white substance -- r_associated #0: 10 / 0.083 -> encéphalopathie porto-cave
    n1=en:white substance | n2=encéphalopathie porto-cave | rel=r_associated | relid=0 | w=10
  4891. en:white substance -- r_associated #0: 10 / 0.083 -> enzymologie
    n1=en:white substance | n2=enzymologie | rel=r_associated | relid=0 | w=10
  4892. en:white substance -- r_associated #0: 10 / 0.083 -> enzymology
    n1=en:white substance | n2=enzymology | rel=r_associated | relid=0 | w=10
  4893. en:white substance -- r_associated #0: 10 / 0.083 -> épendyme
    n1=en:white substance | n2=épendyme | rel=r_associated | relid=0 | w=10
  4894. en:white substance -- r_associated #0: 10 / 0.083 -> épilepsie partielle continue
    n1=en:white substance | n2=épilepsie partielle continue | rel=r_associated | relid=0 | w=10
  4895. en:white substance -- r_associated #0: 10 / 0.083 -> Épilepsie partielle continue
    n1=en:white substance | n2=Épilepsie partielle continue | rel=r_associated | relid=0 | w=10
  4896. en:white substance -- r_associated #0: 10 / 0.083 -> épiphyse
    n1=en:white substance | n2=épiphyse | rel=r_associated | relid=0 | w=10
  4897. en:white substance -- r_associated #0: 10 / 0.083 -> épiphyse cérébrale
    n1=en:white substance | n2=épiphyse cérébrale | rel=r_associated | relid=0 | w=10
  4898. en:white substance -- r_associated #0: 10 / 0.083 -> épiphyse
    (glande pinéale)
    n1=en:white substance | n2=épiphyse
    (glande pinéale)
    | rel=r_associated | relid=0 | w=10
  4899. en:white substance -- r_associated #0: 10 / 0.083 -> état nébuleux
    n1=en:white substance | n2=état nébuleux | rel=r_associated | relid=0 | w=10
  4900. en:white substance -- r_associated #0: 10 / 0.083 -> état vertigineux
    n1=en:white substance | n2=état vertigineux | rel=r_associated | relid=0 | w=10
  4901. en:white substance -- r_associated #0: 10 / 0.083 -> étourdissement
    n1=en:white substance | n2=étourdissement | rel=r_associated | relid=0 | w=10
  4902. en:white substance -- r_associated #0: 10 / 0.083 -> être dévissé
    n1=en:white substance | n2=être dévissé | rel=r_associated | relid=0 | w=10
  4903. en:white substance -- r_associated #0: 10 / 0.083 -> être en diminution
    n1=en:white substance | n2=être en diminution | rel=r_associated | relid=0 | w=10
  4904. en:white substance -- r_associated #0: 10 / 0.083 -> eye
    n1=en:white substance | n2=eye | rel=r_associated | relid=0 | w=10
  4905. en:white substance -- r_associated #0: 10 / 0.083 -> faciès anormal, retard de croissance et retard mental
    n1=en:white substance | n2=faciès anormal, retard de croissance et retard mental | rel=r_associated | relid=0 | w=10
  4906. en:white substance -- r_associated #0: 10 / 0.083 -> faiblesse de muscle
    n1=en:white substance | n2=faiblesse de muscle | rel=r_associated | relid=0 | w=10
  4907. en:white substance -- r_associated #0: 10 / 0.083 -> faiblesse du muscle
    n1=en:white substance | n2=faiblesse du muscle | rel=r_associated | relid=0 | w=10
  4908. en:white substance -- r_associated #0: 10 / 0.083 -> faiblesse musculaire
    n1=en:white substance | n2=faiblesse musculaire | rel=r_associated | relid=0 | w=10
  4909. en:white substance -- r_associated #0: 10 / 0.083 -> faire injure à
    n1=en:white substance | n2=faire injure à | rel=r_associated | relid=0 | w=10
  4910. en:white substance -- r_associated #0: 10 / 0.083 -> faire une chute
    n1=en:white substance | n2=faire une chute | rel=r_associated | relid=0 | w=10
  4911. en:white substance -- r_associated #0: 10 / 0.083 -> fasciculation
    n1=en:white substance | n2=fasciculation | rel=r_associated | relid=0 | w=10
  4912. en:white substance -- r_associated #0: 10 / 0.083 -> fasciculation d'un muscle squelettique
    n1=en:white substance | n2=fasciculation d'un muscle squelettique | rel=r_associated | relid=0 | w=10
  4913. en:white substance -- r_associated #0: 10 / 0.083 -> fasciculation musculaire
    n1=en:white substance | n2=fasciculation musculaire | rel=r_associated | relid=0 | w=10
  4914. en:white substance -- r_associated #0: 10 / 0.083 -> fibrillation
    n1=en:white substance | n2=fibrillation | rel=r_associated | relid=0 | w=10
  4915. en:white substance -- r_associated #0: 10 / 0.083 -> fièvre
    n1=en:white substance | n2=fièvre | rel=r_associated | relid=0 | w=10
  4916. en:white substance -- r_associated #0: 10 / 0.083 -> fièvre
    (médecine)
    n1=en:white substance | n2=fièvre
    (médecine)
    | rel=r_associated | relid=0 | w=10
  4917. en:white substance -- r_associated #0: 10 / 0.083 -> fonte musculaire
    n1=en:white substance | n2=fonte musculaire | rel=r_associated | relid=0 | w=10
  4918. en:white substance -- r_associated #0: 10 / 0.083 -> Fothergill
    n1=en:white substance | n2=Fothergill | rel=r_associated | relid=0 | w=10
  4919. en:white substance -- r_associated #0: 10 / 0.083 -> gaine de Schwann
    n1=en:white substance | n2=gaine de Schwann | rel=r_associated | relid=0 | w=10
  4920. en:white substance -- r_associated #0: 10 / 0.083 -> gaine de schwann
    n1=en:white substance | n2=gaine de schwann | rel=r_associated | relid=0 | w=10
  4921. en:white substance -- r_associated #0: 10 / 0.083 -> Gayet-Wernicke-Korsakoff (encéphalopathie de)
    n1=en:white substance | n2=Gayet-Wernicke-Korsakoff (encéphalopathie de) | rel=r_associated | relid=0 | w=10
  4922. en:white substance -- r_associated #0: 10 / 0.083 -> glande pinéale
    n1=en:white substance | n2=glande pinéale | rel=r_associated | relid=0 | w=10
  4923. en:white substance -- r_associated #0: 10 / 0.083 -> gliose
    n1=en:white substance | n2=gliose | rel=r_associated | relid=0 | w=10
  4924. en:white substance -- r_associated #0: 10 / 0.083 -> handicap moteur
    n1=en:white substance | n2=handicap moteur | rel=r_associated | relid=0 | w=10
  4925. en:white substance -- r_associated #0: 10 / 0.083 -> hæmorrhagie
    n1=en:white substance | n2=hæmorrhagie | rel=r_associated | relid=0 | w=10
  4926. en:white substance -- r_associated #0: 10 / 0.083 -> hémicéphalie
    n1=en:white substance | n2=hémicéphalie | rel=r_associated | relid=0 | w=10
  4927. en:white substance -- r_associated #0: 10 / 0.083 -> hémimégalencéphalie
    n1=en:white substance | n2=hémimégalencéphalie | rel=r_associated | relid=0 | w=10
  4928. en:white substance -- r_associated #0: 10 / 0.083 -> hémiparésie
    n1=en:white substance | n2=hémiparésie | rel=r_associated | relid=0 | w=10
  4929. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie
    n1=en:white substance | n2=hémorragie | rel=r_associated | relid=0 | w=10
  4930. en:white substance -- r_associated #0: 10 / 0.083 -> hemorragie
    n1=en:white substance | n2=hemorragie | rel=r_associated | relid=0 | w=10
  4931. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie cérébrale
    n1=en:white substance | n2=hémorragie cérébrale | rel=r_associated | relid=0 | w=10
  4932. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie du cerveau
    n1=en:white substance | n2=hémorragie du cerveau | rel=r_associated | relid=0 | w=10
  4933. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie encéphalique
    n1=en:white substance | n2=hémorragie encéphalique | rel=r_associated | relid=0 | w=10
  4934. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie intra-crânienne
    n1=en:white substance | n2=hémorragie intra-crânienne | rel=r_associated | relid=0 | w=10
  4935. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie intracranienne
    n1=en:white substance | n2=hémorragie intracranienne | rel=r_associated | relid=0 | w=10
  4936. en:white substance -- r_associated #0: 10 / 0.083 -> hémorragie intracrânienne
    n1=en:white substance | n2=hémorragie intracrânienne | rel=r_associated | relid=0 | w=10
  4937. en:white substance -- r_associated #0: 10 / 0.083 -> hémorrhagie
    n1=en:white substance | n2=hémorrhagie | rel=r_associated | relid=0 | w=10
  4938. en:white substance -- r_associated #0: 10 / 0.083 -> holoprosencéphalie
    n1=en:white substance | n2=holoprosencéphalie | rel=r_associated | relid=0 | w=10
  4939. en:white substance -- r_associated #0: 10 / 0.083 -> holoprosencéphalie de type 2
    n1=en:white substance | n2=holoprosencéphalie de type 2 | rel=r_associated | relid=0 | w=10
  4940. en:white substance -- r_associated #0: 10 / 0.083 -> holoprosencéphalie de type 3
    n1=en:white substance | n2=holoprosencéphalie de type 3 | rel=r_associated | relid=0 | w=10
  4941. en:white substance -- r_associated #0: 10 / 0.083 -> holoprosencéphalie de type 4
    n1=en:white substance | n2=holoprosencéphalie de type 4 | rel=r_associated | relid=0 | w=10
  4942. en:white substance -- r_associated #0: 10 / 0.083 -> holoprosencéphalie familiale alobaire de type 1
    n1=en:white substance | n2=holoprosencéphalie familiale alobaire de type 1 | rel=r_associated | relid=0 | w=10
  4943. en:white substance -- r_associated #0: 10 / 0.083 -> hydrocéphalie
    n1=en:white substance | n2=hydrocéphalie | rel=r_associated | relid=0 | w=10
  4944. en:white substance -- r_associated #0: 10 / 0.083 -> hydrocéphalie communicante
    n1=en:white substance | n2=hydrocéphalie communicante | rel=r_associated | relid=0 | w=10
  4945. en:white substance -- r_associated #0: 10 / 0.083 -> hydrocéphalies
    n1=en:white substance | n2=hydrocéphalies | rel=r_associated | relid=0 | w=10
  4946. en:white substance -- r_associated #0: 10 / 0.083 -> hyperactivité avec déficit de l'attention
    n1=en:white substance | n2=hyperactivité avec déficit de l'attention | rel=r_associated | relid=0 | w=10
  4947. en:white substance -- r_associated #0: 10 / 0.083 -> hyperthermie
    n1=en:white substance | n2=hyperthermie | rel=r_associated | relid=0 | w=10
  4948. en:white substance -- r_associated #0: 10 / 0.083 -> hypertonie
    n1=en:white substance | n2=hypertonie | rel=r_associated | relid=0 | w=10
  4949. en:white substance -- r_associated #0: 10 / 0.083 -> hypokinésie
    n1=en:white substance | n2=hypokinésie | rel=r_associated | relid=0 | w=10
  4950. en:white substance -- r_associated #0: 10 / 0.083 -> hypoplasie du nerf optique
    n1=en:white substance | n2=hypoplasie du nerf optique | rel=r_associated | relid=0 | w=10
  4951. en:white substance -- r_associated #0: 10 / 0.083 -> hypoplasie du nerf optique bilatérale et familiale
    n1=en:white substance | n2=hypoplasie du nerf optique bilatérale et familiale | rel=r_associated | relid=0 | w=10
  4952. en:white substance -- r_associated #0: 10 / 0.083 -> hypoplasie papillaire
    n1=en:white substance | n2=hypoplasie papillaire | rel=r_associated | relid=0 | w=10
  4953. en:white substance -- r_associated #0: 10 / 0.083 -> hypotension orthostatique
    n1=en:white substance | n2=hypotension orthostatique | rel=r_associated | relid=0 | w=10
  4954. en:white substance -- r_associated #0: 10 / 0.083 -> hypotension orthostatique neurogène
    n1=en:white substance | n2=hypotension orthostatique neurogène | rel=r_associated | relid=0 | w=10
  4955. en:white substance -- r_associated #0: 10 / 0.083 -> hypothalamus
    n1=en:white substance | n2=hypothalamus | rel=r_associated | relid=0 | w=10
  4956. en:white substance -- r_associated #0: 10 / 0.083 -> hypothyroïdie (manifestations neuromusculaires dans l')
    n1=en:white substance | n2=hypothyroïdie (manifestations neuromusculaires dans l') | rel=r_associated | relid=0 | w=10
  4957. en:white substance -- r_associated #0: 10 / 0.083 -> hypotonie
    n1=en:white substance | n2=hypotonie | rel=r_associated | relid=0 | w=10
  4958. en:white substance -- r_associated #0: 10 / 0.083 -> hypotonie du nouveau-né
    n1=en:white substance | n2=hypotonie du nouveau-né | rel=r_associated | relid=0 | w=10
  4959. en:white substance -- r_associated #0: 10 / 0.083 -> hypotonie musculaire
    n1=en:white substance | n2=hypotonie musculaire | rel=r_associated | relid=0 | w=10
  4960. en:white substance -- r_associated #0: 10 / 0.083 -> Hypotonie musculaire
    n1=en:white substance | n2=Hypotonie musculaire | rel=r_associated | relid=0 | w=10
  4961. en:white substance -- r_associated #0: 10 / 0.083 -> hypotonie, obésité et incisives proéminentes
    n1=en:white substance | n2=hypotonie, obésité et incisives proéminentes | rel=r_associated | relid=0 | w=10
  4962. en:white substance -- r_associated #0: 10 / 0.083 -> hysteria
    n1=en:white substance | n2=hysteria | rel=r_associated | relid=0 | w=10
  4963. en:white substance -- r_associated #0: 10 / 0.083 -> ictère nucléaire
    n1=en:white substance | n2=ictère nucléaire | rel=r_associated | relid=0 | w=10
  4964. en:white substance -- r_associated #0: 10 / 0.083 -> ictus apoplectique
    n1=en:white substance | n2=ictus apoplectique | rel=r_associated | relid=0 | w=10
  4965. en:white substance -- r_associated #0: 10 / 0.083 -> ictus cérébral
    n1=en:white substance | n2=ictus cérébral | rel=r_associated | relid=0 | w=10
  4966. en:white substance -- r_associated #0: 10 / 0.083 -> illicitement
    n1=en:white substance | n2=illicitement | rel=r_associated | relid=0 | w=10
  4967. en:white substance -- r_associated #0: 10 / 0.083 -> immobilité
    n1=en:white substance | n2=immobilité | rel=r_associated | relid=0 | w=10
  4968. en:white substance -- r_associated #0: 10 / 0.083 -> incapable de marcher
    n1=en:white substance | n2=incapable de marcher | rel=r_associated | relid=0 | w=10
  4969. en:white substance -- r_associated #0: 10 / 0.083 -> infarci
    n1=en:white substance | n2=infarci | rel=r_associated | relid=0 | w=10
  4970. en:white substance -- r_associated #0: 10 / 0.083 -> infarcissement
    n1=en:white substance | n2=infarcissement | rel=r_associated | relid=0 | w=10
  4971. en:white substance -- r_associated #0: 10 / 0.083 -> infarctus
    n1=en:white substance | n2=infarctus | rel=r_associated | relid=0 | w=10
  4972. en:white substance -- r_associated #0: 10 / 0.083 -> insuffisance hépatique transitoire
    n1=en:white substance | n2=insuffisance hépatique transitoire | rel=r_associated | relid=0 | w=10
  4973. en:white substance -- r_associated #0: 10 / 0.083 -> ivre mort
    n1=en:white substance | n2=ivre mort | rel=r_associated | relid=0 | w=10
  4974. en:white substance -- r_associated #0: 10 / 0.083 -> leuco-encéphalopathie
    n1=en:white substance | n2=leuco-encéphalopathie | rel=r_associated | relid=0 | w=10
  4975. en:white substance -- r_associated #0: 10 / 0.083 -> leucoencéphalopathie
    n1=en:white substance | n2=leucoencéphalopathie | rel=r_associated | relid=0 | w=10
  4976. en:white substance -- r_associated #0: 10 / 0.083 -> limbique (système)
    n1=en:white substance | n2=limbique (système) | rel=r_associated | relid=0 | w=10
  4977. en:white substance -- r_associated #0: 10 / 0.083 -> lissencéphalie
    n1=en:white substance | n2=lissencéphalie | rel=r_associated | relid=0 | w=10
  4978. en:white substance -- r_associated #0: 10 / 0.083 -> Lobe occipital
    n1=en:white substance | n2=Lobe occipital | rel=r_associated | relid=0 | w=10
  4979. en:white substance -- r_associated #0: 10 / 0.083 -> lobe occipital
    n1=en:white substance | n2=lobe occipital | rel=r_associated | relid=0 | w=10
  4980. en:white substance -- r_associated #0: 10 / 0.083 -> maladie affective bipolaire
    n1=en:white substance | n2=maladie affective bipolaire | rel=r_associated | relid=0 | w=10
  4981. en:white substance -- r_associated #0: 10 / 0.083 -> maladie cérébrovasculaire aiguë mal définie
    n1=en:white substance | n2=maladie cérébrovasculaire aiguë mal définie | rel=r_associated | relid=0 | w=10
  4982. en:white substance -- r_associated #0: 10 / 0.083 -> maladie de Gélineau
    n1=en:white substance | n2=maladie de Gélineau | rel=r_associated | relid=0 | w=10
  4983. en:white substance -- r_associated #0: 10 / 0.083 -> maladie de Trousseau
    n1=en:white substance | n2=maladie de Trousseau | rel=r_associated | relid=0 | w=10
  4984. en:white substance -- r_associated #0: 10 / 0.083 -> maladie de trousseau
    n1=en:white substance | n2=maladie de trousseau | rel=r_associated | relid=0 | w=10
  4985. en:white substance -- r_associated #0: 10 / 0.083 -> malaise vagal
    n1=en:white substance | n2=malaise vagal | rel=r_associated | relid=0 | w=10
  4986. en:white substance -- r_associated #0: 10 / 0.083 -> Malformation d'Arnold-Chiari
    n1=en:white substance | n2=Malformation d'Arnold-Chiari | rel=r_associated | relid=0 | w=10
  4987. en:white substance -- r_associated #0: 10 / 0.083 -> malformation d'arnold-chiari
    n1=en:white substance | n2=malformation d'arnold-chiari | rel=r_associated | relid=0 | w=10
  4988. en:white substance -- r_associated #0: 10 / 0.083 -> malformation d'Arnold-Chiari
    n1=en:white substance | n2=malformation d'Arnold-Chiari | rel=r_associated | relid=0 | w=10
  4989. en:white substance -- r_associated #0: 10 / 0.083 -> manifestations dyskinétiques tardives
    n1=en:white substance | n2=manifestations dyskinétiques tardives | rel=r_associated | relid=0 | w=10
  4990. en:white substance -- r_associated #0: 10 / 0.083 -> méninge
    n1=en:white substance | n2=méninge | rel=r_associated | relid=0 | w=10
  4991. en:white substance -- r_associated #0: 10 / 0.083 -> méninges
    n1=en:white substance | n2=méninges | rel=r_associated | relid=0 | w=10
  4992. en:white substance -- r_associated #0: 10 / 0.083 -> méningiome
    n1=en:white substance | n2=méningiome | rel=r_associated | relid=0 | w=10
  4993. en:white substance -- r_associated #0: 10 / 0.083 -> méningiome angiomateux
    n1=en:white substance | n2=méningiome angiomateux | rel=r_associated | relid=0 | w=10
  4994. en:white substance -- r_associated #0: 10 / 0.083 -> méningiomes
    n1=en:white substance | n2=méningiomes | rel=r_associated | relid=0 | w=10
  4995. en:white substance -- r_associated #0: 10 / 0.083 -> Méningiomes
    n1=en:white substance | n2=Méningiomes | rel=r_associated | relid=0 | w=10
  4996. en:white substance -- r_associated #0: 10 / 0.083 -> méningite
    n1=en:white substance | n2=méningite | rel=r_associated | relid=0 | w=10
  4997. en:white substance -- r_associated #0: 10 / 0.083 -> Méningite
    n1=en:white substance | n2=Méningite | rel=r_associated | relid=0 | w=10
  4998. en:white substance -- r_associated #0: 10 / 0.083 -> méningo-encéphalite
    n1=en:white substance | n2=méningo-encéphalite | rel=r_associated | relid=0 | w=10
  4999. en:white substance -- r_associated #0: 10 / 0.083 -> méningoencéphalite
    n1=en:white substance | n2=méningoencéphalite | rel=r_associated | relid=0 | w=10
  5000. en:white substance -- r_associated #0: 10 / 0.083 -> microbiologique
    n1=en:white substance | n2=microbiologique | rel=r_associated | relid=0 | w=10
  5001. en:white substance -- r_associated #0: 10 / 0.083 -> migraine accompagnée
    n1=en:white substance | n2=migraine accompagnée | rel=r_associated | relid=0 | w=10
  5002. en:white substance -- r_associated #0: 10 / 0.083 -> migraine avec aura
    n1=en:white substance | n2=migraine avec aura | rel=r_associated | relid=0 | w=10
  5003. en:white substance -- r_associated #0: 10 / 0.083 -> Moelle spinale
    n1=en:white substance | n2=Moelle spinale | rel=r_associated | relid=0 | w=10
  5004. en:white substance -- r_associated #0: 10 / 0.083 -> moelle spinale
    n1=en:white substance | n2=moelle spinale | rel=r_associated | relid=0 | w=10
  5005. en:white substance -- r_associated #0: 10 / 0.083 -> multiracial
    n1=en:white substance | n2=multiracial | rel=r_associated | relid=0 | w=10
  5006. en:white substance -- r_associated #0: 10 / 0.083 -> mutisme
    n1=en:white substance | n2=mutisme | rel=r_associated | relid=0 | w=10
  5007. en:white substance -- r_associated #0: 10 / 0.083 -> mutité
    n1=en:white substance | n2=mutité | rel=r_associated | relid=0 | w=10
  5008. en:white substance -- r_associated #0: 10 / 0.083 -> myatrophie
    n1=en:white substance | n2=myatrophie | rel=r_associated | relid=0 | w=10
  5009. en:white substance -- r_associated #0: 10 / 0.083 -> myélopathie
    n1=en:white substance | n2=myélopathie | rel=r_associated | relid=0 | w=10
  5010. en:white substance -- r_associated #0: 10 / 0.083 -> myokymie
    n1=en:white substance | n2=myokymie | rel=r_associated | relid=0 | w=10
  5011. en:white substance -- r_associated #0: 10 / 0.083 -> nanisme, retard mental, anomalies oculaires
    n1=en:white substance | n2=nanisme, retard mental, anomalies oculaires | rel=r_associated | relid=0 | w=10
  5012. en:white substance -- r_associated #0: 10 / 0.083 -> narcolepsie
    n1=en:white substance | n2=narcolepsie | rel=r_associated | relid=0 | w=10
  5013. en:white substance -- r_associated #0: 10 / 0.083 -> narcolepsy
    n1=en:white substance | n2=narcolepsy | rel=r_associated | relid=0 | w=10
  5014. en:white substance -- r_associated #0: 10 / 0.083 -> neuralgie trigéminale
    n1=en:white substance | n2=neuralgie trigéminale | rel=r_associated | relid=0 | w=10
  5015. en:white substance -- r_associated #0: 10 / 0.083 -> neurilemme
    n1=en:white substance | n2=neurilemme | rel=r_associated | relid=0 | w=10
  5016. en:white substance -- r_associated #0: 10 / 0.083 -> neurolemme
    n1=en:white substance | n2=neurolemme | rel=r_associated | relid=0 | w=10
  5017. en:white substance -- r_associated #0: 10 / 0.083 -> névralgie du nerf trijumeau
    n1=en:white substance | n2=névralgie du nerf trijumeau | rel=r_associated | relid=0 | w=10
  5018. en:white substance -- r_associated #0: 10 / 0.083 -> névralgie du trijumeau
    n1=en:white substance | n2=névralgie du trijumeau | rel=r_associated | relid=0 | w=10
  5019. en:white substance -- r_associated #0: 10 / 0.083 -> Névralgie du trijumeau
    n1=en:white substance | n2=Névralgie du trijumeau | rel=r_associated | relid=0 | w=10
  5020. en:white substance -- r_associated #0: 10 / 0.083 -> névralgie essentielle du trijumeau
    n1=en:white substance | n2=névralgie essentielle du trijumeau | rel=r_associated | relid=0 | w=10
  5021. en:white substance -- r_associated #0: 10 / 0.083 -> névralgie faciale
    n1=en:white substance | n2=névralgie faciale | rel=r_associated | relid=0 | w=10
  5022. en:white substance -- r_associated #0: 10 / 0.083 -> névralgie trigéminale
    n1=en:white substance | n2=névralgie trigéminale | rel=r_associated | relid=0 | w=10
  5023. en:white substance -- r_associated #0: 10 / 0.083 -> névraxe
    n1=en:white substance | n2=névraxe | rel=r_associated | relid=0 | w=10
  5024. en:white substance -- r_associated #0: 10 / 0.083 -> névrilème
    n1=en:white substance | n2=névrilème | rel=r_associated | relid=0 | w=10
  5025. en:white substance -- r_associated #0: 10 / 0.083 -> névrose
    n1=en:white substance | n2=névrose | rel=r_associated | relid=0 | w=10
  5026. en:white substance -- r_associated #0: 10 / 0.083 -> névrose (CIM et DSM)
    n1=en:white substance | n2=névrose (CIM et DSM) | rel=r_associated | relid=0 | w=10
  5027. en:white substance -- r_associated #0: 10 / 0.083 -> névroses
    n1=en:white substance | n2=névroses | rel=r_associated | relid=0 | w=10
  5028. en:white substance -- r_associated #0: 10 / 0.083 -> obnubilation
    n1=en:white substance | n2=obnubilation | rel=r_associated | relid=0 | w=10
  5029. en:white substance -- r_associated #0: 10 / 0.083 -> œil
    n1=en:white substance | n2=œil | rel=r_associated | relid=0 | w=10
  5030. en:white substance -- r_associated #0: 10 / 0.083 -> oligophrénie
    n1=en:white substance | n2=oligophrénie | rel=r_associated | relid=0 | w=10
  5031. en:white substance -- r_associated #0: 10 / 0.083 -> ophtalmoplégie, hypotonie, ataxie, hypoacousie et athétose
    n1=en:white substance | n2=ophtalmoplégie, hypotonie, ataxie, hypoacousie et athétose | rel=r_associated | relid=0 | w=10
  5032. en:white substance -- r_associated #0: 10 / 0.083 -> paa
    n1=en:white substance | n2=paa | rel=r_associated | relid=0 | w=10
  5033. en:white substance -- r_associated #0: 10 / 0.083 -> palpitation
    n1=en:white substance | n2=palpitation | rel=r_associated | relid=0 | w=10
  5034. en:white substance -- r_associated #0: 10 / 0.083 -> panne d'électricité
    n1=en:white substance | n2=panne d'électricité | rel=r_associated | relid=0 | w=10
  5035. en:white substance -- r_associated #0: 10 / 0.083 -> panne de courant
    n1=en:white substance | n2=panne de courant | rel=r_associated | relid=0 | w=10
  5036. en:white substance -- r_associated #0: 10 / 0.083 -> panne électrique
    n1=en:white substance | n2=panne électrique | rel=r_associated | relid=0 | w=10
  5037. en:white substance -- r_associated #0: 10 / 0.083 -> paralysie générale
    n1=en:white substance | n2=paralysie générale | rel=r_associated | relid=0 | w=10
  5038. en:white substance -- r_associated #0: 10 / 0.083 -> paralysis
    n1=en:white substance | n2=paralysis | rel=r_associated | relid=0 | w=10
  5039. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégie
    n1=en:white substance | n2=paraplégie | rel=r_associated | relid=0 | w=10
  5040. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégie ataxique
    n1=en:white substance | n2=paraplégie ataxique | rel=r_associated | relid=0 | w=10
  5041. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégie spasmodique
    n1=en:white substance | n2=paraplégie spasmodique | rel=r_associated | relid=0 | w=10
  5042. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégie spastique
    n1=en:white substance | n2=paraplégie spastique | rel=r_associated | relid=0 | w=10
  5043. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégie spastique avec atrophie optique et démence
    n1=en:white substance | n2=paraplégie spastique avec atrophie optique et démence | rel=r_associated | relid=0 | w=10
  5044. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégie spastique familiale
    n1=en:white substance | n2=paraplégie spastique familiale | rel=r_associated | relid=0 | w=10
  5045. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégies
    n1=en:white substance | n2=paraplégies | rel=r_associated | relid=0 | w=10
  5046. en:white substance -- r_associated #0: 10 / 0.083 -> paraplégique
    n1=en:white substance | n2=paraplégique | rel=r_associated | relid=0 | w=10
  5047. en:white substance -- r_associated #0: 10 / 0.083 -> parasitologie
    n1=en:white substance | n2=parasitologie | rel=r_associated | relid=0 | w=10
  5048. en:white substance -- r_associated #0: 10 / 0.083 -> parésie
    n1=en:white substance | n2=parésie | rel=r_associated | relid=0 | w=10
  5049. en:white substance -- r_associated #0: 10 / 0.083 -> parésié
    n1=en:white substance | n2=parésié | rel=r_associated | relid=0 | w=10
  5050. en:white substance -- r_associated #0: 10 / 0.083 -> parésie musculaire
    n1=en:white substance | n2=parésie musculaire | rel=r_associated | relid=0 | w=10
  5051. en:white substance -- r_associated #0: 10 / 0.083 -> parkinsonisme
    n1=en:white substance | n2=parkinsonisme | rel=r_associated | relid=0 | w=10
  5052. en:white substance -- r_associated #0: 10 / 0.083 -> partie centrale du système nerveux
    n1=en:white substance | n2=partie centrale du système nerveux | rel=r_associated | relid=0 | w=10
  5053. en:white substance -- r_associated #0: 10 / 0.083 -> partir à vau-l'eau
    n1=en:white substance | n2=partir à vau-l'eau | rel=r_associated | relid=0 | w=10
  5054. en:white substance -- r_associated #0: 10 / 0.083 -> passer en seconde
    n1=en:white substance | n2=passer en seconde | rel=r_associated | relid=0 | w=10
  5055. en:white substance -- r_associated #0: 10 / 0.083 -> pause cardiaque
    n1=en:white substance | n2=pause cardiaque | rel=r_associated | relid=0 | w=10
  5056. en:white substance -- r_associated #0: 10 / 0.083 -> perte d'audition sensorineurale
    n1=en:white substance | n2=perte d'audition sensorineurale | rel=r_associated | relid=0 | w=10
  5057. en:white substance -- r_associated #0: 10 / 0.083 -> perte de connaissance
    n1=en:white substance | n2=perte de connaissance | rel=r_associated | relid=0 | w=10
  5058. en:white substance -- r_associated #0: 10 / 0.083 -> Perte de connaissance
    n1=en:white substance | n2=Perte de connaissance | rel=r_associated | relid=0 | w=10
  5059. en:white substance -- r_associated #0: 10 / 0.083 -> perte de conscience
    n1=en:white substance | n2=perte de conscience | rel=r_associated | relid=0 | w=10
  5060. en:white substance -- r_associated #0: 10 / 0.083 -> pleuvoir à seaux
    n1=en:white substance | n2=pleuvoir à seaux | rel=r_associated | relid=0 | w=10
  5061. en:white substance -- r_associated #0: 10 / 0.083 -> pleuvoir à torrents
    n1=en:white substance | n2=pleuvoir à torrents | rel=r_associated | relid=0 | w=10
  5062. en:white substance -- r_associated #0: 10 / 0.083 -> pleuvoir à verse
    n1=en:white substance | n2=pleuvoir à verse | rel=r_associated | relid=0 | w=10
  5063. en:white substance -- r_associated #0: 10 / 0.083 -> pleuvoir comme vache qui pisse
    n1=en:white substance | n2=pleuvoir comme vache qui pisse | rel=r_associated | relid=0 | w=10
  5064. en:white substance -- r_associated #0: 10 / 0.083 -> pleuvoir des cordes
    n1=en:white substance | n2=pleuvoir des cordes | rel=r_associated | relid=0 | w=10
  5065. en:white substance -- r_associated #0: 10 / 0.083 -> pleuvoir des hallebardes
    n1=en:white substance | n2=pleuvoir des hallebardes | rel=r_associated | relid=0 | w=10
  5066. en:white substance -- r_associated #0: 10 / 0.083 -> polio
    n1=en:white substance | n2=polio | rel=r_associated | relid=0 | w=10
  5067. en:white substance -- r_associated #0: 10 / 0.083 -> poliomyélite aiguë
    n1=en:white substance | n2=poliomyélite aiguë | rel=r_associated | relid=0 | w=10
  5068. en:white substance -- r_associated #0: 10 / 0.083 -> poliomyélite aigüe
    n1=en:white substance | n2=poliomyélite aigüe | rel=r_associated | relid=0 | w=10
  5069. en:white substance -- r_associated #0: 10 / 0.083 -> poussée fébrile
    n1=en:white substance | n2=poussée fébrile | rel=r_associated | relid=0 | w=10
  5070. en:white substance -- r_associated #0: 10 / 0.083 -> prendre un gadin
    n1=en:white substance | n2=prendre un gadin | rel=r_associated | relid=0 | w=10
  5071. en:white substance -- r_associated #0: 10 / 0.083 -> prendre une bûche
    n1=en:white substance | n2=prendre une bûche | rel=r_associated | relid=0 | w=10
  5072. en:white substance -- r_associated #0: 10 / 0.083 -> prendre une gamelle
    n1=en:white substance | n2=prendre une gamelle | rel=r_associated | relid=0 | w=10
  5073. en:white substance -- r_associated #0: 10 / 0.083 -> psychose désintégrative
    n1=en:white substance | n2=psychose désintégrative | rel=r_associated | relid=0 | w=10
  5074. en:white substance -- r_associated #0: 10 / 0.083 -> psychose maniaco-dépressive
    n1=en:white substance | n2=psychose maniaco-dépressive | rel=r_associated | relid=0 | w=10
  5075. en:white substance -- r_associated #0: 10 / 0.083 -> psychose, hyponatrémie intermittente, polydipsie (syndrome)
    n1=en:white substance | n2=psychose, hyponatrémie intermittente, polydipsie (syndrome) | rel=r_associated | relid=0 | w=10
  5076. en:white substance -- r_associated #0: 10 / 0.083 -> quadriplégie spastique, rétinite pigmentaire et retard mental
    n1=en:white substance | n2=quadriplégie spastique, rétinite pigmentaire et retard mental | rel=r_associated | relid=0 | w=10
  5077. en:white substance -- r_associated #0: 10 / 0.083 -> queue de cheval (syndrome de la)
    n1=en:white substance | n2=queue de cheval (syndrome de la) | rel=r_associated | relid=0 | w=10
  5078. en:white substance -- r_associated #0: 10 / 0.083 -> rabaisser [qch]
    n1=en:white substance | n2=rabaisser [qch] | rel=r_associated | relid=0 | w=10
  5079. en:white substance -- r_associated #0: 10 / 0.083 -> radiographique
    n1=en:white substance | n2=radiographique | rel=r_associated | relid=0 | w=10
  5080. en:white substance -- r_associated #0: 10 / 0.083 -> ramasser un gadin
    n1=en:white substance | n2=ramasser un gadin | rel=r_associated | relid=0 | w=10
  5081. en:white substance -- r_associated #0: 10 / 0.083 -> ramasser une gamelle
    n1=en:white substance | n2=ramasser une gamelle | rel=r_associated | relid=0 | w=10
  5082. en:white substance -- r_associated #0: 10 / 0.083 -> ramasser une pelle
    n1=en:white substance | n2=ramasser une pelle | rel=r_associated | relid=0 | w=10
  5083. en:white substance -- r_associated #0: 10 / 0.083 -> réaction schizoïde
    n1=en:white substance | n2=réaction schizoïde | rel=r_associated | relid=0 | w=10
  5084. en:white substance -- r_associated #0: 10 / 0.083 -> réaction schizophrène
    n1=en:white substance | n2=réaction schizophrène | rel=r_associated | relid=0 | w=10
  5085. en:white substance -- r_associated #0: 10 / 0.083 -> réaction schizophrénique
    n1=en:white substance | n2=réaction schizophrénique | rel=r_associated | relid=0 | w=10
  5086. en:white substance -- r_associated #0: 10 / 0.083 -> retard mental
    n1=en:white substance | n2=retard mental | rel=r_associated | relid=0 | w=10
  5087. en:white substance -- r_associated #0: 10 / 0.083 -> Retard mental
    n1=en:white substance | n2=Retard mental | rel=r_associated | relid=0 | w=10
  5088. en:white substance -- r_associated #0: 10 / 0.083 -> retard mental, retard de croissance, surdité, microgénitalisme lié au sexe
    n1=en:white substance | n2=retard mental, retard de croissance, surdité, microgénitalisme lié au sexe | rel=r_associated | relid=0 | w=10
  5089. en:white substance -- r_associated #0: 10 / 0.083 -> retardation mentale
    n1=en:white substance | n2=retardation mentale | rel=r_associated | relid=0 | w=10
  5090. en:white substance -- r_associated #0: 10 / 0.083 -> rétinite pigmentaire et retard mental
    n1=en:white substance | n2=rétinite pigmentaire et retard mental | rel=r_associated | relid=0 | w=10
  5091. en:white substance -- r_associated #0: 10 / 0.083 -> rétinite pigmentaire, surdité, retard mental, et hypogonadisme
    n1=en:white substance | n2=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | rel=r_associated | relid=0 | w=10
  5092. en:white substance -- r_associated #0: 10 / 0.083 -> rigidité musculaire
    n1=en:white substance | n2=rigidité musculaire | rel=r_associated | relid=0 | w=10
  5093. en:white substance -- r_associated #0: 10 / 0.083 -> s'abattre
    n1=en:white substance | n2=s'abattre | rel=r_associated | relid=0 | w=10
  5094. en:white substance -- r_associated #0: 10 / 0.083 -> s'afficher en baisse
    n1=en:white substance | n2=s'afficher en baisse | rel=r_associated | relid=0 | w=10
  5095. en:white substance -- r_associated #0: 10 / 0.083 -> s'amortir
    n1=en:white substance | n2=s'amortir | rel=r_associated | relid=0 | w=10
  5096. en:white substance -- r_associated #0: 10 / 0.083 -> s'étaler de tout son long
    n1=en:white substance | n2=s'étaler de tout son long | rel=r_associated | relid=0 | w=10
  5097. en:white substance -- r_associated #0: 10 / 0.083 -> schizophrenia
    n1=en:white substance | n2=schizophrenia | rel=r_associated | relid=0 | w=10
  5098. en:white substance -- r_associated #0: 10 / 0.083 -> schizophrénie
    n1=en:white substance | n2=schizophrénie | rel=r_associated | relid=0 | w=10
  5099. en:white substance -- r_associated #0: 10 / 0.083 -> Schwann (gaine de)
    n1=en:white substance | n2=Schwann (gaine de) | rel=r_associated | relid=0 | w=10
  5100. en:white substance -- r_associated #0: 10 / 0.083 -> se baisser
    n1=en:white substance | n2=se baisser | rel=r_associated | relid=0 | w=10
  5101. en:white substance -- r_associated #0: 10 / 0.083 -> se casser la margoulette
    n1=en:white substance | n2=se casser la margoulette | rel=r_associated | relid=0 | w=10
  5102. en:white substance -- r_associated #0: 10 / 0.083 -> se dévisser
    n1=en:white substance | n2=se dévisser | rel=r_associated | relid=0 | w=10
  5103. en:white substance -- r_associated #0: 10 / 0.083 -> se projeter
    n1=en:white substance | n2=se projeter | rel=r_associated | relid=0 | w=10
  5104. en:white substance -- r_associated #0: 10 / 0.083 -> se retrouver cul par-dessus tête
    n1=en:white substance | n2=se retrouver cul par-dessus tête | rel=r_associated | relid=0 | w=10
  5105. en:white substance -- r_associated #0: 10 / 0.083 -> secousse musculaire
    n1=en:white substance | n2=secousse musculaire | rel=r_associated | relid=0 | w=10
  5106. en:white substance -- r_associated #0: 10 / 0.083 -> sensation de rotation
    n1=en:white substance | n2=sensation de rotation | rel=r_associated | relid=0 | w=10
  5107. en:white substance -- r_associated #0: 10 / 0.083 -> sensation de tournoiement
    n1=en:white substance | n2=sensation de tournoiement | rel=r_associated | relid=0 | w=10
  5108. en:white substance -- r_associated #0: 10 / 0.083 -> sensation rotatoire
    n1=en:white substance | n2=sensation rotatoire | rel=r_associated | relid=0 | w=10
  5109. en:white substance -- r_associated #0: 10 / 0.083 -> sensation vertigineuse
    n1=en:white substance | n2=sensation vertigineuse | rel=r_associated | relid=0 | w=10
  5110. en:white substance -- r_associated #0: 10 / 0.083 -> somnolence
    n1=en:white substance | n2=somnolence | rel=r_associated | relid=0 | w=10
  5111. en:white substance -- r_associated #0: 10 / 0.083 -> sous la table
    n1=en:white substance | n2=sous la table | rel=r_associated | relid=0 | w=10
  5112. en:white substance -- r_associated #0: 10 / 0.083 -> stroke
    n1=en:white substance | n2=stroke | rel=r_associated | relid=0 | w=10
  5113. en:white substance -- r_associated #0: 10 / 0.083 -> Substance grise
    n1=en:white substance | n2=Substance grise | rel=r_associated | relid=0 | w=10
  5114. en:white substance -- r_associated #0: 10 / 0.083 -> suffocation
    n1=en:white substance | n2=suffocation | rel=r_associated | relid=0 | w=10
  5115. en:white substance -- r_associated #0: 10 / 0.083 -> surdi-mutité
    n1=en:white substance | n2=surdi-mutité | rel=r_associated | relid=0 | w=10
  5116. en:white substance -- r_associated #0: 10 / 0.083 -> surdimutité
    n1=en:white substance | n2=surdimutité | rel=r_associated | relid=0 | w=10
  5117. en:white substance -- r_associated #0: 10 / 0.083 -> syncope blanche
    n1=en:white substance | n2=syncope blanche | rel=r_associated | relid=0 | w=10
  5118. en:white substance -- r_associated #0: 10 / 0.083 -> syncope bleue
    n1=en:white substance | n2=syncope bleue | rel=r_associated | relid=0 | w=10
  5119. en:white substance -- r_associated #0: 10 / 0.083 -> syncope due à la chaleur
    n1=en:white substance | n2=syncope due à la chaleur | rel=r_associated | relid=0 | w=10
  5120. en:white substance -- r_associated #0: 10 / 0.083 -> syncope et collapsus
    n1=en:white substance | n2=syncope et collapsus | rel=r_associated | relid=0 | w=10
  5121. en:white substance -- r_associated #0: 10 / 0.083 -> syncope psychogène
    n1=en:white substance | n2=syncope psychogène | rel=r_associated | relid=0 | w=10
  5122. en:white substance -- r_associated #0: 10 / 0.083 -> syndrome de la queue de cheval
    n1=en:white substance | n2=syndrome de la queue de cheval | rel=r_associated | relid=0 | w=10
  5123. en:white substance -- r_associated #0: 10 / 0.083 -> Syndrome de la queue de cheval
    n1=en:white substance | n2=Syndrome de la queue de cheval | rel=r_associated | relid=0 | w=10
  5124. en:white substance -- r_associated #0: 10 / 0.083 -> syndrome du cône terminal
    n1=en:white substance | n2=syndrome du cône terminal | rel=r_associated | relid=0 | w=10
  5125. en:white substance -- r_associated #0: 10 / 0.083 -> syndrome du sinus carotidien
    n1=en:white substance | n2=syndrome du sinus carotidien | rel=r_associated | relid=0 | w=10
  5126. en:white substance -- r_associated #0: 10 / 0.083 -> système central nerveux
    n1=en:white substance | n2=système central nerveux | rel=r_associated | relid=0 | w=10
  5127. en:white substance -- r_associated #0: 10 / 0.083 -> système endocrine
    n1=en:white substance | n2=système endocrine | rel=r_associated | relid=0 | w=10
  5128. en:white substance -- r_associated #0: 10 / 0.083 -> système endocrinien
    n1=en:white substance | n2=système endocrinien | rel=r_associated | relid=0 | w=10
  5129. en:white substance -- r_associated #0: 10 / 0.083 -> système extrapyramidal
    n1=en:white substance | n2=système extrapyramidal | rel=r_associated | relid=0 | w=10
  5130. en:white substance -- r_associated #0: 10 / 0.083 -> système limbique
    n1=en:white substance | n2=système limbique | rel=r_associated | relid=0 | w=10
  5131. en:white substance -- r_associated #0: 10 / 0.083 -> Système limbique
    n1=en:white substance | n2=Système limbique | rel=r_associated | relid=0 | w=10
  5132. en:white substance -- r_associated #0: 10 / 0.083 -> Système Nerveux Central
    n1=en:white substance | n2=Système Nerveux Central | rel=r_associated | relid=0 | w=10
  5133. en:white substance -- r_associated #0: 10 / 0.083 -> température corporelle élevée
    n1=en:white substance | n2=température corporelle élevée | rel=r_associated | relid=0 | w=10
  5134. en:white substance -- r_associated #0: 10 / 0.083 -> tête pensante
    n1=en:white substance | n2=tête pensante | rel=r_associated | relid=0 | w=10
  5135. en:white substance -- r_associated #0: 10 / 0.083 -> tête pivotante
    n1=en:white substance | n2=tête pivotante | rel=r_associated | relid=0 | w=10
  5136. en:white substance -- r_associated #0: 10 / 0.083 -> thrombose artérielle cérébrale
    n1=en:white substance | n2=thrombose artérielle cérébrale | rel=r_associated | relid=0 | w=10
  5137. en:white substance -- r_associated #0: 10 / 0.083 -> thrombose d'un sinus sagittal
    n1=en:white substance | n2=thrombose d'un sinus sagittal | rel=r_associated | relid=0 | w=10
  5138. en:white substance -- r_associated #0: 10 / 0.083 -> thrombose de l'artère cérébrale
    n1=en:white substance | n2=thrombose de l'artère cérébrale | rel=r_associated | relid=0 | w=10
  5139. en:white substance -- r_associated #0: 10 / 0.083 -> thrombose de sinus sagittaux
    n1=en:white substance | n2=thrombose de sinus sagittaux | rel=r_associated | relid=0 | w=10
  5140. en:white substance -- r_associated #0: 10 / 0.083 -> thrombose des sinus sagittaux
    n1=en:white substance | n2=thrombose des sinus sagittaux | rel=r_associated | relid=0 | w=10
  5141. en:white substance -- r_associated #0: 10 / 0.083 -> thrombose du sinus sagittal
    n1=en:white substance | n2=thrombose du sinus sagittal | rel=r_associated | relid=0 | w=10
  5142. en:white substance -- r_associated #0: 10 / 0.083 -> tic douloureux
    n1=en:white substance | n2=tic douloureux | rel=r_associated | relid=0 | w=10
  5143. en:white substance -- r_associated #0: 10 / 0.083 -> tic douloureux de la face
    n1=en:white substance | n2=tic douloureux de la face | rel=r_associated | relid=0 | w=10
  5144. en:white substance -- r_associated #0: 10 / 0.083 -> tics douloureux de la face
    n1=en:white substance | n2=tics douloureux de la face | rel=r_associated | relid=0 | w=10
  5145. en:white substance -- r_associated #0: 10 / 0.083 -> tomber à plat ventre
    n1=en:white substance | n2=tomber à plat ventre | rel=r_associated | relid=0 | w=10
  5146. en:white substance -- r_associated #0: 10 / 0.083 -> tomber à seaux
    n1=en:white substance | n2=tomber à seaux | rel=r_associated | relid=0 | w=10
  5147. en:white substance -- r_associated #0: 10 / 0.083 -> tomber comme à Gravelotte
    n1=en:white substance | n2=tomber comme à Gravelotte | rel=r_associated | relid=0 | w=10
  5148. en:white substance -- r_associated #0: 10 / 0.083 -> tomber de tout son long
    n1=en:white substance | n2=tomber de tout son long | rel=r_associated | relid=0 | w=10
  5149. en:white substance -- r_associated #0: 10 / 0.083 -> tomber des cordes
    n1=en:white substance | n2=tomber des cordes | rel=r_associated | relid=0 | w=10
  5150. en:white substance -- r_associated #0: 10 / 0.083 -> tomber des hallebardes
    n1=en:white substance | n2=tomber des hallebardes | rel=r_associated | relid=0 | w=10
  5151. en:white substance -- r_associated #0: 10 / 0.083 -> tomber en décrépitude
    n1=en:white substance | n2=tomber en décrépitude | rel=r_associated | relid=0 | w=10
  5152. en:white substance -- r_associated #0: 10 / 0.083 -> tomber en miettes
    n1=en:white substance | n2=tomber en miettes | rel=r_associated | relid=0 | w=10
  5153. en:white substance -- r_associated #0: 10 / 0.083 -> tomber en panne
    n1=en:white substance | n2=tomber en panne | rel=r_associated | relid=0 | w=10
  5154. en:white substance -- r_associated #0: 10 / 0.083 -> tomber en rideau
    n1=en:white substance | n2=tomber en rideau | rel=r_associated | relid=0 | w=10
  5155. en:white substance -- r_associated #0: 10 / 0.083 -> tomber en ruine
    n1=en:white substance | n2=tomber en ruine | rel=r_associated | relid=0 | w=10
  5156. en:white substance -- r_associated #0: 10 / 0.083 -> tomber en ruines
    n1=en:white substance | n2=tomber en ruines | rel=r_associated | relid=0 | w=10
  5157. en:white substance -- r_associated #0: 10 / 0.083 -> tomber la tête la première
    n1=en:white substance | n2=tomber la tête la première | rel=r_associated | relid=0 | w=10
  5158. en:white substance -- r_associated #0: 10 / 0.083 -> tomber par terre
    n1=en:white substance | n2=tomber par terre | rel=r_associated | relid=0 | w=10
  5159. en:white substance -- r_associated #0: 10 / 0.083 -> torticolis
    n1=en:white substance | n2=torticolis | rel=r_associated | relid=0 | w=10
  5160. en:white substance -- r_associated #0: 10 / 0.083 -> tremblement essentiel
    n1=en:white substance | n2=tremblement essentiel | rel=r_associated | relid=0 | w=10
  5161. en:white substance -- r_associated #0: 10 / 0.083 -> tremblement essentiel bénin
    n1=en:white substance | n2=tremblement essentiel bénin | rel=r_associated | relid=0 | w=10
  5162. en:white substance -- r_associated #0: 10 / 0.083 -> tremblement familial
    n1=en:white substance | n2=tremblement familial | rel=r_associated | relid=0 | w=10
  5163. en:white substance -- r_associated #0: 10 / 0.083 -> tremblement héréditaire bénin
    n1=en:white substance | n2=tremblement héréditaire bénin | rel=r_associated | relid=0 | w=10
  5164. en:white substance -- r_associated #0: 10 / 0.083 -> tremor
    n1=en:white substance | n2=tremor | rel=r_associated | relid=0 | w=10
  5165. en:white substance -- r_associated #0: 10 / 0.083 -> trémor
    n1=en:white substance | n2=trémor | rel=r_associated | relid=0 | w=10
  5166. en:white substance -- r_associated #0: 10 / 0.083 -> trijumeau (névralgie du)
    n1=en:white substance | n2=trijumeau (névralgie du) | rel=r_associated | relid=0 | w=10
  5167. en:white substance -- r_associated #0: 10 / 0.083 -> trismus
    n1=en:white substance | n2=trismus | rel=r_associated | relid=0 | w=10
  5168. en:white substance -- r_associated #0: 10 / 0.083 -> tronc cérébral
    n1=en:white substance | n2=tronc cérébral | rel=r_associated | relid=0 | w=10
  5169. en:white substance -- r_associated #0: 10 / 0.083 -> Tronc cérébral
    n1=en:white substance | n2=Tronc cérébral | rel=r_associated | relid=0 | w=10
  5170. en:white substance -- r_associated #0: 10 / 0.083 -> Trouble bipolaire
    n1=en:white substance | n2=Trouble bipolaire | rel=r_associated | relid=0 | w=10
  5171. en:white substance -- r_associated #0: 10 / 0.083 -> trouble bipolaire
    n1=en:white substance | n2=trouble bipolaire | rel=r_associated | relid=0 | w=10
  5172. en:white substance -- r_associated #0: 10 / 0.083 -> trouble de l'élocution
    n1=en:white substance | n2=trouble de l'élocution | rel=r_associated | relid=0 | w=10
  5173. en:white substance -- r_associated #0: 10 / 0.083 -> trouble de l'équilibre
    n1=en:white substance | n2=trouble de l'équilibre | rel=r_associated | relid=0 | w=10
  5174. en:white substance -- r_associated #0: 10 / 0.083 -> trouble de la personnalité
    n1=en:white substance | n2=trouble de la personnalité | rel=r_associated | relid=0 | w=10
  5175. en:white substance -- r_associated #0: 10 / 0.083 -> Trouble de la personnalité
    n1=en:white substance | n2=Trouble de la personnalité | rel=r_associated | relid=0 | w=10
  5176. en:white substance -- r_associated #0: 10 / 0.083 -> trouble du caractère
    n1=en:white substance | n2=trouble du caractère | rel=r_associated | relid=0 | w=10
  5177. en:white substance -- r_associated #0: 10 / 0.083 -> trouble mental
    n1=en:white substance | n2=trouble mental | rel=r_associated | relid=0 | w=10
  5178. en:white substance -- r_associated #0: 10 / 0.083 -> trouble psychiatrique
    n1=en:white substance | n2=trouble psychiatrique | rel=r_associated | relid=0 | w=10
  5179. en:white substance -- r_associated #0: 10 / 0.083 -> Trouble psychique
    n1=en:white substance | n2=Trouble psychique | rel=r_associated | relid=0 | w=10
  5180. en:white substance -- r_associated #0: 10 / 0.083 -> troubles névrotiques
    n1=en:white substance | n2=troubles névrotiques | rel=r_associated | relid=0 | w=10
  5181. en:white substance -- r_associated #0: 10 / 0.083 -> tumeur du système nerveux central
    n1=en:white substance | n2=tumeur du système nerveux central | rel=r_associated | relid=0 | w=10
  5182. en:white substance -- r_associated #0: 10 / 0.083 -> vasovagale (syncope)
    n1=en:white substance | n2=vasovagale (syncope) | rel=r_associated | relid=0 | w=10
  5183. en:white substance -- r_associated #0: 10 / 0.083 -> ventriculomégalie cérébrale
    n1=en:white substance | n2=ventriculomégalie cérébrale | rel=r_associated | relid=0 | w=10
  5184. en:white substance -- r_associated #0: 10 / 0.083 -> vertige
    n1=en:white substance | n2=vertige | rel=r_associated | relid=0 | w=10
  5185. en:white substance -- r_associated #0: 10 / 0.083 -> vertige rotatoire
    n1=en:white substance | n2=vertige rotatoire | rel=r_associated | relid=0 | w=10
  5186. en:white substance -- r_associated #0: 10 / 0.083 -> vertige subjectif
    n1=en:white substance | n2=vertige subjectif | rel=r_associated | relid=0 | w=10
  5187. en:white substance -- r_associated #0: 10 / 0.083 -> vertigo
    n1=en:white substance | n2=vertigo | rel=r_associated | relid=0 | w=10
  5188. en:white substance -- r_associated #0: 10 / 0.083 -> vertigo rotatoire
    n1=en:white substance | n2=vertigo rotatoire | rel=r_associated | relid=0 | w=10
  5189. en:white substance -- r_associated #0: 10 / 0.083 -> Voile noir
    n1=en:white substance | n2=Voile noir | rel=r_associated | relid=0 | w=10
  5190. en:white substance -- r_associated #0: 10 / 0.083 -> voile noir
    n1=en:white substance | n2=voile noir | rel=r_associated | relid=0 | w=10
  5191. en:white substance -- r_associated #0: 10 / 0.083 -> Went (atrophie optique liée au sexe de)
    n1=en:white substance | n2=Went (atrophie optique liée au sexe de) | rel=r_associated | relid=0 | w=10
  5192. en:white substance -- r_associated #0: 10 / 0.083 -> yeux
    n1=en:white substance | n2=yeux | rel=r_associated | relid=0 | w=10
  5193. en:white substance -- r_associated #0: 5 / 0.041 -> de gypse
    n1=en:white substance | n2=de gypse | rel=r_associated | relid=0 | w=5
  5194. en:white substance -- r_associated #0: 5 / 0.041 -> en:diffusion magnetic resonance imaging
    n1=en:white substance | n2=en:diffusion magnetic resonance imaging | rel=r_associated | relid=0 | w=5
  5195. en:white substance -- r_associated #0: 5 / 0.041 -> en:diffusion mri
    n1=en:white substance | n2=en:diffusion mri | rel=r_associated | relid=0 | w=5
  5196. en:white substance -- r_associated #0: 5 / 0.041 -> en:gypsum
    n1=en:white substance | n2=en:gypsum | rel=r_associated | relid=0 | w=5
  5197. en:white substance -- r_associated #0: 5 / 0.041 -> en:leukodystrophia
    n1=en:white substance | n2=en:leukodystrophia | rel=r_associated | relid=0 | w=5
  5198. en:white substance -- r_associated #0: 5 / 0.041 -> en:plaster
    n1=en:white substance | n2=en:plaster | rel=r_associated | relid=0 | w=5
  5199. en:white substance -- r_associated #0: 5 / 0.041 -> imagerie de diffusion en irm
    n1=en:white substance | n2=imagerie de diffusion en irm | rel=r_associated | relid=0 | w=5
  5200. en:white substance -- r_associated #0: 5 / 0.041 -> imagerie de diffusion en IRM
    n1=en:white substance | n2=imagerie de diffusion en IRM | rel=r_associated | relid=0 | w=5
  5201. en:white substance -- r_associated #0: 5 / 0.041 -> imagerie de diffusion par résonance magnétique
    n1=en:white substance | n2=imagerie de diffusion par résonance magnétique | rel=r_associated | relid=0 | w=5
  5202. en:white substance -- r_associated #0: 5 / 0.041 -> imagerie par résonance magnétique de diffusion
    n1=en:white substance | n2=imagerie par résonance magnétique de diffusion | rel=r_associated | relid=0 | w=5
  5203. en:white substance -- r_associated #0: 5 / 0.041 -> IRM de diffusion
    n1=en:white substance | n2=IRM de diffusion | rel=r_associated | relid=0 | w=5
  5204. en:white substance -- r_associated #0: 5 / 0.041 -> leucodystrophie
    n1=en:white substance | n2=leucodystrophie | rel=r_associated | relid=0 | w=5
  5205. en:white substance -- r_associated #0: 5 / 0.041 -> leucodystrophie de l'adulte
    n1=en:white substance | n2=leucodystrophie de l'adulte | rel=r_associated | relid=0 | w=5
  5206. en:white substance -- r_associated #0: 5 / 0.041 -> plâtre
    n1=en:white substance | n2=plâtre | rel=r_associated | relid=0 | w=5
≈ 4728 relations entrantes

  1. matière blanche --- r_associated #0: 57 --> en:white substance
    n1=matière blanche | n2=en:white substance | rel=r_associated | relid=0 | w=57
  2. en:white matter --- r_associated #0: 55 --> en:white substance
    n1=en:white matter | n2=en:white substance | rel=r_associated | relid=0 | w=55
  3. substance blanche --- r_associated #0: 50 --> en:white substance
    n1=substance blanche | n2=en:white substance | rel=r_associated | relid=0 | w=50
  4. en:substantia alba --- r_associated #0: 46 --> en:white substance
    n1=en:substantia alba | n2=en:white substance | rel=r_associated | relid=0 | w=46
  5. hyposomnie --- r_associated #0: 45 --> en:white substance
    n1=hyposomnie | n2=en:white substance | rel=r_associated | relid=0 | w=45
  6. trouble insomniaque --- r_associated #0: 45 --> en:white substance
    n1=trouble insomniaque | n2=en:white substance | rel=r_associated | relid=0 | w=45
  7. en:insomnia --- r_associated #0: 40 --> en:white substance
    n1=en:insomnia | n2=en:white substance | rel=r_associated | relid=0 | w=40
  8. en:white material --- r_associated #0: 40 --> en:white substance
    n1=en:white material | n2=en:white substance | rel=r_associated | relid=0 | w=40
  9. trouble endormissement et maintien du sommeil --- r_associated #0: 40 --> en:white substance
    n1=trouble endormissement et maintien du sommeil | n2=en:white substance | rel=r_associated | relid=0 | w=40
  10. Substance blanche --- r_associated #0: 37 --> en:white substance
    n1=Substance blanche | n2=en:white substance | rel=r_associated | relid=0 | w=37
  11. troubles endormissement et maintien du sommeil --- r_associated #0: 35 --> en:white substance
    n1=troubles endormissement et maintien du sommeil | n2=en:white substance | rel=r_associated | relid=0 | w=35
  12. crises fébriles --- r_associated #0: 25 --> en:white substance
    n1=crises fébriles | n2=en:white substance | rel=r_associated | relid=0 | w=25
  13. maladie de trousseau --- r_associated #0: 25 --> en:white substance
    n1=maladie de trousseau | n2=en:white substance | rel=r_associated | relid=0 | w=25
  14. méningiomes --- r_associated #0: 25 --> en:white substance
    n1=méningiomes | n2=en:white substance | rel=r_associated | relid=0 | w=25
  15. neuralgie trigéminale --- r_associated #0: 25 --> en:white substance
    n1=neuralgie trigéminale | n2=en:white substance | rel=r_associated | relid=0 | w=25
  16. névralgie du nerf trijumeau --- r_associated #0: 25 --> en:white substance
    n1=névralgie du nerf trijumeau | n2=en:white substance | rel=r_associated | relid=0 | w=25
  17. tics douloureux de la face --- r_associated #0: 25 --> en:white substance
    n1=tics douloureux de la face | n2=en:white substance | rel=r_associated | relid=0 | w=25
  18. médecine --- r_associated #0: 22 --> en:white substance
    n1=médecine | n2=en:white substance | rel=r_associated | relid=0 | w=22
  19. anatomie --- r_associated #0: 20 --> en:white substance
    n1=anatomie | n2=en:white substance | rel=r_associated | relid=0 | w=20
  20. axone --- r_associated #0: 20 --> en:white substance
    n1=axone | n2=en:white substance | rel=r_associated | relid=0 | w=20
  21. axone
    (biologie)
     --- r_associated #0: 20 --> en:white substance
    n1=axone
    (biologie)
    | n2=en:white substance | rel=r_associated | relid=0 | w=20
  22. biologie --- r_associated #0: 20 --> en:white substance
    n1=biologie | n2=en:white substance | rel=r_associated | relid=0 | w=20
  23. blanche --- r_associated #0: 20 --> en:white substance
    n1=blanche | n2=en:white substance | rel=r_associated | relid=0 | w=20
  24. cellule du tissu nerveux --- r_associated #0: 20 --> en:white substance
    n1=cellule du tissu nerveux | n2=en:white substance | rel=r_associated | relid=0 | w=20
  25. cerveau --- r_associated #0: 20 --> en:white substance
    n1=cerveau | n2=en:white substance | rel=r_associated | relid=0 | w=20
  26. cerveau
    (anatomie)
     --- r_associated #0: 20 --> en:white substance
    n1=cerveau
    (anatomie)
    | n2=en:white substance | rel=r_associated | relid=0 | w=20
  27. débilité mentale --- r_associated #0: 20 --> en:white substance
    n1=débilité mentale | n2=en:white substance | rel=r_associated | relid=0 | w=20
  28. en:'ballooned' neurons with autofluorescent fine granular material --- r_associated #0: 20 --> en:white substance
    n1=en:'ballooned' neurons with autofluorescent fine granular material | n2=en:white substance | rel=r_associated | relid=0 | w=20
  29. en:'double contour' convolutional calcification on ct scan --- r_associated #0: 20 --> en:white substance
    n1=en:'double contour' convolutional calcification on ct scan | n2=en:white substance | rel=r_associated | relid=0 | w=20
  30. en:'dragonfly' pattern on imaging --- r_associated #0: 20 --> en:white substance
    n1=en:'dragonfly' pattern on imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  31. en:'dragonfly-like' pattern --- r_associated #0: 20 --> en:white substance
    n1=en:'dragonfly-like' pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  32. en:'eye of the tiger' sign on mri --- r_associated #0: 20 --> en:white substance
    n1=en:'eye of the tiger' sign on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  33. en:'globoid multinucleated cells' in brain tissue --- r_associated #0: 20 --> en:white substance
    n1=en:'globoid multinucleated cells' in brain tissue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  34. en:'spheroid' inclusions in axons --- r_associated #0: 20 --> en:white substance
    n1=en:'spheroid' inclusions in axons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  35. en:3-4 hz slow sharp waves seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:3-4 hz slow sharp waves seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  36. en:3-6 hz polyspike eeg --- r_associated #0: 20 --> en:white substance
    n1=en:3-6 hz polyspike eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  37. en:a subset of patients develop frontotemporal dementia --- r_associated #0: 20 --> en:white substance
    n1=en:a subset of patients develop frontotemporal dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  38. en:a subset of patients have neurologic abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:a subset of patients have neurologic abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  39. en:abducens nerve palsy (cn vi) --- r_associated #0: 20 --> en:white substance
    n1=en:abducens nerve palsy (cn vi) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  40. en:abnormal 'cap' on the dorsal pons extending into the fourth ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal 'cap' on the dorsal pons extending into the fourth ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  41. en:abnormal 'hobby horse' ataxic gait --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal 'hobby horse' ataxic gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  42. en:abnormal behavior --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal behavior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  43. en:abnormal brain myelination --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal brain myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  44. en:abnormal cell orientation --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal cell orientation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  45. en:abnormal coordination --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  46. en:abnormal cortical eeg discharges triggered by intermittent light --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal cortical eeg discharges triggered by intermittent light | n2=en:white substance | rel=r_associated | relid=0 | w=20
  47. en:abnormal cortical gyration --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal cortical gyration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  48. en:abnormal cortical lamination --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal cortical lamination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  49. en:abnormal cortical layering --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal cortical layering | n2=en:white substance | rel=r_associated | relid=0 | w=20
  50. en:abnormal corticospinal tract decussation --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal corticospinal tract decussation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  51. en:abnormal eeg (abnormal slowing of background activity) --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal eeg (abnormal slowing of background activity) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  52. en:abnormal eeg (poor alpha rhythms) --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal eeg (poor alpha rhythms) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  53. en:abnormal eeg activity during sleep --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal eeg activity during sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  54. en:abnormal eeg with epileptiform changes --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal eeg with epileptiform changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  55. en:abnormal gait (67%) --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal gait (67%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  56. en:abnormal gait due to muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal gait due to muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  57. en:abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on ct scan --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on ct scan | n2=en:white substance | rel=r_associated | relid=0 | w=20
  58. en:abnormal gyral pattern --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal gyral pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  59. en:abnormal gyri --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal gyri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  60. en:abnormal gyri (in 1 of 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal gyri (in 1 of 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  61. en:abnormal hippocampus --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal hippocampus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  62. en:abnormal hypothalamo-pituitary axis --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal hypothalamo-pituitary axis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  63. en:abnormal interictal eeg (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal interictal eeg (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  64. en:abnormal involuntary movement --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal involuntary movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  65. en:abnormal lipid peak on brain mrs --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal lipid peak on brain mrs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  66. en:abnormal lower motor neuron morphology --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal lower motor neuron morphology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  67. en:abnormal movement --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  68. en:abnormal myelination --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  69. en:abnormal ocular motility --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal ocular motility | n2=en:white substance | rel=r_associated | relid=0 | w=20
  70. en:abnormal posture --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal posture | n2=en:white substance | rel=r_associated | relid=0 | w=20
  71. en:abnormal primitive reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal primitive reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  72. en:abnormal purkinje cells --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal purkinje cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  73. en:abnormal rapid eye movement sleep --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal rapid eye movement sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  74. en:abnormal septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  75. en:abnormal signals in the thalami seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal signals in the thalami seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  76. en:abnormal sleep pattern --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal sleep pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  77. en:abnormal sleep-wake cycles --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal sleep-wake cycles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  78. en:abnormal spike waves --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal spike waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  79. en:abnormal sulci --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal sulci | n2=en:white substance | rel=r_associated | relid=0 | w=20
  80. en:abnormal t2-weighted signals in the occipital white and gray matter --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal t2-weighted signals in the occipital white and gray matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  81. en:abnormal visual evoked potential --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal visual evoked potential | n2=en:white substance | rel=r_associated | relid=0 | w=20
  82. en:abnormal visual evoked potential (vep) --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal visual evoked potential (vep) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  83. en:abnormal visual sensitivity of the brain in reaction to intermittent photic stimulation --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal visual sensitivity of the brain in reaction to intermittent photic stimulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  84. en:abnormal white matter signals, in the basal ganglia or cerebellum seen on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:abnormal white matter signals, in the basal ganglia or cerebellum seen on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  85. en:abnormality of brainstem morphology --- r_associated #0: 20 --> en:white substance
    n1=en:abnormality of brainstem morphology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  86. en:abnormality of ocular smooth pursuit --- r_associated #0: 20 --> en:white substance
    n1=en:abnormality of ocular smooth pursuit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  87. en:abnormality of the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:abnormality of the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  88. en:abnormality of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:abnormality of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  89. en:abnormality of the posterior cranial fossa --- r_associated #0: 20 --> en:white substance
    n1=en:abnormality of the posterior cranial fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  90. en:abnormally marked pontobulbar sulcus --- r_associated #0: 20 --> en:white substance
    n1=en:abnormally marked pontobulbar sulcus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  91. en:absence of anterior pituitary --- r_associated #0: 20 --> en:white substance
    n1=en:absence of anterior pituitary | n2=en:white substance | rel=r_associated | relid=0 | w=20
  92. en:absence of balloon cells (in type iia) --- r_associated #0: 20 --> en:white substance
    n1=en:absence of balloon cells (in type iia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  93. en:absence of cerebral aneurysms --- r_associated #0: 20 --> en:white substance
    n1=en:absence of cerebral aneurysms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  94. en:absence of language development --- r_associated #0: 20 --> en:white substance
    n1=en:absence of language development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  95. en:absence of lower motor neuron involvement --- r_associated #0: 20 --> en:white substance
    n1=en:absence of lower motor neuron involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  96. en:absence of myelin in the posterior column of the spinal cord (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:absence of myelin in the posterior column of the spinal cord (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  97. en:absence of neurologic manifestations --- r_associated #0: 20 --> en:white substance
    n1=en:absence of neurologic manifestations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  98. en:absence of neuropathologic findings in the brainstem and anterior horn cells --- r_associated #0: 20 --> en:white substance
    n1=en:absence of neuropathologic findings in the brainstem and anterior horn cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  99. en:absence of olfactory bulbs --- r_associated #0: 20 --> en:white substance
    n1=en:absence of olfactory bulbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  100. en:absence of primitive reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:absence of primitive reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  101. en:absence of septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:absence of septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  102. en:absence of spontaneous movements --- r_associated #0: 20 --> en:white substance
    n1=en:absence of spontaneous movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  103. en:absence of the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:absence of the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  104. en:absence of the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:absence of the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  105. en:absence of the inferior olives --- r_associated #0: 20 --> en:white substance
    n1=en:absence of the inferior olives | n2=en:white substance | rel=r_associated | relid=0 | w=20
  106. en:absence of the olfactory bulbs and tracts --- r_associated #0: 20 --> en:white substance
    n1=en:absence of the olfactory bulbs and tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  107. en:absence of transverse pontine fibers --- r_associated #0: 20 --> en:white substance
    n1=en:absence of transverse pontine fibers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  108. en:absence of vestibular schwannomas at age greater than 18 years --- r_associated #0: 20 --> en:white substance
    n1=en:absence of vestibular schwannomas at age greater than 18 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  109. en:absence or atrophy of the putamen --- r_associated #0: 20 --> en:white substance
    n1=en:absence or atrophy of the putamen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  110. en:absence or hypoplasia of the anterior limb of the internal capsule --- r_associated #0: 20 --> en:white substance
    n1=en:absence or hypoplasia of the anterior limb of the internal capsule | n2=en:white substance | rel=r_associated | relid=0 | w=20
  111. en:absence seizures (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:absence seizures (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  112. en:absence seizures (stage 2 and 3) --- r_associated #0: 20 --> en:white substance
    n1=en:absence seizures (stage 2 and 3) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  113. en:absence seizures may occur --- r_associated #0: 20 --> en:white substance
    n1=en:absence seizures may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  114. en:absent cisterna magna --- r_associated #0: 20 --> en:white substance
    n1=en:absent cisterna magna | n2=en:white substance | rel=r_associated | relid=0 | w=20
  115. en:absent corpus callosum (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:absent corpus callosum (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  116. en:absent cortical responses of somatosensory evoked potentials --- r_associated #0: 20 --> en:white substance
    n1=en:absent cortical responses of somatosensory evoked potentials | n2=en:white substance | rel=r_associated | relid=0 | w=20
  117. en:absent development --- r_associated #0: 20 --> en:white substance
    n1=en:absent development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  118. en:absent myelination of the brain (severe connatal form) --- r_associated #0: 20 --> en:white substance
    n1=en:absent myelination of the brain (severe connatal form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  119. en:absent olfactory bulbs --- r_associated #0: 20 --> en:white substance
    n1=en:absent olfactory bulbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  120. en:absent olfactory tract or bulbs --- r_associated #0: 20 --> en:white substance
    n1=en:absent olfactory tract or bulbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  121. en:absent olfactory tracts and bulbs --- r_associated #0: 20 --> en:white substance
    n1=en:absent olfactory tracts and bulbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  122. en:absent optic nerves, chiasm, and tracts --- r_associated #0: 20 --> en:white substance
    n1=en:absent optic nerves, chiasm, and tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  123. en:absent or delayed psychomotor development, severe --- r_associated #0: 20 --> en:white substance
    n1=en:absent or delayed psychomotor development, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  124. en:absent or delayed speech development --- r_associated #0: 20 --> en:white substance
    n1=en:absent or delayed speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  125. en:absent or immature dentate nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:absent or immature dentate nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  126. en:absent or limited speech development --- r_associated #0: 20 --> en:white substance
    n1=en:absent or limited speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  127. en:absent or poor expressive speech --- r_associated #0: 20 --> en:white substance
    n1=en:absent or poor expressive speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  128. en:absent pituitary --- r_associated #0: 20 --> en:white substance
    n1=en:absent pituitary | n2=en:white substance | rel=r_associated | relid=0 | w=20
  129. en:absent posterior pituitary bright spot --- r_associated #0: 20 --> en:white substance
    n1=en:absent posterior pituitary bright spot | n2=en:white substance | rel=r_associated | relid=0 | w=20
  130. en:absent primitive reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:absent primitive reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  131. en:absent rem sleep --- r_associated #0: 20 --> en:white substance
    n1=en:absent rem sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  132. en:absent speech --- r_associated #0: 20 --> en:white substance
    n1=en:absent speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  133. en:absent superior division of oculomotor nerve and corresponding alpha motor neurons --- r_associated #0: 20 --> en:white substance
    n1=en:absent superior division of oculomotor nerve and corresponding alpha motor neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  134. en:accumulation of autofluorescent material in neurons --- r_associated #0: 20 --> en:white substance
    n1=en:accumulation of autofluorescent material in neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  135. en:accumulation of pas-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (collins bodies) --- r_associated #0: 20 --> en:white substance
    n1=en:accumulation of pas-positive diastase-resistant neuronal inclusion bodies in the cerebral cortex (collins bodies) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  136. en:actin depolymerizing factor/cofilin-immunoreactive eosinophilic rod-like cytoplasmic inclusions in neocortical and thalamic neurons --- r_associated #0: 20 --> en:white substance
    n1=en:actin depolymerizing factor/cofilin-immunoreactive eosinophilic rod-like cytoplasmic inclusions in neocortical and thalamic neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  137. en:actin- and actin depolymerizing factor/cofilin-immunoreactive eosinophilic spherical structures in the striatum --- r_associated #0: 20 --> en:white substance
    n1=en:actin- and actin depolymerizing factor/cofilin-immunoreactive eosinophilic spherical structures in the striatum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  138. en:action and postural tremor --- r_associated #0: 20 --> en:white substance
    n1=en:action and postural tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  139. en:action dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:action dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  140. en:action myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:action myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  141. en:action myoclonus (triggered by voluntary movements) --- r_associated #0: 20 --> en:white substance
    n1=en:action myoclonus (triggered by voluntary movements) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  142. en:actual effective cognition --- r_associated #0: 20 --> en:white substance
    n1=en:actual effective cognition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  143. en:acute cerebrovascular accidents --- r_associated #0: 20 --> en:white substance
    n1=en:acute cerebrovascular accidents | n2=en:white substance | rel=r_associated | relid=0 | w=20
  144. en:acute encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:acute encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  145. en:acute episodes of neuropathic symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:acute episodes of neuropathic symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  146. en:acute episodes of neuropathic symptoms (hcp) --- r_associated #0: 20 --> en:white substance
    n1=en:acute episodes of neuropathic symptoms (hcp) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  147. en:acute necrotizing encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:acute necrotizing encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  148. en:acute neurologic decompensation (in later-onset cases) --- r_associated #0: 20 --> en:white substance
    n1=en:acute neurologic decompensation (in later-onset cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  149. en:acute neurologic deficits due to cerebrovascular disease --- r_associated #0: 20 --> en:white substance
    n1=en:acute neurologic deficits due to cerebrovascular disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  150. en:acute poliomyelitis --- r_associated #0: 20 --> en:white substance
    n1=en:acute poliomyelitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  151. en:addiction --- r_associated #0: 20 --> en:white substance
    n1=en:addiction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  152. en:adipose tissue in subarachnoid space --- r_associated #0: 20 --> en:white substance
    n1=en:adipose tissue in subarachnoid space | n2=en:white substance | rel=r_associated | relid=0 | w=20
  153. en:afebrile seizure --- r_associated #0: 20 --> en:white substance
    n1=en:afebrile seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  154. en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes --- r_associated #0: 20 --> en:white substance
    n1=en:affected arteries have electron-dense granular material close to vascular smooth muscle cell membranes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  155. en:affected arteries show loss of smooth muscle cells --- r_associated #0: 20 --> en:white substance
    n1=en:affected arteries show loss of smooth muscle cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  156. en:affected children are unable to sit without support --- r_associated #0: 20 --> en:white substance
    n1=en:affected children are unable to sit without support | n2=en:white substance | rel=r_associated | relid=0 | w=20
  157. en:agenesis of corpus callosum, partial or complete (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of corpus callosum, partial or complete (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  158. en:agenesis of pineal gland --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of pineal gland | n2=en:white substance | rel=r_associated | relid=0 | w=20
  159. en:agenesis of the anterior commissure --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the anterior commissure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  160. en:agenesis of the corpus callosum (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  161. en:agenesis of the corpus callosum (in 1 of 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (in 1 of 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  162. en:agenesis of the corpus callosum (in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  163. en:agenesis of the corpus callosum (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  164. en:agenesis of the corpus callosum (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  165. en:agenesis of the corpus callosum (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  166. en:agenesis of the corpus callosum (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the corpus callosum (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  167. en:agenesis of the occipital lobes (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the occipital lobes (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  168. en:agenesis of the rostrum of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis of the rostrum of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  169. en:agenesis or hypogenesis of the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis or hypogenesis of the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  170. en:agenesis or hypoplasia of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis or hypoplasia of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  171. en:agenesis or severe hypoplasia of cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:agenesis or severe hypoplasia of cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  172. en:aggregation of snca-immunopositive inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:aggregation of snca-immunopositive inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  173. en:aggression --- r_associated #0: 20 --> en:white substance
    n1=en:aggression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  174. en:agitation --- r_associated #0: 20 --> en:white substance
    n1=en:agitation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  175. en:agnosia --- r_associated #0: 20 --> en:white substance
    n1=en:agnosia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  176. en:agyria (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:agyria (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  177. en:agyria (posterior-to-anterior gradient) --- r_associated #0: 20 --> en:white substance
    n1=en:agyria (posterior-to-anterior gradient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  178. en:agyria (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:agyria (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  179. en:akathisia --- r_associated #0: 20 --> en:white substance
    n1=en:akathisia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  180. en:akinesia --- r_associated #0: 20 --> en:white substance
    n1=en:akinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  181. en:akinetic mutism (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:akinetic mutism (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  182. en:all nervous tissue --- r_associated #0: 20 --> en:white substance
    n1=en:all nervous tissue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  183. en:alobar holoprosencephaly (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:alobar holoprosencephaly (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  184. en:alobar hpe shows absence of interhemispheric cleavage and single ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:alobar hpe shows absence of interhemispheric cleavage and single ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  185. en:alpha-b-crystallin expression in oligodendrocytes --- r_associated #0: 20 --> en:white substance
    n1=en:alpha-b-crystallin expression in oligodendrocytes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  186. en:alpha-synuclein immunoreactive neuronal and glial inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:alpha-synuclein immunoreactive neuronal and glial inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  187. en:alpha-synuclein-containing inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:alpha-synuclein-containing inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  188. en:alpha-synuclein-immunoreactive lewy neurites --- r_associated #0: 20 --> en:white substance
    n1=en:alpha-synuclein-immunoreactive lewy neurites | n2=en:white substance | rel=r_associated | relid=0 | w=20
  189. en:alpha-synuclein-immunreactive lewy bodies --- r_associated #0: 20 --> en:white substance
    n1=en:alpha-synuclein-immunreactive lewy bodies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  190. en:altered breathing patterns --- r_associated #0: 20 --> en:white substance
    n1=en:altered breathing patterns | n2=en:white substance | rel=r_associated | relid=0 | w=20
  191. en:altered mental status --- r_associated #0: 20 --> en:white substance
    n1=en:altered mental status | n2=en:white substance | rel=r_associated | relid=0 | w=20
  192. en:alzheimer disease, early onset --- r_associated #0: 20 --> en:white substance
    n1=en:alzheimer disease, early onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  193. en:alzheimer's disease --- r_associated #0: 20 --> en:white substance
    n1=en:alzheimer's disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  194. en:ambulation difficulty --- r_associated #0: 20 --> en:white substance
    n1=en:ambulation difficulty | n2=en:white substance | rel=r_associated | relid=0 | w=20
  195. en:amnesia --- r_associated #0: 20 --> en:white substance
    n1=en:amnesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  196. en:amyloid deposition in the leptomeningeal vessels, brainstem, spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:amyloid deposition in the leptomeningeal vessels, brainstem, spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  197. en:amyloid plaques may be present --- r_associated #0: 20 --> en:white substance
    n1=en:amyloid plaques may be present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  198. en:amyloid-like plaques are not immunoreactive to app (104760) --- r_associated #0: 20 --> en:white substance
    n1=en:amyloid-like plaques are not immunoreactive to app (104760) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  199. en:amyloid-like plaques, immunoreactive to prp, predominantly in the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:amyloid-like plaques, immunoreactive to prp, predominantly in the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  200. en:amyotrophic lateral sclerosis --- r_associated #0: 20 --> en:white substance
    n1=en:amyotrophic lateral sclerosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  201. en:amyotrophy, distal, severe --- r_associated #0: 20 --> en:white substance
    n1=en:amyotrophy, distal, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  202. en:anarthria speech disorder --- r_associated #0: 20 --> en:white substance
    n1=en:anarthria speech disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  203. en:anencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:anencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  204. en:anencephaly (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:anencephaly (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  205. en:angiitis, cerebral --- r_associated #0: 20 --> en:white substance
    n1=en:angiitis, cerebral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  206. en:angiographically 'silent' --- r_associated #0: 20 --> en:white substance
    n1=en:angiographically 'silent' | n2=en:white substance | rel=r_associated | relid=0 | w=20
  207. en:angiomatous meningioma --- r_associated #0: 20 --> en:white substance
    n1=en:angiomatous meningioma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  208. en:angulation of the frontal horns --- r_associated #0: 20 --> en:white substance
    n1=en:angulation of the frontal horns | n2=en:white substance | rel=r_associated | relid=0 | w=20
  209. en:anisocoria --- r_associated #0: 20 --> en:white substance
    n1=en:anisocoria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  210. en:ankle clonus --- r_associated #0: 20 --> en:white substance
    n1=en:ankle clonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  211. en:ankle clonus (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ankle clonus (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  212. en:ankle clonus (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:ankle clonus (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  213. en:ankle or knee clonus --- r_associated #0: 20 --> en:white substance
    n1=en:ankle or knee clonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  214. en:ankle reflex absent --- r_associated #0: 20 --> en:white substance
    n1=en:ankle reflex absent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  215. en:anomalies of the folding of the right sylvian area --- r_associated #0: 20 --> en:white substance
    n1=en:anomalies of the folding of the right sylvian area | n2=en:white substance | rel=r_associated | relid=0 | w=20
  216. en:anomalies of the temporal area --- r_associated #0: 20 --> en:white substance
    n1=en:anomalies of the temporal area | n2=en:white substance | rel=r_associated | relid=0 | w=20
  217. en:anomia --- r_associated #0: 20 --> en:white substance
    n1=en:anomia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  218. en:anosmia --- r_associated #0: 20 --> en:white substance
    n1=en:anosmia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  219. en:anosmia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:anosmia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  220. en:anosmia (in contiguous gene syndrome patients) --- r_associated #0: 20 --> en:white substance
    n1=en:anosmia (in contiguous gene syndrome patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  221. en:anosmia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:anosmia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  222. en:antenatal intracerebral hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:antenatal intracerebral hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  223. en:anterior basal encephalocele --- r_associated #0: 20 --> en:white substance
    n1=en:anterior basal encephalocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  224. en:anterior commissure not evident --- r_associated #0: 20 --> en:white substance
    n1=en:anterior commissure not evident | n2=en:white substance | rel=r_associated | relid=0 | w=20
  225. en:anterior horn atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:anterior horn atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  226. en:anterior horn cell impairment --- r_associated #0: 20 --> en:white substance
    n1=en:anterior horn cell impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  227. en:anterior pachygyria and posterior agyria --- r_associated #0: 20 --> en:white substance
    n1=en:anterior pachygyria and posterior agyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  228. en:anterior pituitary adenoma --- r_associated #0: 20 --> en:white substance
    n1=en:anterior pituitary adenoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  229. en:anterior pituitary hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:anterior pituitary hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  230. en:anterior sacral meningocele --- r_associated #0: 20 --> en:white substance
    n1=en:anterior sacral meningocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  231. en:anterior temporal lobe subcortical cysts --- r_associated #0: 20 --> en:white substance
    n1=en:anterior temporal lobe subcortical cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  232. en:antisocial behavior --- r_associated #0: 20 --> en:white substance
    n1=en:antisocial behavior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  233. en:anxiety --- r_associated #0: 20 --> en:white substance
    n1=en:anxiety | n2=en:white substance | rel=r_associated | relid=0 | w=20
  234. en:anxiety adverse event --- r_associated #0: 20 --> en:white substance
    n1=en:anxiety adverse event | n2=en:white substance | rel=r_associated | relid=0 | w=20
  235. en:apathy --- r_associated #0: 20 --> en:white substance
    n1=en:apathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  236. en:aphasia --- r_associated #0: 20 --> en:white substance
    n1=en:aphasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  237. en:aplasia of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  238. en:aplasia of olfactory bulbs, bilateral --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia of olfactory bulbs, bilateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  239. en:aplasia of the corpus callosum (wws) encephalocele (1 patient, meb) --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia of the corpus callosum (wws) encephalocele (1 patient, meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  240. en:aplasia of the inferior half of the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia of the inferior half of the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  241. en:aplasia of the vermis --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia of the vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  242. en:aplasia/hypoplasia of the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia/hypoplasia of the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  243. en:aplasia/hypoplasia of the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia/hypoplasia of the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  244. en:aplasia/hypoplasia of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:aplasia/hypoplasia of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  245. en:apoptotic neurons --- r_associated #0: 20 --> en:white substance
    n1=en:apoptotic neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  246. en:appendage of the uterus --- r_associated #0: 20 --> en:white substance
    n1=en:appendage of the uterus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  247. en:appendicular hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:appendicular hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  248. en:approximately 30% of patients show normal early development --- r_associated #0: 20 --> en:white substance
    n1=en:approximately 30% of patients show normal early development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  249. en:apraxia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:apraxia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  250. en:apraxia, verbal --- r_associated #0: 20 --> en:white substance
    n1=en:apraxia, verbal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  251. en:apraxias --- r_associated #0: 20 --> en:white substance
    n1=en:apraxias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  252. en:aqueductal stenosis --- r_associated #0: 20 --> en:white substance
    n1=en:aqueductal stenosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  253. en:arachnoid cyst --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoid cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  254. en:arachnoid cyst (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoid cyst (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  255. en:arachnoid cysts (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoid cysts (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  256. en:arachnoid cysts (in one family) --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoid cysts (in one family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  257. en:arachnoid cysts of the cerebellopontine angle (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoid cysts of the cerebellopontine angle (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  258. en:arachnoid hemangiomata --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoid hemangiomata | n2=en:white substance | rel=r_associated | relid=0 | w=20
  259. en:arachnoidal cysts --- r_associated #0: 20 --> en:white substance
    n1=en:arachnoidal cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  260. en:areflexia --- r_associated #0: 20 --> en:white substance
    n1=en:areflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  261. en:areflexia (30%) --- r_associated #0: 20 --> en:white substance
    n1=en:areflexia (30%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  262. en:areflexia of lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:areflexia of lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  263. en:areflexia of upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:areflexia of upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  264. en:argyrophilic hyperphosphorylated tau-positive inclusions (pick bodies) --- r_associated #0: 20 --> en:white substance
    n1=en:argyrophilic hyperphosphorylated tau-positive inclusions (pick bodies) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  265. en:arhinencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:arhinencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  266. en:arhinencephaly (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:arhinencephaly (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  267. en:arm flexion --- r_associated #0: 20 --> en:white substance
    n1=en:arm flexion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  268. en:arm pain --- r_associated #0: 20 --> en:white substance
    n1=en:arm pain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  269. en:arnold-chiari i malformation --- r_associated #0: 20 --> en:white substance
    n1=en:arnold-chiari i malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  270. en:arnold-chiari malformation --- r_associated #0: 20 --> en:white substance
    n1=en:arnold-chiari malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  271. en:arrest of psychomotor development after seizure onset --- r_associated #0: 20 --> en:white substance
    n1=en:arrest of psychomotor development after seizure onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  272. en:arrested hydrocephalus (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:arrested hydrocephalus (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  273. en:articulation difficulties --- r_associated #0: 20 --> en:white substance
    n1=en:articulation difficulties | n2=en:white substance | rel=r_associated | relid=0 | w=20
  274. en:articulation, unintelligible --- r_associated #0: 20 --> en:white substance
    n1=en:articulation, unintelligible | n2=en:white substance | rel=r_associated | relid=0 | w=20
  275. en:articulatory defect --- r_associated #0: 20 --> en:white substance
    n1=en:articulatory defect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  276. en:aspects of radiation effects --- r_associated #0: 20 --> en:white substance
    n1=en:aspects of radiation effects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  277. en:aspects of radionuclide imaging --- r_associated #0: 20 --> en:white substance
    n1=en:aspects of radionuclide imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  278. en:asperger syndrome (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:asperger syndrome (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  279. en:associated with paresthesias and dysesthesias --- r_associated #0: 20 --> en:white substance
    n1=en:associated with paresthesias and dysesthesias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  280. en:associated with syringomyelia (186700) --- r_associated #0: 20 --> en:white substance
    n1=en:associated with syringomyelia (186700) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  281. en:association between poor metabolizers (pm) and parkinson disease --- r_associated #0: 20 --> en:white substance
    n1=en:association between poor metabolizers (pm) and parkinson disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  282. en:astrocyte --- r_associated #0: 20 --> en:white substance
    n1=en:astrocyte | n2=en:white substance | rel=r_associated | relid=0 | w=20
  283. en:astrocytes show reactive changes --- r_associated #0: 20 --> en:white substance
    n1=en:astrocytes show reactive changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  284. en:astrocytic gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:astrocytic gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  285. en:astrocytosis --- r_associated #0: 20 --> en:white substance
    n1=en:astrocytosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  286. en:astrogliosis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:astrogliosis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  287. en:asymmetric brain development --- r_associated #0: 20 --> en:white substance
    n1=en:asymmetric brain development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  288. en:asymmetry at onset (74%) --- r_associated #0: 20 --> en:white substance
    n1=en:asymmetry at onset (74%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  289. en:asymmetry of symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:asymmetry of symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  290. en:ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  291. en:ataxia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  292. en:ataxia (cvs+) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (cvs+) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  293. en:ataxia (deletion patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (deletion patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  294. en:ataxia (early-onset form) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (early-onset form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  295. en:ataxia (if untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (if untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  296. en:ataxia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  297. en:ataxia (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  298. en:ataxia (type i and type ii, infantile and juvenile) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (type i and type ii, infantile and juvenile) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  299. en:ataxia (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  300. en:ataxia in those who survive --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia in those who survive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  301. en:ataxia may develop in middle age (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia may develop in middle age (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  302. en:ataxia with febrile episodes (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia with febrile episodes (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  303. en:ataxia with jerky arm movements --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia with jerky arm movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  304. en:ataxia worsens in the dark --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia worsens in the dark | n2=en:white substance | rel=r_associated | relid=0 | w=20
  305. en:ataxia, (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  306. en:ataxia, cerebellar (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, cerebellar (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  307. en:ataxia, cerebellar (upper and lower limbs affected) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, cerebellar (upper and lower limbs affected) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  308. en:ataxia, cerebellar, limb and gait --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, cerebellar, limb and gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  309. en:ataxia, episodic (episodes last from hours to days) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, episodic (episodes last from hours to days) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  310. en:ataxia, episodic, occurring after febrile illness or stress --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, episodic, occurring after febrile illness or stress | n2=en:white substance | rel=r_associated | relid=0 | w=20
  311. en:ataxia, gait and appendicular --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, gait and appendicular | n2=en:white substance | rel=r_associated | relid=0 | w=20
  312. en:ataxia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:ataxia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  313. en:ataxias, appendicular --- r_associated #0: 20 --> en:white substance
    n1=en:ataxias, appendicular | n2=en:white substance | rel=r_associated | relid=0 | w=20
  314. en:ataxias, sensory --- r_associated #0: 20 --> en:white substance
    n1=en:ataxias, sensory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  315. en:ataxias, truncal --- r_associated #0: 20 --> en:white substance
    n1=en:ataxias, truncal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  316. en:ataxic gait --- r_associated #0: 20 --> en:white substance
    n1=en:ataxic gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  317. en:ataxic gait (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxic gait (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  318. en:ataxic gait (juvenile form) --- r_associated #0: 20 --> en:white substance
    n1=en:ataxic gait (juvenile form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  319. en:ataxic movements --- r_associated #0: 20 --> en:white substance
    n1=en:ataxic movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  320. en:atelencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:atelencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  321. en:athetoid and dystonic hand movements (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:athetoid and dystonic hand movements (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  322. en:athetosis --- r_associated #0: 20 --> en:white substance
    n1=en:athetosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  323. en:athetosis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:athetosis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  324. en:athetosis (later) --- r_associated #0: 20 --> en:white substance
    n1=en:athetosis (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  325. en:athetosis, mild (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:athetosis, mild (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  326. en:atlantoaxial instability --- r_associated #0: 20 --> en:white substance
    n1=en:atlantoaxial instability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  327. en:atretic occipital cephalocele --- r_associated #0: 20 --> en:white substance
    n1=en:atretic occipital cephalocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  328. en:atrophic pons (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:atrophic pons (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  329. en:atrophy and weakness of limb musculature --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy and weakness of limb musculature | n2=en:white substance | rel=r_associated | relid=0 | w=20
  330. en:atrophy and weakness of the tongue, jaw, and throat muscles --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy and weakness of the tongue, jaw, and throat muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  331. en:atrophy may be more severe in the left hemisphere --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy may be more severe in the left hemisphere | n2=en:white substance | rel=r_associated | relid=0 | w=20
  332. en:atrophy of cerebellum, brainstem, cervical spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of cerebellum, brainstem, cervical spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  333. en:atrophy of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  334. en:atrophy of hippocampal dentate gyrus --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of hippocampal dentate gyrus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  335. en:atrophy of pyramids --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of pyramids | n2=en:white substance | rel=r_associated | relid=0 | w=20
  336. en:atrophy of the cerebellar vermis seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the cerebellar vermis seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  337. en:atrophy of the dentate nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the dentate nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  338. en:atrophy of the frontal and parietal cortex --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the frontal and parietal cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  339. en:atrophy of the granular cell layer of the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the granular cell layer of the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  340. en:atrophy of the motor cortex in older patients seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the motor cortex in older patients seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  341. en:atrophy of the pituitary (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the pituitary (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  342. en:atrophy of the pons (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the pons (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  343. en:atrophy of the posterior columns and spinocerebellar tracts --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the posterior columns and spinocerebellar tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  344. en:atrophy of the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  345. en:atrophy of the spinal cord and cerebellar tracts --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy of the spinal cord and cerebellar tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  346. en:atrophy, thin hemisphere --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy, thin hemisphere | n2=en:white substance | rel=r_associated | relid=0 | w=20
  347. en:atrophy/degeneration involving the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:atrophy/degeneration involving the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  348. en:attacks characterized by lethargy, incoordination, loss of motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:attacks characterized by lethargy, incoordination, loss of motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  349. en:attacks of disabling daytime drowsiness and low alertness --- r_associated #0: 20 --> en:white substance
    n1=en:attacks of disabling daytime drowsiness and low alertness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  350. en:attention deficit disorder --- r_associated #0: 20 --> en:white substance
    n1=en:attention deficit disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  351. en:attention deficit hyperactivity disorder --- r_associated #0: 20 --> en:white substance
    n1=en:attention deficit hyperactivity disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  352. en:attenuated gyri --- r_associated #0: 20 --> en:white substance
    n1=en:attenuated gyri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  353. en:atypical absence seizure --- r_associated #0: 20 --> en:white substance
    n1=en:atypical absence seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  354. en:atypical absence, atonic/tonic, or tonic-clonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:atypical absence, atonic/tonic, or tonic-clonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  355. en:auditory auras --- r_associated #0: 20 --> en:white substance
    n1=en:auditory auras | n2=en:white substance | rel=r_associated | relid=0 | w=20
  356. en:auditory, olfactory, and visual auras --- r_associated #0: 20 --> en:white substance
    n1=en:auditory, olfactory, and visual auras | n2=en:white substance | rel=r_associated | relid=0 | w=20
  357. en:aura --- r_associated #0: 20 --> en:white substance
    n1=en:aura | n2=en:white substance | rel=r_associated | relid=0 | w=20
  358. en:aura (in some instances) --- r_associated #0: 20 --> en:white substance
    n1=en:aura (in some instances) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  359. en:aura may occur --- r_associated #0: 20 --> en:white substance
    n1=en:aura may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  360. en:autism --- r_associated #0: 20 --> en:white substance
    n1=en:autism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  361. en:autism (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:autism (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  362. en:autism or autistic features --- r_associated #0: 20 --> en:white substance
    n1=en:autism or autistic features | n2=en:white substance | rel=r_associated | relid=0 | w=20
  363. en:autofluorescent lipopigment in neurons --- r_associated #0: 20 --> en:white substance
    n1=en:autofluorescent lipopigment in neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  364. en:autofluorescent pigment in microglia and macrophages --- r_associated #0: 20 --> en:white substance
    n1=en:autofluorescent pigment in microglia and macrophages | n2=en:white substance | rel=r_associated | relid=0 | w=20
  365. en:automatism --- r_associated #0: 20 --> en:white substance
    n1=en:automatism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  366. en:autonomic abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  367. en:autonomic disturbances --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic disturbances | n2=en:white substance | rel=r_associated | relid=0 | w=20
  368. en:autonomic dysfunction (in patients with hsan2d) --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic dysfunction (in patients with hsan2d) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  369. en:autonomic dysfunction may occur --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic dysfunction may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  370. en:autonomic dysregulation --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic dysregulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  371. en:autonomic features may occur --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic features may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  372. en:autonomic features may occur (diaphoresis, tachycardia, hyperthermia, hypertension) --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic features may occur (diaphoresis, tachycardia, hyperthermia, hypertension) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  373. en:autonomic instability (22%) --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic instability (22%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  374. en:autonomic involvement --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  375. en:autonomic involvement affecting limbs during episodes --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic involvement affecting limbs during episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  376. en:autonomic involvement may occur --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic involvement may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  377. en:autonomic manifestations --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic manifestations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  378. en:autonomic nervous system disorders --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic nervous system disorders | n2=en:white substance | rel=r_associated | relid=0 | w=20
  379. en:autonomic signs --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  380. en:autonomic symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:autonomic symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  381. en:average intellect --- r_associated #0: 20 --> en:white substance
    n1=en:average intellect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  382. en:axial dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:axial dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  383. en:axial hypotonia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:axial hypotonia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  384. en:axial hypotonia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:axial hypotonia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  385. en:axial imbalance (34%) --- r_associated #0: 20 --> en:white substance
    n1=en:axial imbalance (34%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  386. en:axial muscle stiffness, symmetric --- r_associated #0: 20 --> en:white substance
    n1=en:axial muscle stiffness, symmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  387. en:axial rigidity --- r_associated #0: 20 --> en:white substance
    n1=en:axial rigidity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  388. en:axon bundle --- r_associated #0: 20 --> en:white substance
    n1=en:axon bundle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  389. en:axonal 'spheroid' inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:axonal 'spheroid' inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  390. en:axonal 'spheroid' inclusions in the cns --- r_associated #0: 20 --> en:white substance
    n1=en:axonal 'spheroid' inclusions in the cns | n2=en:white substance | rel=r_associated | relid=0 | w=20
  391. en:axonal dystrophy --- r_associated #0: 20 --> en:white substance
    n1=en:axonal dystrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  392. en:axonal dystrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:axonal dystrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  393. en:axonal loss --- r_associated #0: 20 --> en:white substance
    n1=en:axonal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  394. en:axonal loss and gliosis in the corticospinal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:axonal loss and gliosis in the corticospinal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  395. en:axonal spheroids --- r_associated #0: 20 --> en:white substance
    n1=en:axonal spheroids | n2=en:white substance | rel=r_associated | relid=0 | w=20
  396. en:axonal spheroids in the dorsal column --- r_associated #0: 20 --> en:white substance
    n1=en:axonal spheroids in the dorsal column | n2=en:white substance | rel=r_associated | relid=0 | w=20
  397. en:axonal swelling of spinal nerve roots and cranial nerves --- r_associated #0: 20 --> en:white substance
    n1=en:axonal swelling of spinal nerve roots and cranial nerves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  398. en:axonal swelling or thickening --- r_associated #0: 20 --> en:white substance
    n1=en:axonal swelling or thickening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  399. en:axonal swelling or thickening in the cns --- r_associated #0: 20 --> en:white substance
    n1=en:axonal swelling or thickening in the cns | n2=en:white substance | rel=r_associated | relid=0 | w=20
  400. en:axonal swellings or spheroids --- r_associated #0: 20 --> en:white substance
    n1=en:axonal swellings or spheroids | n2=en:white substance | rel=r_associated | relid=0 | w=20
  401. en:babinski sign --- r_associated #0: 20 --> en:white substance
    n1=en:babinski sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  402. en:back pain --- r_associated #0: 20 --> en:white substance
    n1=en:back pain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  403. en:background slowing --- r_associated #0: 20 --> en:white substance
    n1=en:background slowing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  404. en:balloon cells (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:balloon cells (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  405. en:ballooned neurons --- r_associated #0: 20 --> en:white substance
    n1=en:ballooned neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  406. en:band heterotopia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:band heterotopia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  407. en:basal ganglia atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  408. en:basal ganglia atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  409. en:basal ganglia calcification --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia calcification | n2=en:white substance | rel=r_associated | relid=0 | w=20
  410. en:basal ganglia calcifications (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia calcifications (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  411. en:basal ganglia calcifications (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia calcifications (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  412. en:basal ganglia cysts --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  413. en:basal ganglia dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  414. en:basal ganglia gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  415. en:basal ganglia lesions may be present before onset of clinical symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia lesions may be present before onset of clinical symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  416. en:basal ganglia lesions seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia lesions seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  417. en:basal ganglia lucencies --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglia lucencies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  418. en:basal ganglion degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:basal ganglion degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  419. en:begins in limbs, later generalized (childhood onset) --- r_associated #0: 20 --> en:white substance
    n1=en:begins in limbs, later generalized (childhood onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  420. en:behavioral variant of frontotemporal dementia --- r_associated #0: 20 --> en:white substance
    n1=en:behavioral variant of frontotemporal dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  421. en:beta-amyloid-positive senile plaques --- r_associated #0: 20 --> en:white substance
    n1=en:beta-amyloid-positive senile plaques | n2=en:white substance | rel=r_associated | relid=0 | w=20
  422. en:between 2 and 7% of children will develop afebrile seizure disorders later in life --- r_associated #0: 20 --> en:white substance
    n1=en:between 2 and 7% of children will develop afebrile seizure disorders later in life | n2=en:white substance | rel=r_associated | relid=0 | w=20
  423. en:bilateral calcification of basal ganglia and cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral calcification of basal ganglia and cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  424. en:bilateral convulsive seizures --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral convulsive seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  425. en:bilateral perisylvian cortical malformations on mri --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral perisylvian cortical malformations on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  426. en:bilateral schizencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral schizencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  427. en:bilateral signals in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral signals in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  428. en:bilateral striatal lucencies on imaging --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral striatal lucencies on imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  429. en:bilateral striatal necrosis --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral striatal necrosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  430. en:bilateral thalamic lesions on mri --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral thalamic lesions on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  431. en:bilateral, symmetric intracerebral calcifications, especially in the basal ganglia and periventricular areas --- r_associated #0: 20 --> en:white substance
    n1=en:bilateral, symmetric intracerebral calcifications, especially in the basal ganglia and periventricular areas | n2=en:white substance | rel=r_associated | relid=0 | w=20
  432. en:biopsy in both types shows neuronal cytomegaly (large, bizarre, maloriented neurons) in the laminar cortex --- r_associated #0: 20 --> en:white substance
    n1=en:biopsy in both types shows neuronal cytomegaly (large, bizarre, maloriented neurons) in the laminar cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  433. en:biopsy shows foamy lipid-laden macrophages --- r_associated #0: 20 --> en:white substance
    n1=en:biopsy shows foamy lipid-laden macrophages | n2=en:white substance | rel=r_associated | relid=0 | w=20
  434. en:biopsy shows white matter hypomyelination, demyelination, gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:biopsy shows white matter hypomyelination, demyelination, gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  435. en:bipolar disorder --- r_associated #0: 20 --> en:white substance
    n1=en:bipolar disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  436. en:blake's pouch (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:blake's pouch (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  437. en:blindness --- r_associated #0: 20 --> en:white substance
    n1=en:blindness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  438. en:blood supply aspects --- r_associated #0: 20 --> en:white substance
    n1=en:blood supply aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  439. en:blood-brain barrier --- r_associated #0: 20 --> en:white substance
    n1=en:blood-brain barrier | n2=en:white substance | rel=r_associated | relid=0 | w=20
  440. en:blurring of the gray-white junction (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:blurring of the gray-white junction (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  441. en:blurry cortical-white matter junction due to spillover of abnormal neurons (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:blurry cortical-white matter junction due to spillover of abnormal neurons (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  442. en:board and poorly defined gyri --- r_associated #0: 20 --> en:white substance
    n1=en:board and poorly defined gyri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  443. en:borderline intelligence --- r_associated #0: 20 --> en:white substance
    n1=en:borderline intelligence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  444. en:bradykinesia --- r_associated #0: 20 --> en:white substance
    n1=en:bradykinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  445. en:bradykinesia (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:bradykinesia (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  446. en:brain --- r_associated #0: 20 --> en:white substance
    n1=en:brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  447. en:brain abscess --- r_associated #0: 20 --> en:white substance
    n1=en:brain abscess | n2=en:white substance | rel=r_associated | relid=0 | w=20
  448. en:brain and spinal cord structure --- r_associated #0: 20 --> en:white substance
    n1=en:brain and spinal cord structure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  449. en:brain atrophy (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:brain atrophy (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  450. en:brain atrophy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:brain atrophy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  451. en:brain atrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:brain atrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  452. en:brain atrophy seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:brain atrophy seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  453. en:brain atrophy, particularly of the frontal and temporal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:brain atrophy, particularly of the frontal and temporal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  454. en:brain calcification (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:brain calcification (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  455. en:brain cell --- r_associated #0: 20 --> en:white substance
    n1=en:brain cell | n2=en:white substance | rel=r_associated | relid=0 | w=20
  456. en:brain cerebrospinal fluid pathway --- r_associated #0: 20 --> en:white substance
    n1=en:brain cerebrospinal fluid pathway | n2=en:white substance | rel=r_associated | relid=0 | w=20
  457. en:brain circuit --- r_associated #0: 20 --> en:white substance
    n1=en:brain circuit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  458. en:brain commissure --- r_associated #0: 20 --> en:white substance
    n1=en:brain commissure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  459. en:brain edema --- r_associated #0: 20 --> en:white substance
    n1=en:brain edema | n2=en:white substance | rel=r_associated | relid=0 | w=20
  460. en:brain edema following head injury (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:brain edema following head injury (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  461. en:brain imaging shows calcification of the dentate nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows calcification of the dentate nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  462. en:brain imaging shows cortical atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows cortical atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  463. en:brain imaging shows decreased white matter density --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows decreased white matter density | n2=en:white substance | rel=r_associated | relid=0 | w=20
  464. en:brain imaging shows diffuse white matter abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows diffuse white matter abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  465. en:brain imaging shows functional defects in the cortical and subcortical motor-related areas of the frontal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows functional defects in the cortical and subcortical motor-related areas of the frontal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  466. en:brain imaging shows generalized atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows generalized atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  467. en:brain imaging shows hypomyelination --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows hypomyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  468. en:brain imaging shows lesions in the thalami, brainstem, and cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows lesions in the thalami, brainstem, and cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  469. en:brain imaging shows white-matter hypodensities and demyelination --- r_associated #0: 20 --> en:white substance
    n1=en:brain imaging shows white-matter hypodensities and demyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  470. en:brain injury --- r_associated #0: 20 --> en:white substance
    n1=en:brain injury | n2=en:white substance | rel=r_associated | relid=0 | w=20
  471. en:brain iron accumulation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:brain iron accumulation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  472. en:brain iron accumulation in the basal ganglia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:brain iron accumulation in the basal ganglia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  473. en:brain morphology --- r_associated #0: 20 --> en:white substance
    n1=en:brain morphology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  474. en:brain mri shows abnormal cortical thickening in the anteromesial frontal areas (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows abnormal cortical thickening in the anteromesial frontal areas (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  475. en:brain mri shows abnormal gyral pattern in frontal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows abnormal gyral pattern in frontal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  476. en:brain mri shows arrest in myelination --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows arrest in myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  477. en:brain mri shows cerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows cerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  478. en:brain mri shows cerebellar atrophy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows cerebellar atrophy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  479. en:brain mri shows cerebellar hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows cerebellar hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  480. en:brain mri shows cortical atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows cortical atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  481. en:brain mri shows diffusion abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows diffusion abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  482. en:brain mri shows flattening of the ventral pons --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows flattening of the ventral pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  483. en:brain mri shows hyperintensities in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows hyperintensities in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  484. en:brain mri shows hypoplasia of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows hypoplasia of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  485. en:brain mri shows hypoplastic pituitary --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows hypoplastic pituitary | n2=en:white substance | rel=r_associated | relid=0 | w=20
  486. en:brain mri shows lesions consistent with epileptic episodes --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows lesions consistent with epileptic episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  487. en:brain mri shows lesions in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows lesions in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  488. en:brain mri shows molar tooth sign --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows molar tooth sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  489. en:brain mri shows proportionate pontocerebellar hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows proportionate pontocerebellar hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  490. en:brain mri shows signal abnormalities in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows signal abnormalities in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  491. en:brain mri shows t2-weighted hyperintensities (17%) --- r_associated #0: 20 --> en:white substance
    n1=en:brain mri shows t2-weighted hyperintensities (17%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  492. en:brain mrs shows decreased creatine content --- r_associated #0: 20 --> en:white substance
    n1=en:brain mrs shows decreased creatine content | n2=en:white substance | rel=r_associated | relid=0 | w=20
  493. en:brain mrs shows reduced choline and inositol peaks in the parieto-occipital white matter --- r_associated #0: 20 --> en:white substance
    n1=en:brain mrs shows reduced choline and inositol peaks in the parieto-occipital white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  494. en:brain part --- r_associated #0: 20 --> en:white substance
    n1=en:brain part | n2=en:white substance | rel=r_associated | relid=0 | w=20
  495. en:brain pathway --- r_associated #0: 20 --> en:white substance
    n1=en:brain pathway | n2=en:white substance | rel=r_associated | relid=0 | w=20
  496. en:brain prp-immunoreactive amyloid plaques (in 10% if patients with sporadic cjd and in variant cjd) --- r_associated #0: 20 --> en:white substance
    n1=en:brain prp-immunoreactive amyloid plaques (in 10% if patients with sporadic cjd and in variant cjd) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  497. en:brain region --- r_associated #0: 20 --> en:white substance
    n1=en:brain region | n2=en:white substance | rel=r_associated | relid=0 | w=20
  498. en:brain regulatory center --- r_associated #0: 20 --> en:white substance
    n1=en:brain regulatory center | n2=en:white substance | rel=r_associated | relid=0 | w=20
  499. en:brain small vessel disease with hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:brain small vessel disease with hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  500. en:brain stem --- r_associated #0: 20 --> en:white substance
    n1=en:brain stem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  501. en:brain stem atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:brain stem atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  502. en:brain stem atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:brain stem atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  503. en:brain stem disorder --- r_associated #0: 20 --> en:white substance
    n1=en:brain stem disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  504. en:brain subcortex --- r_associated #0: 20 --> en:white substance
    n1=en:brain subcortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  505. en:brain tissue shows abnormal spherical aggregates of iron and ferritin in the basal ganglia, forebrain, and cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:brain tissue shows abnormal spherical aggregates of iron and ferritin in the basal ganglia, forebrain, and cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  506. en:brain tissue shows cavitation of the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:brain tissue shows cavitation of the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  507. en:brain vascular anomalies (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:brain vascular anomalies (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  508. en:brain ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:brain ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  509. en:brain white matter hyperintensities on mri --- r_associated #0: 20 --> en:white substance
    n1=en:brain white matter hyperintensities on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  510. en:brainstem atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  511. en:brainstem concavity --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem concavity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  512. en:brainstem damage --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem damage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  513. en:brainstem dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  514. en:brainstem hypoplasia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem hypoplasia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  515. en:brainstem hypoplasia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem hypoplasia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  516. en:brainstem lesions, hyperintense on t2-weighted imaging --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem lesions, hyperintense on t2-weighted imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  517. en:brainstem may show neuronal loss --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem may show neuronal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  518. en:brainstem white matter lesions --- r_associated #0: 20 --> en:white substance
    n1=en:brainstem white matter lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  519. en:breathing difficulty due to vocal cord paralysis --- r_associated #0: 20 --> en:white substance
    n1=en:breathing difficulty due to vocal cord paralysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  520. en:brief involuntary movements of upper extremities --- r_associated #0: 20 --> en:white substance
    n1=en:brief involuntary movements of upper extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  521. en:brisk knee reflexes (early-on) --- r_associated #0: 20 --> en:white substance
    n1=en:brisk knee reflexes (early-on) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  522. en:brisk lower limb reflexes (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:brisk lower limb reflexes (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  523. en:brisk reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:brisk reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  524. en:brisk reflexes (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:brisk reflexes (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  525. en:brisk tendon reflex --- r_associated #0: 20 --> en:white substance
    n1=en:brisk tendon reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  526. en:broad gait --- r_associated #0: 20 --> en:white substance
    n1=en:broad gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  527. en:broad-based gait --- r_associated #0: 20 --> en:white substance
    n1=en:broad-based gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  528. en:broad-based gait (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:broad-based gait (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  529. en:broca's aphasia --- r_associated #0: 20 --> en:white substance
    n1=en:broca's aphasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  530. en:buccolingofacial dyspraxia --- r_associated #0: 20 --> en:white substance
    n1=en:buccolingofacial dyspraxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  531. en:bulbar and upper limb symptoms more severe than lower limb symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar and upper limb symptoms more severe than lower limb symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  532. en:bulbar dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  533. en:bulbar dysfunction (e.g. dysarthria and dysphagia) --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar dysfunction (e.g. dysarthria and dysphagia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  534. en:bulbar dysfunction (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar dysfunction (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  535. en:bulbar dysfunction (juvenile-onset, less common) --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar dysfunction (juvenile-onset, less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  536. en:bulbar involvement --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  537. en:bulbar paresis --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar paresis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  538. en:bulbar signs --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  539. en:bulbar spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  540. en:bulbar symptoms may occur (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar symptoms may occur (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  541. en:bulbar weakness --- r_associated #0: 20 --> en:white substance
    n1=en:bulbar weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  542. en:bulging of the caudate nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:bulging of the caudate nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  543. en:burning or tingling of plantar surface of foot (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:burning or tingling of plantar surface of foot (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  544. en:burning pain in the limbs --- r_associated #0: 20 --> en:white substance
    n1=en:burning pain in the limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  545. en:burst suppression pattern on neonatal eeg --- r_associated #0: 20 --> en:white substance
    n1=en:burst suppression pattern on neonatal eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  546. en:burst suppression pattern seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:burst suppression pattern seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  547. en:by 10-15 years after onset, postural dystonia spreads to all limbs --- r_associated #0: 20 --> en:white substance
    n1=en:by 10-15 years after onset, postural dystonia spreads to all limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  548. en:c3hex, decreased ability to smell --- r_associated #0: 20 --> en:white substance
    n1=en:c3hex, decreased ability to smell | n2=en:white substance | rel=r_associated | relid=0 | w=20
  549. en:calcification in the pons and cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:calcification in the pons and cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  550. en:calcification may occur in other brain regions, including cerebellum, thalamus, white matter --- r_associated #0: 20 --> en:white substance
    n1=en:calcification may occur in other brain regions, including cerebellum, thalamus, white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  551. en:calcification of the amygdala and the amygdala-hippocampal transition area --- r_associated #0: 20 --> en:white substance
    n1=en:calcification of the amygdala and the amygdala-hippocampal transition area | n2=en:white substance | rel=r_associated | relid=0 | w=20
  552. en:calcification of the falx --- r_associated #0: 20 --> en:white substance
    n1=en:calcification of the falx | n2=en:white substance | rel=r_associated | relid=0 | w=20
  553. en:calcifications in white matter, basal ganglia, brainstem, cerebellum, and spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:calcifications in white matter, basal ganglia, brainstem, cerebellum, and spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  554. en:calcifications may be seen in the thalamus, hippocampus, subcortical white matter, and cortex --- r_associated #0: 20 --> en:white substance
    n1=en:calcifications may be seen in the thalamus, hippocampus, subcortical white matter, and cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  555. en:calcifications of cerebral ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:calcifications of cerebral ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  556. en:calicification of the falx cerebri --- r_associated #0: 20 --> en:white substance
    n1=en:calicification of the falx cerebri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  557. en:candidal meningitis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:candidal meningitis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  558. en:cataplexy --- r_associated #0: 20 --> en:white substance
    n1=en:cataplexy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  559. en:cataplexy often triggered by strong emotions --- r_associated #0: 20 --> en:white substance
    n1=en:cataplexy often triggered by strong emotions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  560. en:cataplexy, paroxysmal weakness or paralysis --- r_associated #0: 20 --> en:white substance
    n1=en:cataplexy, paroxysmal weakness or paralysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  561. en:catatonia --- r_associated #0: 20 --> en:white substance
    n1=en:catatonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  562. en:catatonic behavior --- r_associated #0: 20 --> en:white substance
    n1=en:catatonic behavior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  563. en:cauda equina syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:cauda equina syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  564. en:caudate atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:caudate atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  565. en:caudate nuclei atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:caudate nuclei atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  566. en:cavitating leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:cavitating leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  567. en:cavitating white matter degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:cavitating white matter degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  568. en:cavum septum pellucidum atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:cavum septum pellucidum atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  569. en:cavum vergae --- r_associated #0: 20 --> en:white substance
    n1=en:cavum vergae | n2=en:white substance | rel=r_associated | relid=0 | w=20
  570. en:ccerebellar ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:ccerebellar ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  571. en:cell loss and gliosis in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:cell loss and gliosis in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  572. en:cellular aspects of --- r_associated #0: 20 --> en:white substance
    n1=en:cellular aspects of | n2=en:white substance | rel=r_associated | relid=0 | w=20
  573. en:cellular secretion --- r_associated #0: 20 --> en:white substance
    n1=en:cellular secretion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  574. en:central canal malformation --- r_associated #0: 20 --> en:white substance
    n1=en:central canal malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  575. en:central facial nerve paralysis (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:central facial nerve paralysis (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  576. en:central facial palsy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:central facial palsy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  577. en:central hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:central hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  578. en:central nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  579. en:central nervous system degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  580. en:central nervous system demyelination --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system demyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  581. en:central nervous system depression (disorder) --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system depression (disorder) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  582. en:central nervous system involvement (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system involvement (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  583. en:central nervous system involvement in approximately 50% of patients --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system involvement in approximately 50% of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  584. en:central nervous system malformations (40%) --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system malformations (40%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  585. en:central nervous system neoplasm --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system neoplasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  586. en:central nervous system part --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system part | n2=en:white substance | rel=r_associated | relid=0 | w=20
  587. en:central nervous system space --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system space | n2=en:white substance | rel=r_associated | relid=0 | w=20
  588. en:central nervous system tract structure --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous system tract structure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  589. en:central nervous tissue --- r_associated #0: 20 --> en:white substance
    n1=en:central nervous tissue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  590. en:central neural pathway/tract --- r_associated #0: 20 --> en:white substance
    n1=en:central neural pathway/tract | n2=en:white substance | rel=r_associated | relid=0 | w=20
  591. en:cerebellar and brainstem atrophy, mild (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar and brainstem atrophy, mild (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  592. en:cerebellar ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  593. en:cerebellar ataxia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  594. en:cerebellar ataxia (in 1 of 3 families) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia (in 1 of 3 families) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  595. en:cerebellar ataxia (may be permanent in 50% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia (may be permanent in 50% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  596. en:cerebellar ataxia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  597. en:cerebellar ataxia (seen in hhs variant) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia (seen in hhs variant) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  598. en:cerebellar ataxia during episodes --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia during episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  599. en:cerebellar ataxia, adult-onset (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia, adult-onset (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  600. en:cerebellar ataxia, gait and stance --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia, gait and stance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  601. en:cerebellar ataxia, limb and trunk --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia, limb and trunk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  602. en:cerebellar ataxia, mild, late-onset --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia, mild, late-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  603. en:cerebellar ataxia, severe --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  604. en:cerebellar ataxia, slowly progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar ataxia, slowly progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  605. en:cerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  606. en:cerebellar atrophy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  607. en:cerebellar atrophy (96% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (96% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  608. en:cerebellar atrophy (especially in the superior cerebellar vermis) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (especially in the superior cerebellar vermis) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  609. en:cerebellar atrophy (especially of the vermis) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (especially of the vermis) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  610. en:cerebellar atrophy (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  611. en:cerebellar atrophy (in adulthood) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (in adulthood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  612. en:cerebellar atrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  613. en:cerebellar atrophy (juvenile form) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (juvenile form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  614. en:cerebellar atrophy (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  615. en:cerebellar atrophy in most cases --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy in most cases | n2=en:white substance | rel=r_associated | relid=0 | w=20
  616. en:cerebellar atrophy in older patients --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy in older patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  617. en:cerebellar atrophy seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  618. en:cerebellar atrophy with signal hyperintensity in the cerebellar cortex seen on t2-weighted mri --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy with signal hyperintensity in the cerebellar cortex seen on t2-weighted mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  619. en:cerebellar atrophy, diffuse, severe --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, diffuse, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  620. en:cerebellar atrophy, mild --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  621. en:cerebellar atrophy, mild (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, mild (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  622. en:cerebellar atrophy, mild (in 1 of 3 families) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, mild (in 1 of 3 families) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  623. en:cerebellar atrophy, particularly of the hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, particularly of the hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  624. en:cerebellar atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  625. en:cerebellar atrophy, progressive (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, progressive (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  626. en:cerebellar atrophy, progressive (cerebellar vermal atrophy before cerebral atrophy) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, progressive (cerebellar vermal atrophy before cerebral atrophy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  627. en:cerebellar atrophy, progressive (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, progressive (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  628. en:cerebellar atrophy, severe --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar atrophy, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  629. en:cerebellar calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  630. en:cerebellar cell paucity, more marked in vermis than hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar cell paucity, more marked in vermis than hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  631. en:cerebellar cortex shows normal layers --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar cortex shows normal layers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  632. en:cerebellar cortical degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar cortical degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  633. en:cerebellar cyst --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  634. en:cerebellar cyst (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar cyst (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  635. en:cerebellar cysts (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar cysts (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  636. en:cerebellar degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  637. en:cerebellar diseases --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar diseases | n2=en:white substance | rel=r_associated | relid=0 | w=20
  638. en:cerebellar dysarthria --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar dysarthria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  639. en:cerebellar dysfunction, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar dysfunction, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  640. en:cerebellar dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  641. en:cerebellar enlargement --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar enlargement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  642. en:cerebellar gangliocytoma manifesting as seizure and tremor --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar gangliocytoma manifesting as seizure and tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  643. en:cerebellar hemangioblastoma --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hemangioblastoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  644. en:cerebellar hemorrhage (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hemorrhage (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  645. en:cerebellar herniation (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar herniation (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  646. en:cerebellar heterotopias --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar heterotopias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  647. en:cerebellar hypoplasia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  648. en:cerebellar hypoplasia (in 1 of 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (in 1 of 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  649. en:cerebellar hypoplasia (in 1 of 2 sibs) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (in 1 of 2 sibs) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  650. en:cerebellar hypoplasia (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  651. en:cerebellar hypoplasia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  652. en:cerebellar hypoplasia (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  653. en:cerebellar hypoplasia (male) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (male) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  654. en:cerebellar hypoplasia (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  655. en:cerebellar hypoplasia (seen in hhs variant) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (seen in hhs variant) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  656. en:cerebellar hypoplasia (seen in recessive form) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (seen in recessive form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  657. en:cerebellar hypoplasia (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  658. en:cerebellar hypoplasia due to enlarged foramen magnum --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia due to enlarged foramen magnum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  659. en:cerebellar hypoplasia or agenesis --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia or agenesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  660. en:cerebellar hypoplasia predominantly affecting the vermis --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia predominantly affecting the vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  661. en:cerebellar hypoplasia, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  662. en:cerebellar hypoplasia, mild asymmetric (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia, mild asymmetric (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  663. en:cerebellar hypoplasia, particularly of the hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia, particularly of the hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  664. en:cerebellar hypoplasia, severe (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia, severe (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  665. en:cerebellar hypoplasia/atrophy (27%) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar hypoplasia/atrophy (27%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  666. en:cerebellar lesion nos --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar lesion nos | n2=en:white substance | rel=r_associated | relid=0 | w=20
  667. en:cerebellar medulla --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar medulla | n2=en:white substance | rel=r_associated | relid=0 | w=20
  668. en:cerebellar medulloblastoma (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar medulloblastoma (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  669. en:cerebellar neuronal loss --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar neuronal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  670. en:cerebellar origin most likely --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar origin most likely | n2=en:white substance | rel=r_associated | relid=0 | w=20
  671. en:cerebellar signs --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  672. en:cerebellar signs (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  673. en:cerebellar signs (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  674. en:cerebellar signs (may be permanent in 50% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs (may be permanent in 50% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  675. en:cerebellar signs (more common in variant cjd) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs (more common in variant cjd) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  676. en:cerebellar signs during episodes --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs during episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  677. en:cerebellar signs may develop --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs may develop | n2=en:white substance | rel=r_associated | relid=0 | w=20
  678. en:cerebellar signs, mild (in 1 of 3 families) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar signs, mild (in 1 of 3 families) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  679. en:cerebellar stroke --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar stroke | n2=en:white substance | rel=r_associated | relid=0 | w=20
  680. en:cerebellar tonsil herniation --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar tonsil herniation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  681. en:cerebellar tonsillar herniation --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar tonsillar herniation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  682. en:cerebellar vermis aplasia or hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar vermis aplasia or hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  683. en:cerebellar vermis atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar vermis atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  684. en:cerebellar vermis hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar vermis hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  685. en:cerebellar vermis hypoplasia (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar vermis hypoplasia (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  686. en:cerebellar vermis hypoplasia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar vermis hypoplasia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  687. en:cerebellar white matter lesions on mri --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellar white matter lesions on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  688. en:cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  689. en:cerebellum white matter --- r_associated #0: 20 --> en:white substance
    n1=en:cerebellum white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  690. en:cerebral and cerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral and cerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  691. en:cerebral arterial hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral arterial hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  692. en:cerebral arterial thrombosis --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral arterial thrombosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  693. en:cerebral atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  694. en:cerebral atrophy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  695. en:cerebral atrophy (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  696. en:cerebral atrophy (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  697. en:cerebral atrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  698. en:cerebral atrophy (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  699. en:cerebral atrophy (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  700. en:cerebral atrophy diffuse --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy diffuse | n2=en:white substance | rel=r_associated | relid=0 | w=20
  701. en:cerebral atrophy, diffuse, severe --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, diffuse, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  702. en:cerebral atrophy, frontotemporal, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, frontotemporal, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  703. en:cerebral atrophy, generalized mild --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, generalized mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  704. en:cerebral atrophy, mild --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  705. en:cerebral atrophy, mild, diffuse --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, mild, diffuse | n2=en:white substance | rel=r_associated | relid=0 | w=20
  706. en:cerebral atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  707. en:cerebral atrophy, progressive, from anterior to posterior --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, progressive, from anterior to posterior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  708. en:cerebral atrophy, severe --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral atrophy, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  709. en:cerebral calcification --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral calcification | n2=en:white substance | rel=r_associated | relid=0 | w=20
  710. en:cerebral cavernous malformation --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cavernous malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  711. en:cerebral cortex myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cortex myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  712. en:cerebral cortex with spongiform changes --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cortex with spongiform changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  713. en:cerebral cortical and cerebellar atrophy (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cortical and cerebellar atrophy (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  714. en:cerebral cortical atrophy, diffuse --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cortical atrophy, diffuse | n2=en:white substance | rel=r_associated | relid=0 | w=20
  715. en:cerebral cortical atrophy, especially frontal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cortical atrophy, especially frontal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  716. en:cerebral cortical neurodegeneration --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cortical neurodegeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  717. en:cerebral cyst --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  718. en:cerebral degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  719. en:cerebral demyelination and inflammation --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral demyelination and inflammation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  720. en:cerebral dysmyelination --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral dysmyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  721. en:cerebral edema --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral edema | n2=en:white substance | rel=r_associated | relid=0 | w=20
  722. en:cerebral hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  723. en:cerebral hypomyelination --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral hypomyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  724. en:cerebral hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  725. en:cerebral infarction --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral infarction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  726. en:cerebral infarction dandy-walker malformation --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral infarction dandy-walker malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  727. en:cerebral malformations --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  728. en:cerebral oligogyria --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral oligogyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  729. en:cerebral palsy --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  730. en:cerebral spongiosis --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral spongiosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  731. en:cerebral thrombosis --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral thrombosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  732. en:cerebral thrombosis (e.g. 612283.0014 protein c deficiency) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral thrombosis (e.g. 612283.0014 protein c deficiency) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  733. en:cerebral vasculitis or vasculopathy (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral vasculitis or vasculopathy (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  734. en:cerebral white matter atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral white matter atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  735. en:cerebral white matter lesion --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral white matter lesion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  736. en:cerebral white matter lesions (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebral white matter lesions (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  737. en:cerebrospinal fluid --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrospinal fluid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  738. en:cerebrospinal fluid glucose decreased --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrospinal fluid glucose decreased | n2=en:white substance | rel=r_associated | relid=0 | w=20
  739. en:cerebrospinal fluid may show decreased levels of homovanillic acid (hva) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrospinal fluid may show decreased levels of homovanillic acid (hva) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  740. en:cerebrovascular accident --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrovascular accident | n2=en:white substance | rel=r_associated | relid=0 | w=20
  741. en:cerebrovascular accident (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrovascular accident (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  742. en:cerebrovascular disorder --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrovascular disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  743. en:cerebrovascular ischemia --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrovascular ischemia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  744. en:cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings) --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrovascular ischemic attacks, transient (proceed secondary neurologic findings) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  745. en:cerebrum --- r_associated #0: 20 --> en:white substance
    n1=en:cerebrum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  746. en:cervical cord compression --- r_associated #0: 20 --> en:white substance
    n1=en:cervical cord compression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  747. en:cervical myelopathy --- r_associated #0: 20 --> en:white substance
    n1=en:cervical myelopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  748. en:cervical segment of spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:cervical segment of spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  749. en:characteristic arm position with wrist and elbow flexion --- r_associated #0: 20 --> en:white substance
    n1=en:characteristic arm position with wrist and elbow flexion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  750. en:characteristic electroencephalogram (eeg) discharges --- r_associated #0: 20 --> en:white substance
    n1=en:characteristic electroencephalogram (eeg) discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  751. en:characteristic findings on mri --- r_associated #0: 20 --> en:white substance
    n1=en:characteristic findings on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  752. en:characteristic periodic eeg complexes (only in sporadic and familial cjd, not in variant cjd) --- r_associated #0: 20 --> en:white substance
    n1=en:characteristic periodic eeg complexes (only in sporadic and familial cjd, not in variant cjd) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  753. en:chemical aspects --- r_associated #0: 20 --> en:white substance
    n1=en:chemical aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  754. en:chiari i malformation of the cerebellum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:chiari i malformation of the cerebellum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  755. en:chiari i malformation on mri --- r_associated #0: 20 --> en:white substance
    n1=en:chiari i malformation on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  756. en:chiari i malformation on mri (some) --- r_associated #0: 20 --> en:white substance
    n1=en:chiari i malformation on mri (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  757. en:chiari malformation (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:chiari malformation (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  758. en:chiari malformation type ii --- r_associated #0: 20 --> en:white substance
    n1=en:chiari malformation type ii | n2=en:white substance | rel=r_associated | relid=0 | w=20
  759. en:chiari type i --- r_associated #0: 20 --> en:white substance
    n1=en:chiari type i | n2=en:white substance | rel=r_associated | relid=0 | w=20
  760. en:chiari type i malformation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:chiari type i malformation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  761. en:childhood polyphagia --- r_associated #0: 20 --> en:white substance
    n1=en:childhood polyphagia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  762. en:chorea --- r_associated #0: 20 --> en:white substance
    n1=en:chorea | n2=en:white substance | rel=r_associated | relid=0 | w=20
  763. en:chorea (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:chorea (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  764. en:chorea of all limbs --- r_associated #0: 20 --> en:white substance
    n1=en:chorea of all limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  765. en:chorea of hands --- r_associated #0: 20 --> en:white substance
    n1=en:chorea of hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  766. en:chorea, mild (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:chorea, mild (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  767. en:chorea, prominent (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:chorea, prominent (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  768. en:chorea-ballism --- r_associated #0: 20 --> en:white substance
    n1=en:chorea-ballism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  769. en:choreic movements (10 to 22% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:choreic movements (10 to 22% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  770. en:choreic movements, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:choreic movements, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  771. en:choreoathetoid movements --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetoid movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  772. en:choreoathetosis --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  773. en:choreoathetosis (2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis (2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  774. en:choreoathetosis (described in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis (described in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  775. en:choreoathetosis (in 79%), more frequent at disease onset --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis (in 79%), more frequent at disease onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  776. en:choreoathetosis (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  777. en:choreoathetosis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  778. en:choreoathetosis of the face, trunk, extremities --- r_associated #0: 20 --> en:white substance
    n1=en:choreoathetosis of the face, trunk, extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  779. en:choreodystonia of the upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:choreodystonia of the upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  780. en:choristoma --- r_associated #0: 20 --> en:white substance
    n1=en:choristoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  781. en:choroid plexus calcification --- r_associated #0: 20 --> en:white substance
    n1=en:choroid plexus calcification | n2=en:white substance | rel=r_associated | relid=0 | w=20
  782. en:choroid plexus cyst --- r_associated #0: 20 --> en:white substance
    n1=en:choroid plexus cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  783. en:choroid plexus papilloma (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:choroid plexus papilloma (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  784. en:chronic encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:chronic encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  785. en:chronic headaches --- r_associated #0: 20 --> en:white substance
    n1=en:chronic headaches | n2=en:white substance | rel=r_associated | relid=0 | w=20
  786. en:chronic lymphocytic meningitis --- r_associated #0: 20 --> en:white substance
    n1=en:chronic lymphocytic meningitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  787. en:chronic pain --- r_associated #0: 20 --> en:white substance
    n1=en:chronic pain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  788. en:chronic subtype, headaches occur without remission for 1 year --- r_associated #0: 20 --> en:white substance
    n1=en:chronic subtype, headaches occur without remission for 1 year | n2=en:white substance | rel=r_associated | relid=0 | w=20
  789. en:chronic-progressive course with episodes of rapid deterioration following fever or head trauma --- r_associated #0: 20 --> en:white substance
    n1=en:chronic-progressive course with episodes of rapid deterioration following fever or head trauma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  790. en:clonic convulsion --- r_associated #0: 20 --> en:white substance
    n1=en:clonic convulsion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  791. en:clonus --- r_associated #0: 20 --> en:white substance
    n1=en:clonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  792. en:clonus may occur --- r_associated #0: 20 --> en:white substance
    n1=en:clonus may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  793. en:closed-lip schizencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:closed-lip schizencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  794. en:clumsiness --- r_associated #0: 20 --> en:white substance
    n1=en:clumsiness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  795. en:clumsiness (82%) --- r_associated #0: 20 --> en:white substance
    n1=en:clumsiness (82%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  796. en:clumsiness (mild) --- r_associated #0: 20 --> en:white substance
    n1=en:clumsiness (mild) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  797. en:clumsiness in childhood --- r_associated #0: 20 --> en:white substance
    n1=en:clumsiness in childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  798. en:clumsiness, unsteadiness --- r_associated #0: 20 --> en:white substance
    n1=en:clumsiness, unsteadiness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  799. en:clumsy gait --- r_associated #0: 20 --> en:white substance
    n1=en:clumsy gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  800. en:cns component --- r_associated #0: 20 --> en:white substance
    n1=en:cns component | n2=en:white substance | rel=r_associated | relid=0 | w=20
  801. en:cns infarctions --- r_associated #0: 20 --> en:white substance
    n1=en:cns infarctions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  802. en:cns stimulation (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:cns stimulation (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  803. en:cns tissue --- r_associated #0: 20 --> en:white substance
    n1=en:cns tissue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  804. en:cns venous malformations --- r_associated #0: 20 --> en:white substance
    n1=en:cns venous malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  805. en:coarse tremors --- r_associated #0: 20 --> en:white substance
    n1=en:coarse tremors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  806. en:coarsened pattern of sulci and gyri --- r_associated #0: 20 --> en:white substance
    n1=en:coarsened pattern of sulci and gyri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  807. en:cobblestone lissencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:cobblestone lissencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  808. en:cobblestone lissencephaly (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cobblestone lissencephaly (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  809. en:cobblestone lissencephaly (posterior brain regions more affected than anterior regions) --- r_associated #0: 20 --> en:white substance
    n1=en:cobblestone lissencephaly (posterior brain regions more affected than anterior regions) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  810. en:cobblestone lissencephaly, posterior frontal and parietal regions --- r_associated #0: 20 --> en:white substance
    n1=en:cobblestone lissencephaly, posterior frontal and parietal regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  811. en:cobblestone lissencephaly, type ii --- r_associated #0: 20 --> en:white substance
    n1=en:cobblestone lissencephaly, type ii | n2=en:white substance | rel=r_associated | relid=0 | w=20
  812. en:cobblestone lissencephaly, type ii (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:cobblestone lissencephaly, type ii (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  813. en:cognition is preserved --- r_associated #0: 20 --> en:white substance
    n1=en:cognition is preserved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  814. en:cognition is spared --- r_associated #0: 20 --> en:white substance
    n1=en:cognition is spared | n2=en:white substance | rel=r_associated | relid=0 | w=20
  815. en:cognitive decline (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  816. en:cognitive decline (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  817. en:cognitive decline (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  818. en:cognitive decline (later in life) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline (later in life) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  819. en:cognitive decline (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  820. en:cognitive decline in adulthood --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline in adulthood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  821. en:cognitive decline in older patients --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline in older patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  822. en:cognitive decline, rapid --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive decline, rapid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  823. en:cognitive defects (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive defects (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  824. en:cognitive defects (variable from mild to severe) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive defects (variable from mild to severe) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  825. en:cognitive defects develop later in the disease --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive defects develop later in the disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  826. en:cognitive defects in executive function and attention --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive defects in executive function and attention | n2=en:white substance | rel=r_associated | relid=0 | w=20
  827. en:cognitive deficits (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive deficits (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  828. en:cognitive deficits may occur --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive deficits may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  829. en:cognitive deficits, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive deficits, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  830. en:cognitive delay --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  831. en:cognitive delay, mild (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive delay, mild (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  832. en:cognitive delay, mild to severe --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive delay, mild to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  833. en:cognitive deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  834. en:cognitive dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  835. en:cognitive dysfunction (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive dysfunction (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  836. en:cognitive dysfunction (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive dysfunction (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  837. en:cognitive function, variable --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive function, variable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  838. en:cognitive impairment --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  839. en:cognitive impairment (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  840. en:cognitive impairment (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  841. en:cognitive impairment (3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  842. en:cognitive impairment (cvs+) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (cvs+) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  843. en:cognitive impairment (in 1 of 3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (in 1 of 3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  844. en:cognitive impairment (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  845. en:cognitive impairment (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  846. en:cognitive impairment, gradual onset --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment, gradual onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  847. en:cognitive impairment, mild (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment, mild (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  848. en:cognitive impairment, mild (44%) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment, mild (44%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  849. en:cognitive impairment, mild (in 2 of 3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment, mild (in 2 of 3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  850. en:cognitive impairment, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  851. en:cognitive impairment, mild to severe --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive impairment, mild to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  852. en:cognitive regression --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  853. en:cognitive regression, mild --- r_associated #0: 20 --> en:white substance
    n1=en:cognitive regression, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  854. en:cogwheel rigidities --- r_associated #0: 20 --> en:white substance
    n1=en:cogwheel rigidities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  855. en:cogwheel rigidity (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cogwheel rigidity (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  856. en:colpocephaly --- r_associated #0: 20 --> en:white substance
    n1=en:colpocephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  857. en:coma --- r_associated #0: 20 --> en:white substance
    n1=en:coma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  858. en:coma (if untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:coma (if untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  859. en:coma (in up to 33% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:coma (in up to 33% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  860. en:coma (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:coma (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  861. en:coma during episodes (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:coma during episodes (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  862. en:coma may occur after force feeding of high protein diet --- r_associated #0: 20 --> en:white substance
    n1=en:coma may occur after force feeding of high protein diet | n2=en:white substance | rel=r_associated | relid=0 | w=20
  863. en:commissure of neuraxis --- r_associated #0: 20 --> en:white substance
    n1=en:commissure of neuraxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  864. en:communicating hydrocephalus --- r_associated #0: 20 --> en:white substance
    n1=en:communicating hydrocephalus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  865. en:communication defects --- r_associated #0: 20 --> en:white substance
    n1=en:communication defects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  866. en:complete or partial absence of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:complete or partial absence of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  867. en:complete or partial absence of the corpus callosum (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:complete or partial absence of the corpus callosum (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  868. en:complex motor behavior such as sleep walking --- r_associated #0: 20 --> en:white substance
    n1=en:complex motor behavior such as sleep walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  869. en:complex partial seizure with impairment of consciousness --- r_associated #0: 20 --> en:white substance
    n1=en:complex partial seizure with impairment of consciousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  870. en:complex partial seizures --- r_associated #0: 20 --> en:white substance
    n1=en:complex partial seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  871. en:complex partial seizures (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:complex partial seizures (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  872. en:complex partial seizures, often with secondary generalization, are the most common type --- r_associated #0: 20 --> en:white substance
    n1=en:complex partial seizures, often with secondary generalization, are the most common type | n2=en:white substance | rel=r_associated | relid=0 | w=20
  873. en:compromised expressive language development, severe --- r_associated #0: 20 --> en:white substance
    n1=en:compromised expressive language development, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  874. en:concentration impairment --- r_associated #0: 20 --> en:white substance
    n1=en:concentration impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  875. en:conducting tissue of heart --- r_associated #0: 20 --> en:white substance
    n1=en:conducting tissue of heart | n2=en:white substance | rel=r_associated | relid=0 | w=20
  876. en:confusion --- r_associated #0: 20 --> en:white substance
    n1=en:confusion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  877. en:confusion (later-onset) --- r_associated #0: 20 --> en:white substance
    n1=en:confusion (later-onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  878. en:confusion adverse event --- r_associated #0: 20 --> en:white substance
    n1=en:confusion adverse event | n2=en:white substance | rel=r_associated | relid=0 | w=20
  879. en:confusion, paroxysmal --- r_associated #0: 20 --> en:white substance
    n1=en:confusion, paroxysmal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  880. en:congenital absence of the vermis --- r_associated #0: 20 --> en:white substance
    n1=en:congenital absence of the vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  881. en:congenital anomaly of brain --- r_associated #0: 20 --> en:white substance
    n1=en:congenital anomaly of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  882. en:congenital cerebellar hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:congenital cerebellar hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  883. en:congenital hyperextension of limb --- r_associated #0: 20 --> en:white substance
    n1=en:congenital hyperextension of limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  884. en:congenital hypotonia, axial or generalized --- r_associated #0: 20 --> en:white substance
    n1=en:congenital hypotonia, axial or generalized | n2=en:white substance | rel=r_associated | relid=0 | w=20
  885. en:congenital hypotonia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:congenital hypotonia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  886. en:congenital porencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:congenital porencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  887. en:consciousness fluctuating --- r_associated #0: 20 --> en:white substance
    n1=en:consciousness fluctuating | n2=en:white substance | rel=r_associated | relid=0 | w=20
  888. en:constructional apraxia (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:constructional apraxia (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  889. en:continuous spike-wave discharges during sleep --- r_associated #0: 20 --> en:white substance
    n1=en:continuous spike-wave discharges during sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  890. en:continuous spike-waves during slow-wave sleep --- r_associated #0: 20 --> en:white substance
    n1=en:continuous spike-waves during slow-wave sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  891. en:contractures (older children and adolescents) --- r_associated #0: 20 --> en:white substance
    n1=en:contractures (older children and adolescents) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  892. en:contralateral hemiparesis, congenital --- r_associated #0: 20 --> en:white substance
    n1=en:contralateral hemiparesis, congenital | n2=en:white substance | rel=r_associated | relid=0 | w=20
  893. en:conus medullaris --- r_associated #0: 20 --> en:white substance
    n1=en:conus medullaris | n2=en:white substance | rel=r_associated | relid=0 | w=20
  894. en:convulsions, febrile (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:convulsions, febrile (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  895. en:convulsive seizures --- r_associated #0: 20 --> en:white substance
    n1=en:convulsive seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  896. en:corprolalia --- r_associated #0: 20 --> en:white substance
    n1=en:corprolalia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  897. en:corpus callosum abnormalities (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:corpus callosum abnormalities (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  898. en:corpus callosum agenesis --- r_associated #0: 20 --> en:white substance
    n1=en:corpus callosum agenesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  899. en:corpus callosum lipoma --- r_associated #0: 20 --> en:white substance
    n1=en:corpus callosum lipoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  900. en:corpus callosum, agenesis of (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:corpus callosum, agenesis of (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  901. en:corpus callosum, thin (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:corpus callosum, thin (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  902. en:cortical and brainstem neuronal loss --- r_associated #0: 20 --> en:white substance
    n1=en:cortical and brainstem neuronal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  903. en:cortical and subcortical atrophy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical and subcortical atrophy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  904. en:cortical and subcortical hyperintensities --- r_associated #0: 20 --> en:white substance
    n1=en:cortical and subcortical hyperintensities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  905. en:cortical and subcortical neuronal loss in the frontal and temporal regions --- r_associated #0: 20 --> en:white substance
    n1=en:cortical and subcortical neuronal loss in the frontal and temporal regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  906. en:cortical and subcortical regions involved --- r_associated #0: 20 --> en:white substance
    n1=en:cortical and subcortical regions involved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  907. en:cortical atrophy (43%) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy (43%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  908. en:cortical atrophy (frontal area) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy (frontal area) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  909. en:cortical atrophy (in 2 siblings) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy (in 2 siblings) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  910. en:cortical atrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  911. en:cortical atrophy (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  912. en:cortical atrophy with loss of pyramidal neurons in the motor cortex --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy with loss of pyramidal neurons in the motor cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  913. en:cortical atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:cortical atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  914. en:cortical blindness (in 1 moroccan patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical blindness (in 1 moroccan patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  915. en:cortical cell layer --- r_associated #0: 20 --> en:white substance
    n1=en:cortical cell layer | n2=en:white substance | rel=r_associated | relid=0 | w=20
  916. en:cortical cytotoxic edema --- r_associated #0: 20 --> en:white substance
    n1=en:cortical cytotoxic edema | n2=en:white substance | rel=r_associated | relid=0 | w=20
  917. en:cortical degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:cortical degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  918. en:cortical dysgenesis --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysgenesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  919. en:cortical dysgenesis, complex --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysgenesis, complex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  920. en:cortical dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  921. en:cortical dysplasia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysplasia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  922. en:cortical dysplasia (2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysplasia (2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  923. en:cortical dysplasia, focal (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysplasia, focal (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  924. en:cortical dysplasia, focal (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical dysplasia, focal (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  925. en:cortical gyral simplification --- r_associated #0: 20 --> en:white substance
    n1=en:cortical gyral simplification | n2=en:white substance | rel=r_associated | relid=0 | w=20
  926. en:cortical hypergyria (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cortical hypergyria (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  927. en:cortical malformations --- r_associated #0: 20 --> en:white substance
    n1=en:cortical malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  928. en:cortical myoclonic tremors characterized by 8 to 10-hz discharges --- r_associated #0: 20 --> en:white substance
    n1=en:cortical myoclonic tremors characterized by 8 to 10-hz discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  929. en:cortical neuronal loss --- r_associated #0: 20 --> en:white substance
    n1=en:cortical neuronal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  930. en:cortical origin of the tremor --- r_associated #0: 20 --> en:white substance
    n1=en:cortical origin of the tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  931. en:cortical reflex myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:cortical reflex myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  932. en:cortical simplification --- r_associated #0: 20 --> en:white substance
    n1=en:cortical simplification | n2=en:white substance | rel=r_associated | relid=0 | w=20
  933. en:cortical thinning --- r_associated #0: 20 --> en:white substance
    n1=en:cortical thinning | n2=en:white substance | rel=r_associated | relid=0 | w=20
  934. en:cortical tubers --- r_associated #0: 20 --> en:white substance
    n1=en:cortical tubers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  935. en:cortical venous thromboses --- r_associated #0: 20 --> en:white substance
    n1=en:cortical venous thromboses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  936. en:corticobasal degeneration (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:corticobasal degeneration (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  937. en:corticospinal signs (87% of patients in 1 report) --- r_associated #0: 20 --> en:white substance
    n1=en:corticospinal signs (87% of patients in 1 report) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  938. en:corticospinal tract atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:corticospinal tract atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  939. en:corticospinal tract disease in lower limbs (in adulthood) --- r_associated #0: 20 --> en:white substance
    n1=en:corticospinal tract disease in lower limbs (in adulthood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  940. en:corticospinal tract hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:corticospinal tract hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  941. en:corticospinal tracts with decreased myelin staining --- r_associated #0: 20 --> en:white substance
    n1=en:corticospinal tracts with decreased myelin staining | n2=en:white substance | rel=r_associated | relid=0 | w=20
  942. en:cranial nerve anomalies --- r_associated #0: 20 --> en:white substance
    n1=en:cranial nerve anomalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  943. en:cranial nerve dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:cranial nerve dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  944. en:cranial nerve palsies can arise with head and neck paragangliomas --- r_associated #0: 20 --> en:white substance
    n1=en:cranial nerve palsies can arise with head and neck paragangliomas | n2=en:white substance | rel=r_associated | relid=0 | w=20
  945. en:cranial nerve palsy --- r_associated #0: 20 --> en:white substance
    n1=en:cranial nerve palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  946. en:cranial nerve palsy, intermittent, transient --- r_associated #0: 20 --> en:white substance
    n1=en:cranial nerve palsy, intermittent, transient | n2=en:white substance | rel=r_associated | relid=0 | w=20
  947. en:crawling and standing not achieved --- r_associated #0: 20 --> en:white substance
    n1=en:crawling and standing not achieved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  948. en:crowding of the posterior fossa --- r_associated #0: 20 --> en:white substance
    n1=en:crowding of the posterior fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  949. en:ct scan shows dense calcifications in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:ct scan shows dense calcifications in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  950. en:cyst of septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:cyst of septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  951. en:cyst of septum pellucidum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:cyst of septum pellucidum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  952. en:cystic cavitation of the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:cystic cavitation of the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  953. en:cystic degeneration of cerebral white matter with preserved cortex --- r_associated #0: 20 --> en:white substance
    n1=en:cystic degeneration of cerebral white matter with preserved cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  954. en:cystic degeneration of the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:cystic degeneration of the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  955. en:cystic destruction of brain tissue, including basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:cystic destruction of brain tissue, including basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  956. en:cystic lesions consistent with leigh syndrome (256000) --- r_associated #0: 20 --> en:white substance
    n1=en:cystic lesions consistent with leigh syndrome (256000) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  957. en:cystic lesions in the basal ganglia, brainstem, and cerebral hemispheres similar to leigh syndrome (256000) --- r_associated #0: 20 --> en:white substance
    n1=en:cystic lesions in the basal ganglia, brainstem, and cerebral hemispheres similar to leigh syndrome (256000) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  958. en:cystic lysis of the deep white matter --- r_associated #0: 20 --> en:white substance
    n1=en:cystic lysis of the deep white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  959. en:cysts tend to enlarge with age --- r_associated #0: 20 --> en:white substance
    n1=en:cysts tend to enlarge with age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  960. en:cytopathic effect --- r_associated #0: 20 --> en:white substance
    n1=en:cytopathic effect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  961. en:dandy walker variant --- r_associated #0: 20 --> en:white substance
    n1=en:dandy walker variant | n2=en:white substance | rel=r_associated | relid=0 | w=20
  962. en:dandy-walker malformation --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  963. en:dandy-walker malformation (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  964. en:dandy-walker malformation (in 1 of 4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation (in 1 of 4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  965. en:dandy-walker malformation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  966. en:dandy-walker malformation (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  967. en:dandy-walker malformation (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  968. en:dandy-walker malformation (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:dandy-walker malformation (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  969. en:deafness --- r_associated #0: 20 --> en:white substance
    n1=en:deafness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  970. en:decerebrate or decorticate posturing late --- r_associated #0: 20 --> en:white substance
    n1=en:decerebrate or decorticate posturing late | n2=en:white substance | rel=r_associated | relid=0 | w=20
  971. en:decerebrate posturings --- r_associated #0: 20 --> en:white substance
    n1=en:decerebrate posturings | n2=en:white substance | rel=r_associated | relid=0 | w=20
  972. en:decorticate posture --- r_associated #0: 20 --> en:white substance
    n1=en:decorticate posture | n2=en:white substance | rel=r_associated | relid=0 | w=20
  973. en:decrease in abstract thinking --- r_associated #0: 20 --> en:white substance
    n1=en:decrease in abstract thinking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  974. en:decreased active movements --- r_associated #0: 20 --> en:white substance
    n1=en:decreased active movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  975. en:decreased amount of myelin-specific lipids --- r_associated #0: 20 --> en:white substance
    n1=en:decreased amount of myelin-specific lipids | n2=en:white substance | rel=r_associated | relid=0 | w=20
  976. en:decreased amount of myelin-specific proteins --- r_associated #0: 20 --> en:white substance
    n1=en:decreased amount of myelin-specific proteins | n2=en:white substance | rel=r_associated | relid=0 | w=20
  977. en:decreased brain volume (female) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased brain volume (female) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  978. en:decreased brain weight --- r_associated #0: 20 --> en:white substance
    n1=en:decreased brain weight | n2=en:white substance | rel=r_associated | relid=0 | w=20
  979. en:decreased cerebellar folia --- r_associated #0: 20 --> en:white substance
    n1=en:decreased cerebellar folia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  980. en:decreased cerebral volume, especially of the frontal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:decreased cerebral volume, especially of the frontal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  981. en:decreased cognition (later-onset) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased cognition (later-onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  982. en:decreased core body temperature --- r_associated #0: 20 --> en:white substance
    n1=en:decreased core body temperature | n2=en:white substance | rel=r_associated | relid=0 | w=20
  983. en:decreased creatine signal seen on magnetic resonance spectroscopy --- r_associated #0: 20 --> en:white substance
    n1=en:decreased creatine signal seen on magnetic resonance spectroscopy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  984. en:decreased csf volume in posterior fossa --- r_associated #0: 20 --> en:white substance
    n1=en:decreased csf volume in posterior fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  985. en:decreased delineation of the basal ganglia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased delineation of the basal ganglia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  986. en:decreased fine motor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:decreased fine motor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  987. en:decreased iq --- r_associated #0: 20 --> en:white substance
    n1=en:decreased iq | n2=en:white substance | rel=r_associated | relid=0 | w=20
  988. en:decreased iq (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased iq (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  989. en:decreased iq (some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased iq (some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  990. en:decreased iron content in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:decreased iron content in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  991. en:decreased mental processing speed --- r_associated #0: 20 --> en:white substance
    n1=en:decreased mental processing speed | n2=en:white substance | rel=r_associated | relid=0 | w=20
  992. en:decreased mitochondrial respiratory chain complex activity --- r_associated #0: 20 --> en:white substance
    n1=en:decreased mitochondrial respiratory chain complex activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  993. en:decreased motor nerve conduction velocity --- r_associated #0: 20 --> en:white substance
    n1=en:decreased motor nerve conduction velocity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  994. en:decreased myelin --- r_associated #0: 20 --> en:white substance
    n1=en:decreased myelin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  995. en:decreased myelination seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:decreased myelination seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  996. en:decreased n-acetylaspartate --- r_associated #0: 20 --> en:white substance
    n1=en:decreased n-acetylaspartate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  997. en:decreased need for sleep --- r_associated #0: 20 --> en:white substance
    n1=en:decreased need for sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  998. en:decreased nonverbal iq --- r_associated #0: 20 --> en:white substance
    n1=en:decreased nonverbal iq | n2=en:white substance | rel=r_associated | relid=0 | w=20
  999. en:decreased numbers of astrocytes --- r_associated #0: 20 --> en:white substance
    n1=en:decreased numbers of astrocytes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1000. en:decreased or absent gyri (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased or absent gyri (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1001. en:decreased or absent motor evoked potentials (mep), indicating dysfunction of the corticospinal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:decreased or absent motor evoked potentials (mep), indicating dysfunction of the corticospinal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1002. en:decreased pain response --- r_associated #0: 20 --> en:white substance
    n1=en:decreased pain response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1003. en:decreased pyramidal cells --- r_associated #0: 20 --> en:white substance
    n1=en:decreased pyramidal cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1004. en:decreased rapid automatized naming (ran) speed --- r_associated #0: 20 --> en:white substance
    n1=en:decreased rapid automatized naming (ran) speed | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1005. en:decreased reflexes (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:decreased reflexes (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1006. en:decreased sleep latency --- r_associated #0: 20 --> en:white substance
    n1=en:decreased sleep latency | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1007. en:decreased somatosensory-evoked potentials --- r_associated #0: 20 --> en:white substance
    n1=en:decreased somatosensory-evoked potentials | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1008. en:decreased speech --- r_associated #0: 20 --> en:white substance
    n1=en:decreased speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1009. en:decreased spontaneous movements at birth --- r_associated #0: 20 --> en:white substance
    n1=en:decreased spontaneous movements at birth | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1010. en:decreased supratentorial volume --- r_associated #0: 20 --> en:white substance
    n1=en:decreased supratentorial volume | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1011. en:decreased tendon reflex --- r_associated #0: 20 --> en:white substance
    n1=en:decreased tendon reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1012. en:decreased upper extremity reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:decreased upper extremity reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1013. en:decreased vibration sense, suggesting posterior column involvement --- r_associated #0: 20 --> en:white substance
    n1=en:decreased vibration sense, suggesting posterior column involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1014. en:decreased vibratory sense --- r_associated #0: 20 --> en:white substance
    n1=en:decreased vibratory sense | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1015. en:decreased volume of the cerebral white matter --- r_associated #0: 20 --> en:white substance
    n1=en:decreased volume of the cerebral white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1016. en:decreased volume of the posterior cranial fossa with normal hindbrain volume --- r_associated #0: 20 --> en:white substance
    n1=en:decreased volume of the posterior cranial fossa with normal hindbrain volume | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1017. en:decreased white matter --- r_associated #0: 20 --> en:white substance
    n1=en:decreased white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1018. en:decreased white matter volume --- r_associated #0: 20 --> en:white substance
    n1=en:decreased white matter volume | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1019. en:decreasing responsiveness --- r_associated #0: 20 --> en:white substance
    n1=en:decreasing responsiveness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1020. en:deep hypointensities (mri, t2) suggestive of past microbleeds --- r_associated #0: 20 --> en:white substance
    n1=en:deep hypointensities (mri, t2) suggestive of past microbleeds | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1021. en:deep interpeduncular fossa --- r_associated #0: 20 --> en:white substance
    n1=en:deep interpeduncular fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1022. en:deep posterior interpeduncular fossa --- r_associated #0: 20 --> en:white substance
    n1=en:deep posterior interpeduncular fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1023. en:deep white matter changes --- r_associated #0: 20 --> en:white substance
    n1=en:deep white matter changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1024. en:deep white matter hypodensities --- r_associated #0: 20 --> en:white substance
    n1=en:deep white matter hypodensities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1025. en:deep white matter lesions, particularly affecting the frontal and parietal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:deep white matter lesions, particularly affecting the frontal and parietal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1026. en:defect in axonal guidance --- r_associated #0: 20 --> en:white substance
    n1=en:defect in axonal guidance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1027. en:defect in morphosyntactic rules --- r_associated #0: 20 --> en:white substance
    n1=en:defect in morphosyntactic rules | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1028. en:defective myelination of the deep white matter --- r_associated #0: 20 --> en:white substance
    n1=en:defective myelination of the deep white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1029. en:defective opercularization --- r_associated #0: 20 --> en:white substance
    n1=en:defective opercularization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1030. en:defects in auditory cue processing --- r_associated #0: 20 --> en:white substance
    n1=en:defects in auditory cue processing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1031. en:defects in fine motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:defects in fine motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1032. en:defects in visual cue processing --- r_associated #0: 20 --> en:white substance
    n1=en:defects in visual cue processing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1033. en:deficient myelination --- r_associated #0: 20 --> en:white substance
    n1=en:deficient myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1034. en:deficit in basic reading --- r_associated #0: 20 --> en:white substance
    n1=en:deficit in basic reading | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1035. en:deficit in expressive language --- r_associated #0: 20 --> en:white substance
    n1=en:deficit in expressive language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1036. en:deficit in nonword repetition (nwr) --- r_associated #0: 20 --> en:white substance
    n1=en:deficit in nonword repetition (nwr) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1037. en:deficit in phonologic short-term memory --- r_associated #0: 20 --> en:white substance
    n1=en:deficit in phonologic short-term memory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1038. en:deficit in reading comprehension --- r_associated #0: 20 --> en:white substance
    n1=en:deficit in reading comprehension | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1039. en:deficit in spelling --- r_associated #0: 20 --> en:white substance
    n1=en:deficit in spelling | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1040. en:deficits in abstraction --- r_associated #0: 20 --> en:white substance
    n1=en:deficits in abstraction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1041. en:deficits in language expression --- r_associated #0: 20 --> en:white substance
    n1=en:deficits in language expression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1042. en:deformed temporal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:deformed temporal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1043. en:degeneration of anterior horn cells --- r_associated #0: 20 --> en:white substance
    n1=en:degeneration of anterior horn cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1044. en:degeneration of purkinje cells in the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:degeneration of purkinje cells in the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1045. en:degeneration of the dentatorubral and pallidoluysian systems --- r_associated #0: 20 --> en:white substance
    n1=en:degeneration of the dentatorubral and pallidoluysian systems | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1046. en:degeneration of the lateral corticospinal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:degeneration of the lateral corticospinal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1047. en:deja vu feeling --- r_associated #0: 20 --> en:white substance
    n1=en:deja vu feeling | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1048. en:delay in gross motor development due to weakness --- r_associated #0: 20 --> en:white substance
    n1=en:delay in gross motor development due to weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1049. en:delay of gross motor function --- r_associated #0: 20 --> en:white substance
    n1=en:delay of gross motor function | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1050. en:delayed adaptive hand use --- r_associated #0: 20 --> en:white substance
    n1=en:delayed adaptive hand use | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1051. en:delayed ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:delayed ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1052. en:delayed brainstem development (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed brainstem development (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1053. en:delayed cerebellar development (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed cerebellar development (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1054. en:delayed cerebral myelination --- r_associated #0: 20 --> en:white substance
    n1=en:delayed cerebral myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1055. en:delayed cognitive development (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed cognitive development (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1056. en:delayed cognitive development, mild (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed cognitive development, mild (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1057. en:delayed cognitive development/learning disabilities (93%) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed cognitive development/learning disabilities (93%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1058. en:delayed development (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1059. en:delayed development (about 25%) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development (about 25%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1060. en:delayed development (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1061. en:delayed development (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1062. en:delayed development if untreated --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development if untreated | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1063. en:delayed development in early childhood (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development in early childhood (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1064. en:delayed development may occur --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1065. en:delayed development, after 8-15 months --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development, after 8-15 months | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1066. en:delayed development, ranging from mild to severe --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development, ranging from mild to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1067. en:delayed development, severe --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1068. en:delayed development, variable (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development, variable (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1069. en:delayed development, variable severity, from birth in some patients --- r_associated #0: 20 --> en:white substance
    n1=en:delayed development, variable severity, from birth in some patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1070. en:delayed developmental milestones --- r_associated #0: 20 --> en:white substance
    n1=en:delayed developmental milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1071. en:delayed gross motor development (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed gross motor development (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1072. en:delayed gyration --- r_associated #0: 20 --> en:white substance
    n1=en:delayed gyration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1073. en:delayed independent walking --- r_associated #0: 20 --> en:white substance
    n1=en:delayed independent walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1074. en:delayed intellectual development --- r_associated #0: 20 --> en:white substance
    n1=en:delayed intellectual development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1075. en:delayed motor and speech development, mild (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor and speech development, mild (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1076. en:delayed motor development (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor development (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1077. en:delayed motor development (secondary to skeletal abnormalities) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor development (secondary to skeletal abnormalities) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1078. en:delayed motor development due to muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor development due to muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1079. en:delayed motor development, mild, transient --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor development, mild, transient | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1080. en:delayed motor development, severe --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor development, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1081. en:delayed motor milestones due to muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:delayed motor milestones due to muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1082. en:delayed myelination --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1083. en:delayed myelination (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1084. en:delayed myelination (1/4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination (1/4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1085. en:delayed myelination (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1086. en:delayed myelination (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1087. en:delayed myelination on brain mri (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination on brain mri (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1088. en:delayed myelination seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1089. en:delayed myelination, mild --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelination, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1090. en:delayed myelinization (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed myelinization (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1091. en:delayed onset of phrase speech (> 36 months) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed onset of phrase speech (> 36 months) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1092. en:delayed opercularization --- r_associated #0: 20 --> en:white substance
    n1=en:delayed opercularization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1093. en:delayed or absent independent walking --- r_associated #0: 20 --> en:white substance
    n1=en:delayed or absent independent walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1094. en:delayed psychomotor development (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1095. en:delayed psychomotor development (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1096. en:delayed psychomotor development (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1097. en:delayed psychomotor development (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1098. en:delayed psychomotor development (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1099. en:delayed psychomotor development (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1100. en:delayed psychomotor development (mild to severe) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (mild to severe) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1101. en:delayed psychomotor development (stops at development levels of 1-2 years) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development (stops at development levels of 1-2 years) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1102. en:delayed psychomotor development after onset of seizures --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development after onset of seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1103. en:delayed psychomotor development, mild --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1104. en:delayed psychomotor development, mild (in 3 of 5 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, mild (in 3 of 5 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1105. en:delayed psychomotor development, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1106. en:delayed psychomotor development, moderate to severe --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, moderate to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1107. en:delayed psychomotor development, profound --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1108. en:delayed psychomotor development, profound (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, profound (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1109. en:delayed psychomotor development, profound (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, profound (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1110. en:delayed psychomotor development, severe --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1111. en:delayed psychomotor development, severe (> 90%) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, severe (> 90%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1112. en:delayed psychomotor development, severe (in 2 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, severe (in 2 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1113. en:delayed psychomotor development, severe to profound --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, severe to profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1114. en:delayed psychomotor development, variable --- r_associated #0: 20 --> en:white substance
    n1=en:delayed psychomotor development, variable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1115. en:delayed speech and language development --- r_associated #0: 20 --> en:white substance
    n1=en:delayed speech and language development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1116. en:delayed speech development, severe --- r_associated #0: 20 --> en:white substance
    n1=en:delayed speech development, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1117. en:delayed walking (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed walking (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1118. en:delayed walking (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed walking (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1119. en:delayed walking (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed walking (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1120. en:delayed walking and running in early childhood --- r_associated #0: 20 --> en:white substance
    n1=en:delayed walking and running in early childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1121. en:delayed walking, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:delayed walking, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1122. en:delirium --- r_associated #0: 20 --> en:white substance
    n1=en:delirium | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1123. en:delirium (later-onset) --- r_associated #0: 20 --> en:white substance
    n1=en:delirium (later-onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1124. en:delusion --- r_associated #0: 20 --> en:white substance
    n1=en:delusion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1125. en:dementia --- r_associated #0: 20 --> en:white substance
    n1=en:dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1126. en:dementia (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1127. en:dementia (5%) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (5%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1128. en:dementia (<20%) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (<20%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1129. en:dementia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1130. en:dementia (later-onset) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (later-onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1131. en:dementia (onset in fifth decade) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (onset in fifth decade) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1132. en:dementia (subtype 3a) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia (subtype 3a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1133. en:dementia in a subset of patients --- r_associated #0: 20 --> en:white substance
    n1=en:dementia in a subset of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1134. en:dementia may occur --- r_associated #0: 20 --> en:white substance
    n1=en:dementia may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1135. en:dementia of frontal lobe type --- r_associated #0: 20 --> en:white substance
    n1=en:dementia of frontal lobe type | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1136. en:dementia, presenile, progressive, beginning around age 30 years --- r_associated #0: 20 --> en:white substance
    n1=en:dementia, presenile, progressive, beginning around age 30 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1137. en:dementia, progressive (more common in males) --- r_associated #0: 20 --> en:white substance
    n1=en:dementia, progressive (more common in males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1138. en:dementia, progressive, with onset of disease --- r_associated #0: 20 --> en:white substance
    n1=en:dementia, progressive, with onset of disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1139. en:dementia, rapidly progressive --- r_associated #0: 20 --> en:white substance
    n1=en:dementia, rapidly progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1140. en:demyelination --- r_associated #0: 20 --> en:white substance
    n1=en:demyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1141. en:demyelination of the posterior and lateral columns of the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:demyelination of the posterior and lateral columns of the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1142. en:demyelination with white matter disease in internal capsule, external capsule, genu of corpus callosum, subcortical white matter, and posterior fossa --- r_associated #0: 20 --> en:white substance
    n1=en:demyelination with white matter disease in internal capsule, external capsule, genu of corpus callosum, subcortical white matter, and posterior fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1143. en:demyelination, symmetric --- r_associated #0: 20 --> en:white substance
    n1=en:demyelination, symmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1144. en:demyelinization --- r_associated #0: 20 --> en:white substance
    n1=en:demyelinization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1145. en:denervation seen on emg --- r_associated #0: 20 --> en:white substance
    n1=en:denervation seen on emg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1146. en:dense calcifications in the cerebellar dentate nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:dense calcifications in the cerebellar dentate nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1147. en:dental arcade --- r_associated #0: 20 --> en:white substance
    n1=en:dental arcade | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1148. en:depersonalization --- r_associated #0: 20 --> en:white substance
    n1=en:depersonalization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1149. en:depression --- r_associated #0: 20 --> en:white substance
    n1=en:depression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1150. en:depression, psychotic --- r_associated #0: 20 --> en:white substance
    n1=en:depression, psychotic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1151. en:dermoid cyst --- r_associated #0: 20 --> en:white substance
    n1=en:dermoid cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1152. en:deterioration of motor development --- r_associated #0: 20 --> en:white substance
    n1=en:deterioration of motor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1153. en:development varies from normal to retarded --- r_associated #0: 20 --> en:white substance
    n1=en:development varies from normal to retarded | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1154. en:developmental arrest, 2nd year of life --- r_associated #0: 20 --> en:white substance
    n1=en:developmental arrest, 2nd year of life | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1155. en:developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1156. en:developmental delay (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1157. en:developmental delay (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1158. en:developmental delay (100%) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (100%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1159. en:developmental delay (20%) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (20%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1160. en:developmental delay (apparent after the first year of life) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (apparent after the first year of life) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1161. en:developmental delay (female) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (female) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1162. en:developmental delay (homozygote) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (homozygote) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1163. en:developmental delay (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1164. en:developmental delay (in some patients who survive infancy) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (in some patients who survive infancy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1165. en:developmental delay (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1166. en:developmental delay (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1167. en:developmental delay (microdeletion patients only) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (microdeletion patients only) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1168. en:developmental delay (mild-severe) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (mild-severe) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1169. en:developmental delay (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1170. en:developmental delay (seen in recessive form) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (seen in recessive form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1171. en:developmental delay (type ii) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (type ii) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1172. en:developmental delay (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1173. en:developmental delay evident by 12-24 months of age --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay evident by 12-24 months of age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1174. en:developmental delay if undiagnosed or untreated --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay if undiagnosed or untreated | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1175. en:developmental delay or regression --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay or regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1176. en:developmental delay, mild --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1177. en:developmental delay, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1178. en:developmental delay, mild (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, mild (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1179. en:developmental delay, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1180. en:developmental delay, moderate (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, moderate (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1181. en:developmental delay, primarily motor, resolves in childhood --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, primarily motor, resolves in childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1182. en:developmental delay, profound --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1183. en:developmental delay, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1184. en:developmental delay, severe --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1185. en:developmental delay, severe (2p21del) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, severe (2p21del) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1186. en:developmental delay, significant --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, significant | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1187. en:developmental delay, variable --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, variable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1188. en:developmental delay, variable severity --- r_associated #0: 20 --> en:white substance
    n1=en:developmental delay, variable severity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1189. en:developmental regression --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1190. en:developmental regression (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1191. en:developmental regression after age 2 years --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression after age 2 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1192. en:developmental regression after onset of seizures --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression after onset of seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1193. en:developmental regression after the first year --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression after the first year | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1194. en:developmental regression before age 6 months --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression before age 6 months | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1195. en:developmental regression in about 50% of patients --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression in about 50% of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1196. en:developmental regression in affected children --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression in affected children | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1197. en:developmental regression, after age 2 years (some) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression, after age 2 years (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1198. en:developmental regression, severe --- r_associated #0: 20 --> en:white substance
    n1=en:developmental regression, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1199. en:developmental retardation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:developmental retardation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1200. en:developmental retardation, profound --- r_associated #0: 20 --> en:white substance
    n1=en:developmental retardation, profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1201. en:developmental retardation, severe --- r_associated #0: 20 --> en:white substance
    n1=en:developmental retardation, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1202. en:developmental stagnation --- r_associated #0: 20 --> en:white substance
    n1=en:developmental stagnation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1203. en:developmental stagnation at onset of seizures --- r_associated #0: 20 --> en:white substance
    n1=en:developmental stagnation at onset of seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1204. en:diabetes with coma (disorder) --- r_associated #0: 20 --> en:white substance
    n1=en:diabetes with coma (disorder) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1205. en:difficulties in fine bimanual activities --- r_associated #0: 20 --> en:white substance
    n1=en:difficulties in fine bimanual activities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1206. en:difficulties in fine movement of the hands --- r_associated #0: 20 --> en:white substance
    n1=en:difficulties in fine movement of the hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1207. en:difficulties with equilibrium --- r_associated #0: 20 --> en:white substance
    n1=en:difficulties with equilibrium | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1208. en:difficulties with fine motor skills and coordination --- r_associated #0: 20 --> en:white substance
    n1=en:difficulties with fine motor skills and coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1209. en:difficulty in phonologic coding --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty in phonologic coding | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1210. en:difficulty in spelling --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty in spelling | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1211. en:difficulty reading --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty reading | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1212. en:difficulty running --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty running | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1213. en:difficulty running and climbing stairs --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty running and climbing stairs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1214. en:difficulty sleeping --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty sleeping | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1215. en:difficulty speaking during seizures --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty speaking during seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1216. en:difficulty standing --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty standing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1217. en:difficulty standing alone --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty standing alone | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1218. en:difficulty walking and climbing stairs --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty walking and climbing stairs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1219. en:difficulty walking in childhood --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty walking in childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1220. en:difficulty walking, running --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty walking, running | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1221. en:difficulty with writing and drawing --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty with writing and drawing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1222. en:difficulty writing --- r_associated #0: 20 --> en:white substance
    n1=en:difficulty writing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1223. en:diffuse atrophy of cerebral hemispheres, corpus callosum, and brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse atrophy of cerebral hemispheres, corpus callosum, and brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1224. en:diffuse axonal swelling --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse axonal swelling | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1225. en:diffuse brain and spinal cord atrophy on brain ct/mri --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse brain and spinal cord atrophy on brain ct/mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1226. en:diffuse brain swelling occurs during coma --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse brain swelling occurs during coma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1227. en:diffuse cerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse cerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1228. en:diffuse cerebral atrophy on ct and mri --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse cerebral atrophy on ct and mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1229. en:diffuse cerebral atrophy seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse cerebral atrophy seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1230. en:diffuse cerebral gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse cerebral gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1231. en:diffuse demyelination (increased signal intensity in t2-weighted images, especially frontal lobes) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse demyelination (increased signal intensity in t2-weighted images, especially frontal lobes) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1232. en:diffuse enlargement of subarachnoid spaces and lateral ventricles (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse enlargement of subarachnoid spaces and lateral ventricles (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1233. en:diffuse fibrillar astrocytosis (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse fibrillar astrocytosis (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1234. en:diffuse hyperintense signal abnormalities in the white matter (in children) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse hyperintense signal abnormalities in the white matter (in children) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1235. en:diffuse hypomyelination --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse hypomyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1236. en:diffuse hyporeflexia (later) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse hyporeflexia (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1237. en:diffuse hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1238. en:diffuse leptomeningeal enhancement seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse leptomeningeal enhancement seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1239. en:diffuse leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1240. en:diffuse lewy bodies throughout the brain (cortical and subcortical regions) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse lewy bodies throughout the brain (cortical and subcortical regions) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1241. en:diffuse lewy body pathology --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse lewy body pathology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1242. en:diffuse paroxysmal discharges --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse paroxysmal discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1243. en:diffuse periventricular leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse periventricular leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1244. en:diffuse signal abnormality of central white matter --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse signal abnormality of central white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1245. en:diffuse slowing --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse slowing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1246. en:diffuse slowing of background --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse slowing of background | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1247. en:diffuse spongiform leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse spongiform leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1248. en:diffuse swelling of cerebral white matter --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse swelling of cerebral white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1249. en:diffuse white matter abnormalities on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse white matter abnormalities on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1250. en:diffuse white matter abnormalities seen on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse white matter abnormalities seen on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1251. en:diffuse white matter changes (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse white matter changes (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1252. en:diffuse white matter dysmyelination --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse white matter dysmyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1253. en:diffuse white matter hyperintensities on t2-weighed imaging --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse white matter hyperintensities on t2-weighed imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1254. en:diffuse white matter loss --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse white matter loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1255. en:diffuse, severe neuronal loss --- r_associated #0: 20 --> en:white substance
    n1=en:diffuse, severe neuronal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1256. en:dilatation of the 3rd ventricle (in one family) --- r_associated #0: 20 --> en:white substance
    n1=en:dilatation of the 3rd ventricle (in one family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1257. en:dilatation of the lateral and third ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:dilatation of the lateral and third ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1258. en:dilatation of the lateral ventricles (in one family) --- r_associated #0: 20 --> en:white substance
    n1=en:dilatation of the lateral ventricles (in one family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1259. en:dilated fourth ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:dilated fourth ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1260. en:dilated lateral ventricles (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dilated lateral ventricles (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1261. en:dilated perivascular spaces --- r_associated #0: 20 --> en:white substance
    n1=en:dilated perivascular spaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1262. en:dilated venous sinuses --- r_associated #0: 20 --> en:white substance
    n1=en:dilated venous sinuses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1263. en:dilated ventricles (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:dilated ventricles (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1264. en:dilation of cerebral ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:dilation of cerebral ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1265. en:dilation of lateral ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:dilation of lateral ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1266. en:dilation of lateral ventricles (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dilation of lateral ventricles (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1267. en:diminished visual activity --- r_associated #0: 20 --> en:white substance
    n1=en:diminished visual activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1268. en:diplegia --- r_associated #0: 20 --> en:white substance
    n1=en:diplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1269. en:discrepancy between verbal and nonverbal abilities --- r_associated #0: 20 --> en:white substance
    n1=en:discrepancy between verbal and nonverbal abilities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1270. en:disdiadochokinesia --- r_associated #0: 20 --> en:white substance
    n1=en:disdiadochokinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1271. en:disordered myelination --- r_associated #0: 20 --> en:white substance
    n1=en:disordered myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1272. en:disordered sleep pattern (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:disordered sleep pattern (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1273. en:disordered thinking --- r_associated #0: 20 --> en:white substance
    n1=en:disordered thinking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1274. en:disorganised speech --- r_associated #0: 20 --> en:white substance
    n1=en:disorganised speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1275. en:disorganization of the anterior cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:disorganization of the anterior cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1276. en:disorganized brain cytoarchitecture --- r_associated #0: 20 --> en:white substance
    n1=en:disorganized brain cytoarchitecture | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1277. en:disorganized cortical architecture --- r_associated #0: 20 --> en:white substance
    n1=en:disorganized cortical architecture | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1278. en:disorganized eeg --- r_associated #0: 20 --> en:white substance
    n1=en:disorganized eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1279. en:disorganized slow background activity seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:disorganized slow background activity seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1280. en:disorientation --- r_associated #0: 20 --> en:white substance
    n1=en:disorientation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1281. en:disproportionately small cerebral cortex --- r_associated #0: 20 --> en:white substance
    n1=en:disproportionately small cerebral cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1282. en:distal amyotrophy --- r_associated #0: 20 --> en:white substance
    n1=en:distal amyotrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1283. en:distal muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:distal muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1284. en:distal muscle weakness and atrophy due to motor neuronopathy --- r_associated #0: 20 --> en:white substance
    n1=en:distal muscle weakness and atrophy due to motor neuronopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1285. en:distal muscle weakness, upper and lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:distal muscle weakness, upper and lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1286. en:distal sensory impairment --- r_associated #0: 20 --> en:white substance
    n1=en:distal sensory impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1287. en:distal sensory loss to all modalities, lower limbs more affected than upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:distal sensory loss to all modalities, lower limbs more affected than upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1288. en:distal tapering of the carotid, cerebellar, and meningeal arteries --- r_associated #0: 20 --> en:white substance
    n1=en:distal tapering of the carotid, cerebellar, and meningeal arteries | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1289. en:distal weakness occurs later --- r_associated #0: 20 --> en:white substance
    n1=en:distal weakness occurs later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1290. en:disturbance of attention --- r_associated #0: 20 --> en:white substance
    n1=en:disturbance of attention | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1291. en:disturbance of consciousness --- r_associated #0: 20 --> en:white substance
    n1=en:disturbance of consciousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1292. en:disturbed equilibrium --- r_associated #0: 20 --> en:white substance
    n1=en:disturbed equilibrium | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1293. en:disturbed gait --- r_associated #0: 20 --> en:white substance
    n1=en:disturbed gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1294. en:disturbed myelination affecting the periventricular and subcortical white matter --- r_associated #0: 20 --> en:white substance
    n1=en:disturbed myelination affecting the periventricular and subcortical white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1295. en:disturbed sleep-wake cycle --- r_associated #0: 20 --> en:white substance
    n1=en:disturbed sleep-wake cycle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1296. en:diurnal fluctuations of symptoms (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:diurnal fluctuations of symptoms (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1297. en:dizziness --- r_associated #0: 20 --> en:white substance
    n1=en:dizziness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1298. en:dizziness adverse event --- r_associated #0: 20 --> en:white substance
    n1=en:dizziness adverse event | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1299. en:dizziness may occur --- r_associated #0: 20 --> en:white substance
    n1=en:dizziness may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1300. en:dizziness, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:dizziness, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1301. en:dopamine-responsive parkinsonism --- r_associated #0: 20 --> en:white substance
    n1=en:dopamine-responsive parkinsonism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1302. en:dopaminergic fiber systems in the brain --- r_associated #0: 20 --> en:white substance
    n1=en:dopaminergic fiber systems in the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1303. en:dorsal horn of the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:dorsal horn of the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1304. en:dorsal intermediate sulcus --- r_associated #0: 20 --> en:white substance
    n1=en:dorsal intermediate sulcus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1305. en:dorsal root of the spinal nerve --- r_associated #0: 20 --> en:white substance
    n1=en:dorsal root of the spinal nerve | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1306. en:dorsolateral sulcus of spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:dorsolateral sulcus of spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1307. en:double cortex syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:double cortex syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1308. en:dream disorder --- r_associated #0: 20 --> en:white substance
    n1=en:dream disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1309. en:dream enactment --- r_associated #0: 20 --> en:white substance
    n1=en:dream enactment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1310. en:drooling --- r_associated #0: 20 --> en:white substance
    n1=en:drooling | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1311. en:drop attack --- r_associated #0: 20 --> en:white substance
    n1=en:drop attack | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1312. en:drug dependence --- r_associated #0: 20 --> en:white substance
    n1=en:drug dependence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1313. en:drug effect --- r_associated #0: 20 --> en:white substance
    n1=en:drug effect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1314. en:drug-resistent seizures (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:drug-resistent seizures (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1315. en:dural and choroid plexus calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:dural and choroid plexus calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1316. en:dural ectasia --- r_associated #0: 20 --> en:white substance
    n1=en:dural ectasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1317. en:dysarthria --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1318. en:dysarthria (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1319. en:dysarthria (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1320. en:dysarthria (74%) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (74%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1321. en:dysarthria (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1322. en:dysarthria (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1323. en:dysarthria (mild) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (mild) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1324. en:dysarthria (most common presenting symptom) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (most common presenting symptom) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1325. en:dysarthria (onset in third decade) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria (onset in third decade) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1326. en:dysarthria may occur --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1327. en:dysarthria, mild (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria, mild (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1328. en:dysarthria, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1329. en:dysarthria, slowly progressive --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthria, slowly progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1330. en:dysarthrias, spastic --- r_associated #0: 20 --> en:white substance
    n1=en:dysarthrias, spastic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1331. en:dysautonomia --- r_associated #0: 20 --> en:white substance
    n1=en:dysautonomia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1332. en:dysautonomia may occur --- r_associated #0: 20 --> en:white substance
    n1=en:dysautonomia may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1333. en:dyscalculia --- r_associated #0: 20 --> en:white substance
    n1=en:dyscalculia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1334. en:dysdiadochokinesis --- r_associated #0: 20 --> en:white substance
    n1=en:dysdiadochokinesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1335. en:dysdiadochokinesis (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:dysdiadochokinesis (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1336. en:dysdiadochokinesis (63%) --- r_associated #0: 20 --> en:white substance
    n1=en:dysdiadochokinesis (63%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1337. en:dysfunction of lateral corticospinal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:dysfunction of lateral corticospinal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1338. en:dysfunction of the autonomic nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:dysfunction of the autonomic nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1339. en:dysgenesis of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:dysgenesis of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1340. en:dysgenesis of the anterior commissure (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:dysgenesis of the anterior commissure (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1341. en:dysgenesis of the corpus callosum (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dysgenesis of the corpus callosum (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1342. en:dysgenesis or agenesis of the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:dysgenesis or agenesis of the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1343. en:dysgenesis or agenesis of the corpus callosum (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:dysgenesis or agenesis of the corpus callosum (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1344. en:dysgraphias --- r_associated #0: 20 --> en:white substance
    n1=en:dysgraphias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1345. en:dyskinesia --- r_associated #0: 20 --> en:white substance
    n1=en:dyskinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1346. en:dyskinesia buccoglossal --- r_associated #0: 20 --> en:white substance
    n1=en:dyskinesia buccoglossal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1347. en:dyskinesia, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:dyskinesia, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1348. en:dyskinesia, limb, exertion-induced --- r_associated #0: 20 --> en:white substance
    n1=en:dyskinesia, limb, exertion-induced | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1349. en:dyskinetic movements --- r_associated #0: 20 --> en:white substance
    n1=en:dyskinetic movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1350. en:dyslexia --- r_associated #0: 20 --> en:white substance
    n1=en:dyslexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1351. en:dysmetria (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetria (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1352. en:dysmetria (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetria (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1353. en:dysmetria (in 1 of 3 families) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetria (in 1 of 3 families) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1354. en:dysmetria (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetria (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1355. en:dysmetria (type i) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetria (type i) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1356. en:dysmetria, mild --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetria, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1357. en:dysmetrias, cerebellar --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetrias, cerebellar | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1358. en:dysmetric saccades --- r_associated #0: 20 --> en:white substance
    n1=en:dysmetric saccades | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1359. en:dysmorphic basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:dysmorphic basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1360. en:dysmorphic basal ganglia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmorphic basal ganglia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1361. en:dysmorphic basal ganglia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmorphic basal ganglia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1362. en:dysmorphic basal ganglia (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:dysmorphic basal ganglia (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1363. en:dysmorphic corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:dysmorphic corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1364. en:dysmyelinating leukodystrophy --- r_associated #0: 20 --> en:white substance
    n1=en:dysmyelinating leukodystrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1365. en:dysmyelination of the brain and spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:dysmyelination of the brain and spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1366. en:dysmyelination of the brain, myelin is not formed properly --- r_associated #0: 20 --> en:white substance
    n1=en:dysmyelination of the brain, myelin is not formed properly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1367. en:dysphagia --- r_associated #0: 20 --> en:white substance
    n1=en:dysphagia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1368. en:dysphasia --- r_associated #0: 20 --> en:white substance
    n1=en:dysphasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1369. en:dysphonia --- r_associated #0: 20 --> en:white substance
    n1=en:dysphonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1370. en:dysplasia of the cerebellar hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:dysplasia of the cerebellar hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1371. en:dysplastic basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1372. en:dysplastic c-shaped inferior olivary nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic c-shaped inferior olivary nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1373. en:dysplastic cerebellar gangliocytoma --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic cerebellar gangliocytoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1374. en:dysplastic cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1375. en:dysplastic cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1376. en:dysplastic pons --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1377. en:dysplastic superior cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:dysplastic superior cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1378. en:dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1379. en:dystonia (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1380. en:dystonia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1381. en:dystonia (14% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (14% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1382. en:dystonia (57%) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (57%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1383. en:dystonia (<20%) (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (<20%) (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1384. en:dystonia (in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1385. en:dystonia (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1386. en:dystonia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1387. en:dystonia (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1388. en:dystonia (may spontaneously remit in childhood or adolescence) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia (may spontaneously remit in childhood or adolescence) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1389. en:dystonia 18 (disorder) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia 18 (disorder) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1390. en:dystonia at onset (16%) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia at onset (16%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1391. en:dystonia disorders --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia disorders | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1392. en:dystonia may become generalized --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia may become generalized | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1393. en:dystonia with diurnal variation --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia with diurnal variation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1394. en:dystonia, episodic, primary affects hands and feet --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, episodic, primary affects hands and feet | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1395. en:dystonia, focal (at onset) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, focal (at onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1396. en:dystonia, focal, limited to orbicularis oculi muscle (blepharospasm) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, focal, limited to orbicularis oculi muscle (blepharospasm) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1397. en:dystonia, generalized, dopa-unresponsive --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, generalized, dopa-unresponsive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1398. en:dystonia, limb, exercise-induced --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, limb, exercise-induced | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1399. en:dystonia, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1400. en:dystonia, severe (in all limbs) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, severe (in all limbs) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1401. en:dystonia, trunk and limbs (upper and lower) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonia, trunk and limbs (upper and lower) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1402. en:dystonic hand posturing (44% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic hand posturing (44% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1403. en:dystonic movements (in 1 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic movements (in 1 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1404. en:dystonic posture --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic posture | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1405. en:dystonic posturing (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic posturing (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1406. en:dystonic posturing of the hands --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic posturing of the hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1407. en:dystonic tongue protrusion --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic tongue protrusion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1408. en:dystonic tremor --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1409. en:dystonic vocal tremor --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic vocal tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1410. en:dystonic writer's cramp --- r_associated #0: 20 --> en:white substance
    n1=en:dystonic writer's cramp | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1411. en:dystrophic neurites --- r_associated #0: 20 --> en:white substance
    n1=en:dystrophic neurites | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1412. en:earlier sleep-offset time (earlier awakening) --- r_associated #0: 20 --> en:white substance
    n1=en:earlier sleep-offset time (earlier awakening) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1413. en:early and severe foot extensor muscle involvement --- r_associated #0: 20 --> en:white substance
    n1=en:early and severe foot extensor muscle involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1414. en:early involvement of the corticospinal pathways --- r_associated #0: 20 --> en:white substance
    n1=en:early involvement of the corticospinal pathways | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1415. en:early severe fetal akinesia sequence --- r_associated #0: 20 --> en:white substance
    n1=en:early severe fetal akinesia sequence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1416. en:early-onset myoclonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:early-onset myoclonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1417. en:echolalia --- r_associated #0: 20 --> en:white substance
    n1=en:echolalia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1418. en:ectopic dorsal pontine transverse bundle of fibers forms the 'cap' --- r_associated #0: 20 --> en:white substance
    n1=en:ectopic dorsal pontine transverse bundle of fibers forms the 'cap' | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1419. en:ectopic posterior pituitary --- r_associated #0: 20 --> en:white substance
    n1=en:ectopic posterior pituitary | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1420. en:ectopic posterior pituitary (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ectopic posterior pituitary (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1421. en:eeg - alpha abolished, continuous spike waves, intense myoclonus on photic stimulation (stage 3) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg - alpha abolished, continuous spike waves, intense myoclonus on photic stimulation (stage 3) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1422. en:eeg - alpha slowing, 4-6 hz spike waves, myoclonus on photic stimulation (stage 2) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg - alpha slowing, 4-6 hz spike waves, myoclonus on photic stimulation (stage 2) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1423. en:eeg - polyspike on photic stimulation (stage 1) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg - polyspike on photic stimulation (stage 1) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1424. en:eeg abnormalities - slow waking background, intermittent rhythmical slowing (3-5hz), epileptiform discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg abnormalities - slow waking background, intermittent rhythmical slowing (3-5hz), epileptiform discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1425. en:eeg abnormalities in 20-50% --- r_associated #0: 20 --> en:white substance
    n1=en:eeg abnormalities in 20-50% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1426. en:eeg abnormalities in 20-50% impaired language development --- r_associated #0: 20 --> en:white substance
    n1=en:eeg abnormalities in 20-50% impaired language development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1427. en:eeg and symptomatology suggest mesial temporal origin --- r_associated #0: 20 --> en:white substance
    n1=en:eeg and symptomatology suggest mesial temporal origin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1428. en:eeg during episodes shows desynchronization --- r_associated #0: 20 --> en:white substance
    n1=en:eeg during episodes shows desynchronization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1429. en:eeg is slowed with polyspike wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg is slowed with polyspike wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1430. en:eeg is usually normal --- r_associated #0: 20 --> en:white substance
    n1=en:eeg is usually normal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1431. en:eeg later shows generalized spike or polyspike waves and focal spikes --- r_associated #0: 20 --> en:white substance
    n1=en:eeg later shows generalized spike or polyspike waves and focal spikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1432. en:eeg may be normal at first --- r_associated #0: 20 --> en:white substance
    n1=en:eeg may be normal at first | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1433. en:eeg may show migrating focal or multifocal origin (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg may show migrating focal or multifocal origin (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1434. en:eeg shows 3-4-hz spike and multispike slow wave complexes --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows 3-4-hz spike and multispike slow wave complexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1435. en:eeg shows 3-4-hz spike waves --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows 3-4-hz spike waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1436. en:eeg shows 3-hz spike-wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows 3-hz spike-wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1437. en:eeg shows abundant slow waves and fast spike activity --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows abundant slow waves and fast spike activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1438. en:eeg shows active generalized spike and wave and polyspike pattern --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows active generalized spike and wave and polyspike pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1439. en:eeg shows burst suppression --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows burst suppression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1440. en:eeg shows centrotemporal spike-wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows centrotemporal spike-wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1441. en:eeg shows epileptiform activity --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows epileptiform activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1442. en:eeg shows epileptiform discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows epileptiform discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1443. en:eeg shows frontal lobe origin --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows frontal lobe origin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1444. en:eeg shows generalized polyspike and wave discharges (4-5 hz) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows generalized polyspike and wave discharges (4-5 hz) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1445. en:eeg shows generalized polyspike and wave discharges (4-6 hz) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows generalized polyspike and wave discharges (4-6 hz) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1446. en:eeg shows generalized, bilateral, synchronous, symmetrical discharge --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows generalized, bilateral, synchronous, symmetrical discharge | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1447. en:eeg shows hypsarrhythmia --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows hypsarrhythmia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1448. en:eeg shows hypsarrhythmia (in 1 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows hypsarrhythmia (in 1 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1449. en:eeg shows multifocal discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows multifocal discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1450. en:eeg shows multifocal epileptic activity --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows multifocal epileptic activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1451. en:eeg shows nonspecific slow-wave paroxysms --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows nonspecific slow-wave paroxysms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1452. en:eeg shows photosensitivity --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows photosensitivity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1453. en:eeg shows rolandic sharp waves and spikes --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows rolandic sharp waves and spikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1454. en:eeg shows slow frequency high amplitude waves with high frequency polyspikes --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows slow frequency high amplitude waves with high frequency polyspikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1455. en:eeg shows slowed dysrhythmia and multifocal discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows slowed dysrhythmia and multifocal discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1456. en:eeg shows spike and multispike waves, 3-4 hz --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows spike and multispike waves, 3-4 hz | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1457. en:eeg shows spike and wave or polyspike and wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows spike and wave or polyspike and wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1458. en:eeg shows suppression with ictal burst activities --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows suppression with ictal burst activities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1459. en:eeg shows suppression-burst pattern --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows suppression-burst pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1460. en:eeg shows unilateral centrotemporal spikes --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows unilateral centrotemporal spikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1461. en:eeg shows with a multifocal pattern with spikes and sharp waves --- r_associated #0: 20 --> en:white substance
    n1=en:eeg shows with a multifocal pattern with spikes and sharp waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1462. en:eeg with burst suppression --- r_associated #0: 20 --> en:white substance
    n1=en:eeg with burst suppression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1463. en:eeg with focal discharge --- r_associated #0: 20 --> en:white substance
    n1=en:eeg with focal discharge | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1464. en:eeg with paroxysmal activity --- r_associated #0: 20 --> en:white substance
    n1=en:eeg with paroxysmal activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1465. en:eeg with photoparoxysmal response --- r_associated #0: 20 --> en:white substance
    n1=en:eeg with photoparoxysmal response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1466. en:effaced gyral pattern --- r_associated #0: 20 --> en:white substance
    n1=en:effaced gyral pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1467. en:electroencephalogram (eeg) abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:electroencephalogram (eeg) abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1468. en:electroencephalogram abnormal --- r_associated #0: 20 --> en:white substance
    n1=en:electroencephalogram abnormal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1469. en:electrophysiologic studies indicate cortical origin --- r_associated #0: 20 --> en:white substance
    n1=en:electrophysiologic studies indicate cortical origin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1470. en:elevated interferon levels in cerebrospinal fluid --- r_associated #0: 20 --> en:white substance
    n1=en:elevated interferon levels in cerebrospinal fluid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1471. en:elevated pterin levels (tetrahydrobiopterin, neopterin) in cerebrospinal fluid --- r_associated #0: 20 --> en:white substance
    n1=en:elevated pterin levels (tetrahydrobiopterin, neopterin) in cerebrospinal fluid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1472. en:elevated white cell count in cerebrospinal fluid --- r_associated #0: 20 --> en:white substance
    n1=en:elevated white cell count in cerebrospinal fluid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1473. en:elevation and splaying of the superior cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:elevation and splaying of the superior cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1474. en:elongated superior cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:elongated superior cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1475. en:embolism, cerebral --- r_associated #0: 20 --> en:white substance
    n1=en:embolism, cerebral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1476. en:embryologic --- r_associated #0: 20 --> en:white substance
    n1=en:embryologic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1477. en:emg shows bursts of activity originating in the masseter muscle and spreading to the orbicularis oris and oculi muscles --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows bursts of activity originating in the masseter muscle and spreading to the orbicularis oris and oculi muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1478. en:emg shows continuous motor unit firing at rest --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows continuous motor unit firing at rest | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1479. en:emg shows evidence of denervation --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows evidence of denervation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1480. en:emg shows fibrillation potentials and mixed myopathic and neurogenic motor unit potentials --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows fibrillation potentials and mixed myopathic and neurogenic motor unit potentials | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1481. en:emg shows fibrillations and fasiculations --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows fibrillations and fasiculations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1482. en:emg shows involuntary continuous motor activity at rest --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows involuntary continuous motor activity at rest | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1483. en:emg shows neurogenic abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows neurogenic abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1484. en:emg shows neurogenic changes --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows neurogenic changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1485. en:emg shows neurogenic changes and denervation --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows neurogenic changes and denervation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1486. en:emg shows neurogenic findings --- r_associated #0: 20 --> en:white substance
    n1=en:emg shows neurogenic findings | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1487. en:emg with spontaneous discharge of normal motor unit potentials --- r_associated #0: 20 --> en:white substance
    n1=en:emg with spontaneous discharge of normal motor unit potentials | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1488. en:empty sella syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:empty sella syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1489. en:encephalitis --- r_associated #0: 20 --> en:white substance
    n1=en:encephalitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1490. en:encephalocele --- r_associated #0: 20 --> en:white substance
    n1=en:encephalocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1491. en:encephalocele (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:encephalocele (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1492. en:encephalocele (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:encephalocele (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1493. en:encephalocele (single case) --- r_associated #0: 20 --> en:white substance
    n1=en:encephalocele (single case) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1494. en:encephalocele (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:encephalocele (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1495. en:encephalocele of orbit --- r_associated #0: 20 --> en:white substance
    n1=en:encephalocele of orbit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1496. en:encephaloceles, frontal --- r_associated #0: 20 --> en:white substance
    n1=en:encephaloceles, frontal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1497. en:encephalomyelopathy --- r_associated #0: 20 --> en:white substance
    n1=en:encephalomyelopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1498. en:encephalomyopathy --- r_associated #0: 20 --> en:white substance
    n1=en:encephalomyopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1499. en:encephalopathic attacks, episodic, associated with infection --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathic attacks, episodic, associated with infection | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1500. en:encephalopathic episodes, often associated with infection --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathic episodes, often associated with infection | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1501. en:encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1502. en:encephalopathy (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1503. en:encephalopathy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1504. en:encephalopathy adverse event --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy adverse event | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1505. en:encephalopathy associated with hypoglycemia --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy associated with hypoglycemia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1506. en:encephalopathy during episodes --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy during episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1507. en:encephalopathy, acute, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, acute, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1508. en:encephalopathy, acute, sudden-onset after febrile illness --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, acute, sudden-onset after febrile illness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1509. en:encephalopathy, acute, sudden-onset during febrile illness --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, acute, sudden-onset during febrile illness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1510. en:encephalopathy, acute-onset --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, acute-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1511. en:encephalopathy, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1512. en:encephalopathy, episodic, associated with febrile illnesses --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, episodic, associated with febrile illnesses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1513. en:encephalopathy, severe, neonatal --- r_associated #0: 20 --> en:white substance
    n1=en:encephalopathy, severe, neonatal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1514. en:end-position nystagmus --- r_associated #0: 20 --> en:white substance
    n1=en:end-position nystagmus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1515. en:endocrine system --- r_associated #0: 20 --> en:white substance
    n1=en:endocrine system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1516. en:endocrine system subdivision --- r_associated #0: 20 --> en:white substance
    n1=en:endocrine system subdivision | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1517. en:endothelial intracytoplasmic globular inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:endothelial intracytoplasmic globular inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1518. en:enhancement of the c-reflex --- r_associated #0: 20 --> en:white substance
    n1=en:enhancement of the c-reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1519. en:enlarged cerebellar cistern --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged cerebellar cistern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1520. en:enlarged cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1521. en:enlarged cisterna magna --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged cisterna magna | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1522. en:enlarged cisterna magna (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged cisterna magna (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1523. en:enlarged corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1524. en:enlarged extraaxial space on brain imaging --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged extraaxial space on brain imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1525. en:enlarged fourth ventricle, mild --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged fourth ventricle, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1526. en:enlarged lateral and third ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged lateral and third ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1527. en:enlarged lateral ventricles (occipital>frontal) --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged lateral ventricles (occipital>frontal) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1528. en:enlarged motor unit action potentials --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged motor unit action potentials | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1529. en:enlarged or prominent ventricles (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged or prominent ventricles (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1530. en:enlarged ventricles (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged ventricles (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1531. en:enlarged ventricles (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged ventricles (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1532. en:enlarged ventricles (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged ventricles (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1533. en:enlarged white matter --- r_associated #0: 20 --> en:white substance
    n1=en:enlarged white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1534. en:entire brain --- r_associated #0: 20 --> en:white substance
    n1=en:entire brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1535. en:entire central nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:entire central nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1536. en:entire nucleus of brain --- r_associated #0: 20 --> en:white substance
    n1=en:entire nucleus of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1537. en:entire spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:entire spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1538. en:enzymology --- r_associated #0: 20 --> en:white substance
    n1=en:enzymology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1539. en:eosinophilic 'cotton wool' plaques without dense congophilic core in various brain regions --- r_associated #0: 20 --> en:white substance
    n1=en:eosinophilic 'cotton wool' plaques without dense congophilic core in various brain regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1540. en:ependyma --- r_associated #0: 20 --> en:white substance
    n1=en:ependyma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1541. en:ependymitis --- r_associated #0: 20 --> en:white substance
    n1=en:ependymitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1542. en:epilepsia partialis continua --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsia partialis continua | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1543. en:epilepsies, myoclonic --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsies, myoclonic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1544. en:epilepsy (in 2 of 3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy (in 2 of 3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1545. en:epilepsy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1546. en:epilepsy, frontal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy, frontal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1547. en:epilepsy, multifocal, intractable --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy, multifocal, intractable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1548. en:epilepsy, myoclonic astatic --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy, myoclonic astatic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1549. en:epilepsy, refractory (onset in adolescence or young adulthood) --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy, refractory (onset in adolescence or young adulthood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1550. en:epilepsy, rolandic --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy, rolandic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1551. en:epilepsy, temporal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:epilepsy, temporal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1552. en:epileptic drop attack --- r_associated #0: 20 --> en:white substance
    n1=en:epileptic drop attack | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1553. en:epileptic encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:epileptic encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1554. en:epileptic encephalopathy (in 2 of 3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:epileptic encephalopathy (in 2 of 3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1555. en:epileptic encephalopathy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:epileptic encephalopathy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1556. en:epileptic encephalopathy with psychomotor retardation (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:epileptic encephalopathy with psychomotor retardation (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1557. en:episodes begin with muscle tightening --- r_associated #0: 20 --> en:white substance
    n1=en:episodes begin with muscle tightening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1558. en:episodes last up to 2 minutes --- r_associated #0: 20 --> en:white substance
    n1=en:episodes last up to 2 minutes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1559. en:episodes may last less than 30 minutes or greater than several hours --- r_associated #0: 20 --> en:white substance
    n1=en:episodes may last less than 30 minutes or greater than several hours | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1560. en:episodes of decreased alertness, hypotonia, and poor respiration requiring mechanical ventilation --- r_associated #0: 20 --> en:white substance
    n1=en:episodes of decreased alertness, hypotonia, and poor respiration requiring mechanical ventilation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1561. en:episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month --- r_associated #0: 20 --> en:white substance
    n1=en:episodes of weakness can last 1 day to several weeks and can occur 1-3 times per month | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1562. en:episodes typically occur several times a week --- r_associated #0: 20 --> en:white substance
    n1=en:episodes typically occur several times a week | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1563. en:episodic absence-like spells --- r_associated #0: 20 --> en:white substance
    n1=en:episodic absence-like spells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1564. en:episodic acute neurologic deterioration/encephalopathy, recurrent --- r_associated #0: 20 --> en:white substance
    n1=en:episodic acute neurologic deterioration/encephalopathy, recurrent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1565. en:episodic ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:episodic ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1566. en:episodic confusion --- r_associated #0: 20 --> en:white substance
    n1=en:episodic confusion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1567. en:episodic generalized skeletal muscle contractions --- r_associated #0: 20 --> en:white substance
    n1=en:episodic generalized skeletal muscle contractions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1568. en:episodic hemiplegia --- r_associated #0: 20 --> en:white substance
    n1=en:episodic hemiplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1569. en:episodic subtype, headaches occur in clusters --- r_associated #0: 20 --> en:white substance
    n1=en:episodic subtype, headaches occur in clusters | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1570. en:episodic sudden headache --- r_associated #0: 20 --> en:white substance
    n1=en:episodic sudden headache | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1571. en:episodic vomiting --- r_associated #0: 20 --> en:white substance
    n1=en:episodic vomiting | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1572. en:equivocal plantar response --- r_associated #0: 20 --> en:white substance
    n1=en:equivocal plantar response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1573. en:essential tremor --- r_associated #0: 20 --> en:white substance
    n1=en:essential tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1574. en:essential tremor (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:essential tremor (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1575. en:euphoric mood --- r_associated #0: 20 --> en:white substance
    n1=en:euphoric mood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1576. en:evolution to severe encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:evolution to severe encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1577. en:exaggerated acoustic startle response --- r_associated #0: 20 --> en:white substance
    n1=en:exaggerated acoustic startle response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1578. en:exaggerated moro reflex --- r_associated #0: 20 --> en:white substance
    n1=en:exaggerated moro reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1579. en:exaggerated startle response --- r_associated #0: 20 --> en:white substance
    n1=en:exaggerated startle response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1580. en:exaggerated startle response to tactile or acoustic stimuli --- r_associated #0: 20 --> en:white substance
    n1=en:exaggerated startle response to tactile or acoustic stimuli | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1581. en:excessive daytime somnolence --- r_associated #0: 20 --> en:white substance
    n1=en:excessive daytime somnolence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1582. en:exocrine system --- r_associated #0: 20 --> en:white substance
    n1=en:exocrine system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1583. en:expressive aphasia --- r_associated #0: 20 --> en:white substance
    n1=en:expressive aphasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1584. en:expressive language delay --- r_associated #0: 20 --> en:white substance
    n1=en:expressive language delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1585. en:expressive language disorder --- r_associated #0: 20 --> en:white substance
    n1=en:expressive language disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1586. en:expressive speech absent --- r_associated #0: 20 --> en:white substance
    n1=en:expressive speech absent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1587. en:expressive speech deficit --- r_associated #0: 20 --> en:white substance
    n1=en:expressive speech deficit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1588. en:extensive melanosis of leptomeninges, amygdala, and cerebellar hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:extensive melanosis of leptomeninges, amygdala, and cerebellar hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1589. en:extensor plantar responses (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1590. en:extensor plantar responses (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1591. en:extensor plantar responses (early-on) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (early-on) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1592. en:extensor plantar responses (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1593. en:extensor plantar responses (later) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1594. en:extensor plantar responses (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1595. en:extensor plantar responses (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1596. en:extensor plantar responses (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:extensor plantar responses (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1597. en:extensor posturing --- r_associated #0: 20 --> en:white substance
    n1=en:extensor posturing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1598. en:external capsule and claustrum may be involved --- r_associated #0: 20 --> en:white substance
    n1=en:external capsule and claustrum may be involved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1599. en:extra superior temporal gyrus (female) --- r_associated #0: 20 --> en:white substance
    n1=en:extra superior temporal gyrus (female) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1600. en:extraneuronal accumulation of autofluorescent pigmented material in various brain regions --- r_associated #0: 20 --> en:white substance
    n1=en:extraneuronal accumulation of autofluorescent pigmented material in various brain regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1601. en:extrapyramidal disorder --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1602. en:extrapyramidal dyskinesia --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal dyskinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1603. en:extrapyramidal dyskinesias (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal dyskinesias (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1604. en:extrapyramidal features --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal features | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1605. en:extrapyramidal muscular rigidity --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal muscular rigidity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1606. en:extrapyramidal sign --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1607. en:extrapyramidal signs (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal signs (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1608. en:extrapyramidal signs (in some patients) thinning of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal signs (in some patients) thinning of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1609. en:extrapyramidal signs (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal signs (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1610. en:extrapyramidal signs may develop --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal signs may develop | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1611. en:extrapyramidal signs, mild --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal signs, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1612. en:extrapyramidal symptoms (later-onset) --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal symptoms (later-onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1613. en:extrapyramidal symptoms may occur --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal symptoms may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1614. en:extrapyramidal tract --- r_associated #0: 20 --> en:white substance
    n1=en:extrapyramidal tract | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1615. en:extremity ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:extremity ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1616. en:eye --- r_associated #0: 20 --> en:white substance
    n1=en:eye | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1617. en:facial muscle sparing --- r_associated #0: 20 --> en:white substance
    n1=en:facial muscle sparing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1618. en:facial muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:facial muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1619. en:facial muscle weakness of muscles innervated by cn vii --- r_associated #0: 20 --> en:white substance
    n1=en:facial muscle weakness of muscles innervated by cn vii | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1620. en:facial myokymia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:facial myokymia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1621. en:facial myokymias --- r_associated #0: 20 --> en:white substance
    n1=en:facial myokymias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1622. en:facial nerve palsy --- r_associated #0: 20 --> en:white substance
    n1=en:facial nerve palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1623. en:facial nerve weakness --- r_associated #0: 20 --> en:white substance
    n1=en:facial nerve weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1624. en:facial neuralgia --- r_associated #0: 20 --> en:white substance
    n1=en:facial neuralgia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1625. en:facial palsy secondary to cranial hyperostosis --- r_associated #0: 20 --> en:white substance
    n1=en:facial palsy secondary to cranial hyperostosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1626. en:facial paralysis --- r_associated #0: 20 --> en:white substance
    n1=en:facial paralysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1627. en:facial paresis, congenital bilateral --- r_associated #0: 20 --> en:white substance
    n1=en:facial paresis, congenital bilateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1628. en:facial, pharyngeal, and masticatory muscle diplegia --- r_associated #0: 20 --> en:white substance
    n1=en:facial, pharyngeal, and masticatory muscle diplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1629. en:facial-faucial-finger mini-myoclonus (fff) --- r_associated #0: 20 --> en:white substance
    n1=en:facial-faucial-finger mini-myoclonus (fff) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1630. en:facial-lingual fasciculations --- r_associated #0: 20 --> en:white substance
    n1=en:facial-lingual fasciculations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1631. en:faciomandibular myoclonus, nocturnal --- r_associated #0: 20 --> en:white substance
    n1=en:faciomandibular myoclonus, nocturnal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1632. en:failure of opercularization of the frontal and temporal lobes on ct --- r_associated #0: 20 --> en:white substance
    n1=en:failure of opercularization of the frontal and temporal lobes on ct | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1633. en:failure to achieve sitting or walking (severe form) --- r_associated #0: 20 --> en:white substance
    n1=en:failure to achieve sitting or walking (severe form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1634. en:fall --- r_associated #0: 20 --> en:white substance
    n1=en:fall | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1635. en:falx cerebri, precocious calcification of --- r_associated #0: 20 --> en:white substance
    n1=en:falx cerebri, precocious calcification of | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1636. en:fascicle --- r_associated #0: 20 --> en:white substance
    n1=en:fascicle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1637. en:fasciculation --- r_associated #0: 20 --> en:white substance
    n1=en:fasciculation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1638. en:fasciculation-like movements --- r_associated #0: 20 --> en:white substance
    n1=en:fasciculation-like movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1639. en:fasciculations (after long disease duration) --- r_associated #0: 20 --> en:white substance
    n1=en:fasciculations (after long disease duration) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1640. en:fasciculations, tongue --- r_associated #0: 20 --> en:white substance
    n1=en:fasciculations, tongue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1641. en:fatal subacute encephalopathy (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:fatal subacute encephalopathy (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1642. en:fatigue --- r_associated #0: 20 --> en:white substance
    n1=en:fatigue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1643. en:favorable response to levodopa --- r_associated #0: 20 --> en:white substance
    n1=en:favorable response to levodopa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1644. en:fearful expression --- r_associated #0: 20 --> en:white substance
    n1=en:fearful expression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1645. en:febrile convulsions --- r_associated #0: 20 --> en:white substance
    n1=en:febrile convulsions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1646. en:febrile seizure --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1647. en:febrile seizures (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizures (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1648. en:febrile seizures (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizures (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1649. en:febrile seizures (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizures (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1650. en:febrile seizures (usually remit by age 6 years) --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizures (usually remit by age 6 years) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1651. en:febrile seizures in infancy --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizures in infancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1652. en:febrile seizures may occur --- r_associated #0: 20 --> en:white substance
    n1=en:febrile seizures may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1653. en:feeding problem --- r_associated #0: 20 --> en:white substance
    n1=en:feeding problem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1654. en:fenestrated basilar artery --- r_associated #0: 20 --> en:white substance
    n1=en:fenestrated basilar artery | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1655. en:festinating (parkinsonian) gait --- r_associated #0: 20 --> en:white substance
    n1=en:festinating (parkinsonian) gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1656. en:fetal akinesia deformation sequence --- r_associated #0: 20 --> en:white substance
    n1=en:fetal akinesia deformation sequence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1657. en:fibrillary plaques in the cerebellar cortex --- r_associated #0: 20 --> en:white substance
    n1=en:fibrillary plaques in the cerebellar cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1658. en:fibrillation --- r_associated #0: 20 --> en:white substance
    n1=en:fibrillation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1659. en:fibrous astrocyte --- r_associated #0: 20 --> en:white substance
    n1=en:fibrous astrocyte | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1660. en:fifth ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:fifth ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1661. en:fine motor delay --- r_associated #0: 20 --> en:white substance
    n1=en:fine motor delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1662. en:fine motor impairment --- r_associated #0: 20 --> en:white substance
    n1=en:fine motor impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1663. en:fine motor skills delayed --- r_associated #0: 20 --> en:white substance
    n1=en:fine motor skills delayed | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1664. en:fine motor task disruption --- r_associated #0: 20 --> en:white substance
    n1=en:fine motor task disruption | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1665. en:fine motor/coordination problems (12%) --- r_associated #0: 20 --> en:white substance
    n1=en:fine motor/coordination problems (12%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1666. en:fine rapid hand tremor, 4-12 hz --- r_associated #0: 20 --> en:white substance
    n1=en:fine rapid hand tremor, 4-12 hz | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1667. en:fine tremors --- r_associated #0: 20 --> en:white substance
    n1=en:fine tremors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1668. en:finger dysmetria --- r_associated #0: 20 --> en:white substance
    n1=en:finger dysmetria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1669. en:finger twitching --- r_associated #0: 20 --> en:white substance
    n1=en:finger twitching | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1670. en:first dorsal interossei muscle atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:first dorsal interossei muscle atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1671. en:first dorsal interossei muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:first dorsal interossei muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1672. en:flaccidity, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:flaccidity, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1673. en:flat pons --- r_associated #0: 20 --> en:white substance
    n1=en:flat pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1674. en:flattening of the caudate --- r_associated #0: 20 --> en:white substance
    n1=en:flattening of the caudate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1675. en:flattening of the pons --- r_associated #0: 20 --> en:white substance
    n1=en:flattening of the pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1676. en:flexor plantar response --- r_associated #0: 20 --> en:white substance
    n1=en:flexor plantar response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1677. en:floppiness --- r_associated #0: 20 --> en:white substance
    n1=en:floppiness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1678. en:floppy infant --- r_associated #0: 20 --> en:white substance
    n1=en:floppy infant | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1679. en:fluctuating neurologic signs --- r_associated #0: 20 --> en:white substance
    n1=en:fluctuating neurologic signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1680. en:fluctuations in consciousness --- r_associated #0: 20 --> en:white substance
    n1=en:fluctuations in consciousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1681. en:fluid filled posterior fossa --- r_associated #0: 20 --> en:white substance
    n1=en:fluid filled posterior fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1682. en:fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (csf) spaces --- r_associated #0: 20 --> en:white substance
    n1=en:fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (csf) spaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1683. en:focal cerebellar dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:focal cerebellar dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1684. en:focal clonic seizure --- r_associated #0: 20 --> en:white substance
    n1=en:focal clonic seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1685. en:focal cortical dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:focal cortical dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1686. en:focal discharges --- r_associated #0: 20 --> en:white substance
    n1=en:focal discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1687. en:focal dyscognitive seizures --- r_associated #0: 20 --> en:white substance
    n1=en:focal dyscognitive seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1688. en:focal dystonia (adult onset) --- r_associated #0: 20 --> en:white substance
    n1=en:focal dystonia (adult onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1689. en:focal dystonia (e.g., writer's cramp) --- r_associated #0: 20 --> en:white substance
    n1=en:focal dystonia (e.g., writer's cramp) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1690. en:focal dystonia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:focal dystonia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1691. en:focal dystonia, upper limb --- r_associated #0: 20 --> en:white substance
    n1=en:focal dystonia, upper limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1692. en:focal dystonia, usually of the hands --- r_associated #0: 20 --> en:white substance
    n1=en:focal dystonia, usually of the hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1693. en:focal dystonias --- r_associated #0: 20 --> en:white substance
    n1=en:focal dystonias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1694. en:focal hyperplasia of the choroid plexus --- r_associated #0: 20 --> en:white substance
    n1=en:focal hyperplasia of the choroid plexus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1695. en:focal interhemispheric fusion --- r_associated #0: 20 --> en:white substance
    n1=en:focal interhemispheric fusion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1696. en:focal lissencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:focal lissencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1697. en:focal microgyria --- r_associated #0: 20 --> en:white substance
    n1=en:focal microgyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1698. en:focal neurologic deficit --- r_associated #0: 20 --> en:white substance
    n1=en:focal neurologic deficit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1699. en:focal neurologic deficits (i.e., hemiparesis) --- r_associated #0: 20 --> en:white substance
    n1=en:focal neurologic deficits (i.e., hemiparesis) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1700. en:focal neurologic signs --- r_associated #0: 20 --> en:white substance
    n1=en:focal neurologic signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1701. en:focal nodular heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:focal nodular heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1702. en:focal pachygyria --- r_associated #0: 20 --> en:white substance
    n1=en:focal pachygyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1703. en:focal parietal pachygyria --- r_associated #0: 20 --> en:white substance
    n1=en:focal parietal pachygyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1704. en:focal paroxysmal discharges --- r_associated #0: 20 --> en:white substance
    n1=en:focal paroxysmal discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1705. en:focal thickening of the cortex on mri (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:focal thickening of the cortex on mri (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1706. en:focal tremor --- r_associated #0: 20 --> en:white substance
    n1=en:focal tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1707. en:focal white matter lesions (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:focal white matter lesions (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1708. en:focal, segmental or multifocal dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:focal, segmental or multifocal dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1709. en:fontanelle --- r_associated #0: 20 --> en:white substance
    n1=en:fontanelle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1710. en:foot-drop --- r_associated #0: 20 --> en:white substance
    n1=en:foot-drop | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1711. en:forebrain --- r_associated #0: 20 --> en:white substance
    n1=en:forebrain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1712. en:forebrain defects --- r_associated #0: 20 --> en:white substance
    n1=en:forebrain defects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1713. en:four-repeat tau plaques in the striatum --- r_associated #0: 20 --> en:white substance
    n1=en:four-repeat tau plaques in the striatum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1714. en:frequency 3.5 hz in midline --- r_associated #0: 20 --> en:white substance
    n1=en:frequency 3.5 hz in midline | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1715. en:frequency 6 hz in lateral gaze --- r_associated #0: 20 --> en:white substance
    n1=en:frequency 6 hz in lateral gaze | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1716. en:frequency of 1 to 20 episodes per day --- r_associated #0: 20 --> en:white substance
    n1=en:frequency of 1 to 20 episodes per day | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1717. en:frequent falls --- r_associated #0: 20 --> en:white substance
    n1=en:frequent falls | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1718. en:frequent falls with preservation of consciousness --- r_associated #0: 20 --> en:white substance
    n1=en:frequent falls with preservation of consciousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1719. en:frequent headache --- r_associated #0: 20 --> en:white substance
    n1=en:frequent headache | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1720. en:frightening sensation --- r_associated #0: 20 --> en:white substance
    n1=en:frightening sensation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1721. en:frontal cortical atophy --- r_associated #0: 20 --> en:white substance
    n1=en:frontal cortical atophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1722. en:frontal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:frontal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1723. en:frontal lobe atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:frontal lobe atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1724. en:frontal lobe hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:frontal lobe hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1725. en:frontal lobe origin --- r_associated #0: 20 --> en:white substance
    n1=en:frontal lobe origin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1726. en:frontal lobe syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:frontal lobe syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1727. en:frontal release signs --- r_associated #0: 20 --> en:white substance
    n1=en:frontal release signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1728. en:frontolimbic dementia --- r_associated #0: 20 --> en:white substance
    n1=en:frontolimbic dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1729. en:frontoparietal polymicrogyria --- r_associated #0: 20 --> en:white substance
    n1=en:frontoparietal polymicrogyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1730. en:frontotemporal atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1731. en:frontotemporal atrophy, mild, seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal atrophy, mild, seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1732. en:frontotemporal dementia --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1733. en:frontotemporal dementia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal dementia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1734. en:frontotemporal dementia (in 30% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal dementia (in 30% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1735. en:frontotemporal dementia, variable severity --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal dementia, variable severity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1736. en:frontotemporal hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1737. en:frontotemporal leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1738. en:frontotemporal lobar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal lobar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1739. en:frontotemporal lobar atrophy with 'knife-edge' distinction --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal lobar atrophy with 'knife-edge' distinction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1740. en:frontotemporal pachygyria (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal pachygyria (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1741. en:frontotemporal polymicrogyria --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal polymicrogyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1742. en:frontotemporal/subcortical dementia --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporal/subcortical dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1743. en:frontotemporoparietal cortical dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:frontotemporoparietal cortical dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1744. en:funnel-shaped signal tapering from subcortical white matter to ventricle (in some type iib patients) --- r_associated #0: 20 --> en:white substance
    n1=en:funnel-shaped signal tapering from subcortical white matter to ventricle (in some type iib patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1745. en:fused hemispheres (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:fused hemispheres (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1746. en:fusion of the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:fusion of the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1747. en:fusion of the cerebellar hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:fusion of the cerebellar hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1748. en:fusion of the dentate nuclei and the superior cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:fusion of the dentate nuclei and the superior cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1749. en:fusion of the left and right thalami --- r_associated #0: 20 --> en:white substance
    n1=en:fusion of the left and right thalami | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1750. en:gait abnormalities (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:gait abnormalities (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1751. en:gait abnormalities (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:gait abnormalities (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1752. en:gait abnormalities due to muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:gait abnormalities due to muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1753. en:gait abnormalities may occur --- r_associated #0: 20 --> en:white substance
    n1=en:gait abnormalities may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1754. en:gait and limb ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:gait and limb ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1755. en:gait apraxia --- r_associated #0: 20 --> en:white substance
    n1=en:gait apraxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1756. en:gait ataxia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:gait ataxia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1757. en:gait ataxias, cerebellar --- r_associated #0: 20 --> en:white substance
    n1=en:gait ataxias, cerebellar | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1758. en:gait difficulties due to contractures of the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:gait difficulties due to contractures of the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1759. en:gait difficulties, late-onset --- r_associated #0: 20 --> en:white substance
    n1=en:gait difficulties, late-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1760. en:gait disability --- r_associated #0: 20 --> en:white substance
    n1=en:gait disability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1761. en:gait disturbance --- r_associated #0: 20 --> en:white substance
    n1=en:gait disturbance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1762. en:gait disturbance (ataxia) --- r_associated #0: 20 --> en:white substance
    n1=en:gait disturbance (ataxia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1763. en:gait imbalance --- r_associated #0: 20 --> en:white substance
    n1=en:gait imbalance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1764. en:gait impairment --- r_associated #0: 20 --> en:white substance
    n1=en:gait impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1765. en:gait impairment (55%) --- r_associated #0: 20 --> en:white substance
    n1=en:gait impairment (55%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1766. en:gait instability, worse in the dark --- r_associated #0: 20 --> en:white substance
    n1=en:gait instability, worse in the dark | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1767. en:gait unsteady --- r_associated #0: 20 --> en:white substance
    n1=en:gait unsteady | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1768. en:gait, drop foot --- r_associated #0: 20 --> en:white substance
    n1=en:gait, drop foot | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1769. en:gait, rigid --- r_associated #0: 20 --> en:white substance
    n1=en:gait, rigid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1770. en:gaze deviation --- r_associated #0: 20 --> en:white substance
    n1=en:gaze deviation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1771. en:generalized amyotrophy --- r_associated #0: 20 --> en:white substance
    n1=en:generalized amyotrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1772. en:generalized and focal spike and wave complexes seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:generalized and focal spike and wave complexes seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1773. en:generalized cerebral hypoplasia/atrophy (45%) --- r_associated #0: 20 --> en:white substance
    n1=en:generalized cerebral hypoplasia/atrophy (45%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1774. en:generalized cerebral, cerebellar, and brainstem atrophy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:generalized cerebral, cerebellar, and brainstem atrophy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1775. en:generalized clonic or tonic-clonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:generalized clonic or tonic-clonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1776. en:generalized cortical atrophy (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:generalized cortical atrophy (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1777. en:generalized cortical atrophy, most prominent in the frontal and parietal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:generalized cortical atrophy, most prominent in the frontal and parietal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1778. en:generalized dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:generalized dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1779. en:generalized hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:generalized hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1780. en:generalized myelin loss --- r_associated #0: 20 --> en:white substance
    n1=en:generalized myelin loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1781. en:generalized seizures --- r_associated #0: 20 --> en:white substance
    n1=en:generalized seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1782. en:generalized slowing --- r_associated #0: 20 --> en:white substance
    n1=en:generalized slowing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1783. en:generalized slowing seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:generalized slowing seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1784. en:generalized spike wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:generalized spike wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1785. en:generalized spike-wave activity seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:generalized spike-wave activity seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1786. en:generalized spike-wave discharges see on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:generalized spike-wave discharges see on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1787. en:generalized stiffening --- r_associated #0: 20 --> en:white substance
    n1=en:generalized stiffening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1788. en:generalized tonic-clonic seizures (gtcs) (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures (gtcs) (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1789. en:generalized tonic-clonic seizures (gtcs) on awakening --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures (gtcs) on awakening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1790. en:generalized tonic-clonic seizures (often develop in adolescence) --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures (often develop in adolescence) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1791. en:generalized tonic-clonic seizures (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1792. en:generalized tonic-clonic seizures (stage 2 and 3) --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures (stage 2 and 3) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1793. en:generalized tonic-clonic seizures in 50% --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures in 50% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1794. en:generalized tonic-clonic seizures on awakening --- r_associated #0: 20 --> en:white substance
    n1=en:generalized tonic-clonic seizures on awakening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1795. en:germinal cysts over the caudate --- r_associated #0: 20 --> en:white substance
    n1=en:germinal cysts over the caudate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1796. en:giant cortical somatosensory evoked potentials (seps) --- r_associated #0: 20 --> en:white substance
    n1=en:giant cortical somatosensory evoked potentials (seps) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1797. en:giant granules in schwann cells --- r_associated #0: 20 --> en:white substance
    n1=en:giant granules in schwann cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1798. en:gilles de la tourette syndrome (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:gilles de la tourette syndrome (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1799. en:glial activation --- r_associated #0: 20 --> en:white substance
    n1=en:glial activation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1800. en:glial cell --- r_associated #0: 20 --> en:white substance
    n1=en:glial cell | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1801. en:glial inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:glial inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1802. en:gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1803. en:gliosis (27%) --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis (27%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1804. en:gliosis (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1805. en:gliosis in the brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis in the brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1806. en:gliosis in the striatum, medial thalamic nuclei, and inferior olives --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis in the striatum, medial thalamic nuclei, and inferior olives | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1807. en:gliosis of the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis of the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1808. en:gliosis, necrosis, neuronal loss in basal ganglia, brainstem, and spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:gliosis, necrosis, neuronal loss in basal ganglia, brainstem, and spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1809. en:global and focal neurologic abnormalities (less than 30%) --- r_associated #0: 20 --> en:white substance
    n1=en:global and focal neurologic abnormalities (less than 30%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1810. en:global brain atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:global brain atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1811. en:global cerebral atrophy, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:global cerebral atrophy, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1812. en:global developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:global developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1813. en:global developmental delay if untreated --- r_associated #0: 20 --> en:white substance
    n1=en:global developmental delay if untreated | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1814. en:global developmental delay, variable severity --- r_associated #0: 20 --> en:white substance
    n1=en:global developmental delay, variable severity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1815. en:global hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:global hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1816. en:global reduction in cerebral blood flow on pet scan --- r_associated #0: 20 --> en:white substance
    n1=en:global reduction in cerebral blood flow on pet scan | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1817. en:globally delayed development --- r_associated #0: 20 --> en:white substance
    n1=en:globally delayed development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1818. en:globular basal ganglia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:globular basal ganglia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1819. en:globular thalamus (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:globular thalamus (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1820. en:glomeruloid vascular proliferation in brain and spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:glomeruloid vascular proliferation in brain and spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1821. en:gowers sign --- r_associated #0: 20 --> en:white substance
    n1=en:gowers sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1822. en:grand mal epilepsy --- r_associated #0: 20 --> en:white substance
    n1=en:grand mal epilepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1823. en:grand mal seizure --- r_associated #0: 20 --> en:white substance
    n1=en:grand mal seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1824. en:granular material in neurons --- r_associated #0: 20 --> en:white substance
    n1=en:granular material in neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1825. en:granular osmiophilic cytoplasmic deposits in schwann cells --- r_associated #0: 20 --> en:white substance
    n1=en:granular osmiophilic cytoplasmic deposits in schwann cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1826. en:granulovacuolar degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:granulovacuolar degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1827. en:gray matter --- r_associated #0: 20 --> en:white substance
    n1=en:gray matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1828. en:gray matter appears relatively unaffected --- r_associated #0: 20 --> en:white substance
    n1=en:gray matter appears relatively unaffected | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1829. en:gray matter heterotopia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:gray matter heterotopia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1830. en:gray matter structure of central nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:gray matter structure of central nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1831. en:grimaces --- r_associated #0: 20 --> en:white substance
    n1=en:grimaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1832. en:gross motor delay --- r_associated #0: 20 --> en:white substance
    n1=en:gross motor delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1833. en:gross motor delay (in one family) --- r_associated #0: 20 --> en:white substance
    n1=en:gross motor delay (in one family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1834. en:gross motor delay, mild --- r_associated #0: 20 --> en:white substance
    n1=en:gross motor delay, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1835. en:gross motor skill delay (infancy) --- r_associated #0: 20 --> en:white substance
    n1=en:gross motor skill delay (infancy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1836. en:gtcs during 'leisure' time (evening) --- r_associated #0: 20 --> en:white substance
    n1=en:gtcs during 'leisure' time (evening) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1837. en:gurgling or drooling during seizures --- r_associated #0: 20 --> en:white substance
    n1=en:gurgling or drooling during seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1838. en:gyral disorganization --- r_associated #0: 20 --> en:white substance
    n1=en:gyral disorganization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1839. en:gyral simplification --- r_associated #0: 20 --> en:white substance
    n1=en:gyral simplification | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1840. en:hallucination --- r_associated #0: 20 --> en:white substance
    n1=en:hallucination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1841. en:hallucinations (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hallucinations (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1842. en:hamartomatous lesions of the brain --- r_associated #0: 20 --> en:white substance
    n1=en:hamartomatous lesions of the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1843. en:hand muscle atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:hand muscle atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1844. en:hand muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:hand muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1845. en:hand tremor (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hand tremor (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1846. en:has tingling sensation --- r_associated #0: 20 --> en:white substance
    n1=en:has tingling sensation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1847. en:head 'tilt' in infancy --- r_associated #0: 20 --> en:white substance
    n1=en:head 'tilt' in infancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1848. en:head bobbing --- r_associated #0: 20 --> en:white substance
    n1=en:head bobbing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1849. en:head lag --- r_associated #0: 20 --> en:white substance
    n1=en:head lag | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1850. en:head movements abnormal --- r_associated #0: 20 --> en:white substance
    n1=en:head movements abnormal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1851. en:head oscillations --- r_associated #0: 20 --> en:white substance
    n1=en:head oscillations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1852. en:head titubation --- r_associated #0: 20 --> en:white substance
    n1=en:head titubation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1853. en:head titubations --- r_associated #0: 20 --> en:white substance
    n1=en:head titubations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1854. en:head tremor --- r_associated #0: 20 --> en:white substance
    n1=en:head tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1855. en:head tremor (14% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:head tremor (14% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1856. en:head tremor (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:head tremor (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1857. en:head tremor, mild --- r_associated #0: 20 --> en:white substance
    n1=en:head tremor, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1858. en:head-rolling movements --- r_associated #0: 20 --> en:white substance
    n1=en:head-rolling movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1859. en:headache --- r_associated #0: 20 --> en:white substance
    n1=en:headache | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1860. en:headache (with pheochromocytoma) --- r_associated #0: 20 --> en:white substance
    n1=en:headache (with pheochromocytoma) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1861. en:headache is unilateral --- r_associated #0: 20 --> en:white substance
    n1=en:headache is unilateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1862. en:headache is usually not a symptom --- r_associated #0: 20 --> en:white substance
    n1=en:headache is usually not a symptom | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1863. en:headache recurrent --- r_associated #0: 20 --> en:white substance
    n1=en:headache recurrent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1864. en:headache, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:headache, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1865. en:headache, suboccipital, migraine-like (most common symptom) precipitated by coughing, sneezing, bending forward, lifting, neck extension --- r_associated #0: 20 --> en:white substance
    n1=en:headache, suboccipital, migraine-like (most common symptom) precipitated by coughing, sneezing, bending forward, lifting, neck extension | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1866. en:headaches, severe, unilateral --- r_associated #0: 20 --> en:white substance
    n1=en:headaches, severe, unilateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1867. en:heightened sensitivity to external stimuli --- r_associated #0: 20 --> en:white substance
    n1=en:heightened sensitivity to external stimuli | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1868. en:hemiclonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hemiclonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1869. en:hemihypoasthesia --- r_associated #0: 20 --> en:white substance
    n1=en:hemihypoasthesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1870. en:hemimegalencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:hemimegalencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1871. en:hemiparesis --- r_associated #0: 20 --> en:white substance
    n1=en:hemiparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1872. en:hemiparesis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hemiparesis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1873. en:hemiparesis, paroxysmal --- r_associated #0: 20 --> en:white substance
    n1=en:hemiparesis, paroxysmal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1874. en:hemiplegia --- r_associated #0: 20 --> en:white substance
    n1=en:hemiplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1875. en:hemiplegia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hemiplegia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1876. en:hemiplegic migraine --- r_associated #0: 20 --> en:white substance
    n1=en:hemiplegic migraine | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1877. en:hemiplegic migraine in some patients --- r_associated #0: 20 --> en:white substance
    n1=en:hemiplegic migraine in some patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1878. en:hemisensory attacks --- r_associated #0: 20 --> en:white substance
    n1=en:hemisensory attacks | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1879. en:hemispheric atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:hemispheric atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1880. en:hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1881. en:hemorrhagic cerebrovascular accident --- r_associated #0: 20 --> en:white substance
    n1=en:hemorrhagic cerebrovascular accident | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1882. en:hemosiderin deposition --- r_associated #0: 20 --> en:white substance
    n1=en:hemosiderin deposition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1883. en:hepatic coma --- r_associated #0: 20 --> en:white substance
    n1=en:hepatic coma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1884. en:hepatic encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:hepatic encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1885. en:herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum --- r_associated #0: 20 --> en:white substance
    n1=en:herniation and elongation of the cerebellar tonsils, cerebellar vermis, brainstem, and fourth ventricle through the foramen magnum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1886. en:herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater --- r_associated #0: 20 --> en:white substance
    n1=en:herniation of the cerebellar tonsils through the foramen magnum 5 mm or greater | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1887. en:heterotopic neurons in the white matter (36%) --- r_associated #0: 20 --> en:white substance
    n1=en:heterotopic neurons in the white matter (36%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1888. en:hiccough --- r_associated #0: 20 --> en:white substance
    n1=en:hiccough | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1889. en:high intensity area in white matter on head mri --- r_associated #0: 20 --> en:white substance
    n1=en:high intensity area in white matter on head mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1890. en:high pain threshold --- r_associated #0: 20 --> en:white substance
    n1=en:high pain threshold | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1891. en:high signal intensities at gray/white matter junction --- r_associated #0: 20 --> en:white substance
    n1=en:high signal intensities at gray/white matter junction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1892. en:high signal intensities in periventricular white matter --- r_associated #0: 20 --> en:white substance
    n1=en:high signal intensities in periventricular white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1893. en:high voltage spikes over the temporal and central regions seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:high voltage spikes over the temporal and central regions seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1894. en:high voltage, fast rhythms seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:high voltage, fast rhythms seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1895. en:high-steppage gait --- r_associated #0: 20 --> en:white substance
    n1=en:high-steppage gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1896. en:high-stepping gait --- r_associated #0: 20 --> en:white substance
    n1=en:high-stepping gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1897. en:hindbrain and midbrain --- r_associated #0: 20 --> en:white substance
    n1=en:hindbrain and midbrain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1898. en:hippocampal atrophy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:hippocampal atrophy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1899. en:hippocampal atrophy (in 2 siblings) --- r_associated #0: 20 --> en:white substance
    n1=en:hippocampal atrophy (in 2 siblings) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1900. en:hippocampal hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:hippocampal hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1901. en:holoprosencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:holoprosencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1902. en:holoprosencephaly (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:holoprosencephaly (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1903. en:holoprosencephaly (100%) --- r_associated #0: 20 --> en:white substance
    n1=en:holoprosencephaly (100%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1904. en:holoprosencephaly (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:holoprosencephaly (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1905. en:holoprosencephaly (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:holoprosencephaly (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1906. en:hooked aspect of the frontal horn of the lateral ventricles due to abnormally shaped basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:hooked aspect of the frontal horn of the lateral ventricles due to abnormally shaped basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1907. en:horner syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:horner syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1908. en:hostility --- r_associated #0: 20 --> en:white substance
    n1=en:hostility | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1909. en:hunger and thirst disturbances (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hunger and thirst disturbances (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1910. en:hydranencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:hydranencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1911. en:hydrocephalus --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1912. en:hydrocephalus (11%) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (11%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1913. en:hydrocephalus (12%) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (12%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1914. en:hydrocephalus (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1915. en:hydrocephalus (in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1916. en:hydrocephalus (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1917. en:hydrocephalus (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1918. en:hydrocephalus (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1919. en:hydrocephalus (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1920. en:hydrocephalus (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1921. en:hydrocephalus, normal pressure --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus, normal pressure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1922. en:hydrocephalus, occasional --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephalus, occasional | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1923. en:hydrocephaly, mild --- r_associated #0: 20 --> en:white substance
    n1=en:hydrocephaly, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1924. en:hyperactive brainstem reflexes (head retraction, palmomental, snout) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperactive brainstem reflexes (head retraction, palmomental, snout) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1925. en:hyperactive deep tendon reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:hyperactive deep tendon reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1926. en:hyperactive deep tendon reflexes in early stage --- r_associated #0: 20 --> en:white substance
    n1=en:hyperactive deep tendon reflexes in early stage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1927. en:hyperactive startle reflex --- r_associated #0: 20 --> en:white substance
    n1=en:hyperactive startle reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1928. en:hyperactivity --- r_associated #0: 20 --> en:white substance
    n1=en:hyperactivity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1929. en:hyperekplexia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperekplexia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1930. en:hyperexplexia --- r_associated #0: 20 --> en:white substance
    n1=en:hyperexplexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1931. en:hyperextension of the neck --- r_associated #0: 20 --> en:white substance
    n1=en:hyperextension of the neck | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1932. en:hyperintense lesions in the basal ganglia on mri --- r_associated #0: 20 --> en:white substance
    n1=en:hyperintense lesions in the basal ganglia on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1933. en:hyperintense lesions of the globi pallidi --- r_associated #0: 20 --> en:white substance
    n1=en:hyperintense lesions of the globi pallidi | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1934. en:hyperintensities in the basal ganglia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperintensities in the basal ganglia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1935. en:hyperintensities in the basal ganglia and/or thalamus --- r_associated #0: 20 --> en:white substance
    n1=en:hyperintensities in the basal ganglia and/or thalamus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1936. en:hyperirritability --- r_associated #0: 20 --> en:white substance
    n1=en:hyperirritability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1937. en:hyperkinesia --- r_associated #0: 20 --> en:white substance
    n1=en:hyperkinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1938. en:hyperkinetic involuntary movements --- r_associated #0: 20 --> en:white substance
    n1=en:hyperkinetic involuntary movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1939. en:hypermetric saccades --- r_associated #0: 20 --> en:white substance
    n1=en:hypermetric saccades | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1940. en:hypermotor automatisms --- r_associated #0: 20 --> en:white substance
    n1=en:hypermotor automatisms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1941. en:hypermotor behavior --- r_associated #0: 20 --> en:white substance
    n1=en:hypermotor behavior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1942. en:hyperreflexia --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1943. en:hyperreflexia (2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1944. en:hyperreflexia (33%) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (33%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1945. en:hyperreflexia (70%) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (70%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1946. en:hyperreflexia (early) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (early) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1947. en:hyperreflexia (later) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1948. en:hyperreflexia (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1949. en:hyperreflexia (particularly in lower extremities, more prevalent in adolescents and adults) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (particularly in lower extremities, more prevalent in adolescents and adults) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1950. en:hyperreflexia (some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1951. en:hyperreflexia (type i) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia (type i) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1952. en:hyperreflexia in some --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia in some | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1953. en:hyperreflexia in the lower limbs (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia in the lower limbs (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1954. en:hyperreflexia may occur --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1955. en:hyperreflexia proximally --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia proximally | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1956. en:hyperreflexia, especially of the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia, especially of the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1957. en:hyperreflexia, lower limbs more than upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia, lower limbs more than upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1958. en:hyperreflexia, lower limbs, mild --- r_associated #0: 20 --> en:white substance
    n1=en:hyperreflexia, lower limbs, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1959. en:hypersensitive to stimuli --- r_associated #0: 20 --> en:white substance
    n1=en:hypersensitive to stimuli | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1960. en:hypersensitivity to sound --- r_associated #0: 20 --> en:white substance
    n1=en:hypersensitivity to sound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1961. en:hypersomnolent --- r_associated #0: 20 --> en:white substance
    n1=en:hypersomnolent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1962. en:hypertensive encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:hypertensive encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1963. en:hyperthermia --- r_associated #0: 20 --> en:white substance
    n1=en:hyperthermia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1964. en:hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1965. en:hypertonia (after age 2 years) --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia (after age 2 years) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1966. en:hypertonia (childhood) --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia (childhood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1967. en:hypertonia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1968. en:hypertonia (older children and adolescents) --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia (older children and adolescents) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1969. en:hypertonia (type ii) --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia (type ii) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1970. en:hypertonia and rigidity during seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia and rigidity during seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1971. en:hypertonia in early stage --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia in early stage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1972. en:hypertonia in neonatal period --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia in neonatal period | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1973. en:hypertonia late --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia late | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1974. en:hypertonia of lower limbs, later --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia of lower limbs, later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1975. en:hypertonia of the extremities --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia of the extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1976. en:hypertonia, mild, transient --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia, mild, transient | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1977. en:hypertonia, peripheral dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonia, peripheral dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1978. en:hypertonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1979. en:hypertonicity --- r_associated #0: 20 --> en:white substance
    n1=en:hypertonicity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1980. en:hypnagogic hallucinations --- r_associated #0: 20 --> en:white substance
    n1=en:hypnagogic hallucinations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1981. en:hypnapompic hallucinations --- r_associated #0: 20 --> en:white substance
    n1=en:hypnapompic hallucinations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1982. en:hypo- and demyelination of the brain --- r_associated #0: 20 --> en:white substance
    n1=en:hypo- and demyelination of the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1983. en:hypocalcemic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hypocalcemic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1984. en:hypocalcemic tetany --- r_associated #0: 20 --> en:white substance
    n1=en:hypocalcemic tetany | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1985. en:hypodensity of caudate --- r_associated #0: 20 --> en:white substance
    n1=en:hypodensity of caudate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1986. en:hypodensity of cerebral white matter seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:hypodensity of cerebral white matter seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1987. en:hypodensity of lenticular nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:hypodensity of lenticular nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1988. en:hypodensity of the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:hypodensity of the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1989. en:hypodysplasia of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:hypodysplasia of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1990. en:hypogenesis of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:hypogenesis of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1991. en:hypoglycemia-related seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hypoglycemia-related seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1992. en:hypoglycemic coma --- r_associated #0: 20 --> en:white substance
    n1=en:hypoglycemic coma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1993. en:hypoglycemic encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:hypoglycemic encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1994. en:hypoglycemic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hypoglycemic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1995. en:hypokinesia --- r_associated #0: 20 --> en:white substance
    n1=en:hypokinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1996. en:hypokinesia in infancy --- r_associated #0: 20 --> en:white substance
    n1=en:hypokinesia in infancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1997. en:hypokinetic movements --- r_associated #0: 20 --> en:white substance
    n1=en:hypokinetic movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1998. en:hypometabolism of the frontal lobe and thalamic regions --- r_associated #0: 20 --> en:white substance
    n1=en:hypometabolism of the frontal lobe and thalamic regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  1999. en:hypomimia --- r_associated #0: 20 --> en:white substance
    n1=en:hypomimia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2000. en:hypomyelinating leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:hypomyelinating leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2001. en:hypomyelination --- r_associated #0: 20 --> en:white substance
    n1=en:hypomyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2002. en:hypomyelination (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:hypomyelination (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2003. en:hypomyelination (patient a) metabolic : hypochloremia metabolic alkalosis (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:hypomyelination (patient a) metabolic : hypochloremia metabolic alkalosis (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2004. en:hypomyelination of the brain white matter, diffuse --- r_associated #0: 20 --> en:white substance
    n1=en:hypomyelination of the brain white matter, diffuse | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2005. en:hypoplasia and displacement of the corticospinal fibers within the brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia and displacement of the corticospinal fibers within the brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2006. en:hypoplasia of anterior or entire pituitary gland (frequent) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of anterior or entire pituitary gland (frequent) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2007. en:hypoplasia of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2008. en:hypoplasia of corpus callosum and cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of corpus callosum and cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2009. en:hypoplasia of dentate nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of dentate nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2010. en:hypoplasia of olfactory tract --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of olfactory tract | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2011. en:hypoplasia of septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2012. en:hypoplasia of the brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2013. en:hypoplasia of the corpus callosum (2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the corpus callosum (2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2014. en:hypoplasia of the hypothalamus --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the hypothalamus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2015. en:hypoplasia of the medulla oblongata --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the medulla oblongata | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2016. en:hypoplasia of the mesencephalic tectum --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the mesencephalic tectum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2017. en:hypoplasia of the optic chiasm --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the optic chiasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2018. en:hypoplasia of the optic tract --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the optic tract | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2019. en:hypoplasia of the pons --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2020. en:hypoplasia of the posterior corpus callosum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the posterior corpus callosum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2021. en:hypoplasia of the pyramidal tract --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the pyramidal tract | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2022. en:hypoplasia of the ventral pons --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia of the ventral pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2023. en:hypoplasia or dysgenesis of the corpus callosum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplasia or dysgenesis of the corpus callosum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2024. en:hypoplastic anterior pituitary (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic anterior pituitary (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2025. en:hypoplastic anterior pituitary gland --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic anterior pituitary gland | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2026. en:hypoplastic brainstem with loss of demarcation at the pontomedullary junction --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic brainstem with loss of demarcation at the pontomedullary junction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2027. en:hypoplastic cerebellar vermis (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic cerebellar vermis (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2028. en:hypoplastic cerebrum --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic cerebrum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2029. en:hypoplastic corpus callosum (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic corpus callosum (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2030. en:hypoplastic corpus callosum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic corpus callosum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2031. en:hypoplastic corpus callosum (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic corpus callosum (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2032. en:hypoplastic corpus callosum (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic corpus callosum (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2033. en:hypoplastic internal capsule (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic internal capsule (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2034. en:hypoplastic olfactory lobes --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic olfactory lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2035. en:hypoplastic or absent middle cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic or absent middle cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2036. en:hypoplastic or absent optic chiasm --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic or absent optic chiasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2037. en:hypoplastic pituitary gland (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic pituitary gland (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2038. en:hypoplastic pons --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2039. en:hypoplastic/atrophic corpus callosum (55%) --- r_associated #0: 20 --> en:white substance
    n1=en:hypoplastic/atrophic corpus callosum (55%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2040. en:hyporeflexia --- r_associated #0: 20 --> en:white substance
    n1=en:hyporeflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2041. en:hyporeflexia (early) --- r_associated #0: 20 --> en:white substance
    n1=en:hyporeflexia (early) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2042. en:hyporeflexia (occurs later) --- r_associated #0: 20 --> en:white substance
    n1=en:hyporeflexia (occurs later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2043. en:hyporeflexia of lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:hyporeflexia of lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2044. en:hyporeflexia or areflexia --- r_associated #0: 20 --> en:white substance
    n1=en:hyporeflexia or areflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2045. en:hyporeflexia to hyperreflexia --- r_associated #0: 20 --> en:white substance
    n1=en:hyporeflexia to hyperreflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2046. en:hyposmia/anosmia --- r_associated #0: 20 --> en:white substance
    n1=en:hyposmia/anosmia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2047. en:hyposmia/anosmia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hyposmia/anosmia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2048. en:hypothalamic hamartoma --- r_associated #0: 20 --> en:white substance
    n1=en:hypothalamic hamartoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2049. en:hypothalamus --- r_associated #0: 20 --> en:white substance
    n1=en:hypothalamus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2050. en:hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2051. en:hypotonia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2052. en:hypotonia (93%) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (93%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2053. en:hypotonia (96%) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (96%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2054. en:hypotonia (congenital form) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (congenital form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2055. en:hypotonia (early infancy) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (early infancy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2056. en:hypotonia (early-onset form) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (early-onset form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2057. en:hypotonia (hcs and 2p21del) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (hcs and 2p21del) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2058. en:hypotonia (in 1/4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (in 1/4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2059. en:hypotonia (in males) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (in males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2060. en:hypotonia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2061. en:hypotonia (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2062. en:hypotonia (newborn) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (newborn) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2063. en:hypotonia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2064. en:hypotonia (type i and type ii, infantile) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia (type i and type ii, infantile) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2065. en:hypotonia at birth --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia at birth | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2066. en:hypotonia changing to hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia changing to hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2067. en:hypotonia in infancy and early childhood --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia in infancy and early childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2068. en:hypotonia in later stages --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia in later stages | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2069. en:hypotonia progressing to hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia progressing to hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2070. en:hypotonia, axial, severe --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, axial, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2071. en:hypotonia, global, severe --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, global, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2072. en:hypotonia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2073. en:hypotonia, mild, transient --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, mild, transient | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2074. en:hypotonia, neonatal (> 90%) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, neonatal (> 90%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2075. en:hypotonia, poor moro reflex --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, poor moro reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2076. en:hypotonia, profound muscular (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, profound muscular (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2077. en:hypotonia, proximal, severe --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, proximal, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2078. en:hypotonia, severe (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonia, severe (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2079. en:hypotonic --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2080. en:hypotonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2081. en:hypotonicity (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypotonicity (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2082. en:hypotrophic brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:hypotrophic brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2083. en:hypoxic convulsions --- r_associated #0: 20 --> en:white substance
    n1=en:hypoxic convulsions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2084. en:hypperreflexia --- r_associated #0: 20 --> en:white substance
    n1=en:hypperreflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2085. en:hypsarrhythmia --- r_associated #0: 20 --> en:white substance
    n1=en:hypsarrhythmia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2086. en:hypsarrhythmia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:hypsarrhythmia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2087. en:hypsarrhythmia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:hypsarrhythmia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2088. en:hypsarrhythmia or severe multifocal epileptic abnormalities with poor background activity on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:hypsarrhythmia or severe multifocal epileptic abnormalities with poor background activity on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2089. en:hypsarrhythmia seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:hypsarrhythmia seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2090. en:hysteria --- r_associated #0: 20 --> en:white substance
    n1=en:hysteria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2091. en:ictal eeg showed partial seizures with frontal lobe origin --- r_associated #0: 20 --> en:white substance
    n1=en:ictal eeg showed partial seizures with frontal lobe origin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2092. en:ictal eeg shows diffuse slow delta and theta activity --- r_associated #0: 20 --> en:white substance
    n1=en:ictal eeg shows diffuse slow delta and theta activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2093. en:ictal eeg shows focal onset in central, parietal, or temporal regions --- r_associated #0: 20 --> en:white substance
    n1=en:ictal eeg shows focal onset in central, parietal, or temporal regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2094. en:ictal eeg shows focal onset, often posterior region of brain --- r_associated #0: 20 --> en:white substance
    n1=en:ictal eeg shows focal onset, often posterior region of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2095. en:ictal eeg shows focal, temporal, unilateral, rhythmic slow wave activity of high amplitude --- r_associated #0: 20 --> en:white substance
    n1=en:ictal eeg shows focal, temporal, unilateral, rhythmic slow wave activity of high amplitude | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2096. en:ictal eeg with bisynchronous spike waves --- r_associated #0: 20 --> en:white substance
    n1=en:ictal eeg with bisynchronous spike waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2097. en:idiopathic generalized epilepsy in childhood (homozygous patient) --- r_associated #0: 20 --> en:white substance
    n1=en:idiopathic generalized epilepsy in childhood (homozygous patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2098. en:idiopathic torsion dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:idiopathic torsion dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2099. en:illegible handwriting --- r_associated #0: 20 --> en:white substance
    n1=en:illegible handwriting | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2100. en:imaging shows noncalcified subependymal periventricular heterotopic nodules of gray matter --- r_associated #0: 20 --> en:white substance
    n1=en:imaging shows noncalcified subependymal periventricular heterotopic nodules of gray matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2101. en:imaging shows signal abnormalities in basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:imaging shows signal abnormalities in basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2102. en:imbalance --- r_associated #0: 20 --> en:white substance
    n1=en:imbalance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2103. en:immature brain with no gyral development --- r_associated #0: 20 --> en:white substance
    n1=en:immature brain with no gyral development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2104. en:immature myelination --- r_associated #0: 20 --> en:white substance
    n1=en:immature myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2105. en:immobile --- r_associated #0: 20 --> en:white substance
    n1=en:immobile | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2106. en:immune system --- r_associated #0: 20 --> en:white substance
    n1=en:immune system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2107. en:immunology aspects --- r_associated #0: 20 --> en:white substance
    n1=en:immunology aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2108. en:impaired ambulation due to muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:impaired ambulation due to muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2109. en:impaired balance --- r_associated #0: 20 --> en:white substance
    n1=en:impaired balance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2110. en:impaired balance (2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:impaired balance (2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2111. en:impaired cognition (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:impaired cognition (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2112. en:impaired executive function (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:impaired executive function (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2113. en:impaired expression of language --- r_associated #0: 20 --> en:white substance
    n1=en:impaired expression of language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2114. en:impaired expressive speech --- r_associated #0: 20 --> en:white substance
    n1=en:impaired expressive speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2115. en:impaired fine motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:impaired fine motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2116. en:impaired gait due to peripheral neuropathy --- r_associated #0: 20 --> en:white substance
    n1=en:impaired gait due to peripheral neuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2117. en:impaired horizontal smooth pursuit --- r_associated #0: 20 --> en:white substance
    n1=en:impaired horizontal smooth pursuit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2118. en:impaired language development --- r_associated #0: 20 --> en:white substance
    n1=en:impaired language development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2119. en:impaired long-term verbal memory --- r_associated #0: 20 --> en:white substance
    n1=en:impaired long-term verbal memory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2120. en:impaired motor control, mild --- r_associated #0: 20 --> en:white substance
    n1=en:impaired motor control, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2121. en:impaired processing of language --- r_associated #0: 20 --> en:white substance
    n1=en:impaired processing of language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2122. en:impaired proprioception --- r_associated #0: 20 --> en:white substance
    n1=en:impaired proprioception | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2123. en:impaired psychomotor development --- r_associated #0: 20 --> en:white substance
    n1=en:impaired psychomotor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2124. en:impaired tandem gait --- r_associated #0: 20 --> en:white substance
    n1=en:impaired tandem gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2125. en:impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures --- r_associated #0: 20 --> en:white substance
    n1=en:impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2126. en:impaired vertical visual pursuit --- r_associated #0: 20 --> en:white substance
    n1=en:impaired vertical visual pursuit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2127. en:impaired vibration sensation at ankles --- r_associated #0: 20 --> en:white substance
    n1=en:impaired vibration sensation at ankles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2128. en:impaired vibration sensation in the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:impaired vibration sensation in the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2129. en:impaired visuospatial skills --- r_associated #0: 20 --> en:white substance
    n1=en:impaired visuospatial skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2130. en:impaired voluntary movement --- r_associated #0: 20 --> en:white substance
    n1=en:impaired voluntary movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2131. en:impaired walking ability (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:impaired walking ability (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2132. en:impairment of balance --- r_associated #0: 20 --> en:white substance
    n1=en:impairment of balance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2133. en:impairment of gross and fine motor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:impairment of gross and fine motor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2134. en:inability to communicate --- r_associated #0: 20 --> en:white substance
    n1=en:inability to communicate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2135. en:inability to generate syntactic grammar rules (i.e., tense, gender, number) --- r_associated #0: 20 --> en:white substance
    n1=en:inability to generate syntactic grammar rules (i.e., tense, gender, number) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2136. en:inability to hold head --- r_associated #0: 20 --> en:white substance
    n1=en:inability to hold head | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2137. en:inability to hold head up --- r_associated #0: 20 --> en:white substance
    n1=en:inability to hold head up | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2138. en:inability to hold neck up ('limber neck') onset at 6 months --- r_associated #0: 20 --> en:white substance
    n1=en:inability to hold neck up ('limber neck') onset at 6 months | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2139. en:inability to reach --- r_associated #0: 20 --> en:white substance
    n1=en:inability to reach | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2140. en:inability to run --- r_associated #0: 20 --> en:white substance
    n1=en:inability to run | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2141. en:inability to run (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:inability to run (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2142. en:inability to sit --- r_associated #0: 20 --> en:white substance
    n1=en:inability to sit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2143. en:inability to sit or control head --- r_associated #0: 20 --> en:white substance
    n1=en:inability to sit or control head | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2144. en:inability to sit or stand independently --- r_associated #0: 20 --> en:white substance
    n1=en:inability to sit or stand independently | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2145. en:inability to sit or walk independently --- r_associated #0: 20 --> en:white substance
    n1=en:inability to sit or walk independently | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2146. en:inability to stand on toes --- r_associated #0: 20 --> en:white substance
    n1=en:inability to stand on toes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2147. en:inability to stand without assistance --- r_associated #0: 20 --> en:white substance
    n1=en:inability to stand without assistance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2148. en:inability to walk independently --- r_associated #0: 20 --> en:white substance
    n1=en:inability to walk independently | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2149. en:inability to walk unaided --- r_associated #0: 20 --> en:white substance
    n1=en:inability to walk unaided | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2150. en:inability to walk unsupported --- r_associated #0: 20 --> en:white substance
    n1=en:inability to walk unsupported | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2151. en:inarticulate speech delayed gross motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:inarticulate speech delayed gross motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2152. en:incomplete myelination --- r_associated #0: 20 --> en:white substance
    n1=en:incomplete myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2153. en:incomprehensible speech --- r_associated #0: 20 --> en:white substance
    n1=en:incomprehensible speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2154. en:incoordination of the hands --- r_associated #0: 20 --> en:white substance
    n1=en:incoordination of the hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2155. en:incoordination of trunk and limbs --- r_associated #0: 20 --> en:white substance
    n1=en:incoordination of trunk and limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2156. en:increased activity period --- r_associated #0: 20 --> en:white substance
    n1=en:increased activity period | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2157. en:increased cerebral lactate --- r_associated #0: 20 --> en:white substance
    n1=en:increased cerebral lactate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2158. en:increased csf lactate --- r_associated #0: 20 --> en:white substance
    n1=en:increased csf lactate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2159. en:increased csf protein --- r_associated #0: 20 --> en:white substance
    n1=en:increased csf protein | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2160. en:increased csf protein with normal cell count --- r_associated #0: 20 --> en:white substance
    n1=en:increased csf protein with normal cell count | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2161. en:increased deep tendon reflexes (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:increased deep tendon reflexes (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2162. en:increased falls --- r_associated #0: 20 --> en:white substance
    n1=en:increased falls | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2163. en:increased intracranial pressure preoperatively (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:increased intracranial pressure preoperatively (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2164. en:increased iron deposition in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:increased iron deposition in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2165. en:increased iron deposition in the basal ganglia (40%) --- r_associated #0: 20 --> en:white substance
    n1=en:increased iron deposition in the basal ganglia (40%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2166. en:increased lactate in the brain --- r_associated #0: 20 --> en:white substance
    n1=en:increased lactate in the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2167. en:increased muscle tone in the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:increased muscle tone in the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2168. en:increased neurologic sequelae of infections (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:increased neurologic sequelae of infections (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2169. en:increased risk of seizures in childhood or adulthood (11-16%) --- r_associated #0: 20 --> en:white substance
    n1=en:increased risk of seizures in childhood or adulthood (11-16%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2170. en:increased signal intensity on t(2)-weighted scans in the periventricular and centrum ovale area --- r_associated #0: 20 --> en:white substance
    n1=en:increased signal intensity on t(2)-weighted scans in the periventricular and centrum ovale area | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2171. en:increased startle response --- r_associated #0: 20 --> en:white substance
    n1=en:increased startle response | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2172. en:increased subdural space around frontal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:increased subdural space around frontal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2173. en:increased t2 signal intensities in the middle cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:increased t2 signal intensities in the middle cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2174. en:increased tone in the upper limbs (occur later) --- r_associated #0: 20 --> en:white substance
    n1=en:increased tone in the upper limbs (occur later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2175. en:increased white matter abnormalities on t2 signalling (in type iib) --- r_associated #0: 20 --> en:white substance
    n1=en:increased white matter abnormalities on t2 signalling (in type iib) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2176. en:independent walking never achieved --- r_associated #0: 20 --> en:white substance
    n1=en:independent walking never achieved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2177. en:individuals can stand or walk with support by 4 to 6 years of age --- r_associated #0: 20 --> en:white substance
    n1=en:individuals can stand or walk with support by 4 to 6 years of age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2178. en:individuals require less sleep in a 24-hour period compared to age-matched controls --- r_associated #0: 20 --> en:white substance
    n1=en:individuals require less sleep in a 24-hour period compared to age-matched controls | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2179. en:infantile encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:infantile encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2180. en:infantile encephalopathy, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:infantile encephalopathy, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2181. en:infantile hemiplegias --- r_associated #0: 20 --> en:white substance
    n1=en:infantile hemiplegias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2182. en:infantile irritability (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:infantile irritability (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2183. en:infantile muscular hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:infantile muscular hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2184. en:infantile nystagmus --- r_associated #0: 20 --> en:white substance
    n1=en:infantile nystagmus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2185. en:infantile seizures --- r_associated #0: 20 --> en:white substance
    n1=en:infantile seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2186. en:infantile seizures (approximately 80% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:infantile seizures (approximately 80% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2187. en:infantile seizures, afebrile, with no neurologic sequelae (in 40% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:infantile seizures, afebrile, with no neurologic sequelae (in 40% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2188. en:infantile spasm --- r_associated #0: 20 --> en:white substance
    n1=en:infantile spasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2189. en:infarction --- r_associated #0: 20 --> en:white substance
    n1=en:infarction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2190. en:inferior olivary nuclei show fetal pattern --- r_associated #0: 20 --> en:white substance
    n1=en:inferior olivary nuclei show fetal pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2191. en:inferior vermis hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:inferior vermis hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2192. en:inflexible adherence to routines or rituals --- r_associated #0: 20 --> en:white substance
    n1=en:inflexible adherence to routines or rituals | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2193. en:infrequent generalized seizures --- r_associated #0: 20 --> en:white substance
    n1=en:infrequent generalized seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2194. en:initial hypotonia, followed by spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:initial hypotonia, followed by spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2195. en:initial normal development --- r_associated #0: 20 --> en:white substance
    n1=en:initial normal development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2196. en:insomnia adverse event --- r_associated #0: 20 --> en:white substance
    n1=en:insomnia adverse event | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2197. en:insomnia, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:insomnia, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2198. en:intellect high (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intellect high (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2199. en:intellectual delay --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2200. en:intellectual disabilities (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disabilities (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2201. en:intellectual disability --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2202. en:intellectual disability (in 1 ashkenazi patient) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability (in 1 ashkenazi patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2203. en:intellectual disability (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2204. en:intellectual disability (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2205. en:intellectual disability, mild (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, mild (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2206. en:intellectual disability, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2207. en:intellectual disability, mild (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, mild (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2208. en:intellectual disability, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2209. en:intellectual disability, mild to moderate (in homozygotes) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, mild to moderate (in homozygotes) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2210. en:intellectual disability, mild to severe --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, mild to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2211. en:intellectual disability, moderate (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, moderate (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2212. en:intellectual disability, moderate to severe --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, moderate to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2213. en:intellectual disability, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual disability, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2214. en:intellectual function may be high in milder cases --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual function may be high in milder cases | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2215. en:intellectual impairment (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual impairment (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2216. en:intellectual impairment, mild --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual impairment, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2217. en:intellectual impairment, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intellectual impairment, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2218. en:intention tremor (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:intention tremor (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2219. en:intention tremor (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intention tremor (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2220. en:intention tremor in those who survive --- r_associated #0: 20 --> en:white substance
    n1=en:intention tremor in those who survive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2221. en:interhemispheric cysts --- r_associated #0: 20 --> en:white substance
    n1=en:interhemispheric cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2222. en:interhemispheric lipoma --- r_associated #0: 20 --> en:white substance
    n1=en:interhemispheric lipoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2223. en:interictal ataxia may occur later in disease course --- r_associated #0: 20 --> en:white substance
    n1=en:interictal ataxia may occur later in disease course | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2224. en:interictal downbeat nystagmus --- r_associated #0: 20 --> en:white substance
    n1=en:interictal downbeat nystagmus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2225. en:interictal dystonia may occur later in disease course --- r_associated #0: 20 --> en:white substance
    n1=en:interictal dystonia may occur later in disease course | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2226. en:interictal eeg is usually normal --- r_associated #0: 20 --> en:white substance
    n1=en:interictal eeg is usually normal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2227. en:interictal eeg may be normal or abnormal --- r_associated #0: 20 --> en:white substance
    n1=en:interictal eeg may be normal or abnormal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2228. en:interictal eeg may show nonspecific changes in 15 to 20% --- r_associated #0: 20 --> en:white substance
    n1=en:interictal eeg may show nonspecific changes in 15 to 20% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2229. en:interictal eeg shows 3-4 hz general spike-wave complexes --- r_associated #0: 20 --> en:white substance
    n1=en:interictal eeg shows 3-4 hz general spike-wave complexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2230. en:interictal neurologic impairment --- r_associated #0: 20 --> en:white substance
    n1=en:interictal neurologic impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2231. en:interictal periods of normal health --- r_associated #0: 20 --> en:white substance
    n1=en:interictal periods of normal health | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2232. en:intermittent episodes associated with lethargy, vomiting --- r_associated #0: 20 --> en:white substance
    n1=en:intermittent episodes associated with lethargy, vomiting | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2233. en:intermittent migraine headaches --- r_associated #0: 20 --> en:white substance
    n1=en:intermittent migraine headaches | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2234. en:intermittent wheelchair dependence (stage 3) --- r_associated #0: 20 --> en:white substance
    n1=en:intermittent wheelchair dependence (stage 3) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2235. en:intermittent, transient episodes of worsening of ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:intermittent, transient episodes of worsening of ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2236. en:interosseus muscle atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:interosseus muscle atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2237. en:interventricular cysts --- r_associated #0: 20 --> en:white substance
    n1=en:interventricular cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2238. en:intracellular accumulation of material resulting in curvilinear profiles on ultrastructural analysis --- r_associated #0: 20 --> en:white substance
    n1=en:intracellular accumulation of material resulting in curvilinear profiles on ultrastructural analysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2239. en:intracellular accumulation of material resulting in fingerprint profiles on ultrastructural analysis --- r_associated #0: 20 --> en:white substance
    n1=en:intracellular accumulation of material resulting in fingerprint profiles on ultrastructural analysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2240. en:intracellular accumulation of material resulting in rectilinear profiles on ultrastructural analysis --- r_associated #0: 20 --> en:white substance
    n1=en:intracellular accumulation of material resulting in rectilinear profiles on ultrastructural analysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2241. en:intracellular lewy bodies --- r_associated #0: 20 --> en:white substance
    n1=en:intracellular lewy bodies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2242. en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) --- r_associated #0: 20 --> en:white substance
    n1=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2243. en:intracerebral calcifications (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intracerebral calcifications (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2244. en:intracerebral cysts (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intracerebral cysts (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2245. en:intracerebral periventricular calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:intracerebral periventricular calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2246. en:intracranial bleeding (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial bleeding (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2247. en:intracranial calcification affecting the basal ganglia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial calcification affecting the basal ganglia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2248. en:intracranial calcification by x-ray or ct --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial calcification by x-ray or ct | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2249. en:intracranial calcifications (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial calcifications (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2250. en:intracranial calcifications (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial calcifications (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2251. en:intracranial calcifications in the anterior mesial temporal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial calcifications in the anterior mesial temporal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2252. en:intracranial calcifications, band-like, particularly periventricular and in the basal ganglia and thalamus --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial calcifications, band-like, particularly periventricular and in the basal ganglia and thalamus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2253. en:intracranial cysts --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2254. en:intracranial hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2255. en:intracranial hypertension --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial hypertension | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2256. en:intracranial lipoma (cerebello-pontine) --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial lipoma (cerebello-pontine) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2257. en:intracranial thin-walled sinusoidal vessel (cavernous) malformations --- r_associated #0: 20 --> en:white substance
    n1=en:intracranial thin-walled sinusoidal vessel (cavernous) malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2258. en:intractable epilepsy --- r_associated #0: 20 --> en:white substance
    n1=en:intractable epilepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2259. en:intraneuronal inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:intraneuronal inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2260. en:intraparenchymal brain hemorrhage, multifocal --- r_associated #0: 20 --> en:white substance
    n1=en:intraparenchymal brain hemorrhage, multifocal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2261. en:intraspinal neoplasm --- r_associated #0: 20 --> en:white substance
    n1=en:intraspinal neoplasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2262. en:involuntary dystonic or choreiform movements --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary dystonic or choreiform movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2263. en:involuntary jerking movements --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary jerking movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2264. en:involuntary movements --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2265. en:involuntary movements may be precipitated by exertion or anxiety --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary movements may be precipitated by exertion or anxiety | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2266. en:involuntary movements of extremities, neck, trunk, and/or face --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary movements of extremities, neck, trunk, and/or face | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2267. en:involuntary movements, asymmetric --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary movements, asymmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2268. en:involuntary repetitive movements --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary repetitive movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2269. en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2270. en:involuntary rhythmic myoclonic movements ('tremor'), upper extremities --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary rhythmic myoclonic movements ('tremor'), upper extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2271. en:involuntary writhing movements --- r_associated #0: 20 --> en:white substance
    n1=en:involuntary writhing movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2272. en:ipsilateral brain hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:ipsilateral brain hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2273. en:ipsilateral cranial nerve hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:ipsilateral cranial nerve hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2274. en:iq 85-115 (female) --- r_associated #0: 20 --> en:white substance
    n1=en:iq 85-115 (female) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2275. en:iron accumulation in the basal ganglia seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:iron accumulation in the basal ganglia seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2276. en:iron accumulation in the globus pallidus and substantia nigra seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:iron accumulation in the globus pallidus and substantia nigra seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2277. en:iron deposition in pallidal nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:iron deposition in pallidal nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2278. en:iron deposition in the basal ganglia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:iron deposition in the basal ganglia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2279. en:iron deposition in the globus pallidus (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:iron deposition in the globus pallidus (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2280. en:iron deposition in the globus pallidus and substantia nigra seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:iron deposition in the globus pallidus and substantia nigra seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2281. en:iron deposits in the globus pallidus, caudate, and substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:iron deposits in the globus pallidus, caudate, and substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2282. en:iron-containing deposits in various brain regions --- r_associated #0: 20 --> en:white substance
    n1=en:iron-containing deposits in various brain regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2283. en:irregular cortical ribbon --- r_associated #0: 20 --> en:white substance
    n1=en:irregular cortical ribbon | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2284. en:irregular folding of the cortex --- r_associated #0: 20 --> en:white substance
    n1=en:irregular folding of the cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2285. en:irregular spike and slow waves --- r_associated #0: 20 --> en:white substance
    n1=en:irregular spike and slow waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2286. en:irresistible desire to move the legs --- r_associated #0: 20 --> en:white substance
    n1=en:irresistible desire to move the legs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2287. en:irritation --- r_associated #0: 20 --> en:white substance
    n1=en:irritation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2288. en:ischemic cerebrovascular accident --- r_associated #0: 20 --> en:white substance
    n1=en:ischemic cerebrovascular accident | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2289. en:ischemic infarct of brain --- r_associated #0: 20 --> en:white substance
    n1=en:ischemic infarct of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2290. en:ischemic infarction (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:ischemic infarction (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2291. en:ischemic necrotic lesions --- r_associated #0: 20 --> en:white substance
    n1=en:ischemic necrotic lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2292. en:ischemic stroke (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ischemic stroke (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2293. en:ischemic stroke in the basal ganglia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:ischemic stroke in the basal ganglia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2294. en:isolated absence of pain sensation --- r_associated #0: 20 --> en:white substance
    n1=en:isolated absence of pain sensation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2295. en:isolated focal dystonia may occur --- r_associated #0: 20 --> en:white substance
    n1=en:isolated focal dystonia may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2296. en:jacksonian seizure --- r_associated #0: 20 --> en:white substance
    n1=en:jacksonian seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2297. en:jerk-locked premyoclonus spikes --- r_associated #0: 20 --> en:white substance
    n1=en:jerk-locked premyoclonus spikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2298. en:jerking may be unidirectional, periodically alternating, or mixed pendular and jerk-like --- r_associated #0: 20 --> en:white substance
    n1=en:jerking may be unidirectional, periodically alternating, or mixed pendular and jerk-like | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2299. en:jerking movements --- r_associated #0: 20 --> en:white substance
    n1=en:jerking movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2300. en:jerky head movements --- r_associated #0: 20 --> en:white substance
    n1=en:jerky head movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2301. en:jerky limb movements --- r_associated #0: 20 --> en:white substance
    n1=en:jerky limb movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2302. en:jerky movements in infancy --- r_associated #0: 20 --> en:white substance
    n1=en:jerky movements in infancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2303. en:joubert syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:joubert syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2304. en:kearns-sayre syndrome (530000), in a subset of patients --- r_associated #0: 20 --> en:white substance
    n1=en:kearns-sayre syndrome (530000), in a subset of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2305. en:kernicterus --- r_associated #0: 20 --> en:white substance
    n1=en:kernicterus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2306. en:knee and ankle clonus --- r_associated #0: 20 --> en:white substance
    n1=en:knee and ankle clonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2307. en:lack of bunina bodies --- r_associated #0: 20 --> en:white substance
    n1=en:lack of bunina bodies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2308. en:lack of communication --- r_associated #0: 20 --> en:white substance
    n1=en:lack of communication | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2309. en:lack of development --- r_associated #0: 20 --> en:white substance
    n1=en:lack of development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2310. en:lack of developmental development --- r_associated #0: 20 --> en:white substance
    n1=en:lack of developmental development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2311. en:lack of developmental milestones --- r_associated #0: 20 --> en:white substance
    n1=en:lack of developmental milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2312. en:lack of ependymal cells --- r_associated #0: 20 --> en:white substance
    n1=en:lack of ependymal cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2313. en:lack of expressive speech --- r_associated #0: 20 --> en:white substance
    n1=en:lack of expressive speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2314. en:lack of head control --- r_associated #0: 20 --> en:white substance
    n1=en:lack of head control | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2315. en:lack of head or postural control (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of head or postural control (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2316. en:lack of independent ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:lack of independent ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2317. en:lack of independent ambulation (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of independent ambulation (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2318. en:lack of independent sitting or walking --- r_associated #0: 20 --> en:white substance
    n1=en:lack of independent sitting or walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2319. en:lack of independent walking (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of independent walking (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2320. en:lack of inflammatory infiltrate --- r_associated #0: 20 --> en:white substance
    n1=en:lack of inflammatory infiltrate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2321. en:lack of motor development --- r_associated #0: 20 --> en:white substance
    n1=en:lack of motor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2322. en:lack of motor development (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of motor development (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2323. en:lack of motor milestones --- r_associated #0: 20 --> en:white substance
    n1=en:lack of motor milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2324. en:lack of neurologic development --- r_associated #0: 20 --> en:white substance
    n1=en:lack of neurologic development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2325. en:lack of peer relationships --- r_associated #0: 20 --> en:white substance
    n1=en:lack of peer relationships | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2326. en:lack of psychomotor development (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of psychomotor development (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2327. en:lack of psychomotor development (severe connatal form) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of psychomotor development (severe connatal form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2328. en:lack of skein-like inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:lack of skein-like inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2329. en:lack of speech (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of speech (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2330. en:lack of speech acquisition --- r_associated #0: 20 --> en:white substance
    n1=en:lack of speech acquisition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2331. en:lack of speech development --- r_associated #0: 20 --> en:white substance
    n1=en:lack of speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2332. en:lack of speech development (some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:lack of speech development (some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2333. en:lack of speech or only a few words --- r_associated #0: 20 --> en:white substance
    n1=en:lack of speech or only a few words | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2334. en:lack of speech or poor speech --- r_associated #0: 20 --> en:white substance
    n1=en:lack of speech or poor speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2335. en:lack of spontaneous movement --- r_associated #0: 20 --> en:white substance
    n1=en:lack of spontaneous movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2336. en:lack of spontaneous play --- r_associated #0: 20 --> en:white substance
    n1=en:lack of spontaneous play | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2337. en:lack of upper motor neuron signs --- r_associated #0: 20 --> en:white substance
    n1=en:lack of upper motor neuron signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2338. en:lack of verbal communication --- r_associated #0: 20 --> en:white substance
    n1=en:lack of verbal communication | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2339. en:lack of visual attention --- r_associated #0: 20 --> en:white substance
    n1=en:lack of visual attention | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2340. en:lack of volitional movement --- r_associated #0: 20 --> en:white substance
    n1=en:lack of volitional movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2341. en:lacunar infarcts develop after age 40 years --- r_associated #0: 20 --> en:white substance
    n1=en:lacunar infarcts develop after age 40 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2342. en:lacunar infarcts in the deep-brain nuclei, brainstem, internal capsule seen on imaging --- r_associated #0: 20 --> en:white substance
    n1=en:lacunar infarcts in the deep-brain nuclei, brainstem, internal capsule seen on imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2343. en:laminar necrosis --- r_associated #0: 20 --> en:white substance
    n1=en:laminar necrosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2344. en:language acquisition difficulties (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:language acquisition difficulties (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2345. en:language delay --- r_associated #0: 20 --> en:white substance
    n1=en:language delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2346. en:language delay (55%) --- r_associated #0: 20 --> en:white substance
    n1=en:language delay (55%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2347. en:language delay/disorder --- r_associated #0: 20 --> en:white substance
    n1=en:language delay/disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2348. en:language development limited to a few words --- r_associated #0: 20 --> en:white substance
    n1=en:language development limited to a few words | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2349. en:language disorder --- r_associated #0: 20 --> en:white substance
    n1=en:language disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2350. en:large basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:large basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2351. en:large cavum vergae --- r_associated #0: 20 --> en:white substance
    n1=en:large cavum vergae | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2352. en:large cerebellum, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:large cerebellum, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2353. en:large sella turcica --- r_associated #0: 20 --> en:white substance
    n1=en:large sella turcica | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2354. en:large subcortical cysts in frontal and temporal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:large subcortical cysts in frontal and temporal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2355. en:late ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:late ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2356. en:late diaphragmatic involvement --- r_associated #0: 20 --> en:white substance
    n1=en:late diaphragmatic involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2357. en:late-onset spinocerebellar degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:late-onset spinocerebellar degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2358. en:lateral corticospinal tracts show atrophy, pallor, and degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:lateral corticospinal tracts show atrophy, pallor, and degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2359. en:lateral horn of the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:lateral horn of the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2360. en:learning and developmental delay (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:learning and developmental delay (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2361. en:learning difficulties --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2362. en:learning difficulties (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2363. en:learning difficulties (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2364. en:learning difficulties (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2365. en:learning difficulties (seen in recessive form) --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties (seen in recessive form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2366. en:learning difficulties in affected females --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties in affected females | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2367. en:learning difficulties, mild (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:learning difficulties, mild (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2368. en:learning disabilities --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2369. en:learning disabilities (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2370. en:learning disabilities (30%) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities (30%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2371. en:learning disabilities (in females) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities (in females) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2372. en:learning disabilities (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2373. en:learning disabilities (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2374. en:learning disabilities (major) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disabilities (major) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2375. en:learning disability (90% patients) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disability (90% patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2376. en:learning disability (early in life) --- r_associated #0: 20 --> en:white substance
    n1=en:learning disability (early in life) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2377. en:learning problems --- r_associated #0: 20 --> en:white substance
    n1=en:learning problems | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2378. en:leg cramp --- r_associated #0: 20 --> en:white substance
    n1=en:leg cramp | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2379. en:leg pain --- r_associated #0: 20 --> en:white substance
    n1=en:leg pain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2380. en:leg stiffness --- r_associated #0: 20 --> en:white substance
    n1=en:leg stiffness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2381. en:leigh disease --- r_associated #0: 20 --> en:white substance
    n1=en:leigh disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2382. en:leigh syndrome (245000), in a subset of patients --- r_associated #0: 20 --> en:white substance
    n1=en:leigh syndrome (245000), in a subset of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2383. en:leigh syndrome (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:leigh syndrome (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2384. en:leptomeningeal melanocytosis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:leptomeningeal melanocytosis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2385. en:leptomeningeal thickening --- r_associated #0: 20 --> en:white substance
    n1=en:leptomeningeal thickening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2386. en:lesions are symmetrical --- r_associated #0: 20 --> en:white substance
    n1=en:lesions are symmetrical | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2387. en:lesions characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation --- r_associated #0: 20 --> en:white substance
    n1=en:lesions characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2388. en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2389. en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2390. en:lesions in the anterior pituitary (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in the anterior pituitary (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2391. en:lesions in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2392. en:lesions in the caudate and putamen --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in the caudate and putamen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2393. en:lesions in the caudate and putamen seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in the caudate and putamen seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2394. en:lesions in the internal capsule after age 40 years --- r_associated #0: 20 --> en:white substance
    n1=en:lesions in the internal capsule after age 40 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2395. en:lesions show signal increase on t2- and signal decrease on t1-weighted images --- r_associated #0: 20 --> en:white substance
    n1=en:lesions show signal increase on t2- and signal decrease on t1-weighted images | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2396. en:lethargy --- r_associated #0: 20 --> en:white substance
    n1=en:lethargy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2397. en:lethargy associated with hypoglycemia --- r_associated #0: 20 --> en:white substance
    n1=en:lethargy associated with hypoglycemia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2398. en:lethargy, neonatal --- r_associated #0: 20 --> en:white substance
    n1=en:lethargy, neonatal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2399. en:leukoaraiosis --- r_associated #0: 20 --> en:white substance
    n1=en:leukoaraiosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2400. en:leukodystrophy --- r_associated #0: 20 --> en:white substance
    n1=en:leukodystrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2401. en:leukodystrophy (in 1 of 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:leukodystrophy (in 1 of 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2402. en:leukodystrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:leukodystrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2403. en:leukodystrophy and white matter changes, which improve with age --- r_associated #0: 20 --> en:white substance
    n1=en:leukodystrophy and white matter changes, which improve with age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2404. en:leukodystrophy, demyelinating --- r_associated #0: 20 --> en:white substance
    n1=en:leukodystrophy, demyelinating | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2405. en:leukodystrophy, hypomyelinating --- r_associated #0: 20 --> en:white substance
    n1=en:leukodystrophy, hypomyelinating | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2406. en:leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2407. en:leukoencephalopathy in the frontal and parietal lobes (later) --- r_associated #0: 20 --> en:white substance
    n1=en:leukoencephalopathy in the frontal and parietal lobes (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2408. en:leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts --- r_associated #0: 20 --> en:white substance
    n1=en:leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2409. en:leukoencephalopathy on ct and mri --- r_associated #0: 20 --> en:white substance
    n1=en:leukoencephalopathy on ct and mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2410. en:leukoencephalopathy, severe --- r_associated #0: 20 --> en:white substance
    n1=en:leukoencephalopathy, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2411. en:leukomalacia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:leukomalacia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2412. en:lewy bodies --- r_associated #0: 20 --> en:white substance
    n1=en:lewy bodies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2413. en:lewy bodies (not always present) --- r_associated #0: 20 --> en:white substance
    n1=en:lewy bodies (not always present) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2414. en:lewy bodies in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:lewy bodies in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2415. en:lewy bodies throughout the brain --- r_associated #0: 20 --> en:white substance
    n1=en:lewy bodies throughout the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2416. en:light-induced sneezing --- r_associated #0: 20 --> en:white substance
    n1=en:light-induced sneezing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2417. en:lightheadedness --- r_associated #0: 20 --> en:white substance
    n1=en:lightheadedness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2418. en:limb ataxia, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:limb ataxia, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2419. en:limb dysmetria --- r_associated #0: 20 --> en:white substance
    n1=en:limb dysmetria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2420. en:limb dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:limb dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2421. en:limb dystonia (18%) --- r_associated #0: 20 --> en:white substance
    n1=en:limb dystonia (18%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2422. en:limb fasciculations --- r_associated #0: 20 --> en:white substance
    n1=en:limb fasciculations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2423. en:limb hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:limb hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2424. en:limb hypertonia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:limb hypertonia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2425. en:limb incoordination (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:limb incoordination (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2426. en:limb muscle stiffness is often asymmetric --- r_associated #0: 20 --> en:white substance
    n1=en:limb muscle stiffness is often asymmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2427. en:limb muscle weakness (distal greater than proximal) --- r_associated #0: 20 --> en:white substance
    n1=en:limb muscle weakness (distal greater than proximal) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2428. en:limb posturing (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:limb posturing (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2429. en:limb spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:limb spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2430. en:limbic malformations --- r_associated #0: 20 --> en:white substance
    n1=en:limbic malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2431. en:limbic system --- r_associated #0: 20 --> en:white substance
    n1=en:limbic system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2432. en:limited expressive language --- r_associated #0: 20 --> en:white substance
    n1=en:limited expressive language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2433. en:limited memory, attention, language --- r_associated #0: 20 --> en:white substance
    n1=en:limited memory, attention, language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2434. en:limited verbal comprehension --- r_associated #0: 20 --> en:white substance
    n1=en:limited verbal comprehension | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2435. en:limited walking ability --- r_associated #0: 20 --> en:white substance
    n1=en:limited walking ability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2436. en:lingual-facial-buccal dyskinesia --- r_associated #0: 20 --> en:white substance
    n1=en:lingual-facial-buccal dyskinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2437. en:lipoma, anterior sacral --- r_associated #0: 20 --> en:white substance
    n1=en:lipoma, anterior sacral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2438. en:lipomyelocystoceles --- r_associated #0: 20 --> en:white substance
    n1=en:lipomyelocystoceles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2439. en:lissencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:lissencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2440. en:lissencephaly (anterior to posterior decreasing gradient of severity, more prominent in anterior brain regions) --- r_associated #0: 20 --> en:white substance
    n1=en:lissencephaly (anterior to posterior decreasing gradient of severity, more prominent in anterior brain regions) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2441. en:lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions) --- r_associated #0: 20 --> en:white substance
    n1=en:lissencephaly (anterior to posterior increasing gradient of severity and more prominent in posterior brain regions) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2442. en:lissencephaly (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:lissencephaly (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2443. en:lissencephaly, posterior to anterior gradient --- r_associated #0: 20 --> en:white substance
    n1=en:lissencephaly, posterior to anterior gradient | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2444. en:little or no speech acquisition --- r_associated #0: 20 --> en:white substance
    n1=en:little or no speech acquisition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2445. en:little polarity in remaining neurons --- r_associated #0: 20 --> en:white substance
    n1=en:little polarity in remaining neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2446. en:little spontaneous limb movement --- r_associated #0: 20 --> en:white substance
    n1=en:little spontaneous limb movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2447. en:little spontaneous movement --- r_associated #0: 20 --> en:white substance
    n1=en:little spontaneous movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2448. en:lobar holoprosencephalies --- r_associated #0: 20 --> en:white substance
    n1=en:lobar holoprosencephalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2449. en:lobar hpe shows clear interhemispheric fissure and 2 lateral ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:lobar hpe shows clear interhemispheric fissure and 2 lateral ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2450. en:locomotor delay (early-onset form) --- r_associated #0: 20 --> en:white substance
    n1=en:locomotor delay (early-onset form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2451. en:long perforating arteries of the brain are affected --- r_associated #0: 20 --> en:white substance
    n1=en:long perforating arteries of the brain are affected | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2452. en:long, thickened cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:long, thickened cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2453. en:long-tract signs --- r_associated #0: 20 --> en:white substance
    n1=en:long-tract signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2454. en:loss of ability to walk --- r_associated #0: 20 --> en:white substance
    n1=en:loss of ability to walk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2455. en:loss of ability to walk in first decade --- r_associated #0: 20 --> en:white substance
    n1=en:loss of ability to walk in first decade | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2456. en:loss of ability to walk later --- r_associated #0: 20 --> en:white substance
    n1=en:loss of ability to walk later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2457. en:loss of ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:loss of ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2458. en:loss of ankle reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:loss of ankle reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2459. en:loss of anterior horn cells and gliosis in the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:loss of anterior horn cells and gliosis in the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2460. en:loss of any acquired abilities in early childhood --- r_associated #0: 20 --> en:white substance
    n1=en:loss of any acquired abilities in early childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2461. en:loss of balance may occur --- r_associated #0: 20 --> en:white substance
    n1=en:loss of balance may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2462. en:loss of cerebellar granular cells --- r_associated #0: 20 --> en:white substance
    n1=en:loss of cerebellar granular cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2463. en:loss of cerebellar purkinje cells --- r_associated #0: 20 --> en:white substance
    n1=en:loss of cerebellar purkinje cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2464. en:loss of cerebral white matter (in 1 of 3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:loss of cerebral white matter (in 1 of 3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2465. en:loss of consciousness --- r_associated #0: 20 --> en:white substance
    n1=en:loss of consciousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2466. en:loss of consciousness (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:loss of consciousness (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2467. en:loss of coordination --- r_associated #0: 20 --> en:white substance
    n1=en:loss of coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2468. en:loss of deep tendon reflexes (later) --- r_associated #0: 20 --> en:white substance
    n1=en:loss of deep tendon reflexes (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2469. en:loss of developmental milestones --- r_associated #0: 20 --> en:white substance
    n1=en:loss of developmental milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2470. en:loss of dopaminergic neurons --- r_associated #0: 20 --> en:white substance
    n1=en:loss of dopaminergic neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2471. en:loss of dopaminergic neurons in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:loss of dopaminergic neurons in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2472. en:loss of dorsal root ganglion cells --- r_associated #0: 20 --> en:white substance
    n1=en:loss of dorsal root ganglion cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2473. en:loss of executive functions --- r_associated #0: 20 --> en:white substance
    n1=en:loss of executive functions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2474. en:loss of fine motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:loss of fine motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2475. en:loss of gait (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:loss of gait (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2476. en:loss of hypocretin (orexin)-secreting neurons in the hypothalamus --- r_associated #0: 20 --> en:white substance
    n1=en:loss of hypocretin (orexin)-secreting neurons in the hypothalamus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2477. en:loss of independent ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:loss of independent ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2478. en:loss of independent ambulation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:loss of independent ambulation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2479. en:loss of independent ambulation approximately 30 years after onset --- r_associated #0: 20 --> en:white substance
    n1=en:loss of independent ambulation approximately 30 years after onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2480. en:loss of independent ambulation by age 10 years --- r_associated #0: 20 --> en:white substance
    n1=en:loss of independent ambulation by age 10 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2481. en:loss of independent ambulation within a few years --- r_associated #0: 20 --> en:white substance
    n1=en:loss of independent ambulation within a few years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2482. en:loss of language ability --- r_associated #0: 20 --> en:white substance
    n1=en:loss of language ability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2483. en:loss of lower alpha-motor neurons in the anterior horn of the spinal cord and lower brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:loss of lower alpha-motor neurons in the anterior horn of the spinal cord and lower brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2484. en:loss of motor functions --- r_associated #0: 20 --> en:white substance
    n1=en:loss of motor functions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2485. en:loss of motor milestones --- r_associated #0: 20 --> en:white substance
    n1=en:loss of motor milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2486. en:loss of motor neurons in the anterior horn of the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:loss of motor neurons in the anterior horn of the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2487. en:loss of motor neurons in the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:loss of motor neurons in the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2488. en:loss of motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:loss of motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2489. en:loss of myelin --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2490. en:loss of myelin and oligodendroglia --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelin and oligodendroglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2491. en:loss of myelin in the cerebral and cerebellar white matter --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelin in the cerebral and cerebellar white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2492. en:loss of myelin in the descending lateral spinal cord tracts --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelin in the descending lateral spinal cord tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2493. en:loss of myelin in the pyramidal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelin in the pyramidal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2494. en:loss of myelinated fibers in spinal cord roots --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelinated fibers in spinal cord roots | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2495. en:loss of myelinated fibers with regenerative clusters on biopsy --- r_associated #0: 20 --> en:white substance
    n1=en:loss of myelinated fibers with regenerative clusters on biopsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2496. en:loss of neurons affecting all cortical layers --- r_associated #0: 20 --> en:white substance
    n1=en:loss of neurons affecting all cortical layers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2497. en:loss of neurons and gliosis in basal ganglia, cranial nerve nuclei, and spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:loss of neurons and gliosis in basal ganglia, cranial nerve nuclei, and spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2498. en:loss of pain and temperature in a cape-like distribution --- r_associated #0: 20 --> en:white substance
    n1=en:loss of pain and temperature in a cape-like distribution | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2499. en:loss of pigmented neurons in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:loss of pigmented neurons in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2500. en:loss of postural tone --- r_associated #0: 20 --> en:white substance
    n1=en:loss of postural tone | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2501. en:loss of primary reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:loss of primary reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2502. en:loss of purkinje cells --- r_associated #0: 20 --> en:white substance
    n1=en:loss of purkinje cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2503. en:loss of purkinje cells in the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:loss of purkinje cells in the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2504. en:loss of purkinje cells in the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:loss of purkinje cells in the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2505. en:loss of purposeful hand movements --- r_associated #0: 20 --> en:white substance
    n1=en:loss of purposeful hand movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2506. en:loss of reflexes due to myopathy --- r_associated #0: 20 --> en:white substance
    n1=en:loss of reflexes due to myopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2507. en:loss of speech --- r_associated #0: 20 --> en:white substance
    n1=en:loss of speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2508. en:loss of speech (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:loss of speech (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2509. en:loss of speech development --- r_associated #0: 20 --> en:white substance
    n1=en:loss of speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2510. en:loss of spontaneous movements --- r_associated #0: 20 --> en:white substance
    n1=en:loss of spontaneous movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2511. en:loss of very early milestones --- r_associated #0: 20 --> en:white substance
    n1=en:loss of very early milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2512. en:loss of white matter --- r_associated #0: 20 --> en:white substance
    n1=en:loss of white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2513. en:low apparent diffusion coefficient (adc) values --- r_associated #0: 20 --> en:white substance
    n1=en:low apparent diffusion coefficient (adc) values | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2514. en:low densities in the basal ganglia similar to leigh syndrome (256000) --- r_associated #0: 20 --> en:white substance
    n1=en:low densities in the basal ganglia similar to leigh syndrome (256000) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2515. en:low density white matter on ct scan --- r_associated #0: 20 --> en:white substance
    n1=en:low density white matter on ct scan | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2516. en:low iq --- r_associated #0: 20 --> en:white substance
    n1=en:low iq | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2517. en:low-lying cerebellar tonsils --- r_associated #0: 20 --> en:white substance
    n1=en:low-lying cerebellar tonsils | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2518. en:low-normal intelligence --- r_associated #0: 20 --> en:white substance
    n1=en:low-normal intelligence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2519. en:low-normal iq --- r_associated #0: 20 --> en:white substance
    n1=en:low-normal iq | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2520. en:lower extremity weakness with febrile episodes (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:lower extremity weakness with febrile episodes (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2521. en:lower limb atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2522. en:lower limb dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2523. en:lower limb hyperreflexia --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb hyperreflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2524. en:lower limb hyperreflexia (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb hyperreflexia (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2525. en:lower limb hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2526. en:lower limb hypotrophy --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb hypotrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2527. en:lower limb muscle atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb muscle atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2528. en:lower limb muscle weakness (occurs later) --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb muscle weakness (occurs later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2529. en:lower limb spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2530. en:lower limb spasticity, mild --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb spasticity, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2531. en:lower limb weakness, proximal --- r_associated #0: 20 --> en:white substance
    n1=en:lower limb weakness, proximal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2532. en:lower limbs affected before upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:lower limbs affected before upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2533. en:lower limbs weakness and atrophy, distal --- r_associated #0: 20 --> en:white substance
    n1=en:lower limbs weakness and atrophy, distal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2534. en:lower motor neuron degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2535. en:lower motor neuron disease affecting upper and lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron disease affecting upper and lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2536. en:lower motor neuron dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2537. en:lower motor neuron dysfunction involving upper and lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron dysfunction involving upper and lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2538. en:lower motor neuron involvement after long disease duration --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron involvement after long disease duration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2539. en:lower motor neuron involvement, mild, seen on emg (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron involvement, mild, seen on emg (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2540. en:lower motor neuron signs, later --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron signs, later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2541. en:lower motor neuron symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor neuron symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2542. en:lower motor signs --- r_associated #0: 20 --> en:white substance
    n1=en:lower motor signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2543. en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis --- r_associated #0: 20 --> en:white substance
    n1=en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2544. en:lumbosacral meningocele --- r_associated #0: 20 --> en:white substance
    n1=en:lumbosacral meningocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2545. en:lymphocytic infiltration of the brain --- r_associated #0: 20 --> en:white substance
    n1=en:lymphocytic infiltration of the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2546. en:macrocephaly (due to dandy-walker malformation) --- r_associated #0: 20 --> en:white substance
    n1=en:macrocephaly (due to dandy-walker malformation) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2547. en:macroencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:macroencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2548. en:magnetic resonance spectroscopy (mrs) shows decreased n-acetylaspartic acid in unaffected white matter --- r_associated #0: 20 --> en:white substance
    n1=en:magnetic resonance spectroscopy (mrs) shows decreased n-acetylaspartic acid in unaffected white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2549. en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2550. en:magnetic resonance spectroscopy shows increased lactate in white matter --- r_associated #0: 20 --> en:white substance
    n1=en:magnetic resonance spectroscopy shows increased lactate in white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2551. en:major developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:major developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2552. en:major developmental milestones are not attained --- r_associated #0: 20 --> en:white substance
    n1=en:major developmental milestones are not attained | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2553. en:malformation of the insula --- r_associated #0: 20 --> en:white substance
    n1=en:malformation of the insula | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2554. en:malformation, cerebral arteriovenous --- r_associated #0: 20 --> en:white substance
    n1=en:malformation, cerebral arteriovenous | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2555. en:malformations of cortical development --- r_associated #0: 20 --> en:white substance
    n1=en:malformations of cortical development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2556. en:malformations of cortical development, variable --- r_associated #0: 20 --> en:white substance
    n1=en:malformations of cortical development, variable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2557. en:malformations of the mid- and hindbrain --- r_associated #0: 20 --> en:white substance
    n1=en:malformations of the mid- and hindbrain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2558. en:mandibular dental arcade --- r_associated #0: 20 --> en:white substance
    n1=en:mandibular dental arcade | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2559. en:manic psychosis --- r_associated #0: 20 --> en:white substance
    n1=en:manic psychosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2560. en:markedly delayed nerve conduction velocities --- r_associated #0: 20 --> en:white substance
    n1=en:markedly delayed nerve conduction velocities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2561. en:mask-like facies --- r_associated #0: 20 --> en:white substance
    n1=en:mask-like facies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2562. en:maxillary dental arcade --- r_associated #0: 20 --> en:white substance
    n1=en:maxillary dental arcade | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2563. en:mean sleep latency is less than 5 to 8 minutes --- r_associated #0: 20 --> en:white substance
    n1=en:mean sleep latency is less than 5 to 8 minutes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2564. en:medulloblastoma --- r_associated #0: 20 --> en:white substance
    n1=en:medulloblastoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2565. en:mega cisterna magna --- r_associated #0: 20 --> en:white substance
    n1=en:mega cisterna magna | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2566. en:megacisterna magna (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:megacisterna magna (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2567. en:megacisterna magna (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:megacisterna magna (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2568. en:memory defects --- r_associated #0: 20 --> en:white substance
    n1=en:memory defects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2569. en:memory impairment --- r_associated #0: 20 --> en:white substance
    n1=en:memory impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2570. en:memory impairment, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:memory impairment, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2571. en:memory loss --- r_associated #0: 20 --> en:white substance
    n1=en:memory loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2572. en:meninges --- r_associated #0: 20 --> en:white substance
    n1=en:meninges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2573. en:meningioma --- r_associated #0: 20 --> en:white substance
    n1=en:meningioma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2574. en:meningioma (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:meningioma (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2575. en:meningitis --- r_associated #0: 20 --> en:white substance
    n1=en:meningitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2576. en:meningoceles, multiple, lateral --- r_associated #0: 20 --> en:white substance
    n1=en:meningoceles, multiple, lateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2577. en:meningoencephalitis --- r_associated #0: 20 --> en:white substance
    n1=en:meningoencephalitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2578. en:meningoencephalocele (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:meningoencephalocele (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2579. en:mental deficiency --- r_associated #0: 20 --> en:white substance
    n1=en:mental deficiency | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2580. en:mental delay or retardation (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:mental delay or retardation (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2581. en:mental deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:mental deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2582. en:mental deterioration beginning 2 to 5 years after onset of seizures --- r_associated #0: 20 --> en:white substance
    n1=en:mental deterioration beginning 2 to 5 years after onset of seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2583. en:mental deterioration in a subset of patients --- r_associated #0: 20 --> en:white substance
    n1=en:mental deterioration in a subset of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2584. en:mental deterioration in childhood --- r_associated #0: 20 --> en:white substance
    n1=en:mental deterioration in childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2585. en:mental handicap --- r_associated #0: 20 --> en:white substance
    n1=en:mental handicap | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2586. en:mental impairment --- r_associated #0: 20 --> en:white substance
    n1=en:mental impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2587. en:mental impairment may develop with repeated acute episodes --- r_associated #0: 20 --> en:white substance
    n1=en:mental impairment may develop with repeated acute episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2588. en:mental impairment, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:mental impairment, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2589. en:mental lethargy --- r_associated #0: 20 --> en:white substance
    n1=en:mental lethargy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2590. en:mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2591. en:mental retardation (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2592. en:mental retardation (15%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (15%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2593. en:mental retardation (18% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (18% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2594. en:mental retardation (2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2595. en:mental retardation (2/3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (2/3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2596. en:mental retardation (20%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (20%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2597. en:mental retardation (25%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (25%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2598. en:mental retardation (3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2599. en:mental retardation (30%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (30%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2600. en:mental retardation (31%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (31%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2601. en:mental retardation (38%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (38%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2602. en:mental retardation (47%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (47%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2603. en:mental retardation (50% patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (50% patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2604. en:mental retardation (6%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (6%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2605. en:mental retardation (7%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (7%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2606. en:mental retardation (70%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (70%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2607. en:mental retardation (about 40%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (about 40%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2608. en:mental retardation (average iq 51) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (average iq 51) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2609. en:mental retardation (average iq 56) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (average iq 56) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2610. en:mental retardation (cvs+) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (cvs+) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2611. en:mental retardation (develops later) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (develops later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2612. en:mental retardation (early-onset form) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (early-onset form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2613. en:mental retardation (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2614. en:mental retardation (if untreated in infancy) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (if untreated in infancy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2615. en:mental retardation (in 2 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in 2 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2616. en:mental retardation (in 2 patients) learning disability (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in 2 patients) learning disability (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2617. en:mental retardation (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2618. en:mental retardation (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2619. en:mental retardation (in most) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in most) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2620. en:mental retardation (in some cases) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in some cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2621. en:mental retardation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2622. en:mental retardation (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2623. en:mental retardation (in type iia) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (in type iia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2624. en:mental retardation (iq 20-78) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (iq 20-78) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2625. en:mental retardation (iq 24-85) (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (iq 24-85) (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2626. en:mental retardation (iq 45-75) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (iq 45-75) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2627. en:mental retardation (iq 50-60 combined griffiths and stanford-binet scale) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (iq 50-60 combined griffiths and stanford-binet scale) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2628. en:mental retardation (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2629. en:mental retardation (males) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2630. en:mental retardation (moderate to severe in males) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (moderate to severe in males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2631. en:mental retardation (one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2632. en:mental retardation (one-third) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (one-third) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2633. en:mental retardation (range mild to severe) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (range mild to severe) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2634. en:mental retardation (rare less than 1% of cases) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (rare less than 1% of cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2635. en:mental retardation (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2636. en:mental retardation (rarely noted) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (rarely noted) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2637. en:mental retardation (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2638. en:mental retardation (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2639. en:mental retardation (secondary to intracranial bleed) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (secondary to intracranial bleed) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2640. en:mental retardation (seen in hhs variant) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (seen in hhs variant) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2641. en:mental retardation (some) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2642. en:mental retardation (sometimes) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (sometimes) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2643. en:mental retardation (type i) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (type i) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2644. en:mental retardation (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2645. en:mental retardation (untreated hypothyroidism) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (untreated hypothyroidism) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2646. en:mental retardation (variable expression) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation (variable expression) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2647. en:mental retardation by age 30 years --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation by age 30 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2648. en:mental retardation by the age of 7 years --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation by the age of 7 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2649. en:mental retardation can occur in patients with repeated episodes of dehydration --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation can occur in patients with repeated episodes of dehydration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2650. en:mental retardation due to repeated episodes of hypoglycemia --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation due to repeated episodes of hypoglycemia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2651. en:mental retardation from rapid mental regression --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation from rapid mental regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2652. en:mental retardation has been reported --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation has been reported | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2653. en:mental retardation if untreated --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation if untreated | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2654. en:mental retardation in 5-13% --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation in 5-13% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2655. en:mental retardation in 75% --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation in 75% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2656. en:mental retardation in survivors --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation in survivors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2657. en:mental retardation may occur --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2658. en:mental retardation, borderline (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, borderline (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2659. en:mental retardation, borderline to severe --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, borderline to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2660. en:mental retardation, borderline-mild in carrier females --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, borderline-mild in carrier females | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2661. en:mental retardation, in subgroup of patients --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, in subgroup of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2662. en:mental retardation, mild (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2663. en:mental retardation, mild (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2664. en:mental retardation, mild (10%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (10%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2665. en:mental retardation, mild (11%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (11%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2666. en:mental retardation, mild (18%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (18%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2667. en:mental retardation, mild (2 families) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (2 families) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2668. en:mental retardation, mild (20% have more severe mental retardation) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (20% have more severe mental retardation) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2669. en:mental retardation, mild (carrier females) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (carrier females) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2670. en:mental retardation, mild (in some females) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (in some females) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2671. en:mental retardation, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2672. en:mental retardation, mild (iq range from 50 to 70) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (iq range from 50 to 70) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2673. en:mental retardation, mild (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2674. en:mental retardation, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2675. en:mental retardation, mild to moderate (20% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to moderate (20% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2676. en:mental retardation, mild to moderate (in 12%) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to moderate (in 12%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2677. en:mental retardation, mild to moderate (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to moderate (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2678. en:mental retardation, mild to moderate (iq 30-76) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to moderate (iq 30-76) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2679. en:mental retardation, mild to profound --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2680. en:mental retardation, mild to severe --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2681. en:mental retardation, mild, in most carrier females --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild, in most carrier females | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2682. en:mental retardation, mild, some patients (iq 70-80) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild, some patients (iq 70-80) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2683. en:mental retardation, mild-borderline, nonprogressive --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild-borderline, nonprogressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2684. en:mental retardation, mild-moderate (28%, usually in males) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild-moderate (28%, usually in males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2685. en:mental retardation, mild-moderate (some) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, mild-moderate (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2686. en:mental retardation, moderate (apparent by age 4 years) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate (apparent by age 4 years) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2687. en:mental retardation, moderate (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2688. en:mental retardation, moderate (in sister) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate (in sister) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2689. en:mental retardation, moderate (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2690. en:mental retardation, moderate to profound --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2691. en:mental retardation, moderate to severe --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2692. en:mental retardation, moderate to severe (10-15% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to severe (10-15% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2693. en:mental retardation, moderate to severe (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to severe (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2694. en:mental retardation, moderate to severe (iq 35-50) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to severe (iq 35-50) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2695. en:mental retardation, moderate to severe (iq 40 to 60) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to severe (iq 40 to 60) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2696. en:mental retardation, moderate to severe (type ii, infantile and juvenile) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate to severe (type ii, infantile and juvenile) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2697. en:mental retardation, moderate-severe (2p21del) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, moderate-severe (2p21del) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2698. en:mental retardation, occasional --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, occasional | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2699. en:mental retardation, profound (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, profound (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2700. en:mental retardation, progressive (50% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, progressive (50% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2701. en:mental retardation, residual mild-to-severe (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, residual mild-to-severe (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2702. en:mental retardation, severe (if untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, severe (if untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2703. en:mental retardation, severe (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, severe (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2704. en:mental retardation, severe in some patients --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, severe in some patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2705. en:mental retardation, severe to profound --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, severe to profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2706. en:mental retardation, severe, profound --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, severe, profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2707. en:mental retardation, variable (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, variable (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2708. en:mental retardation, variable degree (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, variable degree (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2709. en:mental retardation, variable severity --- r_associated #0: 20 --> en:white substance
    n1=en:mental retardation, variable severity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2710. en:mesial temporal brain malformations --- r_associated #0: 20 --> en:white substance
    n1=en:mesial temporal brain malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2711. en:mesial temporal sclerosis (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mesial temporal sclerosis (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2712. en:metabolic aspects --- r_associated #0: 20 --> en:white substance
    n1=en:metabolic aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2713. en:microbiological --- r_associated #0: 20 --> en:white substance
    n1=en:microbiological | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2714. en:microbleeds --- r_associated #0: 20 --> en:white substance
    n1=en:microbleeds | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2715. en:microbleeds (most smaller than 5 mm) occur after age 40 years --- r_associated #0: 20 --> en:white substance
    n1=en:microbleeds (most smaller than 5 mm) occur after age 40 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2716. en:microcephaly --- r_associated #0: 20 --> en:white substance
    n1=en:microcephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2717. en:microcystic degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:microcystic degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2718. en:micrographia --- r_associated #0: 20 --> en:white substance
    n1=en:micrographia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2719. en:microgyria --- r_associated #0: 20 --> en:white substance
    n1=en:microgyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2720. en:microlissencephalies --- r_associated #0: 20 --> en:white substance
    n1=en:microlissencephalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2721. en:microvacuolation --- r_associated #0: 20 --> en:white substance
    n1=en:microvacuolation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2722. en:microvascular spaces, dilated --- r_associated #0: 20 --> en:white substance
    n1=en:microvascular spaces, dilated | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2723. en:midbrain atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:midbrain atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2724. en:midline brain calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:midline brain calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2725. en:midline forebrain defects --- r_associated #0: 20 --> en:white substance
    n1=en:midline forebrain defects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2726. en:migraine --- r_associated #0: 20 --> en:white substance
    n1=en:migraine | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2727. en:migraine (40% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine (40% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2728. en:migraine (in affected males) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine (in affected males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2729. en:migraine (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2730. en:migraine (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2731. en:migraine headache (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine headache (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2732. en:migraine headaches (cvs+) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine headaches (cvs+) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2733. en:migraine headaches (ipsilateral to facial hemangioma) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine headaches (ipsilateral to facial hemangioma) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2734. en:migraine headaches (onset in adolescence) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine headaches (onset in adolescence) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2735. en:migraine with aura --- r_associated #0: 20 --> en:white substance
    n1=en:migraine with aura | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2736. en:migraine with aura, usually visual (in 50% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:migraine with aura, usually visual (in 50% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2737. en:migraine without aura --- r_associated #0: 20 --> en:white substance
    n1=en:migraine without aura | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2738. en:migraine, with or without aura --- r_associated #0: 20 --> en:white substance
    n1=en:migraine, with or without aura | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2739. en:migraines (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:migraines (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2740. en:migrating clonic jerks (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:migrating clonic jerks (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2741. en:migrating discharges from one cortical region to another seen on eeg (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:migrating discharges from one cortical region to another seen on eeg (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2742. en:migrating focal discharges from one cortical region to another seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:migrating focal discharges from one cortical region to another seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2743. en:migrating partial seizures --- r_associated #0: 20 --> en:white substance
    n1=en:migrating partial seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2744. en:mild brain anomalies on mri (e.g., dilated ventricles) (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mild brain anomalies on mri (e.g., dilated ventricles) (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2745. en:mild cerebellar hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:mild cerebellar hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2746. en:mild cognitive decline (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mild cognitive decline (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2747. en:mild cognitive deterioration in adults --- r_associated #0: 20 --> en:white substance
    n1=en:mild cognitive deterioration in adults | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2748. en:mild cognitive disorder --- r_associated #0: 20 --> en:white substance
    n1=en:mild cognitive disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2749. en:mild cognitive impairment (in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mild cognitive impairment (in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2750. en:mild cognitive impairment (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mild cognitive impairment (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2751. en:mild cognitive impairment (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:mild cognitive impairment (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2752. en:mild cortical atrophy (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:mild cortical atrophy (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2753. en:mild cortical atrophy on ct or mri --- r_associated #0: 20 --> en:white substance
    n1=en:mild cortical atrophy on ct or mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2754. en:mild distal sensory deficits --- r_associated #0: 20 --> en:white substance
    n1=en:mild distal sensory deficits | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2755. en:mild global developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:mild global developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2756. en:mild loss of neurons in the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:mild loss of neurons in the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2757. en:mild memory loss --- r_associated #0: 20 --> en:white substance
    n1=en:mild memory loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2758. en:mild mental decline --- r_associated #0: 20 --> en:white substance
    n1=en:mild mental decline | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2759. en:mild mental deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:mild mental deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2760. en:mild mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:mild mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2761. en:mild mental retardation (39%) feeding problems/weak suck (43%) --- r_associated #0: 20 --> en:white substance
    n1=en:mild mental retardation (39%) feeding problems/weak suck (43%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2762. en:mild mental retardation (in 1/4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mild mental retardation (in 1/4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2763. en:mild mental retardation (some) --- r_associated #0: 20 --> en:white substance
    n1=en:mild mental retardation (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2764. en:mild motor development delay --- r_associated #0: 20 --> en:white substance
    n1=en:mild motor development delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2765. en:mild paraparesis --- r_associated #0: 20 --> en:white substance
    n1=en:mild paraparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2766. en:mild psychomotor delay --- r_associated #0: 20 --> en:white substance
    n1=en:mild psychomotor delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2767. en:mild pyramidal signs (variable expression) --- r_associated #0: 20 --> en:white substance
    n1=en:mild pyramidal signs (variable expression) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2768. en:mild sensorimotor neuropathy --- r_associated #0: 20 --> en:white substance
    n1=en:mild sensorimotor neuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2769. en:mild spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:mild spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2770. en:mild structural abnormalities seen mri (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mild structural abnormalities seen mri (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2771. en:mild to moderate learning difficulties --- r_associated #0: 20 --> en:white substance
    n1=en:mild to moderate learning difficulties | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2772. en:mild to severe mental retardation (24%) --- r_associated #0: 20 --> en:white substance
    n1=en:mild to severe mental retardation (24%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2773. en:mild upper limb involvement --- r_associated #0: 20 --> en:white substance
    n1=en:mild upper limb involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2774. en:mild-moderate mental retardation (80% affected males) --- r_associated #0: 20 --> en:white substance
    n1=en:mild-moderate mental retardation (80% affected males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2775. en:mild-moderate ventricular dilatation --- r_associated #0: 20 --> en:white substance
    n1=en:mild-moderate ventricular dilatation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2776. en:mild-severe mental retardation (20%) --- r_associated #0: 20 --> en:white substance
    n1=en:mild-severe mental retardation (20%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2777. en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy --- r_associated #0: 20 --> en:white substance
    n1=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2778. en:mildly decreased intelligence has been reported --- r_associated #0: 20 --> en:white substance
    n1=en:mildly decreased intelligence has been reported | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2779. en:mildly delayed developmental milestones --- r_associated #0: 20 --> en:white substance
    n1=en:mildly delayed developmental milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2780. en:mildly delayed motor development --- r_associated #0: 20 --> en:white substance
    n1=en:mildly delayed motor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2781. en:mildly delayed motor development due to vestibular dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:mildly delayed motor development due to vestibular dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2782. en:mildly enlarged ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:mildly enlarged ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2783. en:mildly thin corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:mildly thin corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2784. en:minimal gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:minimal gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2785. en:minimal or lack of speech --- r_associated #0: 20 --> en:white substance
    n1=en:minimal or lack of speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2786. en:minimal to absent speech --- r_associated #0: 20 --> en:white substance
    n1=en:minimal to absent speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2787. en:minor motor impairment (stage 2) --- r_associated #0: 20 --> en:white substance
    n1=en:minor motor impairment (stage 2) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2788. en:mirror hand movements (bimanual synkinesis, in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mirror hand movements (bimanual synkinesis, in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2789. en:mirror movements disorder --- r_associated #0: 20 --> en:white substance
    n1=en:mirror movements disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2790. en:mirror movements, involuntary, affecting the hand and fingers --- r_associated #0: 20 --> en:white substance
    n1=en:mirror movements, involuntary, affecting the hand and fingers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2791. en:mirror movements, involuntary, usually of the upper limb and hand --- r_associated #0: 20 --> en:white substance
    n1=en:mirror movements, involuntary, usually of the upper limb and hand | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2792. en:misorientation of pyramidal fibers --- r_associated #0: 20 --> en:white substance
    n1=en:misorientation of pyramidal fibers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2793. en:misshapen posterior fossa --- r_associated #0: 20 --> en:white substance
    n1=en:misshapen posterior fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2794. en:mitochondrial dna depletion in brain tissue --- r_associated #0: 20 --> en:white substance
    n1=en:mitochondrial dna depletion in brain tissue | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2795. en:mitochondrial encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:mitochondrial encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2796. en:mixed cerebellar/pseudobulbar dysarthria --- r_associated #0: 20 --> en:white substance
    n1=en:mixed cerebellar/pseudobulbar dysarthria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2797. en:mobility poor --- r_associated #0: 20 --> en:white substance
    n1=en:mobility poor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2798. en:mobius syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:mobius syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2799. en:moderate cortical atrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:moderate cortical atrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2800. en:moderate learning difficulties --- r_associated #0: 20 --> en:white substance
    n1=en:moderate learning difficulties | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2801. en:moderate mental retardation (i.q. 35-49) --- r_associated #0: 20 --> en:white substance
    n1=en:moderate mental retardation (i.q. 35-49) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2802. en:moderate to severe hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:moderate to severe hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2803. en:moderately thickened cortex --- r_associated #0: 20 --> en:white substance
    n1=en:moderately thickened cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2804. en:molar tooth sign on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:molar tooth sign on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2805. en:molar tooth sign on brain mri (subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:molar tooth sign on brain mri (subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2806. en:molar tooth sign on mri --- r_associated #0: 20 --> en:white substance
    n1=en:molar tooth sign on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2807. en:molar tooth sign seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:molar tooth sign seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2808. en:monopareses --- r_associated #0: 20 --> en:white substance
    n1=en:monopareses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2809. en:monotone speech --- r_associated #0: 20 --> en:white substance
    n1=en:monotone speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2810. en:monotonous speech --- r_associated #0: 20 --> en:white substance
    n1=en:monotonous speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2811. en:mood lability --- r_associated #0: 20 --> en:white substance
    n1=en:mood lability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2812. en:morning myoclonic jerks --- r_associated #0: 20 --> en:white substance
    n1=en:morning myoclonic jerks | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2813. en:moro reflex absent --- r_associated #0: 20 --> en:white substance
    n1=en:moro reflex absent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2814. en:most never acquire independent ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:most never acquire independent ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2815. en:most patients achieve walking with aid --- r_associated #0: 20 --> en:white substance
    n1=en:most patients achieve walking with aid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2816. en:most patients are wheelchair-bound --- r_associated #0: 20 --> en:white substance
    n1=en:most patients are wheelchair-bound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2817. en:most patients do not achieve independent sitting or walking --- r_associated #0: 20 --> en:white substance
    n1=en:most patients do not achieve independent sitting or walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2818. en:most patients remain stable or improve in years after the abrupt onset of symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:most patients remain stable or improve in years after the abrupt onset of symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2819. en:mosy patients become wheelchair-bound after 10 years --- r_associated #0: 20 --> en:white substance
    n1=en:mosy patients become wheelchair-bound after 10 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2820. en:motor abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:motor abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2821. en:motor and intellectual disability, severe --- r_associated #0: 20 --> en:white substance
    n1=en:motor and intellectual disability, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2822. en:motor and vocal tics --- r_associated #0: 20 --> en:white substance
    n1=en:motor and vocal tics | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2823. en:motor automatisms --- r_associated #0: 20 --> en:white substance
    n1=en:motor automatisms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2824. en:motor delay (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:motor delay (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2825. en:motor deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:motor deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2826. en:motor deterioration in second decade --- r_associated #0: 20 --> en:white substance
    n1=en:motor deterioration in second decade | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2827. en:motor development delay (83%) --- r_associated #0: 20 --> en:white substance
    n1=en:motor development delay (83%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2828. en:motor development delayed (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:motor development delayed (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2829. en:motor developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:motor developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2830. en:motor developmental delay, severe --- r_associated #0: 20 --> en:white substance
    n1=en:motor developmental delay, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2831. en:motor disturbances --- r_associated #0: 20 --> en:white substance
    n1=en:motor disturbances | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2832. en:motor dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:motor dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2833. en:motor dyspraxia --- r_associated #0: 20 --> en:white substance
    n1=en:motor dyspraxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2834. en:motor incoordination --- r_associated #0: 20 --> en:white substance
    n1=en:motor incoordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2835. en:motor neuron disease --- r_associated #0: 20 --> en:white substance
    n1=en:motor neuron disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2836. en:motor neuron disease (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:motor neuron disease (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2837. en:motor neuron disease, lower --- r_associated #0: 20 --> en:white substance
    n1=en:motor neuron disease, lower | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2838. en:motor regression --- r_associated #0: 20 --> en:white substance
    n1=en:motor regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2839. en:motor retardation, mild --- r_associated #0: 20 --> en:white substance
    n1=en:motor retardation, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2840. en:motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening --- r_associated #0: 20 --> en:white substance
    n1=en:motor seizures, nocturnal, usually occur in clusters (up to 8 per night) during dozing or on awakening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2841. en:motor stereotypy --- r_associated #0: 20 --> en:white substance
    n1=en:motor stereotypy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2842. en:motor symptoms may be present --- r_associated #0: 20 --> en:white substance
    n1=en:motor symptoms may be present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2843. en:motor tic --- r_associated #0: 20 --> en:white substance
    n1=en:motor tic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2844. en:mouth movements --- r_associated #0: 20 --> en:white substance
    n1=en:mouth movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2845. en:movement abnormalities of the extremities --- r_associated #0: 20 --> en:white substance
    n1=en:movement abnormalities of the extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2846. en:movement disorder --- r_associated #0: 20 --> en:white substance
    n1=en:movement disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2847. en:movement of visual image - finding --- r_associated #0: 20 --> en:white substance
    n1=en:movement of visual image - finding | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2848. en:movements ('tremors') characterized by 8 to 10-hz discharges --- r_associated #0: 20 --> en:white substance
    n1=en:movements ('tremors') characterized by 8 to 10-hz discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2849. en:movements are exacerbated by anxiety --- r_associated #0: 20 --> en:white substance
    n1=en:movements are exacerbated by anxiety | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2850. en:moyamoya disease --- r_associated #0: 20 --> en:white substance
    n1=en:moyamoya disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2851. en:mr spectroscopy shows decreased n-acetyl aspartate --- r_associated #0: 20 --> en:white substance
    n1=en:mr spectroscopy shows decreased n-acetyl aspartate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2852. en:mri - diffuse or focal cerebral and cerebellar white matter disease --- r_associated #0: 20 --> en:white substance
    n1=en:mri - diffuse or focal cerebral and cerebellar white matter disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2853. en:mri imaging shows cavitation of the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:mri imaging shows cavitation of the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2854. en:mri is best imaging modality to detect lesions --- r_associated #0: 20 --> en:white substance
    n1=en:mri is best imaging modality to detect lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2855. en:mri may be normal, especially in type iib --- r_associated #0: 20 --> en:white substance
    n1=en:mri may be normal, especially in type iib | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2856. en:mri may show atrophy of the cerebrum --- r_associated #0: 20 --> en:white substance
    n1=en:mri may show atrophy of the cerebrum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2857. en:mri may show lesions in basal ganglia, thalamus, and white matter --- r_associated #0: 20 --> en:white substance
    n1=en:mri may show lesions in basal ganglia, thalamus, and white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2858. en:mri shows absence of the facial nerve --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows absence of the facial nerve | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2859. en:mri shows atretic occipital cephalocele with bony skull defect --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows atretic occipital cephalocele with bony skull defect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2860. en:mri shows brain asymmetry --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows brain asymmetry | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2861. en:mri shows brainstem hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows brainstem hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2862. en:mri shows cerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows cerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2863. en:mri shows cerebral atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows cerebral atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2864. en:mri shows congenital abnormalities of the posterior fossa --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows congenital abnormalities of the posterior fossa | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2865. en:mri shows decreased signal intensities in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows decreased signal intensities in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2866. en:mri shows decreased signal intensity in the pallidal nuclei with central hyperintensity ('eye of the tiger' sign) --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows decreased signal intensity in the pallidal nuclei with central hyperintensity ('eye of the tiger' sign) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2867. en:mri shows defects of the corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows defects of the corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2868. en:mri shows delayed myelination (1 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows delayed myelination (1 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2869. en:mri shows diffuse white matter hyperintensities on t2-weighted imaging --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows diffuse white matter hyperintensities on t2-weighted imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2870. en:mri shows dysmyelination --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows dysmyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2871. en:mri shows frontal and temporal cortical atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows frontal and temporal cortical atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2872. en:mri shows generalized atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows generalized atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2873. en:mri shows global lack of myelination in the cerebral hemispheres --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows global lack of myelination in the cerebral hemispheres | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2874. en:mri shows globus pallidus signal abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows globus pallidus signal abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2875. en:mri shows high signal intensity of the white matter later --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows high signal intensity of the white matter later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2876. en:mri shows hypointensity of the thalami early-on --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows hypointensity of the thalami early-on | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2877. en:mri shows increased t2-weighted signals in the globus pallidi --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows increased t2-weighted signals in the globus pallidi | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2878. en:mri shows leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2879. en:mri shows no normal myelination --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows no normal myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2880. en:mri shows short, thick corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows short, thick corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2881. en:mri shows subcortical leukoencephalopathy with cavitation --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows subcortical leukoencephalopathy with cavitation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2882. en:mri shows symmetric lesions of the basal ganglia (particularly caudate and putamen) --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows symmetric lesions of the basal ganglia (particularly caudate and putamen) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2883. en:mri shows symmetric, diffuse lesions with csf-like signal intensity --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows symmetric, diffuse lesions with csf-like signal intensity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2884. en:mri shows t2-weighted signals in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows t2-weighted signals in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2885. en:mri shows white matter lesions --- r_associated #0: 20 --> en:white substance
    n1=en:mri shows white matter lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2886. en:mrs shows decreased choline in affected white matter --- r_associated #0: 20 --> en:white substance
    n1=en:mrs shows decreased choline in affected white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2887. en:mrs shows decreased creatine in white matter --- r_associated #0: 20 --> en:white substance
    n1=en:mrs shows decreased creatine in white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2888. en:multifocal areas of laminar dysmorphic neurons (in type iia) --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal areas of laminar dysmorphic neurons (in type iia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2889. en:multifocal cerebral white matter abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal cerebral white matter abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2890. en:multifocal discharges --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2891. en:multifocal discharges associated with contralateral jerky movements --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal discharges associated with contralateral jerky movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2892. en:multifocal discharges seen on eeg (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal discharges seen on eeg (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2893. en:multifocal epileptic activity --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal epileptic activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2894. en:multifocal epileptiform discharges on diffuse slow background --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal epileptiform discharges on diffuse slow background | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2895. en:multifocal epileptiform spikes seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal epileptiform spikes seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2896. en:multifocal intractable seizures --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal intractable seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2897. en:multifocal seizure --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2898. en:multifocal spike and wave activity --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal spike and wave activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2899. en:multifocal spike waves --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal spike waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2900. en:multifocal spikes --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal spikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2901. en:multifocal spikes and progressive slowing of background activity seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal spikes and progressive slowing of background activity seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2902. en:multifocal white matter lesions --- r_associated #0: 20 --> en:white substance
    n1=en:multifocal white matter lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2903. en:multiple aneurysms --- r_associated #0: 20 --> en:white substance
    n1=en:multiple aneurysms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2904. en:multiple independent spike foci --- r_associated #0: 20 --> en:white substance
    n1=en:multiple independent spike foci | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2905. en:multiple lesions in the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:multiple lesions in the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2906. en:multiple sclerosis-like illness (516003.0001) --- r_associated #0: 20 --> en:white substance
    n1=en:multiple sclerosis-like illness (516003.0001) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2907. en:muscle atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:muscle atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2908. en:muscle biopsy shows neurogenic changes --- r_associated #0: 20 --> en:white substance
    n1=en:muscle biopsy shows neurogenic changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2909. en:muscle cramp --- r_associated #0: 20 --> en:white substance
    n1=en:muscle cramp | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2910. en:muscle stiffness and rigidity, chronic, fluctuating --- r_associated #0: 20 --> en:white substance
    n1=en:muscle stiffness and rigidity, chronic, fluctuating | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2911. en:muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2912. en:muscle weakness lower limb --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness lower limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2913. en:muscle weakness of limb --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness of limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2914. en:muscle weakness, distal (lower limbs more affected than upper limbs), due to motor neuronopathy --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness, distal (lower limbs more affected than upper limbs), due to motor neuronopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2915. en:muscle weakness, distal, upper and lower --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness, distal, upper and lower | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2916. en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2917. en:muscle weakness, proximal, symmetric (lower limbs more affected than upper limbs) due to motor neuronopathy --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness, proximal, symmetric (lower limbs more affected than upper limbs) due to motor neuronopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2918. en:muscle weakness, symmetric, proximal due to motor neuronopathy --- r_associated #0: 20 --> en:white substance
    n1=en:muscle weakness, symmetric, proximal due to motor neuronopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2919. en:muscular hypotonia of the trunk --- r_associated #0: 20 --> en:white substance
    n1=en:muscular hypotonia of the trunk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2920. en:muscular rigidity --- r_associated #0: 20 --> en:white substance
    n1=en:muscular rigidity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2921. en:musician's cramp --- r_associated #0: 20 --> en:white substance
    n1=en:musician's cramp | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2922. en:mutism --- r_associated #0: 20 --> en:white substance
    n1=en:mutism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2923. en:myclonus (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:myclonus (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2924. en:myelin loss in the corticospinal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:myelin loss in the corticospinal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2925. en:myelin microvacuolation --- r_associated #0: 20 --> en:white substance
    n1=en:myelin microvacuolation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2926. en:myelin sheath --- r_associated #0: 20 --> en:white substance
    n1=en:myelin sheath | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2927. en:myelin-like lamellar structures in schwann cells --- r_associated #0: 20 --> en:white substance
    n1=en:myelin-like lamellar structures in schwann cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2928. en:myelinated nerve fiber --- r_associated #0: 20 --> en:white substance
    n1=en:myelinated nerve fiber | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2929. en:myelination defect --- r_associated #0: 20 --> en:white substance
    n1=en:myelination defect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2930. en:myelination defects (type ii) --- r_associated #0: 20 --> en:white substance
    n1=en:myelination defects (type ii) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2931. en:myelomeningocele --- r_associated #0: 20 --> en:white substance
    n1=en:myelomeningocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2932. en:myelomeningocele (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:myelomeningocele (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2933. en:myelomeningocele (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:myelomeningocele (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2934. en:myoclonic epilepsy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic epilepsy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2935. en:myoclonic jerk --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic jerk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2936. en:myoclonic jerks (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic jerks (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2937. en:myoclonic jerks (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic jerks (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2938. en:myoclonic seizure, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic seizure, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2939. en:myoclonic seizures (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic seizures (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2940. en:myoclonic seizures (subtype 3a) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic seizures (subtype 3a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2941. en:myoclonic seizures may occur --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic seizures may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2942. en:myoclonic seizures, frequent, long-lasting (many hours) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic seizures, frequent, long-lasting (many hours) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2943. en:myoclonic seizures, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic seizures, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2944. en:myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic spasms, superimposed episodic, severe, painful (characterized by activation of antagonistic muscle pairs, may involve facial muscles) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2945. en:myoclonic-astatic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonic-astatic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2946. en:myoclonus (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2947. en:myoclonus (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2948. en:myoclonus (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2949. en:myoclonus (subtype 3a) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus (subtype 3a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2950. en:myoclonus (type i and type ii, infantile and juvenile) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus (type i and type ii, infantile and juvenile) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2951. en:myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture) --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus, axial (predominantly in upper limbs, occurs at rest and increases with activity or changes in posture) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2952. en:myoclonus, cortical, multifocal --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus, cortical, multifocal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2953. en:myoclonus, paroxysmal --- r_associated #0: 20 --> en:white substance
    n1=en:myoclonus, paroxysmal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2954. en:myokymia --- r_associated #0: 20 --> en:white substance
    n1=en:myokymia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2955. en:myokymia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:myokymia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2956. en:myokymia, especially facial --- r_associated #0: 20 --> en:white substance
    n1=en:myokymia, especially facial | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2957. en:myopathy --- r_associated #0: 20 --> en:white substance
    n1=en:myopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2958. en:myotonia --- r_associated #0: 20 --> en:white substance
    n1=en:myotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2959. en:myotonia (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:myotonia (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2960. en:myotonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:myotonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2961. en:narcolepsy --- r_associated #0: 20 --> en:white substance
    n1=en:narcolepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2962. en:neck drop --- r_associated #0: 20 --> en:white substance
    n1=en:neck drop | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2963. en:neck pain --- r_associated #0: 20 --> en:white substance
    n1=en:neck pain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2964. en:necrotic process --- r_associated #0: 20 --> en:white substance
    n1=en:necrotic process | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2965. en:necrotic white matter lesions throughout the brain and brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:necrotic white matter lesions throughout the brain and brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2966. en:neocortical atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:neocortical atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2967. en:neocortical dysplasia (27%) --- r_associated #0: 20 --> en:white substance
    n1=en:neocortical dysplasia (27%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2968. en:neonatal epileptic encephalopathy (nee) --- r_associated #0: 20 --> en:white substance
    n1=en:neonatal epileptic encephalopathy (nee) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2969. en:neonatal hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:neonatal hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2970. en:neonatal irresponsiveness --- r_associated #0: 20 --> en:white substance
    n1=en:neonatal irresponsiveness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2971. en:neonatal irritability --- r_associated #0: 20 --> en:white substance
    n1=en:neonatal irritability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2972. en:neonatal/early-infantile onset encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:neonatal/early-infantile onset encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2973. en:nerve cells show ballooning with membrane-bound vesicles with reticulogranular pattern --- r_associated #0: 20 --> en:white substance
    n1=en:nerve cells show ballooning with membrane-bound vesicles with reticulogranular pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2974. en:nerve degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:nerve degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2975. en:nerve fasciculus --- r_associated #0: 20 --> en:white substance
    n1=en:nerve fasciculus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2976. en:nerve paralysis --- r_associated #0: 20 --> en:white substance
    n1=en:nerve paralysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2977. en:nervousness --- r_associated #0: 20 --> en:white substance
    n1=en:nervousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2978. en:neural ganglion or nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:neural ganglion or nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2979. en:neural tissue of brain --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2980. en:neural tissue of nerve --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of nerve | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2981. en:neural tissue of neural tree organ --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of neural tree organ | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2982. en:neural tissue of neuraxis --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of neuraxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2983. en:neural tissue of peripheral ganglion --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of peripheral ganglion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2984. en:neural tissue of segment of brain --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of segment of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2985. en:neural tissue of segment of spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of segment of spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2986. en:neural tissue of spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2987. en:neural tissue of subsegment of spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:neural tissue of subsegment of spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2988. en:neural tube defect (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:neural tube defect (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2989. en:neural tube defects (4%) --- r_associated #0: 20 --> en:white substance
    n1=en:neural tube defects (4%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2990. en:neural tube defects may occur --- r_associated #0: 20 --> en:white substance
    n1=en:neural tube defects may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2991. en:neuroaxonal abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:neuroaxonal abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2992. en:neuroaxonal dystrophies --- r_associated #0: 20 --> en:white substance
    n1=en:neuroaxonal dystrophies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2993. en:neuroaxonal spheroids --- r_associated #0: 20 --> en:white substance
    n1=en:neuroaxonal spheroids | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2994. en:neurobehavioral changes associated with hyperammonemia --- r_associated #0: 20 --> en:white substance
    n1=en:neurobehavioral changes associated with hyperammonemia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2995. en:neurocognitive impairment, mild (homozygous patient) --- r_associated #0: 20 --> en:white substance
    n1=en:neurocognitive impairment, mild (homozygous patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2996. en:neurodegeneration (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:neurodegeneration (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2997. en:neurodegeneration in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:neurodegeneration in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2998. en:neurodegeneration in the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:neurodegeneration in the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  2999. en:neurodegeneration in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:neurodegeneration in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3000. en:neurodegeneration leading to profound mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:neurodegeneration leading to profound mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3001. en:neurodevelopmental impairment (early-onset form) --- r_associated #0: 20 --> en:white substance
    n1=en:neurodevelopmental impairment (early-onset form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3002. en:neurodevelopmental regression --- r_associated #0: 20 --> en:white substance
    n1=en:neurodevelopmental regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3003. en:neurofibrillary degeneration (morphologic abnormality) --- r_associated #0: 20 --> en:white substance
    n1=en:neurofibrillary degeneration (morphologic abnormality) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3004. en:neurofibrillary mapt (tau)-positive tangles --- r_associated #0: 20 --> en:white substance
    n1=en:neurofibrillary mapt (tau)-positive tangles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3005. en:neurofibrillary tangles composed of disordered microtubules --- r_associated #0: 20 --> en:white substance
    n1=en:neurofibrillary tangles composed of disordered microtubules | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3006. en:neurofibrillary tangles may be present --- r_associated #0: 20 --> en:white substance
    n1=en:neurofibrillary tangles may be present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3007. en:neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels --- r_associated #0: 20 --> en:white substance
    n1=en:neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3008. en:neurogenic bladder --- r_associated #0: 20 --> en:white substance
    n1=en:neurogenic bladder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3009. en:neurogenic muscle atrophy, especially in the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:neurogenic muscle atrophy, especially in the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3010. en:neuroimaging shows cortical atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:neuroimaging shows cortical atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3011. en:neurologia --- r_associated #0: 20 --> en:white substance
    n1=en:neurologia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3012. en:neurologic abnormalities in about 7% --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic abnormalities in about 7% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3013. en:neurologic crises with coma (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic crises with coma (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3014. en:neurologic decompensation --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic decompensation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3015. en:neurologic degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3016. en:neurologic deterioration in longterm survivors --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic deterioration in longterm survivors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3017. en:neurologic dysfunction, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic dysfunction, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3018. en:neurologic involvement (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic involvement (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3019. en:neurologic involvement is rare --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic involvement is rare | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3020. en:neurologic regression --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3021. en:neurologic regression after age 2 years --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic regression after age 2 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3022. en:neurologic regression after prolonged episodes --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic regression after prolonged episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3023. en:neurologic regression around age 3 months --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic regression around age 3 months | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3024. en:neurologic regression following seizure onset --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic regression following seizure onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3025. en:neurologic sequelae not always present --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic sequelae not always present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3026. en:neurologic sequelae of stroke --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic sequelae of stroke | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3027. en:neurologic symptoms, if present, usually result from associated syringomyelia --- r_associated #0: 20 --> en:white substance
    n1=en:neurologic symptoms, if present, usually result from associated syringomyelia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3028. en:neuromuscular disturbances, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:neuromuscular disturbances, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3029. en:neuron apoptotic process --- r_associated #0: 20 --> en:white substance
    n1=en:neuron apoptotic process | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3030. en:neuron covering --- r_associated #0: 20 --> en:white substance
    n1=en:neuron covering | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3031. en:neuron loss --- r_associated #0: 20 --> en:white substance
    n1=en:neuron loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3032. en:neuronal and vascular calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal and vascular calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3033. en:neuronal heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3034. en:neuronal inclusion bodies stain for neuroserpin --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal inclusion bodies stain for neuroserpin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3035. en:neuronal loss (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3036. en:neuronal loss and gliosis in caudate and putamen --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss and gliosis in caudate and putamen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3037. en:neuronal loss and gliosis in the cerebral cortex --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss and gliosis in the cerebral cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3038. en:neuronal loss and gliosis in the dentate nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss and gliosis in the dentate nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3039. en:neuronal loss and gliosis in the inferior olives --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss and gliosis in the inferior olives | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3040. en:neuronal loss and gliosis in the substantia nigra pars compacta --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss and gliosis in the substantia nigra pars compacta | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3041. en:neuronal loss in basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3042. en:neuronal loss in central nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in central nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3043. en:neuronal loss in the brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3044. en:neuronal loss in the cerebral cortex --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the cerebral cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3045. en:neuronal loss in the cerebrum and cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the cerebrum and cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3046. en:neuronal loss in the dentate nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the dentate nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3047. en:neuronal loss in the hippocampus --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the hippocampus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3048. en:neuronal loss in the inferior olives --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the inferior olives | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3049. en:neuronal loss in the locus ceruleus --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the locus ceruleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3050. en:neuronal loss in the purkinje cell layer of the cerebellar vermis --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the purkinje cell layer of the cerebellar vermis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3051. en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3052. en:neuronal loss in the striatum, medial thalamic nuclei, and inferior olives --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the striatum, medial thalamic nuclei, and inferior olives | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3053. en:neuronal loss in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3054. en:neuronal loss, diffuse --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss, diffuse | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3055. en:neuronal loss, particularly of cerebellar purkinje cells --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal loss, particularly of cerebellar purkinje cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3056. en:neuronal migration defect --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal migration defect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3057. en:neuronal migration disorder --- r_associated #0: 20 --> en:white substance
    n1=en:neuronal migration disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3058. en:neuropathologic examination shows calcification of the small brain vessels --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathologic examination shows calcification of the small brain vessels | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3059. en:neuropathologic examination shows extensive spongiosis and gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathologic examination shows extensive spongiosis and gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3060. en:neuropathologic examination shows severe demyelination --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathologic examination shows severe demyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3061. en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially) --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3062. en:neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3063. en:neuropathology shows diffuse demyelination of the cerebral white matter --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathology shows diffuse demyelination of the cerebral white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3064. en:neuropathology shows fmr1 mrna-positive inclusions in neurons and astrocytes --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathology shows fmr1 mrna-positive inclusions in neurons and astrocytes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3065. en:neuropathology shows neuronal degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathology shows neuronal degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3066. en:neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3067. en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3068. en:neurophysiologic abnormalities (eeg, sep, vep) --- r_associated #0: 20 --> en:white substance
    n1=en:neurophysiologic abnormalities (eeg, sep, vep) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3069. en:neurophysiologic abnormalities (eeg, vep, sep) --- r_associated #0: 20 --> en:white substance
    n1=en:neurophysiologic abnormalities (eeg, vep, sep) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3070. en:neurophysiologic studies show evidence of denervation and renervation --- r_associated #0: 20 --> en:white substance
    n1=en:neurophysiologic studies show evidence of denervation and renervation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3071. en:neuropil --- r_associated #0: 20 --> en:white substance
    n1=en:neuropil | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3072. en:neuropsychologic cognitive abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:neuropsychologic cognitive abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3073. en:neuropsychologic impairment --- r_associated #0: 20 --> en:white substance
    n1=en:neuropsychologic impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3074. en:neurosarcoidosis (5-16% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:neurosarcoidosis (5-16% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3075. en:neurosis --- r_associated #0: 20 --> en:white substance
    n1=en:neurosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3076. en:never able to walk --- r_associated #0: 20 --> en:white substance
    n1=en:never able to walk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3077. en:never learn to walk (some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:never learn to walk (some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3078. en:nigrostriatal degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:nigrostriatal degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3079. en:no amyloid plaques --- r_associated #0: 20 --> en:white substance
    n1=en:no amyloid plaques | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3080. en:no autistic features --- r_associated #0: 20 --> en:white substance
    n1=en:no autistic features | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3081. en:no bulbar involvement --- r_associated #0: 20 --> en:white substance
    n1=en:no bulbar involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3082. en:no central nervous system abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:no central nervous system abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3083. en:no cerebellar signs --- r_associated #0: 20 --> en:white substance
    n1=en:no cerebellar signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3084. en:no cerebellar vermis aplasia/hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:no cerebellar vermis aplasia/hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3085. en:no cognitive decline --- r_associated #0: 20 --> en:white substance
    n1=en:no cognitive decline | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3086. en:no dementia --- r_associated #0: 20 --> en:white substance
    n1=en:no dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3087. en:no development --- r_associated #0: 20 --> en:white substance
    n1=en:no development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3088. en:no developmental progress --- r_associated #0: 20 --> en:white substance
    n1=en:no developmental progress | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3089. en:no gaze contact --- r_associated #0: 20 --> en:white substance
    n1=en:no gaze contact | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3090. en:no head control --- r_associated #0: 20 --> en:white substance
    n1=en:no head control | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3091. en:no hippocampal sclerosis --- r_associated #0: 20 --> en:white substance
    n1=en:no hippocampal sclerosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3092. en:no hydrocephalus --- r_associated #0: 20 --> en:white substance
    n1=en:no hydrocephalus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3093. en:no language --- r_associated #0: 20 --> en:white substance
    n1=en:no language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3094. en:no language development --- r_associated #0: 20 --> en:white substance
    n1=en:no language development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3095. en:no lewy bodies --- r_associated #0: 20 --> en:white substance
    n1=en:no lewy bodies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3096. en:no mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:no mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3097. en:no motor skills acquired (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:no motor skills acquired (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3098. en:no myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:no myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3099. en:no neurofibrillary tangles --- r_associated #0: 20 --> en:white substance
    n1=en:no neurofibrillary tangles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3100. en:no neurofibromas --- r_associated #0: 20 --> en:white substance
    n1=en:no neurofibromas | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3101. en:no other neurologic deficits --- r_associated #0: 20 --> en:white substance
    n1=en:no other neurologic deficits | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3102. en:no other neurologic disorder --- r_associated #0: 20 --> en:white substance
    n1=en:no other neurologic disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3103. en:no overt seizures --- r_associated #0: 20 --> en:white substance
    n1=en:no overt seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3104. en:no pick bodies or lewy bodies --- r_associated #0: 20 --> en:white substance
    n1=en:no pick bodies or lewy bodies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3105. en:no response to l-dopa treatment --- r_associated #0: 20 --> en:white substance
    n1=en:no response to l-dopa treatment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3106. en:no seizures --- r_associated #0: 20 --> en:white substance
    n1=en:no seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3107. en:no seizures (hcs) --- r_associated #0: 20 --> en:white substance
    n1=en:no seizures (hcs) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3108. en:no sensory deficit --- r_associated #0: 20 --> en:white substance
    n1=en:no sensory deficit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3109. en:no sensory symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:no sensory symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3110. en:no speech acquisition --- r_associated #0: 20 --> en:white substance
    n1=en:no speech acquisition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3111. en:no speech development (in most patients) --- r_associated #0: 20 --> en:white substance
    n1=en:no speech development (in most patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3112. en:no speech problem --- r_associated #0: 20 --> en:white substance
    n1=en:no speech problem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3113. en:no spontaneous movements --- r_associated #0: 20 --> en:white substance
    n1=en:no spontaneous movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3114. en:no structural brain abnormalities seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:no structural brain abnormalities seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3115. en:no structural brain anomalies --- r_associated #0: 20 --> en:white substance
    n1=en:no structural brain anomalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3116. en:no tau pathology --- r_associated #0: 20 --> en:white substance
    n1=en:no tau pathology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3117. en:no tremor --- r_associated #0: 20 --> en:white substance
    n1=en:no tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3118. en:no visual fixation --- r_associated #0: 20 --> en:white substance
    n1=en:no visual fixation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3119. en:no voluntary movement --- r_associated #0: 20 --> en:white substance
    n1=en:no voluntary movement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3120. en:nocturnal occurrence --- r_associated #0: 20 --> en:white substance
    n1=en:nocturnal occurrence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3121. en:nocturnal occurrence, usually during light sleep --- r_associated #0: 20 --> en:white substance
    n1=en:nocturnal occurrence, usually during light sleep | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3122. en:nocturnal seizures --- r_associated #0: 20 --> en:white substance
    n1=en:nocturnal seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3123. en:nocturnal seizures (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:nocturnal seizures (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3124. en:nocturnal sleep disruption --- r_associated #0: 20 --> en:white substance
    n1=en:nocturnal sleep disruption | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3125. en:nodding of head --- r_associated #0: 20 --> en:white substance
    n1=en:nodding of head | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3126. en:nodular heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:nodular heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3127. en:nodular heterotopia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:nodular heterotopia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3128. en:nodular heterotopia (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:nodular heterotopia (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3129. en:nodular heterotopia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:nodular heterotopia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3130. en:nodular heterotopia of the grey matter --- r_associated #0: 20 --> en:white substance
    n1=en:nodular heterotopia of the grey matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3131. en:non-febrile seizures later --- r_associated #0: 20 --> en:white substance
    n1=en:non-febrile seizures later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3132. en:non-purposeful arm movements, choreoathetoid-like --- r_associated #0: 20 --> en:white substance
    n1=en:non-purposeful arm movements, choreoathetoid-like | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3133. en:nonprogressive cerebellar ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:nonprogressive cerebellar ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3134. en:nonspecific leukoencephalopathy (52%) --- r_associated #0: 20 --> en:white substance
    n1=en:nonspecific leukoencephalopathy (52%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3135. en:nonspecific spongiform degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:nonspecific spongiform degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3136. en:nonverbal (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:nonverbal (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3137. en:normal brain mri or ct scan --- r_associated #0: 20 --> en:white substance
    n1=en:normal brain mri or ct scan | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3138. en:normal cognition (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:normal cognition (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3139. en:normal cognition (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:normal cognition (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3140. en:normal cognition (reported in 1 patient who survived to age 20 years) --- r_associated #0: 20 --> en:white substance
    n1=en:normal cognition (reported in 1 patient who survived to age 20 years) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3141. en:normal cognition (reported in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:normal cognition (reported in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3142. en:normal cognition and intellectual function --- r_associated #0: 20 --> en:white substance
    n1=en:normal cognition and intellectual function | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3143. en:normal development --- r_associated #0: 20 --> en:white substance
    n1=en:normal development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3144. en:normal development (in 2 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:normal development (in 2 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3145. en:normal development in some patients --- r_associated #0: 20 --> en:white substance
    n1=en:normal development in some patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3146. en:normal development until 6-18 months --- r_associated #0: 20 --> en:white substance
    n1=en:normal development until 6-18 months | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3147. en:normal early development --- r_associated #0: 20 --> en:white substance
    n1=en:normal early development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3148. en:normal early development, up to 8 to 15 months of age --- r_associated #0: 20 --> en:white substance
    n1=en:normal early development, up to 8 to 15 months of age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3149. en:normal early developmental milestones --- r_associated #0: 20 --> en:white substance
    n1=en:normal early developmental milestones | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3150. en:normal early psychomotor development --- r_associated #0: 20 --> en:white substance
    n1=en:normal early psychomotor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3151. en:normal fine motor activity --- r_associated #0: 20 --> en:white substance
    n1=en:normal fine motor activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3152. en:normal initial psychomotor development --- r_associated #0: 20 --> en:white substance
    n1=en:normal initial psychomotor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3153. en:normal intellectual development --- r_associated #0: 20 --> en:white substance
    n1=en:normal intellectual development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3154. en:normal intellectual function --- r_associated #0: 20 --> en:white substance
    n1=en:normal intellectual function | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3155. en:normal intelligence (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3156. en:normal intelligence (majority) --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence (majority) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3157. en:normal intelligence in carrier females --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence in carrier females | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3158. en:normal intelligence in iib --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence in iib | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3159. en:normal intelligence in majority --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence in majority | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3160. en:normal intelligence in most cases --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence in most cases | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3161. en:normal intelligence to mild or moderate mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:normal intelligence to mild or moderate mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3162. en:normal interictal eeg --- r_associated #0: 20 --> en:white substance
    n1=en:normal interictal eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3163. en:normal interictal neurologic examination --- r_associated #0: 20 --> en:white substance
    n1=en:normal interictal neurologic examination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3164. en:normal iq in infancy, then iq drops with age --- r_associated #0: 20 --> en:white substance
    n1=en:normal iq in infancy, then iq drops with age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3165. en:normal mental development --- r_associated #0: 20 --> en:white substance
    n1=en:normal mental development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3166. en:normal motor conduction studies (initially) --- r_associated #0: 20 --> en:white substance
    n1=en:normal motor conduction studies (initially) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3167. en:normal motor development --- r_associated #0: 20 --> en:white substance
    n1=en:normal motor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3168. en:normal muscle strength --- r_associated #0: 20 --> en:white substance
    n1=en:normal muscle strength | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3169. en:normal neurologic development in most cases --- r_associated #0: 20 --> en:white substance
    n1=en:normal neurologic development in most cases | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3170. en:normal neurological development is possible --- r_associated #0: 20 --> en:white substance
    n1=en:normal neurological development is possible | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3171. en:normal neuromuscular studies --- r_associated #0: 20 --> en:white substance
    n1=en:normal neuromuscular studies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3172. en:normal psychomotor development --- r_associated #0: 20 --> en:white substance
    n1=en:normal psychomotor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3173. en:normal psychomotor development in most --- r_associated #0: 20 --> en:white substance
    n1=en:normal psychomotor development in most | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3174. en:normal psychomotor development until age 2 to 3 years --- r_associated #0: 20 --> en:white substance
    n1=en:normal psychomotor development until age 2 to 3 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3175. en:normal sleep-onset time (normal time of falling asleep) --- r_associated #0: 20 --> en:white substance
    n1=en:normal sleep-onset time (normal time of falling asleep) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3176. en:normal to mild mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:normal to mild mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3177. en:normal to mildly delayed development --- r_associated #0: 20 --> en:white substance
    n1=en:normal to mildly delayed development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3178. en:normal, timely language development --- r_associated #0: 20 --> en:white substance
    n1=en:normal, timely language development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3179. en:nuclear magnetic resonance imaging brain normal --- r_associated #0: 20 --> en:white substance
    n1=en:nuclear magnetic resonance imaging brain normal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3180. en:numbness --- r_associated #0: 20 --> en:white substance
    n1=en:numbness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3181. en:nystagmus --- r_associated #0: 20 --> en:white substance
    n1=en:nystagmus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3182. en:nystagmus decreases on convergence --- r_associated #0: 20 --> en:white substance
    n1=en:nystagmus decreases on convergence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3183. en:nystagmus is accentuated by fixation, lateral gaze, smooth pursuit --- r_associated #0: 20 --> en:white substance
    n1=en:nystagmus is accentuated by fixation, lateral gaze, smooth pursuit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3184. en:nystagmus, horizontal --- r_associated #0: 20 --> en:white substance
    n1=en:nystagmus, horizontal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3185. en:nystagmus, jerky, horizontal, congenital --- r_associated #0: 20 --> en:white substance
    n1=en:nystagmus, jerky, horizontal, congenital | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3186. en:nystagmus, mild --- r_associated #0: 20 --> en:white substance
    n1=en:nystagmus, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3187. en:obsessive compulsive behavior --- r_associated #0: 20 --> en:white substance
    n1=en:obsessive compulsive behavior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3188. en:obstruction of the foramen of monro (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:obstruction of the foramen of monro (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3189. en:obtundation --- r_associated #0: 20 --> en:white substance
    n1=en:obtundation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3190. en:occasional degeneration of the globus pallidus --- r_associated #0: 20 --> en:white substance
    n1=en:occasional degeneration of the globus pallidus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3191. en:occipital dermal sinus tract --- r_associated #0: 20 --> en:white substance
    n1=en:occipital dermal sinus tract | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3192. en:occipital encephalocele (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:occipital encephalocele (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3193. en:occipital encephalocele (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:occipital encephalocele (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3194. en:occipital encephaloceles --- r_associated #0: 20 --> en:white substance
    n1=en:occipital encephaloceles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3195. en:occipital headache --- r_associated #0: 20 --> en:white substance
    n1=en:occipital headache | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3196. en:occipital lobe --- r_associated #0: 20 --> en:white substance
    n1=en:occipital lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3197. en:occipital lobe atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:occipital lobe atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3198. en:occipital lobe infarct (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:occipital lobe infarct (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3199. en:occipital meningocele --- r_associated #0: 20 --> en:white substance
    n1=en:occipital meningocele | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3200. en:occipital meningocele (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:occipital meningocele (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3201. en:occipital myelomeningocele (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:occipital myelomeningocele (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3202. en:occipital neural tube defects --- r_associated #0: 20 --> en:white substance
    n1=en:occipital neural tube defects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3203. en:occlusive hydrocephalus, congenital --- r_associated #0: 20 --> en:white substance
    n1=en:occlusive hydrocephalus, congenital | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3204. en:occurs most often during the night or early morning --- r_associated #0: 20 --> en:white substance
    n1=en:occurs most often during the night or early morning | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3205. en:ocular motility spared --- r_associated #0: 20 --> en:white substance
    n1=en:ocular motility spared | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3206. en:ocular muscle abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:ocular muscle abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3207. en:ocular palsies --- r_associated #0: 20 --> en:white substance
    n1=en:ocular palsies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3208. en:oculogyric crisis --- r_associated #0: 20 --> en:white substance
    n1=en:oculogyric crisis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3209. en:oculomotor apraxia --- r_associated #0: 20 --> en:white substance
    n1=en:oculomotor apraxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3210. en:olfactory lobe agenesis --- r_associated #0: 20 --> en:white substance
    n1=en:olfactory lobe agenesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3211. en:olfactory or auditory hallucinations --- r_associated #0: 20 --> en:white substance
    n1=en:olfactory or auditory hallucinations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3212. en:oligodendrocytes with foamy cytoplasm --- r_associated #0: 20 --> en:white substance
    n1=en:oligodendrocytes with foamy cytoplasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3213. en:olivopontocerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:olivopontocerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3214. en:olivopontocerebellar hypoplasia, fetal-onset --- r_associated #0: 20 --> en:white substance
    n1=en:olivopontocerebellar hypoplasia, fetal-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3215. en:olivopontocerebellar hypoplasia, severe --- r_associated #0: 20 --> en:white substance
    n1=en:olivopontocerebellar hypoplasia, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3216. en:only some achieve rolling or sitting --- r_associated #0: 20 --> en:white substance
    n1=en:only some achieve rolling or sitting | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3217. en:only walking achieved --- r_associated #0: 20 --> en:white substance
    n1=en:only walking achieved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3218. en:onset may be triggered by emotional stress, fever, exercise, exposure to heat --- r_associated #0: 20 --> en:white substance
    n1=en:onset may be triggered by emotional stress, fever, exercise, exposure to heat | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3219. en:open operculum --- r_associated #0: 20 --> en:white substance
    n1=en:open operculum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3220. en:open spina bifida (myelomeningocele, 182940) --- r_associated #0: 20 --> en:white substance
    n1=en:open spina bifida (myelomeningocele, 182940) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3221. en:open sylvian fissures --- r_associated #0: 20 --> en:white substance
    n1=en:open sylvian fissures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3222. en:opisthotonic posturing --- r_associated #0: 20 --> en:white substance
    n1=en:opisthotonic posturing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3223. en:opisthotonos (type ii) --- r_associated #0: 20 --> en:white substance
    n1=en:opisthotonos (type ii) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3224. en:opisthotonus --- r_associated #0: 20 --> en:white substance
    n1=en:opisthotonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3225. en:opsoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:opsoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3226. en:optic ataxia (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:optic ataxia (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3227. en:optic nerve hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:optic nerve hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3228. en:optic tract agenesis --- r_associated #0: 20 --> en:white substance
    n1=en:optic tract agenesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3229. en:optic tract and chiasm hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:optic tract and chiasm hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3230. en:organic writer's cramp --- r_associated #0: 20 --> en:white substance
    n1=en:organic writer's cramp | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3231. en:orofacial dyspraxia, linguistic and nonlinguistic --- r_associated #0: 20 --> en:white substance
    n1=en:orofacial dyspraxia, linguistic and nonlinguistic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3232. en:orofacial dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:orofacial dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3233. en:oromandibular dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:oromandibular dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3234. en:orthostatic hypotension --- r_associated #0: 20 --> en:white substance
    n1=en:orthostatic hypotension | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3235. en:ossification of the faux cerebri (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:ossification of the faux cerebri (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3236. en:other auras may occur --- r_associated #0: 20 --> en:white substance
    n1=en:other auras may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3237. en:other cranial nerves may be involved --- r_associated #0: 20 --> en:white substance
    n1=en:other cranial nerves may be involved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3238. en:other seizure types (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:other seizure types (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3239. en:over time, white matter vanishes and is replaced by csf --- r_associated #0: 20 --> en:white substance
    n1=en:over time, white matter vanishes and is replaced by csf | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3240. en:overlapping lesion of brain --- r_associated #0: 20 --> en:white substance
    n1=en:overlapping lesion of brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3241. en:pachygyria (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3242. en:pachygyria (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3243. en:pachygyria (posterior-to-anterior gradient) --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria (posterior-to-anterior gradient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3244. en:pachygyria (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3245. en:pachygyria with preferential frontoparietal involvement (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria with preferential frontoparietal involvement (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3246. en:pachygyria, bilateral frontotemporal --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria, bilateral frontotemporal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3247. en:pachygyria, frontoparietal --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria, frontoparietal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3248. en:pachygyria, most prominent in the frontal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria, most prominent in the frontal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3249. en:pachygyria, occipital --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria, occipital | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3250. en:pachygyria, usually posterior --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyria, usually posterior | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3251. en:pachygyrias --- r_associated #0: 20 --> en:white substance
    n1=en:pachygyrias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3252. en:pachymacrogyria --- r_associated #0: 20 --> en:white substance
    n1=en:pachymacrogyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3253. en:pachymeningitis cervicalis (cervical cord compression due to thickened dura) --- r_associated #0: 20 --> en:white substance
    n1=en:pachymeningitis cervicalis (cervical cord compression due to thickened dura) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3254. en:pain --- r_associated #0: 20 --> en:white substance
    n1=en:pain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3255. en:pain (sharp, boring, drilling, piercing) --- r_associated #0: 20 --> en:white substance
    n1=en:pain (sharp, boring, drilling, piercing) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3256. en:pain affects upper body --- r_associated #0: 20 --> en:white substance
    n1=en:pain affects upper body | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3257. en:pain, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:pain, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3258. en:palatal myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:palatal myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3259. en:pallidal degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:pallidal degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3260. en:pallor of dorsal columns of the spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:pallor of dorsal columns of the spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3261. en:paradoxical cerebral emboli --- r_associated #0: 20 --> en:white substance
    n1=en:paradoxical cerebral emboli | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3262. en:paralysis --- r_associated #0: 20 --> en:white substance
    n1=en:paralysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3263. en:paralysis, episodic, after strenuous exercise --- r_associated #0: 20 --> en:white substance
    n1=en:paralysis, episodic, after strenuous exercise | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3264. en:paraneoplastic syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:paraneoplastic syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3265. en:paranoid reaction --- r_associated #0: 20 --> en:white substance
    n1=en:paranoid reaction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3266. en:paraparesis --- r_associated #0: 20 --> en:white substance
    n1=en:paraparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3267. en:paraparesis, spastic --- r_associated #0: 20 --> en:white substance
    n1=en:paraparesis, spastic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3268. en:paraplegia --- r_associated #0: 20 --> en:white substance
    n1=en:paraplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3269. en:paraplegia secondary to spinal cord compression due to severe kyphosis --- r_associated #0: 20 --> en:white substance
    n1=en:paraplegia secondary to spinal cord compression due to severe kyphosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3270. en:parasitology --- r_associated #0: 20 --> en:white substance
    n1=en:parasitology | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3271. en:paraspinal masses --- r_associated #0: 20 --> en:white substance
    n1=en:paraspinal masses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3272. en:paraventricular cysts --- r_associated #0: 20 --> en:white substance
    n1=en:paraventricular cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3273. en:parenchymal neuromelanosis --- r_associated #0: 20 --> en:white substance
    n1=en:parenchymal neuromelanosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3274. en:paresis (hcp) --- r_associated #0: 20 --> en:white substance
    n1=en:paresis (hcp) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3275. en:paresis of extensor muscles of the big toe is presenting symptom --- r_associated #0: 20 --> en:white substance
    n1=en:paresis of extensor muscles of the big toe is presenting symptom | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3276. en:paresthesia --- r_associated #0: 20 --> en:white substance
    n1=en:paresthesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3277. en:parietal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:parietal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3278. en:parietal lobe epilepsy --- r_associated #0: 20 --> en:white substance
    n1=en:parietal lobe epilepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3279. en:parkinsonism --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3280. en:parkinsonism (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3281. en:parkinsonism (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3282. en:parkinsonism (later onset) --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism (later onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3283. en:parkinsonism (later) --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3284. en:parkinsonism (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3285. en:parkinsonism has been described in 1 family --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism has been described in 1 family | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3286. en:parkinsonism may occur --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3287. en:parkinsonism, early-onset --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism, early-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3288. en:parkinsonism, l-dopa responsive --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism, l-dopa responsive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3289. en:parkinsonism, levodopa-responsive (occurs at later stages, may replace dystonia symptoms) --- r_associated #0: 20 --> en:white substance
    n1=en:parkinsonism, levodopa-responsive (occurs at later stages, may replace dystonia symptoms) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3290. en:paroxysmal choreoathetosis --- r_associated #0: 20 --> en:white substance
    n1=en:paroxysmal choreoathetosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3291. en:paroxysmal dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:paroxysmal dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3292. en:paroxysmal lethargy --- r_associated #0: 20 --> en:white substance
    n1=en:paroxysmal lethargy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3293. en:paroxysmal nonkinesigenic dyskinesia --- r_associated #0: 20 --> en:white substance
    n1=en:paroxysmal nonkinesigenic dyskinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3294. en:paroxysmal oculogyric crises --- r_associated #0: 20 --> en:white substance
    n1=en:paroxysmal oculogyric crises | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3295. en:partial absence of the corpus callosum (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:partial absence of the corpus callosum (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3296. en:partial agenesis of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:partial agenesis of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3297. en:partial agenesis of corpus callosum (rare, in males) --- r_associated #0: 20 --> en:white substance
    n1=en:partial agenesis of corpus callosum (rare, in males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3298. en:partial agenesis of the corpus callosum (in 1 of 2 sibs) --- r_associated #0: 20 --> en:white substance
    n1=en:partial agenesis of the corpus callosum (in 1 of 2 sibs) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3299. en:partial agenesis of the corpus callosum (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:partial agenesis of the corpus callosum (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3300. en:partial empty sella turcica --- r_associated #0: 20 --> en:white substance
    n1=en:partial empty sella turcica | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3301. en:partial epilepsy --- r_associated #0: 20 --> en:white substance
    n1=en:partial epilepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3302. en:partial migrating seizures seen on eeg (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:partial migrating seizures seen on eeg (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3303. en:partial or complete absence of the cerebellar vermis consistent with dandy walker malformation --- r_associated #0: 20 --> en:white substance
    n1=en:partial or complete absence of the cerebellar vermis consistent with dandy walker malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3304. en:partial or complete agenesis of corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:partial or complete agenesis of corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3305. en:partial or total agenesis of the corpus callosum (33%) --- r_associated #0: 20 --> en:white substance
    n1=en:partial or total agenesis of the corpus callosum (33%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3306. en:partial pachygyria --- r_associated #0: 20 --> en:white substance
    n1=en:partial pachygyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3307. en:partial response to pyridoxine --- r_associated #0: 20 --> en:white substance
    n1=en:partial response to pyridoxine | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3308. en:partial seizure --- r_associated #0: 20 --> en:white substance
    n1=en:partial seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3309. en:partial seizures, simple and complex --- r_associated #0: 20 --> en:white substance
    n1=en:partial seizures, simple and complex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3310. en:patchy demyelination of subcortical white matter --- r_associated #0: 20 --> en:white substance
    n1=en:patchy demyelination of subcortical white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3311. en:patchy diffuse hyperintensities on t2-weighted mri --- r_associated #0: 20 --> en:white substance
    n1=en:patchy diffuse hyperintensities on t2-weighted mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3312. en:patellar and ankle clonus --- r_associated #0: 20 --> en:white substance
    n1=en:patellar and ankle clonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3313. en:patellar tendon reflexes hyperactive --- r_associated #0: 20 --> en:white substance
    n1=en:patellar tendon reflexes hyperactive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3314. en:pathologic calcification, calcified structure --- r_associated #0: 20 --> en:white substance
    n1=en:pathologic calcification, calcified structure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3315. en:pathologic changes in anterior horn cells and lateral corticospinal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:pathologic changes in anterior horn cells and lateral corticospinal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3316. en:pathological aspects --- r_associated #0: 20 --> en:white substance
    n1=en:pathological aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3317. en:pathology includes spongiform changes, diffuse nerve cell degeneration and glial proliferation --- r_associated #0: 20 --> en:white substance
    n1=en:pathology includes spongiform changes, diffuse nerve cell degeneration and glial proliferation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3318. en:patients 20-30 years old have hyperintense lesions on t2-weighted mri in the frontal and anterior temporal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:patients 20-30 years old have hyperintense lesions on t2-weighted mri in the frontal and anterior temporal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3319. en:patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3320. en:patients achieve ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:patients achieve ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3321. en:patients may develop a seizure disorder later in life --- r_associated #0: 20 --> en:white substance
    n1=en:patients may develop a seizure disorder later in life | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3322. en:patients may have no structural abnormalities in the central nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:patients may have no structural abnormalities in the central nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3323. en:patients may only achieve sitting or walking --- r_associated #0: 20 --> en:white substance
    n1=en:patients may only achieve sitting or walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3324. en:patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds --- r_associated #0: 20 --> en:white substance
    n1=en:patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3325. en:patients show normal psychomotor development --- r_associated #0: 20 --> en:white substance
    n1=en:patients show normal psychomotor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3326. en:paucity of anterior horn motor neurons --- r_associated #0: 20 --> en:white substance
    n1=en:paucity of anterior horn motor neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3327. en:peak frequency of vomiting every 10 to 15 minutes --- r_associated #0: 20 --> en:white substance
    n1=en:peak frequency of vomiting every 10 to 15 minutes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3328. en:peculiar gait (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:peculiar gait (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3329. en:peculiar stance and sitting posture (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:peculiar stance and sitting posture (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3330. en:pericystic abnormal myelination --- r_associated #0: 20 --> en:white substance
    n1=en:pericystic abnormal myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3331. en:periodic paralysis (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:periodic paralysis (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3332. en:periodic paralysis, usually hypokalemic --- r_associated #0: 20 --> en:white substance
    n1=en:periodic paralysis, usually hypokalemic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3333. en:periodic stiffness --- r_associated #0: 20 --> en:white substance
    n1=en:periodic stiffness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3334. en:peripheral hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:peripheral hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3335. en:peripheral motor neuropathy --- r_associated #0: 20 --> en:white substance
    n1=en:peripheral motor neuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3336. en:peripheral nervous system disorder --- r_associated #0: 20 --> en:white substance
    n1=en:peripheral nervous system disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3337. en:peripheral sensory neuropathy --- r_associated #0: 20 --> en:white substance
    n1=en:peripheral sensory neuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3338. en:perisylvian polymicrogyria --- r_associated #0: 20 --> en:white substance
    n1=en:perisylvian polymicrogyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3339. en:perivascular spaces --- r_associated #0: 20 --> en:white substance
    n1=en:perivascular spaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3340. en:periventricular and subcortical white matter abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular and subcortical white matter abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3341. en:periventricular calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3342. en:periventricular cysts --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular cysts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3343. en:periventricular gray matter heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular gray matter heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3344. en:periventricular hemorrhagic infarction --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular hemorrhagic infarction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3345. en:periventricular leukomalacia --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular leukomalacia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3346. en:periventricular leukomalacia (reported in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular leukomalacia (reported in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3347. en:periventricular nodular heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular nodular heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3348. en:periventricular nodular heterotopia seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular nodular heterotopia seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3349. en:periventricular white matter abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3350. en:periventricular white matter abnormalities (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter abnormalities (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3351. en:periventricular white matter changes --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3352. en:periventricular white matter changes (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter changes (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3353. en:periventricular white matter gliosis (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter gliosis (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3354. en:periventricular white matter hyperintensities, bilateral --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter hyperintensities, bilateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3355. en:periventricular white matter lesions --- r_associated #0: 20 --> en:white substance
    n1=en:periventricular white matter lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3356. en:perseveration --- r_associated #0: 20 --> en:white substance
    n1=en:perseveration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3357. en:persistent cavum septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:persistent cavum septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3358. en:persistent cavus septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:persistent cavus septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3359. en:persistent falcine venous sinus --- r_associated #0: 20 --> en:white substance
    n1=en:persistent falcine venous sinus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3360. en:personality change --- r_associated #0: 20 --> en:white substance
    n1=en:personality change | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3361. en:personality disorder --- r_associated #0: 20 --> en:white substance
    n1=en:personality disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3362. en:petit mal epilepsy --- r_associated #0: 20 --> en:white substance
    n1=en:petit mal epilepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3363. en:pharyngeal gag reflex negative --- r_associated #0: 20 --> en:white substance
    n1=en:pharyngeal gag reflex negative | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3364. en:phonology deficits --- r_associated #0: 20 --> en:white substance
    n1=en:phonology deficits | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3365. en:phonophobia --- r_associated #0: 20 --> en:white substance
    n1=en:phonophobia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3366. en:photoparoxysmal and photomyoclonic responses --- r_associated #0: 20 --> en:white substance
    n1=en:photoparoxysmal and photomyoclonic responses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3367. en:photoparoxysmal response (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:photoparoxysmal response (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3368. en:photophobia --- r_associated #0: 20 --> en:white substance
    n1=en:photophobia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3369. en:photosensitive tonic-clonic seizures --- r_associated #0: 20 --> en:white substance
    n1=en:photosensitive tonic-clonic seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3370. en:photosensitivity in one-third of patients --- r_associated #0: 20 --> en:white substance
    n1=en:photosensitivity in one-third of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3371. en:physiological aspects --- r_associated #0: 20 --> en:white substance
    n1=en:physiological aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3372. en:physiopathological --- r_associated #0: 20 --> en:white substance
    n1=en:physiopathological | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3373. en:pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus --- r_associated #0: 20 --> en:white substance
    n1=en:pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3374. en:pigmentary loss in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:pigmentary loss in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3375. en:pineal gland --- r_associated #0: 20 --> en:white substance
    n1=en:pineal gland | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3376. en:pineal hypertrophy --- r_associated #0: 20 --> en:white substance
    n1=en:pineal hypertrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3377. en:pituitary agenesis --- r_associated #0: 20 --> en:white substance
    n1=en:pituitary agenesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3378. en:pituitary agenesis (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:pituitary agenesis (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3379. en:pituitary aplasia or dysplasia --- r_associated #0: 20 --> en:white substance
    n1=en:pituitary aplasia or dysplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3380. en:pituitary gland adenoma --- r_associated #0: 20 --> en:white substance
    n1=en:pituitary gland adenoma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3381. en:pituitary gland hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:pituitary gland hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3382. en:pituitary hypoplasia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:pituitary hypoplasia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3383. en:plaque, amyloid --- r_associated #0: 20 --> en:white substance
    n1=en:plaque, amyloid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3384. en:platybasia --- r_associated #0: 20 --> en:white substance
    n1=en:platybasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3385. en:polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes --- r_associated #0: 20 --> en:white substance
    n1=en:polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3386. en:polygyria --- r_associated #0: 20 --> en:white substance
    n1=en:polygyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3387. en:polymicrogyria --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3388. en:polymicrogyria (64%) --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria (64%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3389. en:polymicrogyria (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3390. en:polymicrogyria (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3391. en:polymicrogyria (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3392. en:polymicrogyria, anterior to posterior gradient --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, anterior to posterior gradient | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3393. en:polymicrogyria, asymmetric or symmetric --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, asymmetric or symmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3394. en:polymicrogyria, bilateral frontoparietal --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, bilateral frontoparietal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3395. en:polymicrogyria, diffuse, asymmetric --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, diffuse, asymmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3396. en:polymicrogyria, frontal --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, frontal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3397. en:polymicrogyria, most severe in the frontoparietal regions --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, most severe in the frontoparietal regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3398. en:polymicrogyria, occipital --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, occipital | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3399. en:polymicrogyria, predominantly frontal and perisylvian --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, predominantly frontal and perisylvian | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3400. en:polymicrogyria, temporo-occipital --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, temporo-occipital | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3401. en:polymicrogyria, usually frontal (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:polymicrogyria, usually frontal (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3402. en:polyneuropathies, motor --- r_associated #0: 20 --> en:white substance
    n1=en:polyneuropathies, motor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3403. en:polyneuropathy --- r_associated #0: 20 --> en:white substance
    n1=en:polyneuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3404. en:pons damage --- r_associated #0: 20 --> en:white substance
    n1=en:pons damage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3405. en:pontine atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:pontine atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3406. en:pontine dysraphia --- r_associated #0: 20 --> en:white substance
    n1=en:pontine dysraphia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3407. en:pontine hypoplasia (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:pontine hypoplasia (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3408. en:pontine hypoplasia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:pontine hypoplasia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3409. en:pontocerebellar arachnoid cyst (reported in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:pontocerebellar arachnoid cyst (reported in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3410. en:pontocerebellar atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:pontocerebellar atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3411. en:pontoneocerebellar hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:pontoneocerebellar hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3412. en:poor adaptive skills --- r_associated #0: 20 --> en:white substance
    n1=en:poor adaptive skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3413. en:poor balance (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:poor balance (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3414. en:poor cognition --- r_associated #0: 20 --> en:white substance
    n1=en:poor cognition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3415. en:poor communication --- r_associated #0: 20 --> en:white substance
    n1=en:poor communication | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3416. en:poor concentration --- r_associated #0: 20 --> en:white substance
    n1=en:poor concentration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3417. en:poor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:poor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3418. en:poor coordination (83%) --- r_associated #0: 20 --> en:white substance
    n1=en:poor coordination (83%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3419. en:poor delineation of cerebral cortical regions --- r_associated #0: 20 --> en:white substance
    n1=en:poor delineation of cerebral cortical regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3420. en:poor dendritic maturation --- r_associated #0: 20 --> en:white substance
    n1=en:poor dendritic maturation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3421. en:poor differentiation of gray and white matter on t2-weighted mri --- r_associated #0: 20 --> en:white substance
    n1=en:poor differentiation of gray and white matter on t2-weighted mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3422. en:poor eye contact --- r_associated #0: 20 --> en:white substance
    n1=en:poor eye contact | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3423. en:poor feeding (congenital form form) --- r_associated #0: 20 --> en:white substance
    n1=en:poor feeding (congenital form form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3424. en:poor fine and gross motor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:poor fine and gross motor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3425. en:poor fine motor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:poor fine motor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3426. en:poor fine motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:poor fine motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3427. en:poor gross motor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:poor gross motor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3428. en:poor hand-eye coordination --- r_associated #0: 20 --> en:white substance
    n1=en:poor hand-eye coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3429. en:poor head and trunk control in infancy --- r_associated #0: 20 --> en:white substance
    n1=en:poor head and trunk control in infancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3430. en:poor head control --- r_associated #0: 20 --> en:white substance
    n1=en:poor head control | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3431. en:poor language --- r_associated #0: 20 --> en:white substance
    n1=en:poor language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3432. en:poor language and speech development --- r_associated #0: 20 --> en:white substance
    n1=en:poor language and speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3433. en:poor motor coordination --- r_associated #0: 20 --> en:white substance
    n1=en:poor motor coordination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3434. en:poor motor development --- r_associated #0: 20 --> en:white substance
    n1=en:poor motor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3435. en:poor myelination --- r_associated #0: 20 --> en:white substance
    n1=en:poor myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3436. en:poor neonatal suck and swallow reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:poor neonatal suck and swallow reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3437. en:poor or absent independent walking --- r_associated #0: 20 --> en:white substance
    n1=en:poor or absent independent walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3438. en:poor or absent smooth pursuit --- r_associated #0: 20 --> en:white substance
    n1=en:poor or absent smooth pursuit | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3439. en:poor or absent speech --- r_associated #0: 20 --> en:white substance
    n1=en:poor or absent speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3440. en:poor or absent speech acquisition --- r_associated #0: 20 --> en:white substance
    n1=en:poor or absent speech acquisition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3441. en:poor or absent speech development --- r_associated #0: 20 --> en:white substance
    n1=en:poor or absent speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3442. en:poor responsiveness --- r_associated #0: 20 --> en:white substance
    n1=en:poor responsiveness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3443. en:poor school performance --- r_associated #0: 20 --> en:white substance
    n1=en:poor school performance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3444. en:poor speech --- r_associated #0: 20 --> en:white substance
    n1=en:poor speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3445. en:poor speech or lack of speech development --- r_associated #0: 20 --> en:white substance
    n1=en:poor speech or lack of speech development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3446. en:poor speech or no speech --- r_associated #0: 20 --> en:white substance
    n1=en:poor speech or no speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3447. en:poor spontaneous movements --- r_associated #0: 20 --> en:white substance
    n1=en:poor spontaneous movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3448. en:poor vestibuloocular reflex --- r_associated #0: 20 --> en:white substance
    n1=en:poor vestibuloocular reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3449. en:poor visual-motor integration (range 41-80) --- r_associated #0: 20 --> en:white substance
    n1=en:poor visual-motor integration (range 41-80) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3450. en:poor visual-spatial construction --- r_associated #0: 20 --> en:white substance
    n1=en:poor visual-spatial construction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3451. en:poor-absent neurologic development --- r_associated #0: 20 --> en:white substance
    n1=en:poor-absent neurologic development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3452. en:porencephalic changes --- r_associated #0: 20 --> en:white substance
    n1=en:porencephalic changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3453. en:porencephalic cyst --- r_associated #0: 20 --> en:white substance
    n1=en:porencephalic cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3454. en:porencephaly (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:porencephaly (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3455. en:posterior column --- r_associated #0: 20 --> en:white substance
    n1=en:posterior column | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3456. en:posterior column degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:posterior column degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3457. en:posterior column sensory loss --- r_associated #0: 20 --> en:white substance
    n1=en:posterior column sensory loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3458. en:posterior fossa abnormalities (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa abnormalities (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3459. en:posterior fossa arachnoid cyst --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa arachnoid cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3460. en:posterior fossa compression syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa compression syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3461. en:posterior fossa crowding, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa crowding, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3462. en:posterior fossa cyst --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3463. en:posterior fossa cyst (in 1 of 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa cyst (in 1 of 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3464. en:posterior fossa cyst continuous with the fourth ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa cyst continuous with the fourth ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3465. en:posterior fossa cysts (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa cysts (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3466. en:posterior fossa malformations --- r_associated #0: 20 --> en:white substance
    n1=en:posterior fossa malformations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3467. en:posterior pachygyria --- r_associated #0: 20 --> en:white substance
    n1=en:posterior pachygyria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3468. en:posterior slow-wave activity on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:posterior slow-wave activity on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3469. en:postnatal development of hypertonic extremities --- r_associated #0: 20 --> en:white substance
    n1=en:postnatal development of hypertonic extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3470. en:postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia) --- r_associated #0: 20 --> en:white substance
    n1=en:postural dystonia (onset is restricted to 1 extremity, usually lower, with foot dystonia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3471. en:postural hand tremor --- r_associated #0: 20 --> en:white substance
    n1=en:postural hand tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3472. en:postural instability --- r_associated #0: 20 --> en:white substance
    n1=en:postural instability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3473. en:postural instability (63%) --- r_associated #0: 20 --> en:white substance
    n1=en:postural instability (63%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3474. en:postural tremor (later onset, spreads to all limbs and neck) --- r_associated #0: 20 --> en:white substance
    n1=en:postural tremor (later onset, spreads to all limbs and neck) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3475. en:postural tremor, slow, irregular (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:postural tremor, slow, irregular (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3476. en:posturing --- r_associated #0: 20 --> en:white substance
    n1=en:posturing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3477. en:praxis --- r_associated #0: 20 --> en:white substance
    n1=en:praxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3478. en:pre-senile dementia --- r_associated #0: 20 --> en:white substance
    n1=en:pre-senile dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3479. en:premature stroke --- r_associated #0: 20 --> en:white substance
    n1=en:premature stroke | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3480. en:presence of rosenthal fibers (eosinophilic bodies near astrocyte filaments) --- r_associated #0: 20 --> en:white substance
    n1=en:presence of rosenthal fibers (eosinophilic bodies near astrocyte filaments) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3481. en:presenile and senile dementia --- r_associated #0: 20 --> en:white substance
    n1=en:presenile and senile dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3482. en:preservation of u fibers --- r_associated #0: 20 --> en:white substance
    n1=en:preservation of u fibers | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3483. en:primarily affects distal lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:primarily affects distal lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3484. en:primitive reflex --- r_associated #0: 20 --> en:white substance
    n1=en:primitive reflex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3485. en:primitive reflexes (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:primitive reflexes (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3486. en:primitive reflexes (palmomental, snout, glabellar) --- r_associated #0: 20 --> en:white substance
    n1=en:primitive reflexes (palmomental, snout, glabellar) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3487. en:primitive sylvian fissures --- r_associated #0: 20 --> en:white substance
    n1=en:primitive sylvian fissures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3488. en:prion protein-positive senile plaques --- r_associated #0: 20 --> en:white substance
    n1=en:prion protein-positive senile plaques | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3489. en:prnp-immunoreactive cerebral amyloid angiopathy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:prnp-immunoreactive cerebral amyloid angiopathy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3490. en:profound global developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:profound global developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3491. en:profound intellectual disabilities --- r_associated #0: 20 --> en:white substance
    n1=en:profound intellectual disabilities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3492. en:profound mental retardation and hypotonia in survivors --- r_associated #0: 20 --> en:white substance
    n1=en:profound mental retardation and hypotonia in survivors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3493. en:progression to paralysis and atrophy of distal lower limb muscles --- r_associated #0: 20 --> en:white substance
    n1=en:progression to paralysis and atrophy of distal lower limb muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3494. en:progression to tetraplegia and decerebrate state --- r_associated #0: 20 --> en:white substance
    n1=en:progression to tetraplegia and decerebrate state | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3495. en:progressive ataxia (onset second year of life) --- r_associated #0: 20 --> en:white substance
    n1=en:progressive ataxia (onset second year of life) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3496. en:progressive bulbar palsy --- r_associated #0: 20 --> en:white substance
    n1=en:progressive bulbar palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3497. en:progressive cerebellar ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:progressive cerebellar ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3498. en:progressive cerebellar degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:progressive cerebellar degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3499. en:progressive cerebral atrophy seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:progressive cerebral atrophy seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3500. en:progressive choreoathetosis --- r_associated #0: 20 --> en:white substance
    n1=en:progressive choreoathetosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3501. en:progressive cns degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:progressive cns degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3502. en:progressive cognitive decline following normal development in childhood (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:progressive cognitive decline following normal development in childhood (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3503. en:progressive encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:progressive encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3504. en:progressive extrapyramidal movement disorder --- r_associated #0: 20 --> en:white substance
    n1=en:progressive extrapyramidal movement disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3505. en:progressive forgetfulness --- r_associated #0: 20 --> en:white substance
    n1=en:progressive forgetfulness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3506. en:progressive gait ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:progressive gait ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3507. en:progressive impairment of gait --- r_associated #0: 20 --> en:white substance
    n1=en:progressive impairment of gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3508. en:progressive inability to walk --- r_associated #0: 20 --> en:white substance
    n1=en:progressive inability to walk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3509. en:progressive intellectual decline --- r_associated #0: 20 --> en:white substance
    n1=en:progressive intellectual decline | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3510. en:progressive language deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:progressive language deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3511. en:progressive leukoencephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:progressive leukoencephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3512. en:progressive loss of movement control --- r_associated #0: 20 --> en:white substance
    n1=en:progressive loss of movement control | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3513. en:progressive myoclonus epilepsy --- r_associated #0: 20 --> en:white substance
    n1=en:progressive myoclonus epilepsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3514. en:progressive neurologic deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:progressive neurologic deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3515. en:progressive psychomotor deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:progressive psychomotor deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3516. en:progressive pyramidal and cerebellar signs --- r_associated #0: 20 --> en:white substance
    n1=en:progressive pyramidal and cerebellar signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3517. en:progressive spastic diplegia to quadriplegia --- r_associated #0: 20 --> en:white substance
    n1=en:progressive spastic diplegia to quadriplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3518. en:progressive spastic paraplegia --- r_associated #0: 20 --> en:white substance
    n1=en:progressive spastic paraplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3519. en:progressive spastic quadriplegia --- r_associated #0: 20 --> en:white substance
    n1=en:progressive spastic quadriplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3520. en:progressive spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:progressive spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3521. en:progressive truncal ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:progressive truncal ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3522. en:progressive ventriculomegaly --- r_associated #0: 20 --> en:white substance
    n1=en:progressive ventriculomegaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3523. en:progressive white matter lesions in the brain --- r_associated #0: 20 --> en:white substance
    n1=en:progressive white matter lesions in the brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3524. en:progressive, symmetric degeneration of the caudate and putamen --- r_associated #0: 20 --> en:white substance
    n1=en:progressive, symmetric degeneration of the caudate and putamen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3525. en:prolonged seizure --- r_associated #0: 20 --> en:white substance
    n1=en:prolonged seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3526. en:prolonged somatosensory evoked potentials (seps) --- r_associated #0: 20 --> en:white substance
    n1=en:prolonged somatosensory evoked potentials (seps) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3527. en:prominent cortical sulci --- r_associated #0: 20 --> en:white substance
    n1=en:prominent cortical sulci | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3528. en:prominent csf spaces (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:prominent csf spaces (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3529. en:prominent perivascular spaces --- r_associated #0: 20 --> en:white substance
    n1=en:prominent perivascular spaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3530. en:prominent perivascular spaces with surrounding gliosis in periatrial white matter --- r_associated #0: 20 --> en:white substance
    n1=en:prominent perivascular spaces with surrounding gliosis in periatrial white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3531. en:prominent sulci --- r_associated #0: 20 --> en:white substance
    n1=en:prominent sulci | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3532. en:prominent trigone and occipital horns --- r_associated #0: 20 --> en:white substance
    n1=en:prominent trigone and occipital horns | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3533. en:prominent ventricles (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:prominent ventricles (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3534. en:proximal amyotrophy --- r_associated #0: 20 --> en:white substance
    n1=en:proximal amyotrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3535. en:proximal limb muscle stiffness --- r_associated #0: 20 --> en:white substance
    n1=en:proximal limb muscle stiffness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3536. en:proximal muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:proximal muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3537. en:proximal muscle weakness in lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:proximal muscle weakness in lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3538. en:proximal weakness occurs first --- r_associated #0: 20 --> en:white substance
    n1=en:proximal weakness occurs first | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3539. en:proximal weakness occurs later --- r_associated #0: 20 --> en:white substance
    n1=en:proximal weakness occurs later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3540. en:proximal weakness of the lower extremities --- r_associated #0: 20 --> en:white substance
    n1=en:proximal weakness of the lower extremities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3541. en:prp immunoreactivity limited to cerebellum and putamen --- r_associated #0: 20 --> en:white substance
    n1=en:prp immunoreactivity limited to cerebellum and putamen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3542. en:pseudobulbar palsy --- r_associated #0: 20 --> en:white substance
    n1=en:pseudobulbar palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3543. en:pseudobulbar palsy (e.g. involuntary weeping or laughter) --- r_associated #0: 20 --> en:white substance
    n1=en:pseudobulbar palsy (e.g. involuntary weeping or laughter) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3544. en:pseudobulbar signs --- r_associated #0: 20 --> en:white substance
    n1=en:pseudobulbar signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3545. en:pseudobulbar symptoms (uncontrolled laughter, weeping) --- r_associated #0: 20 --> en:white substance
    n1=en:pseudobulbar symptoms (uncontrolled laughter, weeping) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3546. en:pseudolaminar spongiform changes --- r_associated #0: 20 --> en:white substance
    n1=en:pseudolaminar spongiform changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3547. en:pseudotumor --- r_associated #0: 20 --> en:white substance
    n1=en:pseudotumor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3548. en:pseudotumor cerebri --- r_associated #0: 20 --> en:white substance
    n1=en:pseudotumor cerebri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3549. en:psychiatric disorder --- r_associated #0: 20 --> en:white substance
    n1=en:psychiatric disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3550. en:psychiatric symptoms (delusions, hallucinations) --- r_associated #0: 20 --> en:white substance
    n1=en:psychiatric symptoms (delusions, hallucinations) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3551. en:psychomotor agitation --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor agitation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3552. en:psychomotor arrest and regression --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor arrest and regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3553. en:psychomotor delay (evident at 3 months) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor delay (evident at 3 months) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3554. en:psychomotor delay (in one family) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor delay (in one family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3555. en:psychomotor delay (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor delay (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3556. en:psychomotor delay after second year --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor delay after second year | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3557. en:psychomotor delay, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor delay, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3558. en:psychomotor delay, severe --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor delay, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3559. en:psychomotor deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3560. en:psychomotor deterioration (classical form) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor deterioration (classical form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3561. en:psychomotor impairments --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor impairments | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3562. en:psychomotor regression --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3563. en:psychomotor regression (in milder cases) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression (in milder cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3564. en:psychomotor regression (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3565. en:psychomotor regression (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3566. en:psychomotor regression (onset within first year of life) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression (onset within first year of life) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3567. en:psychomotor regression beginning in infancy --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression beginning in infancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3568. en:psychomotor regression in infants --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression in infants | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3569. en:psychomotor regression may occur --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3570. en:psychomotor regression, episodic, often associated with common childhood infections --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression, episodic, often associated with common childhood infections | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3571. en:psychomotor regression, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3572. en:psychomotor regression, severe --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor regression, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3573. en:psychomotor retardation --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3574. en:psychomotor retardation (2/4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation (2/4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3575. en:psychomotor retardation (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3576. en:psychomotor retardation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3577. en:psychomotor retardation in those that survive --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation in those that survive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3578. en:psychomotor retardation, mild --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3579. en:psychomotor retardation, mild to moderate --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, mild to moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3580. en:psychomotor retardation, moderate --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3581. en:psychomotor retardation, profound --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3582. en:psychomotor retardation, profound, in those who survive --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, profound, in those who survive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3583. en:psychomotor retardation, severe to profound --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, severe to profound | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3584. en:psychomotor retardation, variable --- r_associated #0: 20 --> en:white substance
    n1=en:psychomotor retardation, variable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3585. en:psychosis --- r_associated #0: 20 --> en:white substance
    n1=en:psychosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3586. en:psychosis (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:psychosis (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3587. en:psychotic episodes --- r_associated #0: 20 --> en:white substance
    n1=en:psychotic episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3588. en:pulsating quality --- r_associated #0: 20 --> en:white substance
    n1=en:pulsating quality | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3589. en:purposeless movements (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:purposeless movements (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3590. en:putamen atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:putamen atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3591. en:pyramidal features (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal features (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3592. en:pyramidal hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3593. en:pyramidal sign --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3594. en:pyramidal signs (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3595. en:pyramidal signs (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3596. en:pyramidal signs (21% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs (21% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3597. en:pyramidal signs (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3598. en:pyramidal signs (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3599. en:pyramidal signs (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3600. en:pyramidal signs, mild --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3601. en:pyramidal signs, mild (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal signs, mild (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3602. en:pyramidal symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3603. en:pyramidal syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3604. en:pyramidal syndrome of the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal syndrome of the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3605. en:pyramidal system --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3606. en:pyramidal tetraparesis --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal tetraparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3607. en:pyramidal tract dysfunction (juvenile-onset, less common) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal tract dysfunction (juvenile-onset, less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3608. en:pyramidal tract involvement --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal tract involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3609. en:pyramidal tract signs (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal tract signs (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3610. en:pyramidal tracts --- r_associated #0: 20 --> en:white substance
    n1=en:pyramidal tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3611. en:quadriparesis --- r_associated #0: 20 --> en:white substance
    n1=en:quadriparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3612. en:quadriplegia --- r_associated #0: 20 --> en:white substance
    n1=en:quadriplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3613. en:quadriplegia, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:quadriplegia, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3614. en:quadriplegia, flaccid --- r_associated #0: 20 --> en:white substance
    n1=en:quadriplegia, flaccid | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3615. en:quadriplegic dyskinesia --- r_associated #0: 20 --> en:white substance
    n1=en:quadriplegic dyskinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3616. en:quadrupedal gait --- r_associated #0: 20 --> en:white substance
    n1=en:quadrupedal gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3617. en:quadrupedal gait (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:quadrupedal gait (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3618. en:quadrupedal gait (palm of hands, legs straight) with diagonal walking --- r_associated #0: 20 --> en:white substance
    n1=en:quadrupedal gait (palm of hands, legs straight) with diagonal walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3619. en:quadrupedal locomotion (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:quadrupedal locomotion (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3620. en:rapid complete resolution of symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:rapid complete resolution of symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3621. en:rapid initial onset of symptoms (hours to weeks) --- r_associated #0: 20 --> en:white substance
    n1=en:rapid initial onset of symptoms (hours to weeks) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3622. en:rapid onset --- r_associated #0: 20 --> en:white substance
    n1=en:rapid onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3623. en:rapid regression --- r_associated #0: 20 --> en:white substance
    n1=en:rapid regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3624. en:rapid, instantaneous neurologic decline may occur after fright --- r_associated #0: 20 --> en:white substance
    n1=en:rapid, instantaneous neurologic decline may occur after fright | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3625. en:rapid, jerky movements --- r_associated #0: 20 --> en:white substance
    n1=en:rapid, jerky movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3626. en:rapidly progressive brainstem degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:rapidly progressive brainstem degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3627. en:rare dementia --- r_associated #0: 20 --> en:white substance
    n1=en:rare dementia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3628. en:rare secondary generalization --- r_associated #0: 20 --> en:white substance
    n1=en:rare secondary generalization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3629. en:reactive gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:reactive gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3630. en:recurrent bacterial meningitis --- r_associated #0: 20 --> en:white substance
    n1=en:recurrent bacterial meningitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3631. en:recurrent encephalopathy --- r_associated #0: 20 --> en:white substance
    n1=en:recurrent encephalopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3632. en:recurrent meningitis --- r_associated #0: 20 --> en:white substance
    n1=en:recurrent meningitis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3633. en:recurrent muscle twitches (symptom) --- r_associated #0: 20 --> en:white substance
    n1=en:recurrent muscle twitches (symptom) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3634. en:recurrent seizures nos --- r_associated #0: 20 --> en:white substance
    n1=en:recurrent seizures nos | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3635. en:recurrent subcortical infarcts (strokes) --- r_associated #0: 20 --> en:white substance
    n1=en:recurrent subcortical infarcts (strokes) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3636. en:reduced brain gyri --- r_associated #0: 20 --> en:white substance
    n1=en:reduced brain gyri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3637. en:reduced brain size --- r_associated #0: 20 --> en:white substance
    n1=en:reduced brain size | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3638. en:reduced cerebral white matter --- r_associated #0: 20 --> en:white substance
    n1=en:reduced cerebral white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3639. en:reduced concentration span --- r_associated #0: 20 --> en:white substance
    n1=en:reduced concentration span | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3640. en:reduced consciousness --- r_associated #0: 20 --> en:white substance
    n1=en:reduced consciousness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3641. en:reduced consciousness, hypoglycemia-related --- r_associated #0: 20 --> en:white substance
    n1=en:reduced consciousness, hypoglycemia-related | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3642. en:reduced numbers of neurons --- r_associated #0: 20 --> en:white substance
    n1=en:reduced numbers of neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3643. en:reduced posterior white matter volume (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:reduced posterior white matter volume (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3644. en:reduced size of the pituitary gland --- r_associated #0: 20 --> en:white substance
    n1=en:reduced size of the pituitary gland | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3645. en:reduced sleep latency --- r_associated #0: 20 --> en:white substance
    n1=en:reduced sleep latency | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3646. en:reduced tendon reflexes --- r_associated #0: 20 --> en:white substance
    n1=en:reduced tendon reflexes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3647. en:reduced white matter --- r_associated #0: 20 --> en:white substance
    n1=en:reduced white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3648. en:reduced white matter volume --- r_associated #0: 20 --> en:white substance
    n1=en:reduced white matter volume | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3649. en:reduction of white matter, generalized --- r_associated #0: 20 --> en:white substance
    n1=en:reduction of white matter, generalized | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3650. en:reduction or loss of acquired skills (e.g., purposeful hand use, speech) --- r_associated #0: 20 --> en:white substance
    n1=en:reduction or loss of acquired skills (e.g., purposeful hand use, speech) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3651. en:reflex epilepsy, photosensitive --- r_associated #0: 20 --> en:white substance
    n1=en:reflex epilepsy, photosensitive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3652. en:reflex, deep tendon, absent --- r_associated #0: 20 --> en:white substance
    n1=en:reflex, deep tendon, absent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3653. en:region of cell part cluster of neuraxis --- r_associated #0: 20 --> en:white substance
    n1=en:region of cell part cluster of neuraxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3654. en:region of gray matter of neuraxis --- r_associated #0: 20 --> en:white substance
    n1=en:region of gray matter of neuraxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3655. en:regression of development --- r_associated #0: 20 --> en:white substance
    n1=en:regression of development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3656. en:regression of early motor skills --- r_associated #0: 20 --> en:white substance
    n1=en:regression of early motor skills | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3657. en:regression of motor development --- r_associated #0: 20 --> en:white substance
    n1=en:regression of motor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3658. en:relative preservation of purkinje cells, but they are deformed and disaligned --- r_associated #0: 20 --> en:white substance
    n1=en:relative preservation of purkinje cells, but they are deformed and disaligned | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3659. en:relative preservation of the cerebellar folia --- r_associated #0: 20 --> en:white substance
    n1=en:relative preservation of the cerebellar folia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3660. en:relative preservation of the cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:relative preservation of the cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3661. en:relative sparing of language --- r_associated #0: 20 --> en:white substance
    n1=en:relative sparing of language | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3662. en:relief with motor activation --- r_associated #0: 20 --> en:white substance
    n1=en:relief with motor activation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3663. en:rem sleep behavior disorder --- r_associated #0: 20 --> en:white substance
    n1=en:rem sleep behavior disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3664. en:renal medulla --- r_associated #0: 20 --> en:white substance
    n1=en:renal medulla | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3665. en:residual ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:residual ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3666. en:response to pyridoxal phosphate --- r_associated #0: 20 --> en:white substance
    n1=en:response to pyridoxal phosphate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3667. en:resting myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:resting myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3668. en:resting tremor (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:resting tremor (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3669. en:resting tremors --- r_associated #0: 20 --> en:white substance
    n1=en:resting tremors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3670. en:restlessness at birth --- r_associated #0: 20 --> en:white substance
    n1=en:restlessness at birth | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3671. en:restrictive behavior, interests, and activities --- r_associated #0: 20 --> en:white substance
    n1=en:restrictive behavior, interests, and activities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3672. en:results in nocturnal insomnia and chronic sleep deprivation --- r_associated #0: 20 --> en:white substance
    n1=en:results in nocturnal insomnia and chronic sleep deprivation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3673. en:retrocerebellar cyst --- r_associated #0: 20 --> en:white substance
    n1=en:retrocerebellar cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3674. en:retrocerebellar cyst (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:retrocerebellar cyst (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3675. en:retrocerebellar cyst (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:retrocerebellar cyst (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3676. en:retrocollis --- r_associated #0: 20 --> en:white substance
    n1=en:retrocollis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3677. en:retroflexion of the neck --- r_associated #0: 20 --> en:white substance
    n1=en:retroflexion of the neck | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3678. en:reversal sign --- r_associated #0: 20 --> en:white substance
    n1=en:reversal sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3679. en:reye syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:reye syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3680. en:rhombencephalosynapsis --- r_associated #0: 20 --> en:white substance
    n1=en:rhombencephalosynapsis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3681. en:rigidity (juvenile form) --- r_associated #0: 20 --> en:white substance
    n1=en:rigidity (juvenile form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3682. en:rigidity (later) --- r_associated #0: 20 --> en:white substance
    n1=en:rigidity (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3683. en:rigidity during seizures --- r_associated #0: 20 --> en:white substance
    n1=en:rigidity during seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3684. en:rigidity of limbs --- r_associated #0: 20 --> en:white substance
    n1=en:rigidity of limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3685. en:rigidity, axial and limb --- r_associated #0: 20 --> en:white substance
    n1=en:rigidity, axial and limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3686. en:roentgenographic --- r_associated #0: 20 --> en:white substance
    n1=en:roentgenographic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3687. en:romberg's sign positive --- r_associated #0: 20 --> en:white substance
    n1=en:romberg's sign positive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3688. en:rotary head movements ('rolling,' 'tremor') --- r_associated #0: 20 --> en:white substance
    n1=en:rotary head movements ('rolling,' 'tremor') | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3689. en:roving eye movements (infancy) --- r_associated #0: 20 --> en:white substance
    n1=en:roving eye movements (infancy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3690. en:rudimentary white matter --- r_associated #0: 20 --> en:white substance
    n1=en:rudimentary white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3691. en:sagittal sinus thrombosis --- r_associated #0: 20 --> en:white substance
    n1=en:sagittal sinus thrombosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3692. en:salaam seizures --- r_associated #0: 20 --> en:white substance
    n1=en:salaam seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3693. en:scanning speech --- r_associated #0: 20 --> en:white substance
    n1=en:scanning speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3694. en:scant iron deposition in the brain (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:scant iron deposition in the brain (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3695. en:scattered cns demyelination --- r_associated #0: 20 --> en:white substance
    n1=en:scattered cns demyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3696. en:schizencephaly --- r_associated #0: 20 --> en:white substance
    n1=en:schizencephaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3697. en:schizophrenia --- r_associated #0: 20 --> en:white substance
    n1=en:schizophrenia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3698. en:schizophrenic reaction --- r_associated #0: 20 --> en:white substance
    n1=en:schizophrenic reaction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3699. en:school problem (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:school problem (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3700. en:scissoring --- r_associated #0: 20 --> en:white substance
    n1=en:scissoring | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3701. en:scissors gait --- r_associated #0: 20 --> en:white substance
    n1=en:scissors gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3702. en:secondary generalization --- r_associated #0: 20 --> en:white substance
    n1=en:secondary generalization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3703. en:secondary generalization may occur --- r_associated #0: 20 --> en:white substance
    n1=en:secondary generalization may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3704. en:secondary generalization occurs in about 33% of patients --- r_associated #0: 20 --> en:white substance
    n1=en:secondary generalization occurs in about 33% of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3705. en:secondary generalized tonic-clonic seizures may occur --- r_associated #0: 20 --> en:white substance
    n1=en:secondary generalized tonic-clonic seizures may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3706. en:secondary hand muscle weakness predominating at the wrist and finger extensor muscles --- r_associated #0: 20 --> en:white substance
    n1=en:secondary hand muscle weakness predominating at the wrist and finger extensor muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3707. en:secondary hypertonia --- r_associated #0: 20 --> en:white substance
    n1=en:secondary hypertonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3708. en:secondary involvement of proximal and trunk muscles --- r_associated #0: 20 --> en:white substance
    n1=en:secondary involvement of proximal and trunk muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3709. en:secondary motor complications develop in 50% of those on levodopa therapy --- r_associated #0: 20 --> en:white substance
    n1=en:secondary motor complications develop in 50% of those on levodopa therapy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3710. en:secondary seizures (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:secondary seizures (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3711. en:secondary spinal cord compression may occur --- r_associated #0: 20 --> en:white substance
    n1=en:secondary spinal cord compression may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3712. en:see juvenile myoclonic epilepsy (606904) --- r_associated #0: 20 --> en:white substance
    n1=en:see juvenile myoclonic epilepsy (606904) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3713. en:see spg5a (270800) --- r_associated #0: 20 --> en:white substance
    n1=en:see spg5a (270800) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3714. en:segment of cerebellar medulla --- r_associated #0: 20 --> en:white substance
    n1=en:segment of cerebellar medulla | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3715. en:segment of metencephalon --- r_associated #0: 20 --> en:white substance
    n1=en:segment of metencephalon | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3716. en:segment of spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:segment of spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3717. en:segmental callosal hypoplasia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:segmental callosal hypoplasia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3718. en:segmental sensory loss, especially of pain and temperature --- r_associated #0: 20 --> en:white substance
    n1=en:segmental sensory loss, especially of pain and temperature | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3719. en:seizure --- r_associated #0: 20 --> en:white substance
    n1=en:seizure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3720. en:seizure (in a subset of patients in infancy) --- r_associated #0: 20 --> en:white substance
    n1=en:seizure (in a subset of patients in infancy) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3721. en:seizure disorder --- r_associated #0: 20 --> en:white substance
    n1=en:seizure disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3722. en:seizure disorder (homozygote) --- r_associated #0: 20 --> en:white substance
    n1=en:seizure disorder (homozygote) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3723. en:seizure including seizure-like activity in utero starting around 18 weeks gestation --- r_associated #0: 20 --> en:white substance
    n1=en:seizure including seizure-like activity in utero starting around 18 weeks gestation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3724. en:seizure, febrile (2/3 children) --- r_associated #0: 20 --> en:white substance
    n1=en:seizure, febrile (2/3 children) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3725. en:seizure, focal or multifocal onset --- r_associated #0: 20 --> en:white substance
    n1=en:seizure, focal or multifocal onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3726. en:seizures (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3727. en:seizures (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3728. en:seizures (2-10% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (2-10% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3729. en:seizures (3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3730. en:seizures (40%) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (40%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3731. en:seizures (50% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (50% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3732. en:seizures (50%) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (50%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3733. en:seizures (> 90%) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (> 90%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3734. en:seizures (about 50% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (about 50% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3735. en:seizures (adult) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (adult) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3736. en:seizures (cvs+) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (cvs+) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3737. en:seizures (eclampsia) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (eclampsia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3738. en:seizures (if left untreated) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (if left untreated) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3739. en:seizures (in 1 of 2 sibs) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in 1 of 2 sibs) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3740. en:seizures (in 1 of 3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in 1 of 3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3741. en:seizures (in 2 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in 2 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3742. en:seizures (in 2 of 9 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in 2 of 9 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3743. en:seizures (in 35%) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in 35%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3744. en:seizures (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3745. en:seizures (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3746. en:seizures (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3747. en:seizures (juvenile form) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (juvenile form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3748. en:seizures (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3749. en:seizures (may be difficult to control) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (may be difficult to control) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3750. en:seizures (mean onset 4-5 months) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (mean onset 4-5 months) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3751. en:seizures (meb) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (meb) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3752. en:seizures (onset <2 years) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (onset <2 years) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3753. en:seizures (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3754. en:seizures (rare, in males) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (rare, in males) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3755. en:seizures (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3756. en:seizures (reported in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (reported in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3757. en:seizures (tetany) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (tetany) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3758. en:seizures (type i and type ii, juvenile) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (type i and type ii, juvenile) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3759. en:seizures (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3760. en:seizures (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3761. en:seizures affect the vocal cords, lips, mouth, and face --- r_associated #0: 20 --> en:white substance
    n1=en:seizures affect the vocal cords, lips, mouth, and face | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3762. en:seizures are poorly controlled --- r_associated #0: 20 --> en:white substance
    n1=en:seizures are poorly controlled | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3763. en:seizures in 15-30% --- r_associated #0: 20 --> en:white substance
    n1=en:seizures in 15-30% | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3764. en:seizures in the newborn, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:seizures in the newborn, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3765. en:seizures may occur during hypotensive episodes --- r_associated #0: 20 --> en:white substance
    n1=en:seizures may occur during hypotensive episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3766. en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause --- r_associated #0: 20 --> en:white substance
    n1=en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3767. en:seizures occur in clusters --- r_associated #0: 20 --> en:white substance
    n1=en:seizures occur in clusters | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3768. en:seizures occur in clusters over 1 or several days --- r_associated #0: 20 --> en:white substance
    n1=en:seizures occur in clusters over 1 or several days | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3769. en:seizures occur multiple times per day --- r_associated #0: 20 --> en:white substance
    n1=en:seizures occur multiple times per day | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3770. en:seizures often associated with infections --- r_associated #0: 20 --> en:white substance
    n1=en:seizures often associated with infections | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3771. en:seizures often begin focally with head and eye deviation --- r_associated #0: 20 --> en:white substance
    n1=en:seizures often begin focally with head and eye deviation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3772. en:seizures often begin with head and eye deviation --- r_associated #0: 20 --> en:white substance
    n1=en:seizures often begin with head and eye deviation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3773. en:seizures provoked by tactile stimulation or extreme emotion --- r_associated #0: 20 --> en:white substance
    n1=en:seizures provoked by tactile stimulation or extreme emotion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3774. en:seizures recur in 33% of patients --- r_associated #0: 20 --> en:white substance
    n1=en:seizures recur in 33% of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3775. en:seizures usually last 1 to 5 minutes (less commonly up to 10 minutes) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures usually last 1 to 5 minutes (less commonly up to 10 minutes) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3776. en:seizures usually last less than 15 minutes --- r_associated #0: 20 --> en:white substance
    n1=en:seizures usually last less than 15 minutes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3777. en:seizures usually occur less than 3 times --- r_associated #0: 20 --> en:white substance
    n1=en:seizures usually occur less than 3 times | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3778. en:seizures, complex partial, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, complex partial, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3779. en:seizures, complex, myoclonic --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, complex, myoclonic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3780. en:seizures, continuous, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, continuous, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3781. en:seizures, diurnal partial, rare (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, diurnal partial, rare (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3782. en:seizures, early onset --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, early onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3783. en:seizures, early-onset (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, early-onset (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3784. en:seizures, febrile (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, febrile (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3785. en:seizures, focal, partial, motor --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, focal, partial, motor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3786. en:seizures, generalized tonic/clonic, myoclonic, atonic, or atypical absence, aggravated by fatigue and fasting with frequency ranges from daily to monthly (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, generalized tonic/clonic, myoclonic, atonic, or atypical absence, aggravated by fatigue and fasting with frequency ranges from daily to monthly (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3787. en:seizures, generalized, afebrile --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, generalized, afebrile | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3788. en:seizures, generalized, may occur --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, generalized, may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3789. en:seizures, hypoglycemic (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, hypoglycemic (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3790. en:seizures, infantile-onset --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, infantile-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3791. en:seizures, intractable --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, intractable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3792. en:seizures, intractable (in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, intractable (in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3793. en:seizures, juvenile myoclonic --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, juvenile myoclonic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3794. en:seizures, mild --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3795. en:seizures, multiple types --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, multiple types | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3796. en:seizures, neonatal (2p21del) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, neonatal (2p21del) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3797. en:seizures, nocturnal, usually occur in daily clusters --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, nocturnal, usually occur in daily clusters | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3798. en:seizures, onset age 5 to 10 years --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, onset age 5 to 10 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3799. en:seizures, partial complex (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, partial complex (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3800. en:seizures, partial with secondary generalization, focal at onset, usually motor --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, partial with secondary generalization, focal at onset, usually motor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3801. en:seizures, partial, often hemifacial --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, partial, often hemifacial | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3802. en:seizures, partial, unilateral --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, partial, unilateral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3803. en:seizures, particularly absence (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, particularly absence (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3804. en:seizures, poorly controlled --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, poorly controlled | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3805. en:seizures, recurrent, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, recurrent, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3806. en:seizures, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3807. en:seizures, refractory to treatment --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, refractory to treatment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3808. en:seizures, refractory, infantile-onset --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, refractory, infantile-onset | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3809. en:seizures, severe, drug-resistant, intractable --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, severe, drug-resistant, intractable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3810. en:seizures, severe, intractable --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, severe, intractable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3811. en:seizures, sudden-onset, drug-resistant --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, sudden-onset, drug-resistant | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3812. en:seizures, tonic, clonic, focal --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, tonic, clonic, focal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3813. en:seizures, tonic, hyperekplectic --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, tonic, hyperekplectic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3814. en:seizures, tonic-clonic (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, tonic-clonic (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3815. en:seizures, tonic-clonic (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, tonic-clonic (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3816. en:seizures, tonic-clonic or absence (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:seizures, tonic-clonic or absence (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3817. en:selective loss of cerebellar purkinje cells --- r_associated #0: 20 --> en:white substance
    n1=en:selective loss of cerebellar purkinje cells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3818. en:self mutilation --- r_associated #0: 20 --> en:white substance
    n1=en:self mutilation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3819. en:self-injurious behavior, median onset age 2 years --- r_associated #0: 20 --> en:white substance
    n1=en:self-injurious behavior, median onset age 2 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3820. en:semilobar holoprosencephalies --- r_associated #0: 20 --> en:white substance
    n1=en:semilobar holoprosencephalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3821. en:semilobar hpe shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle --- r_associated #0: 20 --> en:white substance
    n1=en:semilobar hpe shows posterior interhemispheric fissure with rudimentary cerebral hemispheres and single ventricle | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3822. en:sensitivity to neuroleptic medication --- r_associated #0: 20 --> en:white substance
    n1=en:sensitivity to neuroleptic medication | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3823. en:sensorineural hearing loss --- r_associated #0: 20 --> en:white substance
    n1=en:sensorineural hearing loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3824. en:sensory ataxia (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:sensory ataxia (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3825. en:sensory aura may occur --- r_associated #0: 20 --> en:white substance
    n1=en:sensory aura may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3826. en:septum of neuraxis --- r_associated #0: 20 --> en:white substance
    n1=en:septum of neuraxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3827. en:septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=en:septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3828. en:septum pellucidum deficient or cavum --- r_associated #0: 20 --> en:white substance
    n1=en:septum pellucidum deficient or cavum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3829. en:set of accessory visual structures --- r_associated #0: 20 --> en:white substance
    n1=en:set of accessory visual structures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3830. en:set of eye and related structures --- r_associated #0: 20 --> en:white substance
    n1=en:set of eye and related structures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3831. en:set of laryngeal cartilages and joints --- r_associated #0: 20 --> en:white substance
    n1=en:set of laryngeal cartilages and joints | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3832. en:severe behavioral problems at age 3-4 --- r_associated #0: 20 --> en:white substance
    n1=en:severe behavioral problems at age 3-4 | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3833. en:severe brain damage --- r_associated #0: 20 --> en:white substance
    n1=en:severe brain damage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3834. en:severe cognitive deficits (develop later) --- r_associated #0: 20 --> en:white substance
    n1=en:severe cognitive deficits (develop later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3835. en:severe cognitive impairment --- r_associated #0: 20 --> en:white substance
    n1=en:severe cognitive impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3836. en:severe delay in myelination --- r_associated #0: 20 --> en:white substance
    n1=en:severe delay in myelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3837. en:severe demyelination of the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:severe demyelination of the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3838. en:severe developmental delay in survivors --- r_associated #0: 20 --> en:white substance
    n1=en:severe developmental delay in survivors | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3839. en:severe expressive language delay --- r_associated #0: 20 --> en:white substance
    n1=en:severe expressive language delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3840. en:severe expressive speech delay --- r_associated #0: 20 --> en:white substance
    n1=en:severe expressive speech delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3841. en:severe form may never achieve sitting or walking --- r_associated #0: 20 --> en:white substance
    n1=en:severe form may never achieve sitting or walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3842. en:severe global developmental delay --- r_associated #0: 20 --> en:white substance
    n1=en:severe global developmental delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3843. en:severe hydrocephalus --- r_associated #0: 20 --> en:white substance
    n1=en:severe hydrocephalus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3844. en:severe involvement of globus pallidus --- r_associated #0: 20 --> en:white substance
    n1=en:severe involvement of globus pallidus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3845. en:severe mental retardation (congenital form) --- r_associated #0: 20 --> en:white substance
    n1=en:severe mental retardation (congenital form) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3846. en:severe mental retardation (i.q. 20-34) --- r_associated #0: 20 --> en:white substance
    n1=en:severe mental retardation (i.q. 20-34) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3847. en:severe mental retardation (iq 10-40) --- r_associated #0: 20 --> en:white substance
    n1=en:severe mental retardation (iq 10-40) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3848. en:severe muscular hypotonia --- r_associated #0: 20 --> en:white substance
    n1=en:severe muscular hypotonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3849. en:severe neonatal hypotonia improving with age --- r_associated #0: 20 --> en:white substance
    n1=en:severe neonatal hypotonia improving with age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3850. en:severe prenatal onset hydrocephalus --- r_associated #0: 20 --> en:white substance
    n1=en:severe prenatal onset hydrocephalus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3851. en:severe psychomotor retardation --- r_associated #0: 20 --> en:white substance
    n1=en:severe psychomotor retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3852. en:severe psychomotor retardation (iq 35-65) --- r_associated #0: 20 --> en:white substance
    n1=en:severe psychomotor retardation (iq 35-65) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3853. en:severe psychomotor retardation from birth --- r_associated #0: 20 --> en:white substance
    n1=en:severe psychomotor retardation from birth | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3854. en:severe speech delay --- r_associated #0: 20 --> en:white substance
    n1=en:severe speech delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3855. en:severe speech impairment --- r_associated #0: 20 --> en:white substance
    n1=en:severe speech impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3856. en:severely delayed psychomotor development --- r_associated #0: 20 --> en:white substance
    n1=en:severely delayed psychomotor development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3857. en:severely impaired or absent speech --- r_associated #0: 20 --> en:white substance
    n1=en:severely impaired or absent speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3858. en:severity of symptoms peak in the second decade and do not progress --- r_associated #0: 20 --> en:white substance
    n1=en:severity of symptoms peak in the second decade and do not progress | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3859. en:sheath of schwann --- r_associated #0: 20 --> en:white substance
    n1=en:sheath of schwann | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3860. en:shivering sensation --- r_associated #0: 20 --> en:white substance
    n1=en:shivering sensation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3861. en:short pons --- r_associated #0: 20 --> en:white substance
    n1=en:short pons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3862. en:shorter daily total sleep times compared to age-matched controls --- r_associated #0: 20 --> en:white substance
    n1=en:shorter daily total sleep times compared to age-matched controls | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3863. en:shrunken inferior olivary nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:shrunken inferior olivary nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3864. en:shuffling gaits --- r_associated #0: 20 --> en:white substance
    n1=en:shuffling gaits | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3865. en:signal abnormalities in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:signal abnormalities in the posterior limbs of the internal capsules, middle cerebral peduncles, pyramidal tracts in the pons, and middle cerebellar peduncles seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3866. en:signal changes in the caudate and putamen --- r_associated #0: 20 --> en:white substance
    n1=en:signal changes in the caudate and putamen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3867. en:simple partial seizures --- r_associated #0: 20 --> en:white substance
    n1=en:simple partial seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3868. en:simple partial seizures with secondary generalization --- r_associated #0: 20 --> en:white substance
    n1=en:simple partial seizures with secondary generalization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3869. en:simplified cortical gyral pattern --- r_associated #0: 20 --> en:white substance
    n1=en:simplified cortical gyral pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3870. en:simplified cortical gyration pattern --- r_associated #0: 20 --> en:white substance
    n1=en:simplified cortical gyration pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3871. en:simplified gyral pattern (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:simplified gyral pattern (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3872. en:simplified gyral pattern (in 1 of 2 sibs) --- r_associated #0: 20 --> en:white substance
    n1=en:simplified gyral pattern (in 1 of 2 sibs) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3873. en:simplified gyral pattern (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:simplified gyral pattern (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3874. en:simplified gyral pattern (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:simplified gyral pattern (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3875. en:simplified gyration in the frontal cortex (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:simplified gyration in the frontal cortex (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3876. en:simplified gyration pattern --- r_associated #0: 20 --> en:white substance
    n1=en:simplified gyration pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3877. en:sinus pericranii (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:sinus pericranii (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3878. en:skin photosensitivity --- r_associated #0: 20 --> en:white substance
    n1=en:skin photosensitivity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3879. en:sleep abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:sleep abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3880. en:sleep apnea --- r_associated #0: 20 --> en:white substance
    n1=en:sleep apnea | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3881. en:sleep apnea (in 1/4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:sleep apnea (in 1/4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3882. en:sleep benefit (31%) --- r_associated #0: 20 --> en:white substance
    n1=en:sleep benefit (31%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3883. en:sleep disorder --- r_associated #0: 20 --> en:white substance
    n1=en:sleep disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3884. en:sleep disorder (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:sleep disorder (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3885. en:sleep disorder with severe insomnia (in adulthood) --- r_associated #0: 20 --> en:white substance
    n1=en:sleep disorder with severe insomnia (in adulthood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3886. en:sleep disturbances --- r_associated #0: 20 --> en:white substance
    n1=en:sleep disturbances | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3887. en:sleep disturbances (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:sleep disturbances (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3888. en:sleep disturbances common --- r_associated #0: 20 --> en:white substance
    n1=en:sleep disturbances common | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3889. en:sleep impairment, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:sleep impairment, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3890. en:sleep paralysis at beginning or end of sleep period (in 60% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:sleep paralysis at beginning or end of sleep period (in 60% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3891. en:sleep pattern disturbance --- r_associated #0: 20 --> en:white substance
    n1=en:sleep pattern disturbance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3892. en:sleep talking --- r_associated #0: 20 --> en:white substance
    n1=en:sleep talking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3893. en:sleep-onset rem --- r_associated #0: 20 --> en:white substance
    n1=en:sleep-onset rem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3894. en:sleep-wake cycle disturbance --- r_associated #0: 20 --> en:white substance
    n1=en:sleep-wake cycle disturbance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3895. en:sleepiness --- r_associated #0: 20 --> en:white substance
    n1=en:sleepiness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3896. en:slow gait --- r_associated #0: 20 --> en:white substance
    n1=en:slow gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3897. en:slow gross motor activity --- r_associated #0: 20 --> en:white substance
    n1=en:slow gross motor activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3898. en:slow paraparetic gait --- r_associated #0: 20 --> en:white substance
    n1=en:slow paraparetic gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3899. en:slow reactions --- r_associated #0: 20 --> en:white substance
    n1=en:slow reactions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3900. en:slow speech --- r_associated #0: 20 --> en:white substance
    n1=en:slow speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3901. en:slow spike-wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:slow spike-wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3902. en:slow, broad-based gait --- r_associated #0: 20 --> en:white substance
    n1=en:slow, broad-based gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3903. en:slowed background activity --- r_associated #0: 20 --> en:white substance
    n1=en:slowed background activity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3904. en:slowing mental development by 1.5 to 3 years --- r_associated #0: 20 --> en:white substance
    n1=en:slowing mental development by 1.5 to 3 years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3905. en:slowing mental development by 1.5 to 3 years of age --- r_associated #0: 20 --> en:white substance
    n1=en:slowing mental development by 1.5 to 3 years of age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3906. en:slowly progressive neurologic deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:slowly progressive neurologic deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3907. en:slurred speech --- r_associated #0: 20 --> en:white substance
    n1=en:slurred speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3908. en:slurred speech, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:slurred speech, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3909. en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration --- r_associated #0: 20 --> en:white substance
    n1=en:small and medium-sized leptomeningeal arteries show luminal narrowing or obliteration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3910. en:small anterior commissure --- r_associated #0: 20 --> en:white substance
    n1=en:small anterior commissure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3911. en:small brain --- r_associated #0: 20 --> en:white substance
    n1=en:small brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3912. en:small brain size (some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:small brain size (some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3913. en:small brain with no other malformation see on mri --- r_associated #0: 20 --> en:white substance
    n1=en:small brain with no other malformation see on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3914. en:small but structurally normal cerebral cortex --- r_associated #0: 20 --> en:white substance
    n1=en:small but structurally normal cerebral cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3915. en:small caudate --- r_associated #0: 20 --> en:white substance
    n1=en:small caudate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3916. en:small cavum septum --- r_associated #0: 20 --> en:white substance
    n1=en:small cavum septum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3917. en:small cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:small cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3918. en:small cerebellum (especially vermis) --- r_associated #0: 20 --> en:white substance
    n1=en:small cerebellum (especially vermis) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3919. en:small cerebral cortex --- r_associated #0: 20 --> en:white substance
    n1=en:small cerebral cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3920. en:small frontal lobes (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:small frontal lobes (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3921. en:small hippocampi (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:small hippocampi (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3922. en:small midbrain --- r_associated #0: 20 --> en:white substance
    n1=en:small midbrain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3923. en:small pituitary gland (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:small pituitary gland (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3924. en:small rotary component may be present --- r_associated #0: 20 --> en:white substance
    n1=en:small rotary component may be present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3925. en:small sella --- r_associated #0: 20 --> en:white substance
    n1=en:small sella | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3926. en:small shrunken brain --- r_associated #0: 20 --> en:white substance
    n1=en:small shrunken brain | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3927. en:small size of the left hippocampus gyri --- r_associated #0: 20 --> en:white substance
    n1=en:small size of the left hippocampus gyri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3928. en:small thalami --- r_associated #0: 20 --> en:white substance
    n1=en:small thalami | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3929. en:small, smooth cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:small, smooth cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3930. en:small, thin cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:small, thin cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3931. en:smooth brain surface --- r_associated #0: 20 --> en:white substance
    n1=en:smooth brain surface | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3932. en:smooth, thin cortical mantle (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:smooth, thin cortical mantle (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3933. en:social and occupational deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:social and occupational deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3934. en:social communication disorder --- r_associated #0: 20 --> en:white substance
    n1=en:social communication disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3935. en:somatosensory evoked potentials show prolonged latency --- r_associated #0: 20 --> en:white substance
    n1=en:somatosensory evoked potentials show prolonged latency | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3936. en:some may not achieve ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:some may not achieve ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3937. en:some patients do not achieve ability to walk --- r_associated #0: 20 --> en:white substance
    n1=en:some patients do not achieve ability to walk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3938. en:some patients have neurologic involvement --- r_associated #0: 20 --> en:white substance
    n1=en:some patients have neurologic involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3939. en:some patients have no structural brain abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:some patients have no structural brain abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3940. en:some patients have periodic wave complexes on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:some patients have periodic wave complexes on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3941. en:some patients may develop afebrile seizures later in life --- r_associated #0: 20 --> en:white substance
    n1=en:some patients may develop afebrile seizures later in life | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3942. en:some patients may show normal early development --- r_associated #0: 20 --> en:white substance
    n1=en:some patients may show normal early development | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3943. en:some patients never achieve independent ambulation --- r_associated #0: 20 --> en:white substance
    n1=en:some patients never achieve independent ambulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3944. en:some patients only achieve sitting --- r_associated #0: 20 --> en:white substance
    n1=en:some patients only achieve sitting | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3945. en:somnolence --- r_associated #0: 20 --> en:white substance
    n1=en:somnolence | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3946. en:sparing of central white matter structures --- r_associated #0: 20 --> en:white substance
    n1=en:sparing of central white matter structures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3947. en:sparing of optic tracts --- r_associated #0: 20 --> en:white substance
    n1=en:sparing of optic tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3948. en:sparing of the inferior olives --- r_associated #0: 20 --> en:white substance
    n1=en:sparing of the inferior olives | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3949. en:spasmodic dysphonia --- r_associated #0: 20 --> en:white substance
    n1=en:spasmodic dysphonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3950. en:spasmodic torticollis --- r_associated #0: 20 --> en:white substance
    n1=en:spasmodic torticollis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3951. en:spastic ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:spastic ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3952. en:spastic cerebral palsy --- r_associated #0: 20 --> en:white substance
    n1=en:spastic cerebral palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3953. en:spastic diplegia --- r_associated #0: 20 --> en:white substance
    n1=en:spastic diplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3954. en:spastic diplegia (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic diplegia (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3955. en:spastic diplegia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic diplegia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3956. en:spastic diplegia, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:spastic diplegia, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3957. en:spastic diplegia, symmetric --- r_associated #0: 20 --> en:white substance
    n1=en:spastic diplegia, symmetric | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3958. en:spastic dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:spastic dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3959. en:spastic gait --- r_associated #0: 20 --> en:white substance
    n1=en:spastic gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3960. en:spastic paralysis --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paralysis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3961. en:spastic paraparesis (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraparesis (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3962. en:spastic paraparesis (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraparesis (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3963. en:spastic paraplegia --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3964. en:spastic paraplegia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraplegia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3965. en:spastic paraplegia, later onset (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraplegia, later onset (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3966. en:spastic paraplegia, pure --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraplegia, pure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3967. en:spastic paraplegia, severe --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraplegia, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3968. en:spastic paraplegia, slowly progressive --- r_associated #0: 20 --> en:white substance
    n1=en:spastic paraplegia, slowly progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3969. en:spastic quadriplegia --- r_associated #0: 20 --> en:white substance
    n1=en:spastic quadriplegia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3970. en:spastic quadriplegia (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic quadriplegia (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3971. en:spastic quadriplegia, residual mild-to-severe (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic quadriplegia, residual mild-to-severe (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3972. en:spastic quadriplegia, severe --- r_associated #0: 20 --> en:white substance
    n1=en:spastic quadriplegia, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3973. en:spastic tetraparesis --- r_associated #0: 20 --> en:white substance
    n1=en:spastic tetraparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3974. en:spastic tetraparesis (in severe cases) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic tetraparesis (in severe cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3975. en:spastic tetraplegia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic tetraplegia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3976. en:spastic tetraplegia (onset in the second decade) --- r_associated #0: 20 --> en:white substance
    n1=en:spastic tetraplegia (onset in the second decade) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3977. en:spastic-ataxic gait --- r_associated #0: 20 --> en:white substance
    n1=en:spastic-ataxic gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3978. en:spastic-ataxic tetraparesis --- r_associated #0: 20 --> en:white substance
    n1=en:spastic-ataxic tetraparesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3979. en:spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3980. en:spasticity (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3981. en:spasticity (1 of 4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (1 of 4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3982. en:spasticity (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3983. en:spasticity (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3984. en:spasticity (later onset) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (later onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3985. en:spasticity (later) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (later) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3986. en:spasticity (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3987. en:spasticity (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3988. en:spasticity (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3989. en:spasticity (reported in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (reported in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3990. en:spasticity (type ii) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity (type ii) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3991. en:spasticity in infancy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity in infancy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3992. en:spasticity may be present --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity may be present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3993. en:spasticity may occur --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3994. en:spasticity of facial muscles --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity of facial muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3995. en:spasticity of lower and upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity of lower and upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3996. en:spasticity of pharyngeal muscles --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity of pharyngeal muscles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3997. en:spasticity, distal --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, distal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3998. en:spasticity, hyperreflexia --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, hyperreflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  3999. en:spasticity, lower limbs greater than upper limbs --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, lower limbs greater than upper limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4000. en:spasticity, mainly in the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, mainly in the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4001. en:spasticity, mild (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, mild (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4002. en:spasticity, more apparent in the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, more apparent in the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4003. en:spasticity, primarily lower limbs, but upper limbs may be involved --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, primarily lower limbs, but upper limbs may be involved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4004. en:spasticity, progressive, develops in childhood --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, progressive, develops in childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4005. en:spasticity, severe --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4006. en:spasticity, severe, affecting lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, severe, affecting lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4007. en:spasticity, usually of the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity, usually of the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4008. en:spasticity/paresis (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:spasticity/paresis (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4009. en:specific visual spatial processing defect --- r_associated #0: 20 --> en:white substance
    n1=en:specific visual spatial processing defect | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4010. en:spect scan may show hypermetabolism of the temporal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:spect scan may show hypermetabolism of the temporal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4011. en:speech abnormalities (palilalia) --- r_associated #0: 20 --> en:white substance
    n1=en:speech abnormalities (palilalia) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4012. en:speech absent or delayed --- r_associated #0: 20 --> en:white substance
    n1=en:speech absent or delayed | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4013. en:speech and language delay (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:speech and language delay (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4014. en:speech and language delay, severe --- r_associated #0: 20 --> en:white substance
    n1=en:speech and language delay, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4015. en:speech and language disorder --- r_associated #0: 20 --> en:white substance
    n1=en:speech and language disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4016. en:speech and language regression --- r_associated #0: 20 --> en:white substance
    n1=en:speech and language regression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4017. en:speech articulation defects --- r_associated #0: 20 --> en:white substance
    n1=en:speech articulation defects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4018. en:speech articulation problems --- r_associated #0: 20 --> en:white substance
    n1=en:speech articulation problems | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4019. en:speech deficits --- r_associated #0: 20 --> en:white substance
    n1=en:speech deficits | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4020. en:speech delay --- r_associated #0: 20 --> en:white substance
    n1=en:speech delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4021. en:speech delay (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:speech delay (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4022. en:speech delay (10%) --- r_associated #0: 20 --> en:white substance
    n1=en:speech delay (10%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4023. en:speech delay (59%) --- r_associated #0: 20 --> en:white substance
    n1=en:speech delay (59%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4024. en:speech delay (in all patients) --- r_associated #0: 20 --> en:white substance
    n1=en:speech delay (in all patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4025. en:speech delay (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:speech delay (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4026. en:speech deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:speech deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4027. en:speech development delayed (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:speech development delayed (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4028. en:speech difficulties (48%) --- r_associated #0: 20 --> en:white substance
    n1=en:speech difficulties (48%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4029. en:speech difficulties due to hypoglossia --- r_associated #0: 20 --> en:white substance
    n1=en:speech difficulties due to hypoglossia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4030. en:speech disability --- r_associated #0: 20 --> en:white substance
    n1=en:speech disability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4031. en:speech disorder --- r_associated #0: 20 --> en:white substance
    n1=en:speech disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4032. en:speech disorder (in 1 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:speech disorder (in 1 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4033. en:speech disorders (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:speech disorders (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4034. en:speech hesitancy --- r_associated #0: 20 --> en:white substance
    n1=en:speech hesitancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4035. en:speech impairment --- r_associated #0: 20 --> en:white substance
    n1=en:speech impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4036. en:speech limited --- r_associated #0: 20 --> en:white substance
    n1=en:speech limited | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4037. en:speech limited to single word or no words --- r_associated #0: 20 --> en:white substance
    n1=en:speech limited to single word or no words | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4038. en:speech never acquired --- r_associated #0: 20 --> en:white substance
    n1=en:speech never acquired | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4039. en:speech severely limited or absent --- r_associated #0: 20 --> en:white substance
    n1=en:speech severely limited or absent | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4040. en:speech, limited or nonverbal --- r_associated #0: 20 --> en:white substance
    n1=en:speech, limited or nonverbal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4041. en:spheroids contain neurofilaments --- r_associated #0: 20 --> en:white substance
    n1=en:spheroids contain neurofilaments | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4042. en:spina bifida --- r_associated #0: 20 --> en:white substance
    n1=en:spina bifida | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4043. en:spina bifida (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:spina bifida (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4044. en:spina bifida occulta --- r_associated #0: 20 --> en:white substance
    n1=en:spina bifida occulta | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4045. en:spinal arteriovenous malformation --- r_associated #0: 20 --> en:white substance
    n1=en:spinal arteriovenous malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4046. en:spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4047. en:spinal cord atrophy (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord atrophy (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4048. en:spinal cord atrophy (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord atrophy (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4049. en:spinal cord compression --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord compression | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4050. en:spinal cord compression by tumor infiltration --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord compression by tumor infiltration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4051. en:spinal cord disorder --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord disorder | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4052. en:spinal cord dorsal median sulcus --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord dorsal median sulcus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4053. en:spinal cord glial hyperplasia --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord glial hyperplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4054. en:spinal cord paresis --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord paresis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4055. en:spinal cord part --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord part | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4056. en:spinal cord syrinx (in 2 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cord syrinx (in 2 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4057. en:spinal cysts (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spinal cysts (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4058. en:spinal muscular atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:spinal muscular atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4059. en:spinal nerve root --- r_associated #0: 20 --> en:white substance
    n1=en:spinal nerve root | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4060. en:spinal neurofibromas (64%) --- r_associated #0: 20 --> en:white substance
    n1=en:spinal neurofibromas (64%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4061. en:spinal neuropathy --- r_associated #0: 20 --> en:white substance
    n1=en:spinal neuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4062. en:spinal stenosis --- r_associated #0: 20 --> en:white substance
    n1=en:spinal stenosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4063. en:spinal tract degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:spinal tract degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4064. en:spinocerebellar ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:spinocerebellar ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4065. en:spinocerebellar ataxia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:spinocerebellar ataxia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4066. en:spinocerebellar ataxia (upper and lower limb involvement) --- r_associated #0: 20 --> en:white substance
    n1=en:spinocerebellar ataxia (upper and lower limb involvement) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4067. en:spinocerebellar degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:spinocerebellar degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4068. en:spinocerebellar tract degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:spinocerebellar tract degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4069. en:spinocerebellar tract disease in lower limbs (in adulthood) --- r_associated #0: 20 --> en:white substance
    n1=en:spinocerebellar tract disease in lower limbs (in adulthood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4070. en:spinothalamic tracts --- r_associated #0: 20 --> en:white substance
    n1=en:spinothalamic tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4071. en:spongiform changes are mild or may not be present --- r_associated #0: 20 --> en:white substance
    n1=en:spongiform changes are mild or may not be present | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4072. en:spongiform degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:spongiform degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4073. en:spongiform encephalomyelopathy --- r_associated #0: 20 --> en:white substance
    n1=en:spongiform encephalomyelopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4074. en:spongiosis, mild --- r_associated #0: 20 --> en:white substance
    n1=en:spongiosis, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4075. en:spongy degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:spongy degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4076. en:spongy gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:spongy gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4077. en:stance ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:stance ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4078. en:staring --- r_associated #0: 20 --> en:white substance
    n1=en:staring | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4079. en:staring episodes during seizures --- r_associated #0: 20 --> en:white substance
    n1=en:staring episodes during seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4080. en:staring spells --- r_associated #0: 20 --> en:white substance
    n1=en:staring spells | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4081. en:start with tonic posturing --- r_associated #0: 20 --> en:white substance
    n1=en:start with tonic posturing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4082. en:startle myoclonus --- r_associated #0: 20 --> en:white substance
    n1=en:startle myoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4083. en:status dystonicus --- r_associated #0: 20 --> en:white substance
    n1=en:status dystonicus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4084. en:status epilepticus --- r_associated #0: 20 --> en:white substance
    n1=en:status epilepticus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4085. en:status epilepticus (in 1 of 6 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:status epilepticus (in 1 of 6 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4086. en:status epilepticus (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:status epilepticus (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4087. en:status epilepticus (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:status epilepticus (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4088. en:status epilepticus may occur --- r_associated #0: 20 --> en:white substance
    n1=en:status epilepticus may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4089. en:status epilepticus rarely occurs --- r_associated #0: 20 --> en:white substance
    n1=en:status epilepticus rarely occurs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4090. en:stenosis of the aqueduct of sylvius (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:stenosis of the aqueduct of sylvius (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4091. en:stenosis of the jugular foramen --- r_associated #0: 20 --> en:white substance
    n1=en:stenosis of the jugular foramen | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4092. en:stereotypic movements --- r_associated #0: 20 --> en:white substance
    n1=en:stereotypic movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4093. en:stiff gait --- r_associated #0: 20 --> en:white substance
    n1=en:stiff gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4094. en:stiff limbs --- r_associated #0: 20 --> en:white substance
    n1=en:stiff limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4095. en:stiffness --- r_associated #0: 20 --> en:white substance
    n1=en:stiffness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4096. en:stiffness of the lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:stiffness of the lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4097. en:stiffness while walking --- r_associated #0: 20 --> en:white substance
    n1=en:stiffness while walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4098. en:stimulation sensitive generalized myoclonus (stage 3) --- r_associated #0: 20 --> en:white substance
    n1=en:stimulation sensitive generalized myoclonus (stage 3) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4099. en:stimulation sensitive segmental myoclonus (stage 2) --- r_associated #0: 20 --> en:white substance
    n1=en:stimulation sensitive segmental myoclonus (stage 2) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4100. en:stoke-like lesions --- r_associated #0: 20 --> en:white substance
    n1=en:stoke-like lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4101. en:stretched cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:stretched cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4102. en:striatal atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:striatal atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4103. en:striatal lesions --- r_associated #0: 20 --> en:white substance
    n1=en:striatal lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4104. en:striatal necrosis --- r_associated #0: 20 --> en:white substance
    n1=en:striatal necrosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4105. en:stroke (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:stroke (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4106. en:stroke (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:stroke (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4107. en:stroke (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:stroke (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4108. en:stroke-like episodes --- r_associated #0: 20 --> en:white substance
    n1=en:stroke-like episodes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4109. en:stroke-like episodes (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:stroke-like episodes (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4110. en:stroke-like symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:stroke-like symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4111. en:strokes due to coagulopathy --- r_associated #0: 20 --> en:white substance
    n1=en:strokes due to coagulopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4112. en:structural abnormalities in the basal ganglia (especially caudate) --- r_associated #0: 20 --> en:white substance
    n1=en:structural abnormalities in the basal ganglia (especially caudate) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4113. en:structural abnormalities of cerebellum --- r_associated #0: 20 --> en:white substance
    n1=en:structural abnormalities of cerebellum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4114. en:structural brain abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:structural brain abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4115. en:structural brain anomalies --- r_associated #0: 20 --> en:white substance
    n1=en:structural brain anomalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4116. en:structural changes in the temporal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:structural changes in the temporal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4117. en:structure of anterior median fissure of medulla oblongata --- r_associated #0: 20 --> en:white substance
    n1=en:structure of anterior median fissure of medulla oblongata | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4118. en:structure of central auditory system --- r_associated #0: 20 --> en:white substance
    n1=en:structure of central auditory system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4119. en:structure of central sensory visual system --- r_associated #0: 20 --> en:white substance
    n1=en:structure of central sensory visual system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4120. en:structure of cervical spinal cord ventral horn --- r_associated #0: 20 --> en:white substance
    n1=en:structure of cervical spinal cord ventral horn | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4121. en:structure of decussation of superior cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:structure of decussation of superior cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4122. en:structure of spinal cord ventral lateral sulcus --- r_associated #0: 20 --> en:white substance
    n1=en:structure of spinal cord ventral lateral sulcus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4123. en:structure of spinal sensory afferent system --- r_associated #0: 20 --> en:white substance
    n1=en:structure of spinal sensory afferent system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4124. en:sturge-weber syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:sturge-weber syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4125. en:subacute neurologic deterioration --- r_associated #0: 20 --> en:white substance
    n1=en:subacute neurologic deterioration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4126. en:subarachnoid cyst --- r_associated #0: 20 --> en:white substance
    n1=en:subarachnoid cyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4127. en:subarachnoid hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:subarachnoid hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4128. en:subarachnoid hemorrhage (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:subarachnoid hemorrhage (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4129. en:subclinical absence seizures --- r_associated #0: 20 --> en:white substance
    n1=en:subclinical absence seizures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4130. en:subcortical and periventricular white matter abnormalities seen on mri (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical and periventricular white matter abnormalities seen on mri (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4131. en:subcortical atrophy (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical atrophy (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4132. en:subcortical band or laminar heterotopia (in female carriers) --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical band or laminar heterotopia (in female carriers) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4133. en:subcortical cysts in frontal and temporal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical cysts in frontal and temporal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4134. en:subcortical cysts may occur elsewhere --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical cysts may occur elsewhere | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4135. en:subcortical cysts temporal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical cysts temporal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4136. en:subcortical dementia, progressive (6% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical dementia, progressive (6% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4137. en:subcortical focal lacunae --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical focal lacunae | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4138. en:subcortical gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4139. en:subcortical heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4140. en:subcortical hypomyelination --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical hypomyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4141. en:subcortical lacunar lesions seen early in disease --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical lacunar lesions seen early in disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4142. en:subcortical lesions --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4143. en:subcortical lesions with edema --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical lesions with edema | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4144. en:subcortical leukodystrophy --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical leukodystrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4145. en:subcortical nodular grey matter heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical nodular grey matter heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4146. en:subcortical nodular lesions in perivascular white matter --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical nodular lesions in perivascular white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4147. en:subcortical origin of the myoclonus based on neurophysiologic studies --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical origin of the myoclonus based on neurophysiologic studies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4148. en:subcortical temporal white matter disease, moderate --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical temporal white matter disease, moderate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4149. en:subcortical white matter abnormalities (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical white matter abnormalities (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4150. en:subcortical white matter abnormalities seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical white matter abnormalities seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4151. en:subcortical white matter calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical white matter calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4152. en:subcortical white matter lesions in the temporal lobes seen on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:subcortical white matter lesions in the temporal lobes seen on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4153. en:subdivision of genital system --- r_associated #0: 20 --> en:white substance
    n1=en:subdivision of genital system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4154. en:subdivision of hemolymphoid system --- r_associated #0: 20 --> en:white substance
    n1=en:subdivision of hemolymphoid system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4155. en:subdivision of nervous system --- r_associated #0: 20 --> en:white substance
    n1=en:subdivision of nervous system | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4156. en:subependymal calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:subependymal calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4157. en:subependymal hemorrhage --- r_associated #0: 20 --> en:white substance
    n1=en:subependymal hemorrhage | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4158. en:subependymal heterotopias --- r_associated #0: 20 --> en:white substance
    n1=en:subependymal heterotopias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4159. en:subependymal heterotopic nodules --- r_associated #0: 20 --> en:white substance
    n1=en:subependymal heterotopic nodules | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4160. en:subependymal nodules --- r_associated #0: 20 --> en:white substance
    n1=en:subependymal nodules | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4161. en:subependymal pseudocyst --- r_associated #0: 20 --> en:white substance
    n1=en:subependymal pseudocyst | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4162. en:subnormal cognition --- r_associated #0: 20 --> en:white substance
    n1=en:subnormal cognition | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4163. en:subnormal intelligence (62%) --- r_associated #0: 20 --> en:white substance
    n1=en:subnormal intelligence (62%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4164. en:substance withdrawal syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:substance withdrawal syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4165. en:substantia nigra gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:substantia nigra gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4166. en:sudden arousal from slow-wave sleep with screaming, autonomic, and behavioral manifestations of intense fear (sleep terrors) --- r_associated #0: 20 --> en:white substance
    n1=en:sudden arousal from slow-wave sleep with screaming, autonomic, and behavioral manifestations of intense fear (sleep terrors) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4167. en:sudden awakening --- r_associated #0: 20 --> en:white substance
    n1=en:sudden awakening | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4168. en:sudden onset of neuropsychiatric symptoms --- r_associated #0: 20 --> en:white substance
    n1=en:sudden onset of neuropsychiatric symptoms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4169. en:superficial laminar spongiosis --- r_associated #0: 20 --> en:white substance
    n1=en:superficial laminar spongiosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4170. en:suppression-burst pattern --- r_associated #0: 20 --> en:white substance
    n1=en:suppression-burst pattern | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4171. en:suppression-burst pattern see on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:suppression-burst pattern see on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4172. en:supranuclear gaze palsy --- r_associated #0: 20 --> en:white substance
    n1=en:supranuclear gaze palsy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4173. en:supratentorial structures unformed or regressed --- r_associated #0: 20 --> en:white substance
    n1=en:supratentorial structures unformed or regressed | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4174. en:surgical aspects --- r_associated #0: 20 --> en:white substance
    n1=en:surgical aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4175. en:sweating problem --- r_associated #0: 20 --> en:white substance
    n1=en:sweating problem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4176. en:swelling of the cerebral white matter --- r_associated #0: 20 --> en:white substance
    n1=en:swelling of the cerebral white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4177. en:swelling of the deep white matter seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:swelling of the deep white matter seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4178. en:swollen achromatic cells (pick cells) --- r_associated #0: 20 --> en:white substance
    n1=en:swollen achromatic cells (pick cells) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4179. en:symmetric lesions in the basal ganglia consistent with leigh syndrome (256000), in a subset of patients --- r_associated #0: 20 --> en:white substance
    n1=en:symmetric lesions in the basal ganglia consistent with leigh syndrome (256000), in a subset of patients | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4180. en:symmetric spinal nerve root neurofibromas --- r_associated #0: 20 --> en:white substance
    n1=en:symmetric spinal nerve root neurofibromas | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4181. en:symmetric ventriculomegaly --- r_associated #0: 20 --> en:white substance
    n1=en:symmetric ventriculomegaly | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4182. en:symmetrical progressive demyelination --- r_associated #0: 20 --> en:white substance
    n1=en:symmetrical progressive demyelination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4183. en:symptoms are exacerbated during pregnancy --- r_associated #0: 20 --> en:white substance
    n1=en:symptoms are exacerbated during pregnancy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4184. en:symptoms occur at rest --- r_associated #0: 20 --> en:white substance
    n1=en:symptoms occur at rest | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4185. en:symptoms of hypothalamic disturbances (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:symptoms of hypothalamic disturbances (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4186. en:symptoms stabilize within 4 weeks --- r_associated #0: 20 --> en:white substance
    n1=en:symptoms stabilize within 4 weeks | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4187. en:syncope --- r_associated #0: 20 --> en:white substance
    n1=en:syncope | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4188. en:syndrome screaming --- r_associated #0: 20 --> en:white substance
    n1=en:syndrome screaming | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4189. en:synkinesia (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:synkinesia (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4190. en:synkinesis --- r_associated #0: 20 --> en:white substance
    n1=en:synkinesis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4191. en:syringomyelia --- r_associated #0: 20 --> en:white substance
    n1=en:syringomyelia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4192. en:syringomyelia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:syringomyelia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4193. en:syringomyelia, noncommunicating (80% of cases) --- r_associated #0: 20 --> en:white substance
    n1=en:syringomyelia, noncommunicating (80% of cases) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4194. en:t1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra --- r_associated #0: 20 --> en:white substance
    n1=en:t1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4195. en:t2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4196. en:t2-weighted hyperintensities in deep brain regions --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in deep brain regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4197. en:t2-weighted hyperintensities in deep cerebral white matter, brainstem, and cerebellar white matter with sparing of the periventricular rim --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in deep cerebral white matter, brainstem, and cerebellar white matter with sparing of the periventricular rim | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4198. en:t2-weighted hyperintensities in subcortical brain regions seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in subcortical brain regions seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4199. en:t2-weighted hyperintensities in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4200. en:t2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4201. en:t2-weighted hyperintensities in the corticospinal tracts and posterior arms of the internal capsule in older patients seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in the corticospinal tracts and posterior arms of the internal capsule in older patients seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4202. en:t2-weighted hyperintensities in the periventricular and deep subcortical white matter --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in the periventricular and deep subcortical white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4203. en:t2-weighted hyperintensities in the putamen and caudate nuclei --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in the putamen and caudate nuclei | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4204. en:t2-weighted hyperintensities in the supratentorial white matter seen on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hyperintensities in the supratentorial white matter seen on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4205. en:t2-weighted hypodensities in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted hypodensities in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4206. en:t2-weighted mri shows hyperintensities in the thalamus, basal ganglia, and brainstem during acute illness (may later resolve) --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted mri shows hyperintensities in the thalamus, basal ganglia, and brainstem during acute illness (may later resolve) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4207. en:t2-weighted signal abnormalities in the deep white matter --- r_associated #0: 20 --> en:white substance
    n1=en:t2-weighted signal abnormalities in the deep white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4208. en:tardive dyskinesia --- r_associated #0: 20 --> en:white substance
    n1=en:tardive dyskinesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4209. en:tau immunreactivity --- r_associated #0: 20 --> en:white substance
    n1=en:tau immunreactivity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4210. en:tau inclusions are 'flame-shaped' or 'tuft-like' --- r_associated #0: 20 --> en:white substance
    n1=en:tau inclusions are 'flame-shaped' or 'tuft-like' | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4211. en:tau-containing inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:tau-containing inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4212. en:tau-immunoreactive inclusions in neurons and astrocytes --- r_associated #0: 20 --> en:white substance
    n1=en:tau-immunoreactive inclusions in neurons and astrocytes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4213. en:tau-positive inclusions may be found --- r_associated #0: 20 --> en:white substance
    n1=en:tau-positive inclusions may be found | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4214. en:tbp- and 1c2-immunoreactive neuronal inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:tbp- and 1c2-immunoreactive neuronal inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4215. en:tdp43-positive inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:tdp43-positive inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4216. en:tdp43-positive neuronal and glial cytoplasmic inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:tdp43-positive neuronal and glial cytoplasmic inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4217. en:tdp43-positive neuronal inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:tdp43-positive neuronal inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4218. en:tectal enlargement --- r_associated #0: 20 --> en:white substance
    n1=en:tectal enlargement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4219. en:temporal epileptiform discharges seen on eeg --- r_associated #0: 20 --> en:white substance
    n1=en:temporal epileptiform discharges seen on eeg | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4220. en:temporal lobe --- r_associated #0: 20 --> en:white substance
    n1=en:temporal lobe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4221. en:temporal lobe epilepsy (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:temporal lobe epilepsy (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4222. en:temporal lobe heterotopias --- r_associated #0: 20 --> en:white substance
    n1=en:temporal lobe heterotopias | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4223. en:temporal lobe infarct (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:temporal lobe infarct (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4224. en:temporal lobe seizures (in 1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:temporal lobe seizures (in 1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4225. en:tendency to walk on toes --- r_associated #0: 20 --> en:white substance
    n1=en:tendency to walk on toes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4226. en:teratologic --- r_associated #0: 20 --> en:white substance
    n1=en:teratologic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4227. en:tetany --- r_associated #0: 20 --> en:white substance
    n1=en:tetany | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4228. en:tetany, hypocalcemic (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:tetany, hypocalcemic (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4229. en:tetany, hypocalcemic, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:tetany, hypocalcemic, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4230. en:tethered cord (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:tethered cord (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4231. en:tethered cord (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:tethered cord (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4232. en:tethered spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:tethered spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4233. en:tethered spinal cord syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:tethered spinal cord syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4234. en:tetraplegic spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:tetraplegic spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4235. en:tfg- and tdp43-positive intraneuronal inclusions in some sensory and motor spinal cord neurons --- r_associated #0: 20 --> en:white substance
    n1=en:tfg- and tdp43-positive intraneuronal inclusions in some sensory and motor spinal cord neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4236. en:thalamic hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:thalamic hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4237. en:thalamic lesions --- r_associated #0: 20 --> en:white substance
    n1=en:thalamic lesions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4238. en:thalamic neuronal loss, especially in the medial dorsal nucleus --- r_associated #0: 20 --> en:white substance
    n1=en:thalamic neuronal loss, especially in the medial dorsal nucleus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4239. en:thenar muscle atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:thenar muscle atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4240. en:thenar muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:thenar muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4241. en:thick and elongated superior cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:thick and elongated superior cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4242. en:thick corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:thick corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4243. en:thick cortex --- r_associated #0: 20 --> en:white substance
    n1=en:thick cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4244. en:thick, maloriented superior cerebellar peduncles --- r_associated #0: 20 --> en:white substance
    n1=en:thick, maloriented superior cerebellar peduncles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4245. en:thick, short corpus callosum --- r_associated #0: 20 --> en:white substance
    n1=en:thick, short corpus callosum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4246. en:thickened cortices --- r_associated #0: 20 --> en:white substance
    n1=en:thickened cortices | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4247. en:thickened frontal cortex --- r_associated #0: 20 --> en:white substance
    n1=en:thickened frontal cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4248. en:thickened optic nerve sheath --- r_associated #0: 20 --> en:white substance
    n1=en:thickened optic nerve sheath | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4249. en:thickening of the skull (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:thickening of the skull (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4250. en:thin bony cortex --- r_associated #0: 20 --> en:white substance
    n1=en:thin bony cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4251. en:thin brainstem --- r_associated #0: 20 --> en:white substance
    n1=en:thin brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4252. en:thin cerebral cortex --- r_associated #0: 20 --> en:white substance
    n1=en:thin cerebral cortex | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4253. en:thin corpus callosum (1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:thin corpus callosum (1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4254. en:thin corpus callosum (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:thin corpus callosum (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4255. en:thin corpus callosum (1/4 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:thin corpus callosum (1/4 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4256. en:thin corpus callosum (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:thin corpus callosum (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4257. en:thin corpus callosum enlarged ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:thin corpus callosum enlarged ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4258. en:thin cortical mantle (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:thin cortical mantle (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4259. en:thin optic chiasm --- r_associated #0: 20 --> en:white substance
    n1=en:thin optic chiasm | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4260. en:thin pituitary stalk --- r_associated #0: 20 --> en:white substance
    n1=en:thin pituitary stalk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4261. en:thinning of the cerebellopontine tracts --- r_associated #0: 20 --> en:white substance
    n1=en:thinning of the cerebellopontine tracts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4262. en:third ventricle subependymal focal gliosis --- r_associated #0: 20 --> en:white substance
    n1=en:third ventricle subependymal focal gliosis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4263. en:thrombosis of cerebral veins --- r_associated #0: 20 --> en:white substance
    n1=en:thrombosis of cerebral veins | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4264. en:tip-toe gait --- r_associated #0: 20 --> en:white substance
    n1=en:tip-toe gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4265. en:toe-walking gait --- r_associated #0: 20 --> en:white substance
    n1=en:toe-walking gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4266. en:toe-walking in early childhood --- r_associated #0: 20 --> en:white substance
    n1=en:toe-walking in early childhood | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4267. en:tongue movements, protrusions --- r_associated #0: 20 --> en:white substance
    n1=en:tongue movements, protrusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4268. en:tonic clonic seizures, infrequent (in one patient) --- r_associated #0: 20 --> en:white substance
    n1=en:tonic clonic seizures, infrequent (in one patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4269. en:tonic convulsion --- r_associated #0: 20 --> en:white substance
    n1=en:tonic convulsion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4270. en:tonic head extension --- r_associated #0: 20 --> en:white substance
    n1=en:tonic head extension | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4271. en:tonic posturing --- r_associated #0: 20 --> en:white substance
    n1=en:tonic posturing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4272. en:tonic seizures, refractory --- r_associated #0: 20 --> en:white substance
    n1=en:tonic seizures, refractory | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4273. en:tonic spasms --- r_associated #0: 20 --> en:white substance
    n1=en:tonic spasms | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4274. en:tonic-clonic seizures (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:tonic-clonic seizures (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4275. en:tonus dysregulation --- r_associated #0: 20 --> en:white substance
    n1=en:tonus dysregulation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4276. en:torsion dystonia (involuntary sustained muscle contractions, twisting and repetitive movements, abnormal posturing) --- r_associated #0: 20 --> en:white substance
    n1=en:torsion dystonia (involuntary sustained muscle contractions, twisting and repetitive movements, abnormal posturing) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4277. en:torticollis --- r_associated #0: 20 --> en:white substance
    n1=en:torticollis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4278. en:total body paralysis, paroxysmal --- r_associated #0: 20 --> en:white substance
    n1=en:total body paralysis, paroxysmal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4279. en:touch, vibration, and limb position may or may not be affected --- r_associated #0: 20 --> en:white substance
    n1=en:touch, vibration, and limb position may or may not be affected | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4280. en:tow-walking --- r_associated #0: 20 --> en:white substance
    n1=en:tow-walking | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4281. en:transient ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:transient ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4282. en:transient ischemic attack --- r_associated #0: 20 --> en:white substance
    n1=en:transient ischemic attack | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4283. en:transient mild dystonia may precede abrupt onset of disorder by several years --- r_associated #0: 20 --> en:white substance
    n1=en:transient mild dystonia may precede abrupt onset of disorder by several years | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4284. en:transient, reversible neurologic deficits --- r_associated #0: 20 --> en:white substance
    n1=en:transient, reversible neurologic deficits | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4285. en:transitional facial palsy (15%) --- r_associated #0: 20 --> en:white substance
    n1=en:transitional facial palsy (15%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4286. en:transplantation aspects --- r_associated #0: 20 --> en:white substance
    n1=en:transplantation aspects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4287. en:trauma qualifier --- r_associated #0: 20 --> en:white substance
    n1=en:trauma qualifier | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4288. en:tremor --- r_associated #0: 20 --> en:white substance
    n1=en:tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4289. en:tremor (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4290. en:tremor (3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4291. en:tremor (30%) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (30%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4292. en:tremor (57% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (57% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4293. en:tremor (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4294. en:tremor (later-onset) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (later-onset) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4295. en:tremor (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4296. en:tremor (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4297. en:tremor adverse event --- r_associated #0: 20 --> en:white substance
    n1=en:tremor adverse event | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4298. en:tremor due to hyperthyroidism --- r_associated #0: 20 --> en:white substance
    n1=en:tremor due to hyperthyroidism | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4299. en:tremor is exacerbated by stress and exercise --- r_associated #0: 20 --> en:white substance
    n1=en:tremor is exacerbated by stress and exercise | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4300. en:tremor of hands --- r_associated #0: 20 --> en:white substance
    n1=en:tremor of hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4301. en:tremor of palate --- r_associated #0: 20 --> en:white substance
    n1=en:tremor of palate | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4302. en:tremor of the upper limb --- r_associated #0: 20 --> en:white substance
    n1=en:tremor of the upper limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4303. en:tremor with febrile episodes (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor with febrile episodes (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4304. en:tremor, action (arms, tongue, head, legs and trunk) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, action (arms, tongue, head, legs and trunk) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4305. en:tremor, action, progressive --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, action, progressive | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4306. en:tremor, mild --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4307. en:tremor, postural (arms, tongue, head, legs and trunk) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, postural (arms, tongue, head, legs and trunk) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4308. en:tremor, postural, upper limb, onset in fourth decade (reported in 1 family) --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, postural, upper limb, onset in fourth decade (reported in 1 family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4309. en:tremor, small-amplitude, high-frequency, restricted to the hands --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, small-amplitude, high-frequency, restricted to the hands | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4310. en:tremor, static --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, static | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4311. en:tremor, variable --- r_associated #0: 20 --> en:white substance
    n1=en:tremor, variable | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4312. en:tremors, action --- r_associated #0: 20 --> en:white substance
    n1=en:tremors, action | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4313. en:tremors, limb --- r_associated #0: 20 --> en:white substance
    n1=en:tremors, limb | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4314. en:trigeminal anesthesia --- r_associated #0: 20 --> en:white substance
    n1=en:trigeminal anesthesia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4315. en:trigeminal neuralgia --- r_associated #0: 20 --> en:white substance
    n1=en:trigeminal neuralgia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4316. en:trismus --- r_associated #0: 20 --> en:white substance
    n1=en:trismus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4317. en:trismus (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:trismus (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4318. en:truncal arching --- r_associated #0: 20 --> en:white substance
    n1=en:truncal arching | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4319. en:truncal ataxia, mild --- r_associated #0: 20 --> en:white substance
    n1=en:truncal ataxia, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4320. en:truncal ataxia, severe --- r_associated #0: 20 --> en:white substance
    n1=en:truncal ataxia, severe | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4321. en:truncal instability --- r_associated #0: 20 --> en:white substance
    n1=en:truncal instability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4322. en:truncal titubation --- r_associated #0: 20 --> en:white substance
    n1=en:truncal titubation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4323. en:tussive syncopes --- r_associated #0: 20 --> en:white substance
    n1=en:tussive syncopes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4324. en:twitching of the fingers and toes --- r_associated #0: 20 --> en:white substance
    n1=en:twitching of the fingers and toes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4325. en:type i arnold chiari malformation --- r_associated #0: 20 --> en:white substance
    n1=en:type i arnold chiari malformation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4326. en:type i eeg response is occipital spikes --- r_associated #0: 20 --> en:white substance
    n1=en:type i eeg response is occipital spikes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4327. en:type ii eeg response is parietooccipital spikes followed by biphasic slow waves --- r_associated #0: 20 --> en:white substance
    n1=en:type ii eeg response is parietooccipital spikes followed by biphasic slow waves | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4328. en:type iii eeg response is parietooccipital spikes followed by biphasic slow waves and spreading to the frontal region --- r_associated #0: 20 --> en:white substance
    n1=en:type iii eeg response is parietooccipital spikes followed by biphasic slow waves and spreading to the frontal region | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4329. en:type iv eeg response is generalized spike-wave discharges --- r_associated #0: 20 --> en:white substance
    n1=en:type iv eeg response is generalized spike-wave discharges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4330. en:ubiquitin-positive cytoplasmic and intranuclear neuronal inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:ubiquitin-positive cytoplasmic and intranuclear neuronal inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4331. en:ubiquitin-positive inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:ubiquitin-positive inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4332. en:ubiquitin-positive intranuclear neuronal inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:ubiquitin-positive intranuclear neuronal inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4333. en:ubqln2- and tdp43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons --- r_associated #0: 20 --> en:white substance
    n1=en:ubqln2- and tdp43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4334. en:ultrastructure --- r_associated #0: 20 --> en:white substance
    n1=en:ultrastructure | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4335. en:unable to grasp objects --- r_associated #0: 20 --> en:white substance
    n1=en:unable to grasp objects | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4336. en:unable to sit unsupported --- r_associated #0: 20 --> en:white substance
    n1=en:unable to sit unsupported | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4337. en:unable to stand --- r_associated #0: 20 --> en:white substance
    n1=en:unable to stand | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4338. en:unable to talk --- r_associated #0: 20 --> en:white substance
    n1=en:unable to talk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4339. en:unable to walk --- r_associated #0: 20 --> en:white substance
    n1=en:unable to walk | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4340. en:uncoordinated movements --- r_associated #0: 20 --> en:white substance
    n1=en:uncoordinated movements | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4341. en:underdeveloped corpus callosum (3 patients) --- r_associated #0: 20 --> en:white substance
    n1=en:underdeveloped corpus callosum (3 patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4342. en:undersulcation of the frontal lobes --- r_associated #0: 20 --> en:white substance
    n1=en:undersulcation of the frontal lobes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4343. en:unidentified bright objects on brain mri --- r_associated #0: 20 --> en:white substance
    n1=en:unidentified bright objects on brain mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4344. en:unilateral cerebellar hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:unilateral cerebellar hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4345. en:unilateral headache location --- r_associated #0: 20 --> en:white substance
    n1=en:unilateral headache location | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4346. en:unintelligible speech, vocalizations, grunting --- r_associated #0: 20 --> en:white substance
    n1=en:unintelligible speech, vocalizations, grunting | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4347. en:unresponsive to stimuli --- r_associated #0: 20 --> en:white substance
    n1=en:unresponsive to stimuli | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4348. en:unresponsiveness --- r_associated #0: 20 --> en:white substance
    n1=en:unresponsiveness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4349. en:unstable, ataxic gait --- r_associated #0: 20 --> en:white substance
    n1=en:unstable, ataxic gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4350. en:unsteadiness, episodic --- r_associated #0: 20 --> en:white substance
    n1=en:unsteadiness, episodic | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4351. en:unsteady gait due to muscle weakness --- r_associated #0: 20 --> en:white substance
    n1=en:unsteady gait due to muscle weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4352. en:unsteady standing --- r_associated #0: 20 --> en:white substance
    n1=en:unsteady standing | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4353. en:unusual aura symptoms include alien limb phenomenon, diplopia, apraxia, dysarthria, impaired hearing, vertigo --- r_associated #0: 20 --> en:white substance
    n1=en:unusual aura symptoms include alien limb phenomenon, diplopia, apraxia, dysarthria, impaired hearing, vertigo | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4354. en:upbeat central vestibular nystagmus --- r_associated #0: 20 --> en:white substance
    n1=en:upbeat central vestibular nystagmus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4355. en:upper and lower motor neuron degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:upper and lower motor neuron degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4356. en:upper and lower motor neuron disease --- r_associated #0: 20 --> en:white substance
    n1=en:upper and lower motor neuron disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4357. en:upper and lower neuron manifestations --- r_associated #0: 20 --> en:white substance
    n1=en:upper and lower neuron manifestations | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4358. en:upper body involvement --- r_associated #0: 20 --> en:white substance
    n1=en:upper body involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4359. en:upper extremities may be involved --- r_associated #0: 20 --> en:white substance
    n1=en:upper extremities may be involved | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4360. en:upper extremity action tremor --- r_associated #0: 20 --> en:white substance
    n1=en:upper extremity action tremor | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4361. en:upper limb ataxia --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb ataxia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4362. en:upper limb dysmetria --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb dysmetria | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4363. en:upper limb dystonia --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb dystonia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4364. en:upper limb hyperreflexia (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb hyperreflexia (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4365. en:upper limb hyperreflexia (some) --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb hyperreflexia (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4366. en:upper limb involvement --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4367. en:upper limb involvement (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb involvement (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4368. en:upper limb involvement (onset in the first decade) --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb involvement (onset in the first decade) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4369. en:upper limb involvement may occur --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb involvement may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4370. en:upper limb spasticity --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb spasticity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4371. en:upper limb spasticity (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb spasticity (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4372. en:upper limb spasticity (some) --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb spasticity (some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4373. en:upper limb spasticity, mild --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb spasticity, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4374. en:upper limb weakness --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4375. en:upper limb weakness may occur later --- r_associated #0: 20 --> en:white substance
    n1=en:upper limb weakness may occur later | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4376. en:upper limbs affected --- r_associated #0: 20 --> en:white substance
    n1=en:upper limbs affected | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4377. en:upper limbs may be affected --- r_associated #0: 20 --> en:white substance
    n1=en:upper limbs may be affected | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4378. en:upper limbs may show hyperreflexia --- r_associated #0: 20 --> en:white substance
    n1=en:upper limbs may show hyperreflexia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4379. en:upper limbs may show mild involvement --- r_associated #0: 20 --> en:white substance
    n1=en:upper limbs may show mild involvement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4380. en:upper limbs more often affected than lower limbs --- r_associated #0: 20 --> en:white substance
    n1=en:upper limbs more often affected than lower limbs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4381. en:upper motor involvement (some patient) --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor involvement (some patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4382. en:upper motor neuron degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor neuron degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4383. en:upper motor neuron dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor neuron dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4384. en:upper motor neuron signs --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor neuron signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4385. en:upper motor neuron signs (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor neuron signs (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4386. en:upper motor neuron signs, early --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor neuron signs, early | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4387. en:upper motor signs --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor signs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4388. en:upper motor signs (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:upper motor signs (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4389. en:uremic coma --- r_associated #0: 20 --> en:white substance
    n1=en:uremic coma | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4390. en:use of ultrasonography --- r_associated #0: 20 --> en:white substance
    n1=en:use of ultrasonography | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4391. en:usually occurs at night --- r_associated #0: 20 --> en:white substance
    n1=en:usually occurs at night | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4392. en:vacuolated neurons --- r_associated #0: 20 --> en:white substance
    n1=en:vacuolated neurons | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4393. en:vacuolization (patient a) --- r_associated #0: 20 --> en:white substance
    n1=en:vacuolization (patient a) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4394. en:vacuolizing myelinopathy --- r_associated #0: 20 --> en:white substance
    n1=en:vacuolizing myelinopathy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4395. en:variable delay (iq range 52-104) --- r_associated #0: 20 --> en:white substance
    n1=en:variable delay (iq range 52-104) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4396. en:variable intracranial abnormalities --- r_associated #0: 20 --> en:white substance
    n1=en:variable intracranial abnormalities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4397. en:variable mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:variable mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4398. en:variable mental retardation (40%) --- r_associated #0: 20 --> en:white substance
    n1=en:variable mental retardation (40%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4399. en:variable mental retardation ranging from severe neurodegeneration to mild mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:variable mental retardation ranging from severe neurodegeneration to mild mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4400. en:variable neurologic deterioration (likely result of hemophagocytic syndrome) --- r_associated #0: 20 --> en:white substance
    n1=en:variable neurologic deterioration (likely result of hemophagocytic syndrome) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4401. en:variable outcome after acute illness --- r_associated #0: 20 --> en:white substance
    n1=en:variable outcome after acute illness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4402. en:varying degree of mental retardation --- r_associated #0: 20 --> en:white substance
    n1=en:varying degree of mental retardation | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4403. en:vasculopathy of the small arteries penetrating the white matter --- r_associated #0: 20 --> en:white substance
    n1=en:vasculopathy of the small arteries penetrating the white matter | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4404. en:vasovagal syncope --- r_associated #0: 20 --> en:white substance
    n1=en:vasovagal syncope | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4405. en:vcp-positive inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:vcp-positive inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4406. en:ventral funiculus --- r_associated #0: 20 --> en:white substance
    n1=en:ventral funiculus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4407. en:ventral nerve root --- r_associated #0: 20 --> en:white substance
    n1=en:ventral nerve root | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4408. en:ventricles slightly enlarged --- r_associated #0: 20 --> en:white substance
    n1=en:ventricles slightly enlarged | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4409. en:ventricular anomalies --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular anomalies | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4410. en:ventricular asymmetry --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular asymmetry | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4411. en:ventricular dilatation (29%) --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular dilatation (29%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4412. en:ventricular dilatation (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular dilatation (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4413. en:ventricular dilatation (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular dilatation (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4414. en:ventricular enlargement --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular enlargement | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4415. en:ventricular enlargement, mild --- r_associated #0: 20 --> en:white substance
    n1=en:ventricular enlargement, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4416. en:ventriculomegaly (38%) --- r_associated #0: 20 --> en:white substance
    n1=en:ventriculomegaly (38%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4417. en:ventriculomegaly (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:ventriculomegaly (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4418. en:ventriculomegaly (variable) --- r_associated #0: 20 --> en:white substance
    n1=en:ventriculomegaly (variable) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4419. en:ventriculomegaly, mild (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:ventriculomegaly, mild (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4420. en:ventriculomeglia --- r_associated #0: 20 --> en:white substance
    n1=en:ventriculomeglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4421. en:verbal delay (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:verbal delay (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4422. en:vermian hypoplasia --- r_associated #0: 20 --> en:white substance
    n1=en:vermian hypoplasia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4423. en:vertical orientation of hippocampus --- r_associated #0: 20 --> en:white substance
    n1=en:vertical orientation of hippocampus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4424. en:vertigo --- r_associated #0: 20 --> en:white substance
    n1=en:vertigo | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4425. en:vertigo, episodic (onset in second or third decade) --- r_associated #0: 20 --> en:white substance
    n1=en:vertigo, episodic (onset in second or third decade) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4426. en:vertigo, mild --- r_associated #0: 20 --> en:white substance
    n1=en:vertigo, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4427. en:very poor expressive speech --- r_associated #0: 20 --> en:white substance
    n1=en:very poor expressive speech | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4428. en:vestibular anomalies (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:vestibular anomalies (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4429. en:vestibular diseases --- r_associated #0: 20 --> en:white substance
    n1=en:vestibular diseases | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4430. en:vestibular dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:vestibular dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4431. en:vestibular dysfunction, mild --- r_associated #0: 20 --> en:white substance
    n1=en:vestibular dysfunction, mild | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4432. en:vestibulopathy, bilateral, progressive (onset in fourth or fifth decade) --- r_associated #0: 20 --> en:white substance
    n1=en:vestibulopathy, bilateral, progressive (onset in fourth or fifth decade) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4433. en:virtual absence of pyramidal tracts (wws) --- r_associated #0: 20 --> en:white substance
    n1=en:virtual absence of pyramidal tracts (wws) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4434. en:viruses --- r_associated #0: 20 --> en:white substance
    n1=en:viruses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4435. en:visceroautonomic dysfunction --- r_associated #0: 20 --> en:white substance
    n1=en:visceroautonomic dysfunction | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4436. en:visual acuity is normal --- r_associated #0: 20 --> en:white substance
    n1=en:visual acuity is normal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4437. en:visual auras --- r_associated #0: 20 --> en:white substance
    n1=en:visual auras | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4438. en:visual blackouts (stage 1) --- r_associated #0: 20 --> en:white substance
    n1=en:visual blackouts (stage 1) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4439. en:visual changes --- r_associated #0: 20 --> en:white substance
    n1=en:visual changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4440. en:visual hallucination --- r_associated #0: 20 --> en:white substance
    n1=en:visual hallucination | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4441. en:visual hallucinations may occur --- r_associated #0: 20 --> en:white substance
    n1=en:visual hallucinations may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4442. en:visual impairment --- r_associated #0: 20 --> en:white substance
    n1=en:visual impairment | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4443. en:visual inattention --- r_associated #0: 20 --> en:white substance
    n1=en:visual inattention | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4444. en:visual symptoms (in 60% of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:visual symptoms (in 60% of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4445. en:visuospatial agnosia (in a subset of patients) --- r_associated #0: 20 --> en:white substance
    n1=en:visuospatial agnosia (in a subset of patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4446. en:vocalization (finding) --- r_associated #0: 20 --> en:white substance
    n1=en:vocalization (finding) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4447. en:waddling gait --- r_associated #0: 20 --> en:white substance
    n1=en:waddling gait | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4448. en:walking delay --- r_associated #0: 20 --> en:white substance
    n1=en:walking delay | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4449. en:walking during slow-wave sleep (sleepwalking) --- r_associated #0: 20 --> en:white substance
    n1=en:walking during slow-wave sleep (sleepwalking) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4450. en:walking impairment due to myoclonus late in disease --- r_associated #0: 20 --> en:white substance
    n1=en:walking impairment due to myoclonus late in disease | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4451. en:walking independently at 2.5 years to 4 years of age --- r_associated #0: 20 --> en:white substance
    n1=en:walking independently at 2.5 years to 4 years of age | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4452. en:weak or absent tendon reflexes of knees and ankles (in some patients) --- r_associated #0: 20 --> en:white substance
    n1=en:weak or absent tendon reflexes of knees and ankles (in some patients) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4453. en:weakness --- r_associated #0: 20 --> en:white substance
    n1=en:weakness | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4454. en:weakness of hip and ankle flexion --- r_associated #0: 20 --> en:white substance
    n1=en:weakness of hip and ankle flexion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4455. en:west syndrome --- r_associated #0: 20 --> en:white substance
    n1=en:west syndrome | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4456. en:white mater abnormalities in the posterior periventricular region --- r_associated #0: 20 --> en:white substance
    n1=en:white mater abnormalities in the posterior periventricular region | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4457. en:white matter abnormalities (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4458. en:white matter abnormalities (in some) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities (in some) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4459. en:white matter abnormalities (rare) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities (rare) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4460. en:white matter abnormalities (uncommon) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities (uncommon) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4461. en:white matter abnormalities in the periventricular regions (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities in the periventricular regions (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4462. en:white matter abnormalities on mri --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4463. en:white matter abnormalities seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4464. en:white matter abnormalities seen on mri which resolve over time --- r_associated #0: 20 --> en:white substance
    n1=en:white matter abnormalities seen on mri which resolve over time | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4465. en:white matter alterations (in one family) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter alterations (in one family) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4466. en:white matter buckling sign --- r_associated #0: 20 --> en:white substance
    n1=en:white matter buckling sign | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4467. en:white matter changes --- r_associated #0: 20 --> en:white substance
    n1=en:white matter changes | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4468. en:white matter changes may occur (in adulthood) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter changes may occur (in adulthood) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4469. en:white matter changes on brain imaging (less common) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter changes on brain imaging (less common) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4470. en:white matter degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:white matter degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4471. en:white matter dysmyelination/demyelination (71%) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter dysmyelination/demyelination (71%) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4472. en:white matter hyperintensities --- r_associated #0: 20 --> en:white substance
    n1=en:white matter hyperintensities | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4473. en:white matter hyperintensities (mri, t2 images) suggestive of old infarcts --- r_associated #0: 20 --> en:white substance
    n1=en:white matter hyperintensities (mri, t2 images) suggestive of old infarcts | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4474. en:white matter hyperintensities in t2 imaging --- r_associated #0: 20 --> en:white substance
    n1=en:white matter hyperintensities in t2 imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4475. en:white matter hyperintensities in various brain regions --- r_associated #0: 20 --> en:white substance
    n1=en:white matter hyperintensities in various brain regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4476. en:white matter hypodensities on brain imaging --- r_associated #0: 20 --> en:white substance
    n1=en:white matter hypodensities on brain imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4477. en:white matter hypodensities seen on mri --- r_associated #0: 20 --> en:white substance
    n1=en:white matter hypodensities seen on mri | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4478. en:white matter immaturity --- r_associated #0: 20 --> en:white substance
    n1=en:white matter immaturity | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4479. en:white matter lacks axons and myelin --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lacks axons and myelin | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4480. en:white matter lesion --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesion | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4481. en:white matter lesions (1 patient) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesions (1 patient) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4482. en:white matter lesions in the basal ganglia --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesions in the basal ganglia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4483. en:white matter lesions in the brainstem may occur --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesions in the brainstem may occur | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4484. en:white matter lesions in the supratentorial white matter, brainstem, cerebellum, and spinal cord --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesions in the supratentorial white matter, brainstem, cerebellum, and spinal cord | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4485. en:white matter lesions may occur in the thalami, basal ganglia, and periventricular white matter (see leigh syndrome, 256000) --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesions may occur in the thalami, basal ganglia, and periventricular white matter (see leigh syndrome, 256000) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4486. en:white matter lesions seen on brain imaging --- r_associated #0: 20 --> en:white substance
    n1=en:white matter lesions seen on brain imaging | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4487. en:white matter neuronal heterotopia --- r_associated #0: 20 --> en:white substance
    n1=en:white matter neuronal heterotopia | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4488. en:white matter of thalamus --- r_associated #0: 20 --> en:white substance
    n1=en:white matter of thalamus | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4489. en:white matter rarefaction and cystic degeneration --- r_associated #0: 20 --> en:white substance
    n1=en:white matter rarefaction and cystic degeneration | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4490. en:white matter signal abnormalities in the deep white matter and periventricular regions --- r_associated #0: 20 --> en:white substance
    n1=en:white matter signal abnormalities in the deep white matter and periventricular regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4491. en:white matter signal abnormalities in various brain regions --- r_associated #0: 20 --> en:white substance
    n1=en:white matter signal abnormalities in various brain regions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4492. en:white matter streaks --- r_associated #0: 20 --> en:white substance
    n1=en:white matter streaks | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4493. en:white matter vacuolization --- r_associated #0: 20 --> en:white substance
    n1=en:white matter vacuolization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4494. en:wide subarachnoid spaces --- r_associated #0: 20 --> en:white substance
    n1=en:wide subarachnoid spaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4495. en:wide sylvian fissures --- r_associated #0: 20 --> en:white substance
    n1=en:wide sylvian fissures | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4496. en:wide sylvian fissures with incomplete opercularization --- r_associated #0: 20 --> en:white substance
    n1=en:wide sylvian fissures with incomplete opercularization | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4497. en:widened lateral ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:widened lateral ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4498. en:widened subarachnoid spaces --- r_associated #0: 20 --> en:white substance
    n1=en:widened subarachnoid spaces | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4499. en:widening of cortical sulci --- r_associated #0: 20 --> en:white substance
    n1=en:widening of cortical sulci | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4500. en:widening of the operculum --- r_associated #0: 20 --> en:white substance
    n1=en:widening of the operculum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4501. en:widening of the spinal canal --- r_associated #0: 20 --> en:white substance
    n1=en:widening of the spinal canal | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4502. en:widening of the ventricles --- r_associated #0: 20 --> en:white substance
    n1=en:widening of the ventricles | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4503. en:widespread brain atrophy --- r_associated #0: 20 --> en:white substance
    n1=en:widespread brain atrophy | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4504. en:widespread brain calcifications --- r_associated #0: 20 --> en:white substance
    n1=en:widespread brain calcifications | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4505. en:widespread neuronal loss --- r_associated #0: 20 --> en:white substance
    n1=en:widespread neuronal loss | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4506. en:widespread tau (mapt)-positive glial and neuronal inclusions --- r_associated #0: 20 --> en:white substance
    n1=en:widespread tau (mapt)-positive glial and neuronal inclusions | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4507. en:word finding difficulty (disorder) --- r_associated #0: 20 --> en:white substance
    n1=en:word finding difficulty (disorder) | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4508. en:writing fatigability --- r_associated #0: 20 --> en:white substance
    n1=en:writing fatigability | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4509. en:zone of neuraxis --- r_associated #0: 20 --> en:white substance
    n1=en:zone of neuraxis | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4510. encéphale --- r_associated #0: 20 --> en:white substance
    n1=encéphale | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4511. fibre --- r_associated #0: 20 --> en:white substance
    n1=fibre | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4512. fibre
    (biologie)
     --- r_associated #0: 20 --> en:white substance
    n1=fibre
    (biologie)
    | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4513. fibres nerveuses --- r_associated #0: 20 --> en:white substance
    n1=fibres nerveuses | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4514. insomnie --- r_associated #0: 20 --> en:white substance
    n1=insomnie | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4515. matière --- r_associated #0: 20 --> en:white substance
    n1=matière | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4516. moelle épinière --- r_associated #0: 20 --> en:white substance
    n1=moelle épinière | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4517. myéline --- r_associated #0: 20 --> en:white substance
    n1=myéline | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4518. méninge --- r_associated #0: 20 --> en:white substance
    n1=méninge | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4519. méninges --- r_associated #0: 20 --> en:white substance
    n1=méninges | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4520. narcolepsie --- r_associated #0: 20 --> en:white substance
    n1=narcolepsie | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4521. neurologie --- r_associated #0: 20 --> en:white substance
    n1=neurologie | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4522. septum pellucidum --- r_associated #0: 20 --> en:white substance
    n1=septum pellucidum | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4523. substance --- r_associated #0: 20 --> en:white substance
    n1=substance | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4524. substance blanche de la moelle allongée --- r_associated #0: 20 --> en:white substance
    n1=substance blanche de la moelle allongée | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4525. substance blanche de la moelle spinale --- r_associated #0: 20 --> en:white substance
    n1=substance blanche de la moelle spinale | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4526. substance blanche hémisphérique --- r_associated #0: 20 --> en:white substance
    n1=substance blanche hémisphérique | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4527. substance grise --- r_associated #0: 20 --> en:white substance
    n1=substance grise | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4528. substance noire --- r_associated #0: 20 --> en:white substance
    n1=substance noire | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4529. système nerveux central --- r_associated #0: 20 --> en:white substance
    n1=système nerveux central | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4530. tissu --- r_associated #0: 20 --> en:white substance
    n1=tissu | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4531. tissu cellulaire --- r_associated #0: 20 --> en:white substance
    n1=tissu cellulaire | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4532. tissu des nerfs --- r_associated #0: 20 --> en:white substance
    n1=tissu des nerfs | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4533. tissu nerveux --- r_associated #0: 20 --> en:white substance
    n1=tissu nerveux | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4534. tissu
    (tissu cellulaire)
     --- r_associated #0: 20 --> en:white substance
    n1=tissu
    (tissu cellulaire)
    | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4535. tronc cérébral --- r_associated #0: 20 --> en:white substance
    n1=tronc cérébral | n2=en:white substance | rel=r_associated | relid=0 | w=20
  4536. apoplexie cérébrale --- r_associated #0: 15 --> en:white substance
    n1=apoplexie cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4537. coma hépatique --- r_associated #0: 15 --> en:white substance
    n1=coma hépatique | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4538. encéphalopathie hépato-cérébrale --- r_associated #0: 15 --> en:white substance
    n1=encéphalopathie hépato-cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4539. encéphalopathie porto-cave --- r_associated #0: 15 --> en:white substance
    n1=encéphalopathie porto-cave | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4540. gaine de Schwann --- r_associated #0: 15 --> en:white substance
    n1=gaine de Schwann | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4541. gonflement axonal des racines nerveuses spinales et des nerfs crâniens --- r_associated #0: 15 --> en:white substance
    n1=gonflement axonal des racines nerveuses spinales et des nerfs crâniens | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4542. ictus apoplectique --- r_associated #0: 15 --> en:white substance
    n1=ictus apoplectique | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4543. ictus cérébral --- r_associated #0: 15 --> en:white substance
    n1=ictus cérébral | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4544. insuffisance hépatique transitoire --- r_associated #0: 15 --> en:white substance
    n1=insuffisance hépatique transitoire | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4545. maladie cérébrovasculaire aiguë mal définie --- r_associated #0: 15 --> en:white substance
    n1=maladie cérébrovasculaire aiguë mal définie | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4546. malformation artérioveineuse cérébrovasculaire --- r_associated #0: 15 --> en:white substance
    n1=malformation artérioveineuse cérébrovasculaire | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4547. malformation d'Arnold-Chiari --- r_associated #0: 15 --> en:white substance
    n1=malformation d'Arnold-Chiari | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4548. parésie musculaire --- r_associated #0: 15 --> en:white substance
    n1=parésie musculaire | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4549. perturbation du développement psychomoteur --- r_associated #0: 15 --> en:white substance
    n1=perturbation du développement psychomoteur | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4550. réaction schizophrénique --- r_associated #0: 15 --> en:white substance
    n1=réaction schizophrénique | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4551. Épilepsie partielle --- r_associated #0: 15 --> en:white substance
    n1=Épilepsie partielle | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4552. épilepsie partielle --- r_associated #0: 15 --> en:white substance
    n1=épilepsie partielle | n2=en:white substance | rel=r_associated | relid=0 | w=15
  4553. Fothergill --- r_associated #0: 10 --> en:white substance
    n1=Fothergill | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4554. Matière blanche --- r_associated #0: 10 --> en:white substance
    n1=Matière blanche | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4555. Myéline --- r_associated #0: 10 --> en:white substance
    n1=Myéline | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4556. Neurologie --- r_associated #0: 10 --> en:white substance
    n1=Neurologie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4557. abcès du cerveau --- r_associated #0: 10 --> en:white substance
    n1=abcès du cerveau | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4558. accident cérébro-vasculaire --- r_associated #0: 10 --> en:white substance
    n1=accident cérébro-vasculaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4559. accident ischémique cérébral --- r_associated #0: 10 --> en:white substance
    n1=accident ischémique cérébral | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4560. accidents vasculaires cérébraux --- r_associated #0: 10 --> en:white substance
    n1=accidents vasculaires cérébraux | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4561. affection du système nerveux périphérique --- r_associated #0: 10 --> en:white substance
    n1=affection du système nerveux périphérique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4562. affection extrapyramidale --- r_associated #0: 10 --> en:white substance
    n1=affection extrapyramidale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4563. agrypnie --- r_associated #0: 10 --> en:white substance
    n1=agrypnie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4564. algie rachidienne --- r_associated #0: 10 --> en:white substance
    n1=algie rachidienne | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4565. altération du développement psychomoteur --- r_associated #0: 10 --> en:white substance
    n1=altération du développement psychomoteur | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4566. amyotrophie --- r_associated #0: 10 --> en:white substance
    n1=amyotrophie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4567. anencéphalie --- r_associated #0: 10 --> en:white substance
    n1=anencéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4568. anosmie --- r_associated #0: 10 --> en:white substance
    n1=anosmie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4569. aphasie --- r_associated #0: 10 --> en:white substance
    n1=aphasie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4570. astroglie --- r_associated #0: 10 --> en:white substance
    n1=astroglie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4571. ataxie appendiculaire --- r_associated #0: 10 --> en:white substance
    n1=ataxie appendiculaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4572. atrophie des muscles --- r_associated #0: 10 --> en:white substance
    n1=atrophie des muscles | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4573. atrophie musculaire --- r_associated #0: 10 --> en:white substance
    n1=atrophie musculaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4574. attaque apoplectique --- r_associated #0: 10 --> en:white substance
    n1=attaque apoplectique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4575. attaque d'apoplexie --- r_associated #0: 10 --> en:white substance
    n1=attaque d'apoplexie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4576. belligérance --- r_associated #0: 10 --> en:white substance
    n1=belligérance | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4577. cataplexie --- r_associated #0: 10 --> en:white substance
    n1=cataplexie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4578. cervelet --- r_associated #0: 10 --> en:white substance
    n1=cervelet | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4579. clonus --- r_associated #0: 10 --> en:white substance
    n1=clonus | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4580. colpocéphalie --- r_associated #0: 10 --> en:white substance
    n1=colpocéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4581. coma urémique --- r_associated #0: 10 --> en:white substance
    n1=coma urémique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4582. convulsions fébriles --- r_associated #0: 10 --> en:white substance
    n1=convulsions fébriles | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4583. cordon nerveux --- r_associated #0: 10 --> en:white substance
    n1=cordon nerveux | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4584. demence --- r_associated #0: 10 --> en:white substance
    n1=demence | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4585. douleur de la face --- r_associated #0: 10 --> en:white substance
    n1=douleur de la face | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4586. drop attack --- r_associated #0: 10 --> en:white substance
    n1=drop attack | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4587. dysphasie --- r_associated #0: 10 --> en:white substance
    n1=dysphasie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4588. dysplasie corticale focale --- r_associated #0: 10 --> en:white substance
    n1=dysplasie corticale focale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4589. dystonie --- r_associated #0: 10 --> en:white substance
    n1=dystonie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4590. dégénérescence granulovacuolaire --- r_associated #0: 10 --> en:white substance
    n1=dégénérescence granulovacuolaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4591. détérioration mentale --- r_associated #0: 10 --> en:white substance
    n1=détérioration mentale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4592. en:accessory visual structures --- r_associated #0: 10 --> en:white substance
    n1=en:accessory visual structures | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4593. en:cerebral ventriculomegaly --- r_associated #0: 10 --> en:white substance
    n1=en:cerebral ventriculomegaly | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4594. en:laryngeal cartilages and joints --- r_associated #0: 10 --> en:white substance
    n1=en:laryngeal cartilages and joints | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4595. en:learning disability --- r_associated #0: 10 --> en:white substance
    n1=en:learning disability | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4596. en:muscular fasciculation --- r_associated #0: 10 --> en:white substance
    n1=en:muscular fasciculation | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4597. en:myelin --- r_associated #0: 10 --> en:white substance
    n1=en:myelin | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4598. en:nerve tissue --- r_associated #0: 10 --> en:white substance
    n1=en:nerve tissue | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4599. en:paresis --- r_associated #0: 10 --> en:white substance
    n1=en:paresis | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4600. encéphalite --- r_associated #0: 10 --> en:white substance
    n1=encéphalite | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4601. encéphalocèle --- r_associated #0: 10 --> en:white substance
    n1=encéphalocèle | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4602. encéphalopathie --- r_associated #0: 10 --> en:white substance
    n1=encéphalopathie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4603. encéphalopathie hépatique --- r_associated #0: 10 --> en:white substance
    n1=encéphalopathie hépatique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4604. faiblesse de muscle --- r_associated #0: 10 --> en:white substance
    n1=faiblesse de muscle | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4605. faiblesse du muscle --- r_associated #0: 10 --> en:white substance
    n1=faiblesse du muscle | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4606. faiblesse du visage --- r_associated #0: 10 --> en:white substance
    n1=faiblesse du visage | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4607. faiblesse musculaire --- r_associated #0: 10 --> en:white substance
    n1=faiblesse musculaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4608. fonte musculaire --- r_associated #0: 10 --> en:white substance
    n1=fonte musculaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4609. gaine de myéline --- r_associated #0: 10 --> en:white substance
    n1=gaine de myéline | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4610. grimaces --- r_associated #0: 10 --> en:white substance
    n1=grimaces | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4611. holoprosencéphalie --- r_associated #0: 10 --> en:white substance
    n1=holoprosencéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4612. hydranencéphalie --- r_associated #0: 10 --> en:white substance
    n1=hydranencéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4613. hypoplasie du nerf optique --- r_associated #0: 10 --> en:white substance
    n1=hypoplasie du nerf optique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4614. hémimégalencéphalie --- r_associated #0: 10 --> en:white substance
    n1=hémimégalencéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4615. hémorragie cérébrale --- r_associated #0: 10 --> en:white substance
    n1=hémorragie cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4616. hémorragie intracranienne --- r_associated #0: 10 --> en:white substance
    n1=hémorragie intracranienne | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4617. hémorragie intracrânienne --- r_associated #0: 10 --> en:white substance
    n1=hémorragie intracrânienne | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4618. immobilité --- r_associated #0: 10 --> en:white substance
    n1=immobilité | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4619. infirmité motrice cérébrale --- r_associated #0: 10 --> en:white substance
    n1=infirmité motrice cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4620. je-m'en-fichisme --- r_associated #0: 10 --> en:white substance
    n1=je-m'en-fichisme | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4621. liquide céphalo-rachidien --- r_associated #0: 10 --> en:white substance
    n1=liquide céphalo-rachidien | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4622. lissencéphalie --- r_associated #0: 10 --> en:white substance
    n1=lissencéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4623. lobe pariétal --- r_associated #0: 10 --> en:white substance
    n1=lobe pariétal | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4624. maladie du système nerveux périphérique --- r_associated #0: 10 --> en:white substance
    n1=maladie du système nerveux périphérique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4625. malaise vagal --- r_associated #0: 10 --> en:white substance
    n1=malaise vagal | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4626. malformation artérioveineuse intracrânienne --- r_associated #0: 10 --> en:white substance
    n1=malformation artérioveineuse intracrânienne | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4627. manque de sommeil --- r_associated #0: 10 --> en:white substance
    n1=manque de sommeil | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4628. matière grise --- r_associated #0: 10 --> en:white substance
    n1=matière grise | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4629. migraine avec aura --- r_associated #0: 10 --> en:white substance
    n1=migraine avec aura | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4630. myopathie --- r_associated #0: 10 --> en:white substance
    n1=myopathie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4631. myotonia --- r_associated #0: 10 --> en:white substance
    n1=myotonia | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4632. myéloméningocèle --- r_associated #0: 10 --> en:white substance
    n1=myéloméningocèle | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4633. méningiome --- r_associated #0: 10 --> en:white substance
    n1=méningiome | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4634. neurilemme --- r_associated #0: 10 --> en:white substance
    n1=neurilemme | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4635. neurolemme --- r_associated #0: 10 --> en:white substance
    n1=neurolemme | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4636. névralgie du trijumeau --- r_associated #0: 10 --> en:white substance
    n1=névralgie du trijumeau | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4637. névralgie essentielle du trijumeau --- r_associated #0: 10 --> en:white substance
    n1=névralgie essentielle du trijumeau | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4638. névralgie faciale --- r_associated #0: 10 --> en:white substance
    n1=névralgie faciale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4639. névralgie trigéminale --- r_associated #0: 10 --> en:white substance
    n1=névralgie trigéminale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4640. névraxe --- r_associated #0: 10 --> en:white substance
    n1=névraxe | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4641. névrose --- r_associated #0: 10 --> en:white substance
    n1=névrose | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4642. oedème cytotoxique cortical --- r_associated #0: 10 --> en:white substance
    n1=oedème cytotoxique cortical | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4643. opsoclonus --- r_associated #0: 10 --> en:white substance
    n1=opsoclonus | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4644. paralysie générale --- r_associated #0: 10 --> en:white substance
    n1=paralysie générale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4645. parkinsonisme --- r_associated #0: 10 --> en:white substance
    n1=parkinsonisme | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4646. parésie --- r_associated #0: 10 --> en:white substance
    n1=parésie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4647. parésie faciale --- r_associated #0: 10 --> en:white substance
    n1=parésie faciale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4648. polyneuropathie --- r_associated #0: 10 --> en:white substance
    n1=polyneuropathie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4649. pseudo-tumeur --- r_associated #0: 10 --> en:white substance
    n1=pseudo-tumeur | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4650. réaction schizophrène --- r_associated #0: 10 --> en:white substance
    n1=réaction schizophrène | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4651. schizencéphalie --- r_associated #0: 10 --> en:white substance
    n1=schizencéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4652. spina bifida --- r_associated #0: 10 --> en:white substance
    n1=spina bifida | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4653. spina bifida occulta --- r_associated #0: 10 --> en:white substance
    n1=spina bifida occulta | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4654. surdité --- r_associated #0: 10 --> en:white substance
    n1=surdité | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4655. syndrome de la selle turcique vide --- r_associated #0: 10 --> en:white substance
    n1=syndrome de la selle turcique vide | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4656. système immunitaire --- r_associated #0: 10 --> en:white substance
    n1=système immunitaire | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4657. thrombose d'un sinus sagittal --- r_associated #0: 10 --> en:white substance
    n1=thrombose d'un sinus sagittal | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4658. thrombose de l'artère cérébrale --- r_associated #0: 10 --> en:white substance
    n1=thrombose de l'artère cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4659. thrombose de sinus sagittaux --- r_associated #0: 10 --> en:white substance
    n1=thrombose de sinus sagittaux | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4660. thrombose des sinus sagittaux --- r_associated #0: 10 --> en:white substance
    n1=thrombose des sinus sagittaux | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4661. thrombose du sinus sagittal --- r_associated #0: 10 --> en:white substance
    n1=thrombose du sinus sagittal | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4662. tic douloureux --- r_associated #0: 10 --> en:white substance
    n1=tic douloureux | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4663. tic douloureux de la face --- r_associated #0: 10 --> en:white substance
    n1=tic douloureux de la face | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4664. torticolis --- r_associated #0: 10 --> en:white substance
    n1=torticolis | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4665. trouble déficitaire de l'attention --- r_associated #0: 10 --> en:white substance
    n1=trouble déficitaire de l'attention | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4666. tumeur du système nerveux central --- r_associated #0: 10 --> en:white substance
    n1=tumeur du système nerveux central | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4667. tétanie --- r_associated #0: 10 --> en:white substance
    n1=tétanie | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4668. ventriculomégalie cérébrale --- r_associated #0: 10 --> en:white substance
    n1=ventriculomégalie cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4669. état de mal épileptique --- r_associated #0: 10 --> en:white substance
    n1=état de mal épileptique | n2=en:white substance | rel=r_associated | relid=0 | w=10
  4670. Effet cytopathique --- r_associated #0: 5 --> en:white substance
    n1=Effet cytopathique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4671. Substance grise --- r_associated #0: 5 --> en:white substance
    n1=Substance grise | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4672. Système Nerveux Central --- r_associated #0: 5 --> en:white substance
    n1=Système Nerveux Central | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4673. Système nerveux central --- r_associated #0: 5 --> en:white substance
    n1=Système nerveux central | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4674. Tronc cérébral --- r_associated #0: 5 --> en:white substance
    n1=Tronc cérébral | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4675. abcès cérébral --- r_associated #0: 5 --> en:white substance
    n1=abcès cérébral | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4676. accident cérébrovasculaire --- r_associated #0: 5 --> en:white substance
    n1=accident cérébrovasculaire | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4677. accident vasculaire cérébral --- r_associated #0: 5 --> en:white substance
    n1=accident vasculaire cérébral | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4678. accès fébriles --- r_associated #0: 5 --> en:white substance
    n1=accès fébriles | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4679. affection nerveuse périphérique --- r_associated #0: 5 --> en:white substance
    n1=affection nerveuse périphérique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4680. altération de la conscience --- r_associated #0: 5 --> en:white substance
    n1=altération de la conscience | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4681. altération mentale --- r_associated #0: 5 --> en:white substance
    n1=altération mentale | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4682. astrocyte --- r_associated #0: 5 --> en:white substance
    n1=astrocyte | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4683. atteinte extrapyramidale --- r_associated #0: 5 --> en:white substance
    n1=atteinte extrapyramidale | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4684. blindness --- r_associated #0: 5 --> en:white substance
    n1=blindness | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4685. contraction clonique --- r_associated #0: 5 --> en:white substance
    n1=contraction clonique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4686. cordon médullaire --- r_associated #0: 5 --> en:white substance
    n1=cordon médullaire | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4687. coupant avec des ciseaux --- r_associated #0: 5 --> en:white substance
    n1=coupant avec des ciseaux | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4688. dysphagia --- r_associated #0: 5 --> en:white substance
    n1=dysphagia | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4689. décalage de la tête --- r_associated #0: 5 --> en:white substance
    n1=décalage de la tête | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4690. défaut articulatoire --- r_associated #0: 5 --> en:white substance
    n1=défaut articulatoire | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4691. déficit du développement psychomoteur --- r_associated #0: 5 --> en:white substance
    n1=déficit du développement psychomoteur | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4692. dégénérescence cytopathique --- r_associated #0: 5 --> en:white substance
    n1=dégénérescence cytopathique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4693. dégénérescence des ganglions de la base --- r_associated #0: 5 --> en:white substance
    n1=dégénérescence des ganglions de la base | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4694. dégénérescence spongieuse --- r_associated #0: 5 --> en:white substance
    n1=dégénérescence spongieuse | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4695. détérioration intellectuelle --- r_associated #0: 5 --> en:white substance
    n1=détérioration intellectuelle | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4696. effet cytopathique --- r_associated #0: 5 --> en:white substance
    n1=effet cytopathique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4697. en:brains --- r_associated #0: 5 --> en:white substance
    n1=en:brains | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4698. en:brainstem --- r_associated #0: 5 --> en:white substance
    n1=en:brainstem | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4699. en:eye and related structures --- r_associated #0: 5 --> en:white substance
    n1=en:eye and related structures | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4700. en:meninx --- r_associated #0: 5 --> en:white substance
    n1=en:meninx | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4701. en:muscle twitch --- r_associated #0: 5 --> en:white substance
    n1=en:muscle twitch | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4702. en:peripheral neuropathy --- r_associated #0: 5 --> en:white substance
    n1=en:peripheral neuropathy | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4703. en:twitching --- r_associated #0: 5 --> en:white substance
    n1=en:twitching | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4704. faiblesse musculaire du visage --- r_associated #0: 5 --> en:white substance
    n1=faiblesse musculaire du visage | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4705. fasciculation d'un muscle squelettique --- r_associated #0: 5 --> en:white substance
    n1=fasciculation d'un muscle squelettique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4706. hydrocéphalie --- r_associated #0: 5 --> en:white substance
    n1=hydrocéphalie | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4707. hypotonie du nouveau-né --- r_associated #0: 5 --> en:white substance
    n1=hypotonie du nouveau-né | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4708. intelligence moyenne --- r_associated #0: 5 --> en:white substance
    n1=intelligence moyenne | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4709. leuco-encéphalopathie --- r_associated #0: 5 --> en:white substance
    n1=leuco-encéphalopathie | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4710. leucoencéphalopathie --- r_associated #0: 5 --> en:white substance
    n1=leucoencéphalopathie | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4711. malformation artérioveineuse cérébrale --- r_associated #0: 5 --> en:white substance
    n1=malformation artérioveineuse cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4712. myatrophie --- r_associated #0: 5 --> en:white substance
    n1=myatrophie | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4713. méningiome angiomateux --- r_associated #0: 5 --> en:white substance
    n1=méningiome angiomateux | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4714. neuropathie périphérique --- r_associated #0: 5 --> en:white substance
    n1=neuropathie périphérique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4715. paralysie cérébrale --- r_associated #0: 5 --> en:white substance
    n1=paralysie cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4716. poliomyélite aiguë --- r_associated #0: 5 --> en:white substance
    n1=poliomyélite aiguë | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4717. pseudotumeur --- r_associated #0: 5 --> en:white substance
    n1=pseudotumeur | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4718. quotient intellectuel moyen --- r_associated #0: 5 --> en:white substance
    n1=quotient intellectuel moyen | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4719. retardation mentale --- r_associated #0: 5 --> en:white substance
    n1=retardation mentale | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4720. réaction schizoïde --- r_associated #0: 5 --> en:white substance
    n1=réaction schizoïde | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4721. secousse musculaire --- r_associated #0: 5 --> en:white substance
    n1=secousse musculaire | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4722. sommeil paradoxal (REM) anormal --- r_associated #0: 5 --> en:white substance
    n1=sommeil paradoxal (REM) anormal | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4723. syndrome de Reye --- r_associated #0: 5 --> en:white substance
    n1=syndrome de Reye | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4724. thrombose artérielle cérébrale --- r_associated #0: 5 --> en:white substance
    n1=thrombose artérielle cérébrale | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4725. trouble extrapyramidal --- r_associated #0: 5 --> en:white substance
    n1=trouble extrapyramidal | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4726. trouble nerveux périphérique --- r_associated #0: 5 --> en:white substance
    n1=trouble nerveux périphérique | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4727. écholalie --- r_associated #0: 5 --> en:white substance
    n1=écholalie | n2=en:white substance | rel=r_associated | relid=0 | w=5
  4728. évolution chronique-progressive avec épisodes de détérioration rapide après fièvre ou traumatisme crânien --- r_associated #0: 5 --> en:white substance
    n1=évolution chronique-progressive avec épisodes de détérioration rapide après fièvre ou traumatisme crânien | n2=en:white substance | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr